data_6y96_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6y96 _Structure_validation_residue.Date_analyzed 2020-07-24 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.42 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 5.0 tp60 . . . . . 0 C--O 1.236 0.378 0 CA-C-O 121.263 0.554 . . . . 1.88 111.382 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -79.0 114.04 17.61 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.393 -0.595 . . . . 2.59 109.393 172.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -99.9 156.39 17.16 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.851 -0.613 . . . . 1.84 110.4 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -125.93 128.74 48.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.858 0.361 . . . . 1.99 110.449 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.91 179.45 9.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.514 -0.766 . . . . 0.96 109.477 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.25 143.45 32.95 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.672 -0.492 . . . . 0.86 109.672 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.516 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 41.3 t -63.54 119.4 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.265 0.555 . . . . 1.01 110.074 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.96 -44.68 30.36 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.987 -1.006 . . . . 0.6 109.526 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.0 m -161.17 164.56 30.45 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.613 -0.721 . . . . 1.18 110.251 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.8 mt -141.63 130.38 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.056 0.455 . . . . 1.03 109.987 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -125.43 104.05 8.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.479 -0.782 . . . . 2.16 110.469 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.07 -108.52 1.94 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.028 -0.606 . . . . 0.34 112.515 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -100.54 10.58 41.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.455 0.169 . . . . 2.6 110.693 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -128.89 140.63 51.59 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.163 0.506 . . . . 0.38 111.003 -173.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.483 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.88 157.36 17.42 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 120.638 -0.791 . . . . 0.11 111.433 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 77.0 m-85 -132.22 137.58 47.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.161 -0.681 . . . . 0.19 109.161 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.479 HD11 ' CD2' ' A' ' 73' ' ' PHE . 7.1 mt -110.13 154.65 23.01 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.714 -0.476 . . . . 1.28 109.714 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -74.76 73.09 2.05 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.587 0.708 . . . . 1.77 109.558 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -148.02 97.57 2.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.832 -1.076 . . . . 0.33 108.678 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 23.9 mp0 -85.65 110.01 18.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.723 -0.671 . . . . 1.81 109.966 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 84' ' ' SER . 28.8 m -78.73 -36.4 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 1.51 112.024 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -156.42 123.16 5.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.511 -0.313 . . . . 2.24 110.488 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.2 t70 60.97 12.92 4.19 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.641 0.734 . . . . 1.55 111.966 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.0 21.08 14.43 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.635 -0.793 . . . . 0.77 112.979 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 4.0 mmtm -69.41 110.93 4.96 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.874 -0.417 . . . . 3.03 109.874 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -71.72 129.61 39.11 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.669 -0.493 . . . . 1.87 109.669 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.1 mt -66.66 123.3 19.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.594 -0.276 . . . . 1.05 110.97 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -105.28 158.3 16.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.045 0.45 . . . . 0.48 110.661 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.483 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 32.3 p90 -151.44 155.22 38.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.682 -0.69 . . . . 0.2 109.163 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -97.08 152.04 19.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.994 -0.743 . . . . 0.47 108.994 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.54 ' SD ' HG22 ' A' ' 58' ' ' VAL . 14.2 mmt -64.51 -3.06 2.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.431 0.53 . . . . 2.84 112.431 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.8 t -82.76 -25.31 32.94 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.851 -0.426 . . . . 1.41 109.851 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.84 -6.17 59.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.922 0.391 . . . . 1.96 110.421 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.54 HG22 ' SD ' ' A' ' 55' ' ' MET . 2.0 t -71.6 152.38 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.69 -0.686 . . . . 1.06 112.45 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.78 98.33 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.483 -1.235 . . . . 1.85 112.041 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.87 -84.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.0 -0.545 . . . . 0.62 113.602 172.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -106.68 142.31 36.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.758 0.313 . . . . 2.3 110.179 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.7 p -67.7 -21.37 65.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.271 0.558 . . . . 1.45 111.503 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.6 t -95.01 2.19 9.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.285 0.564 . . . . 1.95 110.428 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.63 -13.8 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.443 -0.344 . . . . 1.21 111.297 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.475 HD13 HG11 ' A' ' 71' ' ' VAL . 1.1 tm? -110.65 124.69 52.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.976 -0.75 . . . . 2.19 108.976 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -117.92 150.19 46.76 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.559 -0.291 . . . . 1.12 111.121 -172.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.516 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.2 Cg_endo -66.49 135.76 40.49 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.443 2.095 . . . . 0.28 111.933 173.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.53 -2.36 73.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.916 -0.659 . . . . 0.23 112.367 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -95.91 154.7 17.09 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.804 -0.443 . . . . 1.28 109.804 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 m -79.72 136.03 36.67 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.466 -0.568 . . . . 1.05 109.466 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.475 HG11 HD13 ' A' ' 65' ' ' LEU . 20.0 m -136.48 161.3 37.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.432 0.634 . . . . 1.16 110.805 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.45 139.0 49.88 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.837 -1.172 . . . . 0.78 107.837 171.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CD2' HD11 ' A' ' 41' ' ' LEU . 19.2 p90 -148.53 179.82 7.52 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.824 0.345 . . . . 0.15 110.193 -174.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.8 m -129.85 115.01 16.61 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.088 -0.708 . . . . 1.3 109.088 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.4 p -85.37 101.93 10.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.538 0.685 . . . . 1.11 110.834 -175.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.63 121.58 59.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.757 -0.656 . . . . 1.13 109.87 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.8 m -79.62 128.34 33.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.861 -0.608 . . . . 1.27 111.068 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -68.48 102.32 1.42 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.516 -0.765 . . . . 1.96 109.218 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -64.23 -8.03 11.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.217 0.532 . . . . 2.24 111.413 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -93.73 -39.34 10.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.883 -0.599 . . . . 4.49 111.044 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -114.28 -21.25 10.53 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.554 0.575 . . . . 2.66 112.554 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.7 -20.18 51.66 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.764 -0.731 . . . . 0.88 113.36 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -81.78 174.6 11.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.005 -0.739 . . . . 2.9 109.005 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.448 ' HB2' HG12 ' A' ' 45' ' ' VAL . 19.1 m -128.81 175.68 8.43 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.284 -0.566 . . . . 1.49 110.632 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.2 p -145.91 155.97 43.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.274 -0.421 . . . . 1.31 110.433 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.467 ' HB2' ' HB2' ' A' ' 73' ' ' PHE . . . -93.2 118.31 31.09 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.118 0.485 . . . . 1.05 110.24 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 97.3 m -116.74 144.05 44.91 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.132 -0.692 . . . . 1.17 109.132 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 63.68 69.01 0.56 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.084 -0.71 . . . . 2.17 109.084 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 71.0 t -87.94 116.66 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.406 -0.815 . . . . 1.06 110.722 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.35 149.03 30.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.903 -0.589 . . . . 1.77 110.705 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -77.91 126.42 30.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.139 -0.482 . . . . 2.02 109.891 176.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.0 mm . . . . . 0 C--N 1.323 -0.574 0 N-CA-C 110.072 -0.344 . . . . 1.05 110.072 179.121 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 . . . . . 0 C--O 1.234 0.256 0 CA-C-O 121.047 0.451 . . . . 1.88 110.906 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -99.37 115.4 29.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 2.59 110.172 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 28.2 mmtp -99.03 151.35 21.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.893 -0.594 . . . . 1.84 111.859 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.414 ' HD3' ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -115.02 127.15 55.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.73 -0.668 . . . . 1.99 110.264 176.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.25 178.94 9.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.269 -0.271 . . . . 0.96 110.269 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.07 148.02 26.73 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.442 -0.345 . . . . 0.86 110.098 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.483 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 45.5 t -68.77 122.14 19.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.978 0.418 . . . . 1.01 110.624 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -75.07 -40.79 59.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.313 -0.858 . . . . 0.6 110.053 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 t -171.65 169.41 6.0 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.643 -0.708 . . . . 1.18 109.113 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.2 mt -136.45 126.4 39.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.254 0.55 . . . . 1.03 109.618 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 62.6 mmtt -120.16 85.54 2.4 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.325 -0.852 . . . . 2.16 110.361 -175.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.11 -114.55 4.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.746 -0.74 . . . . 0.34 112.549 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.59 12.78 24.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.074 -0.343 . . . . 2.6 110.074 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -132.19 140.11 48.6 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.013 0.435 . . . . 0.38 110.417 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.526 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.29 159.61 16.86 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.631 -0.795 . . . . 0.11 111.215 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 77.5 m-85 -131.47 149.54 52.49 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.03 -0.73 . . . . 0.19 109.03 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.564 HD12 ' CD2' ' A' ' 73' ' ' PHE . 7.0 mt -124.14 157.6 34.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.15 -0.315 . . . . 1.28 110.15 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -76.78 73.33 3.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.509 0.671 . . . . 1.77 109.554 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.406 ' HB3' HD11 ' A' ' 51' ' ' LEU . 16.7 t80 -148.04 98.79 2.98 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.049 -0.978 . . . . 0.33 108.859 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 43.4 mt-10 -86.95 103.36 15.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.292 -0.413 . . . . 1.81 110.135 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.472 HG23 ' H ' ' A' ' 84' ' ' SER . 27.6 m -80.65 -30.34 12.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.624 0.602 . . . . 1.51 112.624 -173.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 5.2 tp10 -161.31 110.82 1.62 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 110.57 -0.159 . . . . 2.24 110.57 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.8 t0 55.23 37.88 29.57 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.294 0.569 . . . . 1.55 111.735 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.85 20.98 54.7 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.365 -0.921 . . . . 0.77 113.087 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 38.3 mmtm -74.19 110.05 8.17 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.135 -0.691 . . . . 3.03 109.135 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -72.61 126.1 29.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.644 -0.873 . . . . 1.87 108.644 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.5 mt -63.25 128.58 36.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.114 -0.494 . . . . 1.05 110.847 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -112.49 156.72 22.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.345 -0.389 . . . . 0.48 110.302 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.526 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 25.8 p90 -146.48 149.07 32.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.623 -0.717 . . . . 0.2 109.717 174.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -91.74 145.48 24.54 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.555 -0.906 . . . . 0.47 108.555 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.485 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -58.11 -11.95 3.02 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.522 0.564 . . . . 2.84 112.522 -177.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.1 t -67.39 -25.85 66.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.823 0.345 . . . . 1.41 110.454 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -86.6 -13.87 44.46 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.242 -0.435 . . . . 1.96 110.464 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -65.82 148.39 12.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.42 -0.809 . . . . 1.06 112.298 -175.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.16 102.21 0.36 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 114.748 -1.115 . . . . 1.85 111.241 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.58 -91.59 0.26 Allowed Glycine 0 C--O 1.237 0.301 0 CA-C-N 115.952 -0.567 . . . . 0.62 113.61 173.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -101.44 151.31 22.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.648 -0.501 . . . . 2.3 109.648 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.3 p -77.71 -15.36 59.19 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.928 -0.578 . . . . 1.45 111.168 -173.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.74 2.92 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.609 -0.723 . . . . 1.95 110.078 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.48 -24.65 19.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 1.21 111.335 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.506 HD13 HG11 ' A' ' 71' ' ' VAL . 1.6 tm? -98.42 125.06 43.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.155 -0.683 . . . . 2.19 109.155 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -117.41 152.96 50.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 111.93 0.344 . . . . 1.12 111.93 -171.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.483 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 52.1 Cg_endo -69.65 141.9 46.95 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.991 2.461 . . . . 0.28 111.48 173.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.54 -5.13 82.58 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.776 -0.726 . . . . 0.23 112.031 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -93.93 159.61 15.1 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.401 -0.592 . . . . 1.28 109.401 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.5 m -85.02 132.19 34.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.353 -0.61 . . . . 1.05 109.353 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.506 HG11 HD13 ' A' ' 65' ' ' LEU . 6.3 m -135.3 165.2 31.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.162 0.506 . . . . 1.16 109.984 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -120.32 146.08 46.48 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.364 -0.976 . . . . 0.78 108.364 174.227 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.564 ' CD2' HD12 ' A' ' 41' ' ' LEU . 25.3 p90 -152.57 179.19 8.81 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.682 -0.488 . . . . 0.15 109.682 -174.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.4 m -126.83 123.32 37.06 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.877 -0.786 . . . . 1.3 108.877 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 p -92.69 99.49 9.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.666 0.746 . . . . 1.11 111.642 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.7 p -111.7 123.51 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.567 -0.742 . . . . 1.13 109.994 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 30.2 m -72.88 129.02 37.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.911 0.386 . . . . 1.27 110.933 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.415 ' N ' HD21 ' A' ' 78' ' ' ASN . 0.9 OUTLIER -69.37 117.82 11.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 1.96 109.631 177.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -71.36 -15.72 62.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.156 0.503 . . . . 2.24 110.76 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -94.89 -42.28 8.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.703 -0.681 . . . . 4.49 111.095 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -94.97 -29.09 14.82 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.317 -0.401 . . . . 2.66 111.724 -171.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.52 -24.21 26.69 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.88 112.568 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -95.24 155.85 16.56 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.46 -0.57 . . . . 2.9 109.46 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 4.4 m -88.08 175.59 7.67 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.094 0.474 . . . . 1.49 111.289 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -141.32 153.08 44.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.692 -0.685 . . . . 1.31 109.376 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -90.73 119.62 31.11 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.112 0.482 . . . . 1.05 110.044 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.6 m -117.01 149.32 40.46 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.321 -0.854 . . . . 1.17 109.921 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 t30 56.87 69.26 0.76 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 123.593 0.558 . . . . 2.17 110.62 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 74.5 t -85.88 122.75 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 1.06 111.708 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.94 147.57 35.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.517 -0.765 . . . . 1.77 110.209 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.455 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -79.4 117.0 19.98 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.942 -0.762 . . . . 2.02 108.942 175.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.7 mm . . . . . 0 C--N 1.315 -0.919 0 CA-C-O 121.116 0.484 . . . . 1.05 110.216 -178.185 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.694 0.283 . . . . 1.88 111.087 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -118.37 136.89 53.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.28 0.562 . . . . 2.59 111.308 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -112.75 150.71 31.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.232 -0.894 . . . . 1.84 110.561 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -120.46 127.17 51.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.907 0.385 . . . . 1.99 110.408 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.97 179.87 8.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.802 -0.635 . . . . 0.96 109.529 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 144.52 30.64 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 110.194 -0.299 . . . . 0.86 110.194 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 47.5 t -66.32 114.0 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.2 -0.296 . . . . 1.01 110.2 176.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 7.1 t70 -66.95 -50.21 63.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.955 -0.566 . . . . 0.6 109.861 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.9 m -159.79 163.81 34.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.468 -0.787 . . . . 1.18 110.016 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.412 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 7.7 mt -137.47 126.1 33.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.456 -0.572 . . . . 1.03 109.456 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -118.77 90.45 3.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.256 -0.884 . . . . 2.16 109.862 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.37 -112.1 4.14 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.721 -0.752 . . . . 0.34 112.476 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -96.84 11.69 34.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 2.6 110.246 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -129.71 142.04 50.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.143 0.497 . . . . 0.38 110.751 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.92 155.95 17.27 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.379 -0.828 . . . . 0.11 111.378 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.545 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 70.7 m-85 -129.82 139.75 51.17 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.826 -0.805 . . . . 0.19 108.826 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.547 HD11 ' CD2' ' A' ' 73' ' ' PHE . 7.4 mt -111.58 156.7 21.37 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.784 -0.45 . . . . 1.28 109.784 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.62 73.25 1.99 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.966 -0.753 . . . . 1.77 108.966 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -149.57 98.43 2.76 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.624 -0.717 . . . . 0.33 109.289 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 23.0 mp0 -75.73 100.71 4.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 1.81 109.712 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.592 ' CG1' ' HG ' ' A' ' 51' ' ' LEU . 35.3 m -74.39 -30.39 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.713 -0.676 . . . . 1.51 111.519 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -156.73 109.79 2.59 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 116.092 -0.504 . . . . 2.24 110.354 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t0 54.52 29.6 11.55 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.185 0.517 . . . . 1.55 112.286 171.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.11 1.49 44.97 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.161 -1.018 . . . . 0.77 113.151 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 4.0 mmtp -64.64 111.77 2.89 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.862 0.331 . . . . 3.03 110.61 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -65.78 138.89 58.23 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.271 0.357 . . . . 1.87 110.181 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.592 ' HG ' ' CG1' ' A' ' 45' ' ' VAL . 1.3 mt -74.68 125.22 28.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.45 -0.341 . . . . 1.05 110.348 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -106.87 157.22 17.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.48 110.064 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.506 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 28.1 p90 -151.05 157.06 42.33 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.596 -0.729 . . . . 0.2 109.394 174.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -98.92 151.01 21.34 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.111 -0.7 . . . . 0.47 109.111 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.467 ' SD ' HG22 ' A' ' 58' ' ' VAL . 9.4 mmt -62.39 -6.94 3.69 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.797 0.665 . . . . 2.84 112.797 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -81.23 -25.28 36.77 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.241 -0.184 . . . . 1.41 111.068 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -81.77 -15.69 53.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.032 0.444 . . . . 1.96 110.157 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.467 HG22 ' SD ' ' A' ' 55' ' ' MET . 2.8 t -62.56 151.84 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.212 -0.904 . . . . 1.06 112.188 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -64.63 88.96 0.06 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.005 -0.998 . . . . 1.85 112.38 -173.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.37 -66.47 2.28 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.974 -0.557 . . . . 0.62 113.337 170.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -122.31 143.7 49.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.296 0.57 . . . . 2.3 110.264 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.7 p -72.3 -26.64 62.03 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.119 -0.946 . . . . 1.45 110.926 -174.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -95.67 22.99 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.753 0.787 . . . . 1.95 109.633 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.9 -15.68 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.598 -0.728 . . . . 1.21 109.765 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.49 124.74 47.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.889 -1.05 . . . . 2.19 109.603 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -122.99 153.63 64.21 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.682 -0.235 . . . . 1.12 111.235 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 41.4 Cg_endo -68.47 129.06 18.27 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.523 2.149 . . . . 0.28 111.972 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.58 -14.04 56.51 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.918 -0.583 . . . . 0.23 111.84 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.16 154.14 25.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 1.28 110.323 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m -78.71 141.88 37.54 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.298 -0.63 . . . . 1.05 109.298 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.87 161.41 26.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.654 0.74 . . . . 1.16 111.761 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.33 137.51 51.71 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.447 -1.251 . . . . 0.78 108.096 172.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.547 ' CD2' HD11 ' A' ' 41' ' ' LEU . 30.8 p90 -149.48 178.55 8.71 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.29 -0.633 . . . . 0.15 109.29 -174.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 m -124.29 132.33 53.56 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.09 -0.707 . . . . 1.3 109.09 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.02 99.14 8.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.504 0.668 . . . . 1.11 110.978 -175.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.46 116.95 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.47 0.653 . . . . 1.13 110.719 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.9 m -69.98 125.96 28.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.703 -0.681 . . . . 1.27 110.483 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.96 114.44 5.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 1.96 109.326 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -58.59 -31.24 67.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.41 -0.359 . . . . 2.24 111.357 -175.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.42 -36.79 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.341 -0.391 . . . . 4.49 111.42 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -92.83 -23.36 18.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.054 0.39 . . . . 2.66 112.054 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.58 -24.57 7.32 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.028 -0.606 . . . . 0.88 113.484 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -88.44 149.94 23.41 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.812 -0.44 . . . . 2.9 109.812 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.434 ' HB3' HG13 ' A' ' 45' ' ' VAL . 42.7 t -85.32 177.59 7.77 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.794 0.331 . . . . 1.49 110.709 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.4 m -150.74 149.96 30.43 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.286 -0.635 . . . . 1.31 109.286 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.94 121.51 33.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.025 0.441 . . . . 1.05 110.614 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.0 m -117.49 144.39 45.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.028 -0.533 . . . . 1.17 109.909 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 57.71 73.11 0.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.743 0.652 . . . . 2.17 110.31 -175.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 94.0 t -92.05 105.01 16.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.568 -0.742 . . . . 1.06 110.308 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.492 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 11.1 mp -105.89 149.08 26.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.594 -0.73 . . . . 1.77 110.735 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.18 103.25 14.64 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.907 -0.588 . . . . 2.02 110.795 -174.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.6 mm . . . . . 0 C--N 1.32 -0.702 0 CA-C-N 115.585 -0.734 . . . . 1.05 110.235 -179.614 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 120.993 0.425 . . . . 1.88 110.775 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -109.61 123.72 49.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.02 -0.537 . . . . 2.59 110.558 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -109.08 153.02 24.26 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.625 -0.716 . . . . 1.84 110.687 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -122.85 128.34 50.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.738 0.304 . . . . 1.99 110.303 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.73 179.7 8.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.641 -0.709 . . . . 0.96 109.095 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.74 145.38 29.21 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.761 -0.459 . . . . 0.86 109.761 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.487 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 41.9 t -64.85 114.37 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.159 0.504 . . . . 1.01 109.977 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.466 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 9.9 t70 -67.86 -45.28 75.02 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.858 -1.065 . . . . 0.6 109.747 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.7 m -169.05 166.5 10.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.514 -0.766 . . . . 1.18 109.868 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 mt -137.96 128.48 36.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.944 -0.391 . . . . 1.03 109.944 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -115.22 88.02 2.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.686 -0.688 . . . . 2.16 109.856 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.03 -106.99 1.88 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.733 -0.746 . . . . 0.34 112.816 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -96.35 5.34 51.12 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.58 0.228 . . . . 2.6 111.178 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -125.75 140.38 52.74 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.002 0.43 . . . . 0.38 110.368 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.54 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.17 158.28 16.86 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.51 -0.852 . . . . 0.11 111.323 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -132.08 141.12 49.08 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.867 -0.79 . . . . 0.19 108.867 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.537 HD13 ' CD2' ' A' ' 73' ' ' PHE . 4.8 mt -115.09 150.75 35.47 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.427 -0.953 . . . . 1.28 108.427 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -75.21 72.97 2.32 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.272 0.558 . . . . 1.77 109.64 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -142.61 98.07 3.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.156 -0.929 . . . . 0.33 108.57 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 15.4 mp0 -90.23 107.62 19.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.039 -0.528 . . . . 1.81 109.791 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.41 HG11 ' HB2' ' A' ' 84' ' ' SER . 29.2 m -74.62 -32.69 30.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.622 -0.717 . . . . 1.51 111.851 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -156.45 114.06 3.23 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.532 -0.304 . . . . 2.24 110.572 -174.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 51.8 34.06 12.46 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.387 0.884 . . . . 1.55 113.387 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.97 20.34 43.43 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.233 -0.984 . . . . 0.77 112.725 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -79.98 109.16 14.15 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.033 -0.728 . . . . 3.03 109.033 176.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -71.63 138.81 48.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.636 -0.711 . . . . 1.87 110.726 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 51' ' ' LEU . 4.5 mt -74.89 122.65 23.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.477 -0.329 . . . . 1.05 111.222 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -107.37 161.29 14.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.427 -0.351 . . . . 0.48 110.07 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.545 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 17.1 p90 -152.69 158.77 42.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.132 -0.485 . . . . 0.2 109.741 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -99.97 156.05 17.36 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.718 -0.845 . . . . 0.47 108.718 176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.46 ' SD ' HG22 ' A' ' 58' ' ' VAL . 13.2 mmt -65.03 3.18 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.257 0.465 . . . . 2.84 112.257 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.3 t -87.39 -28.01 22.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 1.41 110.127 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -84.53 -11.01 56.91 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.236 -0.438 . . . . 1.96 110.188 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.465 HG21 HD23 ' A' ' 65' ' ' LEU . 2.4 t -68.38 150.3 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.463 -0.789 . . . . 1.06 111.649 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -58.23 88.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.045 -0.979 . . . . 1.85 111.736 -177.218 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.11 -91.2 0.03 OUTLIER Glycine 0 CA--C 1.52 0.403 0 O-C-N 123.501 0.501 . . . . 0.62 113.199 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -79.27 129.93 34.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.482 0.658 . . . . 2.3 110.587 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.5 p -80.44 -10.3 59.75 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.062 -0.972 . . . . 1.45 110.963 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.54 -11.12 10.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.529 -0.76 . . . . 1.95 110.234 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.5 -19.11 31.69 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.939 0.4 . . . . 1.21 111.693 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.465 HD23 HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -105.91 124.29 49.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.595 -0.52 . . . . 2.19 109.595 -177.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -123.35 156.21 64.06 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.583 0.23 . . . . 1.12 111.058 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.475 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 47.4 Cg_endo -69.23 129.09 17.51 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.425 2.084 . . . . 0.28 111.477 174.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.487 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 102.5 -13.02 56.85 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.674 -0.775 . . . . 0.23 112.114 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -82.02 152.57 26.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.275 -0.269 . . . . 1.28 110.275 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -76.5 137.81 39.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.051 -0.722 . . . . 1.05 109.051 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -139.13 163.71 26.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.902 0.382 . . . . 1.16 111.216 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 3.4 pt-20 -114.02 150.56 33.72 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.294 -1.372 . . . . 0.78 107.294 170.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.537 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.3 p90 -156.97 179.85 8.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.192 -0.67 . . . . 0.15 109.192 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.7 m -129.88 113.89 15.21 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.828 -0.805 . . . . 1.3 108.828 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 75' ' ' VAL . 7.1 p -86.31 97.76 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 122.019 0.914 . . . . 1.11 110.488 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -105.68 117.13 50.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.174 -0.921 . . . . 1.13 109.315 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.8 m -73.65 126.53 30.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.333 0.587 . . . . 1.27 110.786 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -69.78 113.76 7.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.0 -1.0 . . . . 1.96 110.001 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -65.52 -16.8 64.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.314 0.578 . . . . 2.24 110.402 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -91.07 -38.19 12.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.58 -0.736 . . . . 4.49 111.584 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -103.44 -26.61 12.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.119 0.414 . . . . 2.66 112.119 -171.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.82 -23.21 24.43 Favored Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 121.053 -0.594 . . . . 0.88 112.013 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -91.28 174.74 7.23 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.27 -0.641 . . . . 2.9 109.27 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.41 ' HB2' HG11 ' A' ' 45' ' ' VAL . 19.0 m -114.28 179.92 3.82 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.741 -0.384 . . . . 1.49 110.643 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.8 m -147.19 147.01 30.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.7 -0.682 . . . . 1.31 109.338 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . . . -86.33 117.38 25.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.171 0.51 . . . . 1.05 110.53 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.4 m -116.25 150.04 38.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.579 -0.737 . . . . 1.17 109.407 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.526 ' ND2' HD13 ' A' ' 90' ' ' LEU . 0.2 OUTLIER 61.91 59.17 1.77 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.16 -0.681 . . . . 2.17 109.16 -178.002 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 90.1 t -85.05 101.49 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.854 -0.612 . . . . 1.06 110.147 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.526 HD13 ' ND2' ' A' ' 88' ' ' ASN . 3.2 mp -106.21 145.99 30.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.242 0.544 . . . . 1.77 111.517 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.84 117.46 17.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.548 -0.751 . . . . 2.02 110.807 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mm . . . . . 0 C--N 1.317 -0.817 0 CA-C-N 115.719 -0.673 . . . . 1.05 111.114 -175.907 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.5 tp60 . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 120.586 0.231 . . . . 1.88 110.664 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.34 112.59 20.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.015 0.436 . . . . 2.59 110.426 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -96.05 160.64 14.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.592 . . . . 1.84 111.041 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.499 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 71.6 mtm-85 -132.31 127.86 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.033 0.444 . . . . 1.99 111.348 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.72 179.92 8.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.593 -0.73 . . . . 0.96 109.359 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.44 145.07 30.55 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 110.01 -0.367 . . . . 0.86 110.01 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.53 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 47.5 t -65.79 120.41 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 120.923 0.392 . . . . 1.01 109.958 176.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.56 -44.14 68.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.308 -0.86 . . . . 0.6 109.574 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.2 m -173.48 169.25 4.41 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.438 -0.801 . . . . 1.18 109.87 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.7 mt -136.69 135.2 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.945 0.402 . . . . 1.03 110.2 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -123.91 97.38 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.555 -0.748 . . . . 2.16 110.17 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.7 -107.1 1.78 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.819 -0.705 . . . . 0.34 112.405 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -98.67 4.07 47.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.568 0.223 . . . . 2.6 110.771 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -123.71 141.14 52.3 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 120.468 -0.493 . . . . 0.38 111.16 -171.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.41 156.08 18.39 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 120.579 -0.82 . . . . 0.11 111.319 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 74.3 m-85 -130.16 141.47 50.67 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.179 -0.675 . . . . 0.19 109.179 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.503 HD11 ' CD2' ' A' ' 73' ' ' PHE . 5.5 mt -112.09 156.17 22.67 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.739 -0.467 . . . . 1.28 109.739 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -78.26 72.83 4.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.566 0.698 . . . . 1.77 109.677 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.446 ' HB3' HD13 ' A' ' 51' ' ' LEU . 25.2 t80 -142.59 98.57 3.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.797 -1.092 . . . . 0.33 108.186 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 41.8 mt-10 -93.16 104.34 16.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.35 0.595 . . . . 1.81 110.928 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.2 m -72.74 -34.13 46.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.407 -0.815 . . . . 1.51 111.529 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 5.6 tt0 -155.05 118.34 4.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.631 -0.259 . . . . 2.24 110.756 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.9 t70 56.11 29.48 14.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.524 0.678 . . . . 1.55 112.162 167.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.403 ' HA2' ' CD ' ' A' ' 44' ' ' GLU . . . 88.5 24.5 33.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.149 -1.024 . . . . 0.77 112.873 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 12.5 mmtm -71.71 109.81 5.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.917 -0.771 . . . . 3.03 108.917 172.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -77.97 121.53 24.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.24 -0.436 . . . . 1.87 109.97 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 43' ' ' PHE . 2.5 mt -58.83 123.93 18.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.945 -0.571 . . . . 1.05 110.912 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -106.12 157.46 17.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.93 0.395 . . . . 0.48 110.701 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.441 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 35.7 p90 -151.2 153.79 35.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.718 -0.674 . . . . 0.2 109.277 173.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -95.3 150.66 20.01 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.441 -0.948 . . . . 0.47 108.441 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.7 mtt -64.66 2.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.317 0.488 . . . . 2.84 112.317 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 t -83.71 -27.09 29.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.897 -0.408 . . . . 1.41 109.897 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.32 -8.03 58.69 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.979 0.419 . . . . 1.96 110.203 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.63 152.21 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.354 -0.839 . . . . 1.06 112.709 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 12.9 tm0? -66.62 95.15 0.32 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.166 -0.924 . . . . 1.85 112.299 -175.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.87 -81.43 0.54 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.939 -0.573 . . . . 0.62 113.461 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -107.7 148.2 29.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.896 0.379 . . . . 2.3 110.294 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.8 p -67.48 -24.77 65.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.869 -0.605 . . . . 1.45 110.832 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.5 t -93.18 3.42 8.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.787 -0.642 . . . . 1.95 110.637 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.79 -24.07 23.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.018 0.437 . . . . 1.21 110.709 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.57 HD22 ' HG2' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -105.67 124.74 50.05 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.842 -0.799 . . . . 2.19 108.842 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -119.99 149.78 49.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.668 -0.242 . . . . 1.12 110.892 -173.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.432 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 36.9 Cg_endo -67.34 122.0 9.2 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.33 2.02 . . . . 0.28 111.358 172.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.53 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 102.58 -11.42 56.5 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.779 -0.724 . . . . 0.23 112.203 -176.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.5 155.28 22.24 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.912 -0.403 . . . . 1.28 109.912 175.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.4 m -78.77 141.72 37.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.218 -0.66 . . . . 1.05 109.218 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.509 HG12 HD13 ' A' ' 65' ' ' LEU . 6.2 m -136.92 165.7 27.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.842 0.83 . . . . 1.16 111.251 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -121.51 144.05 48.92 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.216 -1.356 . . . . 0.78 107.988 171.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 41' ' ' LEU . 23.0 p90 -154.04 178.99 9.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.868 -0.419 . . . . 0.15 109.868 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.1 m -127.43 118.15 23.51 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.883 -0.784 . . . . 1.3 108.883 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.438 HG11 ' O ' ' A' ' 75' ' ' VAL . 7.3 p -82.95 98.97 5.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 122.072 0.939 . . . . 1.11 110.777 -175.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.9 122.86 64.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.152 -0.931 . . . . 1.13 109.863 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.4 m -76.53 130.34 37.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.987 -0.552 . . . . 1.27 111.022 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -73.98 106.55 5.72 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.994 -0.743 . . . . 1.96 108.994 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -64.65 -15.39 61.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.639 0.256 . . . . 2.24 111.681 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.54 ' HA ' ' NE ' ' A' ' 80' ' ' ARG . 4.3 tpm_? -90.83 -43.84 9.79 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.675 0.25 . . . . 4.49 111.675 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.493 ' OD1' ' HG2' ' A' ' 83' ' ' LYS . 22.6 t-20 -95.28 -31.97 13.21 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.803 -0.359 . . . . 2.66 111.18 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.42 -21.01 40.59 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.126 -0.559 . . . . 0.88 113.014 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.493 ' HG2' ' OD1' ' A' ' 81' ' ' ASN . 58.7 pttt -91.32 171.16 9.41 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 109.455 -0.572 . . . . 2.9 109.455 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.7 m -108.93 176.16 5.2 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.606 -0.438 . . . . 1.49 111.396 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.1 p -145.83 154.78 42.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.621 . . . . 1.31 109.881 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -93.27 117.46 30.1 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.273 0.558 . . . . 1.05 110.417 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.4 m -117.26 145.18 44.12 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.741 -0.663 . . . . 1.17 109.602 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.13 71.33 0.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.427 0.632 . . . . 2.17 109.777 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 80.2 t -89.8 121.81 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.077 -0.965 . . . . 1.06 111.223 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 4.3 mm? -112.26 148.37 34.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.79 -0.641 . . . . 1.77 109.916 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.57 ' HG2' HD22 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -87.51 118.18 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.155 -0.683 . . . . 2.02 109.155 177.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.0 mm . . . . . 0 C--N 1.313 -1.006 0 CA-C-N 115.275 -0.875 . . . . 1.05 110.781 -174.212 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 120.891 0.376 . . . . 1.88 110.506 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -104.54 122.66 46.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.126 0.488 . . . . 2.59 110.312 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 72.0 mmtt -100.43 144.8 29.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.652 -0.704 . . . . 1.84 110.78 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.523 ' HE ' ' HB2' ' A' ' 72' ' ' GLU . 9.5 mmt85 -112.77 128.37 56.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.204 -0.453 . . . . 1.99 110.056 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.04 179.98 8.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.84 -0.43 . . . . 0.96 109.84 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.76 147.4 28.64 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.289 -0.263 . . . . 0.86 110.289 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.478 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 38.5 t -66.42 113.83 3.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.199 0.523 . . . . 1.01 109.824 174.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.404 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 20.7 t70 -72.5 -44.36 62.35 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.053 -0.976 . . . . 0.6 109.615 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.3 m -164.28 166.86 20.52 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.805 -0.634 . . . . 1.18 110.562 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.419 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 5.3 mt -139.76 134.52 38.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.168 0.508 . . . . 1.03 109.942 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -127.53 91.88 3.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.423 -0.808 . . . . 2.16 110.313 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.51 -106.66 1.81 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.721 -0.752 . . . . 0.34 112.786 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -98.27 6.43 47.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.611 0.243 . . . . 2.6 110.363 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.47 140.85 51.61 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.125 0.488 . . . . 0.38 110.72 -173.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.516 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.67 158.73 15.56 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.313 -0.858 . . . . 0.11 111.148 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 80.7 m-85 -131.86 131.41 42.77 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.79 -0.819 . . . . 0.19 108.79 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.492 HD11 ' CD2' ' A' ' 73' ' ' PHE . 9.6 mt -103.93 153.49 20.74 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.573 -0.529 . . . . 1.28 109.573 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -76.32 73.4 3.1 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.995 -0.743 . . . . 1.77 108.995 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.403 ' HB3' HD12 ' A' ' 51' ' ' LEU . 28.0 t80 -150.1 98.68 2.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.735 -1.121 . . . . 0.33 109.091 -178.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.467 ' HG2' ' HA2' ' A' ' 48' ' ' GLY . 3.3 mp0 -82.12 100.75 9.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.452 -0.795 . . . . 1.81 109.978 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.516 HG12 ' HB3' ' A' ' 84' ' ' SER . 7.4 m -71.36 -39.37 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.422 -0.808 . . . . 1.51 111.978 -176.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.435 ' H ' ' HB2' ' A' ' 49' ' ' LYS . 5.9 tp10 -140.44 101.57 4.14 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.881 0.372 . . . . 2.24 111.0 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 t70 58.92 20.17 7.84 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.565 -0.743 . . . . 1.55 112.927 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.467 ' HA2' ' HG2' ' A' ' 44' ' ' GLU . . . 111.43 11.73 16.89 Favored Glycine 0 C--N 1.315 -0.589 0 C-N-CA 119.976 -1.107 . . . . 0.77 112.737 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 23.3 mmtm -69.72 110.63 5.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.344 -0.613 . . . . 3.03 109.344 173.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -70.55 132.19 45.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.878 -0.416 . . . . 1.87 109.878 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 3.0 mt -71.85 122.02 20.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.423 -0.353 . . . . 1.05 111.098 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -105.07 157.56 17.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.286 -0.416 . . . . 0.48 109.955 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.523 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 26.6 p90 -151.44 153.35 34.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.903 -0.59 . . . . 0.2 109.518 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -96.58 152.22 18.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.962 -0.755 . . . . 0.47 108.962 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.567 ' SD ' HG22 ' A' ' 58' ' ' VAL . 15.5 mmt -65.14 -1.66 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.417 0.525 . . . . 2.84 112.417 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.8 t -84.92 -19.47 32.17 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.08 -0.387 . . . . 1.41 110.209 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -90.03 -6.03 55.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.313 -0.403 . . . . 1.96 110.326 176.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.567 HG22 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -71.42 150.11 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.786 0.661 . . . . 1.06 112.786 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.42 93.5 0.07 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.87 -1.059 . . . . 1.85 112.128 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.99 -66.38 3.41 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 121.201 -0.523 . . . . 0.62 113.969 169.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -131.27 141.86 50.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.19 0.519 . . . . 2.3 110.018 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.8 p -70.87 -23.58 62.34 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.129 -0.941 . . . . 1.45 110.89 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.6 t -93.47 12.07 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 115.252 -0.885 . . . . 1.95 110.075 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.75 -38.0 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.484 -0.326 . . . . 1.21 111.226 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.525 HD21 HG11 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -90.17 124.99 35.3 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.158 -0.682 . . . . 2.19 109.158 -178.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -132.15 160.88 66.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.415 -0.357 . . . . 1.12 111.211 -173.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.478 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 27.0 Cg_endo -62.38 140.81 84.49 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.592 2.195 . . . . 0.28 111.887 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.26 -14.36 63.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.075 -0.583 . . . . 0.23 112.468 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -79.0 148.69 32.44 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.981 -0.378 . . . . 1.28 109.981 174.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 5.5 m -81.67 140.27 34.45 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.821 -0.807 . . . . 1.05 108.821 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.525 HG11 HD21 ' A' ' 65' ' ' LEU . 34.4 m -135.5 157.24 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.962 0.887 . . . . 1.16 111.351 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.523 ' HB2' ' HE ' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -114.74 132.25 56.5 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.856 -1.52 . . . . 0.78 107.688 171.597 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.492 ' CD2' HD11 ' A' ' 41' ' ' LEU . 20.1 p90 -143.25 179.54 7.01 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.639 -0.504 . . . . 0.15 109.639 -175.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 m -127.1 121.46 31.52 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.957 -0.757 . . . . 1.3 108.957 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 p -81.22 98.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.701 0.762 . . . . 1.11 110.593 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.55 120.53 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.717 -0.674 . . . . 1.13 110.45 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.7 m -68.78 133.0 47.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.736 -0.666 . . . . 1.27 111.279 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -71.05 105.23 3.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.736 -0.839 . . . . 1.96 108.736 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -63.93 -13.25 44.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.287 -0.415 . . . . 2.24 112.046 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -96.0 -36.8 10.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.472 -0.331 . . . . 4.49 111.563 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -107.38 -31.41 8.19 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.363 0.505 . . . . 2.66 112.363 -169.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.91 -21.24 38.8 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.236 -0.983 . . . . 0.88 113.663 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -85.33 175.46 8.89 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.287 -0.635 . . . . 2.9 109.287 177.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.516 ' HB3' HG12 ' A' ' 45' ' ' VAL . 19.6 t -117.43 -178.15 3.39 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.587 -0.445 . . . . 1.49 110.981 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.0 p -156.79 152.99 27.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.908 -0.587 . . . . 1.31 109.942 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' A' ' 53' ' ' PHE . . . -86.73 118.4 26.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.939 0.4 . . . . 1.05 110.627 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 33.9 m -116.74 140.86 48.94 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.269 -0.423 . . . . 1.17 109.916 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 63.39 72.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.622 0.725 . . . . 2.17 109.237 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 54.5 t -87.98 116.8 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.803 -1.09 . . . . 1.06 110.505 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 4.1 mm? -108.47 148.91 29.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.03 -0.532 . . . . 1.77 110.523 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.498 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -81.56 125.4 30.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.267 -0.642 . . . . 2.02 109.267 173.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.46 ' O ' ' HB ' ' A' ' 70' ' ' THR . 40.1 mm . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 116.12 -0.491 . . . . 1.05 111.037 -175.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.482 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 5.5 tp60 . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.97 0.415 . . . . 1.88 110.99 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.44 ' HZ1' ' CD ' ' A' ' 72' ' ' GLU . 7.7 mtmp? -96.24 126.14 41.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.691 -0.485 . . . . 2.59 109.691 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 12.9 mmtm -113.3 145.5 40.94 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.775 -0.648 . . . . 1.84 110.28 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -116.89 132.49 56.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.94 0.4 . . . . 1.99 110.696 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.73 179.84 8.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.802 -0.636 . . . . 0.96 109.787 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.8 144.15 31.87 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.206 -0.452 . . . . 0.86 110.023 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.475 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 61.3 t -67.2 116.34 6.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.133 0.492 . . . . 1.01 110.463 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.421 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 10.6 t70 -67.69 -51.79 45.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.08 -0.963 . . . . 0.6 109.636 177.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.7 m -159.41 166.76 30.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.893 -0.594 . . . . 1.18 110.564 -175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.405 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 6.0 mt -142.55 132.39 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.876 -0.602 . . . . 1.03 110.07 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -126.76 93.84 3.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.623 -0.717 . . . . 2.16 110.641 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.85 -106.43 1.64 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.73 -0.748 . . . . 0.34 112.393 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -99.02 7.65 45.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.633 0.254 . . . . 2.6 110.687 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -126.79 143.34 51.28 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.279 0.562 . . . . 0.38 111.469 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.499 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.18 161.95 21.97 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.713 -0.756 . . . . 0.11 111.52 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 70.7 m-85 -136.96 143.35 42.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.174 -0.676 . . . . 0.19 109.174 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.5 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.5 mt -117.81 156.53 28.19 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.335 -0.246 . . . . 1.28 110.335 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -74.85 72.81 2.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.35 0.595 . . . . 1.77 109.729 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -146.53 100.79 3.4 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.107 -0.951 . . . . 0.33 109.284 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -81.56 106.03 13.19 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.271 -0.877 . . . . 1.81 110.062 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.1 t -71.01 -66.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.522 -0.763 . . . . 1.51 111.194 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.616 ' H ' ' HB2' ' A' ' 49' ' ' LYS . 1.0 OUTLIER -133.71 116.29 15.6 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.081 -0.963 . . . . 2.24 109.49 -178.213 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 t70 64.18 19.17 11.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.466 0.651 . . . . 1.55 111.637 171.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.35 21.4 13.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.557 -0.83 . . . . 0.77 112.841 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.616 ' HB2' ' H ' ' A' ' 46' ' ' GLU . 27.6 mmtm -65.09 109.97 2.35 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.443 -0.577 . . . . 3.03 109.443 175.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -72.3 118.62 15.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.098 -0.705 . . . . 1.87 109.098 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.1 mt -60.38 125.2 22.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.417 -0.356 . . . . 1.05 111.506 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -106.44 157.29 17.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.138 -0.483 . . . . 0.48 109.916 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.499 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 27.0 p90 -148.86 154.66 39.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.68 -0.691 . . . . 0.2 109.178 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -98.32 151.87 20.05 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.619 -0.882 . . . . 0.47 108.619 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.574 ' SD ' HG22 ' A' ' 58' ' ' VAL . 14.3 mmt -61.03 -12.44 11.71 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.37 0.507 . . . . 2.84 112.37 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.9 m -72.48 -25.39 61.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.192 -0.318 . . . . 1.41 110.82 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.45 -13.74 51.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 1.96 110.71 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.574 HG22 ' SD ' ' A' ' 55' ' ' MET . 2.0 t -64.04 152.31 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 112.861 0.689 . . . . 1.06 112.861 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.403 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -62.77 95.79 0.08 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.948 -1.024 . . . . 1.85 112.173 -176.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.47 -81.62 0.6 Allowed Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.62 113.288 172.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -110.92 143.6 41.29 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.677 -0.49 . . . . 2.3 109.677 -177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.42 HG21 ' HB3' ' A' ' 55' ' ' MET . 66.6 p -57.9 -42.69 85.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.127 0.489 . . . . 1.45 111.873 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.94 4.7 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.952 -0.567 . . . . 1.95 112.477 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.5 -9.78 40.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.69 0.281 . . . . 1.21 111.21 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.479 ' CD2' ' HG2' ' A' ' 91' ' ' LYS . 1.6 tm? -115.9 125.46 52.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.915 -0.772 . . . . 2.19 108.915 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -120.33 149.78 50.35 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-O 120.579 0.228 . . . . 1.12 111.065 -171.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.475 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 37.0 Cg_endo -66.04 139.52 56.4 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.655 2.237 . . . . 0.28 111.881 174.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.67 -15.48 61.46 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.921 -0.657 . . . . 0.23 111.999 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.7 149.75 27.13 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.39 -0.226 . . . . 1.28 110.39 177.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.1 m -76.22 137.85 40.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.199 -0.667 . . . . 1.05 109.199 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.469 HG13 HD23 ' A' ' 65' ' ' LEU . 16.1 m -136.07 157.51 38.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.525 0.678 . . . . 1.16 109.98 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.44 ' CD ' ' HZ1' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -114.78 132.07 56.59 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.203 -1.036 . . . . 0.78 108.203 173.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.5 ' CD2' HD13 ' A' ' 41' ' ' LEU . 36.7 p90 -141.93 179.15 7.04 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.855 -0.611 . . . . 0.15 109.889 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.0 m -128.63 119.69 25.19 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.917 -0.772 . . . . 1.3 108.917 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 75' ' ' VAL . 8.5 p -91.4 108.38 19.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.767 0.794 . . . . 1.11 111.269 -172.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.8 p -116.0 124.42 72.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.533 -0.758 . . . . 1.13 110.061 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.2 m -83.35 127.03 33.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.173 0.511 . . . . 1.27 110.611 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.576 ' CB ' ' HB3' ' A' ' 81' ' ' ASN . 9.2 m120 -70.45 121.29 17.49 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.518 -0.764 . . . . 1.96 109.765 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -73.78 -21.46 60.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.942 0.401 . . . . 2.24 111.222 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -96.09 -33.67 12.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.023 0.439 . . . . 4.49 110.979 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.576 ' HB3' ' CB ' ' A' ' 78' ' ' ASN . 60.4 t30 -97.05 -18.23 19.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.331 0.586 . . . . 2.66 110.788 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.99 -25.96 2.96 Favored Glycine 0 C--O 1.229 -0.175 0 CA-C-N 115.525 -0.761 . . . . 0.88 113.919 174.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.439 ' HE2' HD22 ' A' ' 81' ' ' ASN . 18.5 pttm -99.62 168.47 9.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.22 0.51 . . . . 2.9 111.358 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.5 m -102.34 175.45 5.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.561 -0.745 . . . . 1.49 111.64 -175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -143.69 156.39 44.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.566 -0.743 . . . . 1.31 109.157 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' A' ' 53' ' ' PHE . . . -99.47 118.59 36.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 110.029 -0.36 . . . . 1.05 110.029 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.2 m -116.56 148.33 40.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.437 -0.347 . . . . 1.17 110.664 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.2 m120 62.06 52.09 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.646 0.591 . . . . 2.17 109.881 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 77.2 t -72.89 100.62 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.473 -0.785 . . . . 1.06 110.81 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 8.0 mp -102.84 148.31 25.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.641 -0.709 . . . . 1.77 110.95 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -77.17 127.95 33.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.014 -0.539 . . . . 2.02 110.006 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.1 mm . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 116.301 -0.409 . . . . 1.05 110.267 -179.644 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.414 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 6.5 tp60 . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.984 0.421 . . . . 1.88 110.912 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -93.91 135.02 35.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.117 -0.492 . . . . 2.59 110.105 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 16.1 mmtm -118.84 147.33 44.05 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.764 -0.653 . . . . 1.84 109.781 174.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -122.94 132.19 54.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.019 0.438 . . . . 1.99 110.617 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.78 179.75 8.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.454 -0.794 . . . . 0.96 109.623 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.53 144.47 31.37 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.07 -0.344 . . . . 0.86 110.07 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.477 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 43.7 t -64.27 124.24 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.932 0.396 . . . . 1.01 110.383 176.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.72 -48.44 13.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.725 -0.67 . . . . 0.6 109.988 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 m -158.48 166.06 33.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.649 -0.705 . . . . 1.18 110.057 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.3 mt -140.9 126.89 19.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.033 0.444 . . . . 1.03 109.987 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -114.13 86.68 2.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.417 -0.81 . . . . 2.16 110.257 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.71 -106.28 1.43 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.606 -0.807 . . . . 0.34 112.899 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -93.28 4.66 53.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.562 0.22 . . . . 2.6 111.263 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -126.98 140.33 52.39 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.038 0.447 . . . . 0.38 110.614 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.42 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.29 161.0 14.72 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.422 -0.894 . . . . 0.11 111.422 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 84.1 m-85 -132.88 137.08 46.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.496 -0.557 . . . . 0.19 109.496 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.527 HD13 ' CD2' ' A' ' 73' ' ' PHE . 4.7 mt -114.6 154.49 28.24 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.539 -0.541 . . . . 1.28 109.539 -177.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.474 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 65.1 t30 -78.03 73.65 4.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.621 0.724 . . . . 1.77 109.821 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -140.53 106.35 5.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.761 -1.108 . . . . 0.33 108.442 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -94.63 105.33 17.27 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.427 0.632 . . . . 1.81 110.814 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.66 -77.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.797 -1.092 . . . . 1.51 111.788 -173.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 10.1 tt0 -111.75 111.37 22.3 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.392 -0.822 . . . . 2.24 110.479 -173.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.9 t70 61.22 22.5 12.83 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.459 0.647 . . . . 1.55 111.714 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.36 27.84 8.95 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.317 -0.944 . . . . 0.77 112.669 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 27.4 mmmt -77.92 110.93 13.25 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.153 -0.684 . . . . 3.03 109.153 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 9.3 tppt? -75.56 126.15 30.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.134 -0.691 . . . . 1.87 109.134 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 4.5 mt -62.6 130.24 44.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.404 0.52 . . . . 1.05 112.404 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -111.62 159.31 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.659 -0.7 . . . . 0.48 109.216 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.433 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 32.7 p90 -149.41 149.78 31.37 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.705 -0.479 . . . . 0.2 109.705 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -90.32 149.68 22.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.068 -0.716 . . . . 0.47 109.068 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -0.93 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.249 0.463 . . . . 2.84 112.249 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.6 t -71.32 -32.18 68.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.076 0.465 . . . . 1.41 110.045 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -86.65 -10.55 53.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.87 -0.605 . . . . 1.96 110.956 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.26 145.14 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.467 0.651 . . . . 1.06 112.417 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.496 ' HG3' ' H ' ' A' ' 91' ' ' LYS . 0.9 OUTLIER -66.1 110.12 2.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.578 -1.192 . . . . 1.85 111.79 -175.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.66 -93.14 0.72 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.035 -0.602 . . . . 0.62 113.083 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.54 155.99 23.41 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.231 -0.285 . . . . 2.3 110.231 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.3 p -61.56 -32.04 72.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.157 -0.474 . . . . 1.45 111.35 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.39 17.62 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.283 0.563 . . . . 1.95 110.61 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.58 2.04 27.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.183 0.516 . . . . 1.21 111.179 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.438 HD11 HG11 ' A' ' 71' ' ' VAL . 1.8 tm? -129.25 125.63 37.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.344 -0.984 . . . . 2.19 108.344 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -122.8 154.02 63.69 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 111.685 0.254 . . . . 1.12 111.685 -171.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.477 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.4 Cg_endo -68.07 134.81 32.85 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.8 2.333 . . . . 0.28 112.369 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.87 -4.73 72.14 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.692 -0.766 . . . . 0.23 111.98 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -95.7 155.25 16.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.594 -0.521 . . . . 1.28 109.594 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -83.47 132.07 34.98 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.62 -0.511 . . . . 1.05 109.62 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.438 HG11 HD11 ' A' ' 65' ' ' LEU . 4.3 m -134.26 160.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.787 0.803 . . . . 1.16 110.84 -176.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -119.12 138.8 52.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.359 -1.291 . . . . 0.78 108.911 177.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.527 ' CD2' HD13 ' A' ' 41' ' ' LEU . 36.5 p90 -150.81 180.0 7.75 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.935 -0.575 . . . . 0.15 109.854 -173.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.1 m -127.41 131.49 50.28 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.913 -0.773 . . . . 1.3 108.913 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.422 HG22 ' OG ' ' A' ' 84' ' ' SER . 3.5 p -91.35 98.11 8.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.985 0.898 . . . . 1.11 110.436 -175.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.5 p -102.53 114.36 41.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.193 -0.912 . . . . 1.13 110.241 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.2 m -80.15 127.14 31.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.853 -0.612 . . . . 1.27 110.922 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.97 104.3 2.49 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.019 -0.734 . . . . 1.96 109.019 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -57.23 -26.98 61.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.843 0.354 . . . . 2.24 111.652 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.438 ' HA ' ' HE ' ' A' ' 80' ' ' ARG . 5.1 tpm_? -84.41 -41.35 16.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 4.49 111.599 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -95.05 -30.71 13.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.221 0.452 . . . . 2.66 112.221 -170.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.89 -24.16 32.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.078 -0.582 . . . . 0.88 112.907 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -86.75 175.88 8.02 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.661 -0.317 . . . . 2.9 110.495 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.422 ' OG ' HG22 ' A' ' 75' ' ' VAL . 32.7 t -116.95 -179.23 3.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.104 0.478 . . . . 1.49 110.969 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 m -149.56 147.84 28.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.317 -0.994 . . . . 1.31 108.317 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . . . -86.97 121.63 29.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.867 0.365 . . . . 1.05 110.653 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 68.4 m -117.33 144.59 44.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.857 -0.611 . . . . 1.17 110.359 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.45 70.43 0.65 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.991 0.807 . . . . 2.17 110.336 -177.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 92.7 t -84.99 115.34 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.273 0.559 . . . . 1.06 111.021 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.27 149.1 30.66 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.793 -0.64 . . . . 1.77 110.509 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.496 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -81.56 124.12 29.24 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.105 -0.702 . . . . 2.02 109.105 174.404 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.1 mm . . . . . 0 C--N 1.316 -0.873 0 CA-C-N 115.962 -0.563 . . . . 1.05 111.559 -174.716 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 . . . . . 0 C--O 1.236 0.35 0 CA-C-O 120.941 0.401 . . . . 1.88 111.361 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -91.76 132.92 36.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.031 0.443 . . . . 2.59 110.377 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -114.47 149.71 35.91 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.799 -0.637 . . . . 1.84 109.663 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.471 ' HG2' ' CB ' ' A' ' 72' ' ' GLU . 59.5 mtm-85 -122.96 127.89 49.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.067 0.461 . . . . 1.99 111.059 177.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 179.53 9.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.183 -0.917 . . . . 0.96 109.807 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.4 146.18 29.21 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.849 -0.426 . . . . 0.86 109.849 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.481 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 40.8 t -67.2 123.06 19.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.856 0.36 . . . . 1.01 110.866 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -75.16 -42.46 55.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.6 110.144 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 p -172.04 165.25 6.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.517 -0.765 . . . . 1.18 110.201 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.7 mt -135.48 129.93 49.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.092 0.472 . . . . 1.03 109.965 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -126.16 95.23 4.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.562 -0.744 . . . . 2.16 110.613 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.83 -106.28 1.77 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.34 112.726 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -103.07 9.99 38.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.686 0.279 . . . . 2.6 110.417 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -129.58 141.12 51.02 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.225 0.536 . . . . 0.38 111.054 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -123.97 159.02 18.63 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.137 -0.785 . . . . 0.11 111.137 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 76.8 m-85 -131.06 147.49 52.63 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.859 -0.422 . . . . 0.19 109.859 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.592 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 5.7 mt -124.82 146.99 48.98 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.385 -0.598 . . . . 1.28 109.385 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -72.92 74.63 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.574 0.702 . . . . 1.77 110.505 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -138.0 97.63 3.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.836 -1.074 . . . . 0.33 108.539 177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.501 ' CG ' ' HA2' ' A' ' 48' ' ' GLY . 19.5 mp0 -74.15 102.15 4.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.948 -1.024 . . . . 1.81 110.966 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 84' ' ' SER . 28.6 m -80.12 -32.44 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.494 -0.775 . . . . 1.51 111.108 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -157.98 116.89 3.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.128 -0.487 . . . . 2.24 110.33 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.2 t70 58.87 22.57 10.37 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.507 0.558 . . . . 1.55 112.507 169.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.501 ' HA2' ' CG ' ' A' ' 44' ' ' GLU . . . 102.38 2.68 50.75 Favored Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.418 -0.896 . . . . 0.77 112.966 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -60.72 115.08 3.38 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 122.167 0.187 . . . . 3.03 110.795 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -70.49 148.95 47.69 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.628 -0.508 . . . . 1.87 109.628 176.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 3.4 mt -79.02 132.68 36.72 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.904 -0.589 . . . . 1.05 110.274 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -107.31 154.24 21.56 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.579 -0.526 . . . . 0.48 109.579 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 18.5 p90 -146.4 156.22 43.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.338 -0.616 . . . . 0.2 109.338 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -97.33 149.64 21.86 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.897 -0.779 . . . . 0.47 108.897 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.446 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -61.82 -8.23 4.61 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.909 0.337 . . . . 2.84 111.909 -178.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 t -79.25 -19.55 50.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.95 0.405 . . . . 1.41 110.288 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -92.2 -10.83 37.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.977 0.418 . . . . 1.96 110.171 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.1 t -64.62 149.14 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.454 -0.793 . . . . 1.06 111.897 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -63.31 92.01 0.06 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.219 -0.9 . . . . 1.85 112.52 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.1 -77.56 0.69 Allowed Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.006 -0.543 . . . . 0.62 113.732 172.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -103.93 140.16 38.09 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.606 -0.516 . . . . 2.3 109.606 -175.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 69.6 p -70.53 -22.67 62.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.974 -0.557 . . . . 1.45 111.64 -173.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.4 t -100.38 7.16 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.271 0.558 . . . . 1.95 110.503 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.69 -11.1 32.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.316 -0.402 . . . . 1.21 110.928 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.493 HD12 HG13 ' A' ' 71' ' ' VAL . 1.4 tm? -110.04 124.51 51.58 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.702 -0.851 . . . . 2.19 108.702 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -115.46 150.66 44.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.743 0.306 . . . . 1.12 111.533 -170.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.481 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.2 Cg_endo -68.06 140.82 50.94 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.379 2.053 . . . . 0.28 111.895 173.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.55 -1.31 88.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.645 -0.788 . . . . 0.23 112.451 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -96.16 159.32 15.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.729 -0.471 . . . . 1.28 109.729 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -83.96 134.97 34.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.565 -0.531 . . . . 1.05 109.565 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.493 HG13 HD12 ' A' ' 65' ' ' LEU . 10.2 m -136.7 160.04 37.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 110.068 -0.345 . . . . 1.16 110.068 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.548 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 4.6 pt-20 -116.03 141.65 47.84 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.601 -0.888 . . . . 0.78 108.601 170.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 41' ' ' LEU . 26.5 p90 -146.82 179.7 7.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.33 -0.85 . . . . 0.15 109.672 -173.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m -127.65 127.18 43.34 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.942 -0.762 . . . . 1.3 108.942 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 75' ' ' VAL . 8.2 p -92.68 99.4 9.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.835 0.826 . . . . 1.11 111.508 -172.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 84' ' ' SER . 5.1 p -99.11 112.34 31.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.819 -0.628 . . . . 1.13 109.944 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.1 m -93.76 140.45 29.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.508 -0.769 . . . . 1.27 111.128 -173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 80' ' ' ARG . 5.1 t-20 -71.61 134.64 46.53 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.711 0.291 . . . . 1.96 110.359 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 19.2 pm0 -76.87 -12.48 59.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.497 -0.319 . . . . 2.24 111.07 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.462 ' HB3' ' OD1' ' A' ' 78' ' ' ASN . 7.0 tpm_? -95.56 -59.27 1.91 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.568 -0.287 . . . . 4.49 111.605 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -109.04 -0.48 19.48 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.202 0.445 . . . . 2.66 112.202 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.93 80.03 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.494 -0.86 . . . . 0.88 113.159 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.51 131.55 34.86 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.42 0.628 . . . . 2.9 111.494 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 65.3 m -106.7 170.2 8.08 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.912 -1.04 . . . . 1.49 111.357 -172.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.8 m -148.6 152.91 37.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.63 -0.714 . . . . 1.31 109.338 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.432 ' HB1' ' HB3' ' A' ' 53' ' ' PHE . . . -95.33 122.55 38.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 120.87 0.367 . . . . 1.05 110.373 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 94.1 m -116.69 148.55 40.95 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.129 -0.487 . . . . 1.17 110.22 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.8 m120 59.32 62.03 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.674 0.609 . . . . 2.17 110.338 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.7 t -80.87 99.14 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.472 -0.786 . . . . 1.06 110.656 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.548 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 6.7 mp -99.79 147.87 25.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.349 -0.841 . . . . 1.77 110.545 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.453 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -78.62 123.71 27.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.969 -0.382 . . . . 2.02 109.969 178.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.1 mm . . . . . 0 C--N 1.317 -0.818 0 CA-C-O 121.093 0.473 . . . . 1.05 110.667 -178.626 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 . . . . . 0 CA--C 1.516 -0.332 0 N-CA-C 110.491 -0.188 . . . . 1.88 110.491 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -109.1 112.31 24.41 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.349 -0.54 . . . . 2.59 110.228 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -90.72 154.31 19.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.595 -0.729 . . . . 1.84 109.59 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -128.11 128.32 44.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.999 -0.371 . . . . 1.99 109.999 176.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 179.53 9.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.803 -0.635 . . . . 0.96 109.376 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.55 140.09 38.0 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 110.345 -0.243 . . . . 0.86 110.345 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 43.7 t -62.04 115.7 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 120.986 0.422 . . . . 1.01 110.337 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.03 -47.26 65.87 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.446 -0.797 . . . . 0.6 110.019 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.1 m -168.86 168.56 10.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 1.18 109.36 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.409 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 11.2 mt -135.79 126.97 44.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.639 -0.504 . . . . 1.03 109.639 175.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -116.88 92.16 3.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.643 -0.708 . . . . 2.16 110.089 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.96 -109.27 2.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.789 -0.72 . . . . 0.34 112.238 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -96.99 6.02 49.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.71 0.255 . . . . 2.6 110.758 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -125.06 144.18 50.54 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.321 0.581 . . . . 0.38 111.234 -173.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.79 159.41 15.45 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.595 -0.812 . . . . 0.11 111.308 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.0 142.47 47.65 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.376 -0.601 . . . . 0.19 109.376 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.479 HD13 ' CD2' ' A' ' 73' ' ' PHE . 8.8 mt -116.15 152.22 34.13 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.247 -0.649 . . . . 1.28 109.247 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -75.48 76.0 2.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.505 0.669 . . . . 1.77 109.417 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.414 ' HB3' HD13 ' A' ' 51' ' ' LEU . 23.9 t80 -147.73 98.13 2.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.983 -1.008 . . . . 0.33 109.121 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 33.3 mt-10 -87.88 101.99 14.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.325 0.583 . . . . 1.81 110.573 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 84' ' ' SER . 15.6 m -73.35 -45.09 53.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.41 -0.814 . . . . 1.51 112.078 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 4.8 tt0 -140.71 116.61 10.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.572 -0.286 . . . . 2.24 110.537 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 t70 57.87 21.83 8.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.324 0.583 . . . . 1.55 112.131 167.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.47 19.82 19.41 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.443 -0.884 . . . . 0.77 112.955 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 32.6 mmtm -70.99 110.41 5.67 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.892 -0.41 . . . . 3.03 109.892 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -75.24 126.89 31.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.503 -0.554 . . . . 1.87 109.503 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 51' ' ' LEU . 3.8 mt -66.75 126.83 30.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.532 -0.304 . . . . 1.05 111.314 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.438 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 9.5 p90 -111.25 162.53 14.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.427 -0.351 . . . . 0.48 110.138 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 30.2 p90 -155.17 159.75 40.38 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.174 -0.676 . . . . 0.2 109.174 174.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -99.86 153.65 18.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.342 -0.614 . . . . 0.47 109.342 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 19.6 mtt -66.76 3.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.44 0.533 . . . . 2.84 112.44 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.1 t -89.45 -22.75 22.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.542 -0.54 . . . . 1.41 109.542 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -90.07 -5.67 56.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.511 . . . . 1.96 110.27 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.436 HG22 HD13 ' A' ' 65' ' ' LEU . 1.3 t -67.62 152.45 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.223 -0.899 . . . . 1.06 112.818 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.441 ' HG3' ' H ' ' A' ' 91' ' ' LYS . 1.1 tm0? -59.41 99.02 0.05 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 114.863 -1.062 . . . . 1.85 112.419 -176.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.44 -85.0 0.25 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.62 113.258 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -105.71 145.67 30.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.677 -0.49 . . . . 2.3 109.677 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.0 p -59.98 -40.36 88.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.619 0.6 . . . . 1.45 112.619 -174.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.36 19.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.512 0.672 . . . . 1.95 110.522 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.52 11.54 38.84 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.429 0.633 . . . . 1.21 110.141 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.436 HD13 HG22 ' A' ' 58' ' ' VAL . 1.8 tt -137.86 124.03 20.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.121 -0.945 . . . . 2.19 108.534 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -121.78 159.2 52.08 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.755 0.312 . . . . 1.12 111.151 -171.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.441 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.2 Cg_endo -67.41 144.71 68.61 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.436 2.09 . . . . 0.28 111.924 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -9.15 77.96 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.053 -0.594 . . . . 0.23 112.063 -177.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.14 141.36 28.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.583 0.23 . . . . 1.28 110.722 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 m -70.01 139.25 52.71 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.172 -0.677 . . . . 1.05 109.172 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -139.19 161.02 28.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.364 0.602 . . . . 1.16 111.1 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.13 134.53 54.83 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.826 -1.175 . . . . 0.78 107.826 173.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' A' ' 41' ' ' LEU . 23.5 p90 -146.13 178.93 7.85 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.86 -0.609 . . . . 0.15 109.471 -174.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.1 t -126.19 126.63 44.4 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.954 -0.758 . . . . 1.3 108.954 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.9 98.4 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.705 -0.679 . . . . 1.11 110.54 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 p -100.85 113.83 38.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.522 -0.763 . . . . 1.13 109.917 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.9 m -76.78 130.53 37.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.708 -0.678 . . . . 1.27 110.926 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.516 ' HB3' ' H ' ' A' ' 82' ' ' GLY . 3.6 t-20 -65.22 111.91 3.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.923 -0.769 . . . . 1.96 108.923 175.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -12.28 60.38 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.905 -0.318 . . . . 2.24 111.287 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -96.74 -58.55 2.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.035 -0.53 . . . . 4.49 111.558 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -90.75 -28.67 18.12 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.677 0.621 . . . . 2.66 112.677 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.516 ' H ' ' HB3' ' A' ' 78' ' ' ASN . . . 103.7 -24.57 29.34 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.416 -0.897 . . . . 0.88 113.851 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -74.8 151.33 39.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.439 0.62 . . . . 2.9 110.006 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.468 ' HB2' HG11 ' A' ' 45' ' ' VAL . 8.3 m -99.43 175.05 5.99 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.563 -0.455 . . . . 1.49 111.469 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 m -142.78 163.24 33.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.419 -0.809 . . . . 1.31 109.161 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.16 117.06 33.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.248 0.547 . . . . 1.05 110.358 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 64.5 m -116.97 147.99 41.81 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.914 -0.773 . . . . 1.17 108.914 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.466 ' ND2' HD22 ' A' ' 90' ' ' LEU . 8.0 t30 64.55 69.24 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.082 -0.71 . . . . 2.17 109.082 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.404 HG11 HD12 ' A' ' 65' ' ' LEU . 84.9 t -93.41 105.98 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 115.426 -0.806 . . . . 1.06 110.9 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.466 HD22 ' ND2' ' A' ' 88' ' ' ASN . 4.2 mm? -112.3 150.32 31.15 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.61 -0.723 . . . . 1.77 111.016 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.441 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -83.35 123.75 29.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.553 -0.748 . . . . 2.02 110.948 -172.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.5 mm . . . . . 0 C--N 1.319 -0.756 0 CA-C-N 115.83 -0.623 . . . . 1.05 111.05 -175.842 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 . . . . . 0 C--O 1.235 0.304 0 CA-C-O 121.091 0.472 . . . . 1.88 110.65 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HZ2' ' CD ' ' A' ' 72' ' ' GLU . 4.0 tmmm? -97.6 118.32 33.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.44 0.638 . . . . 2.59 110.286 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -99.99 156.44 17.15 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.868 -1.06 . . . . 1.84 109.719 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.452 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 11.0 mtm180 -130.27 127.31 39.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.49 . . . . 1.99 110.559 175.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.46 -179.96 8.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.256 -0.884 . . . . 0.96 110.031 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.4 145.6 28.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.366 -0.379 . . . . 0.86 109.984 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.432 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 48.8 t -68.33 123.33 21.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.516 -0.311 . . . . 1.01 110.379 175.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.39 -41.9 46.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.109 -0.496 . . . . 0.6 110.406 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.5 p -171.04 161.69 6.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.845 -0.616 . . . . 1.18 110.014 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.1 mt -133.73 129.13 54.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.079 0.466 . . . . 1.03 110.114 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -119.59 95.19 4.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 2.16 110.132 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.17 -114.13 5.85 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.815 -0.707 . . . . 0.34 112.282 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -96.38 14.81 23.13 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 110.031 -0.359 . . . . 2.6 110.031 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -128.13 141.06 51.59 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.563 -0.455 . . . . 0.38 111.014 -175.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.517 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -127.19 158.71 21.14 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.503 -0.856 . . . . 0.11 111.525 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -132.33 142.71 49.44 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.235 -0.654 . . . . 0.19 109.235 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.484 HD12 ' CD2' ' A' ' 73' ' ' PHE . 6.3 mt -116.74 152.53 34.14 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.146 -0.686 . . . . 1.28 109.146 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -75.09 73.47 2.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.782 0.801 . . . . 1.77 109.585 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -147.51 110.69 4.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.623 -1.172 . . . . 0.33 108.674 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 90.1 mt-10 -105.82 107.08 17.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.5 0.667 . . . . 1.81 111.136 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 m -74.06 -55.28 12.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.659 -1.155 . . . . 1.51 112.121 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.683 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 4.1 tp10 -136.38 118.92 15.88 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.552 -0.294 . . . . 2.24 110.703 -171.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.1 t70 61.86 16.59 8.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.41 0.624 . . . . 1.55 112.057 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.09 31.13 9.37 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.205 -0.997 . . . . 0.77 112.107 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.683 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 41.2 mmtm -75.49 109.88 9.41 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.509 -0.923 . . . . 3.03 108.509 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' HZ3' ' HB2' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -73.93 122.32 22.37 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.726 -0.842 . . . . 1.87 108.726 179.085 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 mt -59.7 126.55 28.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.131 -0.486 . . . . 1.05 111.6 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -108.41 161.82 14.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.856 -0.611 . . . . 0.48 110.229 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.517 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 30.0 p90 -152.5 151.88 31.25 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.558 -0.746 . . . . 0.2 109.205 173.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.448 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . 23.3 t-80 -93.69 156.39 16.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.628 -0.879 . . . . 0.47 108.628 174.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.457 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 51.0 ttm -71.73 3.69 3.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.875 0.369 . . . . 2.84 111.538 -176.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.2 t -88.38 -27.57 21.52 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.777 -0.453 . . . . 1.41 109.777 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.448 ' OE2' ' HB3' ' A' ' 54' ' ' HIS . 1.9 mp0 -79.36 -14.97 58.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.855 -0.611 . . . . 1.96 109.626 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.463 ' HA ' ' HB ' ' A' ' 89' ' ' VAL . 1.8 t -62.68 152.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.882 -1.054 . . . . 1.06 111.939 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.445 HE21 ' HB3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -45.07 158.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.359 -1.291 . . . . 1.85 110.985 176.005 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -44.78 -32.5 3.08 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 114.62 0.608 . . . . 0.62 114.62 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -104.26 125.03 50.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.645 -0.502 . . . . 2.3 109.645 173.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.457 ' HB ' ' SD ' ' A' ' 55' ' ' MET . 70.7 p -79.18 -36.54 40.11 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.413 -0.812 . . . . 1.45 111.977 -171.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 t -87.15 7.35 2.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.484 0.659 . . . . 1.95 110.257 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.33 -3.12 31.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 1.21 111.087 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.472 HD12 HG13 ' A' ' 71' ' ' VAL . 1.5 tm? -104.71 124.04 48.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.031 -1.1 . . . . 2.19 108.031 175.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -121.02 151.81 55.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.828 0.347 . . . . 1.12 111.549 -171.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.432 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 43.0 Cg_endo -67.8 137.41 41.69 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.721 2.28 . . . . 0.28 111.856 173.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.31 -8.99 72.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.815 -0.707 . . . . 0.23 112.628 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -95.25 159.69 14.89 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.418 -0.586 . . . . 1.28 109.418 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 m -80.27 135.96 36.34 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.208 -0.664 . . . . 1.05 109.208 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.472 HG13 HD12 ' A' ' 65' ' ' LEU . 12.1 m -135.71 161.6 38.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.25 0.548 . . . . 1.16 109.895 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.65 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.59 149.13 37.04 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.726 -0.842 . . . . 0.78 108.726 177.502 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.484 ' CD2' HD12 ' A' ' 41' ' ' LEU . 37.9 p90 -163.06 178.61 8.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.006 0.431 . . . . 0.15 110.515 -172.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -128.85 131.56 47.7 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.022 -0.733 . . . . 1.3 109.022 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.9 p -99.35 98.84 7.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.802 0.81 . . . . 1.11 111.018 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.0 p -110.2 118.89 58.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.558 -0.746 . . . . 1.13 110.006 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.0 m -73.32 126.19 29.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.138 -0.483 . . . . 1.27 110.778 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 29.1 m-80 -68.79 115.18 7.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.203 -0.453 . . . . 1.96 109.955 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -60.47 -30.85 69.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.166 -0.47 . . . . 2.24 112.113 -173.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.459 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 1.6 tpm_? -95.28 -31.9 13.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.959 0.409 . . . . 4.49 111.645 -176.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -95.94 -26.41 15.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.286 0.565 . . . . 2.66 110.455 -171.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 -24.84 18.38 Favored Glycine 0 C--O 1.23 -0.127 0 C-N-CA 121.201 -0.523 . . . . 0.88 113.421 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 20.1 pttm -98.77 151.95 20.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.216 0.508 . . . . 2.9 110.808 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -87.45 179.47 6.56 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.859 -0.61 . . . . 1.49 111.082 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.8 p -153.45 139.17 17.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.004 -0.543 . . . . 1.31 109.773 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . . . -74.01 119.25 17.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.191 0.52 . . . . 1.05 111.105 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 99.4 m -116.89 143.88 45.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.778 -0.646 . . . . 1.17 109.306 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 62.52 70.51 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.418 0.628 . . . . 2.17 109.717 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 90.4 t -93.11 113.05 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.328 -0.851 . . . . 1.06 111.159 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.25 150.05 32.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.178 -0.464 . . . . 1.77 110.92 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.468 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -73.71 128.48 35.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.043 -0.526 . . . . 2.02 109.906 176.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.4 mm . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 120.803 0.335 . . . . 1.05 110.91 -179.103 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 120.691 0.282 . . . . 1.88 110.899 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -95.51 121.05 36.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.419 0.628 . . . . 2.59 110.559 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 31.0 mmtp -105.37 144.12 32.59 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.152 -0.931 . . . . 1.84 109.544 177.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -120.01 127.37 52.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.085 0.469 . . . . 1.99 110.196 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.478 ' HB3' ' OD1' ' A' ' 42' ' ' ASN . . . -150.87 -179.63 7.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.516 -0.765 . . . . 0.96 109.448 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.91 143.42 32.52 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.81 -0.441 . . . . 0.86 109.81 -177.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.42 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 43.8 t -64.89 114.19 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.904 0.383 . . . . 1.01 110.433 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -65.07 -45.12 86.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.121 -0.945 . . . . 0.6 110.153 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 p -171.71 164.73 6.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.396 -0.82 . . . . 1.18 110.093 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.4 mt -137.57 128.95 40.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.669 -0.493 . . . . 1.03 109.669 176.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 71.4 mmtt -122.92 94.31 4.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.534 -0.757 . . . . 2.16 109.807 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.88 -106.92 2.0 Allowed Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.717 -0.754 . . . . 0.34 112.434 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -101.06 4.25 42.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.178 0.191 . . . . 2.6 110.793 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -122.87 140.5 52.89 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.254 0.55 . . . . 0.38 111.374 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.01 157.09 21.01 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.116 -0.947 . . . . 0.11 111.416 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -130.46 151.79 50.55 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.362 -0.607 . . . . 0.19 109.362 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.576 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.2 mt -125.09 155.28 40.08 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.329 -0.619 . . . . 1.28 109.329 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' A' ' 29' ' ' ALA . 28.0 p-10 -76.23 72.9 3.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 122.229 1.014 . . . . 1.77 109.994 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -148.15 98.63 2.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.757 -1.11 . . . . 0.33 109.028 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 21.3 mt-10 -95.58 100.97 12.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.746 0.784 . . . . 1.81 110.284 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.587 HG22 ' N ' ' A' ' 46' ' ' GLU . 16.2 m -68.12 -43.31 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.222 -1.354 . . . . 1.51 111.301 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.587 ' N ' HG22 ' A' ' 45' ' ' VAL . 8.7 tp10 -129.87 176.06 8.35 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.281 -1.748 . . . . 2.24 106.281 -176.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.49 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 28.3 t70 -33.19 86.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.195 1.183 . . . . 1.55 114.195 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.533 ' HA2' ' OE2' ' A' ' 44' ' ' GLU . . . 68.58 16.55 69.87 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.654 -0.784 . . . . 0.77 111.464 171.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.694 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 32.0 mmtm -82.29 107.03 14.65 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.569 -0.53 . . . . 3.03 109.569 -178.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -79.52 129.62 34.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.062 -0.718 . . . . 1.87 109.062 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mt -63.69 124.09 20.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.728 0.299 . . . . 1.05 111.157 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -106.61 158.91 16.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.833 -0.622 . . . . 0.48 109.998 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.473 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 30.4 p90 -150.29 154.87 38.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.517 -0.765 . . . . 0.2 109.166 173.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -99.03 149.87 22.56 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.657 -0.868 . . . . 0.47 108.657 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.531 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 27.5 mtt -60.23 -7.07 1.71 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.215 0.45 . . . . 2.84 112.215 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 t -68.66 -29.96 68.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.221 -0.445 . . . . 1.41 110.776 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -92.93 -1.21 56.92 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.845 0.355 . . . . 1.96 111.138 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' A' ' 62' ' ' THR . 2.1 t -74.42 150.66 7.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.593 0.59 . . . . 1.06 112.593 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.529 ' CG ' HD12 ' A' ' 90' ' ' LEU . 1.4 tm0? -54.37 100.06 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 114.758 -1.11 . . . . 1.85 111.805 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.52 -92.18 0.01 OUTLIER Glycine 0 C--N 1.332 0.317 0 O-C-N 123.873 0.733 . . . . 0.62 114.342 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -89.73 131.34 35.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 2.3 110.174 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.531 ' HB ' ' SD ' ' A' ' 55' ' ' MET . 30.7 p -75.45 -12.04 60.16 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.471 -0.786 . . . . 1.45 111.096 -172.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.0 t -92.85 -2.15 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.499 -0.773 . . . . 1.95 110.05 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.88 -14.54 29.51 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.394 0.616 . . . . 1.21 110.895 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.34 124.6 48.99 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.528 -0.76 . . . . 2.19 109.084 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 95.3 m-70 -121.8 153.14 60.05 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.884 0.373 . . . . 1.12 111.316 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.0 Cg_endo -67.64 134.85 34.04 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.499 2.132 . . . . 0.28 111.243 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.22 -17.34 59.32 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.826 -0.702 . . . . 0.23 111.93 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 66' ' ' HIS . 23.5 m-20 -74.23 151.05 40.01 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 110.101 -0.333 . . . . 1.28 110.101 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 m -81.17 135.18 35.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.395 -0.965 . . . . 1.05 108.395 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.6 m -134.9 167.09 26.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.214 0.531 . . . . 1.16 110.945 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -113.88 150.07 34.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.014 -1.106 . . . . 0.78 108.014 172.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.576 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.2 p90 -157.85 179.06 9.55 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.335 -0.617 . . . . 0.15 109.335 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -130.29 133.69 46.66 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.253 -1.017 . . . . 1.3 108.253 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 p -94.5 98.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.658 0.742 . . . . 1.11 111.087 -172.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -102.54 107.64 22.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.39 -0.823 . . . . 1.13 109.725 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 26.8 m -74.43 129.67 38.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.983 0.421 . . . . 1.27 110.864 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 39.7 m-80 -76.83 101.06 5.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.879 -0.6 . . . . 1.96 109.528 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -60.9 -21.31 63.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.957 0.408 . . . . 2.24 111.119 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -72.52 -41.11 66.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.714 -0.675 . . . . 4.49 111.585 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -114.65 -31.49 6.16 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.517 0.562 . . . . 2.66 112.517 -172.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.44 -20.36 25.46 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.003 -0.618 . . . . 0.88 113.303 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 21.1 pttp -96.89 150.72 20.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.036 0.418 . . . . 2.9 110.752 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 13.4 m -93.3 -176.29 4.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.11 -0.496 . . . . 1.49 111.607 -175.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.8 m -150.05 150.08 31.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.828 -0.624 . . . . 1.31 109.434 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . . . -89.82 120.93 31.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.217 0.532 . . . . 1.05 111.101 -177.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 50.0 m -117.32 144.38 44.95 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.759 -0.655 . . . . 1.17 110.126 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.5 t30 62.82 66.84 0.73 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.764 0.665 . . . . 2.17 109.792 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.637 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 95.2 t -89.33 100.85 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.518 -0.764 . . . . 1.06 110.675 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.529 HD12 ' CG ' ' A' ' 59' ' ' GLN . 2.1 mm? -105.45 147.53 28.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.833 -0.621 . . . . 1.77 110.81 -177.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.36 122.75 24.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 2.02 110.741 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.4 mm . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.597 -0.728 . . . . 1.05 110.738 -176.464 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.115 0.483 . . . . 1.88 110.878 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.488 ' HZ2' ' CD ' ' A' ' 72' ' ' GLU . 9.6 mtmp? -109.31 112.73 25.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.145 0.497 . . . . 2.59 110.628 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -89.51 150.29 22.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.57 -0.741 . . . . 1.84 110.294 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -123.66 127.3 48.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.95 0.405 . . . . 1.99 110.347 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.58 179.36 9.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.015 -0.735 . . . . 0.96 109.015 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.93 142.62 32.15 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 110.133 -0.321 . . . . 0.86 110.133 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.22 117.54 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.517 -0.549 . . . . 1.01 109.517 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.93 -40.47 63.07 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.768 -0.651 . . . . 0.6 110.513 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 p -174.41 156.0 2.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.56 -0.746 . . . . 1.18 109.697 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.4 mt -127.6 132.38 69.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.186 -0.461 . . . . 1.03 110.005 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -121.96 85.95 2.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.568 -0.742 . . . . 2.16 110.458 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.37 -107.13 1.95 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.915 -0.659 . . . . 0.34 112.605 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -97.63 10.7 39.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 2.6 110.509 -175.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -132.73 142.22 48.93 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 120.942 0.401 . . . . 0.38 110.643 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.6 153.88 19.83 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.226 -0.749 . . . . 0.11 111.226 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 64.6 m-85 -127.88 146.11 50.73 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.57 -0.529 . . . . 0.19 109.57 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.531 HD11 ' CD2' ' A' ' 73' ' ' PHE . 6.0 mt -117.65 157.12 27.0 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.926 -0.398 . . . . 1.28 109.926 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -76.75 73.53 3.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.508 0.67 . . . . 1.77 109.677 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.419 ' HB3' HD11 ' A' ' 51' ' ' LEU . 33.7 t80 -146.19 102.46 3.62 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.293 -0.867 . . . . 0.33 109.301 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.56 101.0 12.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.934 -0.575 . . . . 1.81 110.275 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 46' ' ' GLU . 21.3 m -74.06 -46.42 45.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.801 0.81 . . . . 1.51 110.648 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 45' ' ' VAL . 34.5 tt0 -124.55 -179.11 4.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.803 -1.554 . . . . 2.24 106.803 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.443 ' H ' ' CG ' ' A' ' 46' ' ' GLU . 8.1 t70 -41.09 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.089 0.956 . . . . 1.55 112.948 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.16 13.96 67.9 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.651 -0.785 . . . . 0.77 111.701 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.94 108.99 10.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.23 -0.655 . . . . 3.03 109.23 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -72.61 136.15 45.67 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.161 -0.681 . . . . 1.87 109.161 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -70.2 123.68 22.25 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.837 -0.431 . . . . 1.05 109.837 177.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -107.0 156.85 18.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.714 -0.476 . . . . 0.48 109.714 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.459 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 22.7 p90 -147.84 152.73 38.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.655 -0.702 . . . . 0.2 109.11 172.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -91.87 146.93 23.36 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.048 -0.723 . . . . 0.47 109.048 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.571 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 41.8 ttp -53.23 -17.16 1.55 Allowed 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 123.704 0.801 . . . . 2.84 112.274 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -64.57 -32.32 73.92 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.601 0.239 . . . . 1.41 110.868 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -78.08 -15.12 59.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.141 0.496 . . . . 1.96 110.822 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -64.03 147.46 12.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.395 -0.82 . . . . 1.06 111.956 -174.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.48 ' HG3' ' CD1' ' A' ' 90' ' ' LEU . 1.1 tt0 -64.06 86.77 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.776 -1.102 . . . . 1.85 112.933 -171.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.69 -90.82 0.25 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.293 -0.479 . . . . 0.62 113.26 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -92.99 143.83 25.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.277 0.56 . . . . 2.3 110.589 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.1 p -69.31 -33.56 73.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.217 -0.901 . . . . 1.45 110.926 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.56 -11.47 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.43 -0.805 . . . . 1.95 111.162 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.58 -8.5 50.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.607 -0.724 . . . . 1.21 111.728 -173.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.48 124.63 49.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.411 -0.589 . . . . 2.19 109.411 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -122.2 150.03 55.89 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.731 0.3 . . . . 1.12 111.055 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.77 130.32 21.67 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.365 2.043 . . . . 0.28 111.092 172.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.91 -9.73 58.38 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.834 -0.698 . . . . 0.23 111.967 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -87.48 145.47 26.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.258 -0.275 . . . . 1.28 110.258 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 m -72.22 134.37 45.6 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.462 -0.57 . . . . 1.05 109.462 173.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.53 160.2 37.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.776 0.798 . . . . 1.16 111.098 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.488 ' CD ' ' HZ2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -114.84 132.08 56.62 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.429 -1.259 . . . . 0.78 108.65 178.259 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.531 ' CD2' HD11 ' A' ' 41' ' ' LEU . 26.0 p90 -142.48 178.67 7.44 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.612 -0.722 . . . . 0.15 109.583 -172.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.1 m -128.68 119.35 24.5 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.163 -0.68 . . . . 1.3 109.163 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.29 99.44 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.81 0.814 . . . . 1.11 110.986 -173.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.68 122.99 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.423 -0.808 . . . . 1.13 109.794 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 36.7 m -86.09 125.77 33.7 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.094 -0.503 . . . . 1.27 111.008 -177.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -63.98 109.92 1.95 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.826 -0.625 . . . . 1.96 109.527 175.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.413 ' H ' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -60.86 -23.14 64.92 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.238 0.459 . . . . 2.24 112.238 -175.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.413 ' HA ' ' NE ' ' A' ' 80' ' ' ARG . 7.2 tpm_? -93.66 -47.11 6.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.655 -0.418 . . . . 4.49 111.145 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -81.36 -30.81 33.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 2.66 111.586 -174.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.45 -10.24 75.07 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.952 -0.642 . . . . 0.88 112.463 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -93.98 156.08 16.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.022 -0.733 . . . . 2.9 109.022 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.471 ' HB2' HG13 ' A' ' 45' ' ' VAL . 3.2 m -107.75 170.62 7.88 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.435 -0.506 . . . . 1.49 111.173 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.3 p -144.07 159.84 41.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.69 -0.686 . . . . 1.31 110.122 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 73' ' ' PHE . . . -96.3 123.98 40.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.349 -0.387 . . . . 1.05 110.367 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -116.86 149.16 40.53 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.001 -1.111 . . . . 1.17 108.001 176.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 57.11 72.25 0.52 Allowed 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.82 0.7 . . . . 2.17 110.321 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 96.2 t -89.58 105.4 16.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.565 0.697 . . . . 1.06 110.639 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.48 ' CD1' ' HG3' ' A' ' 59' ' ' GLN . 4.0 mm? -106.7 148.95 27.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.161 -0.927 . . . . 1.77 110.648 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.406 ' HB2' ' OE1' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -81.66 129.47 34.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.676 -0.693 . . . . 2.02 111.224 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.5 mm . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.704 -0.68 . . . . 1.05 110.427 -178.232 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.536 0.207 . . . . 1.88 110.992 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.447 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 2.6 mppt? -106.86 120.99 43.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.145 0.498 . . . . 2.59 110.423 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -105.11 144.89 31.29 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.484 -0.78 . . . . 1.84 110.26 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -118.84 127.17 53.27 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.664 -0.414 . . . . 1.99 110.578 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.63 179.67 8.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.69 -0.686 . . . . 0.96 109.579 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.44 144.5 30.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.045 -0.354 . . . . 0.86 110.045 -177.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 57.6 t -63.98 117.43 4.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.142 0.496 . . . . 1.01 110.577 176.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.442 ' CG ' ' HZ2' ' A' ' 50' ' ' LYS . 8.5 t70 -69.2 -47.86 63.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.031 -0.986 . . . . 0.6 109.616 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.409 ' HG ' ' C ' ' A' ' 32' ' ' ASP . 74.1 m -167.92 164.49 13.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.775 -0.648 . . . . 1.18 109.699 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 mt -136.52 132.97 49.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.672 -0.492 . . . . 1.03 109.672 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -126.79 89.34 2.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 2.16 110.227 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.37 -107.77 2.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.75 -0.738 . . . . 0.34 112.592 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -97.37 9.64 41.78 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.808 -0.231 . . . . 2.6 110.761 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.51 141.2 51.05 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.184 0.516 . . . . 0.38 111.006 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.9 157.16 21.47 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.387 -0.824 . . . . 0.11 111.152 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 68.8 m-85 -129.73 148.61 51.63 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.09 -0.708 . . . . 0.19 109.09 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.52 HD13 ' CD2' ' A' ' 73' ' ' PHE . 8.8 mt -123.72 153.05 41.42 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.662 -0.495 . . . . 1.28 109.662 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -75.1 73.59 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.487 -0.56 . . . . 1.77 109.487 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.409 ' HB3' HD13 ' A' ' 51' ' ' LEU . 27.9 t80 -150.26 98.56 2.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.41 -0.814 . . . . 0.33 109.536 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 47.2 mt-10 -81.67 100.5 9.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.485 0.66 . . . . 1.81 109.695 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 84' ' ' SER . 27.2 m -72.21 -35.68 53.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.078 -0.965 . . . . 1.51 111.446 -176.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.56 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 7.9 tp10 -145.05 179.65 7.21 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.376 -1.713 . . . . 2.24 106.376 -175.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.56 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 23.8 t70 -27.75 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.271 1.428 . . . . 1.55 114.38 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.511 ' HA2' ' OE1' ' A' ' 44' ' ' GLU . . . 66.84 19.72 69.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.992 -0.623 . . . . 0.77 111.768 173.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 40.8 mmtm -82.88 109.05 16.67 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 110.061 -0.348 . . . . 3.03 110.061 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HZ2' ' CG ' ' A' ' 32' ' ' ASP . 2.9 tppp? -74.39 128.95 36.83 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.712 -0.847 . . . . 1.87 108.712 175.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 1.1 mt -64.66 126.73 28.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.597 -0.274 . . . . 1.05 110.646 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -112.27 156.66 22.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.97 0.414 . . . . 0.48 110.031 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 17.2 p90 -146.84 161.46 40.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.911 -0.586 . . . . 0.2 109.524 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -102.09 140.35 36.48 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.246 -0.65 . . . . 0.47 109.246 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.455 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 1.8 tmt? -51.13 -23.84 3.56 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.827 0.851 . . . . 2.84 112.657 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.6 t -60.27 -23.22 63.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.642 0.258 . . . . 1.41 111.215 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -95.74 0.06 52.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.8 -0.182 . . . . 1.96 111.474 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -74.91 137.35 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.305 0.574 . . . . 1.06 111.422 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.83 104.07 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.858 -1.064 . . . . 1.85 111.972 -175.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.03 -84.55 0.49 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.62 113.074 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -135.19 158.17 45.06 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.893 -0.41 . . . . 2.3 109.893 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.9 p -74.5 -8.52 56.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.568 0.699 . . . . 1.45 110.138 178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.43 -1.09 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.306 -0.861 . . . . 1.95 109.904 175.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.87 -39.85 4.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.79 -0.641 . . . . 1.21 110.423 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.5 HD11 HG13 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -95.32 123.35 38.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.298 -0.63 . . . . 2.19 109.298 178.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -134.58 158.2 75.62 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.637 -0.256 . . . . 1.12 111.116 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.545 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 28.1 Cg_endo -63.53 142.19 83.43 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.689 2.259 . . . . 0.28 111.745 176.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.96 -6.49 83.11 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.58 -0.819 . . . . 0.23 112.742 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -95.08 158.65 15.37 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.61 -0.515 . . . . 1.28 109.61 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -81.75 137.79 35.29 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.229 -0.656 . . . . 1.05 109.229 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.5 HG13 HD11 ' A' ' 65' ' ' LEU . 10.4 m -137.91 156.46 31.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.421 0.629 . . . . 1.16 109.857 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.39 133.16 55.91 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.505 -0.924 . . . . 0.78 108.505 175.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.52 ' CD2' HD13 ' A' ' 41' ' ' LEU . 28.6 p90 -142.5 179.46 6.95 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.71 -0.677 . . . . 0.15 109.789 -173.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.4 t -127.95 116.31 19.88 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.995 -1.113 . . . . 1.3 107.995 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.3 p -81.64 98.22 4.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.906 0.86 . . . . 1.11 110.557 -173.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 p -102.62 116.31 46.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.23 -0.896 . . . . 1.13 109.788 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 30.2 m -73.99 130.7 40.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.117 -0.492 . . . . 1.27 110.496 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 33.8 m-80 -68.96 112.18 5.45 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.212 -0.662 . . . . 1.96 109.212 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -52.91 -31.32 39.35 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.826 0.704 . . . . 2.24 111.889 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -94.24 -53.86 3.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.828 0.347 . . . . 4.49 111.591 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -74.06 -18.41 60.83 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.296 0.48 . . . . 2.66 112.296 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.93 -24.38 6.06 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.991 -0.624 . . . . 0.88 113.173 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 53.9 pttt -91.4 154.12 19.4 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.457 -0.571 . . . . 2.9 109.457 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.458 ' HB2' HG13 ' A' ' 45' ' ' VAL . 17.6 m -101.11 179.98 4.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.951 0.405 . . . . 1.49 111.706 -174.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.1 m -146.37 155.94 42.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.794 -0.639 . . . . 1.31 109.43 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 73' ' ' PHE . . . -96.23 120.67 36.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.89 0.376 . . . . 1.05 110.601 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.3 m -116.99 156.97 26.56 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.954 -0.758 . . . . 1.17 108.954 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.423 HD22 HD23 ' A' ' 90' ' ' LEU . 7.0 t30 55.9 62.54 2.35 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.694 0.621 . . . . 2.17 109.988 -177.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.7 t -81.25 104.95 10.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.771 -0.649 . . . . 1.06 110.892 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.423 HD23 HD22 ' A' ' 88' ' ' ASN . 4.0 mp -107.29 150.53 26.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.293 -0.867 . . . . 1.77 111.364 -176.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.91 129.23 34.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.996 -0.547 . . . . 2.02 110.253 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mm . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 120.757 0.313 . . . . 1.05 110.766 -177.635 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 6.4 tp60 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.923 0.392 . . . . 1.88 110.319 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -109.22 112.84 25.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.316 0.579 . . . . 2.59 110.337 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -99.07 151.25 21.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.378 -0.828 . . . . 1.84 110.856 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -119.25 127.89 53.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.714 0.292 . . . . 1.99 110.385 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.63 179.71 8.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.871 -0.604 . . . . 0.96 109.491 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.82 141.56 36.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 110.155 -0.313 . . . . 0.86 110.155 -177.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.471 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 47.1 t -62.77 118.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.762 0.315 . . . . 1.01 110.257 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.05 -43.81 77.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.459 -0.791 . . . . 0.6 110.098 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.6 p -178.52 165.66 1.74 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.31 -0.859 . . . . 1.18 109.511 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.5 mt -131.19 131.45 63.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.264 0.554 . . . . 1.03 109.958 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -123.66 85.71 2.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.385 -0.825 . . . . 2.16 110.249 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.09 -111.25 3.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.829 -0.7 . . . . 0.34 112.415 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -96.83 11.7 34.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.681 0.277 . . . . 2.6 110.746 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -131.61 139.73 49.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.191 0.52 . . . . 0.38 110.621 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.528 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -121.96 156.15 16.74 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.783 -0.927 . . . . 0.11 110.783 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -129.32 146.63 51.17 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.036 -0.727 . . . . 0.19 109.036 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.556 HD12 ' CD2' ' A' ' 73' ' ' PHE . 7.1 mt -117.69 152.68 34.74 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.103 -0.703 . . . . 1.28 109.103 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.66 72.94 2.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.926 0.869 . . . . 1.77 109.532 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -145.58 99.92 3.36 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.417 -1.265 . . . . 0.33 108.027 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 92.6 mt-10 -98.75 103.15 15.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.571 0.701 . . . . 1.81 110.763 -174.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.5 m -70.67 -37.11 68.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.521 -1.218 . . . . 1.51 112.483 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 2.5 tp10 -151.25 121.3 7.16 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 121.485 -0.086 . . . . 2.24 111.018 -176.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.9 t70 62.39 15.92 8.13 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.625 0.726 . . . . 1.55 111.87 169.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.52 ' HA2' ' OE2' ' A' ' 44' ' ' GLU . . . 94.33 28.42 10.66 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.577 -0.821 . . . . 0.77 112.056 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -81.07 110.16 16.33 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.604 -0.517 . . . . 3.03 109.604 179.164 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -68.63 130.27 42.36 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.649 0.593 . . . . 1.87 109.772 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 51' ' ' LEU . 2.1 mt -66.41 124.22 22.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.158 -0.474 . . . . 1.05 110.737 176.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -107.4 160.09 15.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.247 -0.433 . . . . 0.48 110.1 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.528 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 33.7 p90 -152.03 152.61 32.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.464 -0.789 . . . . 0.2 109.037 173.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -91.79 152.87 19.94 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.692 -0.855 . . . . 0.47 108.692 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.461 ' SD ' HG21 ' A' ' 58' ' ' VAL . 3.4 tpt -68.65 0.68 3.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.635 0.374 . . . . 2.84 111.927 -173.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 p -79.95 -37.54 34.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.958 0.409 . . . . 1.41 110.877 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -72.37 -16.23 61.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.771 -0.65 . . . . 1.96 110.14 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.461 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -61.06 150.81 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.141 -0.936 . . . . 1.06 111.778 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.429 ' CG ' ' HG ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -66.32 93.81 0.24 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.347 -0.842 . . . . 1.85 112.16 -176.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.86 -91.87 0.52 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.566 -0.743 . . . . 0.62 113.58 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -103.87 159.34 15.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.848 0.356 . . . . 2.3 110.098 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.5 p -79.86 -21.12 44.46 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.045 -0.525 . . . . 1.45 111.542 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.8 p -83.18 -9.42 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.373 0.606 . . . . 1.95 110.667 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 -19.7 28.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.551 -0.749 . . . . 1.21 111.383 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.84 123.89 50.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.637 -0.71 . . . . 2.19 109.272 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -123.47 155.88 64.95 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 1.12 111.452 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.471 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.7 Cg_endo -68.98 132.53 24.79 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.502 2.135 . . . . 0.28 111.535 174.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.21 -11.04 63.75 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.931 -0.652 . . . . 0.23 111.758 -177.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -84.47 149.45 25.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.04 -0.356 . . . . 1.28 110.04 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 m -75.69 139.0 41.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.519 -0.549 . . . . 1.05 109.519 174.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.22 162.92 24.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 120.829 0.347 . . . . 1.16 111.218 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.491 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -114.43 148.0 38.42 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.869 -1.16 . . . . 0.78 107.869 172.289 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.556 ' CD2' HD12 ' A' ' 41' ' ' LEU . 29.5 p90 -153.62 -179.46 7.81 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.381 -0.6 . . . . 0.15 109.381 -175.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.6 m -128.07 114.26 16.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.988 -0.745 . . . . 1.3 108.988 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 75' ' ' VAL . 7.6 p -84.24 99.87 7.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.597 0.713 . . . . 1.11 111.293 -175.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.81 121.89 60.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.685 -0.689 . . . . 1.13 109.589 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 22.1 m -80.36 128.58 33.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.71 0.29 . . . . 1.27 111.166 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 75.1 m-20 -74.09 114.66 12.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.157 -0.474 . . . . 1.96 109.875 177.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -64.03 -24.82 67.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.384 . . . . 2.24 111.835 -173.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -90.34 -45.54 8.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 4.49 111.342 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -85.72 -23.05 27.51 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.913 0.338 . . . . 2.66 111.913 -174.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.54 -21.08 14.94 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 121.237 -0.506 . . . . 0.88 112.764 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 39.7 pttt -98.05 142.76 29.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.292 0.568 . . . . 2.9 110.757 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.4 m -84.94 179.51 7.29 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.24 -0.891 . . . . 1.49 111.876 -175.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.4 m -147.37 157.45 43.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.652 -0.704 . . . . 1.31 109.479 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' A' ' 53' ' ' PHE . . . -98.86 122.2 41.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.901 0.381 . . . . 1.05 110.843 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 80.1 m -116.21 141.55 48.0 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.05 -0.523 . . . . 1.17 110.14 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.25 67.84 0.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.801 0.688 . . . . 2.17 110.144 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 92.7 t -84.73 103.76 12.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.593 -0.73 . . . . 1.06 110.645 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.491 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 8.1 mp -108.14 147.85 30.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.79 -0.641 . . . . 1.77 111.199 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.28 129.04 35.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.636 -0.711 . . . . 2.02 111.414 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.6 mm . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.963 -0.562 . . . . 1.05 111.518 -176.416 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 120.817 0.341 . . . . 1.88 110.483 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -97.1 111.73 23.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.465 0.65 . . . . 2.59 110.254 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 73.1 mmtt -94.27 160.21 14.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.992 -1.004 . . . . 1.84 110.308 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 17.6 mtm180 -128.72 127.52 42.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.959 0.409 . . . . 1.99 110.131 175.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.49 178.21 9.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.679 -0.691 . . . . 0.96 109.724 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.04 141.21 33.17 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.276 -0.639 . . . . 0.86 109.276 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.448 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 51.1 t -62.31 114.42 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.821 -0.437 . . . . 1.01 109.821 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.29 -47.15 62.5 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.307 -0.86 . . . . 0.6 109.973 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.5 m -160.72 160.14 31.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.596 -0.729 . . . . 1.18 110.392 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.2 mt -137.26 120.12 20.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.174 -0.676 . . . . 1.03 109.174 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -110.23 86.38 2.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.544 -0.753 . . . . 2.16 109.767 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.8 -109.15 2.76 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.683 -0.77 . . . . 0.34 112.247 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -91.18 2.75 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.926 -0.161 . . . . 2.6 111.269 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -124.07 141.0 52.43 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.305 -0.558 . . . . 0.38 111.335 -174.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -122.56 158.66 17.23 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.517 -0.765 . . . . 0.11 111.415 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.51 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 49.6 m-85 -136.11 136.23 39.95 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.882 -0.784 . . . . 0.19 108.882 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.432 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -106.26 155.08 19.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.458 -0.942 . . . . 1.28 108.458 177.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -76.32 73.5 3.11 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.419 0.628 . . . . 1.77 109.581 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -141.66 98.82 3.42 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.065 -0.971 . . . . 0.33 109.657 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.75 100.69 7.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.616 0.722 . . . . 1.81 110.101 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.478 ' CG1' ' HG ' ' A' ' 51' ' ' LEU . 31.6 m -80.23 -34.5 14.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.014 -0.993 . . . . 1.51 110.992 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.539 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 8.3 tp10 -137.08 177.61 7.73 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.019 -1.845 . . . . 2.24 106.019 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.539 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 29.2 t70 -40.56 85.94 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.815 1.043 . . . . 1.55 113.815 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.22 16.99 71.68 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.775 -0.93 . . . . 0.77 110.775 173.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -88.5 109.42 20.03 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.004 -0.739 . . . . 3.03 109.004 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -75.46 134.32 40.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.65 -0.5 . . . . 1.87 109.65 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 1.4 mt -64.69 125.01 23.41 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.253 0.346 . . . . 1.05 111.037 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -108.78 158.61 17.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.962 -0.384 . . . . 0.48 109.962 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.432 ' CD2' HD23 ' A' ' 41' ' ' LEU . 45.9 p90 -153.11 154.25 34.45 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.065 -0.717 . . . . 0.2 109.065 173.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.411 ' C ' ' H ' ' A' ' 56' ' ' SER . 9.0 t-160 -94.54 152.07 18.84 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.627 -0.879 . . . . 0.47 108.627 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.503 ' SD ' HG23 ' A' ' 58' ' ' VAL . 9.4 mmt -63.87 0.79 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.28 0.474 . . . . 2.84 112.28 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 54' ' ' HIS . 22.3 t -86.13 -23.05 26.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.713 0.292 . . . . 1.41 110.327 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -91.11 -2.59 57.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.025 0.44 . . . . 1.96 110.079 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.503 HG23 ' SD ' ' A' ' 55' ' ' MET . 2.2 t -72.66 151.28 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.53 -0.759 . . . . 1.06 112.389 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.53 96.27 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.05 -0.977 . . . . 1.85 111.57 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.17 -84.11 0.41 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.753 -0.658 . . . . 0.62 113.569 170.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -113.25 145.74 40.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.139 0.495 . . . . 2.3 110.579 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.416 HG23 ' HB3' ' A' ' 55' ' ' MET . 81.6 p -72.3 -9.63 58.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 1.45 111.705 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.8 t -95.36 -2.92 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.499 -0.773 . . . . 1.95 110.373 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.94 -17.59 22.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.096 0.474 . . . . 1.21 111.445 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.1 124.0 51.56 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.163 -0.68 . . . . 2.19 109.163 -176.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -123.29 155.63 64.71 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.656 0.265 . . . . 1.12 111.269 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.448 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.0 Cg_endo -67.12 128.36 18.44 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.341 2.027 . . . . 0.28 111.339 172.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.74 -11.62 53.31 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.684 -0.769 . . . . 0.23 112.072 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -81.14 149.16 29.25 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.645 0.259 . . . . 1.28 110.522 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.6 m -76.86 131.35 38.56 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.525 -0.917 . . . . 1.05 108.525 171.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.01 159.48 41.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 122.04 0.924 . . . . 1.16 111.006 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -114.52 139.75 49.31 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.844 -1.526 . . . . 0.78 108.708 177.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 29.9 p90 -152.37 -179.68 7.77 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.463 -0.569 . . . . 0.15 109.463 -174.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 t -124.99 127.81 47.59 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.803 -0.814 . . . . 1.3 108.803 177.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 75' ' ' VAL . 7.4 p -95.01 98.45 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.919 0.866 . . . . 1.11 110.835 -176.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.0 p -104.7 110.82 31.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.246 -0.888 . . . . 1.13 110.09 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 31.8 m -69.37 123.8 22.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.095 -0.502 . . . . 1.27 110.454 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 0.9 OUTLIER -69.92 109.38 4.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.516 -0.549 . . . . 1.96 109.516 178.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -13.37 52.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.788 0.328 . . . . 2.24 111.316 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -94.37 -36.14 12.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.402 -0.363 . . . . 4.49 111.47 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -99.82 -29.36 12.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.253 0.464 . . . . 2.66 112.253 -174.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.17 -24.38 25.24 Favored Glycine 0 C--N 1.32 -0.313 0 C-N-CA 121.239 -0.505 . . . . 0.88 112.103 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 18.3 pttm -95.03 154.46 17.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.622 -0.511 . . . . 2.9 109.622 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 2.0 m -94.97 -179.26 4.77 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.843 0.354 . . . . 1.49 110.736 -177.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -146.36 146.88 30.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.244 -0.65 . . . . 1.31 109.244 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 73' ' ' PHE . . . -88.92 118.41 28.62 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.912 0.386 . . . . 1.05 110.424 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.8 m -117.16 149.09 40.95 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.257 -0.646 . . . . 1.17 109.257 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 m120 61.61 67.95 0.74 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.491 0.662 . . . . 2.17 109.532 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 86.0 t -89.92 111.76 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.286 -0.87 . . . . 1.06 110.748 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.46 147.27 30.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.574 -0.739 . . . . 1.77 110.903 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 114.17 21.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.748 -0.66 . . . . 2.02 110.136 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.9 mm . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 115.56 -0.746 . . . . 1.05 111.135 -175.831 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.335 0.112 . . . . 1.88 110.965 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.26 125.51 51.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.314 0.578 . . . . 2.59 110.836 176.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -104.12 147.55 27.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.58 -0.736 . . . . 1.84 109.198 171.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -124.16 128.11 48.76 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.96 -0.296 . . . . 1.99 110.852 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.79 179.49 9.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.753 . . . . 0.96 110.429 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.07 146.65 28.05 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.117 -0.492 . . . . 0.86 110.335 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.477 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 31.0 t -67.26 121.73 16.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.157 0.503 . . . . 1.01 110.325 176.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -80.95 -41.69 22.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.434 -0.803 . . . . 0.6 109.914 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.3 p -163.96 166.9 21.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 1.18 110.643 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.3 mt -140.86 130.92 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.256 0.551 . . . . 1.03 109.873 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -124.82 88.16 2.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.383 -0.826 . . . . 2.16 110.411 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.48 -110.91 3.49 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.674 -0.774 . . . . 0.34 112.192 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -92.34 5.81 49.24 Favored 'General case' 0 C--O 1.225 -0.236 0 O-C-N 122.77 -0.253 . . . . 2.6 110.88 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -126.36 140.72 52.28 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.212 -0.595 . . . . 0.38 111.499 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.465 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.82 157.95 17.43 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.319 -0.855 . . . . 0.11 111.176 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 80.1 m-85 -130.26 140.54 50.68 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.292 -0.633 . . . . 0.19 109.292 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.457 HD11 ' CD2' ' A' ' 73' ' ' PHE . 6.8 mt -116.28 153.42 31.96 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.777 -0.453 . . . . 1.28 109.777 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -75.97 73.84 2.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.597 0.713 . . . . 1.77 109.817 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -144.45 109.27 4.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.845 -1.07 . . . . 0.33 109.275 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -92.81 115.02 27.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.848 -0.614 . . . . 1.81 110.576 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.9 m -85.62 -47.49 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.78 -0.645 . . . . 1.51 111.46 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.614 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 8.4 pt-20 -157.1 144.64 18.91 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.486 -0.561 . . . . 2.24 109.486 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.9 t70 59.63 10.76 2.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.969 0.89 . . . . 1.55 112.009 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.13 30.58 37.4 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.609 -0.805 . . . . 0.77 112.106 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.614 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 8.1 mtpp -73.34 112.45 9.41 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.451 -0.203 . . . . 3.03 110.451 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.07 120.73 14.76 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.58 0.55 . . . . 1.87 109.527 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.4 mt -58.54 128.02 35.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.025 -0.534 . . . . 1.05 112.074 -176.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -106.17 161.65 14.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.905 0.383 . . . . 0.48 110.559 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.498 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 21.2 p90 -152.76 157.17 40.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.95 -0.568 . . . . 0.2 109.572 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -99.49 150.66 21.97 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.952 -0.759 . . . . 0.47 108.952 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.491 ' SD ' HG23 ' A' ' 58' ' ' VAL . 16.4 mmt -61.89 -9.43 6.84 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.114 0.412 . . . . 2.84 112.114 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.1 t -71.36 -26.06 62.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.823 0.344 . . . . 1.41 110.196 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -92.98 -2.07 56.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.417 -0.356 . . . . 1.96 110.588 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.491 HG23 ' SD ' ' A' ' 55' ' ' MET . 1.2 t -73.25 151.44 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.397 0.617 . . . . 1.06 112.569 -174.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 17.1 tm0? -68.03 98.82 0.8 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.903 -1.044 . . . . 1.85 112.5 -174.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.55 -81.89 0.39 Allowed Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.814 -0.63 . . . . 0.62 113.354 172.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -114.34 150.11 35.04 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.928 0.394 . . . . 2.3 110.159 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.7 p -71.22 -16.44 62.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.808 -0.633 . . . . 1.45 110.625 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 t -97.36 10.46 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.449 -0.796 . . . . 1.95 109.856 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.32 -27.22 12.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.118 0.485 . . . . 1.21 110.916 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.553 ' CD2' ' HG2' ' A' ' 91' ' ' LYS . 0.9 OUTLIER -102.29 124.29 47.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.042 -0.725 . . . . 2.19 109.042 178.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.6 154.19 69.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.618 0.246 . . . . 1.12 111.33 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.456 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.6 Cg_endo -67.49 121.56 8.68 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.307 2.005 . . . . 0.28 111.422 173.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.477 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 103.05 -5.91 50.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.813 -0.708 . . . . 0.23 111.786 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.28 152.23 22.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.374 -0.602 . . . . 1.28 109.374 176.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 7.1 m -81.1 141.59 34.15 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.077 -0.712 . . . . 1.05 109.077 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.44 HG11 HD22 ' A' ' 65' ' ' LEU . 4.3 m -137.26 161.65 34.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.412 0.625 . . . . 1.16 110.83 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.61 141.33 47.91 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.43 -1.322 . . . . 0.78 107.43 170.075 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 30.9 p90 -151.64 178.98 8.8 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.978 0.418 . . . . 0.15 110.103 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.2 m -127.31 129.91 48.55 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.871 -0.788 . . . . 1.3 108.871 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 p -89.25 99.79 9.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.69 0.757 . . . . 1.11 110.979 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.4 p -107.33 101.93 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.741 0.781 . . . . 1.13 109.932 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 m -70.46 130.83 42.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.416 -0.811 . . . . 1.27 110.867 -177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.45 104.8 3.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.7 -0.852 . . . . 1.96 108.7 172.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -62.65 -16.78 58.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.847 0.356 . . . . 2.24 111.407 -176.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -90.75 -40.79 11.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.126 -0.488 . . . . 4.49 111.038 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -94.37 -31.47 14.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.864 0.364 . . . . 2.66 111.709 -173.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.28 -23.76 33.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.108 -0.568 . . . . 0.88 112.273 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.401 ' HD3' ' HE2' ' A' ' 49' ' ' LYS . 21.4 pttt -91.44 154.08 19.4 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.052 -0.351 . . . . 2.9 110.052 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.6 t -108.25 -176.46 3.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.439 -0.346 . . . . 1.49 110.808 -173.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 p -155.28 147.13 23.35 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.787 -0.642 . . . . 1.31 109.338 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 73' ' ' PHE . . . -87.22 123.01 31.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 120.974 0.416 . . . . 1.05 111.081 -177.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 89.5 m -117.35 150.95 37.99 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.876 -0.602 . . . . 1.17 109.475 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 58.4 63.01 1.82 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.413 0.446 . . . . 2.17 109.809 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 79.3 t -84.16 103.78 11.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.873 -0.603 . . . . 1.06 110.325 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 4.6 mm? -101.31 147.59 26.13 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.698 -0.683 . . . . 1.77 109.888 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.553 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -82.3 126.93 32.71 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.47 -0.567 . . . . 2.02 109.47 178.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.512 ' O ' ' HB ' ' A' ' 70' ' ' THR . 38.7 mm . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 115.906 -0.588 . . . . 1.05 110.103 -176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.033 0.444 . . . . 1.88 111.903 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -111.7 111.67 22.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.741 -0.663 . . . . 2.59 110.22 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -87.14 153.66 21.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.686 -0.688 . . . . 1.84 110.215 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.441 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 43.9 mtm180 -125.5 135.63 52.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.859 0.361 . . . . 1.99 110.527 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.81 179.34 8.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.558 -0.746 . . . . 0.96 109.447 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.25 147.09 28.44 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.003 -0.369 . . . . 0.86 110.003 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.54 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 26.7 t -69.34 120.33 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.077 0.465 . . . . 1.01 110.317 177.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -72.18 -41.81 66.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.312 -0.858 . . . . 0.6 110.631 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.8 p -175.66 163.3 2.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.685 -0.688 . . . . 1.18 109.477 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 mt -131.06 131.28 64.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.259 0.552 . . . . 1.03 110.264 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -121.86 86.37 2.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.141 -0.936 . . . . 2.16 109.775 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.15 -112.48 4.06 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.659 -0.782 . . . . 0.34 112.193 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -93.34 7.28 45.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.59 0.233 . . . . 2.6 110.743 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.24 141.64 51.4 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.081 0.467 . . . . 0.38 111.007 -174.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.74 157.52 18.18 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 111.038 -0.825 . . . . 0.11 111.038 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 81.1 m-85 -130.19 143.28 50.69 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.82 -0.437 . . . . 0.19 109.82 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.488 HD12 ' CD2' ' A' ' 73' ' ' PHE . 8.4 mt -117.5 152.88 34.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.075 -0.512 . . . . 1.28 109.918 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -74.37 74.76 1.89 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.671 0.748 . . . . 1.77 109.723 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -151.06 99.26 2.67 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.882 -1.054 . . . . 0.33 108.654 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 14.1 mt-10 -94.41 101.54 13.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.709 0.766 . . . . 1.81 111.296 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.595 HG21 ' H ' ' A' ' 46' ' ' GLU . 2.4 m -75.43 -59.07 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.247 -1.342 . . . . 1.51 111.262 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.595 ' H ' HG21 ' A' ' 45' ' ' VAL . 10.9 tp10 -106.82 179.87 4.14 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.131 -1.433 . . . . 2.24 107.131 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.441 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 31.3 t70 -30.54 83.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.854 1.262 . . . . 1.55 113.914 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 66.23 16.09 64.16 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.792 -0.718 . . . . 0.77 111.512 172.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.661 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 2.4 mmmt -77.14 108.09 9.98 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 110.021 -0.363 . . . . 3.03 110.021 -174.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -74.93 123.11 24.51 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.976 -1.12 . . . . 1.87 107.976 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 4.1 mt -57.55 122.22 12.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.818 0.342 . . . . 1.05 111.423 -174.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -101.07 155.07 18.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.896 -0.593 . . . . 0.48 109.954 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.472 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 33.1 p90 -149.4 157.13 43.05 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.632 -0.713 . . . . 0.2 109.276 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -99.77 150.11 22.66 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.238 -0.653 . . . . 0.47 109.238 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 58' ' ' VAL . 11.0 mmt -60.47 -6.89 1.77 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.631 0.604 . . . . 2.84 112.631 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.404 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . 17.6 t -79.01 -28.98 43.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.693 0.282 . . . . 1.41 110.284 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' OE2' ' HB3' ' A' ' 56' ' ' SER . 2.6 mp0 -85.61 -4.47 59.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.972 0.415 . . . . 1.96 110.593 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.529 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -69.5 148.38 11.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.605 -0.725 . . . . 1.06 112.486 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.4 ' HG2' HD11 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -64.15 99.9 0.3 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.467 -1.242 . . . . 1.85 111.883 -175.499 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.56 -89.65 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.866 -0.607 . . . . 0.62 113.131 173.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -106.07 151.06 25.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.986 0.422 . . . . 2.3 110.603 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.0 p -63.76 -33.79 76.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.478 -0.783 . . . . 1.45 111.076 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.6 t -88.3 7.22 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.828 -0.624 . . . . 1.95 110.443 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.82 -9.42 34.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.093 0.473 . . . . 1.21 110.788 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.529 ' CD2' ' HG2' ' A' ' 91' ' ' LYS . 1.1 tm? -121.36 124.5 44.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.622 -0.881 . . . . 2.19 108.622 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -122.87 152.33 62.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.452 -0.34 . . . . 1.12 111.407 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.414 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 44.8 Cg_endo -69.74 115.92 4.31 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.585 2.19 . . . . 0.28 111.907 176.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.54 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 119.77 -18.85 9.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.14 -0.553 . . . . 0.23 112.247 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.21 155.92 24.68 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.755 -0.461 . . . . 1.28 109.755 175.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 3.0 m -78.45 143.11 36.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.677 -0.49 . . . . 1.05 109.677 176.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.495 HG11 HD23 ' A' ' 65' ' ' LEU . 26.6 m -137.53 157.52 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 121.699 0.762 . . . . 1.16 110.215 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.441 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -115.41 141.51 47.94 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.27 -1.332 . . . . 0.78 108.359 171.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.488 ' CD2' HD12 ' A' ' 41' ' ' LEU . 30.5 p90 -152.04 179.57 8.36 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.05 -0.722 . . . . 0.15 109.05 -173.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.85 128.51 47.75 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.961 -0.755 . . . . 1.3 108.961 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.05 98.69 7.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.759 0.79 . . . . 1.11 110.61 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.88 125.64 67.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.292 -0.867 . . . . 1.13 109.367 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.7 m -81.4 128.98 34.44 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.351 -0.386 . . . . 1.27 110.48 -178.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -68.1 111.14 4.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.68 -0.489 . . . . 1.96 109.68 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.55 -18.84 44.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.081 -0.509 . . . . 2.24 112.035 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -95.06 -38.12 10.78 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.841 0.312 . . . . 4.49 111.841 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.426 ' HB3' ' HE2' ' A' ' 83' ' ' LYS . 11.2 m120 -113.73 -5.74 13.31 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.045 0.758 . . . . 2.66 113.045 -172.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.94 -9.42 24.77 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.893 -0.67 . . . . 0.88 114.017 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -97.45 152.87 18.53 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.581 -0.526 . . . . 2.9 109.581 179.227 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.1 t -97.01 -179.67 4.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.158 0.504 . . . . 1.49 111.745 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.7 p -154.97 150.4 27.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.35 -0.841 . . . . 1.31 108.783 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -87.22 122.58 31.2 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.201 0.524 . . . . 1.05 110.51 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 84.0 m -116.92 144.88 44.03 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.524 -0.762 . . . . 1.17 109.739 178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 56.79 73.26 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.812 0.695 . . . . 2.17 109.792 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 73.3 t -87.75 105.69 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.741 -0.663 . . . . 1.06 110.46 -178.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.4 HD11 ' HG2' ' A' ' 59' ' ' GLN . 4.3 mm? -101.98 149.05 24.62 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.358 -0.837 . . . . 1.77 110.298 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.529 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -84.54 115.85 22.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.326 -0.62 . . . . 2.02 109.326 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.402 ' O ' ' HB ' ' A' ' 70' ' ' THR . 43.2 mm . . . . . 0 C--N 1.319 -0.72 0 CA-C-O 121.158 0.504 . . . . 1.05 111.801 -172.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.494 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 4.0 tp60 . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.202 0.525 . . . . 1.88 110.767 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.593 ' HZ1' ' CD ' ' A' ' 72' ' ' GLU . 6.5 mtpm? -104.11 112.63 25.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.656 -0.702 . . . . 2.59 110.421 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 67.7 mmtt -100.05 157.52 16.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.424 -0.807 . . . . 1.84 111.4 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -124.53 140.04 53.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.44 -0.346 . . . . 1.99 110.122 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.42 179.26 6.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.048 -0.523 . . . . 0.96 110.184 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.01 145.14 30.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.239 -0.437 . . . . 0.86 110.103 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 67' ' ' PRO . 46.2 t -68.98 119.9 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.38 -0.373 . . . . 1.01 110.565 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -72.88 -40.41 65.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.826 -0.625 . . . . 0.6 110.344 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 p -171.12 164.3 7.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.067 -0.515 . . . . 1.18 110.628 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.7 mt -136.56 130.82 47.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.587 -0.523 . . . . 1.03 109.587 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -128.27 101.29 6.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.475 -0.784 . . . . 2.16 110.171 -175.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.27 -105.89 1.43 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.665 -0.778 . . . . 0.34 112.392 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -106.12 6.76 31.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.934 -0.395 . . . . 2.6 109.934 -177.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -125.4 140.64 52.62 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.377 0.608 . . . . 0.38 111.091 -174.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -123.79 156.58 18.04 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.957 -0.857 . . . . 0.11 110.957 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -131.0 144.95 51.87 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.711 -0.478 . . . . 0.19 109.711 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.543 HD11 ' CD2' ' A' ' 73' ' ' PHE . 4.8 mt -121.07 152.1 39.05 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.275 -0.639 . . . . 1.28 109.275 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -75.54 75.26 2.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.314 0.578 . . . . 1.77 109.585 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -143.12 98.17 3.22 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.433 -0.803 . . . . 0.33 109.509 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -79.47 101.31 8.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.915 -0.584 . . . . 1.81 109.844 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' A' ' 84' ' ' SER . 31.5 m -75.21 -43.96 43.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.536 -0.756 . . . . 1.51 110.609 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 6.0 tp10 -129.08 179.37 5.79 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 106.328 -1.731 . . . . 2.24 106.328 174.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.546 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 14.2 t70 -31.23 83.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.229 1.412 . . . . 1.55 114.059 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.03 8.65 61.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.273 -0.489 . . . . 0.77 111.954 173.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -74.32 110.38 8.57 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.505 -0.554 . . . . 3.03 109.505 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.55 ' HB2' ' HZ2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -78.9 129.77 34.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.668 -0.696 . . . . 1.87 110.193 -173.716 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mt -67.95 127.56 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.318 -0.401 . . . . 1.05 111.274 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -113.51 157.27 22.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.738 -0.664 . . . . 0.48 109.47 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.432 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 32.3 p90 -146.05 153.23 40.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.992 -0.549 . . . . 0.2 109.759 174.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.401 ' C ' ' H ' ' A' ' 56' ' ' SER . 12.5 t-160 -94.36 148.13 22.53 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.142 -0.688 . . . . 0.47 109.142 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.628 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 21.7 ttp -65.12 2.9 0.68 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.272 0.629 . . . . 2.84 111.635 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 54' ' ' HIS . 24.7 t -89.53 -19.23 25.28 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.648 -0.251 . . . . 1.41 110.751 176.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -85.85 -11.19 53.97 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 121.378 0.608 . . . . 1.96 109.426 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.6 t -64.41 146.78 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.783 -1.099 . . . . 1.06 112.593 -174.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.37 98.65 0.25 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.831 -1.077 . . . . 1.85 111.899 -173.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.92 -77.54 1.12 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.62 113.512 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -119.87 149.92 41.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.068 0.461 . . . . 2.3 110.025 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.628 ' HB ' ' SD ' ' A' ' 55' ' ' MET . 43.0 p -69.21 -21.89 63.92 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.33 -0.85 . . . . 1.45 112.233 -171.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.9 t -98.92 4.9 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.568 0.699 . . . . 1.95 110.169 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.13 -25.54 27.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.162 -0.472 . . . . 1.21 110.493 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.482 HD23 HG12 ' A' ' 71' ' ' VAL . 1.1 tm? -104.04 125.28 50.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.862 -0.608 . . . . 2.19 109.563 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -124.15 154.81 68.47 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.523 0.201 . . . . 1.12 111.134 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 39.3 Cg_endo -68.55 144.57 61.22 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.659 2.239 . . . . 0.28 112.152 176.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.48 -11.98 64.36 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.925 -0.655 . . . . 0.23 112.345 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.02 154.03 20.81 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.43 -0.211 . . . . 1.28 110.43 177.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.6 m -76.33 138.5 40.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.705 -0.48 . . . . 1.05 109.705 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.482 HG12 HD23 ' A' ' 65' ' ' LEU . 11.3 m -138.09 163.22 29.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.398 0.618 . . . . 1.16 109.877 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.593 ' CD ' ' HZ1' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -116.5 149.21 39.92 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.98 -1.009 . . . . 0.78 108.476 172.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.543 ' CD2' HD11 ' A' ' 41' ' ' LEU . 36.1 p90 -156.75 178.25 10.55 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.039 -0.356 . . . . 0.15 110.039 -175.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -124.36 132.67 53.55 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.94 -0.763 . . . . 1.3 108.94 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.32 99.01 8.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.693 0.759 . . . . 1.11 110.496 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.19 126.71 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.459 -0.792 . . . . 1.13 110.589 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.6 m -74.33 132.66 42.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.088 -0.506 . . . . 1.27 111.287 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -75.17 116.46 15.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.092 -0.707 . . . . 1.96 109.092 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -58.16 -28.03 64.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.08 0.4 . . . . 2.24 112.08 -175.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -94.08 -51.58 4.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.919 0.34 . . . . 4.49 111.919 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -81.77 -31.69 31.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.941 0.349 . . . . 2.66 111.941 -172.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.13 -21.98 43.21 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.676 -0.773 . . . . 0.88 112.674 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -82.35 166.59 19.32 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 109.467 -0.568 . . . . 2.9 109.467 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.511 ' HB2' HG11 ' A' ' 45' ' ' VAL . 11.4 m -104.93 -177.66 3.43 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.577 -0.449 . . . . 1.49 111.008 -177.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.6 m -147.82 144.84 28.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.455 -0.572 . . . . 1.31 109.455 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.406 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . . . -84.59 120.59 26.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.969 0.414 . . . . 1.05 110.647 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.4 m -117.7 146.02 44.02 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.528 -0.76 . . . . 1.17 109.738 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.4 m120 56.6 74.45 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.677 0.611 . . . . 2.17 110.766 -175.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 76.1 t -86.93 110.44 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.634 -0.712 . . . . 1.06 110.991 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.59 148.82 24.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.706 -0.679 . . . . 1.77 110.833 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.421 ' HG2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -79.92 122.58 26.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.197 -0.668 . . . . 2.02 109.197 174.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mm . . . . . 0 C--N 1.321 -0.659 0 CA-C-O 121.09 0.471 . . . . 1.05 111.352 -177.315 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.449 HE21 ' HE3' ' A' ' 27' ' ' LYS . 62.9 tp60 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 112.008 0.373 . . . . 1.88 112.008 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HZ3' ' CD ' ' A' ' 72' ' ' GLU . 31.8 mtmt -111.83 135.53 52.32 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.517 -0.549 . . . . 2.59 109.517 172.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HE3' HE21 ' A' ' 25' ' ' GLN . 28.7 mmtp -112.76 144.88 41.55 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.106 -0.702 . . . . 1.84 109.106 172.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.404 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 4.1 mtm180 -121.74 127.59 50.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.051 0.453 . . . . 1.99 110.846 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.67 179.65 9.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.39 -0.823 . . . . 0.96 110.059 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.81 144.05 30.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.547 -0.297 . . . . 0.86 110.566 -178.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.527 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 43.4 t -65.08 115.73 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.827 -0.434 . . . . 1.01 109.827 175.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.73 -48.68 58.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.082 -0.508 . . . . 0.6 110.079 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 m -159.64 160.64 34.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.632 -0.713 . . . . 1.18 109.687 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 mt -138.09 130.79 40.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.426 -0.583 . . . . 1.03 109.426 173.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -129.88 94.73 3.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.648 -0.706 . . . . 2.16 110.242 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.45 -106.04 1.56 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.815 -0.707 . . . . 0.34 112.554 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -100.86 13.64 34.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.521 -0.178 . . . . 2.6 110.521 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -133.18 142.39 48.59 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.201 0.524 . . . . 0.38 111.381 -174.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.455 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -126.48 157.4 20.27 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 111.002 -0.839 . . . . 0.11 111.002 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -130.86 149.3 52.56 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.438 -0.578 . . . . 0.19 109.438 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.527 HD11 ' CD2' ' A' ' 73' ' ' PHE . 5.9 mt -124.38 148.64 47.4 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.812 -0.81 . . . . 1.28 108.812 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.05 72.9 4.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.578 0.704 . . . . 1.77 109.731 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -139.47 98.75 3.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.952 -1.022 . . . . 0.33 109.104 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 50.6 mt-10 -84.82 101.2 12.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.612 0.72 . . . . 1.81 110.356 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 84' ' ' SER . 34.1 m -81.12 -32.0 12.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.911 -1.04 . . . . 1.51 110.622 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 5.5 tp10 -134.09 177.47 7.71 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.77 -1.937 . . . . 2.24 105.77 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.519 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 26.4 t0 -39.78 84.93 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.119 0.968 . . . . 1.55 113.44 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 73.26 8.29 74.47 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.751 -0.54 . . . . 0.77 111.751 174.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 9.0 mmtm -67.53 110.32 3.61 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.831 -0.184 . . . . 3.03 110.686 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -79.53 123.7 27.82 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.12 -0.696 . . . . 1.87 109.12 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 51' ' ' LEU . 1.7 mt -61.06 136.03 57.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.585 -0.279 . . . . 1.05 111.046 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -118.3 160.7 21.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.404 . . . . 0.48 110.54 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.543 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 28.6 p90 -150.38 153.74 36.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.711 -0.677 . . . . 0.2 109.509 173.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -92.34 147.29 23.03 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.621 -0.881 . . . . 0.47 108.621 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.433 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 11.6 tmm? -59.3 -15.57 16.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.997 -0.547 . . . . 2.84 112.175 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 t -64.33 -29.25 70.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.785 0.326 . . . . 1.41 110.189 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -91.27 -3.79 56.55 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.539 -0.3 . . . . 1.96 111.161 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.478 HG22 HD13 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -63.21 152.0 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.944 -0.571 . . . . 1.06 111.053 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.488 ' CG ' HD11 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -67.38 96.93 0.53 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.118 -0.492 . . . . 1.85 111.417 -176.599 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.36 -99.13 0.13 Allowed Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.611 0.57 . . . . 0.62 113.578 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -88.79 140.3 29.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.779 0.799 . . . . 2.3 110.41 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.4 p -75.43 -19.81 59.25 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.102 -0.954 . . . . 1.45 111.219 -174.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.1 t -90.31 7.51 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.673 . . . . 1.95 109.717 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -102.73 -13.92 16.86 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.966 -0.561 . . . . 1.21 110.76 177.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.478 HD13 HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -121.83 123.4 41.68 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.244 -0.65 . . . . 2.19 109.244 -177.439 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -135.4 159.01 73.28 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.661 0.267 . . . . 1.12 111.444 -174.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.527 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 30.7 Cg_endo -64.78 129.86 24.6 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.132 1.888 . . . . 0.28 111.94 175.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.15 -16.1 54.0 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.939 -0.648 . . . . 0.23 111.823 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -79.21 147.23 32.69 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.909 -0.404 . . . . 1.28 109.909 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 5.5 m -76.31 137.48 39.89 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.735 -0.839 . . . . 1.05 108.735 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.42 159.18 28.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 122.205 -0.31 . . . . 1.16 110.504 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.666 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 10.4 pt-20 -115.63 144.97 43.15 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.605 -0.887 . . . . 0.78 108.605 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.527 ' CD2' HD11 ' A' ' 41' ' ' LEU . 17.8 p90 -148.05 178.89 8.16 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.501 -0.772 . . . . 0.15 109.431 -172.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 m -125.65 126.01 44.02 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.817 -0.808 . . . . 1.3 108.817 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.414 HG11 ' O ' ' A' ' 75' ' ' VAL . 8.3 p -90.02 98.69 8.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 122.058 0.932 . . . . 1.11 111.165 -171.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.0 p -106.77 131.11 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.57 -0.741 . . . . 1.13 109.662 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.4 m -77.9 132.28 37.86 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.904 -0.589 . . . . 1.27 111.627 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.61 122.36 24.53 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.584 -0.525 . . . . 1.96 109.584 173.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -69.73 -5.11 22.95 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.422 0.527 . . . . 2.24 112.422 -174.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.16 -60.94 1.83 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.998 -0.371 . . . . 4.49 109.998 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.438 ' HB2' ' HG2' ' A' ' 83' ' ' LYS . 18.9 m120 -96.62 -30.48 13.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.815 0.341 . . . . 2.66 111.576 -173.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.44 -3.17 63.4 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.545 -0.836 . . . . 0.88 111.253 -171.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.438 ' HG2' ' HB2' ' A' ' 81' ' ' ASN . 60.1 pttt -79.02 144.72 34.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.322 -0.621 . . . . 2.9 109.322 175.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.439 ' HB2' HG11 ' A' ' 45' ' ' VAL . 9.8 m -89.56 177.56 6.52 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.393 0.616 . . . . 1.49 111.894 -174.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.9 m -149.04 153.74 38.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.98 -1.009 . . . . 1.31 109.322 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.543 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -93.89 121.88 35.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.979 0.419 . . . . 1.05 109.998 177.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.7 t -117.35 157.42 26.18 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.167 -1.049 . . . . 1.17 108.167 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.4 t30 55.77 63.99 1.88 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.793 0.683 . . . . 2.17 109.764 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.4 t -83.77 118.41 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.36 -0.836 . . . . 1.06 111.276 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.666 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 4.2 mm? -112.93 148.56 34.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.261 -0.427 . . . . 1.77 110.943 -178.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -83.49 116.17 22.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.408 0.623 . . . . 2.02 111.216 178.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.452 ' O ' ' HB ' ' A' ' 70' ' ' THR . 48.7 mm . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 115.305 -0.861 . . . . 1.05 109.926 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 111.884 -0.486 . . . . 19.3 111.884 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.21 121.56 33.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.847 0.356 . . . . 17.75 110.987 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -97.98 116.85 31.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.615 -0.513 . . . . 17.68 109.615 174.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.83 55.77 4.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.778 -0.725 . . . . 14.41 112.225 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -76.09 149.9 37.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.971 0.415 . . . . 13.69 110.473 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.65 166.57 11.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.068 -0.515 . . . . 11.63 110.547 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.409 ' C ' ' H ' ' A' ' 9' ' ' PHE . 9.3 p -121.08 128.29 76.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.406 -0.59 . . . . 8.84 109.406 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 m -78.55 32.88 0.2 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.136 0.493 . . . . 8.01 111.213 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.409 ' H ' ' C ' ' A' ' 7' ' ' VAL . 53.7 t80 -104.85 -48.15 3.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.978 -0.555 . . . . 7.63 111.293 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.82 114.05 7.4 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.608 -0.437 . . . . 7.38 111.448 -175.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.3 mm -129.78 150.69 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.453 -0.944 . . . . 3.34 108.453 173.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -66.34 -37.24 84.9 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.563 0.579 . . . . 3.29 112.563 -175.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -9.78 38.45 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.055 0.455 . . . . 2.96 111.745 -176.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.9 t -78.49 -0.81 30.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.278 0.561 . . . . 2.5 110.125 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.39 56.95 2.05 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.697 -0.763 . . . . 1.9 111.831 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -78.6 98.8 6.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.051 0.453 . . . . 5.69 110.952 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.12 -22.31 25.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.433 -0.803 . . . . 2.83 111.134 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.11 -28.84 66.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.925 -0.579 . . . . 2.82 111.024 -175.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.3 t -136.56 129.47 30.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.693 -0.854 . . . . 3.08 108.693 173.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 p -169.53 153.22 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.37 -0.604 . . . . 2.34 109.37 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -83.24 -48.37 10.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.648 0.261 . . . . 2.96 110.965 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.36 151.28 20.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.71 -0.223 . . . . 1.95 110.533 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.28 93.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 123.169 0.293 . . . . 2.27 111.329 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.9 25.82 0.06 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.596 1.159 . . . . 3.4 112.733 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.42 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 5.0 tp60 -103.75 52.46 0.77 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.263 0.554 . . . . 1.88 111.382 -171.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -79.0 114.04 17.61 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.393 -0.595 . . . . 2.59 109.393 172.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -99.9 156.39 17.16 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.851 -0.613 . . . . 1.84 110.4 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -125.93 128.74 48.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.858 0.361 . . . . 1.99 110.449 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.91 179.45 9.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.514 -0.766 . . . . 0.96 109.477 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.25 143.45 32.95 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.672 -0.492 . . . . 0.86 109.672 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.516 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 41.3 t -63.54 119.4 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.265 0.555 . . . . 1.01 110.074 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.96 -44.68 30.36 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.987 -1.006 . . . . 0.6 109.526 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.0 m -161.17 164.56 30.45 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.613 -0.721 . . . . 1.18 110.251 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.8 mt -141.63 130.38 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.056 0.455 . . . . 1.03 109.987 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -125.43 104.05 8.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.479 -0.782 . . . . 2.16 110.469 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.07 -108.52 1.94 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.028 -0.606 . . . . 0.34 112.515 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -100.54 10.58 41.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.455 0.169 . . . . 2.6 110.693 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -128.89 140.63 51.59 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.163 0.506 . . . . 0.38 111.003 -173.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.483 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.88 157.36 17.42 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 120.638 -0.791 . . . . 0.11 111.433 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 77.0 m-85 -132.22 137.58 47.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.161 -0.681 . . . . 0.19 109.161 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.479 HD11 ' CD2' ' A' ' 73' ' ' PHE . 7.1 mt -110.13 154.65 23.01 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.714 -0.476 . . . . 1.28 109.714 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -74.76 73.09 2.05 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.587 0.708 . . . . 1.77 109.558 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -148.02 97.57 2.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.832 -1.076 . . . . 0.33 108.678 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 23.9 mp0 -85.65 110.01 18.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.723 -0.671 . . . . 1.81 109.966 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 84' ' ' SER . 28.8 m -78.73 -36.4 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 1.51 112.024 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -156.42 123.16 5.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.511 -0.313 . . . . 2.24 110.488 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.2 t70 60.97 12.92 4.19 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.641 0.734 . . . . 1.55 111.966 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.0 21.08 14.43 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.635 -0.793 . . . . 0.77 112.979 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 4.0 mmtm -69.41 110.93 4.96 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.874 -0.417 . . . . 3.03 109.874 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -71.72 129.61 39.11 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.669 -0.493 . . . . 1.87 109.669 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.1 mt -66.66 123.3 19.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.594 -0.276 . . . . 1.05 110.97 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -105.28 158.3 16.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.045 0.45 . . . . 0.48 110.661 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.483 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 32.3 p90 -151.44 155.22 38.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.682 -0.69 . . . . 0.2 109.163 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -97.08 152.04 19.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.994 -0.743 . . . . 0.47 108.994 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.54 ' SD ' HG22 ' A' ' 58' ' ' VAL . 14.2 mmt -64.51 -3.06 2.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.431 0.53 . . . . 2.84 112.431 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.8 t -82.76 -25.31 32.94 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.851 -0.426 . . . . 1.41 109.851 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.84 -6.17 59.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.922 0.391 . . . . 1.96 110.421 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.54 HG22 ' SD ' ' A' ' 55' ' ' MET . 2.0 t -71.6 152.38 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.69 -0.686 . . . . 1.06 112.45 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.78 98.33 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.483 -1.235 . . . . 1.85 112.041 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.87 -84.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.0 -0.545 . . . . 0.62 113.602 172.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -106.68 142.31 36.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.758 0.313 . . . . 2.3 110.179 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.7 p -67.7 -21.37 65.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.271 0.558 . . . . 1.45 111.503 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.6 t -95.01 2.19 9.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.285 0.564 . . . . 1.95 110.428 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.63 -13.8 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.443 -0.344 . . . . 1.21 111.297 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.475 HD13 HG11 ' A' ' 71' ' ' VAL . 1.1 tm? -110.65 124.69 52.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.976 -0.75 . . . . 2.19 108.976 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -117.92 150.19 46.76 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.559 -0.291 . . . . 1.12 111.121 -172.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.516 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.2 Cg_endo -66.49 135.76 40.49 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.443 2.095 . . . . 0.28 111.933 173.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.53 -2.36 73.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.916 -0.659 . . . . 0.23 112.367 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -95.91 154.7 17.09 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.804 -0.443 . . . . 1.28 109.804 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 m -79.72 136.03 36.67 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.466 -0.568 . . . . 1.05 109.466 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.475 HG11 HD13 ' A' ' 65' ' ' LEU . 20.0 m -136.48 161.3 37.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.432 0.634 . . . . 1.16 110.805 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.45 139.0 49.88 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.837 -1.172 . . . . 0.78 107.837 171.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CD2' HD11 ' A' ' 41' ' ' LEU . 19.2 p90 -148.53 179.82 7.52 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.824 0.345 . . . . 0.15 110.193 -174.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.8 m -129.85 115.01 16.61 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.088 -0.708 . . . . 1.3 109.088 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.4 p -85.37 101.93 10.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.538 0.685 . . . . 1.11 110.834 -175.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.63 121.58 59.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.757 -0.656 . . . . 1.13 109.87 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.8 m -79.62 128.34 33.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.861 -0.608 . . . . 1.27 111.068 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -68.48 102.32 1.42 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.516 -0.765 . . . . 1.96 109.218 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -64.23 -8.03 11.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.217 0.532 . . . . 2.24 111.413 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -93.73 -39.34 10.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.883 -0.599 . . . . 4.49 111.044 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -114.28 -21.25 10.53 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.554 0.575 . . . . 2.66 112.554 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.7 -20.18 51.66 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.764 -0.731 . . . . 0.88 113.36 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -81.78 174.6 11.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.005 -0.739 . . . . 2.9 109.005 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.448 ' HB2' HG12 ' A' ' 45' ' ' VAL . 19.1 m -128.81 175.68 8.43 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.284 -0.566 . . . . 1.49 110.632 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.2 p -145.91 155.97 43.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.274 -0.421 . . . . 1.31 110.433 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.467 ' HB2' ' HB2' ' A' ' 73' ' ' PHE . . . -93.2 118.31 31.09 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.118 0.485 . . . . 1.05 110.24 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 97.3 m -116.74 144.05 44.91 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.132 -0.692 . . . . 1.17 109.132 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 63.68 69.01 0.56 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.084 -0.71 . . . . 2.17 109.084 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 71.0 t -87.94 116.66 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.406 -0.815 . . . . 1.06 110.722 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.35 149.03 30.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.903 -0.589 . . . . 1.77 110.705 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -77.91 126.42 30.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.139 -0.482 . . . . 2.02 109.891 176.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.09 138.85 46.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 110.072 -0.344 . . . . 1.05 110.072 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -104.35 125.87 50.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.823 0.344 . . . . 3.31 110.699 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.052 -0.522 . . . . 3.08 110.216 176.75 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 111.967 -0.453 . . . . 19.3 111.967 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.23 121.64 44.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.837 0.351 . . . . 17.75 110.523 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.474 ' HZ1' ' CG ' ' A' ' 5' ' ' ASP . 56.6 tttm -105.76 92.73 4.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.117 0.485 . . . . 17.68 110.723 -176.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.52 -28.19 7.22 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.02 -0.832 . . . . 14.41 111.02 173.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.474 ' CG ' ' HZ1' ' A' ' 3' ' ' LYS . 33.0 m-20 72.9 -2.14 2.8 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.861 0.865 . . . . 13.69 112.853 173.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt -86.34 80.46 8.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.881 0.372 . . . . 11.63 110.307 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.0 p -140.88 145.82 24.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.059 -0.519 . . . . 8.84 110.021 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 m -79.63 36.35 0.32 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.478 -0.328 . . . . 8.01 111.356 -176.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -125.17 -9.67 7.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.988 0.423 . . . . 7.63 111.174 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.437 ' HA ' ' HD3' ' A' ' 10' ' ' ARG . 18.8 mmt180 -115.81 158.48 22.83 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.1 -0.64 . . . . 7.38 112.701 -175.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.1 mt -129.88 125.4 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 114.898 -1.047 . . . . 3.34 111.32 -171.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -92.04 -43.42 9.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.988 0.423 . . . . 3.29 110.544 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.482 ' HB2' HH12 ' A' ' 28' ' ' ARG . 12.3 pt-20 -59.53 -14.17 11.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.501 -0.772 . . . . 2.96 112.196 -174.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 t -62.9 -27.56 69.45 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.116 -0.327 . . . . 2.5 110.116 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.74 57.56 4.47 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.964 -0.636 . . . . 1.9 112.616 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -88.53 133.45 34.15 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.943 -0.303 . . . . 5.69 110.282 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.96 -15.15 3.07 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.944 0.72 . . . . 2.83 112.944 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.11 -16.62 64.44 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.773 0.32 . . . . 2.82 110.758 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.5 t -146.66 130.6 17.21 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.68 -0.859 . . . . 3.08 108.68 171.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 p -147.25 141.2 19.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.803 0.335 . . . . 2.34 110.1 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -144.57 154.07 42.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.52 -0.309 . . . . 2.96 111.411 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 57.1 22.76 7.76 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.95 0.782 . . . . 1.95 111.659 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.408 ' C ' ' HG3' ' A' ' 24' ' ' ARG . 15.8 t 57.78 67.98 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.818 -0.628 . . . . 2.27 109.75 -172.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.408 ' HG3' ' C ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER 47.01 30.77 1.34 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.409 1.084 . . . . 3.4 113.142 178.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -107.48 74.87 0.99 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.047 0.451 . . . . 1.88 110.906 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -99.37 115.4 29.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 2.59 110.172 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 28.2 mmtp -99.03 151.35 21.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.893 -0.594 . . . . 1.84 111.859 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.482 HH12 ' HB2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -115.02 127.15 55.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.73 -0.668 . . . . 1.99 110.264 176.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.25 178.94 9.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.269 -0.271 . . . . 0.96 110.269 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.07 148.02 26.73 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.442 -0.345 . . . . 0.86 110.098 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.483 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 45.5 t -68.77 122.14 19.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.978 0.418 . . . . 1.01 110.624 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -75.07 -40.79 59.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.313 -0.858 . . . . 0.6 110.053 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 t -171.65 169.41 6.0 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.643 -0.708 . . . . 1.18 109.113 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.2 mt -136.45 126.4 39.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.254 0.55 . . . . 1.03 109.618 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 62.6 mmtt -120.16 85.54 2.4 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.325 -0.852 . . . . 2.16 110.361 -175.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.11 -114.55 4.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.746 -0.74 . . . . 0.34 112.549 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.59 12.78 24.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.074 -0.343 . . . . 2.6 110.074 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -132.19 140.11 48.6 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.013 0.435 . . . . 0.38 110.417 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.526 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.29 159.61 16.86 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.631 -0.795 . . . . 0.11 111.215 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 77.5 m-85 -131.47 149.54 52.49 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.03 -0.73 . . . . 0.19 109.03 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.564 HD12 ' CD2' ' A' ' 73' ' ' PHE . 7.0 mt -124.14 157.6 34.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.15 -0.315 . . . . 1.28 110.15 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -76.78 73.33 3.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.509 0.671 . . . . 1.77 109.554 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.406 ' HB3' HD11 ' A' ' 51' ' ' LEU . 16.7 t80 -148.04 98.79 2.98 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.049 -0.978 . . . . 0.33 108.859 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 43.4 mt-10 -86.95 103.36 15.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.292 -0.413 . . . . 1.81 110.135 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.472 HG23 ' H ' ' A' ' 84' ' ' SER . 27.6 m -80.65 -30.34 12.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.624 0.602 . . . . 1.51 112.624 -173.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 5.2 tp10 -161.31 110.82 1.62 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 110.57 -0.159 . . . . 2.24 110.57 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.8 t0 55.23 37.88 29.57 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.294 0.569 . . . . 1.55 111.735 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.85 20.98 54.7 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.365 -0.921 . . . . 0.77 113.087 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 38.3 mmtm -74.19 110.05 8.17 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.135 -0.691 . . . . 3.03 109.135 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -72.61 126.1 29.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.644 -0.873 . . . . 1.87 108.644 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.5 mt -63.25 128.58 36.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.114 -0.494 . . . . 1.05 110.847 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -112.49 156.72 22.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.345 -0.389 . . . . 0.48 110.302 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.526 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 25.8 p90 -146.48 149.07 32.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.623 -0.717 . . . . 0.2 109.717 174.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -91.74 145.48 24.54 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.555 -0.906 . . . . 0.47 108.555 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.485 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -58.11 -11.95 3.02 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.522 0.564 . . . . 2.84 112.522 -177.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.1 t -67.39 -25.85 66.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.823 0.345 . . . . 1.41 110.454 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -86.6 -13.87 44.46 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.242 -0.435 . . . . 1.96 110.464 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -65.82 148.39 12.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.42 -0.809 . . . . 1.06 112.298 -175.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.16 102.21 0.36 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 114.748 -1.115 . . . . 1.85 111.241 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.58 -91.59 0.26 Allowed Glycine 0 C--O 1.237 0.301 0 CA-C-N 115.952 -0.567 . . . . 0.62 113.61 173.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -101.44 151.31 22.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.648 -0.501 . . . . 2.3 109.648 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.3 p -77.71 -15.36 59.19 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.928 -0.578 . . . . 1.45 111.168 -173.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.74 2.92 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.609 -0.723 . . . . 1.95 110.078 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.48 -24.65 19.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 1.21 111.335 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.506 HD13 HG11 ' A' ' 71' ' ' VAL . 1.6 tm? -98.42 125.06 43.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.155 -0.683 . . . . 2.19 109.155 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -117.41 152.96 50.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 111.93 0.344 . . . . 1.12 111.93 -171.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.483 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 52.1 Cg_endo -69.65 141.9 46.95 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.991 2.461 . . . . 0.28 111.48 173.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.54 -5.13 82.58 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.776 -0.726 . . . . 0.23 112.031 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -93.93 159.61 15.1 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.401 -0.592 . . . . 1.28 109.401 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.5 m -85.02 132.19 34.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.353 -0.61 . . . . 1.05 109.353 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.506 HG11 HD13 ' A' ' 65' ' ' LEU . 6.3 m -135.3 165.2 31.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.162 0.506 . . . . 1.16 109.984 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -120.32 146.08 46.48 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.364 -0.976 . . . . 0.78 108.364 174.227 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.564 ' CD2' HD12 ' A' ' 41' ' ' LEU . 25.3 p90 -152.57 179.19 8.81 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.682 -0.488 . . . . 0.15 109.682 -174.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.4 m -126.83 123.32 37.06 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.877 -0.786 . . . . 1.3 108.877 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 p -92.69 99.49 9.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.666 0.746 . . . . 1.11 111.642 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.7 p -111.7 123.51 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.567 -0.742 . . . . 1.13 109.994 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 30.2 m -72.88 129.02 37.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.911 0.386 . . . . 1.27 110.933 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.415 ' N ' HD21 ' A' ' 78' ' ' ASN . 0.9 OUTLIER -69.37 117.82 11.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 1.96 109.631 177.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -71.36 -15.72 62.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.156 0.503 . . . . 2.24 110.76 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -94.89 -42.28 8.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.703 -0.681 . . . . 4.49 111.095 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -94.97 -29.09 14.82 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.317 -0.401 . . . . 2.66 111.724 -171.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.52 -24.21 26.69 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.88 112.568 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -95.24 155.85 16.56 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.46 -0.57 . . . . 2.9 109.46 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 4.4 m -88.08 175.59 7.67 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.094 0.474 . . . . 1.49 111.289 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -141.32 153.08 44.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.692 -0.685 . . . . 1.31 109.376 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -90.73 119.62 31.11 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.112 0.482 . . . . 1.05 110.044 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.6 m -117.01 149.32 40.46 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.321 -0.854 . . . . 1.17 109.921 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 t30 56.87 69.26 0.76 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 123.593 0.558 . . . . 2.17 110.62 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 74.5 t -85.88 122.75 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 1.06 111.708 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.94 147.57 35.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.517 -0.765 . . . . 1.77 110.209 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.455 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -79.4 117.0 19.98 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.942 -0.762 . . . . 2.02 108.942 175.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.7 mm -101.46 121.55 52.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.116 0.484 . . . . 1.05 110.216 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -90.29 126.62 35.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.595 -0.73 . . . . 3.31 110.495 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 115.401 -0.818 . . . . 3.08 110.857 175.096 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.27 -0.332 . . . . 19.3 112.27 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.47 152.72 49.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.696 0.284 . . . . 17.75 110.63 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -137.69 168.25 20.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.09 -0.504 . . . . 17.68 110.007 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.72 85.91 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.768 -0.73 . . . . 14.41 112.115 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.28 86.78 4.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.73 -0.47 . . . . 13.69 109.73 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.95 118.04 29.22 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.189 -0.671 . . . . 11.63 109.189 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.8 t -77.18 71.33 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.497 0.665 . . . . 8.84 110.537 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.6 p -91.96 85.01 5.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.945 -0.571 . . . . 8.01 110.123 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -89.01 -25.46 21.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.855 -0.611 . . . . 7.63 110.965 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.85 107.2 2.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.562 0.696 . . . . 7.38 110.246 175.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 36.7 mm -140.86 117.26 7.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.4 -0.818 . . . . 3.34 109.463 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.4 -40.78 97.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.314 0.578 . . . . 3.29 110.722 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 1.8 pt-20 -81.41 15.02 2.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.857 -1.065 . . . . 2.96 111.733 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.459 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 5.8 t -77.35 -18.22 57.59 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.06 -0.4 . . . . 2.5 110.559 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.72 58.01 0.31 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.217 -0.992 . . . . 1.9 112.353 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -75.16 114.26 13.46 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.063 -0.347 . . . . 5.69 110.063 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.59 -15.92 58.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.263 -0.426 . . . . 2.83 112.002 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.68 -23.98 64.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.534 -0.303 . . . . 2.82 111.4 -176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.2 p -140.07 129.83 24.52 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.375 -0.602 . . . . 3.08 109.375 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.6 p -169.39 164.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 110.361 -0.237 . . . . 2.34 110.361 -175.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -129.83 -176.29 3.88 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.98 -0.748 . . . . 2.96 108.98 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.411 ' CB ' ' HB ' ' A' ' 76' ' ' VAL . . . 57.84 23.95 10.28 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.845 0.458 . . . . 1.95 112.191 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.41 ' C ' ' HG3' ' A' ' 24' ' ' ARG . 21.6 t 62.21 71.09 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.734 -0.666 . . . . 2.27 110.78 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.41 ' HG3' ' C ' ' A' ' 23' ' ' VAL . 3.2 ppt_? 45.84 32.56 1.31 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.44 1.096 . . . . 3.4 113.921 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -123.12 112.6 17.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.694 0.283 . . . . 1.88 111.087 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -118.37 136.89 53.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.28 0.562 . . . . 2.59 111.308 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -112.75 150.71 31.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.232 -0.894 . . . . 1.84 110.561 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -120.46 127.17 51.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.907 0.385 . . . . 1.99 110.408 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.97 179.87 8.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.802 -0.635 . . . . 0.96 109.529 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 144.52 30.64 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 110.194 -0.299 . . . . 0.86 110.194 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 47.5 t -66.32 114.0 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.2 -0.296 . . . . 1.01 110.2 176.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 7.1 t70 -66.95 -50.21 63.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.955 -0.566 . . . . 0.6 109.861 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.9 m -159.79 163.81 34.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.468 -0.787 . . . . 1.18 110.016 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.412 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 7.7 mt -137.47 126.1 33.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.456 -0.572 . . . . 1.03 109.456 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -118.77 90.45 3.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.256 -0.884 . . . . 2.16 109.862 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.37 -112.1 4.14 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.721 -0.752 . . . . 0.34 112.476 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -96.84 11.69 34.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 2.6 110.246 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -129.71 142.04 50.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.143 0.497 . . . . 0.38 110.751 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.92 155.95 17.27 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.379 -0.828 . . . . 0.11 111.378 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.545 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 70.7 m-85 -129.82 139.75 51.17 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.826 -0.805 . . . . 0.19 108.826 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.547 HD11 ' CD2' ' A' ' 73' ' ' PHE . 7.4 mt -111.58 156.7 21.37 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.784 -0.45 . . . . 1.28 109.784 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.62 73.25 1.99 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.966 -0.753 . . . . 1.77 108.966 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -149.57 98.43 2.76 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.624 -0.717 . . . . 0.33 109.289 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 23.0 mp0 -75.73 100.71 4.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 1.81 109.712 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.592 ' CG1' ' HG ' ' A' ' 51' ' ' LEU . 35.3 m -74.39 -30.39 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.713 -0.676 . . . . 1.51 111.519 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -156.73 109.79 2.59 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 116.092 -0.504 . . . . 2.24 110.354 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t0 54.52 29.6 11.55 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.185 0.517 . . . . 1.55 112.286 171.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.11 1.49 44.97 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.161 -1.018 . . . . 0.77 113.151 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 4.0 mmtp -64.64 111.77 2.89 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.862 0.331 . . . . 3.03 110.61 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -65.78 138.89 58.23 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.271 0.357 . . . . 1.87 110.181 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.592 ' HG ' ' CG1' ' A' ' 45' ' ' VAL . 1.3 mt -74.68 125.22 28.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.45 -0.341 . . . . 1.05 110.348 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -106.87 157.22 17.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.48 110.064 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.506 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 28.1 p90 -151.05 157.06 42.33 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.596 -0.729 . . . . 0.2 109.394 174.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -98.92 151.01 21.34 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.111 -0.7 . . . . 0.47 109.111 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.467 ' SD ' HG22 ' A' ' 58' ' ' VAL . 9.4 mmt -62.39 -6.94 3.69 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.797 0.665 . . . . 2.84 112.797 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -81.23 -25.28 36.77 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.241 -0.184 . . . . 1.41 111.068 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -81.77 -15.69 53.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.032 0.444 . . . . 1.96 110.157 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.467 HG22 ' SD ' ' A' ' 55' ' ' MET . 2.8 t -62.56 151.84 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.212 -0.904 . . . . 1.06 112.188 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -64.63 88.96 0.06 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.005 -0.998 . . . . 1.85 112.38 -173.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.37 -66.47 2.28 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.974 -0.557 . . . . 0.62 113.337 170.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -122.31 143.7 49.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.296 0.57 . . . . 2.3 110.264 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.7 p -72.3 -26.64 62.03 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.119 -0.946 . . . . 1.45 110.926 -174.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -95.67 22.99 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.753 0.787 . . . . 1.95 109.633 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.9 -15.68 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.598 -0.728 . . . . 1.21 109.765 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.49 124.74 47.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.889 -1.05 . . . . 2.19 109.603 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -122.99 153.63 64.21 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.682 -0.235 . . . . 1.12 111.235 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 41.4 Cg_endo -68.47 129.06 18.27 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.523 2.149 . . . . 0.28 111.972 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.58 -14.04 56.51 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.918 -0.583 . . . . 0.23 111.84 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.16 154.14 25.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 1.28 110.323 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m -78.71 141.88 37.54 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.298 -0.63 . . . . 1.05 109.298 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.87 161.41 26.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.654 0.74 . . . . 1.16 111.761 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.33 137.51 51.71 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.447 -1.251 . . . . 0.78 108.096 172.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.547 ' CD2' HD11 ' A' ' 41' ' ' LEU . 30.8 p90 -149.48 178.55 8.71 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.29 -0.633 . . . . 0.15 109.29 -174.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 22' ' ' ALA . 3.7 m -124.29 132.33 53.56 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.09 -0.707 . . . . 1.3 109.09 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.02 99.14 8.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.504 0.668 . . . . 1.11 110.978 -175.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.411 ' HB ' ' CB ' ' A' ' 22' ' ' ALA . 7.5 p -114.46 116.95 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.47 0.653 . . . . 1.13 110.719 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.9 m -69.98 125.96 28.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.703 -0.681 . . . . 1.27 110.483 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.96 114.44 5.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 1.96 109.326 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -58.59 -31.24 67.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.41 -0.359 . . . . 2.24 111.357 -175.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.42 -36.79 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.341 -0.391 . . . . 4.49 111.42 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -92.83 -23.36 18.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.054 0.39 . . . . 2.66 112.054 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.58 -24.57 7.32 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.028 -0.606 . . . . 0.88 113.484 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -88.44 149.94 23.41 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.812 -0.44 . . . . 2.9 109.812 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.434 ' HB3' HG13 ' A' ' 45' ' ' VAL . 42.7 t -85.32 177.59 7.77 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.794 0.331 . . . . 1.49 110.709 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.4 m -150.74 149.96 30.43 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.286 -0.635 . . . . 1.31 109.286 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.94 121.51 33.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.025 0.441 . . . . 1.05 110.614 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.0 m -117.49 144.39 45.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.028 -0.533 . . . . 1.17 109.909 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 57.71 73.11 0.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.743 0.652 . . . . 2.17 110.31 -175.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 94.0 t -92.05 105.01 16.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.568 -0.742 . . . . 1.06 110.308 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.492 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 11.1 mp -105.89 149.08 26.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.594 -0.73 . . . . 1.77 110.735 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.18 103.25 14.64 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.907 -0.588 . . . . 2.02 110.795 -174.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.6 mm -85.21 118.54 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.585 -0.734 . . . . 1.05 110.235 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -86.09 110.87 19.83 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.069 -0.514 . . . . 3.31 110.997 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 3.08 109.598 173.947 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 -0.079 0 N-CA-C 112.121 -0.392 . . . . 19.3 112.121 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.37 135.02 33.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.805 0.336 . . . . 17.75 110.747 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -108.92 122.04 46.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.075 -0.511 . . . . 17.68 109.694 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.26 21.5 0.23 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.346 -0.93 . . . . 14.41 112.824 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -87.56 82.53 7.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.236 -0.653 . . . . 13.69 109.236 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.0 mt -88.27 107.33 18.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.965 -0.561 . . . . 11.63 110.498 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 t -91.6 80.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.267 0.556 . . . . 8.84 110.905 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 t -101.43 84.91 2.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.008 -0.738 . . . . 8.01 109.008 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -85.44 8.58 18.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.677 -0.692 . . . . 7.63 111.375 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.55 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 1.2 ppt_? -145.42 144.07 30.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.173 0.511 . . . . 7.38 112.081 -172.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.0 mm -110.27 120.91 62.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 107.883 -1.155 . . . . 3.34 107.883 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.409 ' HB2' HD22 ' A' ' 90' ' ' LEU . 72.8 m-20 -63.69 -29.97 71.14 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.583 0.586 . . . . 3.29 112.583 -168.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -80.34 10.28 4.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.717 0.294 . . . . 2.96 111.588 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.1 t -72.52 -12.09 60.93 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.56 0.219 . . . . 2.5 111.163 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.56 58.44 1.0 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.427 -0.892 . . . . 1.9 112.787 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -63.23 100.55 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.825 0.345 . . . . 5.69 110.823 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.59 -21.99 28.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.023 -0.535 . . . . 2.83 110.889 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.52 -21.53 61.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.871 -0.604 . . . . 2.82 111.727 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 53.7 t -159.22 132.63 7.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.802 0.334 . . . . 3.08 110.61 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -168.49 151.4 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.842 -0.617 . . . . 2.34 109.42 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -95.16 44.89 1.09 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.566 0.698 . . . . 2.96 110.341 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -170.72 160.09 6.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.368 -0.833 . . . . 1.95 109.211 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.87 82.09 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.73 -0.388 . . . . 2.27 110.146 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 43.16 30.35 0.27 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.522 1.129 . . . . 3.4 113.183 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -115.29 90.17 3.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.993 0.425 . . . . 1.88 110.775 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -109.61 123.72 49.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.02 -0.537 . . . . 2.59 110.558 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -109.08 153.02 24.26 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.625 -0.716 . . . . 1.84 110.687 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -122.85 128.34 50.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.738 0.304 . . . . 1.99 110.303 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.73 179.7 8.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.641 -0.709 . . . . 0.96 109.095 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.74 145.38 29.21 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.761 -0.459 . . . . 0.86 109.761 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.487 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 41.9 t -64.85 114.37 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.159 0.504 . . . . 1.01 109.977 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.466 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 9.9 t70 -67.86 -45.28 75.02 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.858 -1.065 . . . . 0.6 109.747 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.7 m -169.05 166.5 10.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.514 -0.766 . . . . 1.18 109.868 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 mt -137.96 128.48 36.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.944 -0.391 . . . . 1.03 109.944 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -115.22 88.02 2.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.686 -0.688 . . . . 2.16 109.856 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.03 -106.99 1.88 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.733 -0.746 . . . . 0.34 112.816 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -96.35 5.34 51.12 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.58 0.228 . . . . 2.6 111.178 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -125.75 140.38 52.74 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.002 0.43 . . . . 0.38 110.368 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.54 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.17 158.28 16.86 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.51 -0.852 . . . . 0.11 111.323 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -132.08 141.12 49.08 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.867 -0.79 . . . . 0.19 108.867 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.537 HD13 ' CD2' ' A' ' 73' ' ' PHE . 4.8 mt -115.09 150.75 35.47 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.427 -0.953 . . . . 1.28 108.427 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -75.21 72.97 2.32 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.272 0.558 . . . . 1.77 109.64 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -142.61 98.07 3.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.156 -0.929 . . . . 0.33 108.57 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 15.4 mp0 -90.23 107.62 19.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.039 -0.528 . . . . 1.81 109.791 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.41 HG11 ' HB2' ' A' ' 84' ' ' SER . 29.2 m -74.62 -32.69 30.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.622 -0.717 . . . . 1.51 111.851 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -156.45 114.06 3.23 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.532 -0.304 . . . . 2.24 110.572 -174.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 51.8 34.06 12.46 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.387 0.884 . . . . 1.55 113.387 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.97 20.34 43.43 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.233 -0.984 . . . . 0.77 112.725 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -79.98 109.16 14.15 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.033 -0.728 . . . . 3.03 109.033 176.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -71.63 138.81 48.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.636 -0.711 . . . . 1.87 110.726 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 51' ' ' LEU . 4.5 mt -74.89 122.65 23.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.477 -0.329 . . . . 1.05 111.222 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -107.37 161.29 14.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.427 -0.351 . . . . 0.48 110.07 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.545 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 17.1 p90 -152.69 158.77 42.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.132 -0.485 . . . . 0.2 109.741 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -99.97 156.05 17.36 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.718 -0.845 . . . . 0.47 108.718 176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.46 ' SD ' HG22 ' A' ' 58' ' ' VAL . 13.2 mmt -65.03 3.18 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.257 0.465 . . . . 2.84 112.257 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.3 t -87.39 -28.01 22.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 1.41 110.127 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -84.53 -11.01 56.91 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.236 -0.438 . . . . 1.96 110.188 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.465 HG21 HD23 ' A' ' 65' ' ' LEU . 2.4 t -68.38 150.3 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.463 -0.789 . . . . 1.06 111.649 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -58.23 88.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.045 -0.979 . . . . 1.85 111.736 -177.218 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.11 -91.2 0.03 OUTLIER Glycine 0 CA--C 1.52 0.403 0 O-C-N 123.501 0.501 . . . . 0.62 113.199 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -79.27 129.93 34.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.482 0.658 . . . . 2.3 110.587 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.5 p -80.44 -10.3 59.75 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.062 -0.972 . . . . 1.45 110.963 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.54 -11.12 10.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.529 -0.76 . . . . 1.95 110.234 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.5 -19.11 31.69 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.939 0.4 . . . . 1.21 111.693 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.465 HD23 HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -105.91 124.29 49.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.595 -0.52 . . . . 2.19 109.595 -177.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -123.35 156.21 64.06 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.583 0.23 . . . . 1.12 111.058 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.475 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 47.4 Cg_endo -69.23 129.09 17.51 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.425 2.084 . . . . 0.28 111.477 174.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.487 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 102.5 -13.02 56.85 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.674 -0.775 . . . . 0.23 112.114 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -82.02 152.57 26.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.275 -0.269 . . . . 1.28 110.275 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -76.5 137.81 39.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.051 -0.722 . . . . 1.05 109.051 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -139.13 163.71 26.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.902 0.382 . . . . 1.16 111.216 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 3.4 pt-20 -114.02 150.56 33.72 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.294 -1.372 . . . . 0.78 107.294 170.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.537 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.3 p90 -156.97 179.85 8.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.192 -0.67 . . . . 0.15 109.192 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.7 m -129.88 113.89 15.21 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.828 -0.805 . . . . 1.3 108.828 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 75' ' ' VAL . 7.1 p -86.31 97.76 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 122.019 0.914 . . . . 1.11 110.488 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -105.68 117.13 50.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.174 -0.921 . . . . 1.13 109.315 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.8 m -73.65 126.53 30.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.333 0.587 . . . . 1.27 110.786 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -69.78 113.76 7.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.0 -1.0 . . . . 1.96 110.001 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -65.52 -16.8 64.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.314 0.578 . . . . 2.24 110.402 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -91.07 -38.19 12.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.58 -0.736 . . . . 4.49 111.584 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -103.44 -26.61 12.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.119 0.414 . . . . 2.66 112.119 -171.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.82 -23.21 24.43 Favored Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 121.053 -0.594 . . . . 0.88 112.013 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -91.28 174.74 7.23 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.27 -0.641 . . . . 2.9 109.27 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.41 ' HB2' HG11 ' A' ' 45' ' ' VAL . 19.0 m -114.28 179.92 3.82 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.741 -0.384 . . . . 1.49 110.643 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.8 m -147.19 147.01 30.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.7 -0.682 . . . . 1.31 109.338 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . . . -86.33 117.38 25.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.171 0.51 . . . . 1.05 110.53 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.4 m -116.25 150.04 38.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.579 -0.737 . . . . 1.17 109.407 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.526 ' ND2' HD13 ' A' ' 90' ' ' LEU . 0.2 OUTLIER 61.91 59.17 1.77 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.16 -0.681 . . . . 2.17 109.16 -178.002 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 90.1 t -85.05 101.49 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.854 -0.612 . . . . 1.06 110.147 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.526 HD13 ' ND2' ' A' ' 88' ' ' ASN . 3.2 mp -106.21 145.99 30.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.242 0.544 . . . . 1.77 111.517 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.84 117.46 17.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.548 -0.751 . . . . 2.02 110.807 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mm -103.76 125.84 58.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.719 -0.673 . . . . 1.05 111.114 -175.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -96.07 133.03 40.81 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.282 -0.872 . . . . 3.31 108.797 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 116.491 -0.322 . . . . 3.08 110.74 -178.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.309 -0.317 . . . . 19.3 112.309 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.34 76.76 1.04 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.066 0.46 . . . . 17.75 110.772 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -139.54 171.57 14.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.834 -0.621 . . . . 17.68 109.605 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.16 -131.61 4.16 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.538 -0.625 . . . . 14.41 111.538 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -110.41 125.29 53.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.936 0.398 . . . . 13.69 110.017 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.3 mt -77.76 -46.53 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.219 0.533 . . . . 11.63 109.824 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.9 p -125.37 121.03 59.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.696 -0.684 . . . . 8.84 109.962 176.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.8 t -78.41 78.28 4.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.397 0.618 . . . . 8.01 109.579 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -151.66 -66.39 0.18 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.443 -0.799 . . . . 7.63 109.309 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.741 ' HD3' ' O ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -91.91 95.0 9.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.027 0.918 . . . . 7.38 110.093 175.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.9 mm -106.45 120.55 57.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.706 -0.679 . . . . 3.34 110.132 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.2 -49.2 75.17 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.36 -0.836 . . . . 3.29 111.243 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.732 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 13.3 pt-20 -61.22 -26.91 68.06 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.156 0.503 . . . . 2.96 111.141 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.6 m -70.37 -36.03 73.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.107 -0.497 . . . . 2.5 110.543 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 57.46 16.68 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.182 -0.532 . . . . 1.9 113.197 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -68.02 145.39 54.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.77 0.285 . . . . 5.69 110.651 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.81 -17.39 9.09 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.184 0.809 . . . . 2.83 113.184 -172.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.42 -16.64 63.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.605 0.224 . . . . 2.82 111.605 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.6 p -154.43 130.78 10.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.688 0.28 . . . . 3.08 110.657 176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 p -168.6 150.11 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.986 -0.376 . . . . 2.34 109.986 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -86.64 -57.09 3.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.755 0.312 . . . . 2.96 110.497 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.75 176.93 9.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.9 0.381 . . . . 1.95 110.238 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -78.64 84.54 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.123 -0.49 . . . . 2.27 110.137 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.7 37.0 0.66 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.633 1.173 . . . . 3.4 113.436 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.5 tp60 -128.67 104.02 7.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.487 -0.324 . . . . 1.88 110.664 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.34 112.59 20.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.015 0.436 . . . . 2.59 110.426 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -96.05 160.64 14.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.592 . . . . 1.84 111.041 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.499 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 71.6 mtm-85 -132.31 127.86 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.033 0.444 . . . . 1.99 111.348 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.72 179.92 8.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.593 -0.73 . . . . 0.96 109.359 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.44 145.07 30.55 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 110.01 -0.367 . . . . 0.86 110.01 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.53 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 47.5 t -65.79 120.41 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 120.923 0.392 . . . . 1.01 109.958 176.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.56 -44.14 68.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.308 -0.86 . . . . 0.6 109.574 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.2 m -173.48 169.25 4.41 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.438 -0.801 . . . . 1.18 109.87 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.7 mt -136.69 135.2 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.945 0.402 . . . . 1.03 110.2 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -123.91 97.38 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.555 -0.748 . . . . 2.16 110.17 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.7 -107.1 1.78 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.819 -0.705 . . . . 0.34 112.405 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -98.67 4.07 47.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.568 0.223 . . . . 2.6 110.771 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -123.71 141.14 52.3 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 120.468 -0.493 . . . . 0.38 111.16 -171.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.41 156.08 18.39 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 120.579 -0.82 . . . . 0.11 111.319 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 74.3 m-85 -130.16 141.47 50.67 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.179 -0.675 . . . . 0.19 109.179 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.503 HD11 ' CD2' ' A' ' 73' ' ' PHE . 5.5 mt -112.09 156.17 22.67 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.739 -0.467 . . . . 1.28 109.739 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -78.26 72.83 4.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.566 0.698 . . . . 1.77 109.677 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.446 ' HB3' HD13 ' A' ' 51' ' ' LEU . 25.2 t80 -142.59 98.57 3.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.797 -1.092 . . . . 0.33 108.186 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 41.8 mt-10 -93.16 104.34 16.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.35 0.595 . . . . 1.81 110.928 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.2 m -72.74 -34.13 46.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.407 -0.815 . . . . 1.51 111.529 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 5.6 tt0 -155.05 118.34 4.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.631 -0.259 . . . . 2.24 110.756 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.9 t70 56.11 29.48 14.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.524 0.678 . . . . 1.55 112.162 167.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.403 ' HA2' ' CD ' ' A' ' 44' ' ' GLU . . . 88.5 24.5 33.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.149 -1.024 . . . . 0.77 112.873 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 12.5 mmtm -71.71 109.81 5.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.917 -0.771 . . . . 3.03 108.917 172.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -77.97 121.53 24.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.24 -0.436 . . . . 1.87 109.97 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 43' ' ' PHE . 2.5 mt -58.83 123.93 18.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.945 -0.571 . . . . 1.05 110.912 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -106.12 157.46 17.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.93 0.395 . . . . 0.48 110.701 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.441 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 35.7 p90 -151.2 153.79 35.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.718 -0.674 . . . . 0.2 109.277 173.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -95.3 150.66 20.01 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.441 -0.948 . . . . 0.47 108.441 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.7 mtt -64.66 2.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.317 0.488 . . . . 2.84 112.317 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 t -83.71 -27.09 29.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.897 -0.408 . . . . 1.41 109.897 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.32 -8.03 58.69 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.979 0.419 . . . . 1.96 110.203 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.63 152.21 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.354 -0.839 . . . . 1.06 112.709 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.511 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 12.9 tm0? -66.62 95.15 0.32 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.166 -0.924 . . . . 1.85 112.299 -175.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.87 -81.43 0.54 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.939 -0.573 . . . . 0.62 113.461 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -107.7 148.2 29.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.896 0.379 . . . . 2.3 110.294 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.8 p -67.48 -24.77 65.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.869 -0.605 . . . . 1.45 110.832 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.5 t -93.18 3.42 8.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.787 -0.642 . . . . 1.95 110.637 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.79 -24.07 23.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.018 0.437 . . . . 1.21 110.709 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.57 HD22 ' HG2' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -105.67 124.74 50.05 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.842 -0.799 . . . . 2.19 108.842 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -119.99 149.78 49.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.668 -0.242 . . . . 1.12 110.892 -173.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.432 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 36.9 Cg_endo -67.34 122.0 9.2 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.33 2.02 . . . . 0.28 111.358 172.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.53 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 102.58 -11.42 56.5 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.779 -0.724 . . . . 0.23 112.203 -176.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.5 155.28 22.24 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.912 -0.403 . . . . 1.28 109.912 175.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.4 m -78.77 141.72 37.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.218 -0.66 . . . . 1.05 109.218 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.509 HG12 HD13 ' A' ' 65' ' ' LEU . 6.2 m -136.92 165.7 27.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.842 0.83 . . . . 1.16 111.251 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.732 ' OE1' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -121.51 144.05 48.92 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.216 -1.356 . . . . 0.78 107.988 171.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 41' ' ' LEU . 23.0 p90 -154.04 178.99 9.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.868 -0.419 . . . . 0.15 109.868 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.1 m -127.43 118.15 23.51 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.883 -0.784 . . . . 1.3 108.883 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.438 HG11 ' O ' ' A' ' 75' ' ' VAL . 7.3 p -82.95 98.97 5.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 122.072 0.939 . . . . 1.11 110.777 -175.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.9 122.86 64.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.152 -0.931 . . . . 1.13 109.863 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.4 m -76.53 130.34 37.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.987 -0.552 . . . . 1.27 111.022 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -73.98 106.55 5.72 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.994 -0.743 . . . . 1.96 108.994 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -64.65 -15.39 61.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.639 0.256 . . . . 2.24 111.681 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.54 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 4.3 tpm_? -90.83 -43.84 9.79 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.675 0.25 . . . . 4.49 111.675 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.493 ' OD1' ' HG2' ' A' ' 83' ' ' LYS . 22.6 t-20 -95.28 -31.97 13.21 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.803 -0.359 . . . . 2.66 111.18 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.42 -21.01 40.59 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.126 -0.559 . . . . 0.88 113.014 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.493 ' HG2' ' OD1' ' A' ' 81' ' ' ASN . 58.7 pttt -91.32 171.16 9.41 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 109.455 -0.572 . . . . 2.9 109.455 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.7 m -108.93 176.16 5.2 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.606 -0.438 . . . . 1.49 111.396 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.1 p -145.83 154.78 42.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.621 . . . . 1.31 109.881 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -93.27 117.46 30.1 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.273 0.558 . . . . 1.05 110.417 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.4 m -117.26 145.18 44.12 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.741 -0.663 . . . . 1.17 109.602 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.13 71.33 0.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.427 0.632 . . . . 2.17 109.777 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 80.2 t -89.8 121.81 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.077 -0.965 . . . . 1.06 111.223 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 4.3 mm? -112.26 148.37 34.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.79 -0.641 . . . . 1.77 109.916 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.57 ' HG2' HD22 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -87.51 118.18 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.155 -0.683 . . . . 2.02 109.155 177.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.0 mm -104.75 131.1 54.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.275 -0.875 . . . . 1.05 110.781 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -81.0 117.1 21.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.21 -0.45 . . . . 3.31 110.021 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.394 -0.821 . . . . 3.08 111.415 -179.664 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.103 0 N-CA-C 112.282 -0.327 . . . . 19.3 112.282 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.84 164.24 33.8 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.01 -0.367 . . . . 17.75 110.01 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -93.14 110.79 22.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.055 0.455 . . . . 17.68 110.087 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.4 42.34 1.94 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.742 -0.742 . . . . 14.41 112.348 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.08 160.74 23.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.12 0.485 . . . . 13.69 110.897 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.1 mt -102.54 163.12 12.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.519 . . . . 11.63 110.976 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.7 p -111.78 119.93 61.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.084 -0.507 . . . . 8.84 110.041 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.5 p -74.01 88.49 1.88 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.116 0.484 . . . . 8.01 110.569 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -161.21 -47.17 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.776 -0.647 . . . . 7.63 110.634 -174.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.05 103.67 7.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.133 0.492 . . . . 7.38 111.274 -176.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.1 mm -123.94 143.23 37.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.251 -0.648 . . . . 3.34 109.251 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.11 -44.22 69.43 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.327 0.492 . . . . 3.29 112.327 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -10.74 48.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.36 0.6 . . . . 2.96 111.309 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.4 m -77.36 -13.46 59.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 2.5 111.291 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.78 58.3 0.6 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.537 -0.839 . . . . 1.9 112.073 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -89.16 100.93 13.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.134 0.493 . . . . 5.69 111.437 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.17 -17.22 37.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.781 -0.645 . . . . 2.83 110.541 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.96 -25.43 64.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.638 . . . . 2.82 112.051 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.2 t -152.43 130.99 12.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.885 0.374 . . . . 3.08 110.715 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -168.81 131.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.759 -0.655 . . . . 2.34 109.326 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -73.99 -27.3 60.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 2.96 111.43 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.81 175.59 5.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.199 -0.455 . . . . 1.95 110.247 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -81.62 78.45 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.983 -0.377 . . . . 2.27 109.983 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? 44.29 26.39 0.16 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.409 1.084 . . . . 3.4 113.06 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -105.46 92.24 4.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.891 0.376 . . . . 1.88 110.506 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -104.54 122.66 46.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.126 0.488 . . . . 2.59 110.312 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 72.0 mmtt -100.43 144.8 29.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.652 -0.704 . . . . 1.84 110.78 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.523 ' HE ' ' HB2' ' A' ' 72' ' ' GLU . 9.5 mmt85 -112.77 128.37 56.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.204 -0.453 . . . . 1.99 110.056 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.04 179.98 8.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.84 -0.43 . . . . 0.96 109.84 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.76 147.4 28.64 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.289 -0.263 . . . . 0.86 110.289 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.478 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 38.5 t -66.42 113.83 3.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.199 0.523 . . . . 1.01 109.824 174.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.404 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 20.7 t70 -72.5 -44.36 62.35 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.053 -0.976 . . . . 0.6 109.615 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.3 m -164.28 166.86 20.52 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.805 -0.634 . . . . 1.18 110.562 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.419 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 5.3 mt -139.76 134.52 38.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.168 0.508 . . . . 1.03 109.942 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -127.53 91.88 3.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.423 -0.808 . . . . 2.16 110.313 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.51 -106.66 1.81 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.721 -0.752 . . . . 0.34 112.786 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -98.27 6.43 47.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.611 0.243 . . . . 2.6 110.363 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.47 140.85 51.61 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.125 0.488 . . . . 0.38 110.72 -173.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.516 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.67 158.73 15.56 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.313 -0.858 . . . . 0.11 111.148 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 80.7 m-85 -131.86 131.41 42.77 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.79 -0.819 . . . . 0.19 108.79 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.492 HD11 ' CD2' ' A' ' 73' ' ' PHE . 9.6 mt -103.93 153.49 20.74 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.573 -0.529 . . . . 1.28 109.573 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -76.32 73.4 3.1 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.995 -0.743 . . . . 1.77 108.995 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.403 ' HB3' HD12 ' A' ' 51' ' ' LEU . 28.0 t80 -150.1 98.68 2.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.735 -1.121 . . . . 0.33 109.091 -178.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.467 ' HG2' ' HA2' ' A' ' 48' ' ' GLY . 3.3 mp0 -82.12 100.75 9.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.452 -0.795 . . . . 1.81 109.978 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.516 HG12 ' HB3' ' A' ' 84' ' ' SER . 7.4 m -71.36 -39.37 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.422 -0.808 . . . . 1.51 111.978 -176.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.435 ' H ' ' HB2' ' A' ' 49' ' ' LYS . 5.9 tp10 -140.44 101.57 4.14 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.881 0.372 . . . . 2.24 111.0 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 t70 58.92 20.17 7.84 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.565 -0.743 . . . . 1.55 112.927 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.467 ' HA2' ' HG2' ' A' ' 44' ' ' GLU . . . 111.43 11.73 16.89 Favored Glycine 0 C--N 1.315 -0.589 0 C-N-CA 119.976 -1.107 . . . . 0.77 112.737 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 23.3 mmtm -69.72 110.63 5.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.344 -0.613 . . . . 3.03 109.344 173.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -70.55 132.19 45.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.878 -0.416 . . . . 1.87 109.878 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 3.0 mt -71.85 122.02 20.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.423 -0.353 . . . . 1.05 111.098 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -105.07 157.56 17.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.286 -0.416 . . . . 0.48 109.955 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.523 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 26.6 p90 -151.44 153.35 34.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.903 -0.59 . . . . 0.2 109.518 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -96.58 152.22 18.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.962 -0.755 . . . . 0.47 108.962 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.567 ' SD ' HG22 ' A' ' 58' ' ' VAL . 15.5 mmt -65.14 -1.66 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.417 0.525 . . . . 2.84 112.417 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.8 t -84.92 -19.47 32.17 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.08 -0.387 . . . . 1.41 110.209 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -90.03 -6.03 55.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.313 -0.403 . . . . 1.96 110.326 176.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.567 HG22 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -71.42 150.11 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.786 0.661 . . . . 1.06 112.786 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.42 93.5 0.07 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.87 -1.059 . . . . 1.85 112.128 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.99 -66.38 3.41 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 121.201 -0.523 . . . . 0.62 113.969 169.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -131.27 141.86 50.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.19 0.519 . . . . 2.3 110.018 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.8 p -70.87 -23.58 62.34 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.129 -0.941 . . . . 1.45 110.89 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.6 t -93.47 12.07 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 115.252 -0.885 . . . . 1.95 110.075 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.75 -38.0 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.484 -0.326 . . . . 1.21 111.226 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.525 HD21 HG11 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -90.17 124.99 35.3 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.158 -0.682 . . . . 2.19 109.158 -178.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -132.15 160.88 66.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.415 -0.357 . . . . 1.12 111.211 -173.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.478 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 27.0 Cg_endo -62.38 140.81 84.49 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.592 2.195 . . . . 0.28 111.887 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.26 -14.36 63.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.075 -0.583 . . . . 0.23 112.468 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -79.0 148.69 32.44 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.981 -0.378 . . . . 1.28 109.981 174.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 5.5 m -81.67 140.27 34.45 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.821 -0.807 . . . . 1.05 108.821 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.525 HG11 HD21 ' A' ' 65' ' ' LEU . 34.4 m -135.5 157.24 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.962 0.887 . . . . 1.16 111.351 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.523 ' HB2' ' HE ' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -114.74 132.25 56.5 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.856 -1.52 . . . . 0.78 107.688 171.597 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.492 ' CD2' HD11 ' A' ' 41' ' ' LEU . 20.1 p90 -143.25 179.54 7.01 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.639 -0.504 . . . . 0.15 109.639 -175.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 m -127.1 121.46 31.52 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.957 -0.757 . . . . 1.3 108.957 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 p -81.22 98.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.701 0.762 . . . . 1.11 110.593 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.55 120.53 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.717 -0.674 . . . . 1.13 110.45 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.7 m -68.78 133.0 47.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.736 -0.666 . . . . 1.27 111.279 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -71.05 105.23 3.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.736 -0.839 . . . . 1.96 108.736 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -63.93 -13.25 44.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.287 -0.415 . . . . 2.24 112.046 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -96.0 -36.8 10.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.472 -0.331 . . . . 4.49 111.563 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -107.38 -31.41 8.19 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.363 0.505 . . . . 2.66 112.363 -169.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.91 -21.24 38.8 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.236 -0.983 . . . . 0.88 113.663 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -85.33 175.46 8.89 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.287 -0.635 . . . . 2.9 109.287 177.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.516 ' HB3' HG12 ' A' ' 45' ' ' VAL . 19.6 t -117.43 -178.15 3.39 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.587 -0.445 . . . . 1.49 110.981 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.0 p -156.79 152.99 27.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.908 -0.587 . . . . 1.31 109.942 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' A' ' 53' ' ' PHE . . . -86.73 118.4 26.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.939 0.4 . . . . 1.05 110.627 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 33.9 m -116.74 140.86 48.94 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.269 -0.423 . . . . 1.17 109.916 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 63.39 72.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.622 0.725 . . . . 2.17 109.237 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 54.5 t -87.98 116.8 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.803 -1.09 . . . . 1.06 110.505 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 4.1 mm? -108.47 148.91 29.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.03 -0.532 . . . . 1.77 110.523 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.498 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -81.56 125.4 30.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.267 -0.642 . . . . 2.02 109.267 173.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.46 ' O ' ' HB ' ' A' ' 70' ' ' THR . 40.1 mm -117.38 137.86 49.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.12 -0.491 . . . . 1.05 111.037 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -103.38 120.0 39.96 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.275 -1.009 . . . . 3.31 108.275 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.2 t0 . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 116.569 -0.287 . . . . 3.08 110.51 -174.537 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.147 -0.381 . . . . 19.3 112.147 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.98 149.16 26.95 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.794 -0.203 . . . . 17.75 110.504 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? 61.58 35.38 17.33 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.536 0.684 . . . . 17.68 110.791 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.23 41.89 2.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.905 -0.664 . . . . 14.41 111.996 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -86.77 -179.11 6.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.9 0.381 . . . . 13.69 110.643 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.3 mt -88.08 64.57 7.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.985 0.421 . . . . 11.63 110.597 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.74 100.66 3.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.027 -0.533 . . . . 8.84 110.71 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 p -87.76 81.15 7.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.286 0.565 . . . . 8.01 109.718 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -177.86 9.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.098 -0.955 . . . . 7.63 109.235 -173.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.33 -70.65 0.34 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.102 -0.499 . . . . 7.38 110.614 -170.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.3 mp -120.94 97.33 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 C-N-CA 120.558 -0.457 . . . . 3.34 109.8 171.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -102.07 -18.06 15.76 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.626 -0.715 . . . . 3.29 111.211 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -4.15 15.08 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.69 0.757 . . . . 2.96 110.669 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.4 m -93.54 -8.41 41.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.242 -0.89 . . . . 2.5 111.201 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.31 59.01 0.69 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 119.923 -1.132 . . . . 1.9 113.894 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -89.01 113.22 24.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 117.284 0.542 . . . . 5.69 110.102 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.36 -15.51 57.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.071 -0.513 . . . . 2.83 111.951 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.07 -14.98 62.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.419 -0.355 . . . . 2.82 111.61 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.9 t -136.21 130.38 33.04 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.217 -1.031 . . . . 3.08 108.217 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.1 p -168.81 142.46 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.767 0.318 . . . . 2.34 111.016 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -116.41 -51.85 2.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.128 0.49 . . . . 2.96 109.715 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 74' ' ' SER . . . -97.55 123.63 41.5 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.996 -0.372 . . . . 1.95 109.996 176.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.42 HG13 ' HG3' ' A' ' 24' ' ' ARG . 20.4 t -60.8 108.9 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.929 -0.578 . . . . 2.27 111.773 -174.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.42 ' HG3' HG13 ' A' ' 23' ' ' VAL . 0.1 OUTLIER 44.17 25.93 0.13 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.933 1.293 . . . . 3.4 113.966 178.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.482 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 5.5 tp60 -115.82 75.72 0.97 Allowed 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.999 -0.438 . . . . 1.88 110.99 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.44 ' HZ1' ' CD ' ' A' ' 72' ' ' GLU . 7.7 mtmp? -96.24 126.14 41.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.691 -0.485 . . . . 2.59 109.691 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 12.9 mmtm -113.3 145.5 40.94 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.775 -0.648 . . . . 1.84 110.28 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -116.89 132.49 56.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.94 0.4 . . . . 1.99 110.696 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.73 179.84 8.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.802 -0.636 . . . . 0.96 109.787 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.8 144.15 31.87 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.206 -0.452 . . . . 0.86 110.023 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.475 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 61.3 t -67.2 116.34 6.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.133 0.492 . . . . 1.01 110.463 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.421 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 10.6 t70 -67.69 -51.79 45.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.08 -0.963 . . . . 0.6 109.636 177.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.7 m -159.41 166.76 30.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.893 -0.594 . . . . 1.18 110.564 -175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.405 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 6.0 mt -142.55 132.39 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.876 -0.602 . . . . 1.03 110.07 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -126.76 93.84 3.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.623 -0.717 . . . . 2.16 110.641 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.85 -106.43 1.64 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.73 -0.748 . . . . 0.34 112.393 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -99.02 7.65 45.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.633 0.254 . . . . 2.6 110.687 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -126.79 143.34 51.28 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.279 0.562 . . . . 0.38 111.469 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.499 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.18 161.95 21.97 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.713 -0.756 . . . . 0.11 111.52 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 70.7 m-85 -136.96 143.35 42.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.174 -0.676 . . . . 0.19 109.174 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.5 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.5 mt -117.81 156.53 28.19 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.335 -0.246 . . . . 1.28 110.335 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -74.85 72.81 2.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.35 0.595 . . . . 1.77 109.729 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -146.53 100.79 3.4 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.107 -0.951 . . . . 0.33 109.284 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -81.56 106.03 13.19 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.271 -0.877 . . . . 1.81 110.062 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.1 t -71.01 -66.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.522 -0.763 . . . . 1.51 111.194 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.616 ' H ' ' HB2' ' A' ' 49' ' ' LYS . 1.0 OUTLIER -133.71 116.29 15.6 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.081 -0.963 . . . . 2.24 109.49 -178.213 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 t70 64.18 19.17 11.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.466 0.651 . . . . 1.55 111.637 171.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.35 21.4 13.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.557 -0.83 . . . . 0.77 112.841 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.616 ' HB2' ' H ' ' A' ' 46' ' ' GLU . 27.6 mmtm -65.09 109.97 2.35 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.443 -0.577 . . . . 3.03 109.443 175.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -72.3 118.62 15.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.098 -0.705 . . . . 1.87 109.098 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.1 mt -60.38 125.2 22.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.417 -0.356 . . . . 1.05 111.506 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -106.44 157.29 17.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.138 -0.483 . . . . 0.48 109.916 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.499 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 27.0 p90 -148.86 154.66 39.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.68 -0.691 . . . . 0.2 109.178 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -98.32 151.87 20.05 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.619 -0.882 . . . . 0.47 108.619 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.574 ' SD ' HG22 ' A' ' 58' ' ' VAL . 14.3 mmt -61.03 -12.44 11.71 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.37 0.507 . . . . 2.84 112.37 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.9 m -72.48 -25.39 61.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.192 -0.318 . . . . 1.41 110.82 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.45 -13.74 51.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 1.96 110.71 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.574 HG22 ' SD ' ' A' ' 55' ' ' MET . 2.0 t -64.04 152.31 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 112.861 0.689 . . . . 1.06 112.861 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.403 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -62.77 95.79 0.08 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.948 -1.024 . . . . 1.85 112.173 -176.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.47 -81.62 0.6 Allowed Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.62 113.288 172.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -110.92 143.6 41.29 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.677 -0.49 . . . . 2.3 109.677 -177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.42 HG21 ' HB3' ' A' ' 55' ' ' MET . 66.6 p -57.9 -42.69 85.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.127 0.489 . . . . 1.45 111.873 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.94 4.7 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.952 -0.567 . . . . 1.95 112.477 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.5 -9.78 40.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.69 0.281 . . . . 1.21 111.21 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.479 ' CD2' ' HG2' ' A' ' 91' ' ' LYS . 1.6 tm? -115.9 125.46 52.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.915 -0.772 . . . . 2.19 108.915 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -120.33 149.78 50.35 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-O 120.579 0.228 . . . . 1.12 111.065 -171.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.475 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 37.0 Cg_endo -66.04 139.52 56.4 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.655 2.237 . . . . 0.28 111.881 174.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.67 -15.48 61.46 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.921 -0.657 . . . . 0.23 111.999 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.7 149.75 27.13 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.39 -0.226 . . . . 1.28 110.39 177.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.1 m -76.22 137.85 40.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.199 -0.667 . . . . 1.05 109.199 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.469 HG13 HD23 ' A' ' 65' ' ' LEU . 16.1 m -136.07 157.51 38.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.525 0.678 . . . . 1.16 109.98 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.44 ' CD ' ' HZ1' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -114.78 132.07 56.59 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.203 -1.036 . . . . 0.78 108.203 173.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.5 ' CD2' HD13 ' A' ' 41' ' ' LEU . 36.7 p90 -141.93 179.15 7.04 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.855 -0.611 . . . . 0.15 109.889 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.488 ' HB3' ' HB3' ' A' ' 22' ' ' ALA . 25.0 m -128.63 119.69 25.19 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.917 -0.772 . . . . 1.3 108.917 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 75' ' ' VAL . 8.5 p -91.4 108.38 19.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.767 0.794 . . . . 1.11 111.269 -172.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.8 p -116.0 124.42 72.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.533 -0.758 . . . . 1.13 110.061 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.2 m -83.35 127.03 33.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.173 0.511 . . . . 1.27 110.611 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.576 ' CB ' ' HB3' ' A' ' 81' ' ' ASN . 9.2 m120 -70.45 121.29 17.49 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.518 -0.764 . . . . 1.96 109.765 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -73.78 -21.46 60.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.942 0.401 . . . . 2.24 111.222 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -96.09 -33.67 12.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.023 0.439 . . . . 4.49 110.979 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.576 ' HB3' ' CB ' ' A' ' 78' ' ' ASN . 60.4 t30 -97.05 -18.23 19.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.331 0.586 . . . . 2.66 110.788 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.99 -25.96 2.96 Favored Glycine 0 C--O 1.229 -0.175 0 CA-C-N 115.525 -0.761 . . . . 0.88 113.919 174.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.439 ' HE2' HD22 ' A' ' 81' ' ' ASN . 18.5 pttm -99.62 168.47 9.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.22 0.51 . . . . 2.9 111.358 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.5 m -102.34 175.45 5.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.561 -0.745 . . . . 1.49 111.64 -175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -143.69 156.39 44.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.566 -0.743 . . . . 1.31 109.157 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' A' ' 53' ' ' PHE . . . -99.47 118.59 36.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 110.029 -0.36 . . . . 1.05 110.029 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.2 m -116.56 148.33 40.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.437 -0.347 . . . . 1.17 110.664 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.2 m120 62.06 52.09 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.646 0.591 . . . . 2.17 109.881 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 77.2 t -72.89 100.62 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.473 -0.785 . . . . 1.06 110.81 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 8.0 mp -102.84 148.31 25.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.641 -0.709 . . . . 1.77 110.95 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -77.17 127.95 33.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.014 -0.539 . . . . 2.02 110.006 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.1 mm -115.86 134.24 59.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.301 -0.409 . . . . 1.05 110.267 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -109.87 119.93 40.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.503 -0.317 . . . . 3.31 111.758 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--O 1.235 0.342 0 CA-C-N 115.39 -0.823 . . . . 3.08 109.549 170.922 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.515 -0.234 . . . . 19.3 112.515 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.85 107.08 13.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.982 0.42 . . . . 17.75 110.337 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -89.29 41.42 1.03 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.556 0.693 . . . . 17.68 109.564 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.15 77.72 0.28 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.493 -0.776 . . . . 14.41 113.454 -173.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -132.84 138.0 46.91 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.525 -0.917 . . . . 13.69 108.525 170.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 mp -67.31 117.99 10.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.378 0.609 . . . . 11.63 111.079 -174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.402 ' C ' ' H ' ' A' ' 9' ' ' PHE . 19.8 m -91.85 144.41 9.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.145 -0.934 . . . . 8.84 110.688 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.3 p -74.99 11.17 1.17 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.086 -0.506 . . . . 8.01 111.265 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.402 ' H ' ' C ' ' A' ' 7' ' ' VAL . 74.6 t80 -82.59 -30.87 29.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.105 -0.498 . . . . 7.63 111.239 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HD3' ' C ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -124.46 21.2 8.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.957 0.354 . . . . 7.38 111.957 -173.27 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 14' ' ' SER . 38.9 mm -86.22 149.58 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.753 0.311 . . . . 3.34 110.172 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.453 ' HA ' ' CG ' ' A' ' 16' ' ' ARG . 4.5 m-20 -57.8 -49.41 76.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.12 -0.491 . . . . 3.29 111.839 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 10.3 pt-20 -59.76 -25.55 64.98 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.248 -0.433 . . . . 2.96 111.287 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 11' ' ' ILE . 42.9 m -65.52 -24.0 67.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.017 -0.538 . . . . 2.5 111.22 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.31 58.17 0.3 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.412 -0.899 . . . . 1.9 112.639 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.453 ' CG ' ' HA ' ' A' ' 12' ' ' ASP . 21.0 mmm180 -67.59 99.03 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.879 0.371 . . . . 5.69 110.539 176.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.81 -17.48 35.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.946 -0.57 . . . . 2.83 111.089 176.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.95 -37.7 79.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.113 -0.494 . . . . 2.82 111.039 -175.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.0 m -124.44 130.87 53.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.799 -0.815 . . . . 3.08 108.799 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.27 150.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.859 0.361 . . . . 2.34 110.96 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.459 HD21 ' HB3' ' A' ' 87' ' ' CYS . 94.1 m-20 -108.39 -49.81 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.927 0.394 . . . . 2.96 110.636 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.13 161.78 16.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.377 -0.374 . . . . 1.95 110.037 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.415 ' C ' ' HG3' ' A' ' 24' ' ' ARG . 22.7 t -76.02 84.55 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 121.155 -0.218 . . . . 2.27 110.942 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.415 ' HG3' ' C ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER 45.9 23.6 0.18 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.695 1.198 . . . . 3.4 113.452 177.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.414 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 6.5 tp60 -106.81 84.92 2.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.984 0.421 . . . . 1.88 110.912 -176.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -93.91 135.02 35.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.117 -0.492 . . . . 2.59 110.105 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 16.1 mmtm -118.84 147.33 44.05 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.764 -0.653 . . . . 1.84 109.781 174.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -122.94 132.19 54.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.019 0.438 . . . . 1.99 110.617 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.78 179.75 8.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.454 -0.794 . . . . 0.96 109.623 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.53 144.47 31.37 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.07 -0.344 . . . . 0.86 110.07 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.477 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 43.7 t -64.27 124.24 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.932 0.396 . . . . 1.01 110.383 176.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.72 -48.44 13.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.725 -0.67 . . . . 0.6 109.988 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 m -158.48 166.06 33.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.649 -0.705 . . . . 1.18 110.057 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.3 mt -140.9 126.89 19.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.033 0.444 . . . . 1.03 109.987 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -114.13 86.68 2.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.417 -0.81 . . . . 2.16 110.257 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.71 -106.28 1.43 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.606 -0.807 . . . . 0.34 112.899 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -93.28 4.66 53.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.562 0.22 . . . . 2.6 111.263 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -126.98 140.33 52.39 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.038 0.447 . . . . 0.38 110.614 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.42 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.29 161.0 14.72 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.422 -0.894 . . . . 0.11 111.422 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 84.1 m-85 -132.88 137.08 46.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.496 -0.557 . . . . 0.19 109.496 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.527 HD13 ' CD2' ' A' ' 73' ' ' PHE . 4.7 mt -114.6 154.49 28.24 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.539 -0.541 . . . . 1.28 109.539 -177.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.474 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 65.1 t30 -78.03 73.65 4.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.621 0.724 . . . . 1.77 109.821 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -140.53 106.35 5.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.761 -1.108 . . . . 0.33 108.442 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -94.63 105.33 17.27 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.427 0.632 . . . . 1.81 110.814 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.66 -77.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.797 -1.092 . . . . 1.51 111.788 -173.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 10.1 tt0 -111.75 111.37 22.3 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.392 -0.822 . . . . 2.24 110.479 -173.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.9 t70 61.22 22.5 12.83 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.459 0.647 . . . . 1.55 111.714 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.36 27.84 8.95 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.317 -0.944 . . . . 0.77 112.669 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 27.4 mmmt -77.92 110.93 13.25 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.153 -0.684 . . . . 3.03 109.153 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 9.3 tppt? -75.56 126.15 30.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.134 -0.691 . . . . 1.87 109.134 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 4.5 mt -62.6 130.24 44.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.404 0.52 . . . . 1.05 112.404 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -111.62 159.31 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.659 -0.7 . . . . 0.48 109.216 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.433 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 32.7 p90 -149.41 149.78 31.37 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.705 -0.479 . . . . 0.2 109.705 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -90.32 149.68 22.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.068 -0.716 . . . . 0.47 109.068 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -0.93 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.249 0.463 . . . . 2.84 112.249 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.6 t -71.32 -32.18 68.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.076 0.465 . . . . 1.41 110.045 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -86.65 -10.55 53.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.87 -0.605 . . . . 1.96 110.956 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.26 145.14 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.467 0.651 . . . . 1.06 112.417 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.496 ' HG3' ' H ' ' A' ' 91' ' ' LYS . 0.9 OUTLIER -66.1 110.12 2.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.578 -1.192 . . . . 1.85 111.79 -175.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.66 -93.14 0.72 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.035 -0.602 . . . . 0.62 113.083 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.54 155.99 23.41 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.231 -0.285 . . . . 2.3 110.231 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.3 p -61.56 -32.04 72.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.157 -0.474 . . . . 1.45 111.35 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.39 17.62 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.283 0.563 . . . . 1.95 110.61 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.58 2.04 27.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.183 0.516 . . . . 1.21 111.179 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.438 HD11 HG11 ' A' ' 71' ' ' VAL . 1.8 tm? -129.25 125.63 37.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.344 -0.984 . . . . 2.19 108.344 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -122.8 154.02 63.69 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 111.685 0.254 . . . . 1.12 111.685 -171.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.477 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.4 Cg_endo -68.07 134.81 32.85 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.8 2.333 . . . . 0.28 112.369 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.87 -4.73 72.14 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.692 -0.766 . . . . 0.23 111.98 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -95.7 155.25 16.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.594 -0.521 . . . . 1.28 109.594 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -83.47 132.07 34.98 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.62 -0.511 . . . . 1.05 109.62 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.438 HG11 HD11 ' A' ' 65' ' ' LEU . 4.3 m -134.26 160.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.787 0.803 . . . . 1.16 110.84 -176.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -119.12 138.8 52.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.359 -1.291 . . . . 0.78 108.911 177.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.527 ' CD2' HD13 ' A' ' 41' ' ' LEU . 36.5 p90 -150.81 180.0 7.75 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.935 -0.575 . . . . 0.15 109.854 -173.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.1 m -127.41 131.49 50.28 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.913 -0.773 . . . . 1.3 108.913 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.422 HG22 ' OG ' ' A' ' 84' ' ' SER . 3.5 p -91.35 98.11 8.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.985 0.898 . . . . 1.11 110.436 -175.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.5 p -102.53 114.36 41.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.193 -0.912 . . . . 1.13 110.241 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.2 m -80.15 127.14 31.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.853 -0.612 . . . . 1.27 110.922 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.97 104.3 2.49 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.019 -0.734 . . . . 1.96 109.019 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -57.23 -26.98 61.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.843 0.354 . . . . 2.24 111.652 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.438 ' HE ' ' HA ' ' A' ' 80' ' ' ARG . 5.1 tpm_? -84.41 -41.35 16.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 4.49 111.599 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -95.05 -30.71 13.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.221 0.452 . . . . 2.66 112.221 -170.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.89 -24.16 32.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.078 -0.582 . . . . 0.88 112.907 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -86.75 175.88 8.02 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.661 -0.317 . . . . 2.9 110.495 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.422 ' OG ' HG22 ' A' ' 75' ' ' VAL . 32.7 t -116.95 -179.23 3.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.104 0.478 . . . . 1.49 110.969 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 m -149.56 147.84 28.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.317 -0.994 . . . . 1.31 108.317 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . . . -86.97 121.63 29.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.867 0.365 . . . . 1.05 110.653 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.459 ' HB3' HD21 ' A' ' 21' ' ' ASN . 68.4 m -117.33 144.59 44.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.857 -0.611 . . . . 1.17 110.359 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.45 70.43 0.65 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.991 0.807 . . . . 2.17 110.336 -177.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 92.7 t -84.99 115.34 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.273 0.559 . . . . 1.06 111.021 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.27 149.1 30.66 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.793 -0.64 . . . . 1.77 110.509 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.496 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -81.56 124.12 29.24 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.105 -0.702 . . . . 2.02 109.105 174.404 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.1 mm -105.53 133.52 49.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.962 -0.563 . . . . 1.05 111.559 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -80.32 121.38 25.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.423 -0.808 . . . . 3.31 108.934 173.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.058 -0.519 . . . . 3.08 110.711 -175.563 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.403 0 N-CA-C 111.878 -0.489 . . . . 19.3 111.878 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.56 169.28 11.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.501 0.191 . . . . 17.75 110.614 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -82.1 124.36 29.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.288 0.566 . . . . 17.68 110.214 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.94 5.88 54.59 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.38 -1.088 . . . . 14.41 110.38 -170.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -126.73 146.78 50.09 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.046 -0.724 . . . . 13.69 109.046 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.0 mt -84.16 94.58 8.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.041 0.448 . . . . 11.63 111.297 -174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.32 -34.04 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.693 -0.685 . . . . 8.84 110.548 175.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.5 m 61.69 20.56 11.45 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.452 0.538 . . . . 8.01 112.452 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -92.53 -37.26 12.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.268 0.556 . . . . 7.63 109.554 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -171.82 120.55 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.074 -0.966 . . . . 7.38 109.296 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.502 ' CG2' ' HG3' ' A' ' 13' ' ' GLU . 38.9 mm -122.42 134.11 66.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.225 -0.59 . . . . 3.34 111.468 -177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' OD1' HD21 ' A' ' 90' ' ' LEU . 13.7 p-10 -100.15 -17.33 17.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.887 -0.597 . . . . 3.29 112.424 -174.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.502 ' HG3' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -73.19 -15.1 61.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.716 0.769 . . . . 2.96 109.613 173.115 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 m -68.72 -17.51 64.08 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.92 -1.036 . . . . 2.5 110.846 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.14 53.36 46.34 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 116.035 -0.53 . . . . 1.9 113.23 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -82.36 162.9 22.04 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.215 -0.661 . . . . 5.69 109.215 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.74 -16.67 17.77 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.366 0.506 . . . . 2.83 112.366 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.26 -18.47 63.86 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.872 0.323 . . . . 2.82 111.872 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 52.0 t -155.67 131.19 9.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.902 0.382 . . . . 3.08 110.672 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -164.43 133.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.177 0.513 . . . . 2.34 110.719 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -130.34 159.05 38.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.382 -0.372 . . . . 2.96 110.575 -176.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 64.36 21.43 12.49 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.211 0.604 . . . . 1.95 111.539 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.409 ' C ' ' HG3' ' A' ' 24' ' ' ARG . 17.2 t 59.89 72.56 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.09 -0.505 . . . . 2.27 110.467 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER 47.57 25.61 0.68 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.336 1.054 . . . . 3.4 113.199 178.102 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -107.66 74.12 0.94 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.941 0.401 . . . . 1.88 111.361 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -91.76 132.92 36.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.031 0.443 . . . . 2.59 110.377 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -114.47 149.71 35.91 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.799 -0.637 . . . . 1.84 109.663 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.471 ' HG2' ' CB ' ' A' ' 72' ' ' GLU . 59.5 mtm-85 -122.96 127.89 49.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.067 0.461 . . . . 1.99 111.059 177.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 179.53 9.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.183 -0.917 . . . . 0.96 109.807 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.4 146.18 29.21 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.849 -0.426 . . . . 0.86 109.849 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.481 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 40.8 t -67.2 123.06 19.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.856 0.36 . . . . 1.01 110.866 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -75.16 -42.46 55.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.6 110.144 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 p -172.04 165.25 6.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.517 -0.765 . . . . 1.18 110.201 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.7 mt -135.48 129.93 49.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.092 0.472 . . . . 1.03 109.965 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -126.16 95.23 4.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.562 -0.744 . . . . 2.16 110.613 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.83 -106.28 1.77 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.34 112.726 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -103.07 9.99 38.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.686 0.279 . . . . 2.6 110.417 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -129.58 141.12 51.02 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.225 0.536 . . . . 0.38 111.054 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -123.97 159.02 18.63 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.137 -0.785 . . . . 0.11 111.137 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 76.8 m-85 -131.06 147.49 52.63 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.859 -0.422 . . . . 0.19 109.859 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.592 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 5.7 mt -124.82 146.99 48.98 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.385 -0.598 . . . . 1.28 109.385 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -72.92 74.63 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.574 0.702 . . . . 1.77 110.505 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -138.0 97.63 3.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.836 -1.074 . . . . 0.33 108.539 177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.501 ' CG ' ' HA2' ' A' ' 48' ' ' GLY . 19.5 mp0 -74.15 102.15 4.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.948 -1.024 . . . . 1.81 110.966 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 84' ' ' SER . 28.6 m -80.12 -32.44 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.494 -0.775 . . . . 1.51 111.108 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -157.98 116.89 3.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.128 -0.487 . . . . 2.24 110.33 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.2 t70 58.87 22.57 10.37 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.507 0.558 . . . . 1.55 112.507 169.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.501 ' HA2' ' CG ' ' A' ' 44' ' ' GLU . . . 102.38 2.68 50.75 Favored Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.418 -0.896 . . . . 0.77 112.966 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -60.72 115.08 3.38 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 122.167 0.187 . . . . 3.03 110.795 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -70.49 148.95 47.69 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.628 -0.508 . . . . 1.87 109.628 176.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 3.4 mt -79.02 132.68 36.72 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.904 -0.589 . . . . 1.05 110.274 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -107.31 154.24 21.56 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.579 -0.526 . . . . 0.48 109.579 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 18.5 p90 -146.4 156.22 43.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.338 -0.616 . . . . 0.2 109.338 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -97.33 149.64 21.86 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.897 -0.779 . . . . 0.47 108.897 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.446 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -61.82 -8.23 4.61 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.909 0.337 . . . . 2.84 111.909 -178.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 t -79.25 -19.55 50.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.95 0.405 . . . . 1.41 110.288 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -92.2 -10.83 37.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.977 0.418 . . . . 1.96 110.171 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.1 t -64.62 149.14 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.454 -0.793 . . . . 1.06 111.897 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -63.31 92.01 0.06 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.219 -0.9 . . . . 1.85 112.52 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.1 -77.56 0.69 Allowed Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.006 -0.543 . . . . 0.62 113.732 172.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -103.93 140.16 38.09 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.606 -0.516 . . . . 2.3 109.606 -175.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 69.6 p -70.53 -22.67 62.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.974 -0.557 . . . . 1.45 111.64 -173.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.4 t -100.38 7.16 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.271 0.558 . . . . 1.95 110.503 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.69 -11.1 32.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.316 -0.402 . . . . 1.21 110.928 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.493 HD12 HG13 ' A' ' 71' ' ' VAL . 1.4 tm? -110.04 124.51 51.58 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.702 -0.851 . . . . 2.19 108.702 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -115.46 150.66 44.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.743 0.306 . . . . 1.12 111.533 -170.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.481 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.2 Cg_endo -68.06 140.82 50.94 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.379 2.053 . . . . 0.28 111.895 173.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.55 -1.31 88.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.645 -0.788 . . . . 0.23 112.451 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -96.16 159.32 15.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.729 -0.471 . . . . 1.28 109.729 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -83.96 134.97 34.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.565 -0.531 . . . . 1.05 109.565 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.493 HG13 HD12 ' A' ' 65' ' ' LEU . 10.2 m -136.7 160.04 37.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 110.068 -0.345 . . . . 1.16 110.068 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.548 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 4.6 pt-20 -116.03 141.65 47.84 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.601 -0.888 . . . . 0.78 108.601 170.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 41' ' ' LEU . 26.5 p90 -146.82 179.7 7.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.33 -0.85 . . . . 0.15 109.672 -173.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m -127.65 127.18 43.34 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.942 -0.762 . . . . 1.3 108.942 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 75' ' ' VAL . 8.2 p -92.68 99.4 9.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.835 0.826 . . . . 1.11 111.508 -172.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 84' ' ' SER . 5.1 p -99.11 112.34 31.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.819 -0.628 . . . . 1.13 109.944 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.1 m -93.76 140.45 29.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.508 -0.769 . . . . 1.27 111.128 -173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 80' ' ' ARG . 5.1 t-20 -71.61 134.64 46.53 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.711 0.291 . . . . 1.96 110.359 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 19.2 pm0 -76.87 -12.48 59.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.497 -0.319 . . . . 2.24 111.07 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.462 ' HB3' ' OD1' ' A' ' 78' ' ' ASN . 7.0 tpm_? -95.56 -59.27 1.91 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.568 -0.287 . . . . 4.49 111.605 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -109.04 -0.48 19.48 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.202 0.445 . . . . 2.66 112.202 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.93 80.03 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.494 -0.86 . . . . 0.88 113.159 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.51 131.55 34.86 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.42 0.628 . . . . 2.9 111.494 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 65.3 m -106.7 170.2 8.08 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.912 -1.04 . . . . 1.49 111.357 -172.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.8 m -148.6 152.91 37.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.63 -0.714 . . . . 1.31 109.338 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.432 ' HB1' ' HB3' ' A' ' 53' ' ' PHE . . . -95.33 122.55 38.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 120.87 0.367 . . . . 1.05 110.373 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 94.1 m -116.69 148.55 40.95 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.129 -0.487 . . . . 1.17 110.22 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.8 m120 59.32 62.03 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.674 0.609 . . . . 2.17 110.338 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.7 t -80.87 99.14 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.472 -0.786 . . . . 1.06 110.656 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.548 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 6.7 mp -99.79 147.87 25.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.349 -0.841 . . . . 1.77 110.545 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.453 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -78.62 123.71 27.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.969 -0.382 . . . . 2.02 109.969 178.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.58 120.74 60.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.093 0.473 . . . . 1.05 110.667 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -90.93 107.29 19.1 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.922 -0.581 . . . . 3.31 110.486 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.8 t0 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 116.024 -0.535 . . . . 3.08 110.251 178.982 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 N-CA-C 112.235 -0.346 . . . . 19.3 112.235 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.09 -36.6 64.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.074 0.464 . . . . 17.75 111.253 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -117.08 22.11 12.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.086 -0.506 . . . . 17.68 110.565 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.17 89.63 1.53 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.093 -0.803 . . . . 14.41 111.093 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -81.92 171.4 14.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.92 0.391 . . . . 13.69 110.495 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.441 HD11 ' N ' ' A' ' 6' ' ' LEU . 6.4 mp -85.5 105.86 16.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.161 -0.472 . . . . 11.63 110.81 -174.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.4 p -112.08 137.95 42.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.005 -0.543 . . . . 8.84 110.843 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.0 t -76.86 95.82 4.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.288 -0.634 . . . . 8.01 109.288 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -98.65 -35.98 10.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.843 -0.617 . . . . 7.63 110.993 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -157.99 151.9 24.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.019 -0.537 . . . . 7.38 110.192 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.414 HD11 ' N ' ' A' ' 11' ' ' ILE . 4.1 mp -92.24 121.27 42.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.196 -0.456 . . . . 3.34 109.982 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -69.02 -30.51 68.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.822 0.82 . . . . 3.29 109.926 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.495 ' HG2' HD13 ' A' ' 90' ' ' LEU . 2.6 mt-10 -82.41 15.2 2.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.301 -1.318 . . . . 2.96 110.572 -176.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.2 t -70.85 -25.95 63.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.265 -0.88 . . . . 2.5 111.435 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.97 59.37 0.33 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.197 -1.001 . . . . 1.9 111.39 -174.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -63.41 107.47 1.11 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.73 0.3 . . . . 5.69 111.662 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.52 -17.11 42.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.306 0.574 . . . . 2.83 110.269 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.8 -26.27 64.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.416 -0.811 . . . . 2.82 111.484 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.2 m -135.36 130.08 34.39 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.002 -0.74 . . . . 3.08 109.002 177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.528 HG22 ' H ' ' A' ' 22' ' ' ALA . 14.9 p -168.42 139.46 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.892 0.377 . . . . 2.34 110.031 -178.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -115.74 12.14 15.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.805 0.812 . . . . 2.96 109.706 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.528 ' H ' HG22 ' A' ' 20' ' ' VAL . . . -142.23 -162.31 1.39 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.402 -0.817 . . . . 1.95 110.094 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 24' ' ' ARG . 1.7 t -86.18 175.4 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.423 -0.584 . . . . 2.27 109.423 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.494 ' H ' HG12 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -72.11 24.84 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.752 0.649 . . . . 3.4 112.752 178.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.436 ' H ' ' C ' ' A' ' 23' ' ' VAL . 56.8 tp60 -106.68 111.46 24.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.491 -0.188 . . . . 1.88 110.491 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -109.1 112.31 24.41 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.349 -0.54 . . . . 2.59 110.228 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -90.72 154.31 19.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.595 -0.729 . . . . 1.84 109.59 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -128.11 128.32 44.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.999 -0.371 . . . . 1.99 109.999 176.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 179.53 9.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.803 -0.635 . . . . 0.96 109.376 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.55 140.09 38.0 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 110.345 -0.243 . . . . 0.86 110.345 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 43.7 t -62.04 115.7 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 120.986 0.422 . . . . 1.01 110.337 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.03 -47.26 65.87 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.446 -0.797 . . . . 0.6 110.019 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.1 m -168.86 168.56 10.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 1.18 109.36 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.409 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 11.2 mt -135.79 126.97 44.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.639 -0.504 . . . . 1.03 109.639 175.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -116.88 92.16 3.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.643 -0.708 . . . . 2.16 110.089 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.96 -109.27 2.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.789 -0.72 . . . . 0.34 112.238 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -96.99 6.02 49.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.71 0.255 . . . . 2.6 110.758 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -125.06 144.18 50.54 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.321 0.581 . . . . 0.38 111.234 -173.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.79 159.41 15.45 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.595 -0.812 . . . . 0.11 111.308 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.0 142.47 47.65 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.376 -0.601 . . . . 0.19 109.376 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.479 HD13 ' CD2' ' A' ' 73' ' ' PHE . 8.8 mt -116.15 152.22 34.13 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.247 -0.649 . . . . 1.28 109.247 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -75.48 76.0 2.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.505 0.669 . . . . 1.77 109.417 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.414 ' HB3' HD13 ' A' ' 51' ' ' LEU . 23.9 t80 -147.73 98.13 2.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.983 -1.008 . . . . 0.33 109.121 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 33.3 mt-10 -87.88 101.99 14.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.325 0.583 . . . . 1.81 110.573 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 84' ' ' SER . 15.6 m -73.35 -45.09 53.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.41 -0.814 . . . . 1.51 112.078 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 4.8 tt0 -140.71 116.61 10.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.572 -0.286 . . . . 2.24 110.537 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 t70 57.87 21.83 8.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.324 0.583 . . . . 1.55 112.131 167.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.47 19.82 19.41 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.443 -0.884 . . . . 0.77 112.955 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 32.6 mmtm -70.99 110.41 5.67 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.892 -0.41 . . . . 3.03 109.892 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -75.24 126.89 31.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.503 -0.554 . . . . 1.87 109.503 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 51' ' ' LEU . 3.8 mt -66.75 126.83 30.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.532 -0.304 . . . . 1.05 111.314 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.438 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 9.5 p90 -111.25 162.53 14.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.427 -0.351 . . . . 0.48 110.138 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 30.2 p90 -155.17 159.75 40.38 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.174 -0.676 . . . . 0.2 109.174 174.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -99.86 153.65 18.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.342 -0.614 . . . . 0.47 109.342 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 19.6 mtt -66.76 3.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.44 0.533 . . . . 2.84 112.44 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.1 t -89.45 -22.75 22.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.542 -0.54 . . . . 1.41 109.542 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -90.07 -5.67 56.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.511 . . . . 1.96 110.27 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.436 HG22 HD13 ' A' ' 65' ' ' LEU . 1.3 t -67.62 152.45 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.223 -0.899 . . . . 1.06 112.818 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.441 ' HG3' ' H ' ' A' ' 91' ' ' LYS . 1.1 tm0? -59.41 99.02 0.05 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 114.863 -1.062 . . . . 1.85 112.419 -176.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.44 -85.0 0.25 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.62 113.258 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -105.71 145.67 30.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.677 -0.49 . . . . 2.3 109.677 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.0 p -59.98 -40.36 88.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.619 0.6 . . . . 1.45 112.619 -174.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.36 19.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.512 0.672 . . . . 1.95 110.522 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.52 11.54 38.84 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.429 0.633 . . . . 1.21 110.141 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.436 HD13 HG22 ' A' ' 58' ' ' VAL . 1.8 tt -137.86 124.03 20.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.121 -0.945 . . . . 2.19 108.534 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -121.78 159.2 52.08 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.755 0.312 . . . . 1.12 111.151 -171.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.441 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.2 Cg_endo -67.41 144.71 68.61 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.436 2.09 . . . . 0.28 111.924 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -9.15 77.96 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.053 -0.594 . . . . 0.23 112.063 -177.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.14 141.36 28.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.583 0.23 . . . . 1.28 110.722 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 m -70.01 139.25 52.71 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.172 -0.677 . . . . 1.05 109.172 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -139.19 161.02 28.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.364 0.602 . . . . 1.16 111.1 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.13 134.53 54.83 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.826 -1.175 . . . . 0.78 107.826 173.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' A' ' 41' ' ' LEU . 23.5 p90 -146.13 178.93 7.85 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.86 -0.609 . . . . 0.15 109.471 -174.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.1 t -126.19 126.63 44.4 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.954 -0.758 . . . . 1.3 108.954 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.9 98.4 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.705 -0.679 . . . . 1.11 110.54 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 p -100.85 113.83 38.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.522 -0.763 . . . . 1.13 109.917 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.9 m -76.78 130.53 37.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.708 -0.678 . . . . 1.27 110.926 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.516 ' HB3' ' H ' ' A' ' 82' ' ' GLY . 3.6 t-20 -65.22 111.91 3.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.923 -0.769 . . . . 1.96 108.923 175.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -12.28 60.38 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.905 -0.318 . . . . 2.24 111.287 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -96.74 -58.55 2.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.035 -0.53 . . . . 4.49 111.558 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -90.75 -28.67 18.12 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.677 0.621 . . . . 2.66 112.677 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.516 ' H ' ' HB3' ' A' ' 78' ' ' ASN . . . 103.7 -24.57 29.34 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.416 -0.897 . . . . 0.88 113.851 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -74.8 151.33 39.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.439 0.62 . . . . 2.9 110.006 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.468 ' HB2' HG11 ' A' ' 45' ' ' VAL . 8.3 m -99.43 175.05 5.99 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.563 -0.455 . . . . 1.49 111.469 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 m -142.78 163.24 33.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.419 -0.809 . . . . 1.31 109.161 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.16 117.06 33.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.248 0.547 . . . . 1.05 110.358 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 64.5 m -116.97 147.99 41.81 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.914 -0.773 . . . . 1.17 108.914 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.466 ' ND2' HD22 ' A' ' 90' ' ' LEU . 8.0 t30 64.55 69.24 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.082 -0.71 . . . . 2.17 109.082 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.404 HG11 HD12 ' A' ' 65' ' ' LEU . 84.9 t -93.41 105.98 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 115.426 -0.806 . . . . 1.06 110.9 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.495 HD13 ' HG2' ' A' ' 13' ' ' GLU . 4.2 mm? -112.3 150.32 31.15 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.61 -0.723 . . . . 1.77 111.016 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.441 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -83.35 123.75 29.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.553 -0.748 . . . . 2.02 110.948 -172.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.5 mm -117.37 142.61 30.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.83 -0.623 . . . . 1.05 111.05 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -114.33 146.02 41.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.865 -0.607 . . . . 3.31 109.459 172.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 C--N 1.317 -0.824 0 CA-C-N 116.317 -0.401 . . . . 3.08 109.93 174.897 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.455 -0.258 . . . . 19.3 112.455 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.62 112.22 12.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.049 0.452 . . . . 17.75 110.994 -177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -92.0 83.82 5.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.858 -0.793 . . . . 17.68 108.858 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.36 -158.07 34.3 Favored Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.901 -0.666 . . . . 14.41 113.139 -173.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.07 77.71 3.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.665 0.745 . . . . 13.69 111.058 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.0 mt -91.45 89.52 7.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.771 0.796 . . . . 11.63 109.449 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.5 m -84.83 99.22 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 114.762 -1.108 . . . . 8.84 111.469 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.6 p -84.25 88.14 7.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.851 -0.613 . . . . 8.01 110.005 176.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -105.69 3.23 28.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.305 0.574 . . . . 7.63 109.897 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -155.62 -176.58 6.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.095 -0.957 . . . . 7.38 110.329 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.4 mm -66.07 141.06 18.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 123.395 0.434 . . . . 3.34 110.085 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.23 -47.27 86.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.147 -0.479 . . . . 3.29 112.154 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -3.26 5.15 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.924 -0.58 . . . . 2.96 112.195 -172.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.7 p -58.89 -34.4 71.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.885 -0.598 . . . . 2.5 111.67 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.05 43.41 8.79 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.779 -0.724 . . . . 1.9 112.423 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -78.53 157.14 28.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.133 -0.321 . . . . 5.69 110.133 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.89 -16.75 53.05 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.328 0.492 . . . . 2.83 112.328 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.32 -24.26 63.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.521 -0.308 . . . . 2.82 111.818 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 12.3 p -155.92 130.72 9.14 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.933 -0.307 . . . . 3.08 111.186 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.2 p -169.49 143.57 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.371 -0.377 . . . . 2.34 110.321 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -126.56 162.55 25.4 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.763 0.316 . . . . 2.96 111.37 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.9 19.61 10.82 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.486 -0.779 . . . . 1.95 112.013 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.409 ' C ' ' HG3' ' A' ' 24' ' ' ARG . 46.9 t 60.43 76.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.094 0.473 . . . . 2.27 110.509 -177.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.409 ' HG3' ' C ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER 46.0 26.83 0.44 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.445 1.098 . . . . 3.4 113.422 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -106.4 70.04 0.81 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.091 0.472 . . . . 1.88 110.65 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HZ2' ' CD ' ' A' ' 72' ' ' GLU . 4.0 tmmm? -97.6 118.32 33.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.44 0.638 . . . . 2.59 110.286 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -99.99 156.44 17.15 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.868 -1.06 . . . . 1.84 109.719 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.452 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 11.0 mtm180 -130.27 127.31 39.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.49 . . . . 1.99 110.559 175.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.46 -179.96 8.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.256 -0.884 . . . . 0.96 110.031 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.4 145.6 28.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.366 -0.379 . . . . 0.86 109.984 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.432 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 48.8 t -68.33 123.33 21.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.516 -0.311 . . . . 1.01 110.379 175.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.39 -41.9 46.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.109 -0.496 . . . . 0.6 110.406 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.5 p -171.04 161.69 6.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.845 -0.616 . . . . 1.18 110.014 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.1 mt -133.73 129.13 54.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.079 0.466 . . . . 1.03 110.114 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -119.59 95.19 4.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 2.16 110.132 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.17 -114.13 5.85 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.815 -0.707 . . . . 0.34 112.282 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -96.38 14.81 23.13 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 110.031 -0.359 . . . . 2.6 110.031 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -128.13 141.06 51.59 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.563 -0.455 . . . . 0.38 111.014 -175.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.517 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -127.19 158.71 21.14 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.503 -0.856 . . . . 0.11 111.525 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -132.33 142.71 49.44 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.235 -0.654 . . . . 0.19 109.235 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.484 HD12 ' CD2' ' A' ' 73' ' ' PHE . 6.3 mt -116.74 152.53 34.14 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.146 -0.686 . . . . 1.28 109.146 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -75.09 73.47 2.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.782 0.801 . . . . 1.77 109.585 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -147.51 110.69 4.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.623 -1.172 . . . . 0.33 108.674 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 90.1 mt-10 -105.82 107.08 17.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.5 0.667 . . . . 1.81 111.136 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 m -74.06 -55.28 12.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.659 -1.155 . . . . 1.51 112.121 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.683 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 4.1 tp10 -136.38 118.92 15.88 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.552 -0.294 . . . . 2.24 110.703 -171.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.1 t70 61.86 16.59 8.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.41 0.624 . . . . 1.55 112.057 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.09 31.13 9.37 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.205 -0.997 . . . . 0.77 112.107 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.683 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 41.2 mmtm -75.49 109.88 9.41 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.509 -0.923 . . . . 3.03 108.509 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' HZ3' ' HB2' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -73.93 122.32 22.37 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.726 -0.842 . . . . 1.87 108.726 179.085 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 mt -59.7 126.55 28.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.131 -0.486 . . . . 1.05 111.6 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -108.41 161.82 14.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.856 -0.611 . . . . 0.48 110.229 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.517 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 30.0 p90 -152.5 151.88 31.25 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.558 -0.746 . . . . 0.2 109.205 173.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.448 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . 23.3 t-80 -93.69 156.39 16.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.628 -0.879 . . . . 0.47 108.628 174.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.457 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 51.0 ttm -71.73 3.69 3.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.875 0.369 . . . . 2.84 111.538 -176.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.2 t -88.38 -27.57 21.52 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.777 -0.453 . . . . 1.41 109.777 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.448 ' OE2' ' HB3' ' A' ' 54' ' ' HIS . 1.9 mp0 -79.36 -14.97 58.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.855 -0.611 . . . . 1.96 109.626 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.463 ' HA ' ' HB ' ' A' ' 89' ' ' VAL . 1.8 t -62.68 152.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.882 -1.054 . . . . 1.06 111.939 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.445 HE21 ' HB3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -45.07 158.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.359 -1.291 . . . . 1.85 110.985 176.005 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -44.78 -32.5 3.08 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 114.62 0.608 . . . . 0.62 114.62 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -104.26 125.03 50.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.645 -0.502 . . . . 2.3 109.645 173.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.457 ' HB ' ' SD ' ' A' ' 55' ' ' MET . 70.7 p -79.18 -36.54 40.11 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.413 -0.812 . . . . 1.45 111.977 -171.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 t -87.15 7.35 2.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.484 0.659 . . . . 1.95 110.257 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.33 -3.12 31.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 1.21 111.087 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.472 HD12 HG13 ' A' ' 71' ' ' VAL . 1.5 tm? -104.71 124.04 48.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.031 -1.1 . . . . 2.19 108.031 175.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -121.02 151.81 55.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.828 0.347 . . . . 1.12 111.549 -171.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.432 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 43.0 Cg_endo -67.8 137.41 41.69 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.721 2.28 . . . . 0.28 111.856 173.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.31 -8.99 72.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.815 -0.707 . . . . 0.23 112.628 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -95.25 159.69 14.89 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.418 -0.586 . . . . 1.28 109.418 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 m -80.27 135.96 36.34 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.208 -0.664 . . . . 1.05 109.208 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.472 HG13 HD12 ' A' ' 65' ' ' LEU . 12.1 m -135.71 161.6 38.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.25 0.548 . . . . 1.16 109.895 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.65 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.59 149.13 37.04 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.726 -0.842 . . . . 0.78 108.726 177.502 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.484 ' CD2' HD12 ' A' ' 41' ' ' LEU . 37.9 p90 -163.06 178.61 8.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.006 0.431 . . . . 0.15 110.515 -172.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -128.85 131.56 47.7 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.022 -0.733 . . . . 1.3 109.022 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.9 p -99.35 98.84 7.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.802 0.81 . . . . 1.11 111.018 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.0 p -110.2 118.89 58.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.558 -0.746 . . . . 1.13 110.006 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.0 m -73.32 126.19 29.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.138 -0.483 . . . . 1.27 110.778 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 29.1 m-80 -68.79 115.18 7.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.203 -0.453 . . . . 1.96 109.955 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -60.47 -30.85 69.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.166 -0.47 . . . . 2.24 112.113 -173.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.459 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 1.6 tpm_? -95.28 -31.9 13.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.959 0.409 . . . . 4.49 111.645 -176.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -95.94 -26.41 15.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.286 0.565 . . . . 2.66 110.455 -171.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 -24.84 18.38 Favored Glycine 0 C--O 1.23 -0.127 0 C-N-CA 121.201 -0.523 . . . . 0.88 113.421 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 20.1 pttm -98.77 151.95 20.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.216 0.508 . . . . 2.9 110.808 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -87.45 179.47 6.56 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.859 -0.61 . . . . 1.49 111.082 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.8 p -153.45 139.17 17.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.004 -0.543 . . . . 1.31 109.773 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . . . -74.01 119.25 17.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.191 0.52 . . . . 1.05 111.105 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 99.4 m -116.89 143.88 45.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.778 -0.646 . . . . 1.17 109.306 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 62.52 70.51 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.418 0.628 . . . . 2.17 109.717 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 90.4 t -93.11 113.05 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.328 -0.851 . . . . 1.06 111.159 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.25 150.05 32.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.178 -0.464 . . . . 1.77 110.92 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.468 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -73.71 128.48 35.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.043 -0.526 . . . . 2.02 109.906 176.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.4 mm -119.28 140.14 44.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.803 0.335 . . . . 1.05 110.91 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -99.61 115.08 28.58 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.221 -0.659 . . . . 3.31 109.221 172.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 116.444 -0.344 . . . . 3.08 111.178 -176.033 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 111.643 -0.583 . . . . 19.3 111.643 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.78 161.26 40.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.926 0.393 . . . . 17.75 111.281 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -91.25 124.98 35.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.77 -0.65 . . . . 17.68 109.654 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.57 -29.41 0.34 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.987 -1.101 . . . . 14.41 113.534 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -93.72 176.26 6.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.155 0.478 . . . . 13.69 110.26 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.8 mt -97.65 127.38 43.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.076 0.465 . . . . 11.63 111.44 -174.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.9 p -154.05 126.56 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.711 -0.677 . . . . 8.84 109.464 174.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 m -83.84 97.55 9.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.324 -0.398 . . . . 8.01 110.449 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -123.67 -0.05 8.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.29 0.567 . . . . 7.63 109.83 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -144.53 135.31 24.87 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.599 -0.728 . . . . 7.38 112.195 -173.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' HB ' ' OG ' ' A' ' 14' ' ' SER . 3.9 mp -132.55 121.27 44.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.024 -0.989 . . . . 3.34 109.504 177.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -93.56 -14.97 25.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.749 0.309 . . . . 3.29 111.643 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -85.39 4.05 37.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.449 0.642 . . . . 2.96 109.765 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.421 ' OG ' ' HB ' ' A' ' 11' ' ' ILE . 10.1 m -73.63 17.64 0.15 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.412 -0.813 . . . . 2.5 112.547 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.28 59.99 7.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.878 -0.677 . . . . 1.9 113.571 172.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -60.89 99.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.024 0.412 . . . . 5.69 110.701 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.28 -31.99 19.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.377 0.51 . . . . 2.83 112.377 -177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.02 -34.78 75.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.307 -0.406 . . . . 2.82 111.432 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.8 p -148.78 131.52 15.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.218 -0.447 . . . . 3.08 110.394 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 p -167.22 153.16 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.871 -0.789 . . . . 2.34 108.871 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -92.64 10.47 30.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.912 0.387 . . . . 2.96 110.942 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.98 -162.31 1.41 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.492 -0.558 . . . . 1.95 109.492 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.0 m -86.78 163.16 2.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.092 0.472 . . . . 2.27 110.241 174.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.492 ' HD2' ' H ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -62.13 -10.43 10.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.421 -0.809 . . . . 3.4 111.717 178.635 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -77.6 97.09 4.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.025 -0.534 . . . . 1.88 110.899 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -95.51 121.05 36.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.419 0.628 . . . . 2.59 110.559 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 31.0 mmtp -105.37 144.12 32.59 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.152 -0.931 . . . . 1.84 109.544 177.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -120.01 127.37 52.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.085 0.469 . . . . 1.99 110.196 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.478 ' HB3' ' OD1' ' A' ' 42' ' ' ASN . . . -150.87 -179.63 7.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.516 -0.765 . . . . 0.96 109.448 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.91 143.42 32.52 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.81 -0.441 . . . . 0.86 109.81 -177.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.42 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 43.8 t -64.89 114.19 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.904 0.383 . . . . 1.01 110.433 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -65.07 -45.12 86.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.121 -0.945 . . . . 0.6 110.153 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 p -171.71 164.73 6.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.396 -0.82 . . . . 1.18 110.093 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.4 mt -137.57 128.95 40.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.669 -0.493 . . . . 1.03 109.669 176.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 71.4 mmtt -122.92 94.31 4.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.534 -0.757 . . . . 2.16 109.807 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.88 -106.92 2.0 Allowed Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.717 -0.754 . . . . 0.34 112.434 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -101.06 4.25 42.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.178 0.191 . . . . 2.6 110.793 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -122.87 140.5 52.89 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.254 0.55 . . . . 0.38 111.374 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.01 157.09 21.01 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.116 -0.947 . . . . 0.11 111.416 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -130.46 151.79 50.55 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.362 -0.607 . . . . 0.19 109.362 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.576 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.2 mt -125.09 155.28 40.08 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.329 -0.619 . . . . 1.28 109.329 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' A' ' 29' ' ' ALA . 28.0 p-10 -76.23 72.9 3.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 122.229 1.014 . . . . 1.77 109.994 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -148.15 98.63 2.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.757 -1.11 . . . . 0.33 109.028 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 21.3 mt-10 -95.58 100.97 12.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.746 0.784 . . . . 1.81 110.284 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.587 HG22 ' N ' ' A' ' 46' ' ' GLU . 16.2 m -68.12 -43.31 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.222 -1.354 . . . . 1.51 111.301 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.587 ' N ' HG22 ' A' ' 45' ' ' VAL . 8.7 tp10 -129.87 176.06 8.35 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.281 -1.748 . . . . 2.24 106.281 -176.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.49 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 28.3 t70 -33.19 86.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.195 1.183 . . . . 1.55 114.195 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.533 ' HA2' ' OE2' ' A' ' 44' ' ' GLU . . . 68.58 16.55 69.87 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.654 -0.784 . . . . 0.77 111.464 171.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.694 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 32.0 mmtm -82.29 107.03 14.65 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.569 -0.53 . . . . 3.03 109.569 -178.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -79.52 129.62 34.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.062 -0.718 . . . . 1.87 109.062 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mt -63.69 124.09 20.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.728 0.299 . . . . 1.05 111.157 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -106.61 158.91 16.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.833 -0.622 . . . . 0.48 109.998 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.473 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 30.4 p90 -150.29 154.87 38.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.517 -0.765 . . . . 0.2 109.166 173.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -99.03 149.87 22.56 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.657 -0.868 . . . . 0.47 108.657 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.531 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 27.5 mtt -60.23 -7.07 1.71 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.215 0.45 . . . . 2.84 112.215 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 t -68.66 -29.96 68.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.221 -0.445 . . . . 1.41 110.776 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -92.93 -1.21 56.92 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.845 0.355 . . . . 1.96 111.138 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' A' ' 62' ' ' THR . 2.1 t -74.42 150.66 7.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.593 0.59 . . . . 1.06 112.593 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.529 ' CG ' HD12 ' A' ' 90' ' ' LEU . 1.4 tm0? -54.37 100.06 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 114.758 -1.11 . . . . 1.85 111.805 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.52 -92.18 0.01 OUTLIER Glycine 0 C--N 1.332 0.317 0 O-C-N 123.873 0.733 . . . . 0.62 114.342 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -89.73 131.34 35.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 2.3 110.174 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.531 ' HB ' ' SD ' ' A' ' 55' ' ' MET . 30.7 p -75.45 -12.04 60.16 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.471 -0.786 . . . . 1.45 111.096 -172.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.0 t -92.85 -2.15 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.499 -0.773 . . . . 1.95 110.05 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.88 -14.54 29.51 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.394 0.616 . . . . 1.21 110.895 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.34 124.6 48.99 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.528 -0.76 . . . . 2.19 109.084 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 95.3 m-70 -121.8 153.14 60.05 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.884 0.373 . . . . 1.12 111.316 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.0 Cg_endo -67.64 134.85 34.04 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.499 2.132 . . . . 0.28 111.243 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.22 -17.34 59.32 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.826 -0.702 . . . . 0.23 111.93 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 66' ' ' HIS . 23.5 m-20 -74.23 151.05 40.01 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 110.101 -0.333 . . . . 1.28 110.101 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 m -81.17 135.18 35.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.395 -0.965 . . . . 1.05 108.395 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.6 m -134.9 167.09 26.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.214 0.531 . . . . 1.16 110.945 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -113.88 150.07 34.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.014 -1.106 . . . . 0.78 108.014 172.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.576 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.2 p90 -157.85 179.06 9.55 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.335 -0.617 . . . . 0.15 109.335 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -130.29 133.69 46.66 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.253 -1.017 . . . . 1.3 108.253 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 p -94.5 98.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.658 0.742 . . . . 1.11 111.087 -172.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -102.54 107.64 22.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.39 -0.823 . . . . 1.13 109.725 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 26.8 m -74.43 129.67 38.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.983 0.421 . . . . 1.27 110.864 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 39.7 m-80 -76.83 101.06 5.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.879 -0.6 . . . . 1.96 109.528 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -60.9 -21.31 63.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.957 0.408 . . . . 2.24 111.119 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -72.52 -41.11 66.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.714 -0.675 . . . . 4.49 111.585 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -114.65 -31.49 6.16 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.517 0.562 . . . . 2.66 112.517 -172.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.44 -20.36 25.46 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.003 -0.618 . . . . 0.88 113.303 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 21.1 pttp -96.89 150.72 20.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.036 0.418 . . . . 2.9 110.752 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 13.4 m -93.3 -176.29 4.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.11 -0.496 . . . . 1.49 111.607 -175.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.8 m -150.05 150.08 31.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.828 -0.624 . . . . 1.31 109.434 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . . . -89.82 120.93 31.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.217 0.532 . . . . 1.05 111.101 -177.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 50.0 m -117.32 144.38 44.95 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.759 -0.655 . . . . 1.17 110.126 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.5 t30 62.82 66.84 0.73 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.764 0.665 . . . . 2.17 109.792 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.637 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 95.2 t -89.33 100.85 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.518 -0.764 . . . . 1.06 110.675 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.529 HD12 ' CG ' ' A' ' 59' ' ' GLN . 2.1 mm? -105.45 147.53 28.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.833 -0.621 . . . . 1.77 110.81 -177.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.36 122.75 24.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 2.02 110.741 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.4 mm -110.34 133.31 56.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.597 -0.728 . . . . 1.05 110.738 -176.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -80.66 117.83 21.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.889 -0.596 . . . . 3.31 110.11 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 116.259 -0.428 . . . . 3.08 110.656 178.931 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 111.816 -0.514 . . . . 19.3 111.816 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 176.97 -166.47 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.171 -0.677 . . . . 17.75 109.171 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -95.67 84.98 4.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.99 0.424 . . . . 17.68 110.238 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.74 -135.65 1.86 Allowed Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.78 -0.646 . . . . 14.41 111.688 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.23 -52.11 8.58 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.212 -0.292 . . . . 13.69 110.212 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -71.62 96.11 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.216 0.531 . . . . 11.63 110.221 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 p 178.53 140.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.089 -0.959 . . . . 8.84 109.065 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 t -77.33 95.0 4.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.794 -0.817 . . . . 8.01 108.794 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -173.72 -33.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.976 -1.12 . . . . 7.63 107.976 -172.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.427 ' HE ' ' HB3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -77.59 -175.25 3.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 113.899 -1.5 . . . . 7.38 109.939 175.136 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.2 mt -68.84 101.4 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.383 -0.527 . . . . 3.34 109.992 174.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -87.73 -23.35 24.16 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.509 -0.769 . . . . 3.29 111.514 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -64.89 -21.28 66.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.114 0.483 . . . . 2.96 110.199 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.0 m -65.05 -9.93 26.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.332 -0.849 . . . . 2.5 112.235 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.54 59.56 1.35 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 119.748 -1.215 . . . . 1.9 112.896 175.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 36.8 mmm-85 -59.96 117.54 5.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.119 -0.326 . . . . 5.69 110.119 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.81 -26.92 27.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.853 0.359 . . . . 2.83 111.035 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.09 70.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.04 -0.527 . . . . 2.82 110.973 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 52.5 t -145.44 131.02 18.82 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.716 -0.846 . . . . 3.08 108.716 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.65 155.38 7.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.73 0.3 . . . . 2.34 110.56 -173.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -119.61 149.77 41.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 2.96 110.25 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 64.06 16.57 10.05 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.708 0.63 . . . . 1.95 111.807 176.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.2 t 60.03 75.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.779 -0.646 . . . . 2.27 111.174 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 44.49 31.01 0.55 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.64 1.176 . . . . 3.4 113.992 175.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -115.87 94.22 4.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.115 0.483 . . . . 1.88 110.878 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.488 ' HZ2' ' CD ' ' A' ' 72' ' ' GLU . 9.6 mtmp? -109.31 112.73 25.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.145 0.497 . . . . 2.59 110.628 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -89.51 150.29 22.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.57 -0.741 . . . . 1.84 110.294 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -123.66 127.3 48.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.95 0.405 . . . . 1.99 110.347 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.58 179.36 9.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.015 -0.735 . . . . 0.96 109.015 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.93 142.62 32.15 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 110.133 -0.321 . . . . 0.86 110.133 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.22 117.54 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.517 -0.549 . . . . 1.01 109.517 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.93 -40.47 63.07 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.768 -0.651 . . . . 0.6 110.513 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 p -174.41 156.0 2.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.56 -0.746 . . . . 1.18 109.697 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.4 mt -127.6 132.38 69.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.186 -0.461 . . . . 1.03 110.005 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -121.96 85.95 2.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.568 -0.742 . . . . 2.16 110.458 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.37 -107.13 1.95 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.915 -0.659 . . . . 0.34 112.605 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -97.63 10.7 39.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 2.6 110.509 -175.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -132.73 142.22 48.93 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 120.942 0.401 . . . . 0.38 110.643 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.6 153.88 19.83 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.226 -0.749 . . . . 0.11 111.226 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 64.6 m-85 -127.88 146.11 50.73 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.57 -0.529 . . . . 0.19 109.57 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.531 HD11 ' CD2' ' A' ' 73' ' ' PHE . 6.0 mt -117.65 157.12 27.0 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.926 -0.398 . . . . 1.28 109.926 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -76.75 73.53 3.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.508 0.67 . . . . 1.77 109.677 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.419 ' HB3' HD11 ' A' ' 51' ' ' LEU . 33.7 t80 -146.19 102.46 3.62 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.293 -0.867 . . . . 0.33 109.301 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.56 101.0 12.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.934 -0.575 . . . . 1.81 110.275 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 46' ' ' GLU . 21.3 m -74.06 -46.42 45.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.801 0.81 . . . . 1.51 110.648 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 45' ' ' VAL . 34.5 tt0 -124.55 -179.11 4.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.803 -1.554 . . . . 2.24 106.803 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.443 ' H ' ' CG ' ' A' ' 46' ' ' GLU . 8.1 t70 -41.09 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.089 0.956 . . . . 1.55 112.948 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.16 13.96 67.9 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.651 -0.785 . . . . 0.77 111.701 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.94 108.99 10.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.23 -0.655 . . . . 3.03 109.23 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -72.61 136.15 45.67 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.161 -0.681 . . . . 1.87 109.161 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -70.2 123.68 22.25 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.837 -0.431 . . . . 1.05 109.837 177.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -107.0 156.85 18.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.714 -0.476 . . . . 0.48 109.714 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.459 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 22.7 p90 -147.84 152.73 38.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.655 -0.702 . . . . 0.2 109.11 172.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -91.87 146.93 23.36 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.048 -0.723 . . . . 0.47 109.048 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.571 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 41.8 ttp -53.23 -17.16 1.55 Allowed 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 123.704 0.801 . . . . 2.84 112.274 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -64.57 -32.32 73.92 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.601 0.239 . . . . 1.41 110.868 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -78.08 -15.12 59.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.141 0.496 . . . . 1.96 110.822 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -64.03 147.46 12.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.395 -0.82 . . . . 1.06 111.956 -174.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.48 ' HG3' ' CD1' ' A' ' 90' ' ' LEU . 1.1 tt0 -64.06 86.77 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.776 -1.102 . . . . 1.85 112.933 -171.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.69 -90.82 0.25 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.293 -0.479 . . . . 0.62 113.26 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -92.99 143.83 25.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.277 0.56 . . . . 2.3 110.589 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.1 p -69.31 -33.56 73.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.217 -0.901 . . . . 1.45 110.926 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.56 -11.47 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.43 -0.805 . . . . 1.95 111.162 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.58 -8.5 50.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.607 -0.724 . . . . 1.21 111.728 -173.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.48 124.63 49.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.411 -0.589 . . . . 2.19 109.411 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -122.2 150.03 55.89 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.731 0.3 . . . . 1.12 111.055 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.77 130.32 21.67 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.365 2.043 . . . . 0.28 111.092 172.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.91 -9.73 58.38 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.834 -0.698 . . . . 0.23 111.967 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -87.48 145.47 26.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.258 -0.275 . . . . 1.28 110.258 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 m -72.22 134.37 45.6 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.462 -0.57 . . . . 1.05 109.462 173.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.53 160.2 37.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.776 0.798 . . . . 1.16 111.098 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.488 ' CD ' ' HZ2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -114.84 132.08 56.62 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.429 -1.259 . . . . 0.78 108.65 178.259 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.531 ' CD2' HD11 ' A' ' 41' ' ' LEU . 26.0 p90 -142.48 178.67 7.44 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.612 -0.722 . . . . 0.15 109.583 -172.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.1 m -128.68 119.35 24.5 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.163 -0.68 . . . . 1.3 109.163 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.29 99.44 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.81 0.814 . . . . 1.11 110.986 -173.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.68 122.99 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.423 -0.808 . . . . 1.13 109.794 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 36.7 m -86.09 125.77 33.7 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.094 -0.503 . . . . 1.27 111.008 -177.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -63.98 109.92 1.95 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.826 -0.625 . . . . 1.96 109.527 175.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.413 ' H ' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -60.86 -23.14 64.92 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.238 0.459 . . . . 2.24 112.238 -175.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.413 ' HA ' ' NE ' ' A' ' 80' ' ' ARG . 7.2 tpm_? -93.66 -47.11 6.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.655 -0.418 . . . . 4.49 111.145 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -81.36 -30.81 33.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 2.66 111.586 -174.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.45 -10.24 75.07 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.952 -0.642 . . . . 0.88 112.463 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -93.98 156.08 16.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.022 -0.733 . . . . 2.9 109.022 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.471 ' HB2' HG13 ' A' ' 45' ' ' VAL . 3.2 m -107.75 170.62 7.88 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.435 -0.506 . . . . 1.49 111.173 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.3 p -144.07 159.84 41.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.69 -0.686 . . . . 1.31 110.122 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 73' ' ' PHE . . . -96.3 123.98 40.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.349 -0.387 . . . . 1.05 110.367 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -116.86 149.16 40.53 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.001 -1.111 . . . . 1.17 108.001 176.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 57.11 72.25 0.52 Allowed 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.82 0.7 . . . . 2.17 110.321 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 96.2 t -89.58 105.4 16.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.565 0.697 . . . . 1.06 110.639 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.48 ' CD1' ' HG3' ' A' ' 59' ' ' GLN . 4.0 mm? -106.7 148.95 27.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.161 -0.927 . . . . 1.77 110.648 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.406 ' HB2' ' OE1' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -81.66 129.47 34.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.676 -0.693 . . . . 2.02 111.224 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.5 mm -117.88 142.35 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.704 -0.68 . . . . 1.05 110.427 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -92.45 121.57 34.05 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.158 -0.682 . . . . 3.31 109.158 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.883 -0.599 . . . . 3.08 109.867 -175.141 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 111.993 -0.443 . . . . 19.3 111.993 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.78 147.05 25.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.768 0.318 . . . . 17.75 110.519 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.19 92.32 8.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.286 0.565 . . . . 17.68 109.975 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.88 57.64 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.373 -1.091 . . . . 14.41 110.373 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -90.56 155.8 18.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.114 -0.543 . . . . 13.69 111.51 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.1 tp -145.55 146.65 31.49 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.615 -0.883 . . . . 11.63 108.615 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 p -114.04 98.29 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.887 0.851 . . . . 8.84 111.677 -175.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.1 t -126.51 103.38 7.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.417 -0.81 . . . . 8.01 109.043 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -97.5 11.85 35.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.908 -0.587 . . . . 7.63 110.471 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -157.28 176.88 12.11 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.348 -0.842 . . . . 7.38 109.899 -172.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.487 ' HB ' ' OG ' ' A' ' 14' ' ' SER . 21.3 mm -85.63 142.68 12.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.377 -0.972 . . . . 3.34 108.377 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.62 -39.59 73.63 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.958 -0.464 . . . . 3.29 111.254 -176.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.526 ' HA ' HD22 ' A' ' 90' ' ' LEU . 2.3 pm0 -76.37 14.19 0.8 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.307 -0.406 . . . . 2.96 111.646 177.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.487 ' OG ' ' HB ' ' A' ' 11' ' ' ILE . 57.7 m -77.85 -6.98 56.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.332 . . . . 2.5 110.774 174.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.15 57.17 1.82 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.341 -0.933 . . . . 1.9 112.226 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -62.73 113.35 2.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.914 0.388 . . . . 5.69 110.956 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.75 -20.38 31.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.265 -0.425 . . . . 2.83 111.307 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.29 -13.94 61.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.389 -0.369 . . . . 2.82 111.475 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.8 m -145.99 129.96 17.34 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.785 -0.45 . . . . 3.08 109.785 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -168.76 140.94 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.911 -0.586 . . . . 2.34 109.833 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -90.03 30.03 1.14 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.711 0.291 . . . . 2.96 111.782 -174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HB3' ' OG ' ' A' ' 74' ' ' SER . . . -164.42 -177.79 5.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.096 -0.705 . . . . 1.95 109.096 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.56 74.39 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.803 0.335 . . . . 2.27 110.837 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 43.16 26.13 0.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.755 1.222 . . . . 3.4 113.959 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -102.97 96.97 7.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.233 -0.439 . . . . 1.88 110.992 -175.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.447 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 2.6 mppt? -106.86 120.99 43.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.145 0.498 . . . . 2.59 110.423 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -105.11 144.89 31.29 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.484 -0.78 . . . . 1.84 110.26 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -118.84 127.17 53.27 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.664 -0.414 . . . . 1.99 110.578 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.63 179.67 8.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.69 -0.686 . . . . 0.96 109.579 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.44 144.5 30.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.045 -0.354 . . . . 0.86 110.045 -177.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 57.6 t -63.98 117.43 4.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.142 0.496 . . . . 1.01 110.577 176.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.442 ' CG ' ' HZ2' ' A' ' 50' ' ' LYS . 8.5 t70 -69.2 -47.86 63.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.031 -0.986 . . . . 0.6 109.616 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.409 ' HG ' ' C ' ' A' ' 32' ' ' ASP . 74.1 m -167.92 164.49 13.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.775 -0.648 . . . . 1.18 109.699 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 mt -136.52 132.97 49.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.672 -0.492 . . . . 1.03 109.672 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -126.79 89.34 2.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 2.16 110.227 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.37 -107.77 2.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.75 -0.738 . . . . 0.34 112.592 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -97.37 9.64 41.78 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.808 -0.231 . . . . 2.6 110.761 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.51 141.2 51.05 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.184 0.516 . . . . 0.38 111.006 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.9 157.16 21.47 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.387 -0.824 . . . . 0.11 111.152 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 68.8 m-85 -129.73 148.61 51.63 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.09 -0.708 . . . . 0.19 109.09 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.52 HD13 ' CD2' ' A' ' 73' ' ' PHE . 8.8 mt -123.72 153.05 41.42 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.662 -0.495 . . . . 1.28 109.662 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -75.1 73.59 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.487 -0.56 . . . . 1.77 109.487 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.409 ' HB3' HD13 ' A' ' 51' ' ' LEU . 27.9 t80 -150.26 98.56 2.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.41 -0.814 . . . . 0.33 109.536 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 47.2 mt-10 -81.67 100.5 9.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.485 0.66 . . . . 1.81 109.695 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 84' ' ' SER . 27.2 m -72.21 -35.68 53.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.078 -0.965 . . . . 1.51 111.446 -176.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.56 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 7.9 tp10 -145.05 179.65 7.21 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.376 -1.713 . . . . 2.24 106.376 -175.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.56 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 23.8 t70 -27.75 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.271 1.428 . . . . 1.55 114.38 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.511 ' HA2' ' OE1' ' A' ' 44' ' ' GLU . . . 66.84 19.72 69.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.992 -0.623 . . . . 0.77 111.768 173.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 40.8 mmtm -82.88 109.05 16.67 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 110.061 -0.348 . . . . 3.03 110.061 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HZ2' ' CG ' ' A' ' 32' ' ' ASP . 2.9 tppp? -74.39 128.95 36.83 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.712 -0.847 . . . . 1.87 108.712 175.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 1.1 mt -64.66 126.73 28.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.597 -0.274 . . . . 1.05 110.646 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -112.27 156.66 22.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.97 0.414 . . . . 0.48 110.031 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 17.2 p90 -146.84 161.46 40.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.911 -0.586 . . . . 0.2 109.524 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -102.09 140.35 36.48 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.246 -0.65 . . . . 0.47 109.246 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.455 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 1.8 tmt? -51.13 -23.84 3.56 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.827 0.851 . . . . 2.84 112.657 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.6 t -60.27 -23.22 63.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.642 0.258 . . . . 1.41 111.215 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -95.74 0.06 52.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.8 -0.182 . . . . 1.96 111.474 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -74.91 137.35 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.305 0.574 . . . . 1.06 111.422 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.83 104.07 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.858 -1.064 . . . . 1.85 111.972 -175.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.03 -84.55 0.49 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.62 113.074 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -135.19 158.17 45.06 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.893 -0.41 . . . . 2.3 109.893 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.9 p -74.5 -8.52 56.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.568 0.699 . . . . 1.45 110.138 178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.43 -1.09 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.306 -0.861 . . . . 1.95 109.904 175.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.87 -39.85 4.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.79 -0.641 . . . . 1.21 110.423 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.5 HD11 HG13 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -95.32 123.35 38.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.298 -0.63 . . . . 2.19 109.298 178.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -134.58 158.2 75.62 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.637 -0.256 . . . . 1.12 111.116 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.545 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 28.1 Cg_endo -63.53 142.19 83.43 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.689 2.259 . . . . 0.28 111.745 176.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.96 -6.49 83.11 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.58 -0.819 . . . . 0.23 112.742 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -95.08 158.65 15.37 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.61 -0.515 . . . . 1.28 109.61 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -81.75 137.79 35.29 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.229 -0.656 . . . . 1.05 109.229 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.5 HG13 HD11 ' A' ' 65' ' ' LEU . 10.4 m -137.91 156.46 31.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.421 0.629 . . . . 1.16 109.857 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.39 133.16 55.91 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.505 -0.924 . . . . 0.78 108.505 175.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.52 ' CD2' HD13 ' A' ' 41' ' ' LEU . 28.6 p90 -142.5 179.46 6.95 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.71 -0.677 . . . . 0.15 109.789 -173.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 22' ' ' ALA . 5.4 t -127.95 116.31 19.88 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.995 -1.113 . . . . 1.3 107.995 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.3 p -81.64 98.22 4.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.906 0.86 . . . . 1.11 110.557 -173.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 p -102.62 116.31 46.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.23 -0.896 . . . . 1.13 109.788 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 30.2 m -73.99 130.7 40.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.117 -0.492 . . . . 1.27 110.496 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 33.8 m-80 -68.96 112.18 5.45 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.212 -0.662 . . . . 1.96 109.212 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -52.91 -31.32 39.35 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.826 0.704 . . . . 2.24 111.889 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -94.24 -53.86 3.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.828 0.347 . . . . 4.49 111.591 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -74.06 -18.41 60.83 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.296 0.48 . . . . 2.66 112.296 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.93 -24.38 6.06 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.991 -0.624 . . . . 0.88 113.173 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 53.9 pttt -91.4 154.12 19.4 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.457 -0.571 . . . . 2.9 109.457 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.458 ' HB2' HG13 ' A' ' 45' ' ' VAL . 17.6 m -101.11 179.98 4.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.951 0.405 . . . . 1.49 111.706 -174.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.1 m -146.37 155.94 42.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.794 -0.639 . . . . 1.31 109.43 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 73' ' ' PHE . . . -96.23 120.67 36.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.89 0.376 . . . . 1.05 110.601 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.3 m -116.99 156.97 26.56 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.954 -0.758 . . . . 1.17 108.954 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.423 HD22 HD23 ' A' ' 90' ' ' LEU . 7.0 t30 55.9 62.54 2.35 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.694 0.621 . . . . 2.17 109.988 -177.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.7 t -81.25 104.95 10.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.771 -0.649 . . . . 1.06 110.892 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.526 HD22 ' HA ' ' A' ' 13' ' ' GLU . 4.0 mp -107.29 150.53 26.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.293 -0.867 . . . . 1.77 111.364 -176.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.91 129.23 34.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.996 -0.547 . . . . 2.02 110.253 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mm -130.21 148.56 33.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.757 0.313 . . . . 1.05 110.766 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -119.86 103.72 9.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.039 0.447 . . . . 3.31 109.988 169.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 115.825 -0.625 . . . . 3.08 110.892 -177.055 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.225 0 N-CA-C 112.047 -0.421 . . . . 19.3 112.047 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.21 145.8 51.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.269 . . . . 17.75 110.721 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -133.71 132.89 41.16 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.167 -0.469 . . . . 17.68 110.089 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.99 -39.78 0.21 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.033 -1.08 . . . . 14.41 112.811 177.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -75.18 173.4 10.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.991 0.424 . . . . 13.69 110.038 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.478 ' H ' HD22 ' A' ' 6' ' ' LEU . 2.7 pt? -126.36 141.72 51.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.281 -0.418 . . . . 11.63 110.391 -177.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.0 p -120.74 137.17 55.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.649 -0.705 . . . . 8.84 110.381 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -72.34 77.0 1.01 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.379 0.609 . . . . 8.01 110.676 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -149.74 -37.53 0.15 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.949 -1.023 . . . . 7.63 109.556 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 10' ' ' ARG . 9.3 mmt180 -72.55 147.89 45.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.496 -0.775 . . . . 7.38 110.777 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 0.1 OUTLIER -121.89 155.45 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.726 -0.67 . . . . 3.34 112.341 -168.393 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.72 -47.22 2.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.063 -0.971 . . . . 3.29 110.181 173.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.0 9.16 0.75 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.929 0.715 . . . . 2.96 112.929 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.493 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 27.7 t -79.08 1.4 24.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.938 0.399 . . . . 2.5 111.164 -176.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.97 58.44 1.79 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.153 -1.022 . . . . 1.9 112.618 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -67.57 104.19 1.53 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.746 0.308 . . . . 5.69 110.389 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.61 -25.45 28.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.971 0.415 . . . . 2.83 110.746 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.46 -35.88 76.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.035 -0.529 . . . . 2.82 110.759 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 32.8 m -121.13 130.49 53.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.754 -0.832 . . . . 3.08 108.754 175.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -163.81 159.74 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 121.095 -0.242 . . . . 2.34 110.444 -173.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -98.39 -59.47 1.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.505 -0.316 . . . . 2.96 110.537 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.15 -174.29 4.99 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.065 -0.516 . . . . 1.95 110.961 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 m -76.71 69.81 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.967 -0.56 . . . . 2.27 111.469 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? 42.57 31.54 0.3 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.16 0.984 . . . . 3.4 112.523 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 6.4 tp60 -109.44 92.97 4.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.827 -0.624 . . . . 1.88 110.319 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -109.22 112.84 25.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.316 0.579 . . . . 2.59 110.337 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -99.07 151.25 21.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.378 -0.828 . . . . 1.84 110.856 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -119.25 127.89 53.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.714 0.292 . . . . 1.99 110.385 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.63 179.71 8.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.871 -0.604 . . . . 0.96 109.491 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.82 141.56 36.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 110.155 -0.313 . . . . 0.86 110.155 -177.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.471 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 47.1 t -62.77 118.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.762 0.315 . . . . 1.01 110.257 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.05 -43.81 77.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.459 -0.791 . . . . 0.6 110.098 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.6 p -178.52 165.66 1.74 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.31 -0.859 . . . . 1.18 109.511 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.5 mt -131.19 131.45 63.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.264 0.554 . . . . 1.03 109.958 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -123.66 85.71 2.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.385 -0.825 . . . . 2.16 110.249 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.09 -111.25 3.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.829 -0.7 . . . . 0.34 112.415 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -96.83 11.7 34.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.681 0.277 . . . . 2.6 110.746 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -131.61 139.73 49.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.191 0.52 . . . . 0.38 110.621 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.528 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -121.96 156.15 16.74 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.783 -0.927 . . . . 0.11 110.783 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -129.32 146.63 51.17 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.036 -0.727 . . . . 0.19 109.036 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.556 HD12 ' CD2' ' A' ' 73' ' ' PHE . 7.1 mt -117.69 152.68 34.74 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.103 -0.703 . . . . 1.28 109.103 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.66 72.94 2.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.926 0.869 . . . . 1.77 109.532 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -145.58 99.92 3.36 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.417 -1.265 . . . . 0.33 108.027 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 92.6 mt-10 -98.75 103.15 15.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.571 0.701 . . . . 1.81 110.763 -174.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.5 m -70.67 -37.11 68.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.521 -1.218 . . . . 1.51 112.483 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 2.5 tp10 -151.25 121.3 7.16 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 121.485 -0.086 . . . . 2.24 111.018 -176.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.9 t70 62.39 15.92 8.13 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.625 0.726 . . . . 1.55 111.87 169.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.52 ' HA2' ' OE2' ' A' ' 44' ' ' GLU . . . 94.33 28.42 10.66 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.577 -0.821 . . . . 0.77 112.056 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -81.07 110.16 16.33 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.604 -0.517 . . . . 3.03 109.604 179.164 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -68.63 130.27 42.36 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.649 0.593 . . . . 1.87 109.772 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 51' ' ' LEU . 2.1 mt -66.41 124.22 22.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.158 -0.474 . . . . 1.05 110.737 176.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -107.4 160.09 15.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.247 -0.433 . . . . 0.48 110.1 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.528 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 33.7 p90 -152.03 152.61 32.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.464 -0.789 . . . . 0.2 109.037 173.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -91.79 152.87 19.94 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.692 -0.855 . . . . 0.47 108.692 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.461 ' SD ' HG21 ' A' ' 58' ' ' VAL . 3.4 tpt -68.65 0.68 3.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.635 0.374 . . . . 2.84 111.927 -173.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 p -79.95 -37.54 34.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.958 0.409 . . . . 1.41 110.877 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -72.37 -16.23 61.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.771 -0.65 . . . . 1.96 110.14 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.461 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -61.06 150.81 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.141 -0.936 . . . . 1.06 111.778 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.429 ' CG ' ' HG ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -66.32 93.81 0.24 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.347 -0.842 . . . . 1.85 112.16 -176.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.86 -91.87 0.52 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.566 -0.743 . . . . 0.62 113.58 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -103.87 159.34 15.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.848 0.356 . . . . 2.3 110.098 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.5 p -79.86 -21.12 44.46 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.045 -0.525 . . . . 1.45 111.542 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.8 p -83.18 -9.42 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.373 0.606 . . . . 1.95 110.667 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 -19.7 28.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.551 -0.749 . . . . 1.21 111.383 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.84 123.89 50.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.637 -0.71 . . . . 2.19 109.272 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -123.47 155.88 64.95 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 1.12 111.452 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.471 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.7 Cg_endo -68.98 132.53 24.79 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.502 2.135 . . . . 0.28 111.535 174.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.21 -11.04 63.75 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.931 -0.652 . . . . 0.23 111.758 -177.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -84.47 149.45 25.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.04 -0.356 . . . . 1.28 110.04 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 m -75.69 139.0 41.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.519 -0.549 . . . . 1.05 109.519 174.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.22 162.92 24.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 120.829 0.347 . . . . 1.16 111.218 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.491 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -114.43 148.0 38.42 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.869 -1.16 . . . . 0.78 107.869 172.289 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.556 ' CD2' HD12 ' A' ' 41' ' ' LEU . 29.5 p90 -153.62 -179.46 7.81 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.381 -0.6 . . . . 0.15 109.381 -175.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.6 m -128.07 114.26 16.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.988 -0.745 . . . . 1.3 108.988 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 75' ' ' VAL . 7.6 p -84.24 99.87 7.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.597 0.713 . . . . 1.11 111.293 -175.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.81 121.89 60.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.685 -0.689 . . . . 1.13 109.589 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 22.1 m -80.36 128.58 33.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.71 0.29 . . . . 1.27 111.166 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 75.1 m-20 -74.09 114.66 12.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.157 -0.474 . . . . 1.96 109.875 177.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -64.03 -24.82 67.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.384 . . . . 2.24 111.835 -173.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -90.34 -45.54 8.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 4.49 111.342 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -85.72 -23.05 27.51 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.913 0.338 . . . . 2.66 111.913 -174.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.54 -21.08 14.94 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 121.237 -0.506 . . . . 0.88 112.764 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 39.7 pttt -98.05 142.76 29.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.292 0.568 . . . . 2.9 110.757 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.4 m -84.94 179.51 7.29 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.24 -0.891 . . . . 1.49 111.876 -175.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.4 m -147.37 157.45 43.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.652 -0.704 . . . . 1.31 109.479 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' A' ' 53' ' ' PHE . . . -98.86 122.2 41.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.901 0.381 . . . . 1.05 110.843 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 80.1 m -116.21 141.55 48.0 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.05 -0.523 . . . . 1.17 110.14 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.25 67.84 0.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.801 0.688 . . . . 2.17 110.144 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 92.7 t -84.73 103.76 12.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.593 -0.73 . . . . 1.06 110.645 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.491 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 8.1 mp -108.14 147.85 30.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.79 -0.641 . . . . 1.77 111.199 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.28 129.04 35.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.636 -0.711 . . . . 2.02 111.414 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.6 mm -118.7 133.44 65.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.963 -0.562 . . . . 1.05 111.518 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.512 HD21 ' H ' ' A' ' 93' ' ' ASN . 0.1 OUTLIER -90.73 105.87 18.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.639 0.733 . . . . 3.31 110.41 173.4 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 t70 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.633 -0.712 . . . . 3.08 110.632 -176.085 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.122 -0.391 . . . . 19.3 112.122 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.72 150.72 20.07 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.205 -0.294 . . . . 17.75 110.205 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -84.0 159.72 21.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.872 0.368 . . . . 17.68 110.27 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.0 -16.48 30.38 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.677 -0.773 . . . . 14.41 111.373 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -102.18 -170.44 1.81 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.488 -0.56 . . . . 13.69 109.488 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.3 tp -72.16 115.2 11.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.003 0.43 . . . . 11.63 111.178 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.428 HG21 ' CE1' ' A' ' 9' ' ' PHE . 3.1 p -91.54 98.29 8.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.773 0.796 . . . . 8.84 110.86 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.6 p -97.71 7.6 46.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.642 -0.708 . . . . 8.01 111.121 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.428 ' CE1' HG21 ' A' ' 7' ' ' VAL . 34.4 p90 -109.63 9.43 25.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.277 -0.42 . . . . 7.63 111.503 -176.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.18 -177.45 5.94 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.945 0.403 . . . . 7.38 111.697 -174.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.8 mp -102.49 133.88 44.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.525 -0.761 . . . . 3.34 111.294 -170.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -89.96 -43.62 10.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.54 0.209 . . . . 3.29 111.096 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.36 -9.58 1.63 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.165 0.586 . . . . 2.96 111.356 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 t -67.74 -20.76 65.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.507 -0.77 . . . . 2.5 110.791 174.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.32 60.29 0.75 Allowed Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.425 -0.893 . . . . 1.9 112.455 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 4.7 mmp_? -57.82 99.98 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.84 0.352 . . . . 5.69 111.509 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.76 -26.08 26.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.965 0.412 . . . . 2.83 111.22 175.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.19 -34.59 75.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.017 -0.538 . . . . 2.82 111.32 -175.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.8 p -146.98 131.92 18.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.033 -0.53 . . . . 3.08 110.087 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.46 HG23 ' H ' ' A' ' 22' ' ' ALA . 14.7 p -167.51 144.11 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.456 -0.572 . . . . 2.34 109.456 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -97.46 16.8 19.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.045 0.45 . . . . 2.96 110.865 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.46 ' H ' HG23 ' A' ' 20' ' ' VAL . . . -152.7 -168.89 3.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.149 -0.478 . . . . 1.95 110.517 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.483 HG11 ' H ' ' A' ' 24' ' ' ARG . 2.2 t -86.54 177.29 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.796 -0.816 . . . . 2.27 108.796 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.483 ' H ' HG11 ' A' ' 23' ' ' VAL . 3.8 ppt_? -71.84 55.41 0.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.627 0.727 . . . . 3.4 111.292 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -132.76 82.58 2.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.62 -0.718 . . . . 1.88 110.483 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -97.1 111.73 23.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.465 0.65 . . . . 2.59 110.254 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 73.1 mmtt -94.27 160.21 14.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.992 -1.004 . . . . 1.84 110.308 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 17.6 mtm180 -128.72 127.52 42.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.959 0.409 . . . . 1.99 110.131 175.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.49 178.21 9.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.679 -0.691 . . . . 0.96 109.724 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.04 141.21 33.17 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.276 -0.639 . . . . 0.86 109.276 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.448 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 51.1 t -62.31 114.42 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.821 -0.437 . . . . 1.01 109.821 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.29 -47.15 62.5 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.307 -0.86 . . . . 0.6 109.973 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.5 m -160.72 160.14 31.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.596 -0.729 . . . . 1.18 110.392 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.2 mt -137.26 120.12 20.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.174 -0.676 . . . . 1.03 109.174 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -110.23 86.38 2.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.544 -0.753 . . . . 2.16 109.767 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.8 -109.15 2.76 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.683 -0.77 . . . . 0.34 112.247 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -91.18 2.75 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.926 -0.161 . . . . 2.6 111.269 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -124.07 141.0 52.43 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.305 -0.558 . . . . 0.38 111.335 -174.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -122.56 158.66 17.23 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.517 -0.765 . . . . 0.11 111.415 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.51 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 49.6 m-85 -136.11 136.23 39.95 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.882 -0.784 . . . . 0.19 108.882 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.432 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -106.26 155.08 19.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.458 -0.942 . . . . 1.28 108.458 177.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -76.32 73.5 3.11 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.419 0.628 . . . . 1.77 109.581 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -141.66 98.82 3.42 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.065 -0.971 . . . . 0.33 109.657 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.75 100.69 7.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.616 0.722 . . . . 1.81 110.101 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.478 ' CG1' ' HG ' ' A' ' 51' ' ' LEU . 31.6 m -80.23 -34.5 14.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.014 -0.993 . . . . 1.51 110.992 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.539 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 8.3 tp10 -137.08 177.61 7.73 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.019 -1.845 . . . . 2.24 106.019 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.539 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 29.2 t70 -40.56 85.94 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.815 1.043 . . . . 1.55 113.815 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.22 16.99 71.68 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.775 -0.93 . . . . 0.77 110.775 173.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -88.5 109.42 20.03 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.004 -0.739 . . . . 3.03 109.004 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -75.46 134.32 40.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.65 -0.5 . . . . 1.87 109.65 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 1.4 mt -64.69 125.01 23.41 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.253 0.346 . . . . 1.05 111.037 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -108.78 158.61 17.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.962 -0.384 . . . . 0.48 109.962 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.432 ' CD2' HD23 ' A' ' 41' ' ' LEU . 45.9 p90 -153.11 154.25 34.45 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.065 -0.717 . . . . 0.2 109.065 173.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.411 ' C ' ' H ' ' A' ' 56' ' ' SER . 9.0 t-160 -94.54 152.07 18.84 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.627 -0.879 . . . . 0.47 108.627 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.503 ' SD ' HG23 ' A' ' 58' ' ' VAL . 9.4 mmt -63.87 0.79 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.28 0.474 . . . . 2.84 112.28 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 54' ' ' HIS . 22.3 t -86.13 -23.05 26.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.713 0.292 . . . . 1.41 110.327 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -91.11 -2.59 57.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.025 0.44 . . . . 1.96 110.079 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.503 HG23 ' SD ' ' A' ' 55' ' ' MET . 2.2 t -72.66 151.28 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.53 -0.759 . . . . 1.06 112.389 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.53 96.27 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.05 -0.977 . . . . 1.85 111.57 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.17 -84.11 0.41 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.753 -0.658 . . . . 0.62 113.569 170.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -113.25 145.74 40.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.139 0.495 . . . . 2.3 110.579 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.416 HG23 ' HB3' ' A' ' 55' ' ' MET . 81.6 p -72.3 -9.63 58.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 1.45 111.705 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.8 t -95.36 -2.92 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.499 -0.773 . . . . 1.95 110.373 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.94 -17.59 22.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.096 0.474 . . . . 1.21 111.445 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.1 124.0 51.56 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.163 -0.68 . . . . 2.19 109.163 -176.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -123.29 155.63 64.71 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.656 0.265 . . . . 1.12 111.269 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.448 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.0 Cg_endo -67.12 128.36 18.44 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.341 2.027 . . . . 0.28 111.339 172.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.74 -11.62 53.31 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.684 -0.769 . . . . 0.23 112.072 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -81.14 149.16 29.25 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.645 0.259 . . . . 1.28 110.522 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.6 m -76.86 131.35 38.56 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.525 -0.917 . . . . 1.05 108.525 171.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.01 159.48 41.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 122.04 0.924 . . . . 1.16 111.006 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -114.52 139.75 49.31 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.844 -1.526 . . . . 0.78 108.708 177.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE1' ' HB2' ' A' ' 27' ' ' LYS . 29.9 p90 -152.37 -179.68 7.77 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.463 -0.569 . . . . 0.15 109.463 -174.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 t -124.99 127.81 47.59 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.803 -0.814 . . . . 1.3 108.803 177.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 75' ' ' VAL . 7.4 p -95.01 98.45 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.919 0.866 . . . . 1.11 110.835 -176.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.0 p -104.7 110.82 31.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.246 -0.888 . . . . 1.13 110.09 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 31.8 m -69.37 123.8 22.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.095 -0.502 . . . . 1.27 110.454 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 0.9 OUTLIER -69.92 109.38 4.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.516 -0.549 . . . . 1.96 109.516 178.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -13.37 52.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.788 0.328 . . . . 2.24 111.316 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -94.37 -36.14 12.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.402 -0.363 . . . . 4.49 111.47 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -99.82 -29.36 12.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.253 0.464 . . . . 2.66 112.253 -174.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.17 -24.38 25.24 Favored Glycine 0 C--N 1.32 -0.313 0 C-N-CA 121.239 -0.505 . . . . 0.88 112.103 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 18.3 pttm -95.03 154.46 17.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.622 -0.511 . . . . 2.9 109.622 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 2.0 m -94.97 -179.26 4.77 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.843 0.354 . . . . 1.49 110.736 -177.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -146.36 146.88 30.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.244 -0.65 . . . . 1.31 109.244 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 73' ' ' PHE . . . -88.92 118.41 28.62 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.912 0.386 . . . . 1.05 110.424 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.8 m -117.16 149.09 40.95 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.257 -0.646 . . . . 1.17 109.257 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 m120 61.61 67.95 0.74 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.491 0.662 . . . . 2.17 109.532 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 86.0 t -89.92 111.76 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.286 -0.87 . . . . 1.06 110.748 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.46 147.27 30.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.574 -0.739 . . . . 1.77 110.903 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 114.17 21.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.748 -0.66 . . . . 2.02 110.136 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.9 mm -101.29 135.3 38.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.56 -0.746 . . . . 1.05 111.135 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -71.2 115.2 10.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.607 -0.724 . . . . 3.31 110.218 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.812 -0.631 . . . . 3.08 111.069 178.445 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 112.031 -0.428 . . . . 19.3 112.031 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.09 -26.22 62.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.994 0.426 . . . . 17.75 110.839 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -105.13 87.69 2.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.152 0.501 . . . . 17.68 110.994 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.63 81.35 0.29 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.935 -0.866 . . . . 14.41 110.935 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -90.23 -170.8 2.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.109 0.48 . . . . 13.69 112.211 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.2 117.03 13.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 11.63 112.55 -171.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.29 125.59 68.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.847 -0.615 . . . . 8.84 109.843 171.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.417 ' HA ' HH22 ' A' ' 16' ' ' ARG . 17.0 m -83.43 95.18 8.17 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.866 -0.42 . . . . 8.01 109.866 176.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -156.75 -36.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.871 -0.604 . . . . 7.63 110.971 -174.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -84.44 177.71 8.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.155 -0.475 . . . . 7.38 111.976 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.0 mm -70.11 119.07 15.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.611 -0.722 . . . . 3.34 110.908 -175.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -84.79 -29.69 25.22 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.387 0.514 . . . . 3.29 112.387 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 2.0 pt-20 -66.06 -7.01 14.87 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.358 0.599 . . . . 2.96 110.833 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.5 t -71.19 -25.9 62.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.635 -0.711 . . . . 2.5 109.873 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.64 47.11 35.5 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.888 -0.885 . . . . 1.9 110.888 -174.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.417 HH22 ' HA ' ' A' ' 8' ' ' SER . 17.9 ptt180 -57.9 122.81 13.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.356 0.598 . . . . 5.69 111.438 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.27 -14.48 7.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.823 -1.081 . . . . 2.83 112.801 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.76 -27.98 68.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.631 -0.259 . . . . 2.82 110.9 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.4 t -143.6 128.71 18.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 3.08 110.175 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.454 HG21 ' H ' ' A' ' 22' ' ' ALA . 15.0 p -169.95 138.06 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.897 -0.592 . . . . 2.34 109.833 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -93.67 -13.32 27.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.149 0.499 . . . . 2.96 110.57 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.454 ' H ' HG21 ' A' ' 20' ' ' VAL . . . -114.32 -178.54 3.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.046 -0.524 . . . . 1.95 110.585 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.472 ' C ' ' HG3' ' A' ' 24' ' ' ARG . 2.5 m -86.48 73.24 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.18 -0.463 . . . . 2.27 111.993 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.472 ' HG3' ' C ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 40.42 46.1 1.99 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.912 0.885 . . . . 3.4 113.064 175.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -132.73 112.27 11.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.159 -0.473 . . . . 1.88 110.965 -176.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.26 125.51 51.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.314 0.578 . . . . 2.59 110.836 176.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -104.12 147.55 27.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.58 -0.736 . . . . 1.84 109.198 171.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -124.16 128.11 48.76 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.96 -0.296 . . . . 1.99 110.852 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.79 179.49 9.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.753 . . . . 0.96 110.429 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.07 146.65 28.05 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.117 -0.492 . . . . 0.86 110.335 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.477 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 31.0 t -67.26 121.73 16.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.157 0.503 . . . . 1.01 110.325 176.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -80.95 -41.69 22.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.434 -0.803 . . . . 0.6 109.914 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.3 p -163.96 166.9 21.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 1.18 110.643 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.3 mt -140.86 130.92 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.256 0.551 . . . . 1.03 109.873 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -124.82 88.16 2.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.383 -0.826 . . . . 2.16 110.411 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.48 -110.91 3.49 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.674 -0.774 . . . . 0.34 112.192 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -92.34 5.81 49.24 Favored 'General case' 0 C--O 1.225 -0.236 0 O-C-N 122.77 -0.253 . . . . 2.6 110.88 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -126.36 140.72 52.28 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.212 -0.595 . . . . 0.38 111.499 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.465 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.82 157.95 17.43 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.319 -0.855 . . . . 0.11 111.176 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 80.1 m-85 -130.26 140.54 50.68 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.292 -0.633 . . . . 0.19 109.292 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.457 HD11 ' CD2' ' A' ' 73' ' ' PHE . 6.8 mt -116.28 153.42 31.96 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.777 -0.453 . . . . 1.28 109.777 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -75.97 73.84 2.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.597 0.713 . . . . 1.77 109.817 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -144.45 109.27 4.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.845 -1.07 . . . . 0.33 109.275 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -92.81 115.02 27.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.848 -0.614 . . . . 1.81 110.576 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.9 m -85.62 -47.49 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.78 -0.645 . . . . 1.51 111.46 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.614 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 8.4 pt-20 -157.1 144.64 18.91 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.486 -0.561 . . . . 2.24 109.486 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.9 t70 59.63 10.76 2.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.969 0.89 . . . . 1.55 112.009 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.13 30.58 37.4 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.609 -0.805 . . . . 0.77 112.106 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.614 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 8.1 mtpp -73.34 112.45 9.41 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.451 -0.203 . . . . 3.03 110.451 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.07 120.73 14.76 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.58 0.55 . . . . 1.87 109.527 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.4 mt -58.54 128.02 35.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.025 -0.534 . . . . 1.05 112.074 -176.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -106.17 161.65 14.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.905 0.383 . . . . 0.48 110.559 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.498 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 21.2 p90 -152.76 157.17 40.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.95 -0.568 . . . . 0.2 109.572 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -99.49 150.66 21.97 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.952 -0.759 . . . . 0.47 108.952 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.491 ' SD ' HG23 ' A' ' 58' ' ' VAL . 16.4 mmt -61.89 -9.43 6.84 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.114 0.412 . . . . 2.84 112.114 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.1 t -71.36 -26.06 62.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.823 0.344 . . . . 1.41 110.196 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -92.98 -2.07 56.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.417 -0.356 . . . . 1.96 110.588 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.491 HG23 ' SD ' ' A' ' 55' ' ' MET . 1.2 t -73.25 151.44 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.397 0.617 . . . . 1.06 112.569 -174.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 17.1 tm0? -68.03 98.82 0.8 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.903 -1.044 . . . . 1.85 112.5 -174.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.55 -81.89 0.39 Allowed Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.814 -0.63 . . . . 0.62 113.354 172.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -114.34 150.11 35.04 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.928 0.394 . . . . 2.3 110.159 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.7 p -71.22 -16.44 62.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.808 -0.633 . . . . 1.45 110.625 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 t -97.36 10.46 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.449 -0.796 . . . . 1.95 109.856 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.32 -27.22 12.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.118 0.485 . . . . 1.21 110.916 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.553 ' CD2' ' HG2' ' A' ' 91' ' ' LYS . 0.9 OUTLIER -102.29 124.29 47.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.042 -0.725 . . . . 2.19 109.042 178.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.6 154.19 69.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.618 0.246 . . . . 1.12 111.33 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.456 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.6 Cg_endo -67.49 121.56 8.68 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.307 2.005 . . . . 0.28 111.422 173.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.477 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 103.05 -5.91 50.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.813 -0.708 . . . . 0.23 111.786 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.28 152.23 22.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.374 -0.602 . . . . 1.28 109.374 176.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 7.1 m -81.1 141.59 34.15 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.077 -0.712 . . . . 1.05 109.077 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.44 HG11 HD22 ' A' ' 65' ' ' LEU . 4.3 m -137.26 161.65 34.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.412 0.625 . . . . 1.16 110.83 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.61 141.33 47.91 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.43 -1.322 . . . . 0.78 107.43 170.075 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 30.9 p90 -151.64 178.98 8.8 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.978 0.418 . . . . 0.15 110.103 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.2 m -127.31 129.91 48.55 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.871 -0.788 . . . . 1.3 108.871 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 p -89.25 99.79 9.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.69 0.757 . . . . 1.11 110.979 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.4 p -107.33 101.93 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.741 0.781 . . . . 1.13 109.932 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 m -70.46 130.83 42.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.416 -0.811 . . . . 1.27 110.867 -177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.45 104.8 3.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.7 -0.852 . . . . 1.96 108.7 172.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -62.65 -16.78 58.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.847 0.356 . . . . 2.24 111.407 -176.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -90.75 -40.79 11.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.126 -0.488 . . . . 4.49 111.038 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -94.37 -31.47 14.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.864 0.364 . . . . 2.66 111.709 -173.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.28 -23.76 33.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.108 -0.568 . . . . 0.88 112.273 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.401 ' HD3' ' HE2' ' A' ' 49' ' ' LYS . 21.4 pttt -91.44 154.08 19.4 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.052 -0.351 . . . . 2.9 110.052 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.6 t -108.25 -176.46 3.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.439 -0.346 . . . . 1.49 110.808 -173.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 p -155.28 147.13 23.35 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.787 -0.642 . . . . 1.31 109.338 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 73' ' ' PHE . . . -87.22 123.01 31.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 120.974 0.416 . . . . 1.05 111.081 -177.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 89.5 m -117.35 150.95 37.99 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.876 -0.602 . . . . 1.17 109.475 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 58.4 63.01 1.82 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.413 0.446 . . . . 2.17 109.809 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 79.3 t -84.16 103.78 11.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.873 -0.603 . . . . 1.06 110.325 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 4.6 mm? -101.31 147.59 26.13 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.698 -0.683 . . . . 1.77 109.888 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.553 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -82.3 126.93 32.71 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.47 -0.567 . . . . 2.02 109.47 178.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.512 ' O ' ' HB ' ' A' ' 70' ' ' THR . 38.7 mm -116.82 132.23 67.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.906 -0.588 . . . . 1.05 110.103 -176.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -119.74 137.29 54.03 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.402 0.62 . . . . 3.31 111.355 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--N 1.317 -0.817 0 CA-C-N 115.066 -0.97 . . . . 3.08 110.511 175.78 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 111.839 -0.505 . . . . 19.3 111.839 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.44 89.92 3.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.929 0.395 . . . . 17.75 110.499 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -86.63 93.56 9.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.208 0.528 . . . . 17.68 110.298 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.46 175.84 15.87 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.802 -0.713 . . . . 14.41 111.948 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -95.25 102.18 13.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.957 -0.386 . . . . 13.69 109.957 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 mp -87.6 144.26 26.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.822 0.344 . . . . 11.63 110.624 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.75 118.03 33.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.976 -0.556 . . . . 8.84 110.032 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 m -78.3 -8.59 58.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.249 -0.432 . . . . 8.01 110.812 -177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 37.5 p90 50.51 28.45 3.4 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.618 1.167 . . . . 7.63 112.004 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -166.14 129.69 2.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.192 -0.458 . . . . 7.38 110.811 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.519 HG21 ' H ' ' A' ' 13' ' ' GLU . 46.5 mm -116.75 138.86 45.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.325 -0.991 . . . . 3.34 108.325 166.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -66.77 -20.0 65.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.867 0.365 . . . . 3.29 111.251 -174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.519 ' H ' HG21 ' A' ' 11' ' ' ILE . 9.6 mt-10 -73.29 -4.25 32.08 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.26 0.552 . . . . 2.96 110.536 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.4 t -73.73 -16.89 61.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.298 -0.41 . . . . 2.5 110.903 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.01 57.76 2.21 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.202 -0.999 . . . . 1.9 111.024 -176.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -85.94 143.75 28.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.054 0.454 . . . . 5.69 110.925 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.94 -15.04 40.25 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.408 -0.814 . . . . 2.83 112.783 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.0 -27.01 67.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.675 0.25 . . . . 2.82 111.675 -174.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.4 m -149.05 129.28 13.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.828 0.347 . . . . 3.08 110.292 175.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 22' ' ' ALA . 13.6 p -169.34 142.53 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.876 -0.602 . . . . 2.34 109.918 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -116.16 -4.75 11.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.474 0.654 . . . . 2.96 110.3 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 20' ' ' VAL . . . -128.83 -129.11 0.22 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.331 -0.85 . . . . 1.95 109.615 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.19 -165.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.946 0.403 . . . . 2.27 110.912 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -48.9 -27.63 3.22 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.337 1.055 . . . . 3.4 113.594 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -82.26 107.37 14.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.033 0.444 . . . . 1.88 111.903 -168.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -111.7 111.67 22.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.741 -0.663 . . . . 2.59 110.22 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -87.14 153.66 21.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.686 -0.688 . . . . 1.84 110.215 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.441 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 43.9 mtm180 -125.5 135.63 52.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.859 0.361 . . . . 1.99 110.527 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.81 179.34 8.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.558 -0.746 . . . . 0.96 109.447 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.25 147.09 28.44 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.003 -0.369 . . . . 0.86 110.003 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.54 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 26.7 t -69.34 120.33 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.077 0.465 . . . . 1.01 110.317 177.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -72.18 -41.81 66.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.312 -0.858 . . . . 0.6 110.631 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.8 p -175.66 163.3 2.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.685 -0.688 . . . . 1.18 109.477 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 mt -131.06 131.28 64.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.259 0.552 . . . . 1.03 110.264 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -121.86 86.37 2.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.141 -0.936 . . . . 2.16 109.775 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.15 -112.48 4.06 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.659 -0.782 . . . . 0.34 112.193 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -93.34 7.28 45.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.59 0.233 . . . . 2.6 110.743 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.24 141.64 51.4 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.081 0.467 . . . . 0.38 111.007 -174.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.74 157.52 18.18 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 111.038 -0.825 . . . . 0.11 111.038 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 81.1 m-85 -130.19 143.28 50.69 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.82 -0.437 . . . . 0.19 109.82 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.488 HD12 ' CD2' ' A' ' 73' ' ' PHE . 8.4 mt -117.5 152.88 34.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.075 -0.512 . . . . 1.28 109.918 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -74.37 74.76 1.89 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.671 0.748 . . . . 1.77 109.723 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -151.06 99.26 2.67 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.882 -1.054 . . . . 0.33 108.654 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 14.1 mt-10 -94.41 101.54 13.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.709 0.766 . . . . 1.81 111.296 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.595 HG21 ' H ' ' A' ' 46' ' ' GLU . 2.4 m -75.43 -59.07 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.247 -1.342 . . . . 1.51 111.262 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.595 ' H ' HG21 ' A' ' 45' ' ' VAL . 10.9 tp10 -106.82 179.87 4.14 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.131 -1.433 . . . . 2.24 107.131 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.441 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 31.3 t70 -30.54 83.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.854 1.262 . . . . 1.55 113.914 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 66.23 16.09 64.16 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.792 -0.718 . . . . 0.77 111.512 172.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.661 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 2.4 mmmt -77.14 108.09 9.98 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 110.021 -0.363 . . . . 3.03 110.021 -174.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -74.93 123.11 24.51 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.976 -1.12 . . . . 1.87 107.976 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 4.1 mt -57.55 122.22 12.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.818 0.342 . . . . 1.05 111.423 -174.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -101.07 155.07 18.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.896 -0.593 . . . . 0.48 109.954 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.472 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 33.1 p90 -149.4 157.13 43.05 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.632 -0.713 . . . . 0.2 109.276 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -99.77 150.11 22.66 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.238 -0.653 . . . . 0.47 109.238 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 58' ' ' VAL . 11.0 mmt -60.47 -6.89 1.77 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.631 0.604 . . . . 2.84 112.631 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.404 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . 17.6 t -79.01 -28.98 43.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.693 0.282 . . . . 1.41 110.284 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' OE2' ' HB3' ' A' ' 56' ' ' SER . 2.6 mp0 -85.61 -4.47 59.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.972 0.415 . . . . 1.96 110.593 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.529 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -69.5 148.38 11.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.605 -0.725 . . . . 1.06 112.486 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.4 ' HG2' HD11 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -64.15 99.9 0.3 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.467 -1.242 . . . . 1.85 111.883 -175.499 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.56 -89.65 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.866 -0.607 . . . . 0.62 113.131 173.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -106.07 151.06 25.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.986 0.422 . . . . 2.3 110.603 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.0 p -63.76 -33.79 76.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.478 -0.783 . . . . 1.45 111.076 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.6 t -88.3 7.22 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.828 -0.624 . . . . 1.95 110.443 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.82 -9.42 34.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.093 0.473 . . . . 1.21 110.788 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.529 ' CD2' ' HG2' ' A' ' 91' ' ' LYS . 1.1 tm? -121.36 124.5 44.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.622 -0.881 . . . . 2.19 108.622 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -122.87 152.33 62.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.452 -0.34 . . . . 1.12 111.407 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.414 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 44.8 Cg_endo -69.74 115.92 4.31 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.585 2.19 . . . . 0.28 111.907 176.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.54 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 119.77 -18.85 9.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.14 -0.553 . . . . 0.23 112.247 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.21 155.92 24.68 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.755 -0.461 . . . . 1.28 109.755 175.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 3.0 m -78.45 143.11 36.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.677 -0.49 . . . . 1.05 109.677 176.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.495 HG11 HD23 ' A' ' 65' ' ' LEU . 26.6 m -137.53 157.52 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 121.699 0.762 . . . . 1.16 110.215 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.441 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -115.41 141.51 47.94 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.27 -1.332 . . . . 0.78 108.359 171.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.488 ' CD2' HD12 ' A' ' 41' ' ' LEU . 30.5 p90 -152.04 179.57 8.36 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.05 -0.722 . . . . 0.15 109.05 -173.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.85 128.51 47.75 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.961 -0.755 . . . . 1.3 108.961 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.05 98.69 7.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.759 0.79 . . . . 1.11 110.61 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.88 125.64 67.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.292 -0.867 . . . . 1.13 109.367 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.7 m -81.4 128.98 34.44 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.351 -0.386 . . . . 1.27 110.48 -178.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -68.1 111.14 4.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.68 -0.489 . . . . 1.96 109.68 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.55 -18.84 44.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.081 -0.509 . . . . 2.24 112.035 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -95.06 -38.12 10.78 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.841 0.312 . . . . 4.49 111.841 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.426 ' HB3' ' HE2' ' A' ' 83' ' ' LYS . 11.2 m120 -113.73 -5.74 13.31 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.045 0.758 . . . . 2.66 113.045 -172.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.94 -9.42 24.77 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.893 -0.67 . . . . 0.88 114.017 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -97.45 152.87 18.53 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.581 -0.526 . . . . 2.9 109.581 179.227 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.1 t -97.01 -179.67 4.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.158 0.504 . . . . 1.49 111.745 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.7 p -154.97 150.4 27.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.35 -0.841 . . . . 1.31 108.783 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -87.22 122.58 31.2 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.201 0.524 . . . . 1.05 110.51 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 84.0 m -116.92 144.88 44.03 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.524 -0.762 . . . . 1.17 109.739 178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 56.79 73.26 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.812 0.695 . . . . 2.17 109.792 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 73.3 t -87.75 105.69 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.741 -0.663 . . . . 1.06 110.46 -178.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.4 HD11 ' HG2' ' A' ' 59' ' ' GLN . 4.3 mm? -101.98 149.05 24.62 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.358 -0.837 . . . . 1.77 110.298 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.529 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -84.54 115.85 22.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.326 -0.62 . . . . 2.02 109.326 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.402 ' O ' ' HB ' ' A' ' 70' ' ' THR . 43.2 mm -109.62 137.48 41.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.158 0.504 . . . . 1.05 111.801 -172.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -108.45 133.14 53.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.833 -0.802 . . . . 3.31 108.833 169.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 115.905 -0.588 . . . . 3.08 110.93 -175.76 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 111.999 -0.44 . . . . 19.3 111.999 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.01 18.99 11.74 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.264 0.554 . . . . 17.75 111.304 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -105.76 91.0 3.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.905 -0.589 . . . . 17.68 109.612 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.48 -40.85 1.98 Allowed Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.685 -0.769 . . . . 14.41 112.753 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.24 117.33 12.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.036 0.446 . . . . 13.69 110.483 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.9 mt -81.79 119.01 23.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.501 0.667 . . . . 11.63 111.192 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.7 m -91.91 23.5 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.039 -0.982 . . . . 8.84 110.349 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 m 64.17 24.12 13.33 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.299 -0.864 . . . . 8.01 110.827 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -73.65 -30.46 62.94 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.774 0.797 . . . . 7.63 109.277 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -158.13 141.56 15.26 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.701 -1.136 . . . . 7.38 109.496 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.487 HD11 ' N ' ' A' ' 11' ' ' ILE . 3.0 mp -122.27 140.83 44.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.869 -0.789 . . . . 3.34 108.869 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.88 -28.49 66.74 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.09 0.404 . . . . 3.29 112.09 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.77 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 10.7 pt-20 -60.05 -15.01 19.36 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.171 0.51 . . . . 2.96 110.689 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 p -70.15 -27.34 64.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.411 -0.813 . . . . 2.5 111.011 -178.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.98 57.36 2.16 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.584 -0.817 . . . . 1.9 111.704 -175.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -59.09 120.99 10.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.713 0.292 . . . . 5.69 111.472 -176.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.59 -17.68 40.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 2.83 111.961 -177.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.27 -36.57 77.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.654 0.264 . . . . 2.82 111.18 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 44.5 t -151.23 131.85 13.94 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.467 -0.568 . . . . 3.08 109.467 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.9 p -168.04 153.38 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.169 -0.469 . . . . 2.34 109.764 -175.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -84.52 -55.25 4.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.08 0.467 . . . . 2.96 110.646 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.15 -166.03 1.39 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.766 -0.652 . . . . 1.95 110.334 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.526 HG13 ' H ' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -91.94 -160.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.176 -0.676 . . . . 2.27 109.176 178.094 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.526 ' H ' HG13 ' A' ' 23' ' ' VAL . 4.3 ppt_? -71.43 15.4 0.13 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.041 0.386 . . . . 3.4 112.041 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.494 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 4.0 tp60 -91.73 80.15 5.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.202 0.525 . . . . 1.88 110.767 -174.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.593 ' HZ1' ' CD ' ' A' ' 72' ' ' GLU . 6.5 mtpm? -104.11 112.63 25.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.656 -0.702 . . . . 2.59 110.421 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 67.7 mmtt -100.05 157.52 16.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.424 -0.807 . . . . 1.84 111.4 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -124.53 140.04 53.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.44 -0.346 . . . . 1.99 110.122 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.42 179.26 6.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.048 -0.523 . . . . 0.96 110.184 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.01 145.14 30.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.239 -0.437 . . . . 0.86 110.103 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 67' ' ' PRO . 46.2 t -68.98 119.9 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.38 -0.373 . . . . 1.01 110.565 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -72.88 -40.41 65.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.826 -0.625 . . . . 0.6 110.344 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 p -171.12 164.3 7.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.067 -0.515 . . . . 1.18 110.628 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.7 mt -136.56 130.82 47.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.587 -0.523 . . . . 1.03 109.587 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -128.27 101.29 6.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.475 -0.784 . . . . 2.16 110.171 -175.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.27 -105.89 1.43 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.665 -0.778 . . . . 0.34 112.392 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -106.12 6.76 31.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.934 -0.395 . . . . 2.6 109.934 -177.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -125.4 140.64 52.62 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.377 0.608 . . . . 0.38 111.091 -174.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -123.79 156.58 18.04 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.957 -0.857 . . . . 0.11 110.957 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -131.0 144.95 51.87 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.711 -0.478 . . . . 0.19 109.711 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.543 HD11 ' CD2' ' A' ' 73' ' ' PHE . 4.8 mt -121.07 152.1 39.05 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.275 -0.639 . . . . 1.28 109.275 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -75.54 75.26 2.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.314 0.578 . . . . 1.77 109.585 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -143.12 98.17 3.22 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.433 -0.803 . . . . 0.33 109.509 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -79.47 101.31 8.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.915 -0.584 . . . . 1.81 109.844 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' A' ' 84' ' ' SER . 31.5 m -75.21 -43.96 43.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.536 -0.756 . . . . 1.51 110.609 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 6.0 tp10 -129.08 179.37 5.79 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 106.328 -1.731 . . . . 2.24 106.328 174.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.546 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 14.2 t70 -31.23 83.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.229 1.412 . . . . 1.55 114.059 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.03 8.65 61.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.273 -0.489 . . . . 0.77 111.954 173.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -74.32 110.38 8.57 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.505 -0.554 . . . . 3.03 109.505 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.55 ' HB2' ' HZ2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -78.9 129.77 34.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.668 -0.696 . . . . 1.87 110.193 -173.716 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mt -67.95 127.56 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.318 -0.401 . . . . 1.05 111.274 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -113.51 157.27 22.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.738 -0.664 . . . . 0.48 109.47 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.432 ' CZ ' ' HA3' ' A' ' 39' ' ' GLY . 32.3 p90 -146.05 153.23 40.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.992 -0.549 . . . . 0.2 109.759 174.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.401 ' C ' ' H ' ' A' ' 56' ' ' SER . 12.5 t-160 -94.36 148.13 22.53 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.142 -0.688 . . . . 0.47 109.142 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.628 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 21.7 ttp -65.12 2.9 0.68 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.272 0.629 . . . . 2.84 111.635 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 54' ' ' HIS . 24.7 t -89.53 -19.23 25.28 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.648 -0.251 . . . . 1.41 110.751 176.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -85.85 -11.19 53.97 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 121.378 0.608 . . . . 1.96 109.426 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.6 t -64.41 146.78 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.783 -1.099 . . . . 1.06 112.593 -174.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.37 98.65 0.25 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.831 -1.077 . . . . 1.85 111.899 -173.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.92 -77.54 1.12 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.62 113.512 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -119.87 149.92 41.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.068 0.461 . . . . 2.3 110.025 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.628 ' HB ' ' SD ' ' A' ' 55' ' ' MET . 43.0 p -69.21 -21.89 63.92 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.33 -0.85 . . . . 1.45 112.233 -171.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.9 t -98.92 4.9 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.568 0.699 . . . . 1.95 110.169 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.13 -25.54 27.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.162 -0.472 . . . . 1.21 110.493 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.482 HD23 HG12 ' A' ' 71' ' ' VAL . 1.1 tm? -104.04 125.28 50.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.862 -0.608 . . . . 2.19 109.563 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -124.15 154.81 68.47 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.523 0.201 . . . . 1.12 111.134 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 39.3 Cg_endo -68.55 144.57 61.22 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.659 2.239 . . . . 0.28 112.152 176.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.48 -11.98 64.36 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.925 -0.655 . . . . 0.23 112.345 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.02 154.03 20.81 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.43 -0.211 . . . . 1.28 110.43 177.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.6 m -76.33 138.5 40.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.705 -0.48 . . . . 1.05 109.705 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.482 HG12 HD23 ' A' ' 65' ' ' LEU . 11.3 m -138.09 163.22 29.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.398 0.618 . . . . 1.16 109.877 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.77 ' OE1' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -116.5 149.21 39.92 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.98 -1.009 . . . . 0.78 108.476 172.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.543 ' CD2' HD11 ' A' ' 41' ' ' LEU . 36.1 p90 -156.75 178.25 10.55 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.039 -0.356 . . . . 0.15 110.039 -175.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -124.36 132.67 53.55 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.94 -0.763 . . . . 1.3 108.94 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.32 99.01 8.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.693 0.759 . . . . 1.11 110.496 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.19 126.71 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.459 -0.792 . . . . 1.13 110.589 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.6 m -74.33 132.66 42.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.088 -0.506 . . . . 1.27 111.287 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -75.17 116.46 15.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.092 -0.707 . . . . 1.96 109.092 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -58.16 -28.03 64.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.08 0.4 . . . . 2.24 112.08 -175.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -94.08 -51.58 4.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.919 0.34 . . . . 4.49 111.919 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -81.77 -31.69 31.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.941 0.349 . . . . 2.66 111.941 -172.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.13 -21.98 43.21 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.676 -0.773 . . . . 0.88 112.674 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -82.35 166.59 19.32 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 109.467 -0.568 . . . . 2.9 109.467 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.511 ' HB2' HG11 ' A' ' 45' ' ' VAL . 11.4 m -104.93 -177.66 3.43 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.577 -0.449 . . . . 1.49 111.008 -177.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.6 m -147.82 144.84 28.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.455 -0.572 . . . . 1.31 109.455 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.406 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . . . -84.59 120.59 26.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.969 0.414 . . . . 1.05 110.647 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.4 m -117.7 146.02 44.02 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.528 -0.76 . . . . 1.17 109.738 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.4 m120 56.6 74.45 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.677 0.611 . . . . 2.17 110.766 -175.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 76.1 t -86.93 110.44 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.634 -0.712 . . . . 1.06 110.991 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.59 148.82 24.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.706 -0.679 . . . . 1.77 110.833 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.421 ' HG2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -79.92 122.58 26.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.197 -0.668 . . . . 2.02 109.197 174.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mm -118.16 137.25 52.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.09 0.471 . . . . 1.05 111.352 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -113.34 143.24 44.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.015 -0.735 . . . . 3.31 109.015 173.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 120.873 0.368 . . . . 3.08 110.993 179.015 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 111.797 -0.521 . . . . 19.3 111.797 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.27 114.46 20.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.753 0.311 . . . . 17.75 110.605 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -126.0 143.57 51.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.975 -0.557 . . . . 17.68 110.387 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.93 165.78 12.01 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.79 -0.719 . . . . 14.41 112.036 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -149.63 135.25 18.5 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.981 -0.377 . . . . 13.69 109.981 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.22 145.02 27.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.323 -0.399 . . . . 11.63 110.069 -178.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.99 -40.45 83.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.141 -0.481 . . . . 8.84 110.502 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.0 m 59.36 26.85 15.8 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.37 -0.832 . . . . 8.01 111.167 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -76.55 -35.04 58.45 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.563 0.696 . . . . 7.63 109.716 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.426 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 6.5 ppt_? -150.43 133.0 15.74 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.164 -0.926 . . . . 7.38 109.564 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.7 110.26 19.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.862 0.363 . . . . 3.34 110.354 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -107.56 -9.98 15.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.065 -0.516 . . . . 3.29 111.188 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.53 10.05 16.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.466 -0.568 . . . . 2.96 109.466 172.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.5 t -53.8 -36.05 62.04 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.336 -0.847 . . . . 2.5 112.522 -171.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.68 50.94 62.24 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.659 -0.781 . . . . 1.9 111.972 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -68.0 156.03 38.22 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.661 -0.496 . . . . 5.69 109.661 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.95 -16.56 1.94 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.321 0.859 . . . . 2.83 113.321 -173.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.9 -18.82 64.17 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.667 0.247 . . . . 2.82 111.667 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.0 t -154.64 132.41 11.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 3.08 110.696 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.1 p -164.83 139.62 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.026 -0.534 . . . . 2.34 110.491 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -135.06 164.76 26.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.988 -0.375 . . . . 2.96 109.988 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.08 21.54 12.93 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.474 0.484 . . . . 1.95 111.842 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t 60.55 70.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.997 -0.547 . . . . 2.27 110.644 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.75 20.96 0.38 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.056 1.342 . . . . 3.4 114.19 176.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.449 HE21 ' HE3' ' A' ' 27' ' ' LYS . 62.9 tp60 -104.52 112.34 25.37 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.667 -0.413 . . . . 1.88 112.008 -174.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HZ3' ' CD ' ' A' ' 72' ' ' GLU . 31.8 mtmt -111.83 135.53 52.32 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.517 -0.549 . . . . 2.59 109.517 172.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HE3' HE21 ' A' ' 25' ' ' GLN . 28.7 mmtp -112.76 144.88 41.55 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.106 -0.702 . . . . 1.84 109.106 172.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.404 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 4.1 mtm180 -121.74 127.59 50.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.051 0.453 . . . . 1.99 110.846 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.67 179.65 9.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.39 -0.823 . . . . 0.96 110.059 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.81 144.05 30.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.547 -0.297 . . . . 0.86 110.566 -178.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.527 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 43.4 t -65.08 115.73 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.827 -0.434 . . . . 1.01 109.827 175.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.73 -48.68 58.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.082 -0.508 . . . . 0.6 110.079 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 m -159.64 160.64 34.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.632 -0.713 . . . . 1.18 109.687 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 mt -138.09 130.79 40.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.426 -0.583 . . . . 1.03 109.426 173.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -129.88 94.73 3.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.648 -0.706 . . . . 2.16 110.242 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.45 -106.04 1.56 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.815 -0.707 . . . . 0.34 112.554 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -100.86 13.64 34.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.521 -0.178 . . . . 2.6 110.521 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -133.18 142.39 48.59 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.201 0.524 . . . . 0.38 111.381 -174.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.455 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -126.48 157.4 20.27 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 111.002 -0.839 . . . . 0.11 111.002 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -130.86 149.3 52.56 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.438 -0.578 . . . . 0.19 109.438 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.527 HD11 ' CD2' ' A' ' 73' ' ' PHE . 5.9 mt -124.38 148.64 47.4 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.812 -0.81 . . . . 1.28 108.812 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.05 72.9 4.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.578 0.704 . . . . 1.77 109.731 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -139.47 98.75 3.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.952 -1.022 . . . . 0.33 109.104 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 50.6 mt-10 -84.82 101.2 12.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.612 0.72 . . . . 1.81 110.356 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 84' ' ' SER . 34.1 m -81.12 -32.0 12.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.911 -1.04 . . . . 1.51 110.622 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 5.5 tp10 -134.09 177.47 7.71 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.77 -1.937 . . . . 2.24 105.77 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.519 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 26.4 t0 -39.78 84.93 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.119 0.968 . . . . 1.55 113.44 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 73.26 8.29 74.47 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.751 -0.54 . . . . 0.77 111.751 174.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 9.0 mmtm -67.53 110.32 3.61 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.831 -0.184 . . . . 3.03 110.686 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -79.53 123.7 27.82 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.12 -0.696 . . . . 1.87 109.12 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 51' ' ' LEU . 1.7 mt -61.06 136.03 57.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.585 -0.279 . . . . 1.05 111.046 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -118.3 160.7 21.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.404 . . . . 0.48 110.54 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.543 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 28.6 p90 -150.38 153.74 36.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.711 -0.677 . . . . 0.2 109.509 173.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -92.34 147.29 23.03 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.621 -0.881 . . . . 0.47 108.621 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.433 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 11.6 tmm? -59.3 -15.57 16.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.997 -0.547 . . . . 2.84 112.175 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 t -64.33 -29.25 70.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.785 0.326 . . . . 1.41 110.189 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -91.27 -3.79 56.55 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.539 -0.3 . . . . 1.96 111.161 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.478 HG22 HD13 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -63.21 152.0 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.944 -0.571 . . . . 1.06 111.053 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.488 ' CG ' HD11 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -67.38 96.93 0.53 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.118 -0.492 . . . . 1.85 111.417 -176.599 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.36 -99.13 0.13 Allowed Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.611 0.57 . . . . 0.62 113.578 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -88.79 140.3 29.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.779 0.799 . . . . 2.3 110.41 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.4 p -75.43 -19.81 59.25 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.102 -0.954 . . . . 1.45 111.219 -174.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.1 t -90.31 7.51 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.673 . . . . 1.95 109.717 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -102.73 -13.92 16.86 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.966 -0.561 . . . . 1.21 110.76 177.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.478 HD13 HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -121.83 123.4 41.68 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.244 -0.65 . . . . 2.19 109.244 -177.439 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -135.4 159.01 73.28 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.661 0.267 . . . . 1.12 111.444 -174.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.527 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 30.7 Cg_endo -64.78 129.86 24.6 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.132 1.888 . . . . 0.28 111.94 175.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.15 -16.1 54.0 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.939 -0.648 . . . . 0.23 111.823 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -79.21 147.23 32.69 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.909 -0.404 . . . . 1.28 109.909 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 5.5 m -76.31 137.48 39.89 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.735 -0.839 . . . . 1.05 108.735 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.42 159.18 28.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 122.205 -0.31 . . . . 1.16 110.504 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.666 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 10.4 pt-20 -115.63 144.97 43.15 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.605 -0.887 . . . . 0.78 108.605 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.527 ' CD2' HD11 ' A' ' 41' ' ' LEU . 17.8 p90 -148.05 178.89 8.16 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.501 -0.772 . . . . 0.15 109.431 -172.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 m -125.65 126.01 44.02 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.817 -0.808 . . . . 1.3 108.817 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG11 ' O ' ' A' ' 75' ' ' VAL . 8.3 p -90.02 98.69 8.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 122.058 0.932 . . . . 1.11 111.165 -171.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.0 p -106.77 131.11 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.57 -0.741 . . . . 1.13 109.662 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.4 m -77.9 132.28 37.86 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.904 -0.589 . . . . 1.27 111.627 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.61 122.36 24.53 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.584 -0.525 . . . . 1.96 109.584 173.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -69.73 -5.11 22.95 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.422 0.527 . . . . 2.24 112.422 -174.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.16 -60.94 1.83 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.998 -0.371 . . . . 4.49 109.998 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.438 ' HB2' ' HG2' ' A' ' 83' ' ' LYS . 18.9 m120 -96.62 -30.48 13.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.815 0.341 . . . . 2.66 111.576 -173.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.44 -3.17 63.4 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.545 -0.836 . . . . 0.88 111.253 -171.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.438 ' HG2' ' HB2' ' A' ' 81' ' ' ASN . 60.1 pttt -79.02 144.72 34.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.322 -0.621 . . . . 2.9 109.322 175.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.439 ' HB2' HG11 ' A' ' 45' ' ' VAL . 9.8 m -89.56 177.56 6.52 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.393 0.616 . . . . 1.49 111.894 -174.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.9 m -149.04 153.74 38.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.98 -1.009 . . . . 1.31 109.322 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.543 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -93.89 121.88 35.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.979 0.419 . . . . 1.05 109.998 177.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.7 t -117.35 157.42 26.18 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.167 -1.049 . . . . 1.17 108.167 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.4 t30 55.77 63.99 1.88 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.793 0.683 . . . . 2.17 109.764 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.4 t -83.77 118.41 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.36 -0.836 . . . . 1.06 111.276 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.666 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 4.2 mm? -112.93 148.56 34.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.261 -0.427 . . . . 1.77 110.943 -178.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -83.49 116.17 22.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.408 0.623 . . . . 2.02 111.216 178.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.452 ' O ' ' HB ' ' A' ' 70' ' ' THR . 48.7 mm -104.95 115.12 46.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.305 -0.861 . . . . 1.05 109.926 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -96.54 107.14 19.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.611 -0.722 . . . . 3.31 110.537 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.554 -0.748 . . . . 3.08 111.172 -176.965 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 5.0 tp60 . . . . . 0 C--O 1.236 0.378 0 CA-C-O 121.263 0.554 . . . . 1.34 111.382 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -79.0 114.04 17.61 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.393 -0.595 . . . . 2.11 109.393 172.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 74.3 mmtt -99.9 156.39 17.16 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.851 -0.613 . . . . 1.27 110.4 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -125.93 128.74 48.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.858 0.361 . . . . 1.65 110.449 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.91 179.45 9.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.514 -0.766 . . . . 0.08 109.477 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.25 143.45 32.95 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.672 -0.492 . . . . 0.14 109.672 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.495 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 41.3 t -63.54 119.4 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.265 0.555 . . . . 0.14 110.074 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.96 -44.68 30.36 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.987 -1.006 . . . . 0.6 109.526 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.0 m -161.17 164.56 30.45 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.613 -0.721 . . . . 1.07 110.251 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.418 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 5.8 mt -141.63 130.38 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.056 0.455 . . . . 0.19 109.987 175.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 64.3 mmtt -125.43 104.05 8.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.479 -0.782 . . . . 1.56 110.469 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.07 -108.52 1.94 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.028 -0.606 . . . . 0.29 112.515 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -100.54 10.58 41.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.455 0.169 . . . . 2.1 110.693 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -128.89 140.63 51.59 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.163 0.506 . . . . 0.32 111.003 -173.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.88 157.36 17.42 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 120.638 -0.791 . . . . 0.11 111.433 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.508 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 77.0 m-85 -132.22 137.58 47.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.161 -0.681 . . . . 0.18 109.161 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.487 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.1 mt -110.13 154.65 23.01 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.714 -0.476 . . . . 0.59 109.714 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -74.76 73.09 2.05 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.587 0.708 . . . . 1.53 109.558 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -148.02 97.57 2.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.832 -1.076 . . . . 0.28 108.678 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 23.9 mp0 -85.65 110.01 18.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.723 -0.671 . . . . 1.81 109.966 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.486 HG11 ' HB2' ' A' ' 84' ' ' SER . 28.8 m -78.73 -36.4 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.85 112.024 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -156.42 123.16 5.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.511 -0.313 . . . . 2.24 110.488 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.2 t70 60.97 12.92 4.19 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.641 0.734 . . . . 1.55 111.966 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.0 21.08 14.43 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.635 -0.793 . . . . 0.67 112.979 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 4.0 mmtm -69.41 110.93 4.96 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.874 -0.417 . . . . 2.5 109.874 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -71.72 129.61 39.11 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.669 -0.493 . . . . 1.32 109.669 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.1 mt -66.66 123.3 19.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.594 -0.276 . . . . 0.19 110.97 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -105.28 158.3 16.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.045 0.45 . . . . 0.39 110.661 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.86 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 32.3 p90 -151.44 155.22 38.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.682 -0.69 . . . . 0.16 109.163 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -97.08 152.04 19.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.994 -0.743 . . . . 0.34 108.994 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.539 ' SD ' HG21 ' A' ' 58' ' ' VAL . 14.2 mmt -64.51 -3.06 2.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.431 0.53 . . . . 2.43 112.431 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.8 t -82.76 -25.31 32.94 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.851 -0.426 . . . . 0.91 109.851 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.84 -6.17 59.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.922 0.391 . . . . 1.96 110.421 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.539 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.0 t -71.6 152.38 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.69 -0.686 . . . . 0.27 112.45 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.78 98.33 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.483 -1.235 . . . . 1.6 112.041 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.87 -84.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.0 -0.545 . . . . 0.58 113.602 172.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -106.68 142.31 36.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.758 0.313 . . . . 2.2 110.179 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.413 HG22 ' HB3' ' A' ' 55' ' ' MET . 82.7 p -67.7 -21.37 65.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.271 0.558 . . . . 0.95 111.503 -177.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.6 t -95.01 2.19 9.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.285 0.564 . . . . 1.39 110.428 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.63 -13.8 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.443 -0.344 . . . . 0.57 111.297 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.659 HD21 HG12 ' A' ' 71' ' ' VAL . 1.1 tm? -110.65 124.69 52.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.976 -0.75 . . . . 1.51 108.976 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -117.92 150.19 46.76 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.559 -0.291 . . . . 0.91 111.121 -172.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.495 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.2 Cg_endo -66.49 135.76 40.49 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.443 2.095 . . . . 0.28 111.933 173.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.53 -2.36 73.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.916 -0.659 . . . . 0.22 112.367 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -95.91 154.7 17.09 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.804 -0.443 . . . . 1.28 109.804 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 m -79.72 136.03 36.67 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.466 -0.568 . . . . 0.17 109.466 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.659 HG12 HD21 ' A' ' 65' ' ' LEU . 20.0 m -136.48 161.3 37.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.432 0.634 . . . . 0.31 110.805 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.45 139.0 49.88 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.837 -1.172 . . . . 0.78 107.837 171.831 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.487 ' CD2' HD13 ' A' ' 41' ' ' LEU . 19.2 p90 -148.53 179.82 7.52 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.824 0.345 . . . . 0.11 110.193 -174.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.8 m -129.85 115.01 16.61 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.088 -0.708 . . . . 0.86 109.088 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.4 p -85.37 101.93 10.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.538 0.685 . . . . 0.36 110.834 -175.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.63 121.58 59.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.757 -0.656 . . . . 0.42 109.87 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.8 m -79.62 128.34 33.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.861 -0.608 . . . . 0.67 111.068 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -68.48 102.32 1.42 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.516 -0.765 . . . . 1.82 109.218 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -64.23 -8.03 11.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.217 0.532 . . . . 1.95 111.413 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -93.73 -39.34 10.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.883 -0.599 . . . . 3.99 111.044 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -114.28 -21.25 10.53 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.554 0.575 . . . . 2.21 112.554 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.7 -20.18 51.66 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.764 -0.731 . . . . 0.69 113.36 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -81.78 174.6 11.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.005 -0.739 . . . . 2.42 109.005 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.486 ' HB2' HG11 ' A' ' 45' ' ' VAL . 19.1 m -128.81 175.68 8.43 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.284 -0.566 . . . . 1.08 110.632 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.2 p -145.91 155.97 43.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.274 -0.421 . . . . 0.87 110.433 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.86 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -93.2 118.31 31.09 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.118 0.485 . . . . 0.17 110.24 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 97.3 m -116.74 144.05 44.91 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.132 -0.692 . . . . 0.68 109.132 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 63.68 69.01 0.56 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.084 -0.71 . . . . 1.82 109.084 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 71.0 t -87.94 116.66 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.406 -0.815 . . . . 0.32 110.722 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.35 149.03 30.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.903 -0.589 . . . . 1.12 110.705 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -77.91 126.42 30.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.139 -0.482 . . . . 1.33 109.891 176.477 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.0 mm . . . . . 0 C--N 1.323 -0.574 0 N-CA-C 110.072 -0.344 . . . . 0.28 110.072 179.121 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 . . . . . 0 C--O 1.234 0.256 0 CA-C-O 121.047 0.451 . . . . 1.34 110.906 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -99.37 115.4 29.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 2.11 110.172 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 28.2 mmtp -99.03 151.35 21.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.893 -0.594 . . . . 1.27 111.859 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.445 ' HD3' ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -115.02 127.15 55.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.73 -0.668 . . . . 1.65 110.264 176.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . . . -157.25 178.94 9.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.269 -0.271 . . . . 0.08 110.269 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.07 148.02 26.73 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.442 -0.345 . . . . 0.14 110.098 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.531 ' HA ' HD23 ' A' ' 41' ' ' LEU . 45.5 t -68.77 122.14 19.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.978 0.418 . . . . 0.14 110.624 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.41 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 22.3 t70 -75.07 -40.79 59.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.313 -0.858 . . . . 0.6 110.053 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 t -171.65 169.41 6.0 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.643 -0.708 . . . . 1.07 109.113 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.429 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 9.2 mt -136.45 126.4 39.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.254 0.55 . . . . 0.19 109.618 175.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 62.6 mmtt -120.16 85.54 2.4 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.325 -0.852 . . . . 1.56 110.361 -175.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.11 -114.55 4.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.746 -0.74 . . . . 0.29 112.549 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.59 12.78 24.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.074 -0.343 . . . . 2.1 110.074 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -132.19 140.11 48.6 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.013 0.435 . . . . 0.32 110.417 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.29 159.61 16.86 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.631 -0.795 . . . . 0.11 111.215 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 77.5 m-85 -131.47 149.54 52.49 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.03 -0.73 . . . . 0.18 109.03 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.571 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.0 mt -124.14 157.6 34.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.15 -0.315 . . . . 0.59 110.15 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -76.78 73.33 3.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.509 0.671 . . . . 1.53 109.554 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.424 ' HB3' HD12 ' A' ' 51' ' ' LEU . 16.7 t80 -148.04 98.79 2.98 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.049 -0.978 . . . . 0.28 108.859 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 43.4 mt-10 -86.95 103.36 15.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.292 -0.413 . . . . 1.81 110.135 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.535 HG21 ' H ' ' A' ' 84' ' ' SER . 27.6 m -80.65 -30.34 12.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.624 0.602 . . . . 0.85 112.624 -173.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 5.2 tp10 -161.31 110.82 1.62 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 110.57 -0.159 . . . . 2.24 110.57 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.8 t0 55.23 37.88 29.57 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.294 0.569 . . . . 1.55 111.735 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.85 20.98 54.7 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.365 -0.921 . . . . 0.67 113.087 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 38.3 mmtm -74.19 110.05 8.17 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.135 -0.691 . . . . 2.5 109.135 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -72.61 126.1 29.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.644 -0.873 . . . . 1.32 108.644 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.5 mt -63.25 128.58 36.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.114 -0.494 . . . . 0.19 110.847 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -112.49 156.72 22.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.345 -0.389 . . . . 0.39 110.302 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.906 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 25.8 p90 -146.48 149.07 32.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.623 -0.717 . . . . 0.16 109.717 174.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -91.74 145.48 24.54 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.555 -0.906 . . . . 0.34 108.555 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.51 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -58.11 -11.95 3.02 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.522 0.564 . . . . 2.43 112.522 -177.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.1 t -67.39 -25.85 66.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.823 0.345 . . . . 0.91 110.454 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -86.6 -13.87 44.46 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.242 -0.435 . . . . 1.96 110.464 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -65.82 148.39 12.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.42 -0.809 . . . . 0.27 112.298 -175.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.16 102.21 0.36 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 114.748 -1.115 . . . . 1.6 111.241 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.58 -91.59 0.26 Allowed Glycine 0 C--O 1.237 0.301 0 CA-C-N 115.952 -0.567 . . . . 0.58 113.61 173.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -101.44 151.31 22.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.648 -0.501 . . . . 2.2 109.648 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.3 p -77.71 -15.36 59.19 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.928 -0.578 . . . . 0.95 111.168 -173.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.74 2.92 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.609 -0.723 . . . . 1.39 110.078 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.48 -24.65 19.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.57 111.335 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.637 HD21 HG12 ' A' ' 71' ' ' VAL . 1.6 tm? -98.42 125.06 43.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.155 -0.683 . . . . 1.51 109.155 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -117.41 152.96 50.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 111.93 0.344 . . . . 0.91 111.93 -171.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.484 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 52.1 Cg_endo -69.65 141.9 46.95 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.991 2.461 . . . . 0.28 111.48 173.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.54 -5.13 82.58 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.776 -0.726 . . . . 0.22 112.031 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -93.93 159.61 15.1 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.401 -0.592 . . . . 1.28 109.401 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.5 m -85.02 132.19 34.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.353 -0.61 . . . . 0.17 109.353 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.637 HG12 HD21 ' A' ' 65' ' ' LEU . 6.3 m -135.3 165.2 31.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.162 0.506 . . . . 0.31 109.984 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -120.32 146.08 46.48 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.364 -0.976 . . . . 0.78 108.364 174.227 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.571 ' CD2' HD13 ' A' ' 41' ' ' LEU . 25.3 p90 -152.57 179.19 8.81 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.682 -0.488 . . . . 0.11 109.682 -174.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.4 m -126.83 123.32 37.06 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.877 -0.786 . . . . 0.86 108.877 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 p -92.69 99.49 9.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.666 0.746 . . . . 0.36 111.642 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.7 p -111.7 123.51 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.567 -0.742 . . . . 0.42 109.994 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 30.2 m -72.88 129.02 37.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.911 0.386 . . . . 0.67 110.933 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -69.37 117.82 11.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 1.82 109.631 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -71.36 -15.72 62.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.156 0.503 . . . . 1.95 110.76 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -94.89 -42.28 8.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.703 -0.681 . . . . 3.99 111.095 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -94.97 -29.09 14.82 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.317 -0.401 . . . . 2.21 111.724 -171.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.52 -24.21 26.69 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.69 112.568 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -95.24 155.85 16.56 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.46 -0.57 . . . . 2.42 109.46 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.535 ' H ' HG21 ' A' ' 45' ' ' VAL . 4.4 m -88.08 175.59 7.67 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.094 0.474 . . . . 1.08 111.289 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -141.32 153.08 44.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.692 -0.685 . . . . 0.87 109.376 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.906 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -90.73 119.62 31.11 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.112 0.482 . . . . 0.17 110.044 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.6 m -117.01 149.32 40.46 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.321 -0.854 . . . . 0.68 109.921 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 t30 56.87 69.26 0.76 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 123.593 0.558 . . . . 1.82 110.62 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 74.5 t -85.88 122.75 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 0.32 111.708 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.94 147.57 35.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.517 -0.765 . . . . 1.12 110.209 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.455 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -79.4 117.0 19.98 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.942 -0.762 . . . . 1.33 108.942 175.166 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 72' ' ' GLU . 45.7 mm . . . . . 0 C--N 1.315 -0.919 0 CA-C-O 121.116 0.484 . . . . 0.28 110.216 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.694 0.283 . . . . 1.34 111.087 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -118.37 136.89 53.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.28 0.562 . . . . 2.11 111.308 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -112.75 150.71 31.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.232 -0.894 . . . . 1.27 110.561 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -120.46 127.17 51.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.907 0.385 . . . . 1.65 110.408 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.97 179.87 8.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.802 -0.635 . . . . 0.08 109.529 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 144.52 30.64 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 110.194 -0.299 . . . . 0.14 110.194 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.426 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 47.5 t -66.32 114.0 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.2 -0.296 . . . . 0.14 110.2 176.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.451 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 7.1 t70 -66.95 -50.21 63.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.955 -0.566 . . . . 0.6 109.861 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.9 m -159.79 163.81 34.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.468 -0.787 . . . . 1.07 110.016 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.445 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 7.7 mt -137.47 126.1 33.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.456 -0.572 . . . . 0.19 109.456 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -118.77 90.45 3.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.256 -0.884 . . . . 1.56 109.862 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.37 -112.1 4.14 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.721 -0.752 . . . . 0.29 112.476 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -96.84 11.69 34.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 2.1 110.246 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -129.71 142.04 50.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.143 0.497 . . . . 0.32 110.751 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.92 155.95 17.27 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.379 -0.828 . . . . 0.11 111.378 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 70.7 m-85 -129.82 139.75 51.17 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.826 -0.805 . . . . 0.18 108.826 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.541 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.4 mt -111.58 156.7 21.37 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.784 -0.45 . . . . 0.59 109.784 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -74.62 73.25 1.99 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.966 -0.753 . . . . 1.53 108.966 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -149.57 98.43 2.76 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.624 -0.717 . . . . 0.28 109.289 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 23.0 mp0 -75.73 100.71 4.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 1.81 109.712 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.648 HG11 ' HB3' ' A' ' 84' ' ' SER . 35.3 m -74.39 -30.39 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.713 -0.676 . . . . 0.85 111.519 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -156.73 109.79 2.59 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 116.092 -0.504 . . . . 2.24 110.354 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t0 54.52 29.6 11.55 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.185 0.517 . . . . 1.55 112.286 171.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.11 1.49 44.97 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.161 -1.018 . . . . 0.67 113.151 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 4.0 mmtp -64.64 111.77 2.89 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.862 0.331 . . . . 2.5 110.61 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -65.78 138.89 58.23 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.271 0.357 . . . . 1.32 110.181 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.594 ' HG ' ' CG1' ' A' ' 45' ' ' VAL . 1.3 mt -74.68 125.22 28.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.45 -0.341 . . . . 0.19 110.348 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -106.87 157.22 17.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.39 110.064 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.906 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 28.1 p90 -151.05 157.06 42.33 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.596 -0.729 . . . . 0.16 109.394 174.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -98.92 151.01 21.34 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.111 -0.7 . . . . 0.34 109.111 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.441 ' SD ' HG21 ' A' ' 58' ' ' VAL . 9.4 mmt -62.39 -6.94 3.69 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.797 0.665 . . . . 2.43 112.797 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -81.23 -25.28 36.77 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.241 -0.184 . . . . 0.91 111.068 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -81.77 -15.69 53.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.032 0.444 . . . . 1.96 110.157 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.441 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.8 t -62.56 151.84 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.212 -0.904 . . . . 0.27 112.188 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.506 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -64.63 88.96 0.06 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.005 -0.998 . . . . 1.6 112.38 -173.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.37 -66.47 2.28 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.974 -0.557 . . . . 0.58 113.337 170.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -122.31 143.7 49.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.296 0.57 . . . . 2.2 110.264 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.7 p -72.3 -26.64 62.03 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.119 -0.946 . . . . 0.95 110.926 -174.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -95.67 22.99 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.753 0.787 . . . . 1.39 109.633 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.9 -15.68 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.598 -0.728 . . . . 0.57 109.765 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.562 HD21 HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -119.49 124.74 47.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.889 -1.05 . . . . 1.51 109.603 -178.028 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -122.99 153.63 64.21 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.682 -0.235 . . . . 0.91 111.235 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.426 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 41.4 Cg_endo -68.47 129.06 18.27 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.523 2.149 . . . . 0.28 111.972 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.58 -14.04 56.51 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.918 -0.583 . . . . 0.22 111.84 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 1.3 m-20 -82.16 154.14 25.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 1.28 110.323 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m -78.71 141.88 37.54 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.298 -0.63 . . . . 0.17 109.298 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.562 HG11 HD21 ' A' ' 65' ' ' LEU . 30.6 m -139.87 161.41 26.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.654 0.74 . . . . 0.31 111.761 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.33 137.51 51.71 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.447 -1.251 . . . . 0.78 108.096 172.582 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.541 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.8 p90 -149.48 178.55 8.71 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.29 -0.633 . . . . 0.11 109.29 -174.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 m -124.29 132.33 53.56 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.09 -0.707 . . . . 0.86 109.09 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.02 99.14 8.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.504 0.668 . . . . 0.36 110.978 -175.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.46 116.95 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.47 0.653 . . . . 0.42 110.719 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.9 m -69.98 125.96 28.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.703 -0.681 . . . . 0.67 110.483 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -65.96 114.44 5.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 1.82 109.326 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -58.59 -31.24 67.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.41 -0.359 . . . . 1.95 111.357 -175.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.42 -36.79 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.341 -0.391 . . . . 3.99 111.42 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -92.83 -23.36 18.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.054 0.39 . . . . 2.21 112.054 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.58 -24.57 7.32 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.028 -0.606 . . . . 0.69 113.484 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -88.44 149.94 23.41 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.812 -0.44 . . . . 2.42 109.812 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.648 ' HB3' HG11 ' A' ' 45' ' ' VAL . 42.7 t -85.32 177.59 7.77 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.794 0.331 . . . . 1.08 110.709 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.4 m -150.74 149.96 30.43 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.286 -0.635 . . . . 0.87 109.286 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.906 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -91.94 121.51 33.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.025 0.441 . . . . 0.17 110.614 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.0 m -117.49 144.39 45.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.028 -0.533 . . . . 0.68 109.909 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 57.71 73.11 0.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.743 0.652 . . . . 1.82 110.31 -175.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 94.0 t -92.05 105.01 16.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.568 -0.742 . . . . 0.32 110.308 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 11.1 mp -105.89 149.08 26.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.594 -0.73 . . . . 1.12 110.735 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.41 ' HD3' ' HB3' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -86.18 103.25 14.64 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.907 -0.588 . . . . 1.33 110.795 -174.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.6 mm . . . . . 0 C--N 1.32 -0.702 0 CA-C-N 115.585 -0.734 . . . . 0.28 110.235 -179.614 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 120.993 0.425 . . . . 1.34 110.775 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -109.61 123.72 49.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.02 -0.537 . . . . 2.11 110.558 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -109.08 153.02 24.26 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.625 -0.716 . . . . 1.27 110.687 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -122.85 128.34 50.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.738 0.304 . . . . 1.65 110.303 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.73 179.7 8.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.641 -0.709 . . . . 0.08 109.095 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.74 145.38 29.21 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.761 -0.459 . . . . 0.14 109.761 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.519 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 41.9 t -64.85 114.37 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.159 0.504 . . . . 0.14 109.977 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.475 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 9.9 t70 -67.86 -45.28 75.02 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.858 -1.065 . . . . 0.6 109.747 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.7 m -169.05 166.5 10.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.514 -0.766 . . . . 1.07 109.868 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.415 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 8.3 mt -137.96 128.48 36.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.944 -0.391 . . . . 0.19 109.944 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -115.22 88.02 2.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.686 -0.688 . . . . 1.56 109.856 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.03 -106.99 1.88 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.733 -0.746 . . . . 0.29 112.816 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -96.35 5.34 51.12 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.58 0.228 . . . . 2.1 111.178 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -125.75 140.38 52.74 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.002 0.43 . . . . 0.32 110.368 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.541 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.17 158.28 16.86 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.51 -0.852 . . . . 0.11 111.323 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -132.08 141.12 49.08 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.867 -0.79 . . . . 0.18 108.867 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.551 HD13 ' CD2' ' A' ' 73' ' ' PHE . 4.8 mt -115.09 150.75 35.47 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.427 -0.953 . . . . 0.59 108.427 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -75.21 72.97 2.32 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.272 0.558 . . . . 1.53 109.64 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -142.61 98.07 3.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.156 -0.929 . . . . 0.28 108.57 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 15.4 mp0 -90.23 107.62 19.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.039 -0.528 . . . . 1.81 109.791 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.451 HG11 ' HB2' ' A' ' 84' ' ' SER . 29.2 m -74.62 -32.69 30.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.622 -0.717 . . . . 0.85 111.851 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -156.45 114.06 3.23 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.532 -0.304 . . . . 2.24 110.572 -174.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 51.8 34.06 12.46 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.387 0.884 . . . . 1.55 113.387 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 44' ' ' GLU . . . 89.97 20.34 43.43 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.233 -0.984 . . . . 0.67 112.725 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -79.98 109.16 14.15 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.033 -0.728 . . . . 2.5 109.033 176.654 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -71.63 138.81 48.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.636 -0.711 . . . . 1.32 110.726 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.497 HD23 ' HA ' ' A' ' 51' ' ' LEU . 4.5 mt -74.89 122.65 23.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.477 -0.329 . . . . 0.19 111.222 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -107.37 161.29 14.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.427 -0.351 . . . . 0.39 110.07 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.735 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 17.1 p90 -152.69 158.77 42.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.132 -0.485 . . . . 0.16 109.741 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.403 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . 9.5 t-160 -99.97 156.05 17.36 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.718 -0.845 . . . . 0.34 108.718 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.448 ' SD ' HG21 ' A' ' 58' ' ' VAL . 13.2 mmt -65.03 3.18 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.257 0.465 . . . . 2.43 112.257 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.3 t -87.39 -28.01 22.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.91 110.127 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' A' ' 54' ' ' HIS . 9.9 mp0 -84.53 -11.01 56.91 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.236 -0.438 . . . . 1.96 110.188 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.473 HG22 HD22 ' A' ' 65' ' ' LEU . 2.4 t -68.38 150.3 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.463 -0.789 . . . . 0.27 111.649 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -58.23 88.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.045 -0.979 . . . . 1.6 111.736 -177.218 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.11 -91.2 0.03 OUTLIER Glycine 0 CA--C 1.52 0.403 0 O-C-N 123.501 0.501 . . . . 0.58 113.199 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -79.27 129.93 34.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.482 0.658 . . . . 2.2 110.587 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.5 p -80.44 -10.3 59.75 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.062 -0.972 . . . . 0.95 110.963 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.54 -11.12 10.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.529 -0.76 . . . . 1.39 110.234 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.5 -19.11 31.69 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.939 0.4 . . . . 0.57 111.693 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -105.91 124.29 49.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.595 -0.52 . . . . 1.51 109.595 -177.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -123.35 156.21 64.06 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.583 0.23 . . . . 0.91 111.058 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.472 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 47.4 Cg_endo -69.23 129.09 17.51 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.425 2.084 . . . . 0.28 111.477 174.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.519 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 102.5 -13.02 56.85 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.674 -0.775 . . . . 0.22 112.114 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -82.02 152.57 26.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.275 -0.269 . . . . 1.28 110.275 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -76.5 137.81 39.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.051 -0.722 . . . . 0.17 109.051 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -139.13 163.71 26.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.902 0.382 . . . . 0.31 111.216 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.555 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 3.4 pt-20 -114.02 150.56 33.72 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.294 -1.372 . . . . 0.78 107.294 170.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.551 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.3 p90 -156.97 179.85 8.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.192 -0.67 . . . . 0.11 109.192 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.7 m -129.88 113.89 15.21 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.828 -0.805 . . . . 0.86 108.828 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.1 p -86.31 97.76 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 122.019 0.914 . . . . 0.36 110.488 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -105.68 117.13 50.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.174 -0.921 . . . . 0.42 109.315 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.8 m -73.65 126.53 30.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.333 0.587 . . . . 0.67 110.786 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -69.78 113.76 7.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.0 -1.0 . . . . 1.82 110.001 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -65.52 -16.8 64.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.314 0.578 . . . . 1.95 110.402 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -91.07 -38.19 12.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.58 -0.736 . . . . 3.99 111.584 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -103.44 -26.61 12.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.119 0.414 . . . . 2.21 112.119 -171.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.82 -23.21 24.43 Favored Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 121.053 -0.594 . . . . 0.69 112.013 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 49' ' ' LYS . 15.1 pttp -91.28 174.74 7.23 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.27 -0.641 . . . . 2.42 109.27 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.451 ' HB2' HG11 ' A' ' 45' ' ' VAL . 19.0 m -114.28 179.92 3.82 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.741 -0.384 . . . . 1.08 110.643 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.8 m -147.19 147.01 30.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.7 -0.682 . . . . 0.87 109.338 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -86.33 117.38 25.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.171 0.51 . . . . 0.17 110.53 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.4 m -116.25 150.04 38.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.579 -0.737 . . . . 0.68 109.407 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 61.91 59.17 1.77 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.16 -0.681 . . . . 1.82 109.16 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 90.1 t -85.05 101.49 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.854 -0.612 . . . . 0.32 110.147 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.555 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 3.2 mp -106.21 145.99 30.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.242 0.544 . . . . 1.12 111.517 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.84 117.46 17.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.548 -0.751 . . . . 1.33 110.807 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mm . . . . . 0 C--N 1.317 -0.817 0 CA-C-N 115.719 -0.673 . . . . 0.28 111.114 -175.907 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.5 tp60 . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 120.586 0.231 . . . . 1.34 110.664 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.34 112.59 20.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.015 0.436 . . . . 2.11 110.426 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -96.05 160.64 14.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.592 . . . . 1.27 111.041 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.54 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 71.6 mtm-85 -132.31 127.86 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.033 0.444 . . . . 1.65 111.348 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.72 179.92 8.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.593 -0.73 . . . . 0.08 109.359 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.44 145.07 30.55 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 110.01 -0.367 . . . . 0.14 110.01 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.554 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 47.5 t -65.79 120.41 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 120.923 0.392 . . . . 0.14 109.958 176.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.56 -44.14 68.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.308 -0.86 . . . . 0.6 109.574 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.2 m -173.48 169.25 4.41 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.438 -0.801 . . . . 1.07 109.87 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.7 mt -136.69 135.2 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.945 0.402 . . . . 0.19 110.2 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -123.91 97.38 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.555 -0.748 . . . . 1.56 110.17 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.7 -107.1 1.78 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.819 -0.705 . . . . 0.29 112.405 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -98.67 4.07 47.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.568 0.223 . . . . 2.1 110.771 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -123.71 141.14 52.3 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 120.468 -0.493 . . . . 0.32 111.16 -171.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.41 156.08 18.39 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 120.579 -0.82 . . . . 0.11 111.319 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 74.3 m-85 -130.16 141.47 50.67 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.179 -0.675 . . . . 0.18 109.179 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.518 HD13 ' CD2' ' A' ' 73' ' ' PHE . 5.5 mt -112.09 156.17 22.67 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.739 -0.467 . . . . 0.59 109.739 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -78.26 72.83 4.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.566 0.698 . . . . 1.53 109.677 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.467 ' HB3' HD12 ' A' ' 51' ' ' LEU . 25.2 t80 -142.59 98.57 3.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.797 -1.092 . . . . 0.28 108.186 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 41.8 mt-10 -93.16 104.34 16.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.35 0.595 . . . . 1.81 110.928 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.2 m -72.74 -34.13 46.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.407 -0.815 . . . . 0.85 111.529 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 5.6 tt0 -155.05 118.34 4.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.631 -0.259 . . . . 2.24 110.756 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.9 t70 56.11 29.48 14.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.524 0.678 . . . . 1.55 112.162 167.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.416 ' HA2' ' CD ' ' A' ' 44' ' ' GLU . . . 88.5 24.5 33.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.149 -1.024 . . . . 0.67 112.873 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 12.5 mmtm -71.71 109.81 5.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.917 -0.771 . . . . 2.5 108.917 172.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -77.97 121.53 24.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.24 -0.436 . . . . 1.32 109.97 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.467 HD12 ' HB3' ' A' ' 43' ' ' PHE . 2.5 mt -58.83 123.93 18.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.945 -0.571 . . . . 0.19 110.912 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -106.12 157.46 17.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.93 0.395 . . . . 0.39 110.701 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.936 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 35.7 p90 -151.2 153.79 35.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.718 -0.674 . . . . 0.16 109.277 173.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -95.3 150.66 20.01 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.441 -0.948 . . . . 0.34 108.441 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.7 mtt -64.66 2.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.317 0.488 . . . . 2.43 112.317 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 t -83.71 -27.09 29.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.897 -0.408 . . . . 0.91 109.897 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.32 -8.03 58.69 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.979 0.419 . . . . 1.96 110.203 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 65' ' ' LEU . 2.1 t -65.63 152.21 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.354 -0.839 . . . . 0.27 112.709 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 12.9 tm0? -66.62 95.15 0.32 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.166 -0.924 . . . . 1.6 112.299 -175.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.87 -81.43 0.54 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.939 -0.573 . . . . 0.58 113.461 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -107.7 148.2 29.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.896 0.379 . . . . 2.2 110.294 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.8 p -67.48 -24.77 65.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.869 -0.605 . . . . 0.95 110.832 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.5 t -93.18 3.42 8.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.787 -0.642 . . . . 1.39 110.637 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -87.79 -24.07 23.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.018 0.437 . . . . 0.57 110.709 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.711 HD22 ' HG2' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -105.67 124.74 50.05 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.842 -0.799 . . . . 1.51 108.842 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -119.99 149.78 49.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.668 -0.242 . . . . 0.91 110.892 -173.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.425 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 36.9 Cg_endo -67.34 122.0 9.2 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.33 2.02 . . . . 0.28 111.358 172.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.554 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 102.58 -11.42 56.5 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.779 -0.724 . . . . 0.22 112.203 -176.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.5 155.28 22.24 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.912 -0.403 . . . . 1.28 109.912 175.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.4 m -78.77 141.72 37.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.218 -0.66 . . . . 0.17 109.218 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.665 HG11 HD11 ' A' ' 65' ' ' LEU . 6.2 m -136.92 165.7 27.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.842 0.83 . . . . 0.31 111.251 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -121.51 144.05 48.92 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.216 -1.356 . . . . 0.78 107.988 171.064 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.518 ' CD2' HD13 ' A' ' 41' ' ' LEU . 23.0 p90 -154.04 178.99 9.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.868 -0.419 . . . . 0.11 109.868 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.1 m -127.43 118.15 23.51 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.883 -0.784 . . . . 0.86 108.883 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.3 p -82.95 98.97 5.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 122.072 0.939 . . . . 0.36 110.777 -175.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.9 122.86 64.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.152 -0.931 . . . . 0.42 109.863 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.4 m -76.53 130.34 37.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.987 -0.552 . . . . 0.67 111.022 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -73.98 106.55 5.72 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.994 -0.743 . . . . 1.82 108.994 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -64.65 -15.39 61.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.639 0.256 . . . . 1.95 111.681 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.547 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 4.3 tpm_? -90.83 -43.84 9.79 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.675 0.25 . . . . 3.99 111.675 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.488 ' OD1' ' HG2' ' A' ' 83' ' ' LYS . 22.6 t-20 -95.28 -31.97 13.21 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.803 -0.359 . . . . 2.21 111.18 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.42 -21.01 40.59 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.126 -0.559 . . . . 0.69 113.014 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.488 ' HG2' ' OD1' ' A' ' 81' ' ' ASN . 58.7 pttt -91.32 171.16 9.41 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 109.455 -0.572 . . . . 2.42 109.455 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.7 m -108.93 176.16 5.2 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.606 -0.438 . . . . 1.08 111.396 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.1 p -145.83 154.78 42.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.621 . . . . 0.87 109.881 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.936 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -93.27 117.46 30.1 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.273 0.558 . . . . 0.17 110.417 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.4 m -117.26 145.18 44.12 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.741 -0.663 . . . . 0.68 109.602 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 58.2 t30 62.13 71.33 0.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.427 0.632 . . . . 1.82 109.777 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 80.2 t -89.8 121.81 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.077 -0.965 . . . . 0.32 111.223 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.513 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 4.3 mm? -112.26 148.37 34.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.79 -0.641 . . . . 1.12 109.916 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.711 ' HG2' HD22 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -87.51 118.18 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.155 -0.683 . . . . 1.33 109.155 177.396 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.0 mm . . . . . 0 C--N 1.313 -1.006 0 CA-C-N 115.275 -0.875 . . . . 0.28 110.781 -174.212 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 120.891 0.376 . . . . 1.34 110.506 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -104.54 122.66 46.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.126 0.488 . . . . 2.11 110.312 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 72.0 mmtt -100.43 144.8 29.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.652 -0.704 . . . . 1.27 110.78 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.522 ' HE ' ' HB2' ' A' ' 72' ' ' GLU . 9.5 mmt85 -112.77 128.37 56.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.204 -0.453 . . . . 1.65 110.056 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . . . -159.04 179.98 8.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.84 -0.43 . . . . 0.08 109.84 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.76 147.4 28.64 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.289 -0.263 . . . . 0.14 110.289 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.458 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 38.5 t -66.42 113.83 3.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.199 0.523 . . . . 0.14 109.824 174.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.41 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 20.7 t70 -72.5 -44.36 62.35 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.053 -0.976 . . . . 0.6 109.615 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.3 m -164.28 166.86 20.52 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.805 -0.634 . . . . 1.07 110.562 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.447 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 5.3 mt -139.76 134.52 38.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.168 0.508 . . . . 0.19 109.942 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -127.53 91.88 3.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.423 -0.808 . . . . 1.56 110.313 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.51 -106.66 1.81 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.721 -0.752 . . . . 0.29 112.786 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -98.27 6.43 47.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.611 0.243 . . . . 2.1 110.363 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.47 140.85 51.61 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.125 0.488 . . . . 0.32 110.72 -173.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.519 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.67 158.73 15.56 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.313 -0.858 . . . . 0.11 111.148 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 80.7 m-85 -131.86 131.41 42.77 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.79 -0.819 . . . . 0.18 108.79 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.554 HD22 HG21 ' A' ' 71' ' ' VAL . 9.6 mt -103.93 153.49 20.74 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.573 -0.529 . . . . 0.59 109.573 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -76.32 73.4 3.1 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.995 -0.743 . . . . 1.53 108.995 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.423 ' HB3' HD12 ' A' ' 51' ' ' LEU . 28.0 t80 -150.1 98.68 2.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.735 -1.121 . . . . 0.28 109.091 -178.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.503 ' HG2' ' HA2' ' A' ' 48' ' ' GLY . 3.3 mp0 -82.12 100.75 9.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.452 -0.795 . . . . 1.81 109.978 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.631 HG11 ' HB3' ' A' ' 84' ' ' SER . 7.4 m -71.36 -39.37 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.422 -0.808 . . . . 0.85 111.978 -176.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' H ' ' HB2' ' A' ' 49' ' ' LYS . 5.9 tp10 -140.44 101.57 4.14 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.881 0.372 . . . . 2.24 111.0 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 t70 58.92 20.17 7.84 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.565 -0.743 . . . . 1.55 112.927 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.503 ' HA2' ' HG2' ' A' ' 44' ' ' GLU . . . 111.43 11.73 16.89 Favored Glycine 0 C--N 1.315 -0.589 0 C-N-CA 119.976 -1.107 . . . . 0.67 112.737 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.505 ' HB2' ' H ' ' A' ' 46' ' ' GLU . 23.3 mmtm -69.72 110.63 5.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.344 -0.613 . . . . 2.5 109.344 173.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -70.55 132.19 45.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.878 -0.416 . . . . 1.32 109.878 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 3.0 mt -71.85 122.02 20.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.423 -0.353 . . . . 0.19 111.098 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -105.07 157.56 17.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.286 -0.416 . . . . 0.39 109.955 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.875 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 26.6 p90 -151.44 153.35 34.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.903 -0.59 . . . . 0.16 109.518 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.401 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . 16.6 t-80 -96.58 152.22 18.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.962 -0.755 . . . . 0.34 108.962 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.571 ' SD ' HG21 ' A' ' 58' ' ' VAL . 15.5 mmt -65.14 -1.66 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.417 0.525 . . . . 2.43 112.417 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.8 t -84.92 -19.47 32.17 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.08 -0.387 . . . . 0.91 110.209 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.401 ' OE2' ' HB3' ' A' ' 54' ' ' HIS . 1.8 mp0 -90.03 -6.03 55.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.313 -0.403 . . . . 1.96 110.326 176.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.571 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -71.42 150.11 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.786 0.661 . . . . 0.27 112.786 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.42 93.5 0.07 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.87 -1.059 . . . . 1.6 112.128 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.99 -66.38 3.41 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 121.201 -0.523 . . . . 0.58 113.969 169.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -131.27 141.86 50.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.19 0.519 . . . . 2.2 110.018 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.8 p -70.87 -23.58 62.34 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.129 -0.941 . . . . 0.95 110.89 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.6 t -93.47 12.07 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 115.252 -0.885 . . . . 1.39 110.075 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.75 -38.0 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.484 -0.326 . . . . 0.57 111.226 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.661 HD21 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -90.17 124.99 35.3 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.158 -0.682 . . . . 1.51 109.158 -178.412 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -132.15 160.88 66.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.415 -0.357 . . . . 0.91 111.211 -173.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.458 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 27.0 Cg_endo -62.38 140.81 84.49 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.592 2.195 . . . . 0.28 111.887 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.26 -14.36 63.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.075 -0.583 . . . . 0.22 112.468 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.408 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 2.7 m-20 -79.0 148.69 32.44 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.981 -0.378 . . . . 1.28 109.981 174.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 5.5 m -81.67 140.27 34.45 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.821 -0.807 . . . . 0.17 108.821 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.661 HG12 HD21 ' A' ' 65' ' ' LEU . 34.4 m -135.5 157.24 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.962 0.887 . . . . 0.31 111.351 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.522 ' HB2' ' HE ' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -114.74 132.25 56.5 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.856 -1.52 . . . . 0.78 107.688 171.597 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.501 ' CD2' HD13 ' A' ' 41' ' ' LEU . 20.1 p90 -143.25 179.54 7.01 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.639 -0.504 . . . . 0.11 109.639 -175.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 m -127.1 121.46 31.52 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.957 -0.757 . . . . 0.86 108.957 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 p -81.22 98.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.701 0.762 . . . . 0.36 110.593 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.55 120.53 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.717 -0.674 . . . . 0.42 110.45 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.7 m -68.78 133.0 47.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.736 -0.666 . . . . 0.67 111.279 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -71.05 105.23 3.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.736 -0.839 . . . . 1.82 108.736 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -63.93 -13.25 44.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.287 -0.415 . . . . 1.95 112.046 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -96.0 -36.8 10.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.472 -0.331 . . . . 3.99 111.563 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -107.38 -31.41 8.19 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.363 0.505 . . . . 2.21 112.363 -169.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.91 -21.24 38.8 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.236 -0.983 . . . . 0.69 113.663 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -85.33 175.46 8.89 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.287 -0.635 . . . . 2.42 109.287 177.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.631 ' HB3' HG11 ' A' ' 45' ' ' VAL . 19.6 t -117.43 -178.15 3.39 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.587 -0.445 . . . . 1.08 110.981 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.0 p -156.79 152.99 27.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.908 -0.587 . . . . 0.87 109.942 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.875 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -86.73 118.4 26.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.939 0.4 . . . . 0.17 110.627 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 33.9 m -116.74 140.86 48.94 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.269 -0.423 . . . . 0.68 109.916 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 63.39 72.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.622 0.725 . . . . 1.82 109.237 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 54.5 t -87.98 116.8 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.803 -1.09 . . . . 0.32 110.505 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 4.1 mm? -108.47 148.91 29.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.03 -0.532 . . . . 1.12 110.523 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.505 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -81.56 125.4 30.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.267 -0.642 . . . . 1.33 109.267 173.343 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.465 ' O ' ' HB ' ' A' ' 70' ' ' THR . 40.1 mm . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 116.12 -0.491 . . . . 0.28 111.037 -175.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.491 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 5.5 tp60 . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.97 0.415 . . . . 1.34 110.99 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -96.24 126.14 41.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.691 -0.485 . . . . 2.11 109.691 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 12.9 mmtm -113.3 145.5 40.94 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.775 -0.648 . . . . 1.27 110.28 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -116.89 132.49 56.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.94 0.4 . . . . 1.65 110.696 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.73 179.84 8.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.802 -0.636 . . . . 0.08 109.787 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.8 144.15 31.87 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.206 -0.452 . . . . 0.14 110.023 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.487 ' HA ' HD23 ' A' ' 41' ' ' LEU . 61.3 t -67.2 116.34 6.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.133 0.492 . . . . 0.14 110.463 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.434 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 10.6 t70 -67.69 -51.79 45.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.08 -0.963 . . . . 0.6 109.636 177.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.7 m -159.41 166.76 30.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.893 -0.594 . . . . 1.07 110.564 -175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.432 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 6.0 mt -142.55 132.39 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.876 -0.602 . . . . 0.19 110.07 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -126.76 93.84 3.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.623 -0.717 . . . . 1.56 110.641 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.85 -106.43 1.64 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.73 -0.748 . . . . 0.29 112.393 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -99.02 7.65 45.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.633 0.254 . . . . 2.1 110.687 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -126.79 143.34 51.28 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.279 0.562 . . . . 0.32 111.469 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.18 161.95 21.97 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.713 -0.756 . . . . 0.11 111.52 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 70.7 m-85 -136.96 143.35 42.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.174 -0.676 . . . . 0.18 109.174 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.5 mt -117.81 156.53 28.19 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.335 -0.246 . . . . 0.59 110.335 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -74.85 72.81 2.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.35 0.595 . . . . 1.53 109.729 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -146.53 100.79 3.4 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.107 -0.951 . . . . 0.28 109.284 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -81.56 106.03 13.19 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.271 -0.877 . . . . 1.81 110.062 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.1 t -71.01 -66.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.522 -0.763 . . . . 0.85 111.194 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.66 ' H ' ' HB2' ' A' ' 49' ' ' LYS . 1.0 OUTLIER -133.71 116.29 15.6 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.081 -0.963 . . . . 2.24 109.49 -178.213 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 t70 64.18 19.17 11.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.466 0.651 . . . . 1.55 111.637 171.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.35 21.4 13.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.557 -0.83 . . . . 0.67 112.841 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.66 ' HB2' ' H ' ' A' ' 46' ' ' GLU . 27.6 mmtm -65.09 109.97 2.35 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.443 -0.577 . . . . 2.5 109.443 175.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -72.3 118.62 15.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.098 -0.705 . . . . 1.32 109.098 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.1 mt -60.38 125.2 22.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.417 -0.356 . . . . 0.19 111.506 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -106.44 157.29 17.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.138 -0.483 . . . . 0.39 109.916 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.782 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 27.0 p90 -148.86 154.66 39.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.68 -0.691 . . . . 0.16 109.178 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -98.32 151.87 20.05 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.619 -0.882 . . . . 0.34 108.619 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.594 ' HB3' HG22 ' A' ' 62' ' ' THR . 14.3 mmt -61.03 -12.44 11.71 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.37 0.507 . . . . 2.43 112.37 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.9 m -72.48 -25.39 61.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.192 -0.318 . . . . 0.91 110.82 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.45 -13.74 51.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 1.96 110.71 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.576 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.0 t -64.04 152.31 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 112.861 0.689 . . . . 0.27 112.861 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -62.77 95.79 0.08 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.948 -1.024 . . . . 1.6 112.173 -176.422 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.47 -81.62 0.6 Allowed Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.58 113.288 172.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -110.92 143.6 41.29 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.677 -0.49 . . . . 2.2 109.677 -177.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 ' HB3' ' A' ' 55' ' ' MET . 66.6 p -57.9 -42.69 85.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.127 0.489 . . . . 0.95 111.873 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 63' ' ' VAL . 2.6 m -78.94 4.7 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.952 -0.567 . . . . 1.39 112.477 -177.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.5 -9.78 40.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.69 0.281 . . . . 0.57 111.21 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.732 HD21 HG12 ' A' ' 71' ' ' VAL . 1.6 tm? -115.9 125.46 52.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.915 -0.772 . . . . 1.51 108.915 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 45.4 m-70 -120.33 149.78 50.35 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-O 120.579 0.228 . . . . 0.91 111.065 -171.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.461 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 37.0 Cg_endo -66.04 139.52 56.4 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.655 2.237 . . . . 0.28 111.881 174.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.67 -15.48 61.46 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.921 -0.657 . . . . 0.22 111.999 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -82.7 149.75 27.13 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.39 -0.226 . . . . 1.28 110.39 177.334 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.1 m -76.22 137.85 40.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.199 -0.667 . . . . 0.17 109.199 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.732 HG12 HD21 ' A' ' 65' ' ' LEU . 16.1 m -136.07 157.51 38.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.525 0.678 . . . . 0.31 109.98 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 132.07 56.59 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.203 -1.036 . . . . 0.78 108.203 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.514 ' CD2' HD13 ' A' ' 41' ' ' LEU . 36.7 p90 -141.93 179.15 7.04 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.855 -0.611 . . . . 0.11 109.889 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.0 m -128.63 119.69 25.19 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.917 -0.772 . . . . 0.86 108.917 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 75' ' ' VAL . 8.5 p -91.4 108.38 19.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.767 0.794 . . . . 0.36 111.269 -172.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 84' ' ' SER . 6.8 p -116.0 124.42 72.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.533 -0.758 . . . . 0.42 110.061 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.2 m -83.35 127.03 33.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.173 0.511 . . . . 0.67 110.611 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.595 ' CB ' ' HB3' ' A' ' 81' ' ' ASN . 9.2 m120 -70.45 121.29 17.49 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.518 -0.764 . . . . 1.82 109.765 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -73.78 -21.46 60.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.942 0.401 . . . . 1.95 111.222 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -96.09 -33.67 12.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.023 0.439 . . . . 3.99 110.979 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.595 ' HB3' ' CB ' ' A' ' 78' ' ' ASN . 60.4 t30 -97.05 -18.23 19.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.331 0.586 . . . . 2.21 110.788 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.99 -25.96 2.96 Favored Glycine 0 C--O 1.229 -0.175 0 CA-C-N 115.525 -0.761 . . . . 0.69 113.919 174.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.492 ' HE2' HD21 ' A' ' 81' ' ' ASN . 18.5 pttm -99.62 168.47 9.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.22 0.51 . . . . 2.42 111.358 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 69.5 m -102.34 175.45 5.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.561 -0.745 . . . . 1.08 111.64 -175.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -143.69 156.39 44.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.566 -0.743 . . . . 0.87 109.157 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.782 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -99.47 118.59 36.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 110.029 -0.36 . . . . 0.17 110.029 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.2 m -116.56 148.33 40.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.437 -0.347 . . . . 0.68 110.664 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.2 m120 62.06 52.09 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.646 0.591 . . . . 1.82 109.881 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.468 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 77.2 t -72.89 100.62 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.473 -0.785 . . . . 0.32 110.81 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 8.0 mp -102.84 148.31 25.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.641 -0.709 . . . . 1.12 110.95 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.485 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -77.17 127.95 33.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.014 -0.539 . . . . 1.33 110.006 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.1 mm . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 116.301 -0.409 . . . . 0.28 110.267 -179.644 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 6.5 tp60 . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.984 0.421 . . . . 1.34 110.912 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -93.91 135.02 35.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.117 -0.492 . . . . 2.11 110.105 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 16.1 mmtm -118.84 147.33 44.05 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.764 -0.653 . . . . 1.27 109.781 174.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.404 ' CD ' ' HB2' ' A' ' 72' ' ' GLU . 16.7 mtm180 -122.94 132.19 54.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.019 0.438 . . . . 1.65 110.617 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.78 179.75 8.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.454 -0.794 . . . . 0.08 109.623 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.53 144.47 31.37 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.07 -0.344 . . . . 0.14 110.07 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.479 ' HA ' HD23 ' A' ' 41' ' ' LEU . 43.7 t -64.27 124.24 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.932 0.396 . . . . 0.14 110.383 176.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.72 -48.44 13.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.725 -0.67 . . . . 0.6 109.988 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 m -158.48 166.06 33.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.649 -0.705 . . . . 1.07 110.057 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.407 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 5.3 mt -140.9 126.89 19.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.033 0.444 . . . . 0.19 109.987 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -114.13 86.68 2.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.417 -0.81 . . . . 1.56 110.257 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.71 -106.28 1.43 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.606 -0.807 . . . . 0.29 112.899 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -93.28 4.66 53.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.562 0.22 . . . . 2.1 111.263 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -126.98 140.33 52.39 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.038 0.447 . . . . 0.32 110.614 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.29 161.0 14.72 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.422 -0.894 . . . . 0.11 111.422 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 84.1 m-85 -132.88 137.08 46.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.496 -0.557 . . . . 0.18 109.496 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.541 HD13 ' CD2' ' A' ' 73' ' ' PHE . 4.7 mt -114.6 154.49 28.24 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.539 -0.541 . . . . 0.59 109.539 -177.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.505 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 65.1 t30 -78.03 73.65 4.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.621 0.724 . . . . 1.53 109.821 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -140.53 106.35 5.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.761 -1.108 . . . . 0.28 108.442 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -94.63 105.33 17.27 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.427 0.632 . . . . 1.81 110.814 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 84' ' ' SER . 38.9 t -77.66 -77.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.797 -1.092 . . . . 0.85 111.788 -173.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 10.1 tt0 -111.75 111.37 22.3 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.392 -0.822 . . . . 2.24 110.479 -173.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.9 t70 61.22 22.5 12.83 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.459 0.647 . . . . 1.55 111.714 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.36 27.84 8.95 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.317 -0.944 . . . . 0.67 112.669 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 27.4 mmmt -77.92 110.93 13.25 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.153 -0.684 . . . . 2.5 109.153 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.505 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 9.3 tppt? -75.56 126.15 30.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.134 -0.691 . . . . 1.32 109.134 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 51' ' ' LEU . 4.5 mt -62.6 130.24 44.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.404 0.52 . . . . 0.19 112.404 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -111.62 159.31 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.659 -0.7 . . . . 0.39 109.216 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.931 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 32.7 p90 -149.41 149.78 31.37 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.705 -0.479 . . . . 0.16 109.705 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -90.32 149.68 22.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.068 -0.716 . . . . 0.34 109.068 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -0.93 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.249 0.463 . . . . 2.43 112.249 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.6 t -71.32 -32.18 68.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.076 0.465 . . . . 0.91 110.045 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -86.65 -10.55 53.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.87 -0.605 . . . . 1.96 110.956 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.26 145.14 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.467 0.651 . . . . 0.27 112.417 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.533 ' HG3' ' H ' ' A' ' 91' ' ' LYS . 0.9 OUTLIER -66.1 110.12 2.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.578 -1.192 . . . . 1.6 111.79 -175.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.66 -93.14 0.72 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.035 -0.602 . . . . 0.58 113.083 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -112.54 155.99 23.41 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.231 -0.285 . . . . 2.2 110.231 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.3 p -61.56 -32.04 72.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.157 -0.474 . . . . 0.95 111.35 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.39 17.62 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.283 0.563 . . . . 1.39 110.61 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.58 2.04 27.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.183 0.516 . . . . 0.57 111.179 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.649 HD21 HG12 ' A' ' 71' ' ' VAL . 1.8 tm? -129.25 125.63 37.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.344 -0.984 . . . . 1.51 108.344 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -122.8 154.02 63.69 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 111.685 0.254 . . . . 0.91 111.685 -171.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.463 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.4 Cg_endo -68.07 134.81 32.85 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.8 2.333 . . . . 0.28 112.369 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.87 -4.73 72.14 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.692 -0.766 . . . . 0.22 111.98 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -95.7 155.25 16.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.594 -0.521 . . . . 1.28 109.594 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -83.47 132.07 34.98 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.62 -0.511 . . . . 0.17 109.62 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.649 HG12 HD21 ' A' ' 65' ' ' LEU . 4.3 m -134.26 160.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.787 0.803 . . . . 0.31 110.84 -176.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -119.12 138.8 52.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.359 -1.291 . . . . 0.78 108.911 177.267 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.541 ' CD2' HD13 ' A' ' 41' ' ' LEU . 36.5 p90 -150.81 180.0 7.75 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.935 -0.575 . . . . 0.11 109.854 -173.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.1 m -127.41 131.49 50.28 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.913 -0.773 . . . . 0.86 108.913 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.432 HG23 ' OG ' ' A' ' 84' ' ' SER . 3.5 p -91.35 98.11 8.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.985 0.898 . . . . 0.36 110.436 -175.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.5 p -102.53 114.36 41.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.193 -0.912 . . . . 0.42 110.241 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.2 m -80.15 127.14 31.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.853 -0.612 . . . . 0.67 110.922 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.97 104.3 2.49 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.019 -0.734 . . . . 1.82 109.019 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -57.23 -26.98 61.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.843 0.354 . . . . 1.95 111.652 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.456 ' HE ' ' HA ' ' A' ' 80' ' ' ARG . 5.1 tpm_? -84.41 -41.35 16.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 3.99 111.599 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -95.05 -30.71 13.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.221 0.452 . . . . 2.21 112.221 -170.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.89 -24.16 32.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.078 -0.582 . . . . 0.69 112.907 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -86.75 175.88 8.02 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.661 -0.317 . . . . 2.42 110.495 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.468 ' HB3' HG21 ' A' ' 45' ' ' VAL . 32.7 t -116.95 -179.23 3.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.104 0.478 . . . . 1.08 110.969 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 m -149.56 147.84 28.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.317 -0.994 . . . . 0.87 108.317 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.931 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -86.97 121.63 29.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.867 0.365 . . . . 0.17 110.653 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 68.4 m -117.33 144.59 44.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.857 -0.611 . . . . 0.68 110.359 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.45 70.43 0.65 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.991 0.807 . . . . 1.82 110.336 -177.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 92.7 t -84.99 115.34 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.273 0.559 . . . . 0.32 111.021 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.27 149.1 30.66 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.793 -0.64 . . . . 1.12 110.509 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.533 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -81.56 124.12 29.24 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.105 -0.702 . . . . 1.33 109.105 174.404 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 92' ' ' ILE . 28.1 mm . . . . . 0 C--N 1.316 -0.873 0 CA-C-N 115.962 -0.563 . . . . 0.28 111.559 -174.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 . . . . . 0 C--O 1.236 0.35 0 CA-C-O 120.941 0.401 . . . . 1.34 111.361 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -91.76 132.92 36.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.031 0.443 . . . . 2.11 110.377 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 72.5 mmtt -114.47 149.71 35.91 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.799 -0.637 . . . . 1.27 109.663 175.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.49 ' HG2' ' CB ' ' A' ' 72' ' ' GLU . 59.5 mtm-85 -122.96 127.89 49.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.067 0.461 . . . . 1.65 111.059 177.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 179.53 9.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.183 -0.917 . . . . 0.08 109.807 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.4 146.18 29.21 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.849 -0.426 . . . . 0.14 109.849 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.557 ' HA ' HD23 ' A' ' 41' ' ' LEU . 40.8 t -67.2 123.06 19.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.856 0.36 . . . . 0.14 110.866 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -75.16 -42.46 55.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.6 110.144 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 p -172.04 165.25 6.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.517 -0.765 . . . . 1.07 110.201 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.7 mt -135.48 129.93 49.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.092 0.472 . . . . 0.19 109.965 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -126.16 95.23 4.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.562 -0.744 . . . . 1.56 110.613 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.83 -106.28 1.77 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.29 112.726 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -103.07 9.99 38.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.686 0.279 . . . . 2.1 110.417 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -129.58 141.12 51.02 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.225 0.536 . . . . 0.32 111.054 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.473 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -123.97 159.02 18.63 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.137 -0.785 . . . . 0.11 111.137 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 76.8 m-85 -131.06 147.49 52.63 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.859 -0.422 . . . . 0.18 109.859 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.601 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 5.7 mt -124.82 146.99 48.98 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.385 -0.598 . . . . 0.59 109.385 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -72.92 74.63 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.574 0.702 . . . . 1.53 110.505 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -138.0 97.63 3.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.836 -1.074 . . . . 0.28 108.539 177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.502 ' CG ' ' HA2' ' A' ' 48' ' ' GLY . 19.5 mp0 -74.15 102.15 4.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.948 -1.024 . . . . 1.81 110.966 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.615 HG11 ' HB2' ' A' ' 84' ' ' SER . 28.6 m -80.12 -32.44 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.494 -0.775 . . . . 0.85 111.108 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -157.98 116.89 3.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.128 -0.487 . . . . 2.24 110.33 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.2 t70 58.87 22.57 10.37 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.507 0.558 . . . . 1.55 112.507 169.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.502 ' HA2' ' CG ' ' A' ' 44' ' ' GLU . . . 102.38 2.68 50.75 Favored Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.418 -0.896 . . . . 0.67 112.966 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -60.72 115.08 3.38 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 122.167 0.187 . . . . 2.5 110.795 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -70.49 148.95 47.69 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.628 -0.508 . . . . 1.32 109.628 176.07 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 3.4 mt -79.02 132.68 36.72 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.904 -0.589 . . . . 0.19 110.274 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -107.31 154.24 21.56 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.579 -0.526 . . . . 0.39 109.579 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.852 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 18.5 p90 -146.4 156.22 43.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.338 -0.616 . . . . 0.16 109.338 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -97.33 149.64 21.86 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.897 -0.779 . . . . 0.34 108.897 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.465 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -61.82 -8.23 4.61 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.909 0.337 . . . . 2.43 111.909 -178.404 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 t -79.25 -19.55 50.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.95 0.405 . . . . 0.91 110.288 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' ' 87' ' ' CYS . 2.3 mp0 -92.2 -10.83 37.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.977 0.418 . . . . 1.96 110.171 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.1 t -64.62 149.14 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.454 -0.793 . . . . 0.27 111.897 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -63.31 92.01 0.06 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.219 -0.9 . . . . 1.6 112.52 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.1 -77.56 0.69 Allowed Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.006 -0.543 . . . . 0.58 113.732 172.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 1.9 m-20 -103.93 140.16 38.09 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.606 -0.516 . . . . 2.2 109.606 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 69.6 p -70.53 -22.67 62.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.974 -0.557 . . . . 0.95 111.64 -173.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.4 t -100.38 7.16 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.271 0.558 . . . . 1.39 110.503 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . . . -93.69 -11.1 32.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.316 -0.402 . . . . 0.57 110.928 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.615 HD21 HG12 ' A' ' 71' ' ' VAL . 1.4 tm? -110.04 124.51 51.58 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.702 -0.851 . . . . 1.51 108.702 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -115.46 150.66 44.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.743 0.306 . . . . 0.91 111.533 -170.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.474 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.2 Cg_endo -68.06 140.82 50.94 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.379 2.053 . . . . 0.28 111.895 173.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.55 -1.31 88.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.645 -0.788 . . . . 0.22 112.451 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -96.16 159.32 15.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.729 -0.471 . . . . 1.28 109.729 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -83.96 134.97 34.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.565 -0.531 . . . . 0.17 109.565 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.615 HG12 HD21 ' A' ' 65' ' ' LEU . 10.2 m -136.7 160.04 37.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 110.068 -0.345 . . . . 0.31 110.068 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 4.6 pt-20 -116.03 141.65 47.84 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.601 -0.888 . . . . 0.78 108.601 170.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.522 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 26.5 p90 -146.82 179.7 7.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.33 -0.85 . . . . 0.11 109.672 -173.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m -127.65 127.18 43.34 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.942 -0.762 . . . . 0.86 108.942 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 75' ' ' VAL . 8.2 p -92.68 99.4 9.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.835 0.826 . . . . 0.36 111.508 -172.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 84' ' ' SER . 5.1 p -99.11 112.34 31.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.819 -0.628 . . . . 0.42 109.944 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.1 m -93.76 140.45 29.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.508 -0.769 . . . . 0.67 111.128 -173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 80' ' ' ARG . 5.1 t-20 -71.61 134.64 46.53 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.711 0.291 . . . . 1.82 110.359 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 19.2 pm0 -76.87 -12.48 59.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.497 -0.319 . . . . 1.95 111.07 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.472 ' HB3' ' OD1' ' A' ' 78' ' ' ASN . 7.0 tpm_? -95.56 -59.27 1.91 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.568 -0.287 . . . . 3.99 111.605 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -109.04 -0.48 19.48 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.202 0.445 . . . . 2.21 112.202 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.93 80.03 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.494 -0.86 . . . . 0.69 113.159 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.51 131.55 34.86 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.42 0.628 . . . . 2.42 111.494 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.615 ' HB2' HG11 ' A' ' 45' ' ' VAL . 65.3 m -106.7 170.2 8.08 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.912 -1.04 . . . . 1.08 111.357 -172.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.8 m -148.6 152.91 37.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.63 -0.714 . . . . 0.87 109.338 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.852 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -95.33 122.55 38.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 120.87 0.367 . . . . 0.17 110.373 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.412 ' HA ' ' HG2' ' A' ' 57' ' ' GLU . 94.1 m -116.69 148.55 40.95 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.129 -0.487 . . . . 0.68 110.22 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.8 m120 59.32 62.03 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.674 0.609 . . . . 1.82 110.338 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.7 t -80.87 99.14 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.472 -0.786 . . . . 0.32 110.656 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.609 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 6.7 mp -99.79 147.87 25.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.349 -0.841 . . . . 1.12 110.545 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.485 ' HG2' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -78.62 123.71 27.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.969 -0.382 . . . . 1.33 109.969 178.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.1 mm . . . . . 0 C--N 1.317 -0.818 0 CA-C-O 121.093 0.473 . . . . 0.28 110.667 -178.626 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 . . . . . 0 CA--C 1.516 -0.332 0 N-CA-C 110.491 -0.188 . . . . 1.34 110.491 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -109.1 112.31 24.41 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.349 -0.54 . . . . 2.11 110.228 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -90.72 154.31 19.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.595 -0.729 . . . . 1.27 109.59 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -128.11 128.32 44.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.999 -0.371 . . . . 1.65 109.999 176.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 179.53 9.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.803 -0.635 . . . . 0.08 109.376 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.55 140.09 38.0 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 110.345 -0.243 . . . . 0.14 110.345 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.515 ' HA ' HD23 ' A' ' 41' ' ' LEU . 43.7 t -62.04 115.7 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 120.986 0.422 . . . . 0.14 110.337 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.03 -47.26 65.87 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.446 -0.797 . . . . 0.6 110.019 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.1 m -168.86 168.56 10.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 1.07 109.36 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.434 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 11.2 mt -135.79 126.97 44.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.639 -0.504 . . . . 0.19 109.639 175.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -116.88 92.16 3.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.643 -0.708 . . . . 1.56 110.089 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.96 -109.27 2.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.789 -0.72 . . . . 0.29 112.238 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -96.99 6.02 49.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.71 0.255 . . . . 2.1 110.758 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -125.06 144.18 50.54 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.321 0.581 . . . . 0.32 111.234 -173.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.525 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.79 159.41 15.45 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.595 -0.812 . . . . 0.11 111.308 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.0 142.47 47.65 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.376 -0.601 . . . . 0.18 109.376 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 31' ' ' VAL . 8.8 mt -116.15 152.22 34.13 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.247 -0.649 . . . . 0.59 109.247 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -75.48 76.0 2.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.505 0.669 . . . . 1.53 109.417 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.413 ' HB3' HD12 ' A' ' 51' ' ' LEU . 23.9 t80 -147.73 98.13 2.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.983 -1.008 . . . . 0.28 109.121 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 33.3 mt-10 -87.88 101.99 14.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.325 0.583 . . . . 1.81 110.573 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 84' ' ' SER . 15.6 m -73.35 -45.09 53.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.41 -0.814 . . . . 0.85 112.078 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.462 ' H ' ' HB2' ' A' ' 49' ' ' LYS . 4.8 tt0 -140.71 116.61 10.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.572 -0.286 . . . . 2.24 110.537 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 t70 57.87 21.83 8.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.324 0.583 . . . . 1.55 112.131 167.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.47 19.82 19.41 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.443 -0.884 . . . . 0.67 112.955 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 32.6 mmtm -70.99 110.41 5.67 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.892 -0.41 . . . . 2.5 109.892 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -75.24 126.89 31.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.503 -0.554 . . . . 1.32 109.503 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 51' ' ' LEU . 3.8 mt -66.75 126.83 30.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.532 -0.304 . . . . 0.19 111.314 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.443 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 9.5 p90 -111.25 162.53 14.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.427 -0.351 . . . . 0.39 110.138 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.918 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 30.2 p90 -155.17 159.75 40.38 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.174 -0.676 . . . . 0.16 109.174 174.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -99.86 153.65 18.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.342 -0.614 . . . . 0.34 109.342 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 19.6 mtt -66.76 3.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.44 0.533 . . . . 2.43 112.44 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.1 t -89.45 -22.75 22.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.542 -0.54 . . . . 0.91 109.542 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -90.07 -5.67 56.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.511 . . . . 1.96 110.27 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.465 HG22 HD13 ' A' ' 65' ' ' LEU . 1.3 t -67.62 152.45 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.223 -0.899 . . . . 0.27 112.818 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.499 ' HG3' ' H ' ' A' ' 91' ' ' LYS . 1.1 tm0? -59.41 99.02 0.05 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 114.863 -1.062 . . . . 1.6 112.419 -176.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.44 -85.0 0.25 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.58 113.258 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -105.71 145.67 30.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.677 -0.49 . . . . 2.2 109.677 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.0 p -59.98 -40.36 88.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.619 0.6 . . . . 0.95 112.619 -174.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.36 19.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.512 0.672 . . . . 1.39 110.522 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.52 11.54 38.84 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.429 0.633 . . . . 0.57 110.141 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.549 HD11 HG12 ' A' ' 89' ' ' VAL . 1.8 tt -137.86 124.03 20.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.121 -0.945 . . . . 1.51 108.534 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.409 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 89.8 m-70 -121.78 159.2 52.08 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.755 0.312 . . . . 0.91 111.151 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.424 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 38.2 Cg_endo -67.41 144.71 68.61 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.436 2.09 . . . . 0.28 111.924 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -9.15 77.96 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.053 -0.594 . . . . 0.22 112.063 -177.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' ' 66' ' ' HIS . 3.6 m-20 -87.14 141.36 28.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.583 0.23 . . . . 1.28 110.722 177.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 m -70.01 139.25 52.71 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.172 -0.677 . . . . 0.17 109.172 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -139.19 161.02 28.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.364 0.602 . . . . 0.31 111.1 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.13 134.53 54.83 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.826 -1.175 . . . . 0.78 107.826 173.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.487 ' CD2' HD13 ' A' ' 41' ' ' LEU . 23.5 p90 -146.13 178.93 7.85 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.86 -0.609 . . . . 0.11 109.471 -174.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.1 t -126.19 126.63 44.4 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.954 -0.758 . . . . 0.86 108.954 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.9 98.4 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.705 -0.679 . . . . 0.36 110.54 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 p -100.85 113.83 38.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.522 -0.763 . . . . 0.42 109.917 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.9 m -76.78 130.53 37.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.708 -0.678 . . . . 0.67 110.926 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.562 ' HB3' ' H ' ' A' ' 82' ' ' GLY . 3.6 t-20 -65.22 111.91 3.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.923 -0.769 . . . . 1.82 108.923 175.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -12.28 60.38 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.905 -0.318 . . . . 1.95 111.287 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -96.74 -58.55 2.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.035 -0.53 . . . . 3.99 111.558 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -90.75 -28.67 18.12 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.677 0.621 . . . . 2.21 112.677 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.562 ' H ' ' HB3' ' A' ' 78' ' ' ASN . . . 103.7 -24.57 29.34 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.416 -0.897 . . . . 0.69 113.851 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -74.8 151.33 39.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.439 0.62 . . . . 2.42 110.006 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.496 ' HB2' HG11 ' A' ' 45' ' ' VAL . 8.3 m -99.43 175.05 5.99 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.563 -0.455 . . . . 1.08 111.469 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 m -142.78 163.24 33.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.419 -0.809 . . . . 0.87 109.161 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.918 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -103.16 117.06 33.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.248 0.547 . . . . 0.17 110.358 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 64.5 m -116.97 147.99 41.81 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.914 -0.773 . . . . 0.68 108.914 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 73' ' ' PHE . 23.8 t-20 64.55 69.24 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.082 -0.71 . . . . 1.82 109.082 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.549 HG12 HD11 ' A' ' 65' ' ' LEU . 84.9 t -93.41 105.98 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 115.426 -0.806 . . . . 0.32 110.9 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.3 150.32 31.15 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.61 -0.723 . . . . 1.12 111.016 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.499 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -83.35 123.75 29.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.553 -0.748 . . . . 1.33 110.948 -172.743 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.5 mm . . . . . 0 C--N 1.319 -0.756 0 CA-C-N 115.83 -0.623 . . . . 0.28 111.05 -175.842 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 . . . . . 0 C--O 1.235 0.304 0 CA-C-O 121.091 0.472 . . . . 1.34 110.65 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -97.6 118.32 33.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.44 0.638 . . . . 2.11 110.286 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -99.99 156.44 17.15 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.868 -1.06 . . . . 1.27 109.719 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.466 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 11.0 mtm180 -130.27 127.31 39.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.49 . . . . 1.65 110.559 175.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.46 -179.96 8.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.256 -0.884 . . . . 0.08 110.031 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.4 145.6 28.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.366 -0.379 . . . . 0.14 109.984 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.42 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 48.8 t -68.33 123.33 21.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.516 -0.311 . . . . 0.14 110.379 175.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.39 -41.9 46.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.109 -0.496 . . . . 0.6 110.406 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.5 p -171.04 161.69 6.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.845 -0.616 . . . . 1.07 110.014 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.413 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 13.1 mt -133.73 129.13 54.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.079 0.466 . . . . 0.19 110.114 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -119.59 95.19 4.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 1.56 110.132 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.17 -114.13 5.85 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.815 -0.707 . . . . 0.29 112.282 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -96.38 14.81 23.13 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 110.031 -0.359 . . . . 2.1 110.031 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -128.13 141.06 51.59 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.563 -0.455 . . . . 0.32 111.014 -175.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -127.19 158.71 21.14 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.503 -0.856 . . . . 0.11 111.525 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -132.33 142.71 49.44 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.235 -0.654 . . . . 0.18 109.235 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.491 HD13 ' CD2' ' A' ' 73' ' ' PHE . 6.3 mt -116.74 152.53 34.14 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.146 -0.686 . . . . 0.59 109.146 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -75.09 73.47 2.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.782 0.801 . . . . 1.53 109.585 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -147.51 110.69 4.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.623 -1.172 . . . . 0.28 108.674 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 90.1 mt-10 -105.82 107.08 17.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.5 0.667 . . . . 1.81 111.136 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 m -74.06 -55.28 12.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.659 -1.155 . . . . 0.85 112.121 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.695 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 4.1 tp10 -136.38 118.92 15.88 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.552 -0.294 . . . . 2.24 110.703 -171.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.1 t70 61.86 16.59 8.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.41 0.624 . . . . 1.55 112.057 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.09 31.13 9.37 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.205 -0.997 . . . . 0.67 112.107 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.695 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 41.2 mmtm -75.49 109.88 9.41 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.509 -0.923 . . . . 2.5 108.509 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.93 122.32 22.37 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.726 -0.842 . . . . 1.32 108.726 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 51' ' ' LEU . 3.6 mt -59.7 126.55 28.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.131 -0.486 . . . . 0.19 111.6 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -108.41 161.82 14.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.856 -0.611 . . . . 0.39 110.229 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.956 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 30.0 p90 -152.5 151.88 31.25 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.558 -0.746 . . . . 0.16 109.205 173.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.454 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . 23.3 t-80 -93.69 156.39 16.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.628 -0.879 . . . . 0.34 108.628 174.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.467 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 51.0 ttm -71.73 3.69 3.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.875 0.369 . . . . 2.43 111.538 -176.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.2 t -88.38 -27.57 21.52 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.777 -0.453 . . . . 0.91 109.777 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.454 ' OE2' ' HB3' ' A' ' 54' ' ' HIS . 1.9 mp0 -79.36 -14.97 58.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.855 -0.611 . . . . 1.96 109.626 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.493 HG11 ' HA ' ' A' ' 62' ' ' THR . 1.8 t -62.68 152.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.882 -1.054 . . . . 0.27 111.939 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -45.07 158.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.359 -1.291 . . . . 1.6 110.985 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -44.78 -32.5 3.08 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 114.62 0.608 . . . . 0.58 114.62 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -104.26 125.03 50.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.645 -0.502 . . . . 2.2 109.645 173.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.493 ' HA ' HG11 ' A' ' 58' ' ' VAL . 70.7 p -79.18 -36.54 40.11 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.413 -0.812 . . . . 0.95 111.977 -171.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 t -87.15 7.35 2.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.484 0.659 . . . . 1.39 110.257 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.33 -3.12 31.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 0.57 111.087 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.542 HD21 HG12 ' A' ' 71' ' ' VAL . 1.5 tm? -104.71 124.04 48.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.031 -1.1 . . . . 1.51 108.031 175.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -121.02 151.81 55.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.828 0.347 . . . . 0.91 111.549 -171.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 43.0 Cg_endo -67.8 137.41 41.69 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.721 2.28 . . . . 0.28 111.856 173.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.31 -8.99 72.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.815 -0.707 . . . . 0.22 112.628 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -95.25 159.69 14.89 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.418 -0.586 . . . . 1.28 109.418 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 m -80.27 135.96 36.34 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.208 -0.664 . . . . 0.17 109.208 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.542 HG12 HD21 ' A' ' 65' ' ' LEU . 12.1 m -135.71 161.6 38.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.25 0.548 . . . . 0.31 109.895 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.66 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.59 149.13 37.04 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.726 -0.842 . . . . 0.78 108.726 177.502 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.491 ' CD2' HD13 ' A' ' 41' ' ' LEU . 37.9 p90 -163.06 178.61 8.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.006 0.431 . . . . 0.11 110.515 -172.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -128.85 131.56 47.7 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.022 -0.733 . . . . 0.86 109.022 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.9 p -99.35 98.84 7.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.802 0.81 . . . . 0.36 111.018 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.0 p -110.2 118.89 58.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.558 -0.746 . . . . 0.42 110.006 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.0 m -73.32 126.19 29.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.138 -0.483 . . . . 0.67 110.778 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 29.1 m-80 -68.79 115.18 7.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.203 -0.453 . . . . 1.82 109.955 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -60.47 -30.85 69.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.166 -0.47 . . . . 1.95 112.113 -173.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 1.6 tpm_? -95.28 -31.9 13.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.959 0.409 . . . . 3.99 111.645 -176.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -95.94 -26.41 15.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.286 0.565 . . . . 2.21 110.455 -171.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 -24.84 18.38 Favored Glycine 0 C--O 1.23 -0.127 0 C-N-CA 121.201 -0.523 . . . . 0.69 113.421 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 20.1 pttm -98.77 151.95 20.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.216 0.508 . . . . 2.42 110.808 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -87.45 179.47 6.56 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.859 -0.61 . . . . 1.08 111.082 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.8 p -153.45 139.17 17.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.004 -0.543 . . . . 0.87 109.773 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.956 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -74.01 119.25 17.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.191 0.52 . . . . 0.17 111.105 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 99.4 m -116.89 143.88 45.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.778 -0.646 . . . . 0.68 109.306 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 67.1 t30 62.52 70.51 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.418 0.628 . . . . 1.82 109.717 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 90.4 t -93.11 113.05 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.328 -0.851 . . . . 0.32 111.159 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.25 150.05 32.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.178 -0.464 . . . . 1.12 110.92 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.47 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -73.71 128.48 35.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.043 -0.526 . . . . 1.33 109.906 176.689 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.4 mm . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 120.803 0.335 . . . . 0.28 110.91 -179.103 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 120.691 0.282 . . . . 1.34 110.899 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -95.51 121.05 36.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.419 0.628 . . . . 2.11 110.559 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.461 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 31.0 mmtp -105.37 144.12 32.59 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.152 -0.931 . . . . 1.27 109.544 177.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 28' ' ' ARG . 2.1 mtm180 -120.01 127.37 52.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.085 0.469 . . . . 1.65 110.196 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.496 ' HB1' ' OD1' ' A' ' 42' ' ' ASN . . . -150.87 -179.63 7.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.516 -0.765 . . . . 0.08 109.448 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.91 143.42 32.52 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.81 -0.441 . . . . 0.14 109.81 -177.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.48 ' HA ' HD23 ' A' ' 41' ' ' LEU . 43.8 t -64.89 114.19 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.904 0.383 . . . . 0.14 110.433 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -65.07 -45.12 86.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.121 -0.945 . . . . 0.6 110.153 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 p -171.71 164.73 6.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.396 -0.82 . . . . 1.07 110.093 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.4 mt -137.57 128.95 40.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.669 -0.493 . . . . 0.19 109.669 176.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 71.4 mmtt -122.92 94.31 4.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.534 -0.757 . . . . 1.56 109.807 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.88 -106.92 2.0 Allowed Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.717 -0.754 . . . . 0.29 112.434 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -101.06 4.25 42.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.178 0.191 . . . . 2.1 110.793 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -122.87 140.5 52.89 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.254 0.55 . . . . 0.32 111.374 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.01 157.09 21.01 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.116 -0.947 . . . . 0.11 111.416 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -130.46 151.79 50.55 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.362 -0.607 . . . . 0.18 109.362 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.572 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.2 mt -125.09 155.28 40.08 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.329 -0.619 . . . . 0.59 109.329 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.496 ' OD1' ' HB1' ' A' ' 29' ' ' ALA . 28.0 p-10 -76.23 72.9 3.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 122.229 1.014 . . . . 1.53 109.994 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -148.15 98.63 2.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.757 -1.11 . . . . 0.28 109.028 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 21.3 mt-10 -95.58 100.97 12.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.746 0.784 . . . . 1.81 110.284 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 46' ' ' GLU . 16.2 m -68.12 -43.31 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.222 -1.354 . . . . 0.85 111.301 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 8.7 tp10 -129.87 176.06 8.35 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.281 -1.748 . . . . 2.24 106.281 -176.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 28.3 t70 -33.19 86.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.195 1.183 . . . . 1.55 114.195 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.54 ' HA2' ' OE2' ' A' ' 44' ' ' GLU . . . 68.58 16.55 69.87 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.654 -0.784 . . . . 0.67 111.464 171.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.722 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 32.0 mmtm -82.29 107.03 14.65 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.569 -0.53 . . . . 2.5 109.569 -178.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -79.52 129.62 34.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.062 -0.718 . . . . 1.32 109.062 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 51' ' ' LEU . 3.1 mt -63.69 124.09 20.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.728 0.299 . . . . 0.19 111.157 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -106.61 158.91 16.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.833 -0.622 . . . . 0.39 109.998 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.939 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 30.4 p90 -150.29 154.87 38.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.517 -0.765 . . . . 0.16 109.166 173.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -99.03 149.87 22.56 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.657 -0.868 . . . . 0.34 108.657 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.543 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 27.5 mtt -60.23 -7.07 1.71 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.215 0.45 . . . . 2.43 112.215 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 t -68.66 -29.96 68.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.221 -0.445 . . . . 0.91 110.776 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -92.93 -1.21 56.92 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.845 0.355 . . . . 1.96 111.138 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.562 HG13 HD13 ' A' ' 65' ' ' LEU . 2.1 t -74.42 150.66 7.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.593 0.59 . . . . 0.27 112.593 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.539 ' CG ' HD13 ' A' ' 90' ' ' LEU . 1.4 tm0? -54.37 100.06 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 114.758 -1.11 . . . . 1.6 111.805 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.52 -92.18 0.01 OUTLIER Glycine 0 C--N 1.332 0.317 0 O-C-N 123.873 0.733 . . . . 0.58 114.342 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -89.73 131.34 35.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 2.2 110.174 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.543 ' HB ' ' SD ' ' A' ' 55' ' ' MET . 30.7 p -75.45 -12.04 60.16 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.471 -0.786 . . . . 0.95 111.096 -172.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.0 t -92.85 -2.15 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.499 -0.773 . . . . 1.39 110.05 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.88 -14.54 29.51 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.394 0.616 . . . . 0.57 110.895 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.562 HD13 HG13 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -103.34 124.6 48.99 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.528 -0.76 . . . . 1.51 109.084 179.226 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 95.3 m-70 -121.8 153.14 60.05 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.884 0.373 . . . . 0.91 111.316 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.407 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.0 Cg_endo -67.64 134.85 34.04 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.499 2.132 . . . . 0.28 111.243 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.22 -17.34 59.32 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.826 -0.702 . . . . 0.22 111.93 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 66' ' ' HIS . 23.5 m-20 -74.23 151.05 40.01 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 110.101 -0.333 . . . . 1.28 110.101 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 m -81.17 135.18 35.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.395 -0.965 . . . . 0.17 108.395 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.452 HG11 HD21 ' A' ' 65' ' ' LEU . 29.6 m -134.9 167.09 26.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.214 0.531 . . . . 0.31 110.945 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.641 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -113.88 150.07 34.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.014 -1.106 . . . . 0.78 108.014 172.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.572 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.2 p90 -157.85 179.06 9.55 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.335 -0.617 . . . . 0.11 109.335 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -130.29 133.69 46.66 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.253 -1.017 . . . . 0.86 108.253 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 p -94.5 98.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.658 0.742 . . . . 0.36 111.087 -172.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -102.54 107.64 22.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.39 -0.823 . . . . 0.42 109.725 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 26.8 m -74.43 129.67 38.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.983 0.421 . . . . 0.67 110.864 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 39.7 m-80 -76.83 101.06 5.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.879 -0.6 . . . . 1.82 109.528 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -60.9 -21.31 63.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.957 0.408 . . . . 1.95 111.119 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -72.52 -41.11 66.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.714 -0.675 . . . . 3.99 111.585 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -114.65 -31.49 6.16 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.517 0.562 . . . . 2.21 112.517 -172.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.44 -20.36 25.46 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.003 -0.618 . . . . 0.69 113.303 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 21.1 pttp -96.89 150.72 20.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.036 0.418 . . . . 2.42 110.752 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 13.4 m -93.3 -176.29 4.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.11 -0.496 . . . . 1.08 111.607 -175.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.8 m -150.05 150.08 31.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.828 -0.624 . . . . 0.87 109.434 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.939 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -89.82 120.93 31.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.217 0.532 . . . . 0.17 111.101 -177.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 50.0 m -117.32 144.38 44.95 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.759 -0.655 . . . . 0.68 110.126 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 62.82 66.84 0.73 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.764 0.665 . . . . 1.82 109.792 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 95.2 t -89.33 100.85 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.518 -0.764 . . . . 0.32 110.675 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.539 HD13 ' CG ' ' A' ' 59' ' ' GLN . 2.1 mm? -105.45 147.53 28.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.833 -0.621 . . . . 1.12 110.81 -177.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.36 122.75 24.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 1.33 110.741 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.4 mm . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.597 -0.728 . . . . 0.28 110.738 -176.464 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.115 0.483 . . . . 1.34 110.878 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -109.31 112.73 25.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.145 0.497 . . . . 2.11 110.628 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -89.51 150.29 22.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.57 -0.741 . . . . 1.27 110.294 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -123.66 127.3 48.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.95 0.405 . . . . 1.65 110.347 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.58 179.36 9.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.015 -0.735 . . . . 0.08 109.015 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.93 142.62 32.15 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 110.133 -0.321 . . . . 0.14 110.133 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.522 ' HA ' HD23 ' A' ' 41' ' ' LEU . 43.7 t -64.22 117.54 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.517 -0.549 . . . . 0.14 109.517 174.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.93 -40.47 63.07 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.768 -0.651 . . . . 0.6 110.513 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 p -174.41 156.0 2.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.56 -0.746 . . . . 1.07 109.697 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.4 mt -127.6 132.38 69.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.186 -0.461 . . . . 0.19 110.005 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -121.96 85.95 2.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.568 -0.742 . . . . 1.56 110.458 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.37 -107.13 1.95 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.915 -0.659 . . . . 0.29 112.605 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -97.63 10.7 39.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 2.1 110.509 -175.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -132.73 142.22 48.93 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 120.942 0.401 . . . . 0.32 110.643 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.6 153.88 19.83 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.226 -0.749 . . . . 0.11 111.226 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 64.6 m-85 -127.88 146.11 50.73 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.57 -0.529 . . . . 0.18 109.57 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.544 HD13 ' CD2' ' A' ' 73' ' ' PHE . 6.0 mt -117.65 157.12 27.0 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.926 -0.398 . . . . 0.59 109.926 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -76.75 73.53 3.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.508 0.67 . . . . 1.53 109.677 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.438 ' HB3' HD12 ' A' ' 51' ' ' LEU . 33.7 t80 -146.19 102.46 3.62 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.293 -0.867 . . . . 0.28 109.301 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.56 101.0 12.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.934 -0.575 . . . . 1.81 110.275 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' A' ' 84' ' ' SER . 21.3 m -74.06 -46.42 45.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.801 0.81 . . . . 0.85 110.648 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.476 ' N ' HG23 ' A' ' 45' ' ' VAL . 34.5 tt0 -124.55 -179.11 4.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.803 -1.554 . . . . 2.24 106.803 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.429 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 8.1 t70 -41.09 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.089 0.956 . . . . 1.55 112.948 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.16 13.96 67.9 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.651 -0.785 . . . . 0.67 111.701 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.94 108.99 10.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.23 -0.655 . . . . 2.5 109.23 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -72.61 136.15 45.67 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.161 -0.681 . . . . 1.32 109.161 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -70.2 123.68 22.25 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.837 -0.431 . . . . 0.19 109.837 177.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -107.0 156.85 18.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.714 -0.476 . . . . 0.39 109.714 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.918 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 22.7 p90 -147.84 152.73 38.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.655 -0.702 . . . . 0.16 109.11 172.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -91.87 146.93 23.36 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.048 -0.723 . . . . 0.34 109.048 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.579 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 41.8 ttp -53.23 -17.16 1.55 Allowed 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 123.704 0.801 . . . . 2.43 112.274 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -64.57 -32.32 73.92 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.601 0.239 . . . . 0.91 110.868 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -78.08 -15.12 59.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.141 0.496 . . . . 1.96 110.822 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.579 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -64.03 147.46 12.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.395 -0.82 . . . . 0.27 111.956 -174.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.491 ' HG3' ' CD1' ' A' ' 90' ' ' LEU . 1.1 tt0 -64.06 86.77 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.776 -1.102 . . . . 1.6 112.933 -171.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.69 -90.82 0.25 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.293 -0.479 . . . . 0.58 113.26 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -92.99 143.83 25.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.277 0.56 . . . . 2.2 110.589 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.1 p -69.31 -33.56 73.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.217 -0.901 . . . . 0.95 110.926 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.56 -11.47 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.43 -0.805 . . . . 1.39 111.162 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -90.58 -8.5 50.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.607 -0.724 . . . . 0.57 111.728 -173.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.505 HD11 HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -117.48 124.63 49.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.411 -0.589 . . . . 1.51 109.411 179.38 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -122.2 150.03 55.89 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.731 0.3 . . . . 0.91 111.055 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.77 130.32 21.67 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.365 2.043 . . . . 0.28 111.092 172.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.91 -9.73 58.38 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.834 -0.698 . . . . 0.22 111.967 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -87.48 145.47 26.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.258 -0.275 . . . . 1.28 110.258 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 m -72.22 134.37 45.6 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.462 -0.57 . . . . 0.17 109.462 173.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.53 160.2 37.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.776 0.798 . . . . 0.31 111.098 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.84 132.08 56.62 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.429 -1.259 . . . . 0.78 108.65 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.544 ' CD2' HD13 ' A' ' 41' ' ' LEU . 26.0 p90 -142.48 178.67 7.44 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.612 -0.722 . . . . 0.11 109.583 -172.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.1 m -128.68 119.35 24.5 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.163 -0.68 . . . . 0.86 109.163 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.29 99.44 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.81 0.814 . . . . 0.36 110.986 -173.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.68 122.99 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.423 -0.808 . . . . 0.42 109.794 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 36.7 m -86.09 125.77 33.7 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.094 -0.503 . . . . 0.67 111.008 -177.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -63.98 109.92 1.95 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.826 -0.625 . . . . 1.82 109.527 175.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.432 ' H ' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -60.86 -23.14 64.92 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.238 0.459 . . . . 1.95 112.238 -175.699 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.424 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 7.2 tpm_? -93.66 -47.11 6.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.655 -0.418 . . . . 3.99 111.145 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -81.36 -30.81 33.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 2.21 111.586 -174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.45 -10.24 75.07 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.952 -0.642 . . . . 0.69 112.463 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -93.98 156.08 16.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.022 -0.733 . . . . 2.42 109.022 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.552 ' HB2' HG11 ' A' ' 45' ' ' VAL . 3.2 m -107.75 170.62 7.88 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.435 -0.506 . . . . 1.08 111.173 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.3 p -144.07 159.84 41.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.69 -0.686 . . . . 0.87 110.122 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.918 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -96.3 123.98 40.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.349 -0.387 . . . . 0.17 110.367 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -116.86 149.16 40.53 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.001 -1.111 . . . . 0.68 108.001 176.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 57.11 72.25 0.52 Allowed 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.82 0.7 . . . . 1.82 110.321 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.505 HG12 HD11 ' A' ' 65' ' ' LEU . 96.2 t -89.58 105.4 16.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.565 0.697 . . . . 0.32 110.639 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.491 ' CD1' ' HG3' ' A' ' 59' ' ' GLN . 4.0 mm? -106.7 148.95 27.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.161 -0.927 . . . . 1.12 110.648 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.42 ' HB2' ' OE1' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -81.66 129.47 34.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.676 -0.693 . . . . 1.33 111.224 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.5 mm . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.704 -0.68 . . . . 0.28 110.427 -178.232 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.536 0.207 . . . . 1.34 110.992 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 2.6 mppt? -106.86 120.99 43.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.145 0.498 . . . . 2.11 110.423 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -105.11 144.89 31.29 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.484 -0.78 . . . . 1.27 110.26 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -118.84 127.17 53.27 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.664 -0.414 . . . . 1.65 110.578 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.63 179.67 8.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.69 -0.686 . . . . 0.08 109.579 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.44 144.5 30.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.045 -0.354 . . . . 0.14 110.045 -177.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.531 ' HA ' HD23 ' A' ' 41' ' ' LEU . 57.6 t -63.98 117.43 4.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.142 0.496 . . . . 0.14 110.577 176.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.421 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 8.5 t70 -69.2 -47.86 63.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.031 -0.986 . . . . 0.6 109.616 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 74.1 m -167.92 164.49 13.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.775 -0.648 . . . . 1.07 109.699 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 mt -136.52 132.97 49.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.672 -0.492 . . . . 0.19 109.672 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -126.79 89.34 2.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 1.56 110.227 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.37 -107.77 2.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.75 -0.738 . . . . 0.29 112.592 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -97.37 9.64 41.78 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.808 -0.231 . . . . 2.1 110.761 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.51 141.2 51.05 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.184 0.516 . . . . 0.32 111.006 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.526 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.9 157.16 21.47 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.387 -0.824 . . . . 0.11 111.152 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 68.8 m-85 -129.73 148.61 51.63 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.09 -0.708 . . . . 0.18 109.09 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' A' ' 73' ' ' PHE . 8.8 mt -123.72 153.05 41.42 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.662 -0.495 . . . . 0.59 109.662 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -75.1 73.59 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.487 -0.56 . . . . 1.53 109.487 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.439 ' HB3' HD12 ' A' ' 51' ' ' LEU . 27.9 t80 -150.26 98.56 2.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.41 -0.814 . . . . 0.28 109.536 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 47.2 mt-10 -81.67 100.5 9.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.485 0.66 . . . . 1.81 109.695 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 84' ' ' SER . 27.2 m -72.21 -35.68 53.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.078 -0.965 . . . . 0.85 111.446 -176.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 7.9 tp10 -145.05 179.65 7.21 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.376 -1.713 . . . . 2.24 106.376 -175.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.523 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 23.8 t70 -27.75 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.271 1.428 . . . . 1.55 114.38 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.519 ' HA2' ' OE1' ' A' ' 44' ' ' GLU . . . 66.84 19.72 69.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.992 -0.623 . . . . 0.67 111.768 173.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 40.8 mmtm -82.88 109.05 16.67 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 110.061 -0.348 . . . . 2.5 110.061 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -74.39 128.95 36.83 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.712 -0.847 . . . . 1.32 108.712 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.506 ' HG ' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -64.66 126.73 28.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.597 -0.274 . . . . 0.19 110.646 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -112.27 156.66 22.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.97 0.414 . . . . 0.39 110.031 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.864 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 17.2 p90 -146.84 161.46 40.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.911 -0.586 . . . . 0.16 109.524 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -102.09 140.35 36.48 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.246 -0.65 . . . . 0.34 109.246 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.484 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 1.8 tmt? -51.13 -23.84 3.56 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.827 0.851 . . . . 2.43 112.657 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.6 t -60.27 -23.22 63.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.642 0.258 . . . . 0.91 111.215 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -95.74 0.06 52.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.8 -0.182 . . . . 1.96 111.474 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -74.91 137.35 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.305 0.574 . . . . 0.27 111.422 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.83 104.07 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.858 -1.064 . . . . 1.6 111.972 -175.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.03 -84.55 0.49 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.58 113.074 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -135.19 158.17 45.06 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.893 -0.41 . . . . 2.2 109.893 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.9 p -74.5 -8.52 56.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.568 0.699 . . . . 0.95 110.138 178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.43 -1.09 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.306 -0.861 . . . . 1.39 109.904 175.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.87 -39.85 4.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.79 -0.641 . . . . 0.57 110.423 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.644 HD11 HG11 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -95.32 123.35 38.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.298 -0.63 . . . . 1.51 109.298 178.69 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -134.58 158.2 75.62 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.637 -0.256 . . . . 0.91 111.116 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.529 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 28.1 Cg_endo -63.53 142.19 83.43 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.689 2.259 . . . . 0.28 111.745 176.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.96 -6.49 83.11 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.58 -0.819 . . . . 0.22 112.742 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -95.08 158.65 15.37 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.61 -0.515 . . . . 1.28 109.61 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -81.75 137.79 35.29 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.229 -0.656 . . . . 0.17 109.229 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.644 HG11 HD11 ' A' ' 65' ' ' LEU . 10.4 m -137.91 156.46 31.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.421 0.629 . . . . 0.31 109.857 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.39 133.16 55.91 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.505 -0.924 . . . . 0.78 108.505 175.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.532 ' CD2' HD13 ' A' ' 41' ' ' LEU . 28.6 p90 -142.5 179.46 6.95 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.71 -0.677 . . . . 0.11 109.789 -173.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.4 t -127.95 116.31 19.88 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.995 -1.113 . . . . 0.86 107.995 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.3 p -81.64 98.22 4.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.906 0.86 . . . . 0.36 110.557 -173.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 p -102.62 116.31 46.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.23 -0.896 . . . . 0.42 109.788 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 30.2 m -73.99 130.7 40.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.117 -0.492 . . . . 0.67 110.496 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -68.96 112.18 5.45 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.212 -0.662 . . . . 1.82 109.212 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -52.91 -31.32 39.35 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.826 0.704 . . . . 1.95 111.889 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -94.24 -53.86 3.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.828 0.347 . . . . 3.99 111.591 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -74.06 -18.41 60.83 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.296 0.48 . . . . 2.21 112.296 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.93 -24.38 6.06 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.991 -0.624 . . . . 0.69 113.173 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -91.4 154.12 19.4 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.457 -0.571 . . . . 2.42 109.457 178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.549 ' HB2' HG11 ' A' ' 45' ' ' VAL . 17.6 m -101.11 179.98 4.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.951 0.405 . . . . 1.08 111.706 -174.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.1 m -146.37 155.94 42.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.794 -0.639 . . . . 0.87 109.43 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.864 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -96.23 120.67 36.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.89 0.376 . . . . 0.17 110.601 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.3 m -116.99 156.97 26.56 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.954 -0.758 . . . . 0.68 108.954 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 55.9 62.54 2.35 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.694 0.621 . . . . 1.82 109.988 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.7 t -81.25 104.95 10.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.771 -0.649 . . . . 0.32 110.892 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.0 mp -107.29 150.53 26.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.293 -0.867 . . . . 1.12 111.364 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.91 129.23 34.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.996 -0.547 . . . . 1.33 110.253 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mm . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 120.757 0.313 . . . . 0.28 110.766 -177.635 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.421 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 6.4 tp60 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.923 0.392 . . . . 1.34 110.319 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -109.22 112.84 25.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.316 0.579 . . . . 2.11 110.337 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -99.07 151.25 21.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.378 -0.828 . . . . 1.27 110.856 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.423 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 43.1 mtm180 -119.25 127.89 53.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.714 0.292 . . . . 1.65 110.385 174.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.63 179.71 8.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.871 -0.604 . . . . 0.08 109.491 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.82 141.56 36.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 110.155 -0.313 . . . . 0.14 110.155 -177.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HA ' HD23 ' A' ' 41' ' ' LEU . 47.1 t -62.77 118.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.762 0.315 . . . . 0.14 110.257 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.403 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 4.4 t70 -68.05 -43.81 77.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.459 -0.791 . . . . 0.6 110.098 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.6 p -178.52 165.66 1.74 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.31 -0.859 . . . . 1.07 109.511 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.5 mt -131.19 131.45 63.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.264 0.554 . . . . 0.19 109.958 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -123.66 85.71 2.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.385 -0.825 . . . . 1.56 110.249 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.09 -111.25 3.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.829 -0.7 . . . . 0.29 112.415 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -96.83 11.7 34.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.681 0.277 . . . . 2.1 110.746 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -131.61 139.73 49.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.191 0.52 . . . . 0.32 110.621 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.527 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -121.96 156.15 16.74 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.783 -0.927 . . . . 0.11 110.783 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -129.32 146.63 51.17 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.036 -0.727 . . . . 0.18 109.036 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.564 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.1 mt -117.69 152.68 34.74 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.103 -0.703 . . . . 0.59 109.103 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.66 72.94 2.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.926 0.869 . . . . 1.53 109.532 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.404 ' HB3' HD12 ' A' ' 51' ' ' LEU . 27.1 t80 -145.58 99.92 3.36 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.417 -1.265 . . . . 0.28 108.027 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.614 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 92.6 mt-10 -98.75 103.15 15.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.571 0.701 . . . . 1.81 110.763 -174.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.5 m -70.67 -37.11 68.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.521 -1.218 . . . . 0.85 112.483 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 2.5 tp10 -151.25 121.3 7.16 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 121.485 -0.086 . . . . 2.24 111.018 -176.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.9 t70 62.39 15.92 8.13 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.625 0.726 . . . . 1.55 111.87 169.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.536 ' HA2' ' OE2' ' A' ' 44' ' ' GLU . . . 94.33 28.42 10.66 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.577 -0.821 . . . . 0.67 112.056 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -81.07 110.16 16.33 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.604 -0.517 . . . . 2.5 109.604 179.164 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -68.63 130.27 42.36 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.649 0.593 . . . . 1.32 109.772 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 51' ' ' LEU . 2.1 mt -66.41 124.22 22.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.158 -0.474 . . . . 0.19 110.737 176.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -107.4 160.09 15.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.247 -0.433 . . . . 0.39 110.1 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.815 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 33.7 p90 -152.03 152.61 32.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.464 -0.789 . . . . 0.16 109.037 173.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -91.79 152.87 19.94 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.692 -0.855 . . . . 0.34 108.692 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.452 ' SD ' HG21 ' A' ' 58' ' ' VAL . 3.4 tpt -68.65 0.68 3.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.635 0.374 . . . . 2.43 111.927 -173.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 p -79.95 -37.54 34.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.958 0.409 . . . . 0.91 110.877 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -72.37 -16.23 61.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.771 -0.65 . . . . 1.96 110.14 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.452 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -61.06 150.81 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.141 -0.936 . . . . 0.27 111.778 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.459 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -66.32 93.81 0.24 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.347 -0.842 . . . . 1.6 112.16 -176.867 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.86 -91.87 0.52 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.566 -0.743 . . . . 0.58 113.58 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -103.87 159.34 15.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.848 0.356 . . . . 2.2 110.098 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.5 p -79.86 -21.12 44.46 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.045 -0.525 . . . . 0.95 111.542 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.8 p -83.18 -9.42 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.373 0.606 . . . . 1.39 110.667 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 -19.7 28.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.551 -0.749 . . . . 0.57 111.383 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.512 HD11 HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -114.84 123.89 50.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.637 -0.71 . . . . 1.51 109.272 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -123.47 155.88 64.95 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 0.91 111.452 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.449 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.7 Cg_endo -68.98 132.53 24.79 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.502 2.135 . . . . 0.28 111.535 174.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.21 -11.04 63.75 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.931 -0.652 . . . . 0.22 111.758 -177.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -84.47 149.45 25.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.04 -0.356 . . . . 1.28 110.04 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 m -75.69 139.0 41.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.519 -0.549 . . . . 0.17 109.519 174.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.22 162.92 24.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 120.829 0.347 . . . . 0.31 111.218 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -114.43 148.0 38.42 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.869 -1.16 . . . . 0.78 107.869 172.289 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.564 ' CD2' HD13 ' A' ' 41' ' ' LEU . 29.5 p90 -153.62 -179.46 7.81 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.381 -0.6 . . . . 0.11 109.381 -175.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.6 m -128.07 114.26 16.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.988 -0.745 . . . . 0.86 108.988 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.6 p -84.24 99.87 7.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.597 0.713 . . . . 0.36 111.293 -175.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.81 121.89 60.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.685 -0.689 . . . . 0.42 109.589 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 22.1 m -80.36 128.58 33.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.71 0.29 . . . . 0.67 111.166 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 75.1 m-20 -74.09 114.66 12.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.157 -0.474 . . . . 1.82 109.875 177.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -64.03 -24.82 67.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.384 . . . . 1.95 111.835 -173.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -90.34 -45.54 8.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 3.99 111.342 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -85.72 -23.05 27.51 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.913 0.338 . . . . 2.21 111.913 -174.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.54 -21.08 14.94 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 121.237 -0.506 . . . . 0.69 112.764 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 39.7 pttt -98.05 142.76 29.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.292 0.568 . . . . 2.42 110.757 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.4 m -84.94 179.51 7.29 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.24 -0.891 . . . . 1.08 111.876 -175.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.4 m -147.37 157.45 43.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.652 -0.704 . . . . 0.87 109.479 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.815 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -98.86 122.2 41.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.901 0.381 . . . . 0.17 110.843 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 80.1 m -116.21 141.55 48.0 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.05 -0.523 . . . . 0.68 110.14 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.25 67.84 0.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.801 0.688 . . . . 1.82 110.144 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.512 HG12 HD11 ' A' ' 65' ' ' LEU . 92.7 t -84.73 103.76 12.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.593 -0.73 . . . . 0.32 110.645 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.522 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 8.1 mp -108.14 147.85 30.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.79 -0.641 . . . . 1.12 111.199 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.28 129.04 35.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.636 -0.711 . . . . 1.33 111.414 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.6 mm . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.963 -0.562 . . . . 0.28 111.518 -176.416 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 120.817 0.341 . . . . 1.34 110.483 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -97.1 111.73 23.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.465 0.65 . . . . 2.11 110.254 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 73.1 mmtt -94.27 160.21 14.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.992 -1.004 . . . . 1.27 110.308 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 17.6 mtm180 -128.72 127.52 42.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.959 0.409 . . . . 1.65 110.131 175.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.49 178.21 9.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.679 -0.691 . . . . 0.08 109.724 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.04 141.21 33.17 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.276 -0.639 . . . . 0.14 109.276 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.434 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 51.1 t -62.31 114.42 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.821 -0.437 . . . . 0.14 109.821 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.29 -47.15 62.5 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.307 -0.86 . . . . 0.6 109.973 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.5 m -160.72 160.14 31.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.596 -0.729 . . . . 1.07 110.392 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.413 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 10.2 mt -137.26 120.12 20.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.174 -0.676 . . . . 0.19 109.174 173.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -110.23 86.38 2.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.544 -0.753 . . . . 1.56 109.767 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.8 -109.15 2.76 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.683 -0.77 . . . . 0.29 112.247 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -91.18 2.75 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.926 -0.161 . . . . 2.1 111.269 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -124.07 141.0 52.43 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.305 -0.558 . . . . 0.32 111.335 -174.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 34' ' ' ILE . . . -122.56 158.66 17.23 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.517 -0.765 . . . . 0.11 111.415 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 49.6 m-85 -136.11 136.23 39.95 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.882 -0.784 . . . . 0.18 108.882 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.497 HD21 ' CD2' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -106.26 155.08 19.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.458 -0.942 . . . . 0.59 108.458 177.782 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -76.32 73.5 3.11 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.419 0.628 . . . . 1.53 109.581 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -141.66 98.82 3.42 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.065 -0.971 . . . . 0.28 109.657 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.75 100.69 7.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.616 0.722 . . . . 1.81 110.101 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.48 ' CG1' ' HG ' ' A' ' 51' ' ' LEU . 31.6 m -80.23 -34.5 14.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.014 -0.993 . . . . 0.85 110.992 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.511 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 8.3 tp10 -137.08 177.61 7.73 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.019 -1.845 . . . . 2.24 106.019 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.511 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 29.2 t70 -40.56 85.94 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.815 1.043 . . . . 1.55 113.815 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.22 16.99 71.68 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.775 -0.93 . . . . 0.67 110.775 173.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -88.5 109.42 20.03 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.004 -0.739 . . . . 2.5 109.004 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -75.46 134.32 40.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.65 -0.5 . . . . 1.32 109.65 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 1.4 mt -64.69 125.01 23.41 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.253 0.346 . . . . 0.19 111.037 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -108.78 158.61 17.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.962 -0.384 . . . . 0.39 109.962 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.886 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 45.9 p90 -153.11 154.25 34.45 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.065 -0.717 . . . . 0.16 109.065 173.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -94.54 152.07 18.84 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.627 -0.879 . . . . 0.34 108.627 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.527 ' SD ' HG21 ' A' ' 58' ' ' VAL . 9.4 mmt -63.87 0.79 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.28 0.474 . . . . 2.43 112.28 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.3 t -86.13 -23.05 26.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.713 0.292 . . . . 0.91 110.327 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -91.11 -2.59 57.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.025 0.44 . . . . 1.96 110.079 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.527 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.2 t -72.66 151.28 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.53 -0.759 . . . . 0.27 112.389 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.445 ' HG2' HD13 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -60.53 96.27 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.05 -0.977 . . . . 1.6 111.57 -178.108 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.17 -84.11 0.41 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.753 -0.658 . . . . 0.58 113.569 170.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -113.25 145.74 40.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.139 0.495 . . . . 2.2 110.579 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.482 HG22 ' HB3' ' A' ' 55' ' ' MET . 81.6 p -72.3 -9.63 58.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 0.95 111.705 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.8 t -95.36 -2.92 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.499 -0.773 . . . . 1.39 110.373 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.94 -17.59 22.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.096 0.474 . . . . 0.57 111.445 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.511 HD11 HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -113.1 124.0 51.56 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.163 -0.68 . . . . 1.51 109.163 -176.894 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -123.29 155.63 64.71 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.656 0.265 . . . . 0.91 111.269 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.434 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.0 Cg_endo -67.12 128.36 18.44 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.341 2.027 . . . . 0.28 111.339 172.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.74 -11.62 53.31 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.684 -0.769 . . . . 0.22 112.072 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -81.14 149.16 29.25 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.645 0.259 . . . . 1.28 110.522 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.6 m -76.86 131.35 38.56 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.525 -0.917 . . . . 0.17 108.525 171.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.481 HG11 HD21 ' A' ' 65' ' ' LEU . 35.7 m -135.01 159.48 41.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 122.04 0.924 . . . . 0.31 111.006 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -114.52 139.75 49.31 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.844 -1.526 . . . . 0.78 108.708 177.886 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.535 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 29.9 p90 -152.37 -179.68 7.77 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.463 -0.569 . . . . 0.11 109.463 -174.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 t -124.99 127.81 47.59 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.803 -0.814 . . . . 0.86 108.803 177.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.4 p -95.01 98.45 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.919 0.866 . . . . 0.36 110.835 -176.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.0 p -104.7 110.82 31.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.246 -0.888 . . . . 0.42 110.09 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 31.8 m -69.37 123.8 22.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.095 -0.502 . . . . 0.67 110.454 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 5.1 m-20 -69.92 109.38 4.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.516 -0.549 . . . . 1.82 109.516 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.44 ' CD ' ' H ' ' A' ' 79' ' ' GLN . 3.8 pm0 -64.57 -13.37 52.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.788 0.328 . . . . 1.95 111.316 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -94.37 -36.14 12.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.402 -0.363 . . . . 3.99 111.47 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -99.82 -29.36 12.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.253 0.464 . . . . 2.21 112.253 -174.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.17 -24.38 25.24 Favored Glycine 0 C--N 1.32 -0.313 0 C-N-CA 121.239 -0.505 . . . . 0.69 112.103 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 18.3 pttm -95.03 154.46 17.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.622 -0.511 . . . . 2.42 109.622 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.465 ' H ' HG21 ' A' ' 45' ' ' VAL . 2.0 m -94.97 -179.26 4.77 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.843 0.354 . . . . 1.08 110.736 -177.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -146.36 146.88 30.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.244 -0.65 . . . . 0.87 109.244 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.886 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -88.92 118.41 28.62 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.912 0.386 . . . . 0.17 110.424 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.8 m -117.16 149.09 40.95 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.257 -0.646 . . . . 0.68 109.257 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 m120 61.61 67.95 0.74 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.491 0.662 . . . . 1.82 109.532 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.511 HG12 HD11 ' A' ' 65' ' ' LEU . 86.0 t -89.92 111.76 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.286 -0.87 . . . . 0.32 110.748 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.445 HD13 ' HG2' ' A' ' 59' ' ' GLN . 4.2 mm? -107.46 147.27 30.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.574 -0.739 . . . . 1.12 110.903 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 114.17 21.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.748 -0.66 . . . . 1.33 110.136 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.9 mm . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 115.56 -0.746 . . . . 0.28 111.135 -175.831 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.335 0.112 . . . . 1.34 110.965 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.26 125.51 51.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.314 0.578 . . . . 2.11 110.836 176.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 68.2 mmtt -104.12 147.55 27.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.58 -0.736 . . . . 1.27 109.198 171.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.401 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 17.5 mtm180 -124.16 128.11 48.76 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.96 -0.296 . . . . 1.65 110.852 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.79 179.49 9.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.753 . . . . 0.08 110.429 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.07 146.65 28.05 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.117 -0.492 . . . . 0.14 110.335 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 31.0 t -67.26 121.73 16.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.157 0.503 . . . . 0.14 110.325 176.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -80.95 -41.69 22.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.434 -0.803 . . . . 0.6 109.914 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.3 p -163.96 166.9 21.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 1.07 110.643 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.419 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 7.3 mt -140.86 130.92 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.256 0.551 . . . . 0.19 109.873 175.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -124.82 88.16 2.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.383 -0.826 . . . . 1.56 110.411 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.48 -110.91 3.49 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.674 -0.774 . . . . 0.29 112.192 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -92.34 5.81 49.24 Favored 'General case' 0 C--O 1.225 -0.236 0 O-C-N 122.77 -0.253 . . . . 2.1 110.88 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -126.36 140.72 52.28 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.212 -0.595 . . . . 0.32 111.499 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.82 157.95 17.43 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.319 -0.855 . . . . 0.11 111.176 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 80.1 m-85 -130.26 140.54 50.68 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.292 -0.633 . . . . 0.18 109.292 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.466 HD13 ' CD2' ' A' ' 73' ' ' PHE . 6.8 mt -116.28 153.42 31.96 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.777 -0.453 . . . . 0.59 109.777 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -75.97 73.84 2.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.597 0.713 . . . . 1.53 109.817 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -144.45 109.27 4.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.845 -1.07 . . . . 0.28 109.275 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -92.81 115.02 27.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.848 -0.614 . . . . 1.81 110.576 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' A' ' 84' ' ' SER . 13.9 m -85.62 -47.49 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.78 -0.645 . . . . 0.85 111.46 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.611 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 8.4 pt-20 -157.1 144.64 18.91 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.486 -0.561 . . . . 2.24 109.486 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.9 t70 59.63 10.76 2.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.969 0.89 . . . . 1.55 112.009 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.13 30.58 37.4 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.609 -0.805 . . . . 0.67 112.106 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 8.1 mtpp -73.34 112.45 9.41 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.451 -0.203 . . . . 2.5 110.451 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.07 120.73 14.76 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.58 0.55 . . . . 1.32 109.527 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.4 mt -58.54 128.02 35.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.025 -0.534 . . . . 0.19 112.074 -176.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -106.17 161.65 14.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.905 0.383 . . . . 0.39 110.559 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.911 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 21.2 p90 -152.76 157.17 40.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.95 -0.568 . . . . 0.16 109.572 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -99.49 150.66 21.97 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.952 -0.759 . . . . 0.34 108.952 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.474 ' SD ' HG21 ' A' ' 58' ' ' VAL . 16.4 mmt -61.89 -9.43 6.84 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.114 0.412 . . . . 2.43 112.114 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.1 t -71.36 -26.06 62.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.823 0.344 . . . . 0.91 110.196 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -92.98 -2.07 56.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.417 -0.356 . . . . 1.96 110.588 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.474 HG21 ' SD ' ' A' ' 55' ' ' MET . 1.2 t -73.25 151.44 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.397 0.617 . . . . 0.27 112.569 -174.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.447 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 17.1 tm0? -68.03 98.82 0.8 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.903 -1.044 . . . . 1.6 112.5 -174.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.55 -81.89 0.39 Allowed Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.814 -0.63 . . . . 0.58 113.354 172.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -114.34 150.11 35.04 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.928 0.394 . . . . 2.2 110.159 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.7 p -71.22 -16.44 62.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.808 -0.633 . . . . 0.95 110.625 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 t -97.36 10.46 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.449 -0.796 . . . . 1.39 109.856 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.32 -27.22 12.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.118 0.485 . . . . 0.57 110.916 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.751 HD21 HG12 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -102.29 124.29 47.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.042 -0.725 . . . . 1.51 109.042 178.778 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.6 154.19 69.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.618 0.246 . . . . 0.91 111.33 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.448 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.6 Cg_endo -67.49 121.56 8.68 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.307 2.005 . . . . 0.28 111.422 173.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.494 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 103.05 -5.91 50.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.813 -0.708 . . . . 0.22 111.786 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.28 152.23 22.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.374 -0.602 . . . . 1.28 109.374 176.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 7.1 m -81.1 141.59 34.15 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.077 -0.712 . . . . 0.17 109.077 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.751 HG12 HD21 ' A' ' 65' ' ' LEU . 4.3 m -137.26 161.65 34.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.412 0.625 . . . . 0.31 110.83 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.61 141.33 47.91 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.43 -1.322 . . . . 0.78 107.43 170.075 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.516 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 30.9 p90 -151.64 178.98 8.8 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.978 0.418 . . . . 0.11 110.103 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.2 m -127.31 129.91 48.55 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.871 -0.788 . . . . 0.86 108.871 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 p -89.25 99.79 9.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.69 0.757 . . . . 0.36 110.979 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.4 p -107.33 101.93 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.741 0.781 . . . . 0.42 109.932 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 m -70.46 130.83 42.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.416 -0.811 . . . . 0.67 110.867 -177.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.45 104.8 3.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.7 -0.852 . . . . 1.82 108.7 172.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -62.65 -16.78 58.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.847 0.356 . . . . 1.95 111.407 -176.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -90.75 -40.79 11.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.126 -0.488 . . . . 3.99 111.038 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -94.37 -31.47 14.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.864 0.364 . . . . 2.21 111.709 -173.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.28 -23.76 33.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.108 -0.568 . . . . 0.69 112.273 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.439 ' HD3' ' HE2' ' A' ' 49' ' ' LYS . 21.4 pttt -91.44 154.08 19.4 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.052 -0.351 . . . . 2.42 110.052 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.42 ' HB3' HG11 ' A' ' 45' ' ' VAL . 14.6 t -108.25 -176.46 3.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.439 -0.346 . . . . 1.08 110.808 -173.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 p -155.28 147.13 23.35 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.787 -0.642 . . . . 0.87 109.338 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.911 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -87.22 123.01 31.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 120.974 0.416 . . . . 0.17 111.081 -177.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 89.5 m -117.35 150.95 37.99 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.876 -0.602 . . . . 0.68 109.475 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 58.4 63.01 1.82 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.413 0.446 . . . . 1.82 109.809 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 79.3 t -84.16 103.78 11.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.873 -0.603 . . . . 0.32 110.325 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.447 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 4.6 mm? -101.31 147.59 26.13 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.698 -0.683 . . . . 1.12 109.888 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.568 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -82.3 126.93 32.71 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.47 -0.567 . . . . 1.33 109.47 178.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.517 ' O ' ' HB ' ' A' ' 70' ' ' THR . 38.7 mm . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 115.906 -0.588 . . . . 0.28 110.103 -176.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.033 0.444 . . . . 1.34 111.903 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -111.7 111.67 22.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.741 -0.663 . . . . 2.11 110.22 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -87.14 153.66 21.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.686 -0.688 . . . . 1.27 110.215 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 43.9 mtm180 -125.5 135.63 52.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.859 0.361 . . . . 1.65 110.527 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.81 179.34 8.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.558 -0.746 . . . . 0.08 109.447 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.25 147.09 28.44 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.003 -0.369 . . . . 0.14 110.003 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.548 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 26.7 t -69.34 120.33 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.077 0.465 . . . . 0.14 110.317 177.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -72.18 -41.81 66.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.312 -0.858 . . . . 0.6 110.631 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.8 p -175.66 163.3 2.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.685 -0.688 . . . . 1.07 109.477 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 mt -131.06 131.28 64.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.259 0.552 . . . . 0.19 110.264 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -121.86 86.37 2.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.141 -0.936 . . . . 1.56 109.775 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.15 -112.48 4.06 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.659 -0.782 . . . . 0.29 112.193 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -93.34 7.28 45.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.59 0.233 . . . . 2.1 110.743 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.24 141.64 51.4 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.081 0.467 . . . . 0.32 111.007 -174.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.74 157.52 18.18 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 111.038 -0.825 . . . . 0.11 111.038 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 81.1 m-85 -130.19 143.28 50.69 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.82 -0.437 . . . . 0.18 109.82 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.491 HD13 ' CD2' ' A' ' 73' ' ' PHE . 8.4 mt -117.5 152.88 34.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.075 -0.512 . . . . 0.59 109.918 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -74.37 74.76 1.89 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.671 0.748 . . . . 1.53 109.723 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -151.06 99.26 2.67 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.882 -1.054 . . . . 0.28 108.654 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.671 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 14.1 mt-10 -94.41 101.54 13.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.709 0.766 . . . . 1.81 111.296 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.652 HG23 ' H ' ' A' ' 46' ' ' GLU . 2.4 m -75.43 -59.07 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.247 -1.342 . . . . 0.85 111.262 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.652 ' H ' HG23 ' A' ' 45' ' ' VAL . 10.9 tp10 -106.82 179.87 4.14 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.131 -1.433 . . . . 2.24 107.131 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.422 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 31.3 t70 -30.54 83.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.854 1.262 . . . . 1.55 113.914 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 66.23 16.09 64.16 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.792 -0.718 . . . . 0.67 111.512 172.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 2.4 mmmt -77.14 108.09 9.98 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 110.021 -0.363 . . . . 2.5 110.021 -174.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -74.93 123.11 24.51 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.976 -1.12 . . . . 1.32 107.976 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 4.1 mt -57.55 122.22 12.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.818 0.342 . . . . 0.19 111.423 -174.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -101.07 155.07 18.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.896 -0.593 . . . . 0.39 109.954 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.955 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 33.1 p90 -149.4 157.13 43.05 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.632 -0.713 . . . . 0.16 109.276 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -99.77 150.11 22.66 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.238 -0.653 . . . . 0.34 109.238 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.522 ' SD ' HG21 ' A' ' 58' ' ' VAL . 11.0 mmt -60.47 -6.89 1.77 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.631 0.604 . . . . 2.43 112.631 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.409 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . 17.6 t -79.01 -28.98 43.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.693 0.282 . . . . 0.91 110.284 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' OE2' ' HB3' ' A' ' 56' ' ' SER . 2.6 mp0 -85.61 -4.47 59.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.972 0.415 . . . . 1.96 110.593 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.522 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -69.5 148.38 11.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.605 -0.725 . . . . 0.27 112.486 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.449 ' HG2' HD13 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -64.15 99.9 0.3 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.467 -1.242 . . . . 1.6 111.883 -175.499 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.56 -89.65 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.866 -0.607 . . . . 0.58 113.131 173.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -106.07 151.06 25.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.986 0.422 . . . . 2.2 110.603 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.0 p -63.76 -33.79 76.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.478 -0.783 . . . . 0.95 111.076 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.6 t -88.3 7.22 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.828 -0.624 . . . . 1.39 110.443 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.82 -9.42 34.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.093 0.473 . . . . 0.57 110.788 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.764 HD21 HG12 ' A' ' 71' ' ' VAL . 1.1 tm? -121.36 124.5 44.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.622 -0.881 . . . . 1.51 108.622 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -122.87 152.33 62.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.452 -0.34 . . . . 0.91 111.407 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 44.8 Cg_endo -69.74 115.92 4.31 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.585 2.19 . . . . 0.28 111.907 176.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.548 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 119.77 -18.85 9.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.14 -0.553 . . . . 0.22 112.247 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.21 155.92 24.68 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.755 -0.461 . . . . 1.28 109.755 175.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 3.0 m -78.45 143.11 36.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.677 -0.49 . . . . 0.17 109.677 176.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.764 HG12 HD21 ' A' ' 65' ' ' LEU . 26.6 m -137.53 157.52 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 121.699 0.762 . . . . 0.31 110.215 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -115.41 141.51 47.94 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.27 -1.332 . . . . 0.78 108.359 171.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.491 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.5 p90 -152.04 179.57 8.36 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.05 -0.722 . . . . 0.11 109.05 -173.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.85 128.51 47.75 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.961 -0.755 . . . . 0.86 108.961 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.05 98.69 7.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.759 0.79 . . . . 0.36 110.61 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.88 125.64 67.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.292 -0.867 . . . . 0.42 109.367 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.7 m -81.4 128.98 34.44 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.351 -0.386 . . . . 0.67 110.48 -178.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -68.1 111.14 4.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.68 -0.489 . . . . 1.82 109.68 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.55 -18.84 44.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.081 -0.509 . . . . 1.95 112.035 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -95.06 -38.12 10.78 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.841 0.312 . . . . 3.99 111.841 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.444 ' HB3' ' HE2' ' A' ' 83' ' ' LYS . 86.5 m-20 -113.73 -5.74 13.31 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.045 0.758 . . . . 2.21 113.045 -172.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.94 -9.42 24.77 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.893 -0.67 . . . . 0.69 114.017 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -97.45 152.87 18.53 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.581 -0.526 . . . . 2.42 109.581 179.227 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.1 t -97.01 -179.67 4.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.158 0.504 . . . . 1.08 111.745 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.7 p -154.97 150.4 27.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.35 -0.841 . . . . 0.87 108.783 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.955 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -87.22 122.58 31.2 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.201 0.524 . . . . 0.17 110.51 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 84.0 m -116.92 144.88 44.03 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.524 -0.762 . . . . 0.68 109.739 178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 56.79 73.26 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.812 0.695 . . . . 1.82 109.792 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 73.3 t -87.75 105.69 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.741 -0.663 . . . . 0.32 110.46 -178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.449 HD13 ' HG2' ' A' ' 59' ' ' GLN . 4.3 mm? -101.98 149.05 24.62 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.358 -0.837 . . . . 1.12 110.298 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.537 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -84.54 115.85 22.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.326 -0.62 . . . . 1.33 109.326 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 70' ' ' THR . 43.2 mm . . . . . 0 C--N 1.319 -0.72 0 CA-C-O 121.158 0.504 . . . . 0.28 111.801 -172.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.5 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 4.0 tp60 . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.202 0.525 . . . . 1.34 110.767 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -104.11 112.63 25.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.656 -0.702 . . . . 2.11 110.421 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 67.7 mmtt -100.05 157.52 16.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.424 -0.807 . . . . 1.27 111.4 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -124.53 140.04 53.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.44 -0.346 . . . . 1.65 110.122 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.42 179.26 6.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.048 -0.523 . . . . 0.08 110.184 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.01 145.14 30.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.239 -0.437 . . . . 0.14 110.103 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.512 ' HA ' HD23 ' A' ' 41' ' ' LEU . 46.2 t -68.98 119.9 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.38 -0.373 . . . . 0.14 110.565 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -72.88 -40.41 65.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.826 -0.625 . . . . 0.6 110.344 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 p -171.12 164.3 7.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.067 -0.515 . . . . 1.07 110.628 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.7 mt -136.56 130.82 47.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.587 -0.523 . . . . 0.19 109.587 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -128.27 101.29 6.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.475 -0.784 . . . . 1.56 110.171 -175.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.27 -105.89 1.43 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.665 -0.778 . . . . 0.29 112.392 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -106.12 6.76 31.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.934 -0.395 . . . . 2.1 109.934 -177.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -125.4 140.64 52.62 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.377 0.608 . . . . 0.32 111.091 -174.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -123.79 156.58 18.04 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.957 -0.857 . . . . 0.11 110.957 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -131.0 144.95 51.87 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.711 -0.478 . . . . 0.18 109.711 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.551 HD13 ' CD2' ' A' ' 73' ' ' PHE . 4.8 mt -121.07 152.1 39.05 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.275 -0.639 . . . . 0.59 109.275 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -75.54 75.26 2.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.314 0.578 . . . . 1.53 109.585 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -143.12 98.17 3.22 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.433 -0.803 . . . . 0.28 109.509 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -79.47 101.31 8.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.915 -0.584 . . . . 1.81 109.844 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 84' ' ' SER . 31.5 m -75.21 -43.96 43.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.536 -0.756 . . . . 0.85 110.609 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 6.0 tp10 -129.08 179.37 5.79 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 106.328 -1.731 . . . . 2.24 106.328 174.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.519 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 14.2 t70 -31.23 83.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.229 1.412 . . . . 1.55 114.059 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.03 8.65 61.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.273 -0.489 . . . . 0.67 111.954 173.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -74.32 110.38 8.57 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.505 -0.554 . . . . 2.5 109.505 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.486 ' NZ ' ' HB2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -78.9 129.77 34.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.668 -0.696 . . . . 1.32 110.193 -173.716 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 51' ' ' LEU . 3.2 mt -67.95 127.56 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.318 -0.401 . . . . 0.19 111.274 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -113.51 157.27 22.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.738 -0.664 . . . . 0.39 109.47 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.937 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 32.3 p90 -146.05 153.23 40.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.992 -0.549 . . . . 0.16 109.759 174.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -94.36 148.13 22.53 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.142 -0.688 . . . . 0.34 109.142 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.63 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 21.7 ttp -65.12 2.9 0.68 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.272 0.629 . . . . 2.43 111.635 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.7 t -89.53 -19.23 25.28 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.648 -0.251 . . . . 0.91 110.751 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -85.85 -11.19 53.97 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 121.378 0.608 . . . . 1.96 109.426 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 62' ' ' THR . 1.6 t -64.41 146.78 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.783 -1.099 . . . . 0.27 112.593 -174.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.37 98.65 0.25 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.831 -1.077 . . . . 1.6 111.899 -173.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.92 -77.54 1.12 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.58 113.512 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -119.87 149.92 41.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.068 0.461 . . . . 2.2 110.025 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.63 ' HB ' ' SD ' ' A' ' 55' ' ' MET . 43.0 p -69.21 -21.89 63.92 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.33 -0.85 . . . . 0.95 112.233 -171.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.9 t -98.92 4.9 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.568 0.699 . . . . 1.39 110.169 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.13 -25.54 27.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.162 -0.472 . . . . 0.57 110.493 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.683 HD21 HG12 ' A' ' 71' ' ' VAL . 1.1 tm? -104.04 125.28 50.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.862 -0.608 . . . . 1.51 109.563 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -124.15 154.81 68.47 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.523 0.201 . . . . 0.91 111.134 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 39.3 Cg_endo -68.55 144.57 61.22 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.659 2.239 . . . . 0.28 112.152 176.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.48 -11.98 64.36 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.925 -0.655 . . . . 0.22 112.345 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.02 154.03 20.81 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.43 -0.211 . . . . 1.28 110.43 177.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.6 m -76.33 138.5 40.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.705 -0.48 . . . . 0.17 109.705 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.683 HG12 HD21 ' A' ' 65' ' ' LEU . 11.3 m -138.09 163.22 29.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.398 0.618 . . . . 0.31 109.877 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -116.5 149.21 39.92 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.98 -1.009 . . . . 0.78 108.476 172.651 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.551 ' CD2' HD13 ' A' ' 41' ' ' LEU . 36.1 p90 -156.75 178.25 10.55 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.039 -0.356 . . . . 0.11 110.039 -175.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -124.36 132.67 53.55 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.94 -0.763 . . . . 0.86 108.94 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.32 99.01 8.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.693 0.759 . . . . 0.36 110.496 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.19 126.71 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.459 -0.792 . . . . 0.42 110.589 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.6 m -74.33 132.66 42.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.088 -0.506 . . . . 0.67 111.287 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -75.17 116.46 15.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.092 -0.707 . . . . 1.82 109.092 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -58.16 -28.03 64.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.08 0.4 . . . . 1.95 112.08 -175.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -94.08 -51.58 4.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.919 0.34 . . . . 3.99 111.919 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -81.77 -31.69 31.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.941 0.349 . . . . 2.21 111.941 -172.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.13 -21.98 43.21 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.676 -0.773 . . . . 0.69 112.674 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -82.35 166.59 19.32 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 109.467 -0.568 . . . . 2.42 109.467 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.537 ' HB2' HG11 ' A' ' 45' ' ' VAL . 11.4 m -104.93 -177.66 3.43 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.577 -0.449 . . . . 1.08 111.008 -177.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.6 m -147.82 144.84 28.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.455 -0.572 . . . . 0.87 109.455 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.937 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -84.59 120.59 26.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.969 0.414 . . . . 0.17 110.647 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.4 m -117.7 146.02 44.02 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.528 -0.76 . . . . 0.68 109.738 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.4 m120 56.6 74.45 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.677 0.611 . . . . 1.82 110.766 -175.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 76.1 t -86.93 110.44 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.634 -0.712 . . . . 0.32 110.991 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.59 148.82 24.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.706 -0.679 . . . . 1.12 110.833 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.92 122.58 26.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.197 -0.668 . . . . 1.33 109.197 174.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mm . . . . . 0 C--N 1.321 -0.659 0 CA-C-O 121.09 0.471 . . . . 0.28 111.352 -177.315 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 112.008 0.373 . . . . 1.34 112.008 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -111.83 135.53 52.32 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.517 -0.549 . . . . 2.11 109.517 172.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 28.7 mmtp -112.76 144.88 41.55 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.106 -0.702 . . . . 1.27 109.106 172.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 4.1 mtm180 -121.74 127.59 50.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.051 0.453 . . . . 1.65 110.846 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.67 179.65 9.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.39 -0.823 . . . . 0.08 110.059 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.81 144.05 30.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.547 -0.297 . . . . 0.14 110.566 -178.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.506 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 43.4 t -65.08 115.73 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.827 -0.434 . . . . 0.14 109.827 175.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.73 -48.68 58.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.082 -0.508 . . . . 0.6 110.079 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 m -159.64 160.64 34.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.632 -0.713 . . . . 1.07 109.687 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.43 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 11.5 mt -138.09 130.79 40.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.426 -0.583 . . . . 0.19 109.426 173.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -129.88 94.73 3.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.648 -0.706 . . . . 1.56 110.242 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.45 -106.04 1.56 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.815 -0.707 . . . . 0.29 112.554 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -100.86 13.64 34.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.521 -0.178 . . . . 2.1 110.521 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -133.18 142.39 48.59 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.201 0.524 . . . . 0.32 111.381 -174.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -126.48 157.4 20.27 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 111.002 -0.839 . . . . 0.11 111.002 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -130.86 149.3 52.56 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.438 -0.578 . . . . 0.18 109.438 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 73' ' ' PHE . 5.9 mt -124.38 148.64 47.4 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.812 -0.81 . . . . 0.59 108.812 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 62.4 t30 -78.05 72.9 4.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.578 0.704 . . . . 1.53 109.731 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -139.47 98.75 3.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.952 -1.022 . . . . 0.28 109.104 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 50.6 mt-10 -84.82 101.2 12.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.612 0.72 . . . . 1.81 110.356 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 84' ' ' SER . 34.1 m -81.12 -32.0 12.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.911 -1.04 . . . . 0.85 110.622 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 5.5 tp10 -134.09 177.47 7.71 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.77 -1.937 . . . . 2.24 105.77 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.499 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 26.4 t0 -39.78 84.93 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.119 0.968 . . . . 1.55 113.44 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 73.26 8.29 74.47 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.751 -0.54 . . . . 0.67 111.751 174.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 9.0 mmtm -67.53 110.32 3.61 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.831 -0.184 . . . . 2.5 110.686 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 8.9 tppt? -79.53 123.7 27.82 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.12 -0.696 . . . . 1.32 109.12 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 51' ' ' LEU . 1.7 mt -61.06 136.03 57.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.585 -0.279 . . . . 0.19 111.046 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -118.3 160.7 21.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.404 . . . . 0.39 110.54 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.669 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 28.6 p90 -150.38 153.74 36.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.711 -0.677 . . . . 0.16 109.509 173.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -92.34 147.29 23.03 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.621 -0.881 . . . . 0.34 108.621 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.456 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 11.6 tmm? -59.3 -15.57 16.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.997 -0.547 . . . . 2.43 112.175 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 t -64.33 -29.25 70.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.785 0.326 . . . . 0.91 110.189 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -91.27 -3.79 56.55 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.539 -0.3 . . . . 1.96 111.161 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.827 HG22 HD13 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -63.21 152.0 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.944 -0.571 . . . . 0.27 111.053 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.502 ' HG2' HD13 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -67.38 96.93 0.53 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.118 -0.492 . . . . 1.6 111.417 -176.599 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.36 -99.13 0.13 Allowed Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.611 0.57 . . . . 0.58 113.578 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -88.79 140.3 29.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.779 0.799 . . . . 2.2 110.41 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.4 p -75.43 -19.81 59.25 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.102 -0.954 . . . . 0.95 111.219 -174.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.1 t -90.31 7.51 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.673 . . . . 1.39 109.717 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -102.73 -13.92 16.86 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.966 -0.561 . . . . 0.57 110.76 177.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.827 HD13 HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -121.83 123.4 41.68 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.244 -0.65 . . . . 1.51 109.244 -177.439 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -135.4 159.01 73.28 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.661 0.267 . . . . 0.91 111.444 -174.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.506 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 30.7 Cg_endo -64.78 129.86 24.6 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.132 1.888 . . . . 0.28 111.94 175.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.15 -16.1 54.0 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.939 -0.648 . . . . 0.22 111.823 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -79.21 147.23 32.69 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.909 -0.404 . . . . 1.28 109.909 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 5.5 m -76.31 137.48 39.89 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.735 -0.839 . . . . 0.17 108.735 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.465 HG11 HD21 ' A' ' 65' ' ' LEU . 28.5 m -139.42 159.18 28.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 122.205 -0.31 . . . . 0.31 110.504 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.757 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 10.4 pt-20 -115.63 144.97 43.15 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.605 -0.887 . . . . 0.78 108.605 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.584 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 17.8 p90 -148.05 178.89 8.16 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.501 -0.772 . . . . 0.11 109.431 -172.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 m -125.65 126.01 44.02 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.817 -0.808 . . . . 0.86 108.817 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 75' ' ' VAL . 8.3 p -90.02 98.69 8.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 122.058 0.932 . . . . 0.36 111.165 -171.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.0 p -106.77 131.11 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.57 -0.741 . . . . 0.42 109.662 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.4 m -77.9 132.28 37.86 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.904 -0.589 . . . . 0.67 111.627 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -76.61 122.36 24.53 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.584 -0.525 . . . . 1.82 109.584 173.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -69.73 -5.11 22.95 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.422 0.527 . . . . 1.95 112.422 -174.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.16 -60.94 1.83 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.998 -0.371 . . . . 3.99 109.998 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 83' ' ' LYS . 18.9 m120 -96.62 -30.48 13.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.815 0.341 . . . . 2.21 111.576 -173.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.44 -3.17 63.4 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.545 -0.836 . . . . 0.69 111.253 -171.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.46 ' HG2' ' HB2' ' A' ' 81' ' ' ASN . 60.1 pttt -79.02 144.72 34.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.322 -0.621 . . . . 2.42 109.322 175.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.504 ' HB2' HG11 ' A' ' 45' ' ' VAL . 9.8 m -89.56 177.56 6.52 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.393 0.616 . . . . 1.08 111.894 -174.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.9 m -149.04 153.74 38.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.98 -1.009 . . . . 0.87 109.322 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -93.89 121.88 35.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.979 0.419 . . . . 0.17 109.998 177.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.7 t -117.35 157.42 26.18 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.167 -1.049 . . . . 0.68 108.167 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 55.77 63.99 1.88 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.793 0.683 . . . . 1.82 109.764 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.622 HG12 HD11 ' A' ' 65' ' ' LEU . 78.4 t -83.77 118.41 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.36 -0.836 . . . . 0.32 111.276 -176.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.757 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 4.2 mm? -112.93 148.56 34.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.261 -0.427 . . . . 1.12 110.943 -178.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -83.49 116.17 22.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.408 0.623 . . . . 1.33 111.216 178.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.462 ' O ' ' HB ' ' A' ' 70' ' ' THR . 48.7 mm . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 115.305 -0.861 . . . . 0.28 109.926 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 111.884 -0.486 . . . . 18.87 111.884 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.21 121.56 33.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.847 0.356 . . . . 17.7 110.987 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -97.98 116.85 31.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.615 -0.513 . . . . 17.44 109.615 174.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.83 55.77 4.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.778 -0.725 . . . . 14.34 112.225 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -76.09 149.9 37.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.971 0.415 . . . . 13.69 110.473 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.65 166.57 11.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.068 -0.515 . . . . 11.39 110.547 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.3 p -121.08 128.29 76.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.406 -0.59 . . . . 8.82 109.406 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 m -78.55 32.88 0.2 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.136 0.493 . . . . 7.95 111.213 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -104.85 -48.15 3.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.978 -0.555 . . . . 7.07 111.293 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.82 114.05 7.4 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.608 -0.437 . . . . 6.67 111.448 -175.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.429 HG22 ' HG3' ' A' ' 13' ' ' GLU . 28.3 mm -129.78 150.69 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.453 -0.944 . . . . 2.89 108.453 173.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -66.34 -37.24 84.9 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.563 0.579 . . . . 3.29 112.563 -175.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.429 ' HG3' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -66.55 -9.78 38.45 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.055 0.455 . . . . 2.96 111.745 -176.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.9 t -78.49 -0.81 30.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.278 0.561 . . . . 2.31 110.125 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.39 56.95 2.05 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.697 -0.763 . . . . 1.86 111.831 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -78.6 98.8 6.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.051 0.453 . . . . 5.03 110.952 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.12 -22.31 25.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.433 -0.803 . . . . 2.37 111.134 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.11 -28.84 66.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.925 -0.579 . . . . 2.38 111.024 -175.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.3 t -136.56 129.47 30.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.693 -0.854 . . . . 2.75 108.693 173.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 p -169.53 153.22 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.37 -0.604 . . . . 1.88 109.37 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -83.24 -48.37 10.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.648 0.261 . . . . 2.71 110.965 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.36 151.28 20.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.71 -0.223 . . . . 1.95 110.533 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.28 93.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 123.169 0.293 . . . . 1.72 111.329 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.9 25.82 0.06 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.596 1.159 . . . . 2.92 112.733 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 5.0 tp60 -103.75 52.46 0.77 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.263 0.554 . . . . 1.34 111.382 -171.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -79.0 114.04 17.61 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.393 -0.595 . . . . 2.11 109.393 172.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 74.3 mmtt -99.9 156.39 17.16 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.851 -0.613 . . . . 1.27 110.4 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -125.93 128.74 48.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.858 0.361 . . . . 1.65 110.449 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.91 179.45 9.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.514 -0.766 . . . . 0.08 109.477 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.25 143.45 32.95 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.672 -0.492 . . . . 0.14 109.672 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.495 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 41.3 t -63.54 119.4 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.265 0.555 . . . . 0.14 110.074 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.96 -44.68 30.36 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.987 -1.006 . . . . 0.6 109.526 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.0 m -161.17 164.56 30.45 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.613 -0.721 . . . . 1.07 110.251 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.418 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 5.8 mt -141.63 130.38 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.056 0.455 . . . . 0.19 109.987 175.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 64.3 mmtt -125.43 104.05 8.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.479 -0.782 . . . . 1.56 110.469 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.07 -108.52 1.94 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.028 -0.606 . . . . 0.29 112.515 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -100.54 10.58 41.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.455 0.169 . . . . 2.1 110.693 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -128.89 140.63 51.59 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.163 0.506 . . . . 0.32 111.003 -173.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.88 157.36 17.42 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 120.638 -0.791 . . . . 0.11 111.433 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.508 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 77.0 m-85 -132.22 137.58 47.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.161 -0.681 . . . . 0.18 109.161 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.487 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.1 mt -110.13 154.65 23.01 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.714 -0.476 . . . . 0.59 109.714 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -74.76 73.09 2.05 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.587 0.708 . . . . 1.53 109.558 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -148.02 97.57 2.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.832 -1.076 . . . . 0.28 108.678 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 23.9 mp0 -85.65 110.01 18.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.723 -0.671 . . . . 1.81 109.966 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.486 HG11 ' HB2' ' A' ' 84' ' ' SER . 28.8 m -78.73 -36.4 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.85 112.024 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -156.42 123.16 5.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.511 -0.313 . . . . 2.24 110.488 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.2 t70 60.97 12.92 4.19 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.641 0.734 . . . . 1.55 111.966 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.0 21.08 14.43 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.635 -0.793 . . . . 0.67 112.979 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 4.0 mmtm -69.41 110.93 4.96 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.874 -0.417 . . . . 2.5 109.874 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -71.72 129.61 39.11 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.669 -0.493 . . . . 1.32 109.669 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.1 mt -66.66 123.3 19.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.594 -0.276 . . . . 0.19 110.97 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -105.28 158.3 16.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.045 0.45 . . . . 0.39 110.661 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.86 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 32.3 p90 -151.44 155.22 38.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.682 -0.69 . . . . 0.16 109.163 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -97.08 152.04 19.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.994 -0.743 . . . . 0.34 108.994 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.539 ' SD ' HG21 ' A' ' 58' ' ' VAL . 14.2 mmt -64.51 -3.06 2.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.431 0.53 . . . . 2.43 112.431 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.8 t -82.76 -25.31 32.94 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.851 -0.426 . . . . 0.91 109.851 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.84 -6.17 59.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.922 0.391 . . . . 1.96 110.421 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.539 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.0 t -71.6 152.38 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.69 -0.686 . . . . 0.27 112.45 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.78 98.33 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.483 -1.235 . . . . 1.6 112.041 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.87 -84.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.0 -0.545 . . . . 0.58 113.602 172.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -106.68 142.31 36.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.758 0.313 . . . . 2.2 110.179 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.413 HG22 ' HB3' ' A' ' 55' ' ' MET . 82.7 p -67.7 -21.37 65.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.271 0.558 . . . . 0.95 111.503 -177.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.6 t -95.01 2.19 9.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.285 0.564 . . . . 1.39 110.428 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.63 -13.8 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.443 -0.344 . . . . 0.57 111.297 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.659 HD21 HG12 ' A' ' 71' ' ' VAL . 1.1 tm? -110.65 124.69 52.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.976 -0.75 . . . . 1.51 108.976 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -117.92 150.19 46.76 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.559 -0.291 . . . . 0.91 111.121 -172.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.495 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.2 Cg_endo -66.49 135.76 40.49 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.443 2.095 . . . . 0.28 111.933 173.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.53 -2.36 73.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.916 -0.659 . . . . 0.22 112.367 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -95.91 154.7 17.09 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.804 -0.443 . . . . 1.28 109.804 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 m -79.72 136.03 36.67 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.466 -0.568 . . . . 0.17 109.466 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.659 HG12 HD21 ' A' ' 65' ' ' LEU . 20.0 m -136.48 161.3 37.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.432 0.634 . . . . 0.31 110.805 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.45 139.0 49.88 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.837 -1.172 . . . . 0.78 107.837 171.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.487 ' CD2' HD13 ' A' ' 41' ' ' LEU . 19.2 p90 -148.53 179.82 7.52 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.824 0.345 . . . . 0.11 110.193 -174.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.8 m -129.85 115.01 16.61 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.088 -0.708 . . . . 0.86 109.088 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.4 p -85.37 101.93 10.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.538 0.685 . . . . 0.36 110.834 -175.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.63 121.58 59.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.757 -0.656 . . . . 0.42 109.87 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.8 m -79.62 128.34 33.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.861 -0.608 . . . . 0.67 111.068 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -68.48 102.32 1.42 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.516 -0.765 . . . . 1.82 109.218 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -64.23 -8.03 11.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.217 0.532 . . . . 1.95 111.413 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -93.73 -39.34 10.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.883 -0.599 . . . . 3.99 111.044 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -114.28 -21.25 10.53 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.554 0.575 . . . . 2.21 112.554 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.7 -20.18 51.66 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.764 -0.731 . . . . 0.69 113.36 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -81.78 174.6 11.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.005 -0.739 . . . . 2.42 109.005 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.486 ' HB2' HG11 ' A' ' 45' ' ' VAL . 19.1 m -128.81 175.68 8.43 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.284 -0.566 . . . . 1.08 110.632 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.2 p -145.91 155.97 43.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.274 -0.421 . . . . 0.87 110.433 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.86 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -93.2 118.31 31.09 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.118 0.485 . . . . 0.17 110.24 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 97.3 m -116.74 144.05 44.91 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.132 -0.692 . . . . 0.68 109.132 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 63.68 69.01 0.56 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.084 -0.71 . . . . 1.82 109.084 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 71.0 t -87.94 116.66 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.406 -0.815 . . . . 0.32 110.722 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.35 149.03 30.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.903 -0.589 . . . . 1.12 110.705 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -77.91 126.42 30.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.139 -0.482 . . . . 1.33 109.891 176.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.09 138.85 46.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 110.072 -0.344 . . . . 0.28 110.072 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -104.35 125.87 50.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.823 0.344 . . . . 2.57 110.699 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.052 -0.522 . . . . 3.08 110.216 176.75 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 111.967 -0.453 . . . . 18.87 111.967 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.23 121.64 44.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.837 0.351 . . . . 17.7 110.523 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -105.76 92.73 4.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.117 0.485 . . . . 17.44 110.723 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.52 -28.19 7.22 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.02 -0.832 . . . . 14.34 111.02 173.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 72.9 -2.14 2.8 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.861 0.865 . . . . 13.69 112.853 173.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt -86.34 80.46 8.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.881 0.372 . . . . 11.39 110.307 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.0 p -140.88 145.82 24.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.059 -0.519 . . . . 8.82 110.021 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 m -79.63 36.35 0.32 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.478 -0.328 . . . . 7.95 111.356 -176.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -125.17 -9.67 7.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.988 0.423 . . . . 7.07 111.174 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.451 ' HA ' ' HD3' ' A' ' 10' ' ' ARG . 18.8 mmt180 -115.81 158.48 22.83 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.1 -0.64 . . . . 6.67 112.701 -175.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.1 mt -129.88 125.4 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 114.898 -1.047 . . . . 2.89 111.32 -171.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -92.04 -43.42 9.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.988 0.423 . . . . 3.29 110.544 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.517 ' HB2' HH12 ' A' ' 28' ' ' ARG . 12.3 pt-20 -59.53 -14.17 11.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.501 -0.772 . . . . 2.96 112.196 -174.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 t -62.9 -27.56 69.45 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.116 -0.327 . . . . 2.31 110.116 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.74 57.56 4.47 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.964 -0.636 . . . . 1.86 112.616 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -88.53 133.45 34.15 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.943 -0.303 . . . . 5.03 110.282 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.96 -15.15 3.07 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.944 0.72 . . . . 2.37 112.944 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.11 -16.62 64.44 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.773 0.32 . . . . 2.38 110.758 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.5 t -146.66 130.6 17.21 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.68 -0.859 . . . . 2.75 108.68 171.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 p -147.25 141.2 19.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.803 0.335 . . . . 1.88 110.1 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -144.57 154.07 42.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.52 -0.309 . . . . 2.71 111.411 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 57.1 22.76 7.76 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.95 0.782 . . . . 1.95 111.659 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.8 t 57.78 67.98 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.818 -0.628 . . . . 1.72 109.75 -172.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 47.01 30.77 1.34 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.409 1.084 . . . . 2.92 113.142 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -107.48 74.87 0.99 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.047 0.451 . . . . 1.34 110.906 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -99.37 115.4 29.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 2.11 110.172 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 28.2 mmtp -99.03 151.35 21.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.893 -0.594 . . . . 1.27 111.859 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.517 HH12 ' HB2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -115.02 127.15 55.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.73 -0.668 . . . . 1.65 110.264 176.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . . . -157.25 178.94 9.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.269 -0.271 . . . . 0.08 110.269 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.07 148.02 26.73 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.442 -0.345 . . . . 0.14 110.098 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.531 ' HA ' HD23 ' A' ' 41' ' ' LEU . 45.5 t -68.77 122.14 19.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.978 0.418 . . . . 0.14 110.624 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.41 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 22.3 t70 -75.07 -40.79 59.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.313 -0.858 . . . . 0.6 110.053 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 t -171.65 169.41 6.0 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.643 -0.708 . . . . 1.07 109.113 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.429 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 9.2 mt -136.45 126.4 39.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.254 0.55 . . . . 0.19 109.618 175.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 62.6 mmtt -120.16 85.54 2.4 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.325 -0.852 . . . . 1.56 110.361 -175.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.11 -114.55 4.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.746 -0.74 . . . . 0.29 112.549 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.59 12.78 24.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.074 -0.343 . . . . 2.1 110.074 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -132.19 140.11 48.6 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.013 0.435 . . . . 0.32 110.417 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.29 159.61 16.86 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.631 -0.795 . . . . 0.11 111.215 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 77.5 m-85 -131.47 149.54 52.49 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.03 -0.73 . . . . 0.18 109.03 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.571 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.0 mt -124.14 157.6 34.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.15 -0.315 . . . . 0.59 110.15 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -76.78 73.33 3.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.509 0.671 . . . . 1.53 109.554 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.424 ' HB3' HD12 ' A' ' 51' ' ' LEU . 16.7 t80 -148.04 98.79 2.98 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.049 -0.978 . . . . 0.28 108.859 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 43.4 mt-10 -86.95 103.36 15.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.292 -0.413 . . . . 1.81 110.135 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.535 HG21 ' H ' ' A' ' 84' ' ' SER . 27.6 m -80.65 -30.34 12.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.624 0.602 . . . . 0.85 112.624 -173.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 5.2 tp10 -161.31 110.82 1.62 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 110.57 -0.159 . . . . 2.24 110.57 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.8 t0 55.23 37.88 29.57 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.294 0.569 . . . . 1.55 111.735 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.85 20.98 54.7 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.365 -0.921 . . . . 0.67 113.087 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 38.3 mmtm -74.19 110.05 8.17 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.135 -0.691 . . . . 2.5 109.135 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -72.61 126.1 29.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.644 -0.873 . . . . 1.32 108.644 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.5 mt -63.25 128.58 36.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.114 -0.494 . . . . 0.19 110.847 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -112.49 156.72 22.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.345 -0.389 . . . . 0.39 110.302 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.906 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 25.8 p90 -146.48 149.07 32.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.623 -0.717 . . . . 0.16 109.717 174.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -91.74 145.48 24.54 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.555 -0.906 . . . . 0.34 108.555 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.51 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -58.11 -11.95 3.02 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.522 0.564 . . . . 2.43 112.522 -177.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.1 t -67.39 -25.85 66.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.823 0.345 . . . . 0.91 110.454 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -86.6 -13.87 44.46 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.242 -0.435 . . . . 1.96 110.464 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -65.82 148.39 12.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.42 -0.809 . . . . 0.27 112.298 -175.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.16 102.21 0.36 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 114.748 -1.115 . . . . 1.6 111.241 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.58 -91.59 0.26 Allowed Glycine 0 C--O 1.237 0.301 0 CA-C-N 115.952 -0.567 . . . . 0.58 113.61 173.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -101.44 151.31 22.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.648 -0.501 . . . . 2.2 109.648 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.3 p -77.71 -15.36 59.19 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.928 -0.578 . . . . 0.95 111.168 -173.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.74 2.92 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.609 -0.723 . . . . 1.39 110.078 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.48 -24.65 19.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.57 111.335 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.637 HD21 HG12 ' A' ' 71' ' ' VAL . 1.6 tm? -98.42 125.06 43.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.155 -0.683 . . . . 1.51 109.155 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -117.41 152.96 50.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 111.93 0.344 . . . . 0.91 111.93 -171.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.484 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 52.1 Cg_endo -69.65 141.9 46.95 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.991 2.461 . . . . 0.28 111.48 173.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.54 -5.13 82.58 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.776 -0.726 . . . . 0.22 112.031 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -93.93 159.61 15.1 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.401 -0.592 . . . . 1.28 109.401 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.5 m -85.02 132.19 34.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.353 -0.61 . . . . 0.17 109.353 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.637 HG12 HD21 ' A' ' 65' ' ' LEU . 6.3 m -135.3 165.2 31.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.162 0.506 . . . . 0.31 109.984 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -120.32 146.08 46.48 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.364 -0.976 . . . . 0.78 108.364 174.227 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.571 ' CD2' HD13 ' A' ' 41' ' ' LEU . 25.3 p90 -152.57 179.19 8.81 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.682 -0.488 . . . . 0.11 109.682 -174.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.4 m -126.83 123.32 37.06 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.877 -0.786 . . . . 0.86 108.877 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 p -92.69 99.49 9.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.666 0.746 . . . . 0.36 111.642 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.7 p -111.7 123.51 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.567 -0.742 . . . . 0.42 109.994 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 30.2 m -72.88 129.02 37.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.911 0.386 . . . . 0.67 110.933 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -69.37 117.82 11.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 1.82 109.631 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -71.36 -15.72 62.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.156 0.503 . . . . 1.95 110.76 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -94.89 -42.28 8.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.703 -0.681 . . . . 3.99 111.095 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -94.97 -29.09 14.82 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.317 -0.401 . . . . 2.21 111.724 -171.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.52 -24.21 26.69 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.69 112.568 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -95.24 155.85 16.56 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.46 -0.57 . . . . 2.42 109.46 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.535 ' H ' HG21 ' A' ' 45' ' ' VAL . 4.4 m -88.08 175.59 7.67 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.094 0.474 . . . . 1.08 111.289 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -141.32 153.08 44.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.692 -0.685 . . . . 0.87 109.376 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.906 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -90.73 119.62 31.11 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.112 0.482 . . . . 0.17 110.044 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.6 m -117.01 149.32 40.46 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.321 -0.854 . . . . 0.68 109.921 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 t30 56.87 69.26 0.76 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 123.593 0.558 . . . . 1.82 110.62 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 74.5 t -85.88 122.75 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 0.32 111.708 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.94 147.57 35.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.517 -0.765 . . . . 1.12 110.209 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.455 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -79.4 117.0 19.98 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.942 -0.762 . . . . 1.33 108.942 175.166 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 72' ' ' GLU . 45.7 mm -101.46 121.55 52.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.116 0.484 . . . . 0.28 110.216 -178.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -90.29 126.62 35.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.595 -0.73 . . . . 2.57 110.495 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 115.401 -0.818 . . . . 3.08 110.857 175.096 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.27 -0.332 . . . . 18.87 112.27 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.47 152.72 49.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.696 0.284 . . . . 17.7 110.63 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -137.69 168.25 20.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.09 -0.504 . . . . 17.44 110.007 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.72 85.91 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.768 -0.73 . . . . 14.34 112.115 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.28 86.78 4.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.73 -0.47 . . . . 13.69 109.73 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.95 118.04 29.22 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.189 -0.671 . . . . 11.39 109.189 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.8 t -77.18 71.33 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.497 0.665 . . . . 8.82 110.537 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.6 p -91.96 85.01 5.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.945 -0.571 . . . . 7.95 110.123 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -89.01 -25.46 21.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.855 -0.611 . . . . 7.07 110.965 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.85 107.2 2.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.562 0.696 . . . . 6.67 110.246 175.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 36.7 mm -140.86 117.26 7.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.4 -0.818 . . . . 2.89 109.463 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.4 -40.78 97.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.314 0.578 . . . . 3.29 110.722 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -81.41 15.02 2.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.857 -1.065 . . . . 2.96 111.733 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.466 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 5.8 t -77.35 -18.22 57.59 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.06 -0.4 . . . . 2.31 110.559 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.72 58.01 0.31 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.217 -0.992 . . . . 1.86 112.353 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -75.16 114.26 13.46 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.063 -0.347 . . . . 5.03 110.063 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.59 -15.92 58.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.263 -0.426 . . . . 2.37 112.002 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.68 -23.98 64.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.534 -0.303 . . . . 2.38 111.4 -176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.2 p -140.07 129.83 24.52 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.375 -0.602 . . . . 2.75 109.375 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.6 p -169.39 164.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 110.361 -0.237 . . . . 1.88 110.361 -175.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -129.83 -176.29 3.88 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.98 -0.748 . . . . 2.71 108.98 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 74' ' ' SER . . . 57.84 23.95 10.28 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.845 0.458 . . . . 1.95 112.191 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t 62.21 71.09 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.734 -0.666 . . . . 1.72 110.78 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? 45.84 32.56 1.31 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.44 1.096 . . . . 2.92 113.921 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -123.12 112.6 17.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.694 0.283 . . . . 1.34 111.087 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -118.37 136.89 53.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.28 0.562 . . . . 2.11 111.308 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -112.75 150.71 31.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.232 -0.894 . . . . 1.27 110.561 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -120.46 127.17 51.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.907 0.385 . . . . 1.65 110.408 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.97 179.87 8.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.802 -0.635 . . . . 0.08 109.529 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 144.52 30.64 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 110.194 -0.299 . . . . 0.14 110.194 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.426 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 47.5 t -66.32 114.0 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.2 -0.296 . . . . 0.14 110.2 176.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.451 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 7.1 t70 -66.95 -50.21 63.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.955 -0.566 . . . . 0.6 109.861 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.9 m -159.79 163.81 34.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.468 -0.787 . . . . 1.07 110.016 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.445 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 7.7 mt -137.47 126.1 33.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.456 -0.572 . . . . 0.19 109.456 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -118.77 90.45 3.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.256 -0.884 . . . . 1.56 109.862 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.37 -112.1 4.14 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.721 -0.752 . . . . 0.29 112.476 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -96.84 11.69 34.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 2.1 110.246 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -129.71 142.04 50.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.143 0.497 . . . . 0.32 110.751 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.92 155.95 17.27 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.379 -0.828 . . . . 0.11 111.378 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 70.7 m-85 -129.82 139.75 51.17 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.826 -0.805 . . . . 0.18 108.826 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.541 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.4 mt -111.58 156.7 21.37 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.784 -0.45 . . . . 0.59 109.784 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -74.62 73.25 1.99 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.966 -0.753 . . . . 1.53 108.966 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -149.57 98.43 2.76 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.624 -0.717 . . . . 0.28 109.289 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 23.0 mp0 -75.73 100.71 4.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 1.81 109.712 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.648 HG11 ' HB3' ' A' ' 84' ' ' SER . 35.3 m -74.39 -30.39 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.713 -0.676 . . . . 0.85 111.519 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -156.73 109.79 2.59 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 116.092 -0.504 . . . . 2.24 110.354 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t0 54.52 29.6 11.55 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.185 0.517 . . . . 1.55 112.286 171.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.11 1.49 44.97 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.161 -1.018 . . . . 0.67 113.151 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 4.0 mmtp -64.64 111.77 2.89 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.862 0.331 . . . . 2.5 110.61 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -65.78 138.89 58.23 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.271 0.357 . . . . 1.32 110.181 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.594 ' HG ' ' CG1' ' A' ' 45' ' ' VAL . 1.3 mt -74.68 125.22 28.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.45 -0.341 . . . . 0.19 110.348 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -106.87 157.22 17.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.39 110.064 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.906 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 28.1 p90 -151.05 157.06 42.33 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.596 -0.729 . . . . 0.16 109.394 174.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -98.92 151.01 21.34 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.111 -0.7 . . . . 0.34 109.111 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.441 ' SD ' HG21 ' A' ' 58' ' ' VAL . 9.4 mmt -62.39 -6.94 3.69 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.797 0.665 . . . . 2.43 112.797 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -81.23 -25.28 36.77 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.241 -0.184 . . . . 0.91 111.068 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -81.77 -15.69 53.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.032 0.444 . . . . 1.96 110.157 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.441 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.8 t -62.56 151.84 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.212 -0.904 . . . . 0.27 112.188 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.506 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -64.63 88.96 0.06 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.005 -0.998 . . . . 1.6 112.38 -173.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.37 -66.47 2.28 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.974 -0.557 . . . . 0.58 113.337 170.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -122.31 143.7 49.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.296 0.57 . . . . 2.2 110.264 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.7 p -72.3 -26.64 62.03 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.119 -0.946 . . . . 0.95 110.926 -174.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -95.67 22.99 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.753 0.787 . . . . 1.39 109.633 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.9 -15.68 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.598 -0.728 . . . . 0.57 109.765 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.562 HD21 HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -119.49 124.74 47.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.889 -1.05 . . . . 1.51 109.603 -178.028 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -122.99 153.63 64.21 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.682 -0.235 . . . . 0.91 111.235 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.426 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 41.4 Cg_endo -68.47 129.06 18.27 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.523 2.149 . . . . 0.28 111.972 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.58 -14.04 56.51 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.918 -0.583 . . . . 0.22 111.84 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 1.3 m-20 -82.16 154.14 25.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 1.28 110.323 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m -78.71 141.88 37.54 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.298 -0.63 . . . . 0.17 109.298 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.562 HG11 HD21 ' A' ' 65' ' ' LEU . 30.6 m -139.87 161.41 26.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.654 0.74 . . . . 0.31 111.761 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.33 137.51 51.71 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.447 -1.251 . . . . 0.78 108.096 172.582 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.541 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.8 p90 -149.48 178.55 8.71 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.29 -0.633 . . . . 0.11 109.29 -174.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' A' ' 22' ' ' ALA . 3.7 m -124.29 132.33 53.56 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.09 -0.707 . . . . 0.86 109.09 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.02 99.14 8.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.504 0.668 . . . . 0.36 110.978 -175.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.42 ' HB ' ' CB ' ' A' ' 22' ' ' ALA . 7.5 p -114.46 116.95 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.47 0.653 . . . . 0.42 110.719 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.9 m -69.98 125.96 28.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.703 -0.681 . . . . 0.67 110.483 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -65.96 114.44 5.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 1.82 109.326 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -58.59 -31.24 67.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.41 -0.359 . . . . 1.95 111.357 -175.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.42 -36.79 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.341 -0.391 . . . . 3.99 111.42 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -92.83 -23.36 18.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.054 0.39 . . . . 2.21 112.054 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.58 -24.57 7.32 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.028 -0.606 . . . . 0.69 113.484 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -88.44 149.94 23.41 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.812 -0.44 . . . . 2.42 109.812 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.648 ' HB3' HG11 ' A' ' 45' ' ' VAL . 42.7 t -85.32 177.59 7.77 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.794 0.331 . . . . 1.08 110.709 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.4 m -150.74 149.96 30.43 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.286 -0.635 . . . . 0.87 109.286 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.906 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -91.94 121.51 33.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.025 0.441 . . . . 0.17 110.614 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.0 m -117.49 144.39 45.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.028 -0.533 . . . . 0.68 109.909 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 57.71 73.11 0.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.743 0.652 . . . . 1.82 110.31 -175.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 94.0 t -92.05 105.01 16.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.568 -0.742 . . . . 0.32 110.308 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 11.1 mp -105.89 149.08 26.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.594 -0.73 . . . . 1.12 110.735 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.41 ' HD3' ' HB3' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -86.18 103.25 14.64 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.907 -0.588 . . . . 1.33 110.795 -174.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.6 mm -85.21 118.54 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.585 -0.734 . . . . 0.28 110.235 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -86.09 110.87 19.83 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.069 -0.514 . . . . 2.57 110.997 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 3.08 109.598 173.947 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 -0.079 0 N-CA-C 112.121 -0.392 . . . . 18.87 112.121 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.37 135.02 33.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.805 0.336 . . . . 17.7 110.747 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -108.92 122.04 46.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.075 -0.511 . . . . 17.44 109.694 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.26 21.5 0.23 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.346 -0.93 . . . . 14.34 112.824 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -87.56 82.53 7.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.236 -0.653 . . . . 13.69 109.236 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.0 mt -88.27 107.33 18.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.965 -0.561 . . . . 11.39 110.498 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 t -91.6 80.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.267 0.556 . . . . 8.82 110.905 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 t -101.43 84.91 2.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.008 -0.738 . . . . 7.95 109.008 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -85.44 8.58 18.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.677 -0.692 . . . . 7.07 111.375 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.554 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 1.2 ppt_? -145.42 144.07 30.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.173 0.511 . . . . 6.67 112.081 -172.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.0 mm -110.27 120.91 62.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 107.883 -1.155 . . . . 2.89 107.883 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.504 ' HB2' HD21 ' A' ' 90' ' ' LEU . 72.8 m-20 -63.69 -29.97 71.14 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.583 0.586 . . . . 3.29 112.583 -168.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -80.34 10.28 4.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.717 0.294 . . . . 2.96 111.588 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.1 t -72.52 -12.09 60.93 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.56 0.219 . . . . 2.31 111.163 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.56 58.44 1.0 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.427 -0.892 . . . . 1.86 112.787 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -63.23 100.55 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.825 0.345 . . . . 5.03 110.823 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.59 -21.99 28.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.023 -0.535 . . . . 2.37 110.889 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.52 -21.53 61.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.871 -0.604 . . . . 2.38 111.727 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 53.7 t -159.22 132.63 7.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.802 0.334 . . . . 2.75 110.61 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -168.49 151.4 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.842 -0.617 . . . . 1.88 109.42 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -95.16 44.89 1.09 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.566 0.698 . . . . 2.71 110.341 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -170.72 160.09 6.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.368 -0.833 . . . . 1.95 109.211 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.87 82.09 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.73 -0.388 . . . . 1.72 110.146 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 43.16 30.35 0.27 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.522 1.129 . . . . 2.92 113.183 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -115.29 90.17 3.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.993 0.425 . . . . 1.34 110.775 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -109.61 123.72 49.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.02 -0.537 . . . . 2.11 110.558 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -109.08 153.02 24.26 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.625 -0.716 . . . . 1.27 110.687 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -122.85 128.34 50.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.738 0.304 . . . . 1.65 110.303 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.73 179.7 8.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.641 -0.709 . . . . 0.08 109.095 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.74 145.38 29.21 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.761 -0.459 . . . . 0.14 109.761 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.519 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 41.9 t -64.85 114.37 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.159 0.504 . . . . 0.14 109.977 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.475 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 9.9 t70 -67.86 -45.28 75.02 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.858 -1.065 . . . . 0.6 109.747 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.7 m -169.05 166.5 10.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.514 -0.766 . . . . 1.07 109.868 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.415 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 8.3 mt -137.96 128.48 36.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.944 -0.391 . . . . 0.19 109.944 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -115.22 88.02 2.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.686 -0.688 . . . . 1.56 109.856 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.03 -106.99 1.88 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.733 -0.746 . . . . 0.29 112.816 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -96.35 5.34 51.12 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.58 0.228 . . . . 2.1 111.178 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -125.75 140.38 52.74 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.002 0.43 . . . . 0.32 110.368 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.541 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.17 158.28 16.86 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.51 -0.852 . . . . 0.11 111.323 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -132.08 141.12 49.08 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.867 -0.79 . . . . 0.18 108.867 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.551 HD13 ' CD2' ' A' ' 73' ' ' PHE . 4.8 mt -115.09 150.75 35.47 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.427 -0.953 . . . . 0.59 108.427 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -75.21 72.97 2.32 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.272 0.558 . . . . 1.53 109.64 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -142.61 98.07 3.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.156 -0.929 . . . . 0.28 108.57 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 15.4 mp0 -90.23 107.62 19.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.039 -0.528 . . . . 1.81 109.791 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.451 HG11 ' HB2' ' A' ' 84' ' ' SER . 29.2 m -74.62 -32.69 30.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.622 -0.717 . . . . 0.85 111.851 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -156.45 114.06 3.23 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.532 -0.304 . . . . 2.24 110.572 -174.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 51.8 34.06 12.46 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.387 0.884 . . . . 1.55 113.387 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 44' ' ' GLU . . . 89.97 20.34 43.43 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.233 -0.984 . . . . 0.67 112.725 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -79.98 109.16 14.15 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.033 -0.728 . . . . 2.5 109.033 176.654 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -71.63 138.81 48.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.636 -0.711 . . . . 1.32 110.726 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.497 HD23 ' HA ' ' A' ' 51' ' ' LEU . 4.5 mt -74.89 122.65 23.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.477 -0.329 . . . . 0.19 111.222 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -107.37 161.29 14.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.427 -0.351 . . . . 0.39 110.07 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.735 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 17.1 p90 -152.69 158.77 42.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.132 -0.485 . . . . 0.16 109.741 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.403 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . 9.5 t-160 -99.97 156.05 17.36 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.718 -0.845 . . . . 0.34 108.718 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.448 ' SD ' HG21 ' A' ' 58' ' ' VAL . 13.2 mmt -65.03 3.18 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.257 0.465 . . . . 2.43 112.257 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.3 t -87.39 -28.01 22.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.91 110.127 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' A' ' 54' ' ' HIS . 9.9 mp0 -84.53 -11.01 56.91 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.236 -0.438 . . . . 1.96 110.188 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.473 HG22 HD22 ' A' ' 65' ' ' LEU . 2.4 t -68.38 150.3 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.463 -0.789 . . . . 0.27 111.649 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -58.23 88.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.045 -0.979 . . . . 1.6 111.736 -177.218 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.11 -91.2 0.03 OUTLIER Glycine 0 CA--C 1.52 0.403 0 O-C-N 123.501 0.501 . . . . 0.58 113.199 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -79.27 129.93 34.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.482 0.658 . . . . 2.2 110.587 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.5 p -80.44 -10.3 59.75 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.062 -0.972 . . . . 0.95 110.963 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.54 -11.12 10.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.529 -0.76 . . . . 1.39 110.234 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.5 -19.11 31.69 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.939 0.4 . . . . 0.57 111.693 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -105.91 124.29 49.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.595 -0.52 . . . . 1.51 109.595 -177.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -123.35 156.21 64.06 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.583 0.23 . . . . 0.91 111.058 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.472 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 47.4 Cg_endo -69.23 129.09 17.51 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.425 2.084 . . . . 0.28 111.477 174.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.519 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 102.5 -13.02 56.85 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.674 -0.775 . . . . 0.22 112.114 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -82.02 152.57 26.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.275 -0.269 . . . . 1.28 110.275 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -76.5 137.81 39.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.051 -0.722 . . . . 0.17 109.051 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -139.13 163.71 26.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.902 0.382 . . . . 0.31 111.216 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.555 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 3.4 pt-20 -114.02 150.56 33.72 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.294 -1.372 . . . . 0.78 107.294 170.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.551 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.3 p90 -156.97 179.85 8.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.192 -0.67 . . . . 0.11 109.192 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.7 m -129.88 113.89 15.21 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.828 -0.805 . . . . 0.86 108.828 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.1 p -86.31 97.76 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 122.019 0.914 . . . . 0.36 110.488 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -105.68 117.13 50.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.174 -0.921 . . . . 0.42 109.315 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.8 m -73.65 126.53 30.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.333 0.587 . . . . 0.67 110.786 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -69.78 113.76 7.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.0 -1.0 . . . . 1.82 110.001 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -65.52 -16.8 64.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.314 0.578 . . . . 1.95 110.402 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -91.07 -38.19 12.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.58 -0.736 . . . . 3.99 111.584 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -103.44 -26.61 12.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.119 0.414 . . . . 2.21 112.119 -171.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.82 -23.21 24.43 Favored Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 121.053 -0.594 . . . . 0.69 112.013 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 49' ' ' LYS . 15.1 pttp -91.28 174.74 7.23 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.27 -0.641 . . . . 2.42 109.27 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.451 ' HB2' HG11 ' A' ' 45' ' ' VAL . 19.0 m -114.28 179.92 3.82 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.741 -0.384 . . . . 1.08 110.643 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.8 m -147.19 147.01 30.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.7 -0.682 . . . . 0.87 109.338 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -86.33 117.38 25.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.171 0.51 . . . . 0.17 110.53 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.4 m -116.25 150.04 38.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.579 -0.737 . . . . 0.68 109.407 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 61.91 59.17 1.77 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.16 -0.681 . . . . 1.82 109.16 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 90.1 t -85.05 101.49 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.854 -0.612 . . . . 0.32 110.147 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.555 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 3.2 mp -106.21 145.99 30.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.242 0.544 . . . . 1.12 111.517 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.84 117.46 17.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.548 -0.751 . . . . 1.33 110.807 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mm -103.76 125.84 58.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.719 -0.673 . . . . 0.28 111.114 -175.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -96.07 133.03 40.81 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.282 -0.872 . . . . 2.57 108.797 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 116.491 -0.322 . . . . 3.08 110.74 -178.986 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.309 -0.317 . . . . 18.87 112.309 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.34 76.76 1.04 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.066 0.46 . . . . 17.7 110.772 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -139.54 171.57 14.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.834 -0.621 . . . . 17.44 109.605 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.16 -131.61 4.16 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.538 -0.625 . . . . 14.34 111.538 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -110.41 125.29 53.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.936 0.398 . . . . 13.69 110.017 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.3 mt -77.76 -46.53 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.219 0.533 . . . . 11.39 109.824 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.9 p -125.37 121.03 59.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.696 -0.684 . . . . 8.82 109.962 176.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.8 t -78.41 78.28 4.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.397 0.618 . . . . 7.95 109.579 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -151.66 -66.39 0.18 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.443 -0.799 . . . . 7.07 109.309 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.742 ' HD3' ' O ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -91.91 95.0 9.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.027 0.918 . . . . 6.67 110.093 175.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.434 HG22 ' HG2' ' A' ' 13' ' ' GLU . 43.9 mm -106.45 120.55 57.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.706 -0.679 . . . . 2.89 110.132 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.2 -49.2 75.17 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.36 -0.836 . . . . 3.29 111.243 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.746 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 13.3 pt-20 -61.22 -26.91 68.06 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.156 0.503 . . . . 2.96 111.141 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.6 m -70.37 -36.03 73.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.107 -0.497 . . . . 2.31 110.543 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 57.46 16.68 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.182 -0.532 . . . . 1.86 113.197 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -68.02 145.39 54.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.77 0.285 . . . . 5.03 110.651 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.81 -17.39 9.09 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.184 0.809 . . . . 2.37 113.184 -172.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.42 -16.64 63.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.605 0.224 . . . . 2.38 111.605 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.6 p -154.43 130.78 10.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.688 0.28 . . . . 2.75 110.657 176.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 p -168.6 150.11 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.986 -0.376 . . . . 1.88 109.986 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -86.64 -57.09 3.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.755 0.312 . . . . 2.71 110.497 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 74' ' ' SER . . . -81.75 176.93 9.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.9 0.381 . . . . 1.95 110.238 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -78.64 84.54 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.123 -0.49 . . . . 1.72 110.137 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.7 37.0 0.66 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.633 1.173 . . . . 2.92 113.436 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.5 tp60 -128.67 104.02 7.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.487 -0.324 . . . . 1.34 110.664 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.34 112.59 20.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.015 0.436 . . . . 2.11 110.426 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -96.05 160.64 14.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.592 . . . . 1.27 111.041 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.54 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 71.6 mtm-85 -132.31 127.86 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.033 0.444 . . . . 1.65 111.348 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.72 179.92 8.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.593 -0.73 . . . . 0.08 109.359 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.44 145.07 30.55 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 110.01 -0.367 . . . . 0.14 110.01 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.554 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 47.5 t -65.79 120.41 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 120.923 0.392 . . . . 0.14 109.958 176.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.56 -44.14 68.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.308 -0.86 . . . . 0.6 109.574 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.2 m -173.48 169.25 4.41 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.438 -0.801 . . . . 1.07 109.87 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.7 mt -136.69 135.2 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.945 0.402 . . . . 0.19 110.2 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -123.91 97.38 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.555 -0.748 . . . . 1.56 110.17 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.7 -107.1 1.78 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.819 -0.705 . . . . 0.29 112.405 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -98.67 4.07 47.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.568 0.223 . . . . 2.1 110.771 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -123.71 141.14 52.3 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 120.468 -0.493 . . . . 0.32 111.16 -171.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.41 156.08 18.39 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 120.579 -0.82 . . . . 0.11 111.319 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 74.3 m-85 -130.16 141.47 50.67 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.179 -0.675 . . . . 0.18 109.179 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.518 HD13 ' CD2' ' A' ' 73' ' ' PHE . 5.5 mt -112.09 156.17 22.67 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.739 -0.467 . . . . 0.59 109.739 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -78.26 72.83 4.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.566 0.698 . . . . 1.53 109.677 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.467 ' HB3' HD12 ' A' ' 51' ' ' LEU . 25.2 t80 -142.59 98.57 3.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.797 -1.092 . . . . 0.28 108.186 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 41.8 mt-10 -93.16 104.34 16.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.35 0.595 . . . . 1.81 110.928 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.2 m -72.74 -34.13 46.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.407 -0.815 . . . . 0.85 111.529 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 5.6 tt0 -155.05 118.34 4.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.631 -0.259 . . . . 2.24 110.756 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.9 t70 56.11 29.48 14.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.524 0.678 . . . . 1.55 112.162 167.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.416 ' HA2' ' CD ' ' A' ' 44' ' ' GLU . . . 88.5 24.5 33.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.149 -1.024 . . . . 0.67 112.873 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 12.5 mmtm -71.71 109.81 5.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.917 -0.771 . . . . 2.5 108.917 172.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -77.97 121.53 24.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.24 -0.436 . . . . 1.32 109.97 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.467 HD12 ' HB3' ' A' ' 43' ' ' PHE . 2.5 mt -58.83 123.93 18.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.945 -0.571 . . . . 0.19 110.912 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -106.12 157.46 17.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.93 0.395 . . . . 0.39 110.701 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.936 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 35.7 p90 -151.2 153.79 35.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.718 -0.674 . . . . 0.16 109.277 173.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -95.3 150.66 20.01 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.441 -0.948 . . . . 0.34 108.441 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.7 mtt -64.66 2.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.317 0.488 . . . . 2.43 112.317 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 t -83.71 -27.09 29.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.897 -0.408 . . . . 0.91 109.897 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.32 -8.03 58.69 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.979 0.419 . . . . 1.96 110.203 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 65' ' ' LEU . 2.1 t -65.63 152.21 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.354 -0.839 . . . . 0.27 112.709 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 12.9 tm0? -66.62 95.15 0.32 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.166 -0.924 . . . . 1.6 112.299 -175.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.87 -81.43 0.54 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.939 -0.573 . . . . 0.58 113.461 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -107.7 148.2 29.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.896 0.379 . . . . 2.2 110.294 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.8 p -67.48 -24.77 65.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.869 -0.605 . . . . 0.95 110.832 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.5 t -93.18 3.42 8.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.787 -0.642 . . . . 1.39 110.637 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -87.79 -24.07 23.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.018 0.437 . . . . 0.57 110.709 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.711 HD22 ' HG2' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -105.67 124.74 50.05 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.842 -0.799 . . . . 1.51 108.842 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -119.99 149.78 49.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.668 -0.242 . . . . 0.91 110.892 -173.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.425 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 36.9 Cg_endo -67.34 122.0 9.2 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.33 2.02 . . . . 0.28 111.358 172.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.554 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 102.58 -11.42 56.5 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.779 -0.724 . . . . 0.22 112.203 -176.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.5 155.28 22.24 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.912 -0.403 . . . . 1.28 109.912 175.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.4 m -78.77 141.72 37.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.218 -0.66 . . . . 0.17 109.218 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.665 HG11 HD11 ' A' ' 65' ' ' LEU . 6.2 m -136.92 165.7 27.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.842 0.83 . . . . 0.31 111.251 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.746 ' OE1' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -121.51 144.05 48.92 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.216 -1.356 . . . . 0.78 107.988 171.064 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.518 ' CD2' HD13 ' A' ' 41' ' ' LEU . 23.0 p90 -154.04 178.99 9.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.868 -0.419 . . . . 0.11 109.868 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.465 ' HB3' ' HB3' ' A' ' 22' ' ' ALA . 18.1 m -127.43 118.15 23.51 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.883 -0.784 . . . . 0.86 108.883 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.3 p -82.95 98.97 5.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 122.072 0.939 . . . . 0.36 110.777 -175.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.9 122.86 64.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.152 -0.931 . . . . 0.42 109.863 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.4 m -76.53 130.34 37.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.987 -0.552 . . . . 0.67 111.022 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -73.98 106.55 5.72 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.994 -0.743 . . . . 1.82 108.994 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -64.65 -15.39 61.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.639 0.256 . . . . 1.95 111.681 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.547 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 4.3 tpm_? -90.83 -43.84 9.79 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.675 0.25 . . . . 3.99 111.675 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.488 ' OD1' ' HG2' ' A' ' 83' ' ' LYS . 22.6 t-20 -95.28 -31.97 13.21 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.803 -0.359 . . . . 2.21 111.18 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.42 -21.01 40.59 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.126 -0.559 . . . . 0.69 113.014 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.488 ' HG2' ' OD1' ' A' ' 81' ' ' ASN . 58.7 pttt -91.32 171.16 9.41 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 109.455 -0.572 . . . . 2.42 109.455 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.7 m -108.93 176.16 5.2 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.606 -0.438 . . . . 1.08 111.396 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.1 p -145.83 154.78 42.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.621 . . . . 0.87 109.881 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.936 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -93.27 117.46 30.1 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.273 0.558 . . . . 0.17 110.417 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.4 m -117.26 145.18 44.12 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.741 -0.663 . . . . 0.68 109.602 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 58.2 t30 62.13 71.33 0.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.427 0.632 . . . . 1.82 109.777 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 80.2 t -89.8 121.81 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.077 -0.965 . . . . 0.32 111.223 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.513 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 4.3 mm? -112.26 148.37 34.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.79 -0.641 . . . . 1.12 109.916 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.711 ' HG2' HD22 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -87.51 118.18 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.155 -0.683 . . . . 1.33 109.155 177.396 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.0 mm -104.75 131.1 54.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.275 -0.875 . . . . 0.28 110.781 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -81.0 117.1 21.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.21 -0.45 . . . . 2.57 110.021 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.394 -0.821 . . . . 3.08 111.415 -179.664 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.103 0 N-CA-C 112.282 -0.327 . . . . 18.87 112.282 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.84 164.24 33.8 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.01 -0.367 . . . . 17.7 110.01 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -93.14 110.79 22.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.055 0.455 . . . . 17.44 110.087 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.4 42.34 1.94 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.742 -0.742 . . . . 14.34 112.348 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.08 160.74 23.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.12 0.485 . . . . 13.69 110.897 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.1 mt -102.54 163.12 12.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.519 . . . . 11.39 110.976 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.7 p -111.78 119.93 61.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.084 -0.507 . . . . 8.82 110.041 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.5 p -74.01 88.49 1.88 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.116 0.484 . . . . 7.95 110.569 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -161.21 -47.17 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.776 -0.647 . . . . 7.07 110.634 -174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.05 103.67 7.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.133 0.492 . . . . 6.67 111.274 -176.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.444 HG22 ' HG3' ' A' ' 13' ' ' GLU . 26.1 mm -123.94 143.23 37.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.251 -0.648 . . . . 2.89 109.251 177.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.11 -44.22 69.43 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.327 0.492 . . . . 3.29 112.327 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' HG3' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -66.58 -10.74 48.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.36 0.6 . . . . 2.96 111.309 -177.288 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.4 m -77.36 -13.46 59.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 2.31 111.291 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.78 58.3 0.6 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.537 -0.839 . . . . 1.86 112.073 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -89.16 100.93 13.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.134 0.493 . . . . 5.03 111.437 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.17 -17.22 37.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.781 -0.645 . . . . 2.37 110.541 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.96 -25.43 64.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.638 . . . . 2.38 112.051 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.2 t -152.43 130.99 12.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.885 0.374 . . . . 2.75 110.715 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -168.81 131.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.759 -0.655 . . . . 1.88 109.326 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -73.99 -27.3 60.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 2.71 111.43 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.81 175.59 5.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.199 -0.455 . . . . 1.95 110.247 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -81.62 78.45 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.983 -0.377 . . . . 1.72 109.983 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? 44.29 26.39 0.16 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.409 1.084 . . . . 2.92 113.06 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -105.46 92.24 4.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.891 0.376 . . . . 1.34 110.506 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -104.54 122.66 46.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.126 0.488 . . . . 2.11 110.312 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 72.0 mmtt -100.43 144.8 29.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.652 -0.704 . . . . 1.27 110.78 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.522 ' HE ' ' HB2' ' A' ' 72' ' ' GLU . 9.5 mmt85 -112.77 128.37 56.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.204 -0.453 . . . . 1.65 110.056 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . . . -159.04 179.98 8.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.84 -0.43 . . . . 0.08 109.84 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.76 147.4 28.64 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.289 -0.263 . . . . 0.14 110.289 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.458 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 38.5 t -66.42 113.83 3.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.199 0.523 . . . . 0.14 109.824 174.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.41 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 20.7 t70 -72.5 -44.36 62.35 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.053 -0.976 . . . . 0.6 109.615 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.3 m -164.28 166.86 20.52 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.805 -0.634 . . . . 1.07 110.562 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.447 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 5.3 mt -139.76 134.52 38.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.168 0.508 . . . . 0.19 109.942 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -127.53 91.88 3.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.423 -0.808 . . . . 1.56 110.313 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.51 -106.66 1.81 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.721 -0.752 . . . . 0.29 112.786 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -98.27 6.43 47.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.611 0.243 . . . . 2.1 110.363 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.47 140.85 51.61 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.125 0.488 . . . . 0.32 110.72 -173.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.519 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.67 158.73 15.56 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.313 -0.858 . . . . 0.11 111.148 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 80.7 m-85 -131.86 131.41 42.77 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.79 -0.819 . . . . 0.18 108.79 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.554 HD22 HG21 ' A' ' 71' ' ' VAL . 9.6 mt -103.93 153.49 20.74 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.573 -0.529 . . . . 0.59 109.573 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -76.32 73.4 3.1 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.995 -0.743 . . . . 1.53 108.995 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.423 ' HB3' HD12 ' A' ' 51' ' ' LEU . 28.0 t80 -150.1 98.68 2.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.735 -1.121 . . . . 0.28 109.091 -178.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.503 ' HG2' ' HA2' ' A' ' 48' ' ' GLY . 3.3 mp0 -82.12 100.75 9.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.452 -0.795 . . . . 1.81 109.978 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.631 HG11 ' HB3' ' A' ' 84' ' ' SER . 7.4 m -71.36 -39.37 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.422 -0.808 . . . . 0.85 111.978 -176.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' H ' ' HB2' ' A' ' 49' ' ' LYS . 5.9 tp10 -140.44 101.57 4.14 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.881 0.372 . . . . 2.24 111.0 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 t70 58.92 20.17 7.84 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.565 -0.743 . . . . 1.55 112.927 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.503 ' HA2' ' HG2' ' A' ' 44' ' ' GLU . . . 111.43 11.73 16.89 Favored Glycine 0 C--N 1.315 -0.589 0 C-N-CA 119.976 -1.107 . . . . 0.67 112.737 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.505 ' HB2' ' H ' ' A' ' 46' ' ' GLU . 23.3 mmtm -69.72 110.63 5.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.344 -0.613 . . . . 2.5 109.344 173.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -70.55 132.19 45.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.878 -0.416 . . . . 1.32 109.878 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 3.0 mt -71.85 122.02 20.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.423 -0.353 . . . . 0.19 111.098 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -105.07 157.56 17.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.286 -0.416 . . . . 0.39 109.955 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.875 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 26.6 p90 -151.44 153.35 34.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.903 -0.59 . . . . 0.16 109.518 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.401 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . 16.6 t-80 -96.58 152.22 18.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.962 -0.755 . . . . 0.34 108.962 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.571 ' SD ' HG21 ' A' ' 58' ' ' VAL . 15.5 mmt -65.14 -1.66 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.417 0.525 . . . . 2.43 112.417 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.8 t -84.92 -19.47 32.17 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.08 -0.387 . . . . 0.91 110.209 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.401 ' OE2' ' HB3' ' A' ' 54' ' ' HIS . 1.8 mp0 -90.03 -6.03 55.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.313 -0.403 . . . . 1.96 110.326 176.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.571 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -71.42 150.11 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.786 0.661 . . . . 0.27 112.786 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.42 93.5 0.07 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.87 -1.059 . . . . 1.6 112.128 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.99 -66.38 3.41 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 121.201 -0.523 . . . . 0.58 113.969 169.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -131.27 141.86 50.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.19 0.519 . . . . 2.2 110.018 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.8 p -70.87 -23.58 62.34 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.129 -0.941 . . . . 0.95 110.89 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.6 t -93.47 12.07 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 115.252 -0.885 . . . . 1.39 110.075 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.75 -38.0 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.484 -0.326 . . . . 0.57 111.226 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.661 HD21 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -90.17 124.99 35.3 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.158 -0.682 . . . . 1.51 109.158 -178.412 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -132.15 160.88 66.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.415 -0.357 . . . . 0.91 111.211 -173.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.458 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 27.0 Cg_endo -62.38 140.81 84.49 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.592 2.195 . . . . 0.28 111.887 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.26 -14.36 63.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.075 -0.583 . . . . 0.22 112.468 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.408 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 2.7 m-20 -79.0 148.69 32.44 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.981 -0.378 . . . . 1.28 109.981 174.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 5.5 m -81.67 140.27 34.45 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.821 -0.807 . . . . 0.17 108.821 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.661 HG12 HD21 ' A' ' 65' ' ' LEU . 34.4 m -135.5 157.24 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.962 0.887 . . . . 0.31 111.351 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.522 ' HB2' ' HE ' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -114.74 132.25 56.5 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.856 -1.52 . . . . 0.78 107.688 171.597 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.501 ' CD2' HD13 ' A' ' 41' ' ' LEU . 20.1 p90 -143.25 179.54 7.01 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.639 -0.504 . . . . 0.11 109.639 -175.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 m -127.1 121.46 31.52 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.957 -0.757 . . . . 0.86 108.957 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 p -81.22 98.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.701 0.762 . . . . 0.36 110.593 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.55 120.53 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.717 -0.674 . . . . 0.42 110.45 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.7 m -68.78 133.0 47.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.736 -0.666 . . . . 0.67 111.279 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -71.05 105.23 3.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.736 -0.839 . . . . 1.82 108.736 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -63.93 -13.25 44.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.287 -0.415 . . . . 1.95 112.046 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -96.0 -36.8 10.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.472 -0.331 . . . . 3.99 111.563 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -107.38 -31.41 8.19 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.363 0.505 . . . . 2.21 112.363 -169.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.91 -21.24 38.8 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.236 -0.983 . . . . 0.69 113.663 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -85.33 175.46 8.89 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.287 -0.635 . . . . 2.42 109.287 177.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.631 ' HB3' HG11 ' A' ' 45' ' ' VAL . 19.6 t -117.43 -178.15 3.39 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.587 -0.445 . . . . 1.08 110.981 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.0 p -156.79 152.99 27.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.908 -0.587 . . . . 0.87 109.942 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.875 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -86.73 118.4 26.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.939 0.4 . . . . 0.17 110.627 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 33.9 m -116.74 140.86 48.94 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.269 -0.423 . . . . 0.68 109.916 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 63.39 72.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.622 0.725 . . . . 1.82 109.237 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 54.5 t -87.98 116.8 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.803 -1.09 . . . . 0.32 110.505 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 4.1 mm? -108.47 148.91 29.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.03 -0.532 . . . . 1.12 110.523 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.505 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -81.56 125.4 30.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.267 -0.642 . . . . 1.33 109.267 173.343 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.465 ' O ' ' HB ' ' A' ' 70' ' ' THR . 40.1 mm -117.38 137.86 49.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.12 -0.491 . . . . 0.28 111.037 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -103.38 120.0 39.96 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.275 -1.009 . . . . 2.57 108.275 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.2 t0 . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 116.569 -0.287 . . . . 3.08 110.51 -174.537 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.147 -0.381 . . . . 18.87 112.147 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.98 149.16 26.95 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.794 -0.203 . . . . 17.7 110.504 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? 61.58 35.38 17.33 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.536 0.684 . . . . 17.44 110.791 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.23 41.89 2.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.905 -0.664 . . . . 14.34 111.996 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -86.77 -179.11 6.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.9 0.381 . . . . 13.69 110.643 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.409 ' HA ' HH11 ' A' ' 16' ' ' ARG . 89.3 mt -88.08 64.57 7.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.985 0.421 . . . . 11.39 110.597 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.74 100.66 3.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.027 -0.533 . . . . 8.82 110.71 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 p -87.76 81.15 7.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.286 0.565 . . . . 7.95 109.718 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.412 ' H ' ' H ' ' A' ' 10' ' ' ARG . 87.9 t80 -177.86 9.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.098 -0.955 . . . . 7.07 109.235 -173.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.412 ' H ' ' H ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -142.33 -70.65 0.34 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.102 -0.499 . . . . 6.67 110.614 -170.605 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 10' ' ' ARG . 4.3 mp -120.94 97.33 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 C-N-CA 120.558 -0.457 . . . . 2.89 109.8 171.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.443 ' HA ' ' HG2' ' A' ' 16' ' ' ARG . 3.1 m-20 -102.07 -18.06 15.76 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.626 -0.715 . . . . 3.29 111.211 -176.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -4.15 15.08 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.69 0.757 . . . . 2.96 110.669 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.4 m -93.54 -8.41 41.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.242 -0.89 . . . . 2.31 111.201 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.31 59.01 0.69 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 119.923 -1.132 . . . . 1.86 113.894 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.443 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 27.1 mmt180 -89.01 113.22 24.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 117.284 0.542 . . . . 5.03 110.102 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.36 -15.51 57.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.071 -0.513 . . . . 2.37 111.951 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.07 -14.98 62.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.419 -0.355 . . . . 2.38 111.61 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.9 t -136.21 130.38 33.04 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.217 -1.031 . . . . 2.75 108.217 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.1 p -168.81 142.46 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.767 0.318 . . . . 1.88 111.016 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -116.41 -51.85 2.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.128 0.49 . . . . 2.71 109.715 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' A' ' 74' ' ' SER . . . -97.55 123.63 41.5 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.996 -0.372 . . . . 1.95 109.996 176.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.461 HG12 ' HG3' ' A' ' 24' ' ' ARG . 20.4 t -60.8 108.9 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.929 -0.578 . . . . 1.72 111.773 -174.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HG3' HG12 ' A' ' 23' ' ' VAL . 0.1 OUTLIER 44.17 25.93 0.13 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.933 1.293 . . . . 2.92 113.966 178.662 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 5.5 tp60 -115.82 75.72 0.97 Allowed 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.999 -0.438 . . . . 1.34 110.99 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -96.24 126.14 41.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.691 -0.485 . . . . 2.11 109.691 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 12.9 mmtm -113.3 145.5 40.94 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.775 -0.648 . . . . 1.27 110.28 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -116.89 132.49 56.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.94 0.4 . . . . 1.65 110.696 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.73 179.84 8.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.802 -0.636 . . . . 0.08 109.787 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.8 144.15 31.87 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.206 -0.452 . . . . 0.14 110.023 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.487 ' HA ' HD23 ' A' ' 41' ' ' LEU . 61.3 t -67.2 116.34 6.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.133 0.492 . . . . 0.14 110.463 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.434 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 10.6 t70 -67.69 -51.79 45.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.08 -0.963 . . . . 0.6 109.636 177.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.7 m -159.41 166.76 30.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.893 -0.594 . . . . 1.07 110.564 -175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.432 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 6.0 mt -142.55 132.39 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.876 -0.602 . . . . 0.19 110.07 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -126.76 93.84 3.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.623 -0.717 . . . . 1.56 110.641 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.85 -106.43 1.64 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.73 -0.748 . . . . 0.29 112.393 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -99.02 7.65 45.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.633 0.254 . . . . 2.1 110.687 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -126.79 143.34 51.28 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.279 0.562 . . . . 0.32 111.469 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.18 161.95 21.97 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.713 -0.756 . . . . 0.11 111.52 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 70.7 m-85 -136.96 143.35 42.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.174 -0.676 . . . . 0.18 109.174 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.5 mt -117.81 156.53 28.19 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.335 -0.246 . . . . 0.59 110.335 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -74.85 72.81 2.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.35 0.595 . . . . 1.53 109.729 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -146.53 100.79 3.4 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.107 -0.951 . . . . 0.28 109.284 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -81.56 106.03 13.19 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.271 -0.877 . . . . 1.81 110.062 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.1 t -71.01 -66.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.522 -0.763 . . . . 0.85 111.194 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.66 ' H ' ' HB2' ' A' ' 49' ' ' LYS . 1.0 OUTLIER -133.71 116.29 15.6 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.081 -0.963 . . . . 2.24 109.49 -178.213 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 t70 64.18 19.17 11.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.466 0.651 . . . . 1.55 111.637 171.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.35 21.4 13.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.557 -0.83 . . . . 0.67 112.841 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.66 ' HB2' ' H ' ' A' ' 46' ' ' GLU . 27.6 mmtm -65.09 109.97 2.35 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.443 -0.577 . . . . 2.5 109.443 175.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -72.3 118.62 15.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.098 -0.705 . . . . 1.32 109.098 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.1 mt -60.38 125.2 22.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.417 -0.356 . . . . 0.19 111.506 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -106.44 157.29 17.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.138 -0.483 . . . . 0.39 109.916 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.782 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 27.0 p90 -148.86 154.66 39.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.68 -0.691 . . . . 0.16 109.178 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -98.32 151.87 20.05 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.619 -0.882 . . . . 0.34 108.619 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.594 ' HB3' HG22 ' A' ' 62' ' ' THR . 14.3 mmt -61.03 -12.44 11.71 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.37 0.507 . . . . 2.43 112.37 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.9 m -72.48 -25.39 61.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.192 -0.318 . . . . 0.91 110.82 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.45 -13.74 51.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 1.96 110.71 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.576 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.0 t -64.04 152.31 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 112.861 0.689 . . . . 0.27 112.861 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -62.77 95.79 0.08 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.948 -1.024 . . . . 1.6 112.173 -176.422 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.47 -81.62 0.6 Allowed Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.58 113.288 172.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -110.92 143.6 41.29 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.677 -0.49 . . . . 2.2 109.677 -177.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 ' HB3' ' A' ' 55' ' ' MET . 66.6 p -57.9 -42.69 85.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.127 0.489 . . . . 0.95 111.873 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 63' ' ' VAL . 2.6 m -78.94 4.7 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.952 -0.567 . . . . 1.39 112.477 -177.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.5 -9.78 40.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.69 0.281 . . . . 0.57 111.21 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.732 HD21 HG12 ' A' ' 71' ' ' VAL . 1.6 tm? -115.9 125.46 52.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.915 -0.772 . . . . 1.51 108.915 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 45.4 m-70 -120.33 149.78 50.35 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-O 120.579 0.228 . . . . 0.91 111.065 -171.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.461 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 37.0 Cg_endo -66.04 139.52 56.4 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.655 2.237 . . . . 0.28 111.881 174.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.67 -15.48 61.46 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.921 -0.657 . . . . 0.22 111.999 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -82.7 149.75 27.13 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.39 -0.226 . . . . 1.28 110.39 177.334 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.1 m -76.22 137.85 40.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.199 -0.667 . . . . 0.17 109.199 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.732 HG12 HD21 ' A' ' 65' ' ' LEU . 16.1 m -136.07 157.51 38.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.525 0.678 . . . . 0.31 109.98 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 132.07 56.59 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.203 -1.036 . . . . 0.78 108.203 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.514 ' CD2' HD13 ' A' ' 41' ' ' LEU . 36.7 p90 -141.93 179.15 7.04 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.855 -0.611 . . . . 0.11 109.889 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.648 ' HB3' ' HB3' ' A' ' 22' ' ' ALA . 25.0 m -128.63 119.69 25.19 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.917 -0.772 . . . . 0.86 108.917 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 75' ' ' VAL . 8.5 p -91.4 108.38 19.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.767 0.794 . . . . 0.36 111.269 -172.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 84' ' ' SER . 6.8 p -116.0 124.42 72.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.533 -0.758 . . . . 0.42 110.061 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.2 m -83.35 127.03 33.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.173 0.511 . . . . 0.67 110.611 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.595 ' CB ' ' HB3' ' A' ' 81' ' ' ASN . 9.2 m120 -70.45 121.29 17.49 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.518 -0.764 . . . . 1.82 109.765 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -73.78 -21.46 60.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.942 0.401 . . . . 1.95 111.222 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -96.09 -33.67 12.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.023 0.439 . . . . 3.99 110.979 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.595 ' HB3' ' CB ' ' A' ' 78' ' ' ASN . 60.4 t30 -97.05 -18.23 19.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.331 0.586 . . . . 2.21 110.788 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.99 -25.96 2.96 Favored Glycine 0 C--O 1.229 -0.175 0 CA-C-N 115.525 -0.761 . . . . 0.69 113.919 174.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.492 ' HE2' HD21 ' A' ' 81' ' ' ASN . 18.5 pttm -99.62 168.47 9.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.22 0.51 . . . . 2.42 111.358 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 69.5 m -102.34 175.45 5.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.561 -0.745 . . . . 1.08 111.64 -175.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -143.69 156.39 44.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.566 -0.743 . . . . 0.87 109.157 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.782 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -99.47 118.59 36.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 110.029 -0.36 . . . . 0.17 110.029 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.2 m -116.56 148.33 40.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.437 -0.347 . . . . 0.68 110.664 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.2 m120 62.06 52.09 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.646 0.591 . . . . 1.82 109.881 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.468 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 77.2 t -72.89 100.62 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.473 -0.785 . . . . 0.32 110.81 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 8.0 mp -102.84 148.31 25.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.641 -0.709 . . . . 1.12 110.95 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.485 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -77.17 127.95 33.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.014 -0.539 . . . . 1.33 110.006 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.1 mm -115.86 134.24 59.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.301 -0.409 . . . . 0.28 110.267 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -109.87 119.93 40.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.503 -0.317 . . . . 2.57 111.758 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--O 1.235 0.342 0 CA-C-N 115.39 -0.823 . . . . 3.08 109.549 170.922 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.515 -0.234 . . . . 18.87 112.515 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.85 107.08 13.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.982 0.42 . . . . 17.7 110.337 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -89.29 41.42 1.03 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.556 0.693 . . . . 17.44 109.564 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.15 77.72 0.28 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.493 -0.776 . . . . 14.34 113.454 -173.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -132.84 138.0 46.91 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.525 -0.917 . . . . 13.69 108.525 170.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 mp -67.31 117.99 10.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.378 0.609 . . . . 11.39 111.079 -174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.8 m -91.85 144.41 9.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.145 -0.934 . . . . 8.82 110.688 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.3 p -74.99 11.17 1.17 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.086 -0.506 . . . . 7.95 111.265 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -82.59 -30.87 29.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.105 -0.498 . . . . 7.07 111.239 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.46 21.2 8.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.957 0.354 . . . . 6.67 111.957 -173.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 14' ' ' SER . 38.9 mm -86.22 149.58 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.753 0.311 . . . . 2.89 110.172 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.468 ' HA ' ' CG ' ' A' ' 16' ' ' ARG . 4.5 m-20 -57.8 -49.41 76.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.12 -0.491 . . . . 3.29 111.839 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.428 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 10.3 pt-20 -59.76 -25.55 64.98 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.248 -0.433 . . . . 2.96 111.287 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 11' ' ' ILE . 42.9 m -65.52 -24.0 67.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.017 -0.538 . . . . 2.31 111.22 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.31 58.17 0.3 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.412 -0.899 . . . . 1.86 112.639 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.468 ' CG ' ' HA ' ' A' ' 12' ' ' ASP . 21.0 mmm180 -67.59 99.03 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.879 0.371 . . . . 5.03 110.539 176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.81 -17.48 35.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.946 -0.57 . . . . 2.37 111.089 176.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.95 -37.7 79.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.113 -0.494 . . . . 2.38 111.039 -175.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.0 m -124.44 130.87 53.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.799 -0.815 . . . . 2.75 108.799 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.27 150.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.859 0.361 . . . . 1.88 110.96 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -108.39 -49.81 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.927 0.394 . . . . 2.71 110.636 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.13 161.78 16.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.377 -0.374 . . . . 1.95 110.037 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.404 ' C ' ' HG3' ' A' ' 24' ' ' ARG . 22.7 t -76.02 84.55 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 121.155 -0.218 . . . . 1.72 110.942 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.404 ' HG3' ' C ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER 45.9 23.6 0.18 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.695 1.198 . . . . 2.92 113.452 177.5 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 6.5 tp60 -106.81 84.92 2.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.984 0.421 . . . . 1.34 110.912 -176.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -93.91 135.02 35.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.117 -0.492 . . . . 2.11 110.105 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 16.1 mmtm -118.84 147.33 44.05 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.764 -0.653 . . . . 1.27 109.781 174.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.404 ' CD ' ' HB2' ' A' ' 72' ' ' GLU . 16.7 mtm180 -122.94 132.19 54.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.019 0.438 . . . . 1.65 110.617 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.78 179.75 8.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.454 -0.794 . . . . 0.08 109.623 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.53 144.47 31.37 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.07 -0.344 . . . . 0.14 110.07 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.479 ' HA ' HD23 ' A' ' 41' ' ' LEU . 43.7 t -64.27 124.24 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.932 0.396 . . . . 0.14 110.383 176.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.72 -48.44 13.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.725 -0.67 . . . . 0.6 109.988 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 m -158.48 166.06 33.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.649 -0.705 . . . . 1.07 110.057 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.407 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 5.3 mt -140.9 126.89 19.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.033 0.444 . . . . 0.19 109.987 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -114.13 86.68 2.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.417 -0.81 . . . . 1.56 110.257 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.71 -106.28 1.43 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.606 -0.807 . . . . 0.29 112.899 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -93.28 4.66 53.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.562 0.22 . . . . 2.1 111.263 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -126.98 140.33 52.39 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.038 0.447 . . . . 0.32 110.614 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.29 161.0 14.72 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.422 -0.894 . . . . 0.11 111.422 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 84.1 m-85 -132.88 137.08 46.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.496 -0.557 . . . . 0.18 109.496 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.541 HD13 ' CD2' ' A' ' 73' ' ' PHE . 4.7 mt -114.6 154.49 28.24 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.539 -0.541 . . . . 0.59 109.539 -177.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.505 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 65.1 t30 -78.03 73.65 4.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.621 0.724 . . . . 1.53 109.821 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -140.53 106.35 5.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.761 -1.108 . . . . 0.28 108.442 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -94.63 105.33 17.27 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.427 0.632 . . . . 1.81 110.814 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 84' ' ' SER . 38.9 t -77.66 -77.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.797 -1.092 . . . . 0.85 111.788 -173.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 10.1 tt0 -111.75 111.37 22.3 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.392 -0.822 . . . . 2.24 110.479 -173.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.9 t70 61.22 22.5 12.83 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.459 0.647 . . . . 1.55 111.714 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.36 27.84 8.95 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.317 -0.944 . . . . 0.67 112.669 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 27.4 mmmt -77.92 110.93 13.25 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.153 -0.684 . . . . 2.5 109.153 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.505 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 9.3 tppt? -75.56 126.15 30.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.134 -0.691 . . . . 1.32 109.134 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 51' ' ' LEU . 4.5 mt -62.6 130.24 44.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.404 0.52 . . . . 0.19 112.404 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -111.62 159.31 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.659 -0.7 . . . . 0.39 109.216 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.931 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 32.7 p90 -149.41 149.78 31.37 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.705 -0.479 . . . . 0.16 109.705 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -90.32 149.68 22.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.068 -0.716 . . . . 0.34 109.068 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -0.93 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.249 0.463 . . . . 2.43 112.249 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.6 t -71.32 -32.18 68.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.076 0.465 . . . . 0.91 110.045 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -86.65 -10.55 53.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.87 -0.605 . . . . 1.96 110.956 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.26 145.14 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.467 0.651 . . . . 0.27 112.417 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.533 ' HG3' ' H ' ' A' ' 91' ' ' LYS . 0.9 OUTLIER -66.1 110.12 2.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.578 -1.192 . . . . 1.6 111.79 -175.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.66 -93.14 0.72 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.035 -0.602 . . . . 0.58 113.083 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -112.54 155.99 23.41 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.231 -0.285 . . . . 2.2 110.231 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.3 p -61.56 -32.04 72.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.157 -0.474 . . . . 0.95 111.35 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.39 17.62 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.283 0.563 . . . . 1.39 110.61 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.58 2.04 27.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.183 0.516 . . . . 0.57 111.179 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.649 HD21 HG12 ' A' ' 71' ' ' VAL . 1.8 tm? -129.25 125.63 37.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.344 -0.984 . . . . 1.51 108.344 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -122.8 154.02 63.69 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 111.685 0.254 . . . . 0.91 111.685 -171.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.463 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.4 Cg_endo -68.07 134.81 32.85 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.8 2.333 . . . . 0.28 112.369 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.87 -4.73 72.14 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.692 -0.766 . . . . 0.22 111.98 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -95.7 155.25 16.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.594 -0.521 . . . . 1.28 109.594 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -83.47 132.07 34.98 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.62 -0.511 . . . . 0.17 109.62 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.649 HG12 HD21 ' A' ' 65' ' ' LEU . 4.3 m -134.26 160.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.787 0.803 . . . . 0.31 110.84 -176.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -119.12 138.8 52.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.359 -1.291 . . . . 0.78 108.911 177.267 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.541 ' CD2' HD13 ' A' ' 41' ' ' LEU . 36.5 p90 -150.81 180.0 7.75 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.935 -0.575 . . . . 0.11 109.854 -173.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.1 m -127.41 131.49 50.28 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.913 -0.773 . . . . 0.86 108.913 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.432 HG23 ' OG ' ' A' ' 84' ' ' SER . 3.5 p -91.35 98.11 8.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.985 0.898 . . . . 0.36 110.436 -175.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.5 p -102.53 114.36 41.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.193 -0.912 . . . . 0.42 110.241 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.2 m -80.15 127.14 31.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.853 -0.612 . . . . 0.67 110.922 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.97 104.3 2.49 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.019 -0.734 . . . . 1.82 109.019 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -57.23 -26.98 61.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.843 0.354 . . . . 1.95 111.652 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.456 ' HE ' ' HA ' ' A' ' 80' ' ' ARG . 5.1 tpm_? -84.41 -41.35 16.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 3.99 111.599 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -95.05 -30.71 13.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.221 0.452 . . . . 2.21 112.221 -170.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.89 -24.16 32.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.078 -0.582 . . . . 0.69 112.907 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -86.75 175.88 8.02 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.661 -0.317 . . . . 2.42 110.495 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.468 ' HB3' HG21 ' A' ' 45' ' ' VAL . 32.7 t -116.95 -179.23 3.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.104 0.478 . . . . 1.08 110.969 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 m -149.56 147.84 28.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.317 -0.994 . . . . 0.87 108.317 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.931 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -86.97 121.63 29.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.867 0.365 . . . . 0.17 110.653 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 68.4 m -117.33 144.59 44.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.857 -0.611 . . . . 0.68 110.359 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.45 70.43 0.65 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.991 0.807 . . . . 1.82 110.336 -177.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 92.7 t -84.99 115.34 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.273 0.559 . . . . 0.32 111.021 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.27 149.1 30.66 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.793 -0.64 . . . . 1.12 110.509 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.533 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -81.56 124.12 29.24 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.105 -0.702 . . . . 1.33 109.105 174.404 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 92' ' ' ILE . 28.1 mm -105.53 133.52 49.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.962 -0.563 . . . . 0.28 111.559 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -80.32 121.38 25.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.423 -0.808 . . . . 2.57 108.934 173.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.058 -0.519 . . . . 3.08 110.711 -175.563 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.403 0 N-CA-C 111.878 -0.489 . . . . 18.87 111.878 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.56 169.28 11.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.501 0.191 . . . . 17.7 110.614 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -82.1 124.36 29.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.288 0.566 . . . . 17.44 110.214 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.94 5.88 54.59 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.38 -1.088 . . . . 14.34 110.38 -170.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -126.73 146.78 50.09 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.046 -0.724 . . . . 13.69 109.046 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.0 mt -84.16 94.58 8.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.041 0.448 . . . . 11.39 111.297 -174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.418 HG13 ' H ' ' A' ' 9' ' ' PHE . 7.1 p -76.32 -34.04 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.693 -0.685 . . . . 8.82 110.548 175.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.5 m 61.69 20.56 11.45 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.452 0.538 . . . . 7.95 112.452 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.418 ' H ' HG13 ' A' ' 7' ' ' VAL . 80.8 t80 -92.53 -37.26 12.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.268 0.556 . . . . 7.07 109.554 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -171.82 120.55 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.074 -0.966 . . . . 6.67 109.296 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.513 ' CG2' ' HG3' ' A' ' 13' ' ' GLU . 38.9 mm -122.42 134.11 66.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.225 -0.59 . . . . 2.89 111.468 -177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.492 ' OD1' HD21 ' A' ' 90' ' ' LEU . 13.7 p-10 -100.15 -17.33 17.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.887 -0.597 . . . . 3.29 112.424 -174.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.514 ' HB3' HD23 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -73.19 -15.1 61.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.716 0.769 . . . . 2.96 109.613 173.115 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 m -68.72 -17.51 64.08 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.92 -1.036 . . . . 2.31 110.846 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.14 53.36 46.34 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 116.035 -0.53 . . . . 1.86 113.23 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -82.36 162.9 22.04 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.215 -0.661 . . . . 5.03 109.215 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.74 -16.67 17.77 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.366 0.506 . . . . 2.37 112.366 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.26 -18.47 63.86 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.872 0.323 . . . . 2.38 111.872 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 52.0 t -155.67 131.19 9.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.902 0.382 . . . . 2.75 110.672 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -164.43 133.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.177 0.513 . . . . 1.88 110.719 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -130.34 159.05 38.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.382 -0.372 . . . . 2.71 110.575 -176.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 64.36 21.43 12.49 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.211 0.604 . . . . 1.95 111.539 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 t 59.89 72.56 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.09 -0.505 . . . . 1.72 110.467 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER 47.57 25.61 0.68 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.336 1.054 . . . . 2.92 113.199 178.102 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -107.66 74.12 0.94 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.941 0.401 . . . . 1.34 111.361 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -91.76 132.92 36.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.031 0.443 . . . . 2.11 110.377 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 72.5 mmtt -114.47 149.71 35.91 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.799 -0.637 . . . . 1.27 109.663 175.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.49 ' HG2' ' CB ' ' A' ' 72' ' ' GLU . 59.5 mtm-85 -122.96 127.89 49.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.067 0.461 . . . . 1.65 111.059 177.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 179.53 9.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.183 -0.917 . . . . 0.08 109.807 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.4 146.18 29.21 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.849 -0.426 . . . . 0.14 109.849 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.557 ' HA ' HD23 ' A' ' 41' ' ' LEU . 40.8 t -67.2 123.06 19.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.856 0.36 . . . . 0.14 110.866 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -75.16 -42.46 55.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.6 110.144 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 p -172.04 165.25 6.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.517 -0.765 . . . . 1.07 110.201 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.7 mt -135.48 129.93 49.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.092 0.472 . . . . 0.19 109.965 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -126.16 95.23 4.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.562 -0.744 . . . . 1.56 110.613 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.83 -106.28 1.77 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.29 112.726 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -103.07 9.99 38.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.686 0.279 . . . . 2.1 110.417 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -129.58 141.12 51.02 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.225 0.536 . . . . 0.32 111.054 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.473 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -123.97 159.02 18.63 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.137 -0.785 . . . . 0.11 111.137 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 76.8 m-85 -131.06 147.49 52.63 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.859 -0.422 . . . . 0.18 109.859 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.601 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 5.7 mt -124.82 146.99 48.98 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.385 -0.598 . . . . 0.59 109.385 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -72.92 74.63 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.574 0.702 . . . . 1.53 110.505 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -138.0 97.63 3.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.836 -1.074 . . . . 0.28 108.539 177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.502 ' CG ' ' HA2' ' A' ' 48' ' ' GLY . 19.5 mp0 -74.15 102.15 4.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.948 -1.024 . . . . 1.81 110.966 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.615 HG11 ' HB2' ' A' ' 84' ' ' SER . 28.6 m -80.12 -32.44 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.494 -0.775 . . . . 0.85 111.108 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -157.98 116.89 3.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.128 -0.487 . . . . 2.24 110.33 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.2 t70 58.87 22.57 10.37 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.507 0.558 . . . . 1.55 112.507 169.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.502 ' HA2' ' CG ' ' A' ' 44' ' ' GLU . . . 102.38 2.68 50.75 Favored Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.418 -0.896 . . . . 0.67 112.966 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -60.72 115.08 3.38 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 122.167 0.187 . . . . 2.5 110.795 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -70.49 148.95 47.69 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.628 -0.508 . . . . 1.32 109.628 176.07 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 3.4 mt -79.02 132.68 36.72 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.904 -0.589 . . . . 0.19 110.274 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -107.31 154.24 21.56 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.579 -0.526 . . . . 0.39 109.579 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.852 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 18.5 p90 -146.4 156.22 43.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.338 -0.616 . . . . 0.16 109.338 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -97.33 149.64 21.86 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.897 -0.779 . . . . 0.34 108.897 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.465 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -61.82 -8.23 4.61 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.909 0.337 . . . . 2.43 111.909 -178.404 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 t -79.25 -19.55 50.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.95 0.405 . . . . 0.91 110.288 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' ' 87' ' ' CYS . 2.3 mp0 -92.2 -10.83 37.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.977 0.418 . . . . 1.96 110.171 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.1 t -64.62 149.14 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.454 -0.793 . . . . 0.27 111.897 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -63.31 92.01 0.06 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.219 -0.9 . . . . 1.6 112.52 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.1 -77.56 0.69 Allowed Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.006 -0.543 . . . . 0.58 113.732 172.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 1.9 m-20 -103.93 140.16 38.09 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.606 -0.516 . . . . 2.2 109.606 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 69.6 p -70.53 -22.67 62.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.974 -0.557 . . . . 0.95 111.64 -173.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.4 t -100.38 7.16 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.271 0.558 . . . . 1.39 110.503 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . . . -93.69 -11.1 32.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.316 -0.402 . . . . 0.57 110.928 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.615 HD21 HG12 ' A' ' 71' ' ' VAL . 1.4 tm? -110.04 124.51 51.58 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.702 -0.851 . . . . 1.51 108.702 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -115.46 150.66 44.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.743 0.306 . . . . 0.91 111.533 -170.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.474 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.2 Cg_endo -68.06 140.82 50.94 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.379 2.053 . . . . 0.28 111.895 173.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.55 -1.31 88.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.645 -0.788 . . . . 0.22 112.451 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -96.16 159.32 15.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.729 -0.471 . . . . 1.28 109.729 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -83.96 134.97 34.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.565 -0.531 . . . . 0.17 109.565 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.615 HG12 HD21 ' A' ' 65' ' ' LEU . 10.2 m -136.7 160.04 37.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 110.068 -0.345 . . . . 0.31 110.068 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 4.6 pt-20 -116.03 141.65 47.84 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.601 -0.888 . . . . 0.78 108.601 170.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.522 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 26.5 p90 -146.82 179.7 7.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.33 -0.85 . . . . 0.11 109.672 -173.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m -127.65 127.18 43.34 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.942 -0.762 . . . . 0.86 108.942 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 75' ' ' VAL . 8.2 p -92.68 99.4 9.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.835 0.826 . . . . 0.36 111.508 -172.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 84' ' ' SER . 5.1 p -99.11 112.34 31.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.819 -0.628 . . . . 0.42 109.944 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.1 m -93.76 140.45 29.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.508 -0.769 . . . . 0.67 111.128 -173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 80' ' ' ARG . 5.1 t-20 -71.61 134.64 46.53 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.711 0.291 . . . . 1.82 110.359 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 19.2 pm0 -76.87 -12.48 59.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.497 -0.319 . . . . 1.95 111.07 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.472 ' HB3' ' OD1' ' A' ' 78' ' ' ASN . 7.0 tpm_? -95.56 -59.27 1.91 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.568 -0.287 . . . . 3.99 111.605 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -109.04 -0.48 19.48 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.202 0.445 . . . . 2.21 112.202 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.93 80.03 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.494 -0.86 . . . . 0.69 113.159 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.51 131.55 34.86 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.42 0.628 . . . . 2.42 111.494 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.615 ' HB2' HG11 ' A' ' 45' ' ' VAL . 65.3 m -106.7 170.2 8.08 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.912 -1.04 . . . . 1.08 111.357 -172.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.8 m -148.6 152.91 37.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.63 -0.714 . . . . 0.87 109.338 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.852 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -95.33 122.55 38.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 120.87 0.367 . . . . 0.17 110.373 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.412 ' HA ' ' HG2' ' A' ' 57' ' ' GLU . 94.1 m -116.69 148.55 40.95 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.129 -0.487 . . . . 0.68 110.22 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.8 m120 59.32 62.03 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.674 0.609 . . . . 1.82 110.338 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.7 t -80.87 99.14 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.472 -0.786 . . . . 0.32 110.656 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.609 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 6.7 mp -99.79 147.87 25.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.349 -0.841 . . . . 1.12 110.545 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.485 ' HG2' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -78.62 123.71 27.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.969 -0.382 . . . . 1.33 109.969 178.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.58 120.74 60.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.093 0.473 . . . . 0.28 110.667 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -90.93 107.29 19.1 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.922 -0.581 . . . . 2.57 110.486 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.8 t0 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 116.024 -0.535 . . . . 3.08 110.251 178.982 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 N-CA-C 112.235 -0.346 . . . . 18.87 112.235 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.09 -36.6 64.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.074 0.464 . . . . 17.7 111.253 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 3' ' ' LYS . 24.8 mmtp -117.08 22.11 12.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.086 -0.506 . . . . 17.44 110.565 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.17 89.63 1.53 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.093 -0.803 . . . . 14.34 111.093 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -81.92 171.4 14.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.92 0.391 . . . . 13.69 110.495 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.4 mp -85.5 105.86 16.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.161 -0.472 . . . . 11.39 110.81 -174.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.4 p -112.08 137.95 42.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.005 -0.543 . . . . 8.82 110.843 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.0 t -76.86 95.82 4.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.288 -0.634 . . . . 7.95 109.288 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -98.65 -35.98 10.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.843 -0.617 . . . . 7.07 110.993 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -157.99 151.9 24.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.019 -0.537 . . . . 6.67 110.192 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.439 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.1 mp -92.24 121.27 42.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.196 -0.456 . . . . 2.89 109.982 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -69.02 -30.51 68.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.822 0.82 . . . . 3.29 109.926 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.648 ' HG2' HD12 ' A' ' 90' ' ' LEU . 2.6 mt-10 -82.41 15.2 2.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.301 -1.318 . . . . 2.96 110.572 -176.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.2 t -70.85 -25.95 63.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.265 -0.88 . . . . 2.31 111.435 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.97 59.37 0.33 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.197 -1.001 . . . . 1.86 111.39 -174.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -63.41 107.47 1.11 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.73 0.3 . . . . 5.03 111.662 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.52 -17.11 42.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.306 0.574 . . . . 2.37 110.269 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.8 -26.27 64.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.416 -0.811 . . . . 2.38 111.484 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.2 m -135.36 130.08 34.39 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.002 -0.74 . . . . 2.75 109.002 177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.66 HG22 ' H ' ' A' ' 22' ' ' ALA . 14.9 p -168.42 139.46 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.892 0.377 . . . . 1.88 110.031 -178.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -115.74 12.14 15.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.805 0.812 . . . . 2.71 109.706 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.66 ' H ' HG22 ' A' ' 20' ' ' VAL . . . -142.23 -162.31 1.39 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.402 -0.817 . . . . 1.95 110.094 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 24' ' ' ARG . 1.7 t -86.18 175.4 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.423 -0.584 . . . . 1.72 109.423 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.554 ' H ' HG12 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -72.11 24.84 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.752 0.649 . . . . 2.92 112.752 178.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 23' ' ' VAL . 56.8 tp60 -106.68 111.46 24.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.491 -0.188 . . . . 1.34 110.491 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -109.1 112.31 24.41 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.349 -0.54 . . . . 2.11 110.228 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -90.72 154.31 19.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.595 -0.729 . . . . 1.27 109.59 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -128.11 128.32 44.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.999 -0.371 . . . . 1.65 109.999 176.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 179.53 9.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.803 -0.635 . . . . 0.08 109.376 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.55 140.09 38.0 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 110.345 -0.243 . . . . 0.14 110.345 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.515 ' HA ' HD23 ' A' ' 41' ' ' LEU . 43.7 t -62.04 115.7 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 120.986 0.422 . . . . 0.14 110.337 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.03 -47.26 65.87 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.446 -0.797 . . . . 0.6 110.019 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.1 m -168.86 168.56 10.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 1.07 109.36 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.434 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 11.2 mt -135.79 126.97 44.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.639 -0.504 . . . . 0.19 109.639 175.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -116.88 92.16 3.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.643 -0.708 . . . . 1.56 110.089 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.96 -109.27 2.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.789 -0.72 . . . . 0.29 112.238 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -96.99 6.02 49.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.71 0.255 . . . . 2.1 110.758 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -125.06 144.18 50.54 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.321 0.581 . . . . 0.32 111.234 -173.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.525 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.79 159.41 15.45 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.595 -0.812 . . . . 0.11 111.308 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.0 142.47 47.65 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.376 -0.601 . . . . 0.18 109.376 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 31' ' ' VAL . 8.8 mt -116.15 152.22 34.13 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.247 -0.649 . . . . 0.59 109.247 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -75.48 76.0 2.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.505 0.669 . . . . 1.53 109.417 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.413 ' HB3' HD12 ' A' ' 51' ' ' LEU . 23.9 t80 -147.73 98.13 2.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.983 -1.008 . . . . 0.28 109.121 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 33.3 mt-10 -87.88 101.99 14.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.325 0.583 . . . . 1.81 110.573 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 84' ' ' SER . 15.6 m -73.35 -45.09 53.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.41 -0.814 . . . . 0.85 112.078 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.462 ' H ' ' HB2' ' A' ' 49' ' ' LYS . 4.8 tt0 -140.71 116.61 10.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.572 -0.286 . . . . 2.24 110.537 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 t70 57.87 21.83 8.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.324 0.583 . . . . 1.55 112.131 167.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.47 19.82 19.41 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.443 -0.884 . . . . 0.67 112.955 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 32.6 mmtm -70.99 110.41 5.67 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.892 -0.41 . . . . 2.5 109.892 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -75.24 126.89 31.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.503 -0.554 . . . . 1.32 109.503 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 51' ' ' LEU . 3.8 mt -66.75 126.83 30.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.532 -0.304 . . . . 0.19 111.314 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.443 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 9.5 p90 -111.25 162.53 14.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.427 -0.351 . . . . 0.39 110.138 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.918 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 30.2 p90 -155.17 159.75 40.38 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.174 -0.676 . . . . 0.16 109.174 174.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -99.86 153.65 18.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.342 -0.614 . . . . 0.34 109.342 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 19.6 mtt -66.76 3.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.44 0.533 . . . . 2.43 112.44 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.1 t -89.45 -22.75 22.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.542 -0.54 . . . . 0.91 109.542 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -90.07 -5.67 56.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.511 . . . . 1.96 110.27 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.465 HG22 HD13 ' A' ' 65' ' ' LEU . 1.3 t -67.62 152.45 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.223 -0.899 . . . . 0.27 112.818 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.499 ' HG3' ' H ' ' A' ' 91' ' ' LYS . 1.1 tm0? -59.41 99.02 0.05 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 114.863 -1.062 . . . . 1.6 112.419 -176.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.44 -85.0 0.25 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.58 113.258 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -105.71 145.67 30.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.677 -0.49 . . . . 2.2 109.677 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.0 p -59.98 -40.36 88.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.619 0.6 . . . . 0.95 112.619 -174.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.36 19.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.512 0.672 . . . . 1.39 110.522 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.52 11.54 38.84 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.429 0.633 . . . . 0.57 110.141 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.549 HD11 HG12 ' A' ' 89' ' ' VAL . 1.8 tt -137.86 124.03 20.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.121 -0.945 . . . . 1.51 108.534 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.409 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 89.8 m-70 -121.78 159.2 52.08 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.755 0.312 . . . . 0.91 111.151 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.424 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 38.2 Cg_endo -67.41 144.71 68.61 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.436 2.09 . . . . 0.28 111.924 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -9.15 77.96 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.053 -0.594 . . . . 0.22 112.063 -177.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' ' 66' ' ' HIS . 3.6 m-20 -87.14 141.36 28.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.583 0.23 . . . . 1.28 110.722 177.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 m -70.01 139.25 52.71 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.172 -0.677 . . . . 0.17 109.172 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -139.19 161.02 28.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.364 0.602 . . . . 0.31 111.1 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.13 134.53 54.83 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.826 -1.175 . . . . 0.78 107.826 173.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.487 ' CD2' HD13 ' A' ' 41' ' ' LEU . 23.5 p90 -146.13 178.93 7.85 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.86 -0.609 . . . . 0.11 109.471 -174.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.1 t -126.19 126.63 44.4 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.954 -0.758 . . . . 0.86 108.954 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.9 98.4 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.705 -0.679 . . . . 0.36 110.54 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 p -100.85 113.83 38.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.522 -0.763 . . . . 0.42 109.917 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.9 m -76.78 130.53 37.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.708 -0.678 . . . . 0.67 110.926 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.562 ' HB3' ' H ' ' A' ' 82' ' ' GLY . 3.6 t-20 -65.22 111.91 3.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.923 -0.769 . . . . 1.82 108.923 175.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -12.28 60.38 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.905 -0.318 . . . . 1.95 111.287 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -96.74 -58.55 2.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.035 -0.53 . . . . 3.99 111.558 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -90.75 -28.67 18.12 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.677 0.621 . . . . 2.21 112.677 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.562 ' H ' ' HB3' ' A' ' 78' ' ' ASN . . . 103.7 -24.57 29.34 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.416 -0.897 . . . . 0.69 113.851 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -74.8 151.33 39.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.439 0.62 . . . . 2.42 110.006 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.496 ' HB2' HG11 ' A' ' 45' ' ' VAL . 8.3 m -99.43 175.05 5.99 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.563 -0.455 . . . . 1.08 111.469 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 m -142.78 163.24 33.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.419 -0.809 . . . . 0.87 109.161 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.918 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -103.16 117.06 33.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.248 0.547 . . . . 0.17 110.358 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 64.5 m -116.97 147.99 41.81 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.914 -0.773 . . . . 0.68 108.914 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 73' ' ' PHE . 23.8 t-20 64.55 69.24 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.082 -0.71 . . . . 1.82 109.082 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.549 HG12 HD11 ' A' ' 65' ' ' LEU . 84.9 t -93.41 105.98 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 115.426 -0.806 . . . . 0.32 110.9 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.648 HD12 ' HG2' ' A' ' 13' ' ' GLU . 4.2 mm? -112.3 150.32 31.15 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.61 -0.723 . . . . 1.12 111.016 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.499 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -83.35 123.75 29.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.553 -0.748 . . . . 1.33 110.948 -172.743 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.5 mm -117.37 142.61 30.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.83 -0.623 . . . . 0.28 111.05 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -114.33 146.02 41.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.865 -0.607 . . . . 2.57 109.459 172.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 C--N 1.317 -0.824 0 CA-C-N 116.317 -0.401 . . . . 3.08 109.93 174.897 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.455 -0.258 . . . . 18.87 112.455 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.62 112.22 12.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.049 0.452 . . . . 17.7 110.994 -177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -92.0 83.82 5.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.858 -0.793 . . . . 17.44 108.858 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.36 -158.07 34.3 Favored Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.901 -0.666 . . . . 14.34 113.139 -173.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.07 77.71 3.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.665 0.745 . . . . 13.69 111.058 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.0 mt -91.45 89.52 7.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.771 0.796 . . . . 11.39 109.449 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.5 m -84.83 99.22 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 114.762 -1.108 . . . . 8.82 111.469 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.6 p -84.25 88.14 7.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.851 -0.613 . . . . 7.95 110.005 176.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -105.69 3.23 28.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.305 0.574 . . . . 7.07 109.897 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -155.62 -176.58 6.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.095 -0.957 . . . . 6.67 110.329 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.4 mm -66.07 141.06 18.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 123.395 0.434 . . . . 2.89 110.085 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.23 -47.27 86.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.147 -0.479 . . . . 3.29 112.154 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -3.26 5.15 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.924 -0.58 . . . . 2.96 112.195 -172.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.7 p -58.89 -34.4 71.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.885 -0.598 . . . . 2.31 111.67 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.05 43.41 8.79 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.779 -0.724 . . . . 1.86 112.423 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -78.53 157.14 28.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.133 -0.321 . . . . 5.03 110.133 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.89 -16.75 53.05 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.328 0.492 . . . . 2.37 112.328 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.32 -24.26 63.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.521 -0.308 . . . . 2.38 111.818 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 12.3 p -155.92 130.72 9.14 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.933 -0.307 . . . . 2.75 111.186 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.2 p -169.49 143.57 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.371 -0.377 . . . . 1.88 110.321 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -126.56 162.55 25.4 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.763 0.316 . . . . 2.71 111.37 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.9 19.61 10.82 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.486 -0.779 . . . . 1.95 112.013 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.9 t 60.43 76.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.094 0.473 . . . . 1.72 110.509 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 46.0 26.83 0.44 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.445 1.098 . . . . 2.92 113.422 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -106.4 70.04 0.81 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.091 0.472 . . . . 1.34 110.65 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -97.6 118.32 33.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.44 0.638 . . . . 2.11 110.286 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -99.99 156.44 17.15 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.868 -1.06 . . . . 1.27 109.719 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.466 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 11.0 mtm180 -130.27 127.31 39.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.49 . . . . 1.65 110.559 175.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.46 -179.96 8.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.256 -0.884 . . . . 0.08 110.031 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.4 145.6 28.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.366 -0.379 . . . . 0.14 109.984 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.42 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 48.8 t -68.33 123.33 21.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.516 -0.311 . . . . 0.14 110.379 175.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.39 -41.9 46.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.109 -0.496 . . . . 0.6 110.406 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.5 p -171.04 161.69 6.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.845 -0.616 . . . . 1.07 110.014 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.413 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 13.1 mt -133.73 129.13 54.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.079 0.466 . . . . 0.19 110.114 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -119.59 95.19 4.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 1.56 110.132 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.17 -114.13 5.85 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.815 -0.707 . . . . 0.29 112.282 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -96.38 14.81 23.13 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 110.031 -0.359 . . . . 2.1 110.031 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -128.13 141.06 51.59 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.563 -0.455 . . . . 0.32 111.014 -175.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -127.19 158.71 21.14 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.503 -0.856 . . . . 0.11 111.525 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -132.33 142.71 49.44 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.235 -0.654 . . . . 0.18 109.235 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.491 HD13 ' CD2' ' A' ' 73' ' ' PHE . 6.3 mt -116.74 152.53 34.14 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.146 -0.686 . . . . 0.59 109.146 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -75.09 73.47 2.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.782 0.801 . . . . 1.53 109.585 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -147.51 110.69 4.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.623 -1.172 . . . . 0.28 108.674 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 90.1 mt-10 -105.82 107.08 17.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.5 0.667 . . . . 1.81 111.136 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 m -74.06 -55.28 12.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.659 -1.155 . . . . 0.85 112.121 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.695 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 4.1 tp10 -136.38 118.92 15.88 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.552 -0.294 . . . . 2.24 110.703 -171.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.1 t70 61.86 16.59 8.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.41 0.624 . . . . 1.55 112.057 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.09 31.13 9.37 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.205 -0.997 . . . . 0.67 112.107 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.695 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 41.2 mmtm -75.49 109.88 9.41 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.509 -0.923 . . . . 2.5 108.509 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.93 122.32 22.37 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.726 -0.842 . . . . 1.32 108.726 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 51' ' ' LEU . 3.6 mt -59.7 126.55 28.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.131 -0.486 . . . . 0.19 111.6 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -108.41 161.82 14.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.856 -0.611 . . . . 0.39 110.229 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.956 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 30.0 p90 -152.5 151.88 31.25 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.558 -0.746 . . . . 0.16 109.205 173.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.454 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . 23.3 t-80 -93.69 156.39 16.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.628 -0.879 . . . . 0.34 108.628 174.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.467 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 51.0 ttm -71.73 3.69 3.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.875 0.369 . . . . 2.43 111.538 -176.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.2 t -88.38 -27.57 21.52 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.777 -0.453 . . . . 0.91 109.777 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.454 ' OE2' ' HB3' ' A' ' 54' ' ' HIS . 1.9 mp0 -79.36 -14.97 58.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.855 -0.611 . . . . 1.96 109.626 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.493 HG11 ' HA ' ' A' ' 62' ' ' THR . 1.8 t -62.68 152.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.882 -1.054 . . . . 0.27 111.939 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -45.07 158.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.359 -1.291 . . . . 1.6 110.985 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -44.78 -32.5 3.08 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 114.62 0.608 . . . . 0.58 114.62 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -104.26 125.03 50.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.645 -0.502 . . . . 2.2 109.645 173.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.493 ' HA ' HG11 ' A' ' 58' ' ' VAL . 70.7 p -79.18 -36.54 40.11 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.413 -0.812 . . . . 0.95 111.977 -171.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 t -87.15 7.35 2.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.484 0.659 . . . . 1.39 110.257 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.33 -3.12 31.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 0.57 111.087 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.542 HD21 HG12 ' A' ' 71' ' ' VAL . 1.5 tm? -104.71 124.04 48.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.031 -1.1 . . . . 1.51 108.031 175.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -121.02 151.81 55.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.828 0.347 . . . . 0.91 111.549 -171.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 43.0 Cg_endo -67.8 137.41 41.69 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.721 2.28 . . . . 0.28 111.856 173.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.31 -8.99 72.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.815 -0.707 . . . . 0.22 112.628 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -95.25 159.69 14.89 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.418 -0.586 . . . . 1.28 109.418 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 m -80.27 135.96 36.34 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.208 -0.664 . . . . 0.17 109.208 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.542 HG12 HD21 ' A' ' 65' ' ' LEU . 12.1 m -135.71 161.6 38.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.25 0.548 . . . . 0.31 109.895 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.66 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.59 149.13 37.04 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.726 -0.842 . . . . 0.78 108.726 177.502 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.491 ' CD2' HD13 ' A' ' 41' ' ' LEU . 37.9 p90 -163.06 178.61 8.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.006 0.431 . . . . 0.11 110.515 -172.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -128.85 131.56 47.7 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.022 -0.733 . . . . 0.86 109.022 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.9 p -99.35 98.84 7.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.802 0.81 . . . . 0.36 111.018 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.0 p -110.2 118.89 58.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.558 -0.746 . . . . 0.42 110.006 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.0 m -73.32 126.19 29.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.138 -0.483 . . . . 0.67 110.778 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 29.1 m-80 -68.79 115.18 7.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.203 -0.453 . . . . 1.82 109.955 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -60.47 -30.85 69.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.166 -0.47 . . . . 1.95 112.113 -173.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 1.6 tpm_? -95.28 -31.9 13.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.959 0.409 . . . . 3.99 111.645 -176.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -95.94 -26.41 15.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.286 0.565 . . . . 2.21 110.455 -171.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 -24.84 18.38 Favored Glycine 0 C--O 1.23 -0.127 0 C-N-CA 121.201 -0.523 . . . . 0.69 113.421 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 20.1 pttm -98.77 151.95 20.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.216 0.508 . . . . 2.42 110.808 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -87.45 179.47 6.56 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.859 -0.61 . . . . 1.08 111.082 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.8 p -153.45 139.17 17.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.004 -0.543 . . . . 0.87 109.773 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.956 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -74.01 119.25 17.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.191 0.52 . . . . 0.17 111.105 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 99.4 m -116.89 143.88 45.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.778 -0.646 . . . . 0.68 109.306 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 67.1 t30 62.52 70.51 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.418 0.628 . . . . 1.82 109.717 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 90.4 t -93.11 113.05 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.328 -0.851 . . . . 0.32 111.159 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.25 150.05 32.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.178 -0.464 . . . . 1.12 110.92 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.47 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -73.71 128.48 35.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.043 -0.526 . . . . 1.33 109.906 176.689 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.4 mm -119.28 140.14 44.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.803 0.335 . . . . 0.28 110.91 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -99.61 115.08 28.58 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.221 -0.659 . . . . 2.57 109.221 172.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 116.444 -0.344 . . . . 3.08 111.178 -176.033 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 111.643 -0.583 . . . . 18.87 111.643 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.78 161.26 40.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.926 0.393 . . . . 17.7 111.281 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -91.25 124.98 35.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.77 -0.65 . . . . 17.44 109.654 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.57 -29.41 0.34 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.987 -1.101 . . . . 14.34 113.534 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -93.72 176.26 6.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.155 0.478 . . . . 13.69 110.26 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.8 mt -97.65 127.38 43.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.076 0.465 . . . . 11.39 111.44 -174.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.9 p -154.05 126.56 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.711 -0.677 . . . . 8.82 109.464 174.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 m -83.84 97.55 9.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.324 -0.398 . . . . 7.95 110.449 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -123.67 -0.05 8.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.29 0.567 . . . . 7.07 109.83 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -144.53 135.31 24.87 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.599 -0.728 . . . . 6.67 112.195 -173.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' HB ' ' OG ' ' A' ' 14' ' ' SER . 3.9 mp -132.55 121.27 44.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.024 -0.989 . . . . 2.89 109.504 177.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -93.56 -14.97 25.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.749 0.309 . . . . 3.29 111.643 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -85.39 4.05 37.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.449 0.642 . . . . 2.96 109.765 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.403 ' OG ' ' HB ' ' A' ' 11' ' ' ILE . 10.1 m -73.63 17.64 0.15 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.412 -0.813 . . . . 2.31 112.547 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.28 59.99 7.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.878 -0.677 . . . . 1.86 113.571 172.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -60.89 99.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.024 0.412 . . . . 5.03 110.701 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.28 -31.99 19.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.377 0.51 . . . . 2.37 112.377 -177.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.02 -34.78 75.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.307 -0.406 . . . . 2.38 111.432 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.8 p -148.78 131.52 15.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.218 -0.447 . . . . 2.75 110.394 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 22' ' ' ALA . 12.5 p -167.22 153.16 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.871 -0.789 . . . . 1.88 108.871 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -92.64 10.47 30.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.912 0.387 . . . . 2.71 110.942 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.432 ' H ' HG22 ' A' ' 20' ' ' VAL . . . -142.98 -162.31 1.41 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.492 -0.558 . . . . 1.95 109.492 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.0 m -86.78 163.16 2.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.092 0.472 . . . . 1.72 110.241 174.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.533 ' HD2' ' H ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -62.13 -10.43 10.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.421 -0.809 . . . . 2.92 111.717 178.635 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -77.6 97.09 4.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.025 -0.534 . . . . 1.34 110.899 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -95.51 121.05 36.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.419 0.628 . . . . 2.11 110.559 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.461 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 31.0 mmtp -105.37 144.12 32.59 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.152 -0.931 . . . . 1.27 109.544 177.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 28' ' ' ARG . 2.1 mtm180 -120.01 127.37 52.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.085 0.469 . . . . 1.65 110.196 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.496 ' HB1' ' OD1' ' A' ' 42' ' ' ASN . . . -150.87 -179.63 7.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.516 -0.765 . . . . 0.08 109.448 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.91 143.42 32.52 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.81 -0.441 . . . . 0.14 109.81 -177.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.48 ' HA ' HD23 ' A' ' 41' ' ' LEU . 43.8 t -64.89 114.19 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.904 0.383 . . . . 0.14 110.433 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -65.07 -45.12 86.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.121 -0.945 . . . . 0.6 110.153 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 p -171.71 164.73 6.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.396 -0.82 . . . . 1.07 110.093 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.4 mt -137.57 128.95 40.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.669 -0.493 . . . . 0.19 109.669 176.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 71.4 mmtt -122.92 94.31 4.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.534 -0.757 . . . . 1.56 109.807 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.88 -106.92 2.0 Allowed Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.717 -0.754 . . . . 0.29 112.434 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -101.06 4.25 42.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.178 0.191 . . . . 2.1 110.793 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -122.87 140.5 52.89 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.254 0.55 . . . . 0.32 111.374 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.01 157.09 21.01 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.116 -0.947 . . . . 0.11 111.416 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -130.46 151.79 50.55 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.362 -0.607 . . . . 0.18 109.362 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.572 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.2 mt -125.09 155.28 40.08 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.329 -0.619 . . . . 0.59 109.329 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.496 ' OD1' ' HB1' ' A' ' 29' ' ' ALA . 28.0 p-10 -76.23 72.9 3.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 122.229 1.014 . . . . 1.53 109.994 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -148.15 98.63 2.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.757 -1.11 . . . . 0.28 109.028 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 21.3 mt-10 -95.58 100.97 12.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.746 0.784 . . . . 1.81 110.284 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 46' ' ' GLU . 16.2 m -68.12 -43.31 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.222 -1.354 . . . . 0.85 111.301 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 8.7 tp10 -129.87 176.06 8.35 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.281 -1.748 . . . . 2.24 106.281 -176.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 28.3 t70 -33.19 86.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.195 1.183 . . . . 1.55 114.195 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.54 ' HA2' ' OE2' ' A' ' 44' ' ' GLU . . . 68.58 16.55 69.87 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.654 -0.784 . . . . 0.67 111.464 171.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.722 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 32.0 mmtm -82.29 107.03 14.65 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.569 -0.53 . . . . 2.5 109.569 -178.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -79.52 129.62 34.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.062 -0.718 . . . . 1.32 109.062 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 51' ' ' LEU . 3.1 mt -63.69 124.09 20.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.728 0.299 . . . . 0.19 111.157 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -106.61 158.91 16.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.833 -0.622 . . . . 0.39 109.998 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.939 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 30.4 p90 -150.29 154.87 38.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.517 -0.765 . . . . 0.16 109.166 173.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -99.03 149.87 22.56 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.657 -0.868 . . . . 0.34 108.657 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.543 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 27.5 mtt -60.23 -7.07 1.71 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.215 0.45 . . . . 2.43 112.215 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 t -68.66 -29.96 68.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.221 -0.445 . . . . 0.91 110.776 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -92.93 -1.21 56.92 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.845 0.355 . . . . 1.96 111.138 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.562 HG13 HD13 ' A' ' 65' ' ' LEU . 2.1 t -74.42 150.66 7.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.593 0.59 . . . . 0.27 112.593 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.539 ' CG ' HD13 ' A' ' 90' ' ' LEU . 1.4 tm0? -54.37 100.06 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 114.758 -1.11 . . . . 1.6 111.805 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.52 -92.18 0.01 OUTLIER Glycine 0 C--N 1.332 0.317 0 O-C-N 123.873 0.733 . . . . 0.58 114.342 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -89.73 131.34 35.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 2.2 110.174 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.543 ' HB ' ' SD ' ' A' ' 55' ' ' MET . 30.7 p -75.45 -12.04 60.16 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.471 -0.786 . . . . 0.95 111.096 -172.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.0 t -92.85 -2.15 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.499 -0.773 . . . . 1.39 110.05 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.88 -14.54 29.51 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.394 0.616 . . . . 0.57 110.895 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.562 HD13 HG13 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -103.34 124.6 48.99 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.528 -0.76 . . . . 1.51 109.084 179.226 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 95.3 m-70 -121.8 153.14 60.05 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.884 0.373 . . . . 0.91 111.316 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.407 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.0 Cg_endo -67.64 134.85 34.04 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.499 2.132 . . . . 0.28 111.243 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.22 -17.34 59.32 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.826 -0.702 . . . . 0.22 111.93 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 66' ' ' HIS . 23.5 m-20 -74.23 151.05 40.01 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 110.101 -0.333 . . . . 1.28 110.101 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 m -81.17 135.18 35.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.395 -0.965 . . . . 0.17 108.395 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.452 HG11 HD21 ' A' ' 65' ' ' LEU . 29.6 m -134.9 167.09 26.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.214 0.531 . . . . 0.31 110.945 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.641 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -113.88 150.07 34.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.014 -1.106 . . . . 0.78 108.014 172.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.572 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.2 p90 -157.85 179.06 9.55 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.335 -0.617 . . . . 0.11 109.335 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -130.29 133.69 46.66 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.253 -1.017 . . . . 0.86 108.253 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 p -94.5 98.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.658 0.742 . . . . 0.36 111.087 -172.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -102.54 107.64 22.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.39 -0.823 . . . . 0.42 109.725 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 26.8 m -74.43 129.67 38.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.983 0.421 . . . . 0.67 110.864 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 39.7 m-80 -76.83 101.06 5.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.879 -0.6 . . . . 1.82 109.528 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -60.9 -21.31 63.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.957 0.408 . . . . 1.95 111.119 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -72.52 -41.11 66.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.714 -0.675 . . . . 3.99 111.585 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -114.65 -31.49 6.16 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.517 0.562 . . . . 2.21 112.517 -172.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.44 -20.36 25.46 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.003 -0.618 . . . . 0.69 113.303 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 21.1 pttp -96.89 150.72 20.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.036 0.418 . . . . 2.42 110.752 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 13.4 m -93.3 -176.29 4.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.11 -0.496 . . . . 1.08 111.607 -175.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.8 m -150.05 150.08 31.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.828 -0.624 . . . . 0.87 109.434 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.939 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -89.82 120.93 31.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.217 0.532 . . . . 0.17 111.101 -177.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 50.0 m -117.32 144.38 44.95 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.759 -0.655 . . . . 0.68 110.126 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 62.82 66.84 0.73 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.764 0.665 . . . . 1.82 109.792 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 95.2 t -89.33 100.85 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.518 -0.764 . . . . 0.32 110.675 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.539 HD13 ' CG ' ' A' ' 59' ' ' GLN . 2.1 mm? -105.45 147.53 28.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.833 -0.621 . . . . 1.12 110.81 -177.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.36 122.75 24.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 1.33 110.741 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.4 mm -110.34 133.31 56.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.597 -0.728 . . . . 0.28 110.738 -176.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -80.66 117.83 21.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.889 -0.596 . . . . 2.57 110.11 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 116.259 -0.428 . . . . 3.08 110.656 178.931 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 111.816 -0.514 . . . . 18.87 111.816 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 176.97 -166.47 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.171 -0.677 . . . . 17.7 109.171 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -95.67 84.98 4.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.99 0.424 . . . . 17.44 110.238 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.74 -135.65 1.86 Allowed Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.78 -0.646 . . . . 14.34 111.688 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.23 -52.11 8.58 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.212 -0.292 . . . . 13.69 110.212 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -71.62 96.11 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.216 0.531 . . . . 11.39 110.221 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 p 178.53 140.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.089 -0.959 . . . . 8.82 109.065 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 t -77.33 95.0 4.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.794 -0.817 . . . . 7.95 108.794 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -173.72 -33.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.976 -1.12 . . . . 7.07 107.976 -172.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.434 ' HE ' ' HB3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -77.59 -175.25 3.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 113.899 -1.5 . . . . 6.67 109.939 175.136 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.2 mt -68.84 101.4 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.383 -0.527 . . . . 2.89 109.992 174.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -87.73 -23.35 24.16 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.509 -0.769 . . . . 3.29 111.514 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -64.89 -21.28 66.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.114 0.483 . . . . 2.96 110.199 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.0 m -65.05 -9.93 26.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.332 -0.849 . . . . 2.31 112.235 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.54 59.56 1.35 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 119.748 -1.215 . . . . 1.86 112.896 175.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 36.8 mmm-85 -59.96 117.54 5.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.119 -0.326 . . . . 5.03 110.119 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.81 -26.92 27.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.853 0.359 . . . . 2.37 111.035 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.09 70.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.04 -0.527 . . . . 2.38 110.973 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 52.5 t -145.44 131.02 18.82 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.716 -0.846 . . . . 2.75 108.716 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.65 155.38 7.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.73 0.3 . . . . 1.88 110.56 -173.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -119.61 149.77 41.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 2.71 110.25 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 74' ' ' SER . . . 64.06 16.57 10.05 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.708 0.63 . . . . 1.95 111.807 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.2 t 60.03 75.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.779 -0.646 . . . . 1.72 111.174 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 44.49 31.01 0.55 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.64 1.176 . . . . 2.92 113.992 175.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -115.87 94.22 4.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.115 0.483 . . . . 1.34 110.878 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -109.31 112.73 25.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.145 0.497 . . . . 2.11 110.628 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -89.51 150.29 22.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.57 -0.741 . . . . 1.27 110.294 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -123.66 127.3 48.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.95 0.405 . . . . 1.65 110.347 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.58 179.36 9.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.015 -0.735 . . . . 0.08 109.015 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.93 142.62 32.15 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 110.133 -0.321 . . . . 0.14 110.133 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.522 ' HA ' HD23 ' A' ' 41' ' ' LEU . 43.7 t -64.22 117.54 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.517 -0.549 . . . . 0.14 109.517 174.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.93 -40.47 63.07 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.768 -0.651 . . . . 0.6 110.513 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 p -174.41 156.0 2.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.56 -0.746 . . . . 1.07 109.697 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.4 mt -127.6 132.38 69.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.186 -0.461 . . . . 0.19 110.005 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -121.96 85.95 2.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.568 -0.742 . . . . 1.56 110.458 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.37 -107.13 1.95 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.915 -0.659 . . . . 0.29 112.605 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -97.63 10.7 39.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 2.1 110.509 -175.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -132.73 142.22 48.93 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 120.942 0.401 . . . . 0.32 110.643 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.6 153.88 19.83 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.226 -0.749 . . . . 0.11 111.226 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 64.6 m-85 -127.88 146.11 50.73 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.57 -0.529 . . . . 0.18 109.57 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.544 HD13 ' CD2' ' A' ' 73' ' ' PHE . 6.0 mt -117.65 157.12 27.0 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.926 -0.398 . . . . 0.59 109.926 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -76.75 73.53 3.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.508 0.67 . . . . 1.53 109.677 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.438 ' HB3' HD12 ' A' ' 51' ' ' LEU . 33.7 t80 -146.19 102.46 3.62 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.293 -0.867 . . . . 0.28 109.301 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.56 101.0 12.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.934 -0.575 . . . . 1.81 110.275 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' A' ' 84' ' ' SER . 21.3 m -74.06 -46.42 45.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.801 0.81 . . . . 0.85 110.648 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.476 ' N ' HG23 ' A' ' 45' ' ' VAL . 34.5 tt0 -124.55 -179.11 4.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.803 -1.554 . . . . 2.24 106.803 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.429 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 8.1 t70 -41.09 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.089 0.956 . . . . 1.55 112.948 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.16 13.96 67.9 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.651 -0.785 . . . . 0.67 111.701 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.94 108.99 10.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.23 -0.655 . . . . 2.5 109.23 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -72.61 136.15 45.67 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.161 -0.681 . . . . 1.32 109.161 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -70.2 123.68 22.25 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.837 -0.431 . . . . 0.19 109.837 177.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -107.0 156.85 18.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.714 -0.476 . . . . 0.39 109.714 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.918 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 22.7 p90 -147.84 152.73 38.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.655 -0.702 . . . . 0.16 109.11 172.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -91.87 146.93 23.36 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.048 -0.723 . . . . 0.34 109.048 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.579 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 41.8 ttp -53.23 -17.16 1.55 Allowed 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 123.704 0.801 . . . . 2.43 112.274 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -64.57 -32.32 73.92 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.601 0.239 . . . . 0.91 110.868 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -78.08 -15.12 59.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.141 0.496 . . . . 1.96 110.822 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.579 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -64.03 147.46 12.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.395 -0.82 . . . . 0.27 111.956 -174.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.491 ' HG3' ' CD1' ' A' ' 90' ' ' LEU . 1.1 tt0 -64.06 86.77 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.776 -1.102 . . . . 1.6 112.933 -171.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.69 -90.82 0.25 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.293 -0.479 . . . . 0.58 113.26 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -92.99 143.83 25.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.277 0.56 . . . . 2.2 110.589 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.1 p -69.31 -33.56 73.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.217 -0.901 . . . . 0.95 110.926 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.56 -11.47 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.43 -0.805 . . . . 1.39 111.162 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -90.58 -8.5 50.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.607 -0.724 . . . . 0.57 111.728 -173.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.505 HD11 HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -117.48 124.63 49.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.411 -0.589 . . . . 1.51 109.411 179.38 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -122.2 150.03 55.89 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.731 0.3 . . . . 0.91 111.055 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.77 130.32 21.67 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.365 2.043 . . . . 0.28 111.092 172.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.91 -9.73 58.38 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.834 -0.698 . . . . 0.22 111.967 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -87.48 145.47 26.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.258 -0.275 . . . . 1.28 110.258 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 m -72.22 134.37 45.6 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.462 -0.57 . . . . 0.17 109.462 173.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.53 160.2 37.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.776 0.798 . . . . 0.31 111.098 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.84 132.08 56.62 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.429 -1.259 . . . . 0.78 108.65 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.544 ' CD2' HD13 ' A' ' 41' ' ' LEU . 26.0 p90 -142.48 178.67 7.44 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.612 -0.722 . . . . 0.11 109.583 -172.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 22' ' ' ALA . 4.1 m -128.68 119.35 24.5 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.163 -0.68 . . . . 0.86 109.163 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.29 99.44 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.81 0.814 . . . . 0.36 110.986 -173.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.68 122.99 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.423 -0.808 . . . . 0.42 109.794 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 36.7 m -86.09 125.77 33.7 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.094 -0.503 . . . . 0.67 111.008 -177.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -63.98 109.92 1.95 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.826 -0.625 . . . . 1.82 109.527 175.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.432 ' H ' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -60.86 -23.14 64.92 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.238 0.459 . . . . 1.95 112.238 -175.699 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.424 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 7.2 tpm_? -93.66 -47.11 6.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.655 -0.418 . . . . 3.99 111.145 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -81.36 -30.81 33.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 2.21 111.586 -174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.45 -10.24 75.07 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.952 -0.642 . . . . 0.69 112.463 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -93.98 156.08 16.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.022 -0.733 . . . . 2.42 109.022 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.552 ' HB2' HG11 ' A' ' 45' ' ' VAL . 3.2 m -107.75 170.62 7.88 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.435 -0.506 . . . . 1.08 111.173 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.3 p -144.07 159.84 41.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.69 -0.686 . . . . 0.87 110.122 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.918 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -96.3 123.98 40.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.349 -0.387 . . . . 0.17 110.367 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -116.86 149.16 40.53 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.001 -1.111 . . . . 0.68 108.001 176.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 57.11 72.25 0.52 Allowed 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.82 0.7 . . . . 1.82 110.321 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.505 HG12 HD11 ' A' ' 65' ' ' LEU . 96.2 t -89.58 105.4 16.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.565 0.697 . . . . 0.32 110.639 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.491 ' CD1' ' HG3' ' A' ' 59' ' ' GLN . 4.0 mm? -106.7 148.95 27.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.161 -0.927 . . . . 1.12 110.648 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.42 ' HB2' ' OE1' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -81.66 129.47 34.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.676 -0.693 . . . . 1.33 111.224 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.5 mm -117.88 142.35 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.704 -0.68 . . . . 0.28 110.427 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -92.45 121.57 34.05 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.158 -0.682 . . . . 2.57 109.158 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.883 -0.599 . . . . 3.08 109.867 -175.141 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 111.993 -0.443 . . . . 18.87 111.993 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.78 147.05 25.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.768 0.318 . . . . 17.7 110.519 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.19 92.32 8.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.286 0.565 . . . . 17.44 109.975 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.88 57.64 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.373 -1.091 . . . . 14.34 110.373 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -90.56 155.8 18.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.114 -0.543 . . . . 13.69 111.51 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.1 tp -145.55 146.65 31.49 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.615 -0.883 . . . . 11.39 108.615 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 p -114.04 98.29 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.887 0.851 . . . . 8.82 111.677 -175.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.1 t -126.51 103.38 7.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.417 -0.81 . . . . 7.95 109.043 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -97.5 11.85 35.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.908 -0.587 . . . . 7.07 110.471 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -157.28 176.88 12.11 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.348 -0.842 . . . . 6.67 109.899 -172.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.498 ' HB ' ' OG ' ' A' ' 14' ' ' SER . 21.3 mm -85.63 142.68 12.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.377 -0.972 . . . . 2.89 108.377 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.62 -39.59 73.63 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.958 -0.464 . . . . 3.29 111.254 -176.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.814 ' HA ' HD23 ' A' ' 90' ' ' LEU . 2.3 pm0 -76.37 14.19 0.8 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.307 -0.406 . . . . 2.96 111.646 177.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.498 ' OG ' ' HB ' ' A' ' 11' ' ' ILE . 57.7 m -77.85 -6.98 56.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.332 . . . . 2.31 110.774 174.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.15 57.17 1.82 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.341 -0.933 . . . . 1.86 112.226 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -62.73 113.35 2.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.914 0.388 . . . . 5.03 110.956 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.75 -20.38 31.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.265 -0.425 . . . . 2.37 111.307 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.29 -13.94 61.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.389 -0.369 . . . . 2.38 111.475 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.8 m -145.99 129.96 17.34 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.785 -0.45 . . . . 2.75 109.785 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -168.76 140.94 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.911 -0.586 . . . . 1.88 109.833 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -90.03 30.03 1.14 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.711 0.291 . . . . 2.71 111.782 -174.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.477 ' HB3' ' OG ' ' A' ' 74' ' ' SER . . . -164.42 -177.79 5.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.096 -0.705 . . . . 1.95 109.096 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.56 74.39 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.803 0.335 . . . . 1.72 110.837 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 43.16 26.13 0.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.755 1.222 . . . . 2.92 113.959 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -102.97 96.97 7.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.233 -0.439 . . . . 1.34 110.992 -175.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 2.6 mppt? -106.86 120.99 43.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.145 0.498 . . . . 2.11 110.423 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -105.11 144.89 31.29 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.484 -0.78 . . . . 1.27 110.26 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -118.84 127.17 53.27 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.664 -0.414 . . . . 1.65 110.578 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.63 179.67 8.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.69 -0.686 . . . . 0.08 109.579 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.44 144.5 30.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.045 -0.354 . . . . 0.14 110.045 -177.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.531 ' HA ' HD23 ' A' ' 41' ' ' LEU . 57.6 t -63.98 117.43 4.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.142 0.496 . . . . 0.14 110.577 176.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.421 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 8.5 t70 -69.2 -47.86 63.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.031 -0.986 . . . . 0.6 109.616 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 74.1 m -167.92 164.49 13.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.775 -0.648 . . . . 1.07 109.699 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 mt -136.52 132.97 49.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.672 -0.492 . . . . 0.19 109.672 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -126.79 89.34 2.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 1.56 110.227 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.37 -107.77 2.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.75 -0.738 . . . . 0.29 112.592 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -97.37 9.64 41.78 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.808 -0.231 . . . . 2.1 110.761 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.51 141.2 51.05 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.184 0.516 . . . . 0.32 111.006 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.526 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.9 157.16 21.47 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.387 -0.824 . . . . 0.11 111.152 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 68.8 m-85 -129.73 148.61 51.63 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.09 -0.708 . . . . 0.18 109.09 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' A' ' 73' ' ' PHE . 8.8 mt -123.72 153.05 41.42 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.662 -0.495 . . . . 0.59 109.662 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -75.1 73.59 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.487 -0.56 . . . . 1.53 109.487 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.439 ' HB3' HD12 ' A' ' 51' ' ' LEU . 27.9 t80 -150.26 98.56 2.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.41 -0.814 . . . . 0.28 109.536 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 47.2 mt-10 -81.67 100.5 9.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.485 0.66 . . . . 1.81 109.695 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 84' ' ' SER . 27.2 m -72.21 -35.68 53.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.078 -0.965 . . . . 0.85 111.446 -176.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 7.9 tp10 -145.05 179.65 7.21 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.376 -1.713 . . . . 2.24 106.376 -175.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.523 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 23.8 t70 -27.75 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.271 1.428 . . . . 1.55 114.38 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.519 ' HA2' ' OE1' ' A' ' 44' ' ' GLU . . . 66.84 19.72 69.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.992 -0.623 . . . . 0.67 111.768 173.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 40.8 mmtm -82.88 109.05 16.67 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 110.061 -0.348 . . . . 2.5 110.061 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -74.39 128.95 36.83 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.712 -0.847 . . . . 1.32 108.712 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.506 ' HG ' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -64.66 126.73 28.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.597 -0.274 . . . . 0.19 110.646 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -112.27 156.66 22.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.97 0.414 . . . . 0.39 110.031 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.864 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 17.2 p90 -146.84 161.46 40.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.911 -0.586 . . . . 0.16 109.524 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -102.09 140.35 36.48 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.246 -0.65 . . . . 0.34 109.246 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.484 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 1.8 tmt? -51.13 -23.84 3.56 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.827 0.851 . . . . 2.43 112.657 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.6 t -60.27 -23.22 63.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.642 0.258 . . . . 0.91 111.215 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -95.74 0.06 52.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.8 -0.182 . . . . 1.96 111.474 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -74.91 137.35 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.305 0.574 . . . . 0.27 111.422 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.83 104.07 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.858 -1.064 . . . . 1.6 111.972 -175.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.03 -84.55 0.49 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.58 113.074 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -135.19 158.17 45.06 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.893 -0.41 . . . . 2.2 109.893 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.9 p -74.5 -8.52 56.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.568 0.699 . . . . 0.95 110.138 178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.43 -1.09 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.306 -0.861 . . . . 1.39 109.904 175.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.87 -39.85 4.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.79 -0.641 . . . . 0.57 110.423 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.644 HD11 HG11 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -95.32 123.35 38.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.298 -0.63 . . . . 1.51 109.298 178.69 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -134.58 158.2 75.62 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.637 -0.256 . . . . 0.91 111.116 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.529 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 28.1 Cg_endo -63.53 142.19 83.43 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.689 2.259 . . . . 0.28 111.745 176.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.96 -6.49 83.11 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.58 -0.819 . . . . 0.22 112.742 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -95.08 158.65 15.37 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.61 -0.515 . . . . 1.28 109.61 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 94' ' ' ASP . 3.2 m -81.75 137.79 35.29 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.229 -0.656 . . . . 0.17 109.229 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.644 HG11 HD11 ' A' ' 65' ' ' LEU . 10.4 m -137.91 156.46 31.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.421 0.629 . . . . 0.31 109.857 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.39 133.16 55.91 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.505 -0.924 . . . . 0.78 108.505 175.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.532 ' CD2' HD13 ' A' ' 41' ' ' LEU . 28.6 p90 -142.5 179.46 6.95 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.71 -0.677 . . . . 0.11 109.789 -173.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 22' ' ' ALA . 5.4 t -127.95 116.31 19.88 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.995 -1.113 . . . . 0.86 107.995 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.3 p -81.64 98.22 4.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.906 0.86 . . . . 0.36 110.557 -173.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 p -102.62 116.31 46.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.23 -0.896 . . . . 0.42 109.788 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 30.2 m -73.99 130.7 40.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.117 -0.492 . . . . 0.67 110.496 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -68.96 112.18 5.45 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.212 -0.662 . . . . 1.82 109.212 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -52.91 -31.32 39.35 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.826 0.704 . . . . 1.95 111.889 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -94.24 -53.86 3.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.828 0.347 . . . . 3.99 111.591 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -74.06 -18.41 60.83 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.296 0.48 . . . . 2.21 112.296 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.93 -24.38 6.06 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.991 -0.624 . . . . 0.69 113.173 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -91.4 154.12 19.4 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.457 -0.571 . . . . 2.42 109.457 178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.549 ' HB2' HG11 ' A' ' 45' ' ' VAL . 17.6 m -101.11 179.98 4.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.951 0.405 . . . . 1.08 111.706 -174.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.1 m -146.37 155.94 42.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.794 -0.639 . . . . 0.87 109.43 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.864 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -96.23 120.67 36.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.89 0.376 . . . . 0.17 110.601 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.3 m -116.99 156.97 26.56 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.954 -0.758 . . . . 0.68 108.954 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 55.9 62.54 2.35 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.694 0.621 . . . . 1.82 109.988 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.7 t -81.25 104.95 10.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.771 -0.649 . . . . 0.32 110.892 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.814 HD23 ' HA ' ' A' ' 13' ' ' GLU . 4.0 mp -107.29 150.53 26.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.293 -0.867 . . . . 1.12 111.364 -176.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.91 129.23 34.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.996 -0.547 . . . . 1.33 110.253 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mm -130.21 148.56 33.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.757 0.313 . . . . 0.28 110.766 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -119.86 103.72 9.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.039 0.447 . . . . 2.57 109.988 169.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.403 ' HB2' HG21 ' A' ' 70' ' ' THR . 9.9 t70 . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 115.825 -0.625 . . . . 3.08 110.892 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.225 0 N-CA-C 112.047 -0.421 . . . . 18.87 112.047 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.21 145.8 51.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.269 . . . . 17.7 110.721 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -133.71 132.89 41.16 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.167 -0.469 . . . . 17.44 110.089 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.99 -39.78 0.21 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.033 -1.08 . . . . 14.34 112.811 177.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -75.18 173.4 10.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.991 0.424 . . . . 13.69 110.038 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.561 ' H ' HD23 ' A' ' 6' ' ' LEU . 2.7 pt? -126.36 141.72 51.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.281 -0.418 . . . . 11.39 110.391 -177.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.0 p -120.74 137.17 55.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.649 -0.705 . . . . 8.82 110.381 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -72.34 77.0 1.01 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.379 0.609 . . . . 7.95 110.676 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -149.74 -37.53 0.15 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.949 -1.023 . . . . 7.07 109.556 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.466 ' HA ' ' HD3' ' A' ' 10' ' ' ARG . 9.3 mmt180 -72.55 147.89 45.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.496 -0.775 . . . . 6.67 110.777 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 0.1 OUTLIER -121.89 155.45 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.726 -0.67 . . . . 2.89 112.341 -168.393 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.72 -47.22 2.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.063 -0.971 . . . . 3.29 110.181 173.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.402 ' H ' ' HG3' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -71.0 9.16 0.75 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.929 0.715 . . . . 2.96 112.929 179.111 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.518 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 27.7 t -79.08 1.4 24.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.938 0.399 . . . . 2.31 111.164 -176.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.97 58.44 1.79 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.153 -1.022 . . . . 1.86 112.618 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -67.57 104.19 1.53 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.746 0.308 . . . . 5.03 110.389 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.61 -25.45 28.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.971 0.415 . . . . 2.37 110.746 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.46 -35.88 76.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.035 -0.529 . . . . 2.38 110.759 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 32.8 m -121.13 130.49 53.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.754 -0.832 . . . . 2.75 108.754 175.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -163.81 159.74 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 121.095 -0.242 . . . . 1.88 110.444 -173.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -98.39 -59.47 1.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.505 -0.316 . . . . 2.71 110.537 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.15 -174.29 4.99 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.065 -0.516 . . . . 1.95 110.961 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 m -76.71 69.81 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.967 -0.56 . . . . 1.72 111.469 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? 42.57 31.54 0.3 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.16 0.984 . . . . 2.92 112.523 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.421 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 6.4 tp60 -109.44 92.97 4.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.827 -0.624 . . . . 1.34 110.319 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -109.22 112.84 25.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.316 0.579 . . . . 2.11 110.337 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -99.07 151.25 21.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.378 -0.828 . . . . 1.27 110.856 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.423 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 43.1 mtm180 -119.25 127.89 53.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.714 0.292 . . . . 1.65 110.385 174.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.63 179.71 8.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.871 -0.604 . . . . 0.08 109.491 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.82 141.56 36.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 110.155 -0.313 . . . . 0.14 110.155 -177.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HA ' HD23 ' A' ' 41' ' ' LEU . 47.1 t -62.77 118.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.762 0.315 . . . . 0.14 110.257 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.403 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 4.4 t70 -68.05 -43.81 77.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.459 -0.791 . . . . 0.6 110.098 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.6 p -178.52 165.66 1.74 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.31 -0.859 . . . . 1.07 109.511 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.5 mt -131.19 131.45 63.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.264 0.554 . . . . 0.19 109.958 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -123.66 85.71 2.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.385 -0.825 . . . . 1.56 110.249 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.09 -111.25 3.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.829 -0.7 . . . . 0.29 112.415 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -96.83 11.7 34.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.681 0.277 . . . . 2.1 110.746 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -131.61 139.73 49.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.191 0.52 . . . . 0.32 110.621 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.527 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -121.96 156.15 16.74 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.783 -0.927 . . . . 0.11 110.783 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -129.32 146.63 51.17 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.036 -0.727 . . . . 0.18 109.036 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.564 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.1 mt -117.69 152.68 34.74 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.103 -0.703 . . . . 0.59 109.103 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.66 72.94 2.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.926 0.869 . . . . 1.53 109.532 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.404 ' HB3' HD12 ' A' ' 51' ' ' LEU . 27.1 t80 -145.58 99.92 3.36 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.417 -1.265 . . . . 0.28 108.027 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.614 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 92.6 mt-10 -98.75 103.15 15.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.571 0.701 . . . . 1.81 110.763 -174.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.5 m -70.67 -37.11 68.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.521 -1.218 . . . . 0.85 112.483 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 2.5 tp10 -151.25 121.3 7.16 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 121.485 -0.086 . . . . 2.24 111.018 -176.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.9 t70 62.39 15.92 8.13 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.625 0.726 . . . . 1.55 111.87 169.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.536 ' HA2' ' OE2' ' A' ' 44' ' ' GLU . . . 94.33 28.42 10.66 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.577 -0.821 . . . . 0.67 112.056 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -81.07 110.16 16.33 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.604 -0.517 . . . . 2.5 109.604 179.164 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -68.63 130.27 42.36 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.649 0.593 . . . . 1.32 109.772 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 51' ' ' LEU . 2.1 mt -66.41 124.22 22.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.158 -0.474 . . . . 0.19 110.737 176.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -107.4 160.09 15.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.247 -0.433 . . . . 0.39 110.1 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.815 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 33.7 p90 -152.03 152.61 32.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.464 -0.789 . . . . 0.16 109.037 173.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -91.79 152.87 19.94 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.692 -0.855 . . . . 0.34 108.692 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.452 ' SD ' HG21 ' A' ' 58' ' ' VAL . 3.4 tpt -68.65 0.68 3.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.635 0.374 . . . . 2.43 111.927 -173.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 p -79.95 -37.54 34.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.958 0.409 . . . . 0.91 110.877 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -72.37 -16.23 61.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.771 -0.65 . . . . 1.96 110.14 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.452 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -61.06 150.81 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.141 -0.936 . . . . 0.27 111.778 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.459 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -66.32 93.81 0.24 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.347 -0.842 . . . . 1.6 112.16 -176.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.86 -91.87 0.52 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.566 -0.743 . . . . 0.58 113.58 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -103.87 159.34 15.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.848 0.356 . . . . 2.2 110.098 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.5 p -79.86 -21.12 44.46 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.045 -0.525 . . . . 0.95 111.542 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.8 p -83.18 -9.42 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.373 0.606 . . . . 1.39 110.667 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 -19.7 28.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.551 -0.749 . . . . 0.57 111.383 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.512 HD11 HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -114.84 123.89 50.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.637 -0.71 . . . . 1.51 109.272 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -123.47 155.88 64.95 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 0.91 111.452 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.449 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.7 Cg_endo -68.98 132.53 24.79 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.502 2.135 . . . . 0.28 111.535 174.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.21 -11.04 63.75 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.931 -0.652 . . . . 0.22 111.758 -177.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -84.47 149.45 25.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.04 -0.356 . . . . 1.28 110.04 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 m -75.69 139.0 41.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.519 -0.549 . . . . 0.17 109.519 174.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.22 162.92 24.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 120.829 0.347 . . . . 0.31 111.218 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -114.43 148.0 38.42 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.869 -1.16 . . . . 0.78 107.869 172.289 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.564 ' CD2' HD13 ' A' ' 41' ' ' LEU . 29.5 p90 -153.62 -179.46 7.81 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.381 -0.6 . . . . 0.11 109.381 -175.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.6 m -128.07 114.26 16.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.988 -0.745 . . . . 0.86 108.988 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.6 p -84.24 99.87 7.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.597 0.713 . . . . 0.36 111.293 -175.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.81 121.89 60.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.685 -0.689 . . . . 0.42 109.589 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 22.1 m -80.36 128.58 33.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.71 0.29 . . . . 0.67 111.166 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 75.1 m-20 -74.09 114.66 12.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.157 -0.474 . . . . 1.82 109.875 177.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -64.03 -24.82 67.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.384 . . . . 1.95 111.835 -173.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -90.34 -45.54 8.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 3.99 111.342 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -85.72 -23.05 27.51 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.913 0.338 . . . . 2.21 111.913 -174.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.54 -21.08 14.94 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 121.237 -0.506 . . . . 0.69 112.764 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 39.7 pttt -98.05 142.76 29.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.292 0.568 . . . . 2.42 110.757 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.4 m -84.94 179.51 7.29 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.24 -0.891 . . . . 1.08 111.876 -175.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.4 m -147.37 157.45 43.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.652 -0.704 . . . . 0.87 109.479 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.815 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -98.86 122.2 41.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.901 0.381 . . . . 0.17 110.843 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 80.1 m -116.21 141.55 48.0 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.05 -0.523 . . . . 0.68 110.14 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.25 67.84 0.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.801 0.688 . . . . 1.82 110.144 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.512 HG12 HD11 ' A' ' 65' ' ' LEU . 92.7 t -84.73 103.76 12.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.593 -0.73 . . . . 0.32 110.645 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.522 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 8.1 mp -108.14 147.85 30.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.79 -0.641 . . . . 1.12 111.199 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.28 129.04 35.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.636 -0.711 . . . . 1.33 111.414 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.6 mm -118.7 133.44 65.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.963 -0.562 . . . . 0.28 111.518 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -90.73 105.87 18.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.639 0.733 . . . . 2.57 110.41 173.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 t70 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.633 -0.712 . . . . 3.08 110.632 -176.085 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.122 -0.391 . . . . 18.87 112.122 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.72 150.72 20.07 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.205 -0.294 . . . . 17.7 110.205 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -84.0 159.72 21.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.872 0.368 . . . . 17.44 110.27 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.0 -16.48 30.38 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.677 -0.773 . . . . 14.34 111.373 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -102.18 -170.44 1.81 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.488 -0.56 . . . . 13.69 109.488 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.3 tp -72.16 115.2 11.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.003 0.43 . . . . 11.39 111.178 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.437 HG23 ' CE1' ' A' ' 9' ' ' PHE . 3.1 p -91.54 98.29 8.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.773 0.796 . . . . 8.82 110.86 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.6 p -97.71 7.6 46.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.642 -0.708 . . . . 7.95 111.121 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.437 ' CE1' HG23 ' A' ' 7' ' ' VAL . 34.4 p90 -109.63 9.43 25.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.277 -0.42 . . . . 7.07 111.503 -176.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.18 -177.45 5.94 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.945 0.403 . . . . 6.67 111.697 -174.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.8 mp -102.49 133.88 44.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.525 -0.761 . . . . 2.89 111.294 -170.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -89.96 -43.62 10.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.54 0.209 . . . . 3.29 111.096 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.36 -9.58 1.63 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.165 0.586 . . . . 2.96 111.356 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 t -67.74 -20.76 65.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.507 -0.77 . . . . 2.31 110.791 174.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.32 60.29 0.75 Allowed Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.425 -0.893 . . . . 1.86 112.455 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.418 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 4.7 mmp_? -57.82 99.98 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.84 0.352 . . . . 5.03 111.509 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.76 -26.08 26.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.965 0.412 . . . . 2.37 111.22 175.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.19 -34.59 75.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.017 -0.538 . . . . 2.38 111.32 -175.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.8 p -146.98 131.92 18.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.033 -0.53 . . . . 2.75 110.087 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.52 HG22 ' H ' ' A' ' 22' ' ' ALA . 14.7 p -167.51 144.11 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.456 -0.572 . . . . 1.88 109.456 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -97.46 16.8 19.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.045 0.45 . . . . 2.71 110.865 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.52 ' H ' HG22 ' A' ' 20' ' ' VAL . . . -152.7 -168.89 3.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.149 -0.478 . . . . 1.95 110.517 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 24' ' ' ARG . 2.2 t -86.54 177.29 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.796 -0.816 . . . . 1.72 108.796 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.558 ' H ' HG12 ' A' ' 23' ' ' VAL . 3.8 ppt_? -71.84 55.41 0.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.627 0.727 . . . . 2.92 111.292 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -132.76 82.58 2.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.62 -0.718 . . . . 1.34 110.483 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -97.1 111.73 23.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.465 0.65 . . . . 2.11 110.254 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 73.1 mmtt -94.27 160.21 14.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.992 -1.004 . . . . 1.27 110.308 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 17.6 mtm180 -128.72 127.52 42.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.959 0.409 . . . . 1.65 110.131 175.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.49 178.21 9.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.679 -0.691 . . . . 0.08 109.724 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.04 141.21 33.17 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.276 -0.639 . . . . 0.14 109.276 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.434 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 51.1 t -62.31 114.42 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.821 -0.437 . . . . 0.14 109.821 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.29 -47.15 62.5 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.307 -0.86 . . . . 0.6 109.973 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.5 m -160.72 160.14 31.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.596 -0.729 . . . . 1.07 110.392 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.413 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 10.2 mt -137.26 120.12 20.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.174 -0.676 . . . . 0.19 109.174 173.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -110.23 86.38 2.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.544 -0.753 . . . . 1.56 109.767 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.8 -109.15 2.76 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.683 -0.77 . . . . 0.29 112.247 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -91.18 2.75 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.926 -0.161 . . . . 2.1 111.269 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -124.07 141.0 52.43 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.305 -0.558 . . . . 0.32 111.335 -174.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 34' ' ' ILE . . . -122.56 158.66 17.23 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.517 -0.765 . . . . 0.11 111.415 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 49.6 m-85 -136.11 136.23 39.95 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.882 -0.784 . . . . 0.18 108.882 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.497 HD21 ' CD2' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -106.26 155.08 19.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.458 -0.942 . . . . 0.59 108.458 177.782 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -76.32 73.5 3.11 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.419 0.628 . . . . 1.53 109.581 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -141.66 98.82 3.42 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.065 -0.971 . . . . 0.28 109.657 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.75 100.69 7.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.616 0.722 . . . . 1.81 110.101 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.48 ' CG1' ' HG ' ' A' ' 51' ' ' LEU . 31.6 m -80.23 -34.5 14.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.014 -0.993 . . . . 0.85 110.992 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.511 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 8.3 tp10 -137.08 177.61 7.73 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.019 -1.845 . . . . 2.24 106.019 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.511 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 29.2 t70 -40.56 85.94 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.815 1.043 . . . . 1.55 113.815 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.22 16.99 71.68 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.775 -0.93 . . . . 0.67 110.775 173.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -88.5 109.42 20.03 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.004 -0.739 . . . . 2.5 109.004 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -75.46 134.32 40.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.65 -0.5 . . . . 1.32 109.65 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 1.4 mt -64.69 125.01 23.41 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.253 0.346 . . . . 0.19 111.037 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -108.78 158.61 17.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.962 -0.384 . . . . 0.39 109.962 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.886 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 45.9 p90 -153.11 154.25 34.45 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.065 -0.717 . . . . 0.16 109.065 173.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -94.54 152.07 18.84 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.627 -0.879 . . . . 0.34 108.627 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.527 ' SD ' HG21 ' A' ' 58' ' ' VAL . 9.4 mmt -63.87 0.79 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.28 0.474 . . . . 2.43 112.28 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.3 t -86.13 -23.05 26.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.713 0.292 . . . . 0.91 110.327 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -91.11 -2.59 57.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.025 0.44 . . . . 1.96 110.079 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.527 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.2 t -72.66 151.28 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.53 -0.759 . . . . 0.27 112.389 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.445 ' HG2' HD13 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -60.53 96.27 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.05 -0.977 . . . . 1.6 111.57 -178.108 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.17 -84.11 0.41 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.753 -0.658 . . . . 0.58 113.569 170.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -113.25 145.74 40.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.139 0.495 . . . . 2.2 110.579 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.482 HG22 ' HB3' ' A' ' 55' ' ' MET . 81.6 p -72.3 -9.63 58.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 0.95 111.705 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.8 t -95.36 -2.92 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.499 -0.773 . . . . 1.39 110.373 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.94 -17.59 22.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.096 0.474 . . . . 0.57 111.445 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.511 HD11 HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -113.1 124.0 51.56 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.163 -0.68 . . . . 1.51 109.163 -176.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -123.29 155.63 64.71 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.656 0.265 . . . . 0.91 111.269 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.434 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.0 Cg_endo -67.12 128.36 18.44 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.341 2.027 . . . . 0.28 111.339 172.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.74 -11.62 53.31 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.684 -0.769 . . . . 0.22 112.072 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -81.14 149.16 29.25 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.645 0.259 . . . . 1.28 110.522 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.6 m -76.86 131.35 38.56 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.525 -0.917 . . . . 0.17 108.525 171.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.481 HG11 HD21 ' A' ' 65' ' ' LEU . 35.7 m -135.01 159.48 41.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 122.04 0.924 . . . . 0.31 111.006 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -114.52 139.75 49.31 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.844 -1.526 . . . . 0.78 108.708 177.886 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.535 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 29.9 p90 -152.37 -179.68 7.77 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.463 -0.569 . . . . 0.11 109.463 -174.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 t -124.99 127.81 47.59 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.803 -0.814 . . . . 0.86 108.803 177.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.4 p -95.01 98.45 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.919 0.866 . . . . 0.36 110.835 -176.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.0 p -104.7 110.82 31.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.246 -0.888 . . . . 0.42 110.09 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 31.8 m -69.37 123.8 22.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.095 -0.502 . . . . 0.67 110.454 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 5.1 m-20 -69.92 109.38 4.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.516 -0.549 . . . . 1.82 109.516 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.44 ' CD ' ' H ' ' A' ' 79' ' ' GLN . 3.8 pm0 -64.57 -13.37 52.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.788 0.328 . . . . 1.95 111.316 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -94.37 -36.14 12.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.402 -0.363 . . . . 3.99 111.47 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -99.82 -29.36 12.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.253 0.464 . . . . 2.21 112.253 -174.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.17 -24.38 25.24 Favored Glycine 0 C--N 1.32 -0.313 0 C-N-CA 121.239 -0.505 . . . . 0.69 112.103 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 18.3 pttm -95.03 154.46 17.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.622 -0.511 . . . . 2.42 109.622 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.465 ' H ' HG21 ' A' ' 45' ' ' VAL . 2.0 m -94.97 -179.26 4.77 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.843 0.354 . . . . 1.08 110.736 -177.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -146.36 146.88 30.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.244 -0.65 . . . . 0.87 109.244 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.886 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -88.92 118.41 28.62 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.912 0.386 . . . . 0.17 110.424 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.8 m -117.16 149.09 40.95 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.257 -0.646 . . . . 0.68 109.257 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 m120 61.61 67.95 0.74 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.491 0.662 . . . . 1.82 109.532 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.511 HG12 HD11 ' A' ' 65' ' ' LEU . 86.0 t -89.92 111.76 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.286 -0.87 . . . . 0.32 110.748 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.445 HD13 ' HG2' ' A' ' 59' ' ' GLN . 4.2 mm? -107.46 147.27 30.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.574 -0.739 . . . . 1.12 110.903 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 114.17 21.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.748 -0.66 . . . . 1.33 110.136 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.9 mm -101.29 135.3 38.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.56 -0.746 . . . . 0.28 111.135 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -71.2 115.2 10.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.607 -0.724 . . . . 2.57 110.218 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.812 -0.631 . . . . 3.08 111.069 178.445 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 112.031 -0.428 . . . . 18.87 112.031 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.09 -26.22 62.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.994 0.426 . . . . 17.7 110.839 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -105.13 87.69 2.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.152 0.501 . . . . 17.44 110.994 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.63 81.35 0.29 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.935 -0.866 . . . . 14.34 110.935 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -90.23 -170.8 2.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.109 0.48 . . . . 13.69 112.211 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.2 117.03 13.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 11.39 112.55 -171.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.29 125.59 68.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.847 -0.615 . . . . 8.82 109.843 171.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.458 ' HA ' HH22 ' A' ' 16' ' ' ARG . 17.0 m -83.43 95.18 8.17 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.866 -0.42 . . . . 7.95 109.866 176.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -156.75 -36.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.871 -0.604 . . . . 7.07 110.971 -174.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -84.44 177.71 8.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.155 -0.475 . . . . 6.67 111.976 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.0 mm -70.11 119.07 15.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.611 -0.722 . . . . 2.89 110.908 -175.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -84.79 -29.69 25.22 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.387 0.514 . . . . 3.29 112.387 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 2.0 pt-20 -66.06 -7.01 14.87 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.358 0.599 . . . . 2.96 110.833 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.5 t -71.19 -25.9 62.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.635 -0.711 . . . . 2.31 109.873 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.64 47.11 35.5 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.888 -0.885 . . . . 1.86 110.888 -174.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.458 HH22 ' HA ' ' A' ' 8' ' ' SER . 17.9 ptt180 -57.9 122.81 13.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.356 0.598 . . . . 5.03 111.438 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.27 -14.48 7.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.823 -1.081 . . . . 2.37 112.801 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.76 -27.98 68.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.631 -0.259 . . . . 2.38 110.9 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.4 t -143.6 128.71 18.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 2.75 110.175 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.584 HG22 ' H ' ' A' ' 22' ' ' ALA . 15.0 p -169.95 138.06 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.897 -0.592 . . . . 1.88 109.833 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -93.67 -13.32 27.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.149 0.499 . . . . 2.71 110.57 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.584 ' H ' HG22 ' A' ' 20' ' ' VAL . . . -114.32 -178.54 3.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.046 -0.524 . . . . 1.95 110.585 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.465 ' C ' ' HG3' ' A' ' 24' ' ' ARG . 2.5 m -86.48 73.24 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.18 -0.463 . . . . 1.72 111.993 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HG3' ' C ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 40.42 46.1 1.99 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.912 0.885 . . . . 2.92 113.064 175.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -132.73 112.27 11.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.159 -0.473 . . . . 1.34 110.965 -176.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.26 125.51 51.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.314 0.578 . . . . 2.11 110.836 176.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 68.2 mmtt -104.12 147.55 27.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.58 -0.736 . . . . 1.27 109.198 171.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.401 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 17.5 mtm180 -124.16 128.11 48.76 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.96 -0.296 . . . . 1.65 110.852 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.79 179.49 9.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.753 . . . . 0.08 110.429 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.07 146.65 28.05 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.117 -0.492 . . . . 0.14 110.335 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 31.0 t -67.26 121.73 16.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.157 0.503 . . . . 0.14 110.325 176.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -80.95 -41.69 22.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.434 -0.803 . . . . 0.6 109.914 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.3 p -163.96 166.9 21.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 1.07 110.643 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.419 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 7.3 mt -140.86 130.92 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.256 0.551 . . . . 0.19 109.873 175.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -124.82 88.16 2.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.383 -0.826 . . . . 1.56 110.411 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.48 -110.91 3.49 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.674 -0.774 . . . . 0.29 112.192 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -92.34 5.81 49.24 Favored 'General case' 0 C--O 1.225 -0.236 0 O-C-N 122.77 -0.253 . . . . 2.1 110.88 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -126.36 140.72 52.28 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.212 -0.595 . . . . 0.32 111.499 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.82 157.95 17.43 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.319 -0.855 . . . . 0.11 111.176 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 80.1 m-85 -130.26 140.54 50.68 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.292 -0.633 . . . . 0.18 109.292 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.466 HD13 ' CD2' ' A' ' 73' ' ' PHE . 6.8 mt -116.28 153.42 31.96 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.777 -0.453 . . . . 0.59 109.777 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -75.97 73.84 2.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.597 0.713 . . . . 1.53 109.817 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -144.45 109.27 4.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.845 -1.07 . . . . 0.28 109.275 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -92.81 115.02 27.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.848 -0.614 . . . . 1.81 110.576 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' A' ' 84' ' ' SER . 13.9 m -85.62 -47.49 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.78 -0.645 . . . . 0.85 111.46 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.611 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 8.4 pt-20 -157.1 144.64 18.91 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.486 -0.561 . . . . 2.24 109.486 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.9 t70 59.63 10.76 2.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.969 0.89 . . . . 1.55 112.009 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.13 30.58 37.4 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.609 -0.805 . . . . 0.67 112.106 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 8.1 mtpp -73.34 112.45 9.41 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.451 -0.203 . . . . 2.5 110.451 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.07 120.73 14.76 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.58 0.55 . . . . 1.32 109.527 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.4 mt -58.54 128.02 35.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.025 -0.534 . . . . 0.19 112.074 -176.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -106.17 161.65 14.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.905 0.383 . . . . 0.39 110.559 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.911 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 21.2 p90 -152.76 157.17 40.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.95 -0.568 . . . . 0.16 109.572 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -99.49 150.66 21.97 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.952 -0.759 . . . . 0.34 108.952 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.474 ' SD ' HG21 ' A' ' 58' ' ' VAL . 16.4 mmt -61.89 -9.43 6.84 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.114 0.412 . . . . 2.43 112.114 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.1 t -71.36 -26.06 62.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.823 0.344 . . . . 0.91 110.196 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -92.98 -2.07 56.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.417 -0.356 . . . . 1.96 110.588 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.474 HG21 ' SD ' ' A' ' 55' ' ' MET . 1.2 t -73.25 151.44 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.397 0.617 . . . . 0.27 112.569 -174.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.447 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 17.1 tm0? -68.03 98.82 0.8 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.903 -1.044 . . . . 1.6 112.5 -174.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.55 -81.89 0.39 Allowed Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.814 -0.63 . . . . 0.58 113.354 172.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -114.34 150.11 35.04 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.928 0.394 . . . . 2.2 110.159 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.7 p -71.22 -16.44 62.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.808 -0.633 . . . . 0.95 110.625 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 t -97.36 10.46 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.449 -0.796 . . . . 1.39 109.856 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.32 -27.22 12.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.118 0.485 . . . . 0.57 110.916 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.751 HD21 HG12 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -102.29 124.29 47.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.042 -0.725 . . . . 1.51 109.042 178.778 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.6 154.19 69.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.618 0.246 . . . . 0.91 111.33 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.448 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.6 Cg_endo -67.49 121.56 8.68 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.307 2.005 . . . . 0.28 111.422 173.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.494 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 103.05 -5.91 50.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.813 -0.708 . . . . 0.22 111.786 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.28 152.23 22.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.374 -0.602 . . . . 1.28 109.374 176.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 7.1 m -81.1 141.59 34.15 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.077 -0.712 . . . . 0.17 109.077 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.751 HG12 HD21 ' A' ' 65' ' ' LEU . 4.3 m -137.26 161.65 34.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.412 0.625 . . . . 0.31 110.83 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.61 141.33 47.91 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.43 -1.322 . . . . 0.78 107.43 170.075 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.516 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 30.9 p90 -151.64 178.98 8.8 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.978 0.418 . . . . 0.11 110.103 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.2 m -127.31 129.91 48.55 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.871 -0.788 . . . . 0.86 108.871 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 p -89.25 99.79 9.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.69 0.757 . . . . 0.36 110.979 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.4 p -107.33 101.93 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.741 0.781 . . . . 0.42 109.932 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 m -70.46 130.83 42.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.416 -0.811 . . . . 0.67 110.867 -177.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.45 104.8 3.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.7 -0.852 . . . . 1.82 108.7 172.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -62.65 -16.78 58.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.847 0.356 . . . . 1.95 111.407 -176.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -90.75 -40.79 11.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.126 -0.488 . . . . 3.99 111.038 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -94.37 -31.47 14.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.864 0.364 . . . . 2.21 111.709 -173.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.28 -23.76 33.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.108 -0.568 . . . . 0.69 112.273 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.439 ' HD3' ' HE2' ' A' ' 49' ' ' LYS . 21.4 pttt -91.44 154.08 19.4 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.052 -0.351 . . . . 2.42 110.052 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.42 ' HB3' HG11 ' A' ' 45' ' ' VAL . 14.6 t -108.25 -176.46 3.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.439 -0.346 . . . . 1.08 110.808 -173.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 p -155.28 147.13 23.35 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.787 -0.642 . . . . 0.87 109.338 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.911 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -87.22 123.01 31.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 120.974 0.416 . . . . 0.17 111.081 -177.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 89.5 m -117.35 150.95 37.99 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.876 -0.602 . . . . 0.68 109.475 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 58.4 63.01 1.82 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.413 0.446 . . . . 1.82 109.809 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 79.3 t -84.16 103.78 11.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.873 -0.603 . . . . 0.32 110.325 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.447 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 4.6 mm? -101.31 147.59 26.13 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.698 -0.683 . . . . 1.12 109.888 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.568 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -82.3 126.93 32.71 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.47 -0.567 . . . . 1.33 109.47 178.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.517 ' O ' ' HB ' ' A' ' 70' ' ' THR . 38.7 mm -116.82 132.23 67.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.906 -0.588 . . . . 0.28 110.103 -176.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -119.74 137.29 54.03 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.402 0.62 . . . . 2.57 111.355 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--N 1.317 -0.817 0 CA-C-N 115.066 -0.97 . . . . 3.08 110.511 175.78 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 111.839 -0.505 . . . . 18.87 111.839 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.44 89.92 3.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.929 0.395 . . . . 17.7 110.499 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -86.63 93.56 9.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.208 0.528 . . . . 17.44 110.298 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.46 175.84 15.87 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.802 -0.713 . . . . 14.34 111.948 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -95.25 102.18 13.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.957 -0.386 . . . . 13.69 109.957 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 mp -87.6 144.26 26.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.822 0.344 . . . . 11.39 110.624 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 9' ' ' PHE . 7.4 p -88.75 118.03 33.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.976 -0.556 . . . . 8.82 110.032 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 m -78.3 -8.59 58.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.249 -0.432 . . . . 7.95 110.812 -177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.495 ' H ' HG22 ' A' ' 7' ' ' VAL . 37.5 p90 50.51 28.45 3.4 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.618 1.167 . . . . 7.07 112.004 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -166.14 129.69 2.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.192 -0.458 . . . . 6.67 110.811 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 13' ' ' GLU . 46.5 mm -116.75 138.86 45.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.325 -0.991 . . . . 2.89 108.325 166.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -66.77 -20.0 65.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.867 0.365 . . . . 3.29 111.251 -174.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.603 ' H ' HG22 ' A' ' 11' ' ' ILE . 9.6 mt-10 -73.29 -4.25 32.08 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.26 0.552 . . . . 2.96 110.536 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.4 t -73.73 -16.89 61.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.298 -0.41 . . . . 2.31 110.903 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.01 57.76 2.21 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.202 -0.999 . . . . 1.86 111.024 -176.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -85.94 143.75 28.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.054 0.454 . . . . 5.03 110.925 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.94 -15.04 40.25 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.408 -0.814 . . . . 2.37 112.783 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.0 -27.01 67.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.675 0.25 . . . . 2.38 111.675 -174.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.4 m -149.05 129.28 13.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.828 0.347 . . . . 2.75 110.292 175.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.474 HG22 ' H ' ' A' ' 22' ' ' ALA . 13.6 p -169.34 142.53 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.876 -0.602 . . . . 1.88 109.918 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -116.16 -4.75 11.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.474 0.654 . . . . 2.71 110.3 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.474 ' H ' HG22 ' A' ' 20' ' ' VAL . . . -128.83 -129.11 0.22 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.331 -0.85 . . . . 1.95 109.615 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 25' ' ' GLN . 16.2 m -131.19 -165.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.946 0.403 . . . . 1.72 110.912 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -48.9 -27.63 3.22 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.337 1.055 . . . . 2.92 113.594 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' H ' HG23 ' A' ' 23' ' ' VAL . 27.7 tt0 -82.26 107.37 14.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.033 0.444 . . . . 1.34 111.903 -168.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -111.7 111.67 22.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.741 -0.663 . . . . 2.11 110.22 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -87.14 153.66 21.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.686 -0.688 . . . . 1.27 110.215 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 43.9 mtm180 -125.5 135.63 52.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.859 0.361 . . . . 1.65 110.527 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.81 179.34 8.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.558 -0.746 . . . . 0.08 109.447 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.25 147.09 28.44 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.003 -0.369 . . . . 0.14 110.003 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.548 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 26.7 t -69.34 120.33 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.077 0.465 . . . . 0.14 110.317 177.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -72.18 -41.81 66.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.312 -0.858 . . . . 0.6 110.631 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.8 p -175.66 163.3 2.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.685 -0.688 . . . . 1.07 109.477 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 mt -131.06 131.28 64.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.259 0.552 . . . . 0.19 110.264 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -121.86 86.37 2.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.141 -0.936 . . . . 1.56 109.775 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.15 -112.48 4.06 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.659 -0.782 . . . . 0.29 112.193 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -93.34 7.28 45.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.59 0.233 . . . . 2.1 110.743 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.24 141.64 51.4 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.081 0.467 . . . . 0.32 111.007 -174.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.74 157.52 18.18 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 111.038 -0.825 . . . . 0.11 111.038 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 81.1 m-85 -130.19 143.28 50.69 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.82 -0.437 . . . . 0.18 109.82 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.491 HD13 ' CD2' ' A' ' 73' ' ' PHE . 8.4 mt -117.5 152.88 34.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.075 -0.512 . . . . 0.59 109.918 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -74.37 74.76 1.89 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.671 0.748 . . . . 1.53 109.723 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -151.06 99.26 2.67 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.882 -1.054 . . . . 0.28 108.654 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.671 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 14.1 mt-10 -94.41 101.54 13.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.709 0.766 . . . . 1.81 111.296 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.652 HG23 ' H ' ' A' ' 46' ' ' GLU . 2.4 m -75.43 -59.07 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.247 -1.342 . . . . 0.85 111.262 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.652 ' H ' HG23 ' A' ' 45' ' ' VAL . 10.9 tp10 -106.82 179.87 4.14 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.131 -1.433 . . . . 2.24 107.131 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.422 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 31.3 t70 -30.54 83.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.854 1.262 . . . . 1.55 113.914 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 66.23 16.09 64.16 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.792 -0.718 . . . . 0.67 111.512 172.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 2.4 mmmt -77.14 108.09 9.98 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 110.021 -0.363 . . . . 2.5 110.021 -174.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -74.93 123.11 24.51 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.976 -1.12 . . . . 1.32 107.976 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 4.1 mt -57.55 122.22 12.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.818 0.342 . . . . 0.19 111.423 -174.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -101.07 155.07 18.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.896 -0.593 . . . . 0.39 109.954 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.955 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 33.1 p90 -149.4 157.13 43.05 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.632 -0.713 . . . . 0.16 109.276 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -99.77 150.11 22.66 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.238 -0.653 . . . . 0.34 109.238 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.522 ' SD ' HG21 ' A' ' 58' ' ' VAL . 11.0 mmt -60.47 -6.89 1.77 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.631 0.604 . . . . 2.43 112.631 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.409 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . 17.6 t -79.01 -28.98 43.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.693 0.282 . . . . 0.91 110.284 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' OE2' ' HB3' ' A' ' 56' ' ' SER . 2.6 mp0 -85.61 -4.47 59.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.972 0.415 . . . . 1.96 110.593 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.522 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -69.5 148.38 11.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.605 -0.725 . . . . 0.27 112.486 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.449 ' HG2' HD13 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -64.15 99.9 0.3 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.467 -1.242 . . . . 1.6 111.883 -175.499 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.56 -89.65 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.866 -0.607 . . . . 0.58 113.131 173.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -106.07 151.06 25.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.986 0.422 . . . . 2.2 110.603 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.0 p -63.76 -33.79 76.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.478 -0.783 . . . . 0.95 111.076 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.6 t -88.3 7.22 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.828 -0.624 . . . . 1.39 110.443 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.82 -9.42 34.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.093 0.473 . . . . 0.57 110.788 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.764 HD21 HG12 ' A' ' 71' ' ' VAL . 1.1 tm? -121.36 124.5 44.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.622 -0.881 . . . . 1.51 108.622 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -122.87 152.33 62.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.452 -0.34 . . . . 0.91 111.407 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 44.8 Cg_endo -69.74 115.92 4.31 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.585 2.19 . . . . 0.28 111.907 176.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.548 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 119.77 -18.85 9.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.14 -0.553 . . . . 0.22 112.247 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.21 155.92 24.68 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.755 -0.461 . . . . 1.28 109.755 175.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 3.0 m -78.45 143.11 36.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.677 -0.49 . . . . 0.17 109.677 176.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.764 HG12 HD21 ' A' ' 65' ' ' LEU . 26.6 m -137.53 157.52 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 121.699 0.762 . . . . 0.31 110.215 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -115.41 141.51 47.94 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.27 -1.332 . . . . 0.78 108.359 171.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.491 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.5 p90 -152.04 179.57 8.36 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.05 -0.722 . . . . 0.11 109.05 -173.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.85 128.51 47.75 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.961 -0.755 . . . . 0.86 108.961 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.05 98.69 7.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.759 0.79 . . . . 0.36 110.61 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.88 125.64 67.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.292 -0.867 . . . . 0.42 109.367 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.7 m -81.4 128.98 34.44 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.351 -0.386 . . . . 0.67 110.48 -178.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -68.1 111.14 4.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.68 -0.489 . . . . 1.82 109.68 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.55 -18.84 44.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.081 -0.509 . . . . 1.95 112.035 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -95.06 -38.12 10.78 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.841 0.312 . . . . 3.99 111.841 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.444 ' HB3' ' HE2' ' A' ' 83' ' ' LYS . 86.5 m-20 -113.73 -5.74 13.31 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.045 0.758 . . . . 2.21 113.045 -172.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.94 -9.42 24.77 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.893 -0.67 . . . . 0.69 114.017 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -97.45 152.87 18.53 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.581 -0.526 . . . . 2.42 109.581 179.227 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.1 t -97.01 -179.67 4.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.158 0.504 . . . . 1.08 111.745 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.7 p -154.97 150.4 27.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.35 -0.841 . . . . 0.87 108.783 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.955 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -87.22 122.58 31.2 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.201 0.524 . . . . 0.17 110.51 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 84.0 m -116.92 144.88 44.03 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.524 -0.762 . . . . 0.68 109.739 178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 56.79 73.26 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.812 0.695 . . . . 1.82 109.792 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 73.3 t -87.75 105.69 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.741 -0.663 . . . . 0.32 110.46 -178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.449 HD13 ' HG2' ' A' ' 59' ' ' GLN . 4.3 mm? -101.98 149.05 24.62 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.358 -0.837 . . . . 1.12 110.298 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.537 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -84.54 115.85 22.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.326 -0.62 . . . . 1.33 109.326 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 70' ' ' THR . 43.2 mm -109.62 137.48 41.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.158 0.504 . . . . 0.28 111.801 -172.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -108.45 133.14 53.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.833 -0.802 . . . . 2.57 108.833 169.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 115.905 -0.588 . . . . 3.08 110.93 -175.76 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 111.999 -0.44 . . . . 18.87 111.999 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.01 18.99 11.74 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.264 0.554 . . . . 17.7 111.304 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -105.76 91.0 3.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.905 -0.589 . . . . 17.44 109.612 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.48 -40.85 1.98 Allowed Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.685 -0.769 . . . . 14.34 112.753 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.24 117.33 12.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.036 0.446 . . . . 13.69 110.483 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.9 mt -81.79 119.01 23.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.501 0.667 . . . . 11.39 111.192 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.7 m -91.91 23.5 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.039 -0.982 . . . . 8.82 110.349 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 m 64.17 24.12 13.33 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.299 -0.864 . . . . 7.95 110.827 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -73.65 -30.46 62.94 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.774 0.797 . . . . 7.07 109.277 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -158.13 141.56 15.26 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.701 -1.136 . . . . 6.67 109.496 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 11' ' ' ILE . 3.0 mp -122.27 140.83 44.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.869 -0.789 . . . . 2.89 108.869 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.88 -28.49 66.74 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.09 0.404 . . . . 3.29 112.09 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.777 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 10.7 pt-20 -60.05 -15.01 19.36 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.171 0.51 . . . . 2.96 110.689 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 p -70.15 -27.34 64.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.411 -0.813 . . . . 2.31 111.011 -178.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.98 57.36 2.16 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.584 -0.817 . . . . 1.86 111.704 -175.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -59.09 120.99 10.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.713 0.292 . . . . 5.03 111.472 -176.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.59 -17.68 40.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 2.37 111.961 -177.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.27 -36.57 77.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.654 0.264 . . . . 2.38 111.18 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 44.5 t -151.23 131.85 13.94 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.467 -0.568 . . . . 2.75 109.467 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.9 p -168.04 153.38 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.169 -0.469 . . . . 1.88 109.764 -175.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -84.52 -55.25 4.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.08 0.467 . . . . 2.71 110.646 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.15 -166.03 1.39 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.766 -0.652 . . . . 1.95 110.334 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -91.94 -160.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.176 -0.676 . . . . 1.72 109.176 178.094 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.529 ' H ' HG12 ' A' ' 23' ' ' VAL . 4.3 ppt_? -71.43 15.4 0.13 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.041 0.386 . . . . 2.92 112.041 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.5 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 4.0 tp60 -91.73 80.15 5.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.202 0.525 . . . . 1.34 110.767 -174.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -104.11 112.63 25.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.656 -0.702 . . . . 2.11 110.421 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 67.7 mmtt -100.05 157.52 16.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.424 -0.807 . . . . 1.27 111.4 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -124.53 140.04 53.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.44 -0.346 . . . . 1.65 110.122 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.42 179.26 6.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.048 -0.523 . . . . 0.08 110.184 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.01 145.14 30.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.239 -0.437 . . . . 0.14 110.103 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.512 ' HA ' HD23 ' A' ' 41' ' ' LEU . 46.2 t -68.98 119.9 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.38 -0.373 . . . . 0.14 110.565 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -72.88 -40.41 65.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.826 -0.625 . . . . 0.6 110.344 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 p -171.12 164.3 7.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.067 -0.515 . . . . 1.07 110.628 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.7 mt -136.56 130.82 47.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.587 -0.523 . . . . 0.19 109.587 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -128.27 101.29 6.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.475 -0.784 . . . . 1.56 110.171 -175.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.27 -105.89 1.43 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.665 -0.778 . . . . 0.29 112.392 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -106.12 6.76 31.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.934 -0.395 . . . . 2.1 109.934 -177.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -125.4 140.64 52.62 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.377 0.608 . . . . 0.32 111.091 -174.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -123.79 156.58 18.04 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.957 -0.857 . . . . 0.11 110.957 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -131.0 144.95 51.87 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.711 -0.478 . . . . 0.18 109.711 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.551 HD13 ' CD2' ' A' ' 73' ' ' PHE . 4.8 mt -121.07 152.1 39.05 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.275 -0.639 . . . . 0.59 109.275 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -75.54 75.26 2.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.314 0.578 . . . . 1.53 109.585 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -143.12 98.17 3.22 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.433 -0.803 . . . . 0.28 109.509 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -79.47 101.31 8.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.915 -0.584 . . . . 1.81 109.844 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 84' ' ' SER . 31.5 m -75.21 -43.96 43.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.536 -0.756 . . . . 0.85 110.609 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 6.0 tp10 -129.08 179.37 5.79 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 106.328 -1.731 . . . . 2.24 106.328 174.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.519 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 14.2 t70 -31.23 83.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.229 1.412 . . . . 1.55 114.059 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.03 8.65 61.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.273 -0.489 . . . . 0.67 111.954 173.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -74.32 110.38 8.57 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.505 -0.554 . . . . 2.5 109.505 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.486 ' NZ ' ' HB2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -78.9 129.77 34.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.668 -0.696 . . . . 1.32 110.193 -173.716 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 51' ' ' LEU . 3.2 mt -67.95 127.56 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.318 -0.401 . . . . 0.19 111.274 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -113.51 157.27 22.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.738 -0.664 . . . . 0.39 109.47 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.937 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 32.3 p90 -146.05 153.23 40.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.992 -0.549 . . . . 0.16 109.759 174.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -94.36 148.13 22.53 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.142 -0.688 . . . . 0.34 109.142 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.63 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 21.7 ttp -65.12 2.9 0.68 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.272 0.629 . . . . 2.43 111.635 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.7 t -89.53 -19.23 25.28 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.648 -0.251 . . . . 0.91 110.751 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -85.85 -11.19 53.97 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 121.378 0.608 . . . . 1.96 109.426 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 62' ' ' THR . 1.6 t -64.41 146.78 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.783 -1.099 . . . . 0.27 112.593 -174.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.37 98.65 0.25 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.831 -1.077 . . . . 1.6 111.899 -173.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.92 -77.54 1.12 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.58 113.512 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -119.87 149.92 41.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.068 0.461 . . . . 2.2 110.025 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.63 ' HB ' ' SD ' ' A' ' 55' ' ' MET . 43.0 p -69.21 -21.89 63.92 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.33 -0.85 . . . . 0.95 112.233 -171.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.9 t -98.92 4.9 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.568 0.699 . . . . 1.39 110.169 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.13 -25.54 27.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.162 -0.472 . . . . 0.57 110.493 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.683 HD21 HG12 ' A' ' 71' ' ' VAL . 1.1 tm? -104.04 125.28 50.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.862 -0.608 . . . . 1.51 109.563 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -124.15 154.81 68.47 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.523 0.201 . . . . 0.91 111.134 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 39.3 Cg_endo -68.55 144.57 61.22 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.659 2.239 . . . . 0.28 112.152 176.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.48 -11.98 64.36 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.925 -0.655 . . . . 0.22 112.345 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.02 154.03 20.81 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.43 -0.211 . . . . 1.28 110.43 177.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.6 m -76.33 138.5 40.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.705 -0.48 . . . . 0.17 109.705 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.683 HG12 HD21 ' A' ' 65' ' ' LEU . 11.3 m -138.09 163.22 29.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.398 0.618 . . . . 0.31 109.877 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.777 ' OE1' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -116.5 149.21 39.92 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.98 -1.009 . . . . 0.78 108.476 172.651 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.551 ' CD2' HD13 ' A' ' 41' ' ' LEU . 36.1 p90 -156.75 178.25 10.55 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.039 -0.356 . . . . 0.11 110.039 -175.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -124.36 132.67 53.55 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.94 -0.763 . . . . 0.86 108.94 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.32 99.01 8.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.693 0.759 . . . . 0.36 110.496 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.19 126.71 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.459 -0.792 . . . . 0.42 110.589 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.6 m -74.33 132.66 42.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.088 -0.506 . . . . 0.67 111.287 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -75.17 116.46 15.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.092 -0.707 . . . . 1.82 109.092 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -58.16 -28.03 64.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.08 0.4 . . . . 1.95 112.08 -175.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -94.08 -51.58 4.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.919 0.34 . . . . 3.99 111.919 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -81.77 -31.69 31.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.941 0.349 . . . . 2.21 111.941 -172.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.13 -21.98 43.21 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.676 -0.773 . . . . 0.69 112.674 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -82.35 166.59 19.32 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 109.467 -0.568 . . . . 2.42 109.467 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.537 ' HB2' HG11 ' A' ' 45' ' ' VAL . 11.4 m -104.93 -177.66 3.43 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.577 -0.449 . . . . 1.08 111.008 -177.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.6 m -147.82 144.84 28.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.455 -0.572 . . . . 0.87 109.455 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.937 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -84.59 120.59 26.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.969 0.414 . . . . 0.17 110.647 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.4 m -117.7 146.02 44.02 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.528 -0.76 . . . . 0.68 109.738 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.4 m120 56.6 74.45 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.677 0.611 . . . . 1.82 110.766 -175.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 76.1 t -86.93 110.44 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.634 -0.712 . . . . 0.32 110.991 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.59 148.82 24.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.706 -0.679 . . . . 1.12 110.833 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.92 122.58 26.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.197 -0.668 . . . . 1.33 109.197 174.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mm -118.16 137.25 52.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.09 0.471 . . . . 0.28 111.352 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -113.34 143.24 44.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.015 -0.735 . . . . 2.57 109.015 173.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 120.873 0.368 . . . . 3.08 110.993 179.015 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 111.797 -0.521 . . . . 18.87 111.797 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.27 114.46 20.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.753 0.311 . . . . 17.7 110.605 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -126.0 143.57 51.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.975 -0.557 . . . . 17.44 110.387 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.93 165.78 12.01 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.79 -0.719 . . . . 14.34 112.036 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -149.63 135.25 18.5 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.981 -0.377 . . . . 13.69 109.981 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.22 145.02 27.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.323 -0.399 . . . . 11.39 110.069 -178.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 9' ' ' PHE . 21.4 t -67.99 -40.45 83.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.141 -0.481 . . . . 8.82 110.502 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.0 m 59.36 26.85 15.8 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.37 -0.832 . . . . 7.95 111.167 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.523 ' HB2' HG12 ' A' ' 7' ' ' VAL . 79.2 t80 -76.55 -35.04 58.45 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.563 0.696 . . . . 7.07 109.716 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.429 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 6.5 ppt_? -150.43 133.0 15.74 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.164 -0.926 . . . . 6.67 109.564 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.7 110.26 19.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.862 0.363 . . . . 2.89 110.354 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -107.56 -9.98 15.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.065 -0.516 . . . . 3.29 111.188 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.53 10.05 16.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.466 -0.568 . . . . 2.96 109.466 172.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.5 t -53.8 -36.05 62.04 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.336 -0.847 . . . . 2.31 112.522 -171.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.68 50.94 62.24 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.659 -0.781 . . . . 1.86 111.972 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -68.0 156.03 38.22 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.661 -0.496 . . . . 5.03 109.661 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.95 -16.56 1.94 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.321 0.859 . . . . 2.37 113.321 -173.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.9 -18.82 64.17 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.667 0.247 . . . . 2.38 111.667 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.0 t -154.64 132.41 11.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 2.75 110.696 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.1 p -164.83 139.62 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.026 -0.534 . . . . 1.88 110.491 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -135.06 164.76 26.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.988 -0.375 . . . . 2.71 109.988 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 74' ' ' SER . . . 63.08 21.54 12.93 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.474 0.484 . . . . 1.95 111.842 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t 60.55 70.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.997 -0.547 . . . . 1.72 110.644 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.75 20.96 0.38 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.056 1.342 . . . . 2.92 114.19 176.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -104.52 112.34 25.37 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.667 -0.413 . . . . 1.34 112.008 -174.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -111.83 135.53 52.32 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.517 -0.549 . . . . 2.11 109.517 172.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 28.7 mmtp -112.76 144.88 41.55 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.106 -0.702 . . . . 1.27 109.106 172.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 4.1 mtm180 -121.74 127.59 50.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.051 0.453 . . . . 1.65 110.846 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.67 179.65 9.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.39 -0.823 . . . . 0.08 110.059 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.81 144.05 30.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.547 -0.297 . . . . 0.14 110.566 -178.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.506 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 43.4 t -65.08 115.73 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.827 -0.434 . . . . 0.14 109.827 175.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.73 -48.68 58.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.082 -0.508 . . . . 0.6 110.079 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 m -159.64 160.64 34.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.632 -0.713 . . . . 1.07 109.687 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.43 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 11.5 mt -138.09 130.79 40.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.426 -0.583 . . . . 0.19 109.426 173.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -129.88 94.73 3.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.648 -0.706 . . . . 1.56 110.242 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.45 -106.04 1.56 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.815 -0.707 . . . . 0.29 112.554 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -100.86 13.64 34.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.521 -0.178 . . . . 2.1 110.521 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -133.18 142.39 48.59 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.201 0.524 . . . . 0.32 111.381 -174.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -126.48 157.4 20.27 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 111.002 -0.839 . . . . 0.11 111.002 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -130.86 149.3 52.56 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.438 -0.578 . . . . 0.18 109.438 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 73' ' ' PHE . 5.9 mt -124.38 148.64 47.4 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.812 -0.81 . . . . 0.59 108.812 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 62.4 t30 -78.05 72.9 4.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.578 0.704 . . . . 1.53 109.731 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -139.47 98.75 3.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.952 -1.022 . . . . 0.28 109.104 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 50.6 mt-10 -84.82 101.2 12.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.612 0.72 . . . . 1.81 110.356 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 84' ' ' SER . 34.1 m -81.12 -32.0 12.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.911 -1.04 . . . . 0.85 110.622 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 5.5 tp10 -134.09 177.47 7.71 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.77 -1.937 . . . . 2.24 105.77 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.499 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 26.4 t0 -39.78 84.93 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.119 0.968 . . . . 1.55 113.44 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 73.26 8.29 74.47 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.751 -0.54 . . . . 0.67 111.751 174.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 9.0 mmtm -67.53 110.32 3.61 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.831 -0.184 . . . . 2.5 110.686 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 8.9 tppt? -79.53 123.7 27.82 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.12 -0.696 . . . . 1.32 109.12 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 51' ' ' LEU . 1.7 mt -61.06 136.03 57.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.585 -0.279 . . . . 0.19 111.046 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -118.3 160.7 21.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.404 . . . . 0.39 110.54 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.669 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 28.6 p90 -150.38 153.74 36.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.711 -0.677 . . . . 0.16 109.509 173.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -92.34 147.29 23.03 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.621 -0.881 . . . . 0.34 108.621 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.456 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 11.6 tmm? -59.3 -15.57 16.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.997 -0.547 . . . . 2.43 112.175 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 t -64.33 -29.25 70.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.785 0.326 . . . . 0.91 110.189 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -91.27 -3.79 56.55 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.539 -0.3 . . . . 1.96 111.161 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.827 HG22 HD13 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -63.21 152.0 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.944 -0.571 . . . . 0.27 111.053 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.502 ' HG2' HD13 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -67.38 96.93 0.53 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.118 -0.492 . . . . 1.6 111.417 -176.599 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.36 -99.13 0.13 Allowed Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.611 0.57 . . . . 0.58 113.578 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -88.79 140.3 29.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.779 0.799 . . . . 2.2 110.41 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.4 p -75.43 -19.81 59.25 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.102 -0.954 . . . . 0.95 111.219 -174.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.1 t -90.31 7.51 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.673 . . . . 1.39 109.717 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -102.73 -13.92 16.86 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.966 -0.561 . . . . 0.57 110.76 177.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.827 HD13 HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -121.83 123.4 41.68 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.244 -0.65 . . . . 1.51 109.244 -177.439 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -135.4 159.01 73.28 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.661 0.267 . . . . 0.91 111.444 -174.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.506 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 30.7 Cg_endo -64.78 129.86 24.6 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.132 1.888 . . . . 0.28 111.94 175.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.15 -16.1 54.0 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.939 -0.648 . . . . 0.22 111.823 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -79.21 147.23 32.69 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.909 -0.404 . . . . 1.28 109.909 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 5.5 m -76.31 137.48 39.89 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.735 -0.839 . . . . 0.17 108.735 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.465 HG11 HD21 ' A' ' 65' ' ' LEU . 28.5 m -139.42 159.18 28.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 122.205 -0.31 . . . . 0.31 110.504 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.757 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 10.4 pt-20 -115.63 144.97 43.15 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.605 -0.887 . . . . 0.78 108.605 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.584 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 17.8 p90 -148.05 178.89 8.16 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.501 -0.772 . . . . 0.11 109.431 -172.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 22' ' ' ALA . 18.2 m -125.65 126.01 44.02 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.817 -0.808 . . . . 0.86 108.817 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 75' ' ' VAL . 8.3 p -90.02 98.69 8.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 122.058 0.932 . . . . 0.36 111.165 -171.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.0 p -106.77 131.11 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.57 -0.741 . . . . 0.42 109.662 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.4 m -77.9 132.28 37.86 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.904 -0.589 . . . . 0.67 111.627 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -76.61 122.36 24.53 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.584 -0.525 . . . . 1.82 109.584 173.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -69.73 -5.11 22.95 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.422 0.527 . . . . 1.95 112.422 -174.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.16 -60.94 1.83 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.998 -0.371 . . . . 3.99 109.998 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 83' ' ' LYS . 18.9 m120 -96.62 -30.48 13.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.815 0.341 . . . . 2.21 111.576 -173.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.44 -3.17 63.4 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.545 -0.836 . . . . 0.69 111.253 -171.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.46 ' HG2' ' HB2' ' A' ' 81' ' ' ASN . 60.1 pttt -79.02 144.72 34.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.322 -0.621 . . . . 2.42 109.322 175.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.504 ' HB2' HG11 ' A' ' 45' ' ' VAL . 9.8 m -89.56 177.56 6.52 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.393 0.616 . . . . 1.08 111.894 -174.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.9 m -149.04 153.74 38.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.98 -1.009 . . . . 0.87 109.322 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -93.89 121.88 35.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.979 0.419 . . . . 0.17 109.998 177.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.7 t -117.35 157.42 26.18 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.167 -1.049 . . . . 0.68 108.167 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 55.77 63.99 1.88 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.793 0.683 . . . . 1.82 109.764 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.622 HG12 HD11 ' A' ' 65' ' ' LEU . 78.4 t -83.77 118.41 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.36 -0.836 . . . . 0.32 111.276 -176.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.757 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 4.2 mm? -112.93 148.56 34.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.261 -0.427 . . . . 1.12 110.943 -178.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -83.49 116.17 22.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.408 0.623 . . . . 1.33 111.216 178.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.462 ' O ' ' HB ' ' A' ' 70' ' ' THR . 48.7 mm -104.95 115.12 46.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.305 -0.861 . . . . 0.28 109.926 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -96.54 107.14 19.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.611 -0.722 . . . . 2.57 110.537 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.554 -0.748 . . . . 3.08 111.172 -176.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 5.0 tp60 . . . . . 0 C--O 1.236 0.378 0 CA-C-O 121.263 0.554 . . . . 1.34 111.382 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -79.0 114.04 17.61 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.393 -0.595 . . . . 2.11 109.393 172.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 74.3 mmtt -99.9 156.39 17.16 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.851 -0.613 . . . . 1.27 110.4 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -125.93 128.74 48.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.858 0.361 . . . . 1.65 110.449 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.91 179.45 9.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.514 -0.766 . . . . 0.08 109.477 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.25 143.45 32.95 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.672 -0.492 . . . . 0.14 109.672 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.495 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 41.3 t -63.54 119.4 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.265 0.555 . . . . 0.14 110.074 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.96 -44.68 30.36 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.987 -1.006 . . . . 0.6 109.526 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.0 m -161.17 164.56 30.45 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.613 -0.721 . . . . 1.07 110.251 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.418 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 5.8 mt -141.63 130.38 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.056 0.455 . . . . 0.19 109.987 175.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 64.3 mmtt -125.43 104.05 8.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.479 -0.782 . . . . 1.56 110.469 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.07 -108.52 1.94 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.028 -0.606 . . . . 0.29 112.515 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -100.54 10.58 41.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.455 0.169 . . . . 2.1 110.693 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -128.89 140.63 51.59 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.163 0.506 . . . . 0.32 111.003 -173.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.88 157.36 17.42 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 120.638 -0.791 . . . . 0.11 111.433 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.508 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 77.0 m-85 -132.22 137.58 47.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.161 -0.681 . . . . 0.18 109.161 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.487 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.1 mt -110.13 154.65 23.01 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.714 -0.476 . . . . 0.59 109.714 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -74.76 73.09 2.05 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.587 0.708 . . . . 1.53 109.558 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -148.02 97.57 2.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.832 -1.076 . . . . 0.28 108.678 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 23.9 mp0 -85.65 110.01 18.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.723 -0.671 . . . . 1.81 109.966 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.486 HG11 ' HB2' ' A' ' 84' ' ' SER . 28.8 m -78.73 -36.4 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.85 112.024 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -156.42 123.16 5.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.511 -0.313 . . . . 2.24 110.488 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.2 t70 60.97 12.92 4.19 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.641 0.734 . . . . 1.55 111.966 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.0 21.08 14.43 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.635 -0.793 . . . . 0.67 112.979 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 4.0 mmtm -69.41 110.93 4.96 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.874 -0.417 . . . . 2.5 109.874 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -71.72 129.61 39.11 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.669 -0.493 . . . . 1.32 109.669 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.1 mt -66.66 123.3 19.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.594 -0.276 . . . . 0.19 110.97 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -105.28 158.3 16.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.045 0.45 . . . . 0.39 110.661 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.86 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 32.3 p90 -151.44 155.22 38.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.682 -0.69 . . . . 0.16 109.163 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -97.08 152.04 19.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.994 -0.743 . . . . 0.34 108.994 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.539 ' SD ' HG21 ' A' ' 58' ' ' VAL . 14.2 mmt -64.51 -3.06 2.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.431 0.53 . . . . 2.43 112.431 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.8 t -82.76 -25.31 32.94 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.851 -0.426 . . . . 0.91 109.851 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.84 -6.17 59.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.922 0.391 . . . . 1.96 110.421 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.539 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.0 t -71.6 152.38 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.69 -0.686 . . . . 0.27 112.45 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.78 98.33 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.483 -1.235 . . . . 1.6 112.041 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.87 -84.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.0 -0.545 . . . . 0.58 113.602 172.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -106.68 142.31 36.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.758 0.313 . . . . 2.2 110.179 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.413 HG22 ' HB3' ' A' ' 55' ' ' MET . 82.7 p -67.7 -21.37 65.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.271 0.558 . . . . 0.95 111.503 -177.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.6 t -95.01 2.19 9.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.285 0.564 . . . . 1.39 110.428 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.63 -13.8 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.443 -0.344 . . . . 0.57 111.297 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.659 HD21 HG12 ' A' ' 71' ' ' VAL . 1.1 tm? -110.65 124.69 52.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.976 -0.75 . . . . 1.51 108.976 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -117.92 150.19 46.76 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.559 -0.291 . . . . 0.91 111.121 -172.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.495 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.2 Cg_endo -66.49 135.76 40.49 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.443 2.095 . . . . 0.28 111.933 173.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.53 -2.36 73.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.916 -0.659 . . . . 0.22 112.367 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -95.91 154.7 17.09 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.804 -0.443 . . . . 1.28 109.804 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 m -79.72 136.03 36.67 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.466 -0.568 . . . . 0.17 109.466 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.659 HG12 HD21 ' A' ' 65' ' ' LEU . 20.0 m -136.48 161.3 37.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.432 0.634 . . . . 0.31 110.805 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.45 139.0 49.88 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.837 -1.172 . . . . 0.78 107.837 171.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.487 ' CD2' HD13 ' A' ' 41' ' ' LEU . 19.2 p90 -148.53 179.82 7.52 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.824 0.345 . . . . 0.11 110.193 -174.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.8 m -129.85 115.01 16.61 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.088 -0.708 . . . . 0.86 109.088 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.4 p -85.37 101.93 10.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.538 0.685 . . . . 0.36 110.834 -175.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.63 121.58 59.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.757 -0.656 . . . . 0.42 109.87 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.8 m -79.62 128.34 33.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.861 -0.608 . . . . 0.67 111.068 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -68.48 102.32 1.42 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.516 -0.765 . . . . 1.82 109.218 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -64.23 -8.03 11.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.217 0.532 . . . . 1.95 111.413 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -93.73 -39.34 10.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.883 -0.599 . . . . 3.99 111.044 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -114.28 -21.25 10.53 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.554 0.575 . . . . 2.21 112.554 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.7 -20.18 51.66 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.764 -0.731 . . . . 0.69 113.36 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -81.78 174.6 11.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.005 -0.739 . . . . 2.42 109.005 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.486 ' HB2' HG11 ' A' ' 45' ' ' VAL . 19.1 m -128.81 175.68 8.43 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.284 -0.566 . . . . 1.08 110.632 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.2 p -145.91 155.97 43.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.274 -0.421 . . . . 0.87 110.433 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.86 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -93.2 118.31 31.09 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.118 0.485 . . . . 0.17 110.24 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 97.3 m -116.74 144.05 44.91 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.132 -0.692 . . . . 0.68 109.132 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 63.68 69.01 0.56 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.084 -0.71 . . . . 1.82 109.084 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 71.0 t -87.94 116.66 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.406 -0.815 . . . . 0.32 110.722 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.35 149.03 30.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.903 -0.589 . . . . 1.12 110.705 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -77.91 126.42 30.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.139 -0.482 . . . . 1.33 109.891 176.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.0 mm . . . . . 0 C--N 1.323 -0.574 0 N-CA-C 110.072 -0.344 . . . . 0.28 110.072 179.121 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 . . . . . 0 C--O 1.234 0.256 0 CA-C-O 121.047 0.451 . . . . 1.34 110.906 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -99.37 115.4 29.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 2.11 110.172 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 28.2 mmtp -99.03 151.35 21.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.893 -0.594 . . . . 1.27 111.859 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.445 ' HD3' ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -115.02 127.15 55.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.73 -0.668 . . . . 1.65 110.264 176.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . . . -157.25 178.94 9.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.269 -0.271 . . . . 0.08 110.269 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.07 148.02 26.73 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.442 -0.345 . . . . 0.14 110.098 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.531 ' HA ' HD23 ' A' ' 41' ' ' LEU . 45.5 t -68.77 122.14 19.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.978 0.418 . . . . 0.14 110.624 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.41 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 22.3 t70 -75.07 -40.79 59.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.313 -0.858 . . . . 0.6 110.053 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 t -171.65 169.41 6.0 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.643 -0.708 . . . . 1.07 109.113 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.429 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 9.2 mt -136.45 126.4 39.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.254 0.55 . . . . 0.19 109.618 175.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 62.6 mmtt -120.16 85.54 2.4 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.325 -0.852 . . . . 1.56 110.361 -175.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.11 -114.55 4.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.746 -0.74 . . . . 0.29 112.549 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.59 12.78 24.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.074 -0.343 . . . . 2.1 110.074 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -132.19 140.11 48.6 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.013 0.435 . . . . 0.32 110.417 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.29 159.61 16.86 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.631 -0.795 . . . . 0.11 111.215 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 77.5 m-85 -131.47 149.54 52.49 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.03 -0.73 . . . . 0.18 109.03 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.571 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.0 mt -124.14 157.6 34.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.15 -0.315 . . . . 0.59 110.15 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -76.78 73.33 3.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.509 0.671 . . . . 1.53 109.554 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.424 ' HB3' HD12 ' A' ' 51' ' ' LEU . 16.7 t80 -148.04 98.79 2.98 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.049 -0.978 . . . . 0.28 108.859 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 43.4 mt-10 -86.95 103.36 15.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.292 -0.413 . . . . 1.81 110.135 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.535 HG21 ' H ' ' A' ' 84' ' ' SER . 27.6 m -80.65 -30.34 12.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.624 0.602 . . . . 0.85 112.624 -173.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 5.2 tp10 -161.31 110.82 1.62 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 110.57 -0.159 . . . . 2.24 110.57 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.8 t0 55.23 37.88 29.57 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.294 0.569 . . . . 1.55 111.735 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.85 20.98 54.7 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.365 -0.921 . . . . 0.67 113.087 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 38.3 mmtm -74.19 110.05 8.17 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.135 -0.691 . . . . 2.5 109.135 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -72.61 126.1 29.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.644 -0.873 . . . . 1.32 108.644 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.5 mt -63.25 128.58 36.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.114 -0.494 . . . . 0.19 110.847 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -112.49 156.72 22.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.345 -0.389 . . . . 0.39 110.302 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.906 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 25.8 p90 -146.48 149.07 32.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.623 -0.717 . . . . 0.16 109.717 174.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -91.74 145.48 24.54 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.555 -0.906 . . . . 0.34 108.555 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.51 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -58.11 -11.95 3.02 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.522 0.564 . . . . 2.43 112.522 -177.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.1 t -67.39 -25.85 66.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.823 0.345 . . . . 0.91 110.454 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -86.6 -13.87 44.46 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.242 -0.435 . . . . 1.96 110.464 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -65.82 148.39 12.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.42 -0.809 . . . . 0.27 112.298 -175.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.16 102.21 0.36 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 114.748 -1.115 . . . . 1.6 111.241 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.58 -91.59 0.26 Allowed Glycine 0 C--O 1.237 0.301 0 CA-C-N 115.952 -0.567 . . . . 0.58 113.61 173.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -101.44 151.31 22.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.648 -0.501 . . . . 2.2 109.648 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.3 p -77.71 -15.36 59.19 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.928 -0.578 . . . . 0.95 111.168 -173.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.74 2.92 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.609 -0.723 . . . . 1.39 110.078 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.48 -24.65 19.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.57 111.335 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.637 HD21 HG12 ' A' ' 71' ' ' VAL . 1.6 tm? -98.42 125.06 43.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.155 -0.683 . . . . 1.51 109.155 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -117.41 152.96 50.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 111.93 0.344 . . . . 0.91 111.93 -171.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.484 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 52.1 Cg_endo -69.65 141.9 46.95 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.991 2.461 . . . . 0.28 111.48 173.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.54 -5.13 82.58 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.776 -0.726 . . . . 0.22 112.031 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -93.93 159.61 15.1 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.401 -0.592 . . . . 1.28 109.401 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.5 m -85.02 132.19 34.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.353 -0.61 . . . . 0.17 109.353 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.637 HG12 HD21 ' A' ' 65' ' ' LEU . 6.3 m -135.3 165.2 31.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.162 0.506 . . . . 0.31 109.984 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -120.32 146.08 46.48 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.364 -0.976 . . . . 0.78 108.364 174.227 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.571 ' CD2' HD13 ' A' ' 41' ' ' LEU . 25.3 p90 -152.57 179.19 8.81 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.682 -0.488 . . . . 0.11 109.682 -174.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.4 m -126.83 123.32 37.06 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.877 -0.786 . . . . 0.86 108.877 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 p -92.69 99.49 9.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.666 0.746 . . . . 0.36 111.642 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.7 p -111.7 123.51 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.567 -0.742 . . . . 0.42 109.994 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 30.2 m -72.88 129.02 37.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.911 0.386 . . . . 0.67 110.933 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.415 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.9 OUTLIER -69.37 117.82 11.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 1.82 109.631 177.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -71.36 -15.72 62.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.156 0.503 . . . . 1.95 110.76 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -94.89 -42.28 8.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.703 -0.681 . . . . 3.99 111.095 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -94.97 -29.09 14.82 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.317 -0.401 . . . . 2.21 111.724 -171.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.52 -24.21 26.69 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.69 112.568 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -95.24 155.85 16.56 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.46 -0.57 . . . . 2.42 109.46 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.535 ' H ' HG21 ' A' ' 45' ' ' VAL . 4.4 m -88.08 175.59 7.67 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.094 0.474 . . . . 1.08 111.289 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -141.32 153.08 44.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.692 -0.685 . . . . 0.87 109.376 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.906 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -90.73 119.62 31.11 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.112 0.482 . . . . 0.17 110.044 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.6 m -117.01 149.32 40.46 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.321 -0.854 . . . . 0.68 109.921 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 t30 56.87 69.26 0.76 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 123.593 0.558 . . . . 1.82 110.62 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 74.5 t -85.88 122.75 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 0.32 111.708 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.94 147.57 35.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.517 -0.765 . . . . 1.12 110.209 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.455 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -79.4 117.0 19.98 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.942 -0.762 . . . . 1.33 108.942 175.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 72' ' ' GLU . 45.7 mm . . . . . 0 C--N 1.315 -0.919 0 CA-C-O 121.116 0.484 . . . . 0.28 110.216 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.694 0.283 . . . . 1.34 111.087 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -118.37 136.89 53.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.28 0.562 . . . . 2.11 111.308 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -112.75 150.71 31.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.232 -0.894 . . . . 1.27 110.561 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -120.46 127.17 51.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.907 0.385 . . . . 1.65 110.408 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.97 179.87 8.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.802 -0.635 . . . . 0.08 109.529 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 144.52 30.64 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 110.194 -0.299 . . . . 0.14 110.194 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.426 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 47.5 t -66.32 114.0 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.2 -0.296 . . . . 0.14 110.2 176.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.451 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 7.1 t70 -66.95 -50.21 63.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.955 -0.566 . . . . 0.6 109.861 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.9 m -159.79 163.81 34.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.468 -0.787 . . . . 1.07 110.016 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.445 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 7.7 mt -137.47 126.1 33.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.456 -0.572 . . . . 0.19 109.456 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -118.77 90.45 3.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.256 -0.884 . . . . 1.56 109.862 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.37 -112.1 4.14 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.721 -0.752 . . . . 0.29 112.476 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -96.84 11.69 34.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 2.1 110.246 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -129.71 142.04 50.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.143 0.497 . . . . 0.32 110.751 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.92 155.95 17.27 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.379 -0.828 . . . . 0.11 111.378 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 70.7 m-85 -129.82 139.75 51.17 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.826 -0.805 . . . . 0.18 108.826 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.541 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.4 mt -111.58 156.7 21.37 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.784 -0.45 . . . . 0.59 109.784 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.62 73.25 1.99 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.966 -0.753 . . . . 1.53 108.966 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -149.57 98.43 2.76 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.624 -0.717 . . . . 0.28 109.289 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 23.0 mp0 -75.73 100.71 4.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 1.81 109.712 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.648 HG11 ' HB3' ' A' ' 84' ' ' SER . 35.3 m -74.39 -30.39 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.713 -0.676 . . . . 0.85 111.519 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -156.73 109.79 2.59 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 116.092 -0.504 . . . . 2.24 110.354 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t0 54.52 29.6 11.55 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.185 0.517 . . . . 1.55 112.286 171.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.11 1.49 44.97 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.161 -1.018 . . . . 0.67 113.151 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 4.0 mmtp -64.64 111.77 2.89 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.862 0.331 . . . . 2.5 110.61 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -65.78 138.89 58.23 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.271 0.357 . . . . 1.32 110.181 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.594 ' HG ' ' CG1' ' A' ' 45' ' ' VAL . 1.3 mt -74.68 125.22 28.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.45 -0.341 . . . . 0.19 110.348 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -106.87 157.22 17.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.39 110.064 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.906 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 28.1 p90 -151.05 157.06 42.33 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.596 -0.729 . . . . 0.16 109.394 174.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -98.92 151.01 21.34 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.111 -0.7 . . . . 0.34 109.111 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.441 ' SD ' HG21 ' A' ' 58' ' ' VAL . 9.4 mmt -62.39 -6.94 3.69 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.797 0.665 . . . . 2.43 112.797 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -81.23 -25.28 36.77 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.241 -0.184 . . . . 0.91 111.068 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -81.77 -15.69 53.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.032 0.444 . . . . 1.96 110.157 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.441 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.8 t -62.56 151.84 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.212 -0.904 . . . . 0.27 112.188 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.506 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -64.63 88.96 0.06 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.005 -0.998 . . . . 1.6 112.38 -173.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.37 -66.47 2.28 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.974 -0.557 . . . . 0.58 113.337 170.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -122.31 143.7 49.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.296 0.57 . . . . 2.2 110.264 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.7 p -72.3 -26.64 62.03 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.119 -0.946 . . . . 0.95 110.926 -174.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -95.67 22.99 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.753 0.787 . . . . 1.39 109.633 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.9 -15.68 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.598 -0.728 . . . . 0.57 109.765 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.562 HD21 HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -119.49 124.74 47.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.889 -1.05 . . . . 1.51 109.603 -178.028 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -122.99 153.63 64.21 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.682 -0.235 . . . . 0.91 111.235 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.426 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 41.4 Cg_endo -68.47 129.06 18.27 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.523 2.149 . . . . 0.28 111.972 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.58 -14.04 56.51 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.918 -0.583 . . . . 0.22 111.84 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 1.3 m-20 -82.16 154.14 25.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 1.28 110.323 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m -78.71 141.88 37.54 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.298 -0.63 . . . . 0.17 109.298 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.562 HG11 HD21 ' A' ' 65' ' ' LEU . 30.6 m -139.87 161.41 26.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.654 0.74 . . . . 0.31 111.761 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.33 137.51 51.71 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.447 -1.251 . . . . 0.78 108.096 172.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.541 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.8 p90 -149.48 178.55 8.71 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.29 -0.633 . . . . 0.11 109.29 -174.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 m -124.29 132.33 53.56 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.09 -0.707 . . . . 0.86 109.09 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.02 99.14 8.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.504 0.668 . . . . 0.36 110.978 -175.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.46 116.95 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.47 0.653 . . . . 0.42 110.719 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.9 m -69.98 125.96 28.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.703 -0.681 . . . . 0.67 110.483 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.96 114.44 5.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 1.82 109.326 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -58.59 -31.24 67.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.41 -0.359 . . . . 1.95 111.357 -175.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.42 -36.79 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.341 -0.391 . . . . 3.99 111.42 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -92.83 -23.36 18.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.054 0.39 . . . . 2.21 112.054 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.58 -24.57 7.32 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.028 -0.606 . . . . 0.69 113.484 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -88.44 149.94 23.41 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.812 -0.44 . . . . 2.42 109.812 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.648 ' HB3' HG11 ' A' ' 45' ' ' VAL . 42.7 t -85.32 177.59 7.77 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.794 0.331 . . . . 1.08 110.709 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.4 m -150.74 149.96 30.43 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.286 -0.635 . . . . 0.87 109.286 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.906 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -91.94 121.51 33.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.025 0.441 . . . . 0.17 110.614 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.0 m -117.49 144.39 45.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.028 -0.533 . . . . 0.68 109.909 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 57.71 73.11 0.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.743 0.652 . . . . 1.82 110.31 -175.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 94.0 t -92.05 105.01 16.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.568 -0.742 . . . . 0.32 110.308 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 11.1 mp -105.89 149.08 26.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.594 -0.73 . . . . 1.12 110.735 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.41 ' HD3' ' HB3' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -86.18 103.25 14.64 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.907 -0.588 . . . . 1.33 110.795 -174.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.6 mm . . . . . 0 C--N 1.32 -0.702 0 CA-C-N 115.585 -0.734 . . . . 0.28 110.235 -179.614 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 120.993 0.425 . . . . 1.34 110.775 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -109.61 123.72 49.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.02 -0.537 . . . . 2.11 110.558 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -109.08 153.02 24.26 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.625 -0.716 . . . . 1.27 110.687 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -122.85 128.34 50.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.738 0.304 . . . . 1.65 110.303 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.73 179.7 8.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.641 -0.709 . . . . 0.08 109.095 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.74 145.38 29.21 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.761 -0.459 . . . . 0.14 109.761 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.519 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 41.9 t -64.85 114.37 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.159 0.504 . . . . 0.14 109.977 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.475 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 9.9 t70 -67.86 -45.28 75.02 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.858 -1.065 . . . . 0.6 109.747 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.7 m -169.05 166.5 10.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.514 -0.766 . . . . 1.07 109.868 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.415 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 8.3 mt -137.96 128.48 36.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.944 -0.391 . . . . 0.19 109.944 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -115.22 88.02 2.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.686 -0.688 . . . . 1.56 109.856 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.03 -106.99 1.88 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.733 -0.746 . . . . 0.29 112.816 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -96.35 5.34 51.12 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.58 0.228 . . . . 2.1 111.178 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -125.75 140.38 52.74 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.002 0.43 . . . . 0.32 110.368 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.541 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.17 158.28 16.86 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.51 -0.852 . . . . 0.11 111.323 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -132.08 141.12 49.08 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.867 -0.79 . . . . 0.18 108.867 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.551 HD13 ' CD2' ' A' ' 73' ' ' PHE . 4.8 mt -115.09 150.75 35.47 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.427 -0.953 . . . . 0.59 108.427 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -75.21 72.97 2.32 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.272 0.558 . . . . 1.53 109.64 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -142.61 98.07 3.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.156 -0.929 . . . . 0.28 108.57 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 15.4 mp0 -90.23 107.62 19.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.039 -0.528 . . . . 1.81 109.791 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.451 HG11 ' HB2' ' A' ' 84' ' ' SER . 29.2 m -74.62 -32.69 30.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.622 -0.717 . . . . 0.85 111.851 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -156.45 114.06 3.23 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.532 -0.304 . . . . 2.24 110.572 -174.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 51.8 34.06 12.46 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.387 0.884 . . . . 1.55 113.387 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 44' ' ' GLU . . . 89.97 20.34 43.43 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.233 -0.984 . . . . 0.67 112.725 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -79.98 109.16 14.15 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.033 -0.728 . . . . 2.5 109.033 176.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -71.63 138.81 48.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.636 -0.711 . . . . 1.32 110.726 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.497 HD23 ' HA ' ' A' ' 51' ' ' LEU . 4.5 mt -74.89 122.65 23.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.477 -0.329 . . . . 0.19 111.222 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -107.37 161.29 14.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.427 -0.351 . . . . 0.39 110.07 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.735 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 17.1 p90 -152.69 158.77 42.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.132 -0.485 . . . . 0.16 109.741 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.403 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . 9.5 t-160 -99.97 156.05 17.36 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.718 -0.845 . . . . 0.34 108.718 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.448 ' SD ' HG21 ' A' ' 58' ' ' VAL . 13.2 mmt -65.03 3.18 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.257 0.465 . . . . 2.43 112.257 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.3 t -87.39 -28.01 22.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.91 110.127 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' A' ' 54' ' ' HIS . 9.9 mp0 -84.53 -11.01 56.91 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.236 -0.438 . . . . 1.96 110.188 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.473 HG22 HD22 ' A' ' 65' ' ' LEU . 2.4 t -68.38 150.3 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.463 -0.789 . . . . 0.27 111.649 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -58.23 88.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.045 -0.979 . . . . 1.6 111.736 -177.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.11 -91.2 0.03 OUTLIER Glycine 0 CA--C 1.52 0.403 0 O-C-N 123.501 0.501 . . . . 0.58 113.199 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -79.27 129.93 34.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.482 0.658 . . . . 2.2 110.587 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.5 p -80.44 -10.3 59.75 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.062 -0.972 . . . . 0.95 110.963 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.54 -11.12 10.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.529 -0.76 . . . . 1.39 110.234 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.5 -19.11 31.69 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.939 0.4 . . . . 0.57 111.693 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -105.91 124.29 49.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.595 -0.52 . . . . 1.51 109.595 -177.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -123.35 156.21 64.06 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.583 0.23 . . . . 0.91 111.058 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.472 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 47.4 Cg_endo -69.23 129.09 17.51 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.425 2.084 . . . . 0.28 111.477 174.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.519 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 102.5 -13.02 56.85 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.674 -0.775 . . . . 0.22 112.114 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -82.02 152.57 26.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.275 -0.269 . . . . 1.28 110.275 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -76.5 137.81 39.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.051 -0.722 . . . . 0.17 109.051 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -139.13 163.71 26.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.902 0.382 . . . . 0.31 111.216 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.555 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 3.4 pt-20 -114.02 150.56 33.72 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.294 -1.372 . . . . 0.78 107.294 170.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.551 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.3 p90 -156.97 179.85 8.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.192 -0.67 . . . . 0.11 109.192 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.7 m -129.88 113.89 15.21 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.828 -0.805 . . . . 0.86 108.828 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.1 p -86.31 97.76 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 122.019 0.914 . . . . 0.36 110.488 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -105.68 117.13 50.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.174 -0.921 . . . . 0.42 109.315 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.8 m -73.65 126.53 30.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.333 0.587 . . . . 0.67 110.786 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -69.78 113.76 7.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.0 -1.0 . . . . 1.82 110.001 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -65.52 -16.8 64.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.314 0.578 . . . . 1.95 110.402 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -91.07 -38.19 12.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.58 -0.736 . . . . 3.99 111.584 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -103.44 -26.61 12.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.119 0.414 . . . . 2.21 112.119 -171.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.82 -23.21 24.43 Favored Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 121.053 -0.594 . . . . 0.69 112.013 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 49' ' ' LYS . 15.1 pttp -91.28 174.74 7.23 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.27 -0.641 . . . . 2.42 109.27 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.451 ' HB2' HG11 ' A' ' 45' ' ' VAL . 19.0 m -114.28 179.92 3.82 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.741 -0.384 . . . . 1.08 110.643 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.8 m -147.19 147.01 30.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.7 -0.682 . . . . 0.87 109.338 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -86.33 117.38 25.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.171 0.51 . . . . 0.17 110.53 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.4 m -116.25 150.04 38.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.579 -0.737 . . . . 0.68 109.407 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.53 ' ND2' HD13 ' A' ' 90' ' ' LEU . 0.2 OUTLIER 61.91 59.17 1.77 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.16 -0.681 . . . . 1.82 109.16 -178.002 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 90.1 t -85.05 101.49 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.854 -0.612 . . . . 0.32 110.147 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.555 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 3.2 mp -106.21 145.99 30.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.242 0.544 . . . . 1.12 111.517 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.84 117.46 17.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.548 -0.751 . . . . 1.33 110.807 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mm . . . . . 0 C--N 1.317 -0.817 0 CA-C-N 115.719 -0.673 . . . . 0.28 111.114 -175.907 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.5 tp60 . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 120.586 0.231 . . . . 1.34 110.664 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.34 112.59 20.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.015 0.436 . . . . 2.11 110.426 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -96.05 160.64 14.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.592 . . . . 1.27 111.041 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.54 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 71.6 mtm-85 -132.31 127.86 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.033 0.444 . . . . 1.65 111.348 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.72 179.92 8.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.593 -0.73 . . . . 0.08 109.359 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.44 145.07 30.55 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 110.01 -0.367 . . . . 0.14 110.01 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.554 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 47.5 t -65.79 120.41 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 120.923 0.392 . . . . 0.14 109.958 176.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.56 -44.14 68.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.308 -0.86 . . . . 0.6 109.574 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.2 m -173.48 169.25 4.41 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.438 -0.801 . . . . 1.07 109.87 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.7 mt -136.69 135.2 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.945 0.402 . . . . 0.19 110.2 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -123.91 97.38 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.555 -0.748 . . . . 1.56 110.17 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.7 -107.1 1.78 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.819 -0.705 . . . . 0.29 112.405 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -98.67 4.07 47.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.568 0.223 . . . . 2.1 110.771 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -123.71 141.14 52.3 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 120.468 -0.493 . . . . 0.32 111.16 -171.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.41 156.08 18.39 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 120.579 -0.82 . . . . 0.11 111.319 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 74.3 m-85 -130.16 141.47 50.67 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.179 -0.675 . . . . 0.18 109.179 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.518 HD13 ' CD2' ' A' ' 73' ' ' PHE . 5.5 mt -112.09 156.17 22.67 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.739 -0.467 . . . . 0.59 109.739 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -78.26 72.83 4.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.566 0.698 . . . . 1.53 109.677 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.467 ' HB3' HD12 ' A' ' 51' ' ' LEU . 25.2 t80 -142.59 98.57 3.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.797 -1.092 . . . . 0.28 108.186 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 41.8 mt-10 -93.16 104.34 16.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.35 0.595 . . . . 1.81 110.928 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.2 m -72.74 -34.13 46.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.407 -0.815 . . . . 0.85 111.529 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 5.6 tt0 -155.05 118.34 4.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.631 -0.259 . . . . 2.24 110.756 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.9 t70 56.11 29.48 14.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.524 0.678 . . . . 1.55 112.162 167.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.416 ' HA2' ' CD ' ' A' ' 44' ' ' GLU . . . 88.5 24.5 33.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.149 -1.024 . . . . 0.67 112.873 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 12.5 mmtm -71.71 109.81 5.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.917 -0.771 . . . . 2.5 108.917 172.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -77.97 121.53 24.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.24 -0.436 . . . . 1.32 109.97 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.467 HD12 ' HB3' ' A' ' 43' ' ' PHE . 2.5 mt -58.83 123.93 18.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.945 -0.571 . . . . 0.19 110.912 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -106.12 157.46 17.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.93 0.395 . . . . 0.39 110.701 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.936 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 35.7 p90 -151.2 153.79 35.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.718 -0.674 . . . . 0.16 109.277 173.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -95.3 150.66 20.01 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.441 -0.948 . . . . 0.34 108.441 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.7 mtt -64.66 2.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.317 0.488 . . . . 2.43 112.317 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 t -83.71 -27.09 29.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.897 -0.408 . . . . 0.91 109.897 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.32 -8.03 58.69 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.979 0.419 . . . . 1.96 110.203 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 65' ' ' LEU . 2.1 t -65.63 152.21 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.354 -0.839 . . . . 0.27 112.709 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 12.9 tm0? -66.62 95.15 0.32 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.166 -0.924 . . . . 1.6 112.299 -175.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.87 -81.43 0.54 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.939 -0.573 . . . . 0.58 113.461 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -107.7 148.2 29.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.896 0.379 . . . . 2.2 110.294 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.8 p -67.48 -24.77 65.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.869 -0.605 . . . . 0.95 110.832 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.5 t -93.18 3.42 8.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.787 -0.642 . . . . 1.39 110.637 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -87.79 -24.07 23.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.018 0.437 . . . . 0.57 110.709 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.711 HD22 ' HG2' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -105.67 124.74 50.05 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.842 -0.799 . . . . 1.51 108.842 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -119.99 149.78 49.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.668 -0.242 . . . . 0.91 110.892 -173.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.425 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 36.9 Cg_endo -67.34 122.0 9.2 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.33 2.02 . . . . 0.28 111.358 172.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.554 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 102.58 -11.42 56.5 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.779 -0.724 . . . . 0.22 112.203 -176.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.5 155.28 22.24 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.912 -0.403 . . . . 1.28 109.912 175.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.4 m -78.77 141.72 37.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.218 -0.66 . . . . 0.17 109.218 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.665 HG11 HD11 ' A' ' 65' ' ' LEU . 6.2 m -136.92 165.7 27.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.842 0.83 . . . . 0.31 111.251 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -121.51 144.05 48.92 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.216 -1.356 . . . . 0.78 107.988 171.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.518 ' CD2' HD13 ' A' ' 41' ' ' LEU . 23.0 p90 -154.04 178.99 9.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.868 -0.419 . . . . 0.11 109.868 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.1 m -127.43 118.15 23.51 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.883 -0.784 . . . . 0.86 108.883 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.3 p -82.95 98.97 5.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 122.072 0.939 . . . . 0.36 110.777 -175.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.9 122.86 64.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.152 -0.931 . . . . 0.42 109.863 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.4 m -76.53 130.34 37.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.987 -0.552 . . . . 0.67 111.022 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -73.98 106.55 5.72 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.994 -0.743 . . . . 1.82 108.994 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -64.65 -15.39 61.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.639 0.256 . . . . 1.95 111.681 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.547 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 4.3 tpm_? -90.83 -43.84 9.79 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.675 0.25 . . . . 3.99 111.675 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.488 ' OD1' ' HG2' ' A' ' 83' ' ' LYS . 22.6 t-20 -95.28 -31.97 13.21 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.803 -0.359 . . . . 2.21 111.18 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.42 -21.01 40.59 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.126 -0.559 . . . . 0.69 113.014 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.488 ' HG2' ' OD1' ' A' ' 81' ' ' ASN . 58.7 pttt -91.32 171.16 9.41 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 109.455 -0.572 . . . . 2.42 109.455 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.7 m -108.93 176.16 5.2 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.606 -0.438 . . . . 1.08 111.396 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.1 p -145.83 154.78 42.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.621 . . . . 0.87 109.881 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.936 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -93.27 117.46 30.1 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.273 0.558 . . . . 0.17 110.417 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.4 m -117.26 145.18 44.12 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.741 -0.663 . . . . 0.68 109.602 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.13 71.33 0.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.427 0.632 . . . . 1.82 109.777 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 80.2 t -89.8 121.81 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.077 -0.965 . . . . 0.32 111.223 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.513 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 4.3 mm? -112.26 148.37 34.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.79 -0.641 . . . . 1.12 109.916 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.711 ' HG2' HD22 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -87.51 118.18 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.155 -0.683 . . . . 1.33 109.155 177.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.0 mm . . . . . 0 C--N 1.313 -1.006 0 CA-C-N 115.275 -0.875 . . . . 0.28 110.781 -174.212 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 120.891 0.376 . . . . 1.34 110.506 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -104.54 122.66 46.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.126 0.488 . . . . 2.11 110.312 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 72.0 mmtt -100.43 144.8 29.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.652 -0.704 . . . . 1.27 110.78 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.522 ' HE ' ' HB2' ' A' ' 72' ' ' GLU . 9.5 mmt85 -112.77 128.37 56.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.204 -0.453 . . . . 1.65 110.056 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . . . -159.04 179.98 8.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.84 -0.43 . . . . 0.08 109.84 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.76 147.4 28.64 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.289 -0.263 . . . . 0.14 110.289 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.458 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 38.5 t -66.42 113.83 3.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.199 0.523 . . . . 0.14 109.824 174.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.41 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 20.7 t70 -72.5 -44.36 62.35 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.053 -0.976 . . . . 0.6 109.615 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.3 m -164.28 166.86 20.52 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.805 -0.634 . . . . 1.07 110.562 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.447 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 5.3 mt -139.76 134.52 38.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.168 0.508 . . . . 0.19 109.942 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -127.53 91.88 3.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.423 -0.808 . . . . 1.56 110.313 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.51 -106.66 1.81 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.721 -0.752 . . . . 0.29 112.786 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -98.27 6.43 47.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.611 0.243 . . . . 2.1 110.363 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.47 140.85 51.61 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.125 0.488 . . . . 0.32 110.72 -173.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.519 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.67 158.73 15.56 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.313 -0.858 . . . . 0.11 111.148 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 80.7 m-85 -131.86 131.41 42.77 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.79 -0.819 . . . . 0.18 108.79 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.554 HD22 HG21 ' A' ' 71' ' ' VAL . 9.6 mt -103.93 153.49 20.74 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.573 -0.529 . . . . 0.59 109.573 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -76.32 73.4 3.1 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.995 -0.743 . . . . 1.53 108.995 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.423 ' HB3' HD12 ' A' ' 51' ' ' LEU . 28.0 t80 -150.1 98.68 2.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.735 -1.121 . . . . 0.28 109.091 -178.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.503 ' HG2' ' HA2' ' A' ' 48' ' ' GLY . 3.3 mp0 -82.12 100.75 9.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.452 -0.795 . . . . 1.81 109.978 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.631 HG11 ' HB3' ' A' ' 84' ' ' SER . 7.4 m -71.36 -39.37 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.422 -0.808 . . . . 0.85 111.978 -176.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' H ' ' HB2' ' A' ' 49' ' ' LYS . 5.9 tp10 -140.44 101.57 4.14 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.881 0.372 . . . . 2.24 111.0 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 t70 58.92 20.17 7.84 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.565 -0.743 . . . . 1.55 112.927 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.503 ' HA2' ' HG2' ' A' ' 44' ' ' GLU . . . 111.43 11.73 16.89 Favored Glycine 0 C--N 1.315 -0.589 0 C-N-CA 119.976 -1.107 . . . . 0.67 112.737 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.505 ' HB2' ' H ' ' A' ' 46' ' ' GLU . 23.3 mmtm -69.72 110.63 5.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.344 -0.613 . . . . 2.5 109.344 173.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -70.55 132.19 45.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.878 -0.416 . . . . 1.32 109.878 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 3.0 mt -71.85 122.02 20.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.423 -0.353 . . . . 0.19 111.098 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -105.07 157.56 17.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.286 -0.416 . . . . 0.39 109.955 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.875 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 26.6 p90 -151.44 153.35 34.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.903 -0.59 . . . . 0.16 109.518 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.401 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . 16.6 t-80 -96.58 152.22 18.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.962 -0.755 . . . . 0.34 108.962 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.571 ' SD ' HG21 ' A' ' 58' ' ' VAL . 15.5 mmt -65.14 -1.66 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.417 0.525 . . . . 2.43 112.417 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.8 t -84.92 -19.47 32.17 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.08 -0.387 . . . . 0.91 110.209 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.401 ' OE2' ' HB3' ' A' ' 54' ' ' HIS . 1.8 mp0 -90.03 -6.03 55.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.313 -0.403 . . . . 1.96 110.326 176.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.571 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -71.42 150.11 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.786 0.661 . . . . 0.27 112.786 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.42 93.5 0.07 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.87 -1.059 . . . . 1.6 112.128 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.99 -66.38 3.41 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 121.201 -0.523 . . . . 0.58 113.969 169.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -131.27 141.86 50.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.19 0.519 . . . . 2.2 110.018 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.8 p -70.87 -23.58 62.34 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.129 -0.941 . . . . 0.95 110.89 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.6 t -93.47 12.07 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 115.252 -0.885 . . . . 1.39 110.075 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.75 -38.0 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.484 -0.326 . . . . 0.57 111.226 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.661 HD21 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -90.17 124.99 35.3 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.158 -0.682 . . . . 1.51 109.158 -178.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -132.15 160.88 66.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.415 -0.357 . . . . 0.91 111.211 -173.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.458 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 27.0 Cg_endo -62.38 140.81 84.49 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.592 2.195 . . . . 0.28 111.887 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.26 -14.36 63.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.075 -0.583 . . . . 0.22 112.468 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.408 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 2.7 m-20 -79.0 148.69 32.44 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.981 -0.378 . . . . 1.28 109.981 174.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 5.5 m -81.67 140.27 34.45 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.821 -0.807 . . . . 0.17 108.821 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.661 HG12 HD21 ' A' ' 65' ' ' LEU . 34.4 m -135.5 157.24 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.962 0.887 . . . . 0.31 111.351 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.522 ' HB2' ' HE ' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -114.74 132.25 56.5 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.856 -1.52 . . . . 0.78 107.688 171.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.501 ' CD2' HD13 ' A' ' 41' ' ' LEU . 20.1 p90 -143.25 179.54 7.01 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.639 -0.504 . . . . 0.11 109.639 -175.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 m -127.1 121.46 31.52 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.957 -0.757 . . . . 0.86 108.957 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 p -81.22 98.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.701 0.762 . . . . 0.36 110.593 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.55 120.53 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.717 -0.674 . . . . 0.42 110.45 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.7 m -68.78 133.0 47.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.736 -0.666 . . . . 0.67 111.279 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -71.05 105.23 3.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.736 -0.839 . . . . 1.82 108.736 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -63.93 -13.25 44.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.287 -0.415 . . . . 1.95 112.046 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -96.0 -36.8 10.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.472 -0.331 . . . . 3.99 111.563 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -107.38 -31.41 8.19 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.363 0.505 . . . . 2.21 112.363 -169.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.91 -21.24 38.8 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.236 -0.983 . . . . 0.69 113.663 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -85.33 175.46 8.89 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.287 -0.635 . . . . 2.42 109.287 177.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.631 ' HB3' HG11 ' A' ' 45' ' ' VAL . 19.6 t -117.43 -178.15 3.39 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.587 -0.445 . . . . 1.08 110.981 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.0 p -156.79 152.99 27.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.908 -0.587 . . . . 0.87 109.942 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.875 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -86.73 118.4 26.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.939 0.4 . . . . 0.17 110.627 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 33.9 m -116.74 140.86 48.94 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.269 -0.423 . . . . 0.68 109.916 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 63.39 72.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.622 0.725 . . . . 1.82 109.237 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 54.5 t -87.98 116.8 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.803 -1.09 . . . . 0.32 110.505 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 4.1 mm? -108.47 148.91 29.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.03 -0.532 . . . . 1.12 110.523 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.505 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -81.56 125.4 30.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.267 -0.642 . . . . 1.33 109.267 173.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.465 ' O ' ' HB ' ' A' ' 70' ' ' THR . 40.1 mm . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 116.12 -0.491 . . . . 0.28 111.037 -175.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.491 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 5.5 tp60 . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.97 0.415 . . . . 1.34 110.99 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -96.24 126.14 41.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.691 -0.485 . . . . 2.11 109.691 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 12.9 mmtm -113.3 145.5 40.94 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.775 -0.648 . . . . 1.27 110.28 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -116.89 132.49 56.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.94 0.4 . . . . 1.65 110.696 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.73 179.84 8.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.802 -0.636 . . . . 0.08 109.787 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.8 144.15 31.87 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.206 -0.452 . . . . 0.14 110.023 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.487 ' HA ' HD23 ' A' ' 41' ' ' LEU . 61.3 t -67.2 116.34 6.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.133 0.492 . . . . 0.14 110.463 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.434 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 10.6 t70 -67.69 -51.79 45.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.08 -0.963 . . . . 0.6 109.636 177.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.7 m -159.41 166.76 30.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.893 -0.594 . . . . 1.07 110.564 -175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.432 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 6.0 mt -142.55 132.39 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.876 -0.602 . . . . 0.19 110.07 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -126.76 93.84 3.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.623 -0.717 . . . . 1.56 110.641 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.85 -106.43 1.64 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.73 -0.748 . . . . 0.29 112.393 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -99.02 7.65 45.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.633 0.254 . . . . 2.1 110.687 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -126.79 143.34 51.28 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.279 0.562 . . . . 0.32 111.469 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.18 161.95 21.97 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.713 -0.756 . . . . 0.11 111.52 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 70.7 m-85 -136.96 143.35 42.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.174 -0.676 . . . . 0.18 109.174 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.5 mt -117.81 156.53 28.19 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.335 -0.246 . . . . 0.59 110.335 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -74.85 72.81 2.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.35 0.595 . . . . 1.53 109.729 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -146.53 100.79 3.4 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.107 -0.951 . . . . 0.28 109.284 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -81.56 106.03 13.19 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.271 -0.877 . . . . 1.81 110.062 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.1 t -71.01 -66.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.522 -0.763 . . . . 0.85 111.194 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.66 ' H ' ' HB2' ' A' ' 49' ' ' LYS . 1.0 OUTLIER -133.71 116.29 15.6 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.081 -0.963 . . . . 2.24 109.49 -178.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 t70 64.18 19.17 11.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.466 0.651 . . . . 1.55 111.637 171.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.35 21.4 13.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.557 -0.83 . . . . 0.67 112.841 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.66 ' HB2' ' H ' ' A' ' 46' ' ' GLU . 27.6 mmtm -65.09 109.97 2.35 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.443 -0.577 . . . . 2.5 109.443 175.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -72.3 118.62 15.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.098 -0.705 . . . . 1.32 109.098 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.1 mt -60.38 125.2 22.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.417 -0.356 . . . . 0.19 111.506 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -106.44 157.29 17.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.138 -0.483 . . . . 0.39 109.916 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.782 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 27.0 p90 -148.86 154.66 39.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.68 -0.691 . . . . 0.16 109.178 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -98.32 151.87 20.05 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.619 -0.882 . . . . 0.34 108.619 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.594 ' HB3' HG22 ' A' ' 62' ' ' THR . 14.3 mmt -61.03 -12.44 11.71 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.37 0.507 . . . . 2.43 112.37 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.9 m -72.48 -25.39 61.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.192 -0.318 . . . . 0.91 110.82 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.45 -13.74 51.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 1.96 110.71 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.576 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.0 t -64.04 152.31 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 112.861 0.689 . . . . 0.27 112.861 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -62.77 95.79 0.08 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.948 -1.024 . . . . 1.6 112.173 -176.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.47 -81.62 0.6 Allowed Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.58 113.288 172.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -110.92 143.6 41.29 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.677 -0.49 . . . . 2.2 109.677 -177.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 ' HB3' ' A' ' 55' ' ' MET . 66.6 p -57.9 -42.69 85.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.127 0.489 . . . . 0.95 111.873 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 63' ' ' VAL . 2.6 m -78.94 4.7 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.952 -0.567 . . . . 1.39 112.477 -177.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.5 -9.78 40.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.69 0.281 . . . . 0.57 111.21 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.732 HD21 HG12 ' A' ' 71' ' ' VAL . 1.6 tm? -115.9 125.46 52.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.915 -0.772 . . . . 1.51 108.915 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 45.4 m-70 -120.33 149.78 50.35 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-O 120.579 0.228 . . . . 0.91 111.065 -171.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.461 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 37.0 Cg_endo -66.04 139.52 56.4 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.655 2.237 . . . . 0.28 111.881 174.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.67 -15.48 61.46 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.921 -0.657 . . . . 0.22 111.999 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -82.7 149.75 27.13 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.39 -0.226 . . . . 1.28 110.39 177.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.1 m -76.22 137.85 40.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.199 -0.667 . . . . 0.17 109.199 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.732 HG12 HD21 ' A' ' 65' ' ' LEU . 16.1 m -136.07 157.51 38.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.525 0.678 . . . . 0.31 109.98 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 132.07 56.59 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.203 -1.036 . . . . 0.78 108.203 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.514 ' CD2' HD13 ' A' ' 41' ' ' LEU . 36.7 p90 -141.93 179.15 7.04 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.855 -0.611 . . . . 0.11 109.889 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.0 m -128.63 119.69 25.19 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.917 -0.772 . . . . 0.86 108.917 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 75' ' ' VAL . 8.5 p -91.4 108.38 19.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.767 0.794 . . . . 0.36 111.269 -172.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 84' ' ' SER . 6.8 p -116.0 124.42 72.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.533 -0.758 . . . . 0.42 110.061 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.2 m -83.35 127.03 33.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.173 0.511 . . . . 0.67 110.611 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.595 ' CB ' ' HB3' ' A' ' 81' ' ' ASN . 9.2 m120 -70.45 121.29 17.49 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.518 -0.764 . . . . 1.82 109.765 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -73.78 -21.46 60.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.942 0.401 . . . . 1.95 111.222 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -96.09 -33.67 12.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.023 0.439 . . . . 3.99 110.979 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.595 ' HB3' ' CB ' ' A' ' 78' ' ' ASN . 60.4 t30 -97.05 -18.23 19.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.331 0.586 . . . . 2.21 110.788 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.99 -25.96 2.96 Favored Glycine 0 C--O 1.229 -0.175 0 CA-C-N 115.525 -0.761 . . . . 0.69 113.919 174.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.492 ' HE2' HD21 ' A' ' 81' ' ' ASN . 18.5 pttm -99.62 168.47 9.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.22 0.51 . . . . 2.42 111.358 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 69.5 m -102.34 175.45 5.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.561 -0.745 . . . . 1.08 111.64 -175.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -143.69 156.39 44.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.566 -0.743 . . . . 0.87 109.157 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.782 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -99.47 118.59 36.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 110.029 -0.36 . . . . 0.17 110.029 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.2 m -116.56 148.33 40.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.437 -0.347 . . . . 0.68 110.664 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.2 m120 62.06 52.09 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.646 0.591 . . . . 1.82 109.881 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.468 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 77.2 t -72.89 100.62 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.473 -0.785 . . . . 0.32 110.81 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 8.0 mp -102.84 148.31 25.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.641 -0.709 . . . . 1.12 110.95 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.485 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -77.17 127.95 33.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.014 -0.539 . . . . 1.33 110.006 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.1 mm . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 116.301 -0.409 . . . . 0.28 110.267 -179.644 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 6.5 tp60 . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.984 0.421 . . . . 1.34 110.912 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -93.91 135.02 35.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.117 -0.492 . . . . 2.11 110.105 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 16.1 mmtm -118.84 147.33 44.05 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.764 -0.653 . . . . 1.27 109.781 174.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.404 ' CD ' ' HB2' ' A' ' 72' ' ' GLU . 16.7 mtm180 -122.94 132.19 54.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.019 0.438 . . . . 1.65 110.617 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.78 179.75 8.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.454 -0.794 . . . . 0.08 109.623 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.53 144.47 31.37 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.07 -0.344 . . . . 0.14 110.07 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.479 ' HA ' HD23 ' A' ' 41' ' ' LEU . 43.7 t -64.27 124.24 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.932 0.396 . . . . 0.14 110.383 176.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.72 -48.44 13.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.725 -0.67 . . . . 0.6 109.988 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 m -158.48 166.06 33.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.649 -0.705 . . . . 1.07 110.057 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.407 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 5.3 mt -140.9 126.89 19.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.033 0.444 . . . . 0.19 109.987 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -114.13 86.68 2.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.417 -0.81 . . . . 1.56 110.257 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.71 -106.28 1.43 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.606 -0.807 . . . . 0.29 112.899 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -93.28 4.66 53.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.562 0.22 . . . . 2.1 111.263 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -126.98 140.33 52.39 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.038 0.447 . . . . 0.32 110.614 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.29 161.0 14.72 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.422 -0.894 . . . . 0.11 111.422 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 84.1 m-85 -132.88 137.08 46.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.496 -0.557 . . . . 0.18 109.496 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.541 HD13 ' CD2' ' A' ' 73' ' ' PHE . 4.7 mt -114.6 154.49 28.24 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.539 -0.541 . . . . 0.59 109.539 -177.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.505 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 65.1 t30 -78.03 73.65 4.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.621 0.724 . . . . 1.53 109.821 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -140.53 106.35 5.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.761 -1.108 . . . . 0.28 108.442 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -94.63 105.33 17.27 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.427 0.632 . . . . 1.81 110.814 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 84' ' ' SER . 38.9 t -77.66 -77.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.797 -1.092 . . . . 0.85 111.788 -173.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 10.1 tt0 -111.75 111.37 22.3 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.392 -0.822 . . . . 2.24 110.479 -173.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.9 t70 61.22 22.5 12.83 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.459 0.647 . . . . 1.55 111.714 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.36 27.84 8.95 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.317 -0.944 . . . . 0.67 112.669 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 27.4 mmmt -77.92 110.93 13.25 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.153 -0.684 . . . . 2.5 109.153 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.505 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 9.3 tppt? -75.56 126.15 30.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.134 -0.691 . . . . 1.32 109.134 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 51' ' ' LEU . 4.5 mt -62.6 130.24 44.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.404 0.52 . . . . 0.19 112.404 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -111.62 159.31 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.659 -0.7 . . . . 0.39 109.216 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.931 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 32.7 p90 -149.41 149.78 31.37 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.705 -0.479 . . . . 0.16 109.705 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -90.32 149.68 22.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.068 -0.716 . . . . 0.34 109.068 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -0.93 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.249 0.463 . . . . 2.43 112.249 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.6 t -71.32 -32.18 68.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.076 0.465 . . . . 0.91 110.045 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -86.65 -10.55 53.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.87 -0.605 . . . . 1.96 110.956 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.26 145.14 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.467 0.651 . . . . 0.27 112.417 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.533 ' HG3' ' H ' ' A' ' 91' ' ' LYS . 0.9 OUTLIER -66.1 110.12 2.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.578 -1.192 . . . . 1.6 111.79 -175.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.66 -93.14 0.72 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.035 -0.602 . . . . 0.58 113.083 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.54 155.99 23.41 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.231 -0.285 . . . . 2.2 110.231 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.3 p -61.56 -32.04 72.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.157 -0.474 . . . . 0.95 111.35 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.39 17.62 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.283 0.563 . . . . 1.39 110.61 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.58 2.04 27.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.183 0.516 . . . . 0.57 111.179 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.649 HD21 HG12 ' A' ' 71' ' ' VAL . 1.8 tm? -129.25 125.63 37.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.344 -0.984 . . . . 1.51 108.344 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -122.8 154.02 63.69 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 111.685 0.254 . . . . 0.91 111.685 -171.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.463 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.4 Cg_endo -68.07 134.81 32.85 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.8 2.333 . . . . 0.28 112.369 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.87 -4.73 72.14 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.692 -0.766 . . . . 0.22 111.98 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -95.7 155.25 16.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.594 -0.521 . . . . 1.28 109.594 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -83.47 132.07 34.98 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.62 -0.511 . . . . 0.17 109.62 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.649 HG12 HD21 ' A' ' 65' ' ' LEU . 4.3 m -134.26 160.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.787 0.803 . . . . 0.31 110.84 -176.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -119.12 138.8 52.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.359 -1.291 . . . . 0.78 108.911 177.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.541 ' CD2' HD13 ' A' ' 41' ' ' LEU . 36.5 p90 -150.81 180.0 7.75 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.935 -0.575 . . . . 0.11 109.854 -173.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.1 m -127.41 131.49 50.28 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.913 -0.773 . . . . 0.86 108.913 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.432 HG23 ' OG ' ' A' ' 84' ' ' SER . 3.5 p -91.35 98.11 8.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.985 0.898 . . . . 0.36 110.436 -175.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.5 p -102.53 114.36 41.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.193 -0.912 . . . . 0.42 110.241 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.2 m -80.15 127.14 31.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.853 -0.612 . . . . 0.67 110.922 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.97 104.3 2.49 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.019 -0.734 . . . . 1.82 109.019 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -57.23 -26.98 61.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.843 0.354 . . . . 1.95 111.652 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.456 ' HE ' ' HA ' ' A' ' 80' ' ' ARG . 5.1 tpm_? -84.41 -41.35 16.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 3.99 111.599 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -95.05 -30.71 13.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.221 0.452 . . . . 2.21 112.221 -170.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.89 -24.16 32.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.078 -0.582 . . . . 0.69 112.907 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -86.75 175.88 8.02 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.661 -0.317 . . . . 2.42 110.495 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.468 ' HB3' HG21 ' A' ' 45' ' ' VAL . 32.7 t -116.95 -179.23 3.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.104 0.478 . . . . 1.08 110.969 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 m -149.56 147.84 28.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.317 -0.994 . . . . 0.87 108.317 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.931 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -86.97 121.63 29.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.867 0.365 . . . . 0.17 110.653 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 68.4 m -117.33 144.59 44.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.857 -0.611 . . . . 0.68 110.359 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.45 70.43 0.65 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.991 0.807 . . . . 1.82 110.336 -177.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 92.7 t -84.99 115.34 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.273 0.559 . . . . 0.32 111.021 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.27 149.1 30.66 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.793 -0.64 . . . . 1.12 110.509 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.533 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -81.56 124.12 29.24 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.105 -0.702 . . . . 1.33 109.105 174.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 92' ' ' ILE . 28.1 mm . . . . . 0 C--N 1.316 -0.873 0 CA-C-N 115.962 -0.563 . . . . 0.28 111.559 -174.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 . . . . . 0 C--O 1.236 0.35 0 CA-C-O 120.941 0.401 . . . . 1.34 111.361 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -91.76 132.92 36.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.031 0.443 . . . . 2.11 110.377 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 72.5 mmtt -114.47 149.71 35.91 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.799 -0.637 . . . . 1.27 109.663 175.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.49 ' HG2' ' CB ' ' A' ' 72' ' ' GLU . 59.5 mtm-85 -122.96 127.89 49.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.067 0.461 . . . . 1.65 111.059 177.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 179.53 9.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.183 -0.917 . . . . 0.08 109.807 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.4 146.18 29.21 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.849 -0.426 . . . . 0.14 109.849 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.557 ' HA ' HD23 ' A' ' 41' ' ' LEU . 40.8 t -67.2 123.06 19.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.856 0.36 . . . . 0.14 110.866 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -75.16 -42.46 55.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.6 110.144 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 p -172.04 165.25 6.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.517 -0.765 . . . . 1.07 110.201 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.7 mt -135.48 129.93 49.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.092 0.472 . . . . 0.19 109.965 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -126.16 95.23 4.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.562 -0.744 . . . . 1.56 110.613 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.83 -106.28 1.77 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.29 112.726 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -103.07 9.99 38.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.686 0.279 . . . . 2.1 110.417 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -129.58 141.12 51.02 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.225 0.536 . . . . 0.32 111.054 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.473 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -123.97 159.02 18.63 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.137 -0.785 . . . . 0.11 111.137 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 76.8 m-85 -131.06 147.49 52.63 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.859 -0.422 . . . . 0.18 109.859 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.601 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 5.7 mt -124.82 146.99 48.98 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.385 -0.598 . . . . 0.59 109.385 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -72.92 74.63 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.574 0.702 . . . . 1.53 110.505 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -138.0 97.63 3.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.836 -1.074 . . . . 0.28 108.539 177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.502 ' CG ' ' HA2' ' A' ' 48' ' ' GLY . 19.5 mp0 -74.15 102.15 4.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.948 -1.024 . . . . 1.81 110.966 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.615 HG11 ' HB2' ' A' ' 84' ' ' SER . 28.6 m -80.12 -32.44 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.494 -0.775 . . . . 0.85 111.108 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -157.98 116.89 3.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.128 -0.487 . . . . 2.24 110.33 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.2 t70 58.87 22.57 10.37 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.507 0.558 . . . . 1.55 112.507 169.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.502 ' HA2' ' CG ' ' A' ' 44' ' ' GLU . . . 102.38 2.68 50.75 Favored Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.418 -0.896 . . . . 0.67 112.966 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -60.72 115.08 3.38 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 122.167 0.187 . . . . 2.5 110.795 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -70.49 148.95 47.69 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.628 -0.508 . . . . 1.32 109.628 176.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 3.4 mt -79.02 132.68 36.72 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.904 -0.589 . . . . 0.19 110.274 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -107.31 154.24 21.56 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.579 -0.526 . . . . 0.39 109.579 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.852 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 18.5 p90 -146.4 156.22 43.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.338 -0.616 . . . . 0.16 109.338 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -97.33 149.64 21.86 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.897 -0.779 . . . . 0.34 108.897 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.465 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -61.82 -8.23 4.61 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.909 0.337 . . . . 2.43 111.909 -178.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 t -79.25 -19.55 50.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.95 0.405 . . . . 0.91 110.288 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' ' 87' ' ' CYS . 2.3 mp0 -92.2 -10.83 37.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.977 0.418 . . . . 1.96 110.171 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.1 t -64.62 149.14 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.454 -0.793 . . . . 0.27 111.897 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -63.31 92.01 0.06 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.219 -0.9 . . . . 1.6 112.52 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.1 -77.56 0.69 Allowed Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.006 -0.543 . . . . 0.58 113.732 172.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 1.9 m-20 -103.93 140.16 38.09 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.606 -0.516 . . . . 2.2 109.606 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 69.6 p -70.53 -22.67 62.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.974 -0.557 . . . . 0.95 111.64 -173.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.4 t -100.38 7.16 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.271 0.558 . . . . 1.39 110.503 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . . . -93.69 -11.1 32.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.316 -0.402 . . . . 0.57 110.928 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.615 HD21 HG12 ' A' ' 71' ' ' VAL . 1.4 tm? -110.04 124.51 51.58 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.702 -0.851 . . . . 1.51 108.702 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -115.46 150.66 44.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.743 0.306 . . . . 0.91 111.533 -170.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.474 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.2 Cg_endo -68.06 140.82 50.94 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.379 2.053 . . . . 0.28 111.895 173.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.55 -1.31 88.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.645 -0.788 . . . . 0.22 112.451 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -96.16 159.32 15.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.729 -0.471 . . . . 1.28 109.729 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -83.96 134.97 34.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.565 -0.531 . . . . 0.17 109.565 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.615 HG12 HD21 ' A' ' 65' ' ' LEU . 10.2 m -136.7 160.04 37.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 110.068 -0.345 . . . . 0.31 110.068 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 4.6 pt-20 -116.03 141.65 47.84 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.601 -0.888 . . . . 0.78 108.601 170.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.522 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 26.5 p90 -146.82 179.7 7.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.33 -0.85 . . . . 0.11 109.672 -173.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m -127.65 127.18 43.34 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.942 -0.762 . . . . 0.86 108.942 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 75' ' ' VAL . 8.2 p -92.68 99.4 9.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.835 0.826 . . . . 0.36 111.508 -172.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 84' ' ' SER . 5.1 p -99.11 112.34 31.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.819 -0.628 . . . . 0.42 109.944 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.1 m -93.76 140.45 29.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.508 -0.769 . . . . 0.67 111.128 -173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 80' ' ' ARG . 5.1 t-20 -71.61 134.64 46.53 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.711 0.291 . . . . 1.82 110.359 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 19.2 pm0 -76.87 -12.48 59.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.497 -0.319 . . . . 1.95 111.07 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.472 ' HB3' ' OD1' ' A' ' 78' ' ' ASN . 7.0 tpm_? -95.56 -59.27 1.91 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.568 -0.287 . . . . 3.99 111.605 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -109.04 -0.48 19.48 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.202 0.445 . . . . 2.21 112.202 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.93 80.03 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.494 -0.86 . . . . 0.69 113.159 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.51 131.55 34.86 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.42 0.628 . . . . 2.42 111.494 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.615 ' HB2' HG11 ' A' ' 45' ' ' VAL . 65.3 m -106.7 170.2 8.08 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.912 -1.04 . . . . 1.08 111.357 -172.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.8 m -148.6 152.91 37.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.63 -0.714 . . . . 0.87 109.338 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.852 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -95.33 122.55 38.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 120.87 0.367 . . . . 0.17 110.373 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.412 ' HA ' ' HG2' ' A' ' 57' ' ' GLU . 94.1 m -116.69 148.55 40.95 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.129 -0.487 . . . . 0.68 110.22 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.8 m120 59.32 62.03 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.674 0.609 . . . . 1.82 110.338 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.7 t -80.87 99.14 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.472 -0.786 . . . . 0.32 110.656 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.609 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 6.7 mp -99.79 147.87 25.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.349 -0.841 . . . . 1.12 110.545 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.485 ' HG2' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -78.62 123.71 27.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.969 -0.382 . . . . 1.33 109.969 178.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.1 mm . . . . . 0 C--N 1.317 -0.818 0 CA-C-O 121.093 0.473 . . . . 0.28 110.667 -178.626 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 . . . . . 0 CA--C 1.516 -0.332 0 N-CA-C 110.491 -0.188 . . . . 1.34 110.491 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -109.1 112.31 24.41 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.349 -0.54 . . . . 2.11 110.228 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -90.72 154.31 19.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.595 -0.729 . . . . 1.27 109.59 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -128.11 128.32 44.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.999 -0.371 . . . . 1.65 109.999 176.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 179.53 9.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.803 -0.635 . . . . 0.08 109.376 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.55 140.09 38.0 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 110.345 -0.243 . . . . 0.14 110.345 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.515 ' HA ' HD23 ' A' ' 41' ' ' LEU . 43.7 t -62.04 115.7 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 120.986 0.422 . . . . 0.14 110.337 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.03 -47.26 65.87 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.446 -0.797 . . . . 0.6 110.019 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.1 m -168.86 168.56 10.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 1.07 109.36 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.434 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 11.2 mt -135.79 126.97 44.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.639 -0.504 . . . . 0.19 109.639 175.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -116.88 92.16 3.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.643 -0.708 . . . . 1.56 110.089 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.96 -109.27 2.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.789 -0.72 . . . . 0.29 112.238 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -96.99 6.02 49.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.71 0.255 . . . . 2.1 110.758 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -125.06 144.18 50.54 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.321 0.581 . . . . 0.32 111.234 -173.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.525 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.79 159.41 15.45 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.595 -0.812 . . . . 0.11 111.308 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.0 142.47 47.65 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.376 -0.601 . . . . 0.18 109.376 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 31' ' ' VAL . 8.8 mt -116.15 152.22 34.13 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.247 -0.649 . . . . 0.59 109.247 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -75.48 76.0 2.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.505 0.669 . . . . 1.53 109.417 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.413 ' HB3' HD12 ' A' ' 51' ' ' LEU . 23.9 t80 -147.73 98.13 2.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.983 -1.008 . . . . 0.28 109.121 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 33.3 mt-10 -87.88 101.99 14.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.325 0.583 . . . . 1.81 110.573 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 84' ' ' SER . 15.6 m -73.35 -45.09 53.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.41 -0.814 . . . . 0.85 112.078 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.462 ' H ' ' HB2' ' A' ' 49' ' ' LYS . 4.8 tt0 -140.71 116.61 10.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.572 -0.286 . . . . 2.24 110.537 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 t70 57.87 21.83 8.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.324 0.583 . . . . 1.55 112.131 167.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.47 19.82 19.41 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.443 -0.884 . . . . 0.67 112.955 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 32.6 mmtm -70.99 110.41 5.67 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.892 -0.41 . . . . 2.5 109.892 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -75.24 126.89 31.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.503 -0.554 . . . . 1.32 109.503 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 51' ' ' LEU . 3.8 mt -66.75 126.83 30.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.532 -0.304 . . . . 0.19 111.314 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.443 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 9.5 p90 -111.25 162.53 14.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.427 -0.351 . . . . 0.39 110.138 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.918 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 30.2 p90 -155.17 159.75 40.38 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.174 -0.676 . . . . 0.16 109.174 174.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -99.86 153.65 18.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.342 -0.614 . . . . 0.34 109.342 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 19.6 mtt -66.76 3.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.44 0.533 . . . . 2.43 112.44 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.1 t -89.45 -22.75 22.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.542 -0.54 . . . . 0.91 109.542 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -90.07 -5.67 56.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.511 . . . . 1.96 110.27 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.465 HG22 HD13 ' A' ' 65' ' ' LEU . 1.3 t -67.62 152.45 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.223 -0.899 . . . . 0.27 112.818 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.499 ' HG3' ' H ' ' A' ' 91' ' ' LYS . 1.1 tm0? -59.41 99.02 0.05 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 114.863 -1.062 . . . . 1.6 112.419 -176.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.44 -85.0 0.25 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.58 113.258 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -105.71 145.67 30.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.677 -0.49 . . . . 2.2 109.677 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.0 p -59.98 -40.36 88.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.619 0.6 . . . . 0.95 112.619 -174.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.36 19.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.512 0.672 . . . . 1.39 110.522 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.52 11.54 38.84 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.429 0.633 . . . . 0.57 110.141 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.549 HD11 HG12 ' A' ' 89' ' ' VAL . 1.8 tt -137.86 124.03 20.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.121 -0.945 . . . . 1.51 108.534 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.409 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 89.8 m-70 -121.78 159.2 52.08 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.755 0.312 . . . . 0.91 111.151 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.424 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 38.2 Cg_endo -67.41 144.71 68.61 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.436 2.09 . . . . 0.28 111.924 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -9.15 77.96 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.053 -0.594 . . . . 0.22 112.063 -177.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' ' 66' ' ' HIS . 3.6 m-20 -87.14 141.36 28.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.583 0.23 . . . . 1.28 110.722 177.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 m -70.01 139.25 52.71 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.172 -0.677 . . . . 0.17 109.172 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -139.19 161.02 28.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.364 0.602 . . . . 0.31 111.1 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.13 134.53 54.83 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.826 -1.175 . . . . 0.78 107.826 173.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.487 ' CD2' HD13 ' A' ' 41' ' ' LEU . 23.5 p90 -146.13 178.93 7.85 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.86 -0.609 . . . . 0.11 109.471 -174.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.1 t -126.19 126.63 44.4 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.954 -0.758 . . . . 0.86 108.954 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.9 98.4 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.705 -0.679 . . . . 0.36 110.54 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 p -100.85 113.83 38.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.522 -0.763 . . . . 0.42 109.917 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.9 m -76.78 130.53 37.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.708 -0.678 . . . . 0.67 110.926 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.562 ' HB3' ' H ' ' A' ' 82' ' ' GLY . 3.6 t-20 -65.22 111.91 3.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.923 -0.769 . . . . 1.82 108.923 175.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -12.28 60.38 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.905 -0.318 . . . . 1.95 111.287 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -96.74 -58.55 2.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.035 -0.53 . . . . 3.99 111.558 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -90.75 -28.67 18.12 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.677 0.621 . . . . 2.21 112.677 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.562 ' H ' ' HB3' ' A' ' 78' ' ' ASN . . . 103.7 -24.57 29.34 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.416 -0.897 . . . . 0.69 113.851 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -74.8 151.33 39.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.439 0.62 . . . . 2.42 110.006 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.496 ' HB2' HG11 ' A' ' 45' ' ' VAL . 8.3 m -99.43 175.05 5.99 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.563 -0.455 . . . . 1.08 111.469 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 m -142.78 163.24 33.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.419 -0.809 . . . . 0.87 109.161 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.918 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -103.16 117.06 33.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.248 0.547 . . . . 0.17 110.358 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 64.5 m -116.97 147.99 41.81 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.914 -0.773 . . . . 0.68 108.914 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.473 ' ND2' HD23 ' A' ' 90' ' ' LEU . 8.0 t30 64.55 69.24 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.082 -0.71 . . . . 1.82 109.082 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.549 HG12 HD11 ' A' ' 65' ' ' LEU . 84.9 t -93.41 105.98 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 115.426 -0.806 . . . . 0.32 110.9 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.473 HD23 ' ND2' ' A' ' 88' ' ' ASN . 4.2 mm? -112.3 150.32 31.15 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.61 -0.723 . . . . 1.12 111.016 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.499 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -83.35 123.75 29.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.553 -0.748 . . . . 1.33 110.948 -172.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.5 mm . . . . . 0 C--N 1.319 -0.756 0 CA-C-N 115.83 -0.623 . . . . 0.28 111.05 -175.842 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 . . . . . 0 C--O 1.235 0.304 0 CA-C-O 121.091 0.472 . . . . 1.34 110.65 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -97.6 118.32 33.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.44 0.638 . . . . 2.11 110.286 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -99.99 156.44 17.15 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.868 -1.06 . . . . 1.27 109.719 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.466 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 11.0 mtm180 -130.27 127.31 39.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.49 . . . . 1.65 110.559 175.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.46 -179.96 8.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.256 -0.884 . . . . 0.08 110.031 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.4 145.6 28.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.366 -0.379 . . . . 0.14 109.984 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.42 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 48.8 t -68.33 123.33 21.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.516 -0.311 . . . . 0.14 110.379 175.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.39 -41.9 46.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.109 -0.496 . . . . 0.6 110.406 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.5 p -171.04 161.69 6.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.845 -0.616 . . . . 1.07 110.014 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.413 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 13.1 mt -133.73 129.13 54.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.079 0.466 . . . . 0.19 110.114 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -119.59 95.19 4.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 1.56 110.132 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.17 -114.13 5.85 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.815 -0.707 . . . . 0.29 112.282 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -96.38 14.81 23.13 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 110.031 -0.359 . . . . 2.1 110.031 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -128.13 141.06 51.59 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.563 -0.455 . . . . 0.32 111.014 -175.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -127.19 158.71 21.14 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.503 -0.856 . . . . 0.11 111.525 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -132.33 142.71 49.44 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.235 -0.654 . . . . 0.18 109.235 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.491 HD13 ' CD2' ' A' ' 73' ' ' PHE . 6.3 mt -116.74 152.53 34.14 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.146 -0.686 . . . . 0.59 109.146 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -75.09 73.47 2.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.782 0.801 . . . . 1.53 109.585 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -147.51 110.69 4.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.623 -1.172 . . . . 0.28 108.674 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 90.1 mt-10 -105.82 107.08 17.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.5 0.667 . . . . 1.81 111.136 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 m -74.06 -55.28 12.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.659 -1.155 . . . . 0.85 112.121 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.695 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 4.1 tp10 -136.38 118.92 15.88 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.552 -0.294 . . . . 2.24 110.703 -171.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.1 t70 61.86 16.59 8.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.41 0.624 . . . . 1.55 112.057 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.09 31.13 9.37 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.205 -0.997 . . . . 0.67 112.107 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.695 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 41.2 mmtm -75.49 109.88 9.41 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.509 -0.923 . . . . 2.5 108.509 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.93 122.32 22.37 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.726 -0.842 . . . . 1.32 108.726 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 51' ' ' LEU . 3.6 mt -59.7 126.55 28.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.131 -0.486 . . . . 0.19 111.6 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -108.41 161.82 14.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.856 -0.611 . . . . 0.39 110.229 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.956 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 30.0 p90 -152.5 151.88 31.25 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.558 -0.746 . . . . 0.16 109.205 173.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.454 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . 23.3 t-80 -93.69 156.39 16.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.628 -0.879 . . . . 0.34 108.628 174.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.467 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 51.0 ttm -71.73 3.69 3.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.875 0.369 . . . . 2.43 111.538 -176.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.2 t -88.38 -27.57 21.52 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.777 -0.453 . . . . 0.91 109.777 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.454 ' OE2' ' HB3' ' A' ' 54' ' ' HIS . 1.9 mp0 -79.36 -14.97 58.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.855 -0.611 . . . . 1.96 109.626 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.493 HG11 ' HA ' ' A' ' 62' ' ' THR . 1.8 t -62.68 152.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.882 -1.054 . . . . 0.27 111.939 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.434 HE21 ' HB3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -45.07 158.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.359 -1.291 . . . . 1.6 110.985 176.005 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -44.78 -32.5 3.08 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 114.62 0.608 . . . . 0.58 114.62 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -104.26 125.03 50.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.645 -0.502 . . . . 2.2 109.645 173.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.493 ' HA ' HG11 ' A' ' 58' ' ' VAL . 70.7 p -79.18 -36.54 40.11 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.413 -0.812 . . . . 0.95 111.977 -171.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 t -87.15 7.35 2.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.484 0.659 . . . . 1.39 110.257 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.33 -3.12 31.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 0.57 111.087 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.542 HD21 HG12 ' A' ' 71' ' ' VAL . 1.5 tm? -104.71 124.04 48.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.031 -1.1 . . . . 1.51 108.031 175.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -121.02 151.81 55.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.828 0.347 . . . . 0.91 111.549 -171.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 43.0 Cg_endo -67.8 137.41 41.69 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.721 2.28 . . . . 0.28 111.856 173.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.31 -8.99 72.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.815 -0.707 . . . . 0.22 112.628 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -95.25 159.69 14.89 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.418 -0.586 . . . . 1.28 109.418 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 m -80.27 135.96 36.34 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.208 -0.664 . . . . 0.17 109.208 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.542 HG12 HD21 ' A' ' 65' ' ' LEU . 12.1 m -135.71 161.6 38.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.25 0.548 . . . . 0.31 109.895 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.66 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.59 149.13 37.04 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.726 -0.842 . . . . 0.78 108.726 177.502 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.491 ' CD2' HD13 ' A' ' 41' ' ' LEU . 37.9 p90 -163.06 178.61 8.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.006 0.431 . . . . 0.11 110.515 -172.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -128.85 131.56 47.7 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.022 -0.733 . . . . 0.86 109.022 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.9 p -99.35 98.84 7.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.802 0.81 . . . . 0.36 111.018 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.0 p -110.2 118.89 58.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.558 -0.746 . . . . 0.42 110.006 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.0 m -73.32 126.19 29.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.138 -0.483 . . . . 0.67 110.778 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 29.1 m-80 -68.79 115.18 7.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.203 -0.453 . . . . 1.82 109.955 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -60.47 -30.85 69.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.166 -0.47 . . . . 1.95 112.113 -173.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 1.6 tpm_? -95.28 -31.9 13.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.959 0.409 . . . . 3.99 111.645 -176.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -95.94 -26.41 15.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.286 0.565 . . . . 2.21 110.455 -171.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 -24.84 18.38 Favored Glycine 0 C--O 1.23 -0.127 0 C-N-CA 121.201 -0.523 . . . . 0.69 113.421 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 20.1 pttm -98.77 151.95 20.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.216 0.508 . . . . 2.42 110.808 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -87.45 179.47 6.56 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.859 -0.61 . . . . 1.08 111.082 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.8 p -153.45 139.17 17.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.004 -0.543 . . . . 0.87 109.773 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.956 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -74.01 119.25 17.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.191 0.52 . . . . 0.17 111.105 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 99.4 m -116.89 143.88 45.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.778 -0.646 . . . . 0.68 109.306 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 62.52 70.51 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.418 0.628 . . . . 1.82 109.717 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 90.4 t -93.11 113.05 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.328 -0.851 . . . . 0.32 111.159 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.25 150.05 32.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.178 -0.464 . . . . 1.12 110.92 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.47 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -73.71 128.48 35.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.043 -0.526 . . . . 1.33 109.906 176.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.4 mm . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 120.803 0.335 . . . . 0.28 110.91 -179.103 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 120.691 0.282 . . . . 1.34 110.899 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -95.51 121.05 36.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.419 0.628 . . . . 2.11 110.559 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.461 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 31.0 mmtp -105.37 144.12 32.59 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.152 -0.931 . . . . 1.27 109.544 177.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 28' ' ' ARG . 2.1 mtm180 -120.01 127.37 52.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.085 0.469 . . . . 1.65 110.196 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.496 ' HB1' ' OD1' ' A' ' 42' ' ' ASN . . . -150.87 -179.63 7.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.516 -0.765 . . . . 0.08 109.448 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.91 143.42 32.52 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.81 -0.441 . . . . 0.14 109.81 -177.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.48 ' HA ' HD23 ' A' ' 41' ' ' LEU . 43.8 t -64.89 114.19 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.904 0.383 . . . . 0.14 110.433 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -65.07 -45.12 86.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.121 -0.945 . . . . 0.6 110.153 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 p -171.71 164.73 6.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.396 -0.82 . . . . 1.07 110.093 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.4 mt -137.57 128.95 40.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.669 -0.493 . . . . 0.19 109.669 176.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 71.4 mmtt -122.92 94.31 4.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.534 -0.757 . . . . 1.56 109.807 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.88 -106.92 2.0 Allowed Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.717 -0.754 . . . . 0.29 112.434 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -101.06 4.25 42.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.178 0.191 . . . . 2.1 110.793 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -122.87 140.5 52.89 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.254 0.55 . . . . 0.32 111.374 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.01 157.09 21.01 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.116 -0.947 . . . . 0.11 111.416 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -130.46 151.79 50.55 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.362 -0.607 . . . . 0.18 109.362 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.572 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.2 mt -125.09 155.28 40.08 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.329 -0.619 . . . . 0.59 109.329 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.496 ' OD1' ' HB1' ' A' ' 29' ' ' ALA . 28.0 p-10 -76.23 72.9 3.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 122.229 1.014 . . . . 1.53 109.994 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -148.15 98.63 2.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.757 -1.11 . . . . 0.28 109.028 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 21.3 mt-10 -95.58 100.97 12.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.746 0.784 . . . . 1.81 110.284 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 46' ' ' GLU . 16.2 m -68.12 -43.31 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.222 -1.354 . . . . 0.85 111.301 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 8.7 tp10 -129.87 176.06 8.35 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.281 -1.748 . . . . 2.24 106.281 -176.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 28.3 t70 -33.19 86.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.195 1.183 . . . . 1.55 114.195 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.54 ' HA2' ' OE2' ' A' ' 44' ' ' GLU . . . 68.58 16.55 69.87 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.654 -0.784 . . . . 0.67 111.464 171.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.722 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 32.0 mmtm -82.29 107.03 14.65 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.569 -0.53 . . . . 2.5 109.569 -178.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -79.52 129.62 34.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.062 -0.718 . . . . 1.32 109.062 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 51' ' ' LEU . 3.1 mt -63.69 124.09 20.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.728 0.299 . . . . 0.19 111.157 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -106.61 158.91 16.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.833 -0.622 . . . . 0.39 109.998 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.939 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 30.4 p90 -150.29 154.87 38.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.517 -0.765 . . . . 0.16 109.166 173.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -99.03 149.87 22.56 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.657 -0.868 . . . . 0.34 108.657 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.543 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 27.5 mtt -60.23 -7.07 1.71 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.215 0.45 . . . . 2.43 112.215 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 t -68.66 -29.96 68.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.221 -0.445 . . . . 0.91 110.776 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -92.93 -1.21 56.92 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.845 0.355 . . . . 1.96 111.138 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.562 HG13 HD13 ' A' ' 65' ' ' LEU . 2.1 t -74.42 150.66 7.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.593 0.59 . . . . 0.27 112.593 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.539 ' CG ' HD13 ' A' ' 90' ' ' LEU . 1.4 tm0? -54.37 100.06 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 114.758 -1.11 . . . . 1.6 111.805 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.52 -92.18 0.01 OUTLIER Glycine 0 C--N 1.332 0.317 0 O-C-N 123.873 0.733 . . . . 0.58 114.342 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -89.73 131.34 35.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 2.2 110.174 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.543 ' HB ' ' SD ' ' A' ' 55' ' ' MET . 30.7 p -75.45 -12.04 60.16 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.471 -0.786 . . . . 0.95 111.096 -172.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.0 t -92.85 -2.15 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.499 -0.773 . . . . 1.39 110.05 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.88 -14.54 29.51 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.394 0.616 . . . . 0.57 110.895 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.562 HD13 HG13 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -103.34 124.6 48.99 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.528 -0.76 . . . . 1.51 109.084 179.226 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 95.3 m-70 -121.8 153.14 60.05 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.884 0.373 . . . . 0.91 111.316 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.407 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.0 Cg_endo -67.64 134.85 34.04 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.499 2.132 . . . . 0.28 111.243 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.22 -17.34 59.32 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.826 -0.702 . . . . 0.22 111.93 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 66' ' ' HIS . 23.5 m-20 -74.23 151.05 40.01 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 110.101 -0.333 . . . . 1.28 110.101 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 m -81.17 135.18 35.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.395 -0.965 . . . . 0.17 108.395 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.452 HG11 HD21 ' A' ' 65' ' ' LEU . 29.6 m -134.9 167.09 26.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.214 0.531 . . . . 0.31 110.945 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.641 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -113.88 150.07 34.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.014 -1.106 . . . . 0.78 108.014 172.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.572 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.2 p90 -157.85 179.06 9.55 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.335 -0.617 . . . . 0.11 109.335 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -130.29 133.69 46.66 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.253 -1.017 . . . . 0.86 108.253 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 p -94.5 98.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.658 0.742 . . . . 0.36 111.087 -172.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -102.54 107.64 22.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.39 -0.823 . . . . 0.42 109.725 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 26.8 m -74.43 129.67 38.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.983 0.421 . . . . 0.67 110.864 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 39.7 m-80 -76.83 101.06 5.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.879 -0.6 . . . . 1.82 109.528 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -60.9 -21.31 63.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.957 0.408 . . . . 1.95 111.119 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -72.52 -41.11 66.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.714 -0.675 . . . . 3.99 111.585 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -114.65 -31.49 6.16 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.517 0.562 . . . . 2.21 112.517 -172.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.44 -20.36 25.46 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.003 -0.618 . . . . 0.69 113.303 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 21.1 pttp -96.89 150.72 20.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.036 0.418 . . . . 2.42 110.752 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 13.4 m -93.3 -176.29 4.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.11 -0.496 . . . . 1.08 111.607 -175.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.8 m -150.05 150.08 31.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.828 -0.624 . . . . 0.87 109.434 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.939 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -89.82 120.93 31.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.217 0.532 . . . . 0.17 111.101 -177.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 50.0 m -117.32 144.38 44.95 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.759 -0.655 . . . . 0.68 110.126 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.5 t30 62.82 66.84 0.73 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.764 0.665 . . . . 1.82 109.792 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 95.2 t -89.33 100.85 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.518 -0.764 . . . . 0.32 110.675 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.539 HD13 ' CG ' ' A' ' 59' ' ' GLN . 2.1 mm? -105.45 147.53 28.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.833 -0.621 . . . . 1.12 110.81 -177.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.36 122.75 24.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 1.33 110.741 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.4 mm . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.597 -0.728 . . . . 0.28 110.738 -176.464 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.115 0.483 . . . . 1.34 110.878 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -109.31 112.73 25.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.145 0.497 . . . . 2.11 110.628 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -89.51 150.29 22.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.57 -0.741 . . . . 1.27 110.294 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -123.66 127.3 48.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.95 0.405 . . . . 1.65 110.347 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.58 179.36 9.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.015 -0.735 . . . . 0.08 109.015 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.93 142.62 32.15 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 110.133 -0.321 . . . . 0.14 110.133 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.522 ' HA ' HD23 ' A' ' 41' ' ' LEU . 43.7 t -64.22 117.54 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.517 -0.549 . . . . 0.14 109.517 174.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.93 -40.47 63.07 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.768 -0.651 . . . . 0.6 110.513 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 p -174.41 156.0 2.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.56 -0.746 . . . . 1.07 109.697 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.4 mt -127.6 132.38 69.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.186 -0.461 . . . . 0.19 110.005 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -121.96 85.95 2.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.568 -0.742 . . . . 1.56 110.458 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.37 -107.13 1.95 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.915 -0.659 . . . . 0.29 112.605 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -97.63 10.7 39.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 2.1 110.509 -175.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -132.73 142.22 48.93 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 120.942 0.401 . . . . 0.32 110.643 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.6 153.88 19.83 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.226 -0.749 . . . . 0.11 111.226 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 64.6 m-85 -127.88 146.11 50.73 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.57 -0.529 . . . . 0.18 109.57 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.544 HD13 ' CD2' ' A' ' 73' ' ' PHE . 6.0 mt -117.65 157.12 27.0 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.926 -0.398 . . . . 0.59 109.926 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -76.75 73.53 3.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.508 0.67 . . . . 1.53 109.677 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.438 ' HB3' HD12 ' A' ' 51' ' ' LEU . 33.7 t80 -146.19 102.46 3.62 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.293 -0.867 . . . . 0.28 109.301 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.56 101.0 12.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.934 -0.575 . . . . 1.81 110.275 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' A' ' 84' ' ' SER . 21.3 m -74.06 -46.42 45.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.801 0.81 . . . . 0.85 110.648 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.476 ' N ' HG23 ' A' ' 45' ' ' VAL . 34.5 tt0 -124.55 -179.11 4.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.803 -1.554 . . . . 2.24 106.803 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.429 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 8.1 t70 -41.09 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.089 0.956 . . . . 1.55 112.948 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.16 13.96 67.9 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.651 -0.785 . . . . 0.67 111.701 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.94 108.99 10.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.23 -0.655 . . . . 2.5 109.23 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -72.61 136.15 45.67 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.161 -0.681 . . . . 1.32 109.161 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -70.2 123.68 22.25 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.837 -0.431 . . . . 0.19 109.837 177.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -107.0 156.85 18.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.714 -0.476 . . . . 0.39 109.714 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.918 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 22.7 p90 -147.84 152.73 38.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.655 -0.702 . . . . 0.16 109.11 172.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -91.87 146.93 23.36 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.048 -0.723 . . . . 0.34 109.048 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.579 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 41.8 ttp -53.23 -17.16 1.55 Allowed 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 123.704 0.801 . . . . 2.43 112.274 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -64.57 -32.32 73.92 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.601 0.239 . . . . 0.91 110.868 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -78.08 -15.12 59.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.141 0.496 . . . . 1.96 110.822 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.579 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -64.03 147.46 12.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.395 -0.82 . . . . 0.27 111.956 -174.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.491 ' HG3' ' CD1' ' A' ' 90' ' ' LEU . 1.1 tt0 -64.06 86.77 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.776 -1.102 . . . . 1.6 112.933 -171.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.69 -90.82 0.25 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.293 -0.479 . . . . 0.58 113.26 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -92.99 143.83 25.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.277 0.56 . . . . 2.2 110.589 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.1 p -69.31 -33.56 73.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.217 -0.901 . . . . 0.95 110.926 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.56 -11.47 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.43 -0.805 . . . . 1.39 111.162 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -90.58 -8.5 50.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.607 -0.724 . . . . 0.57 111.728 -173.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.505 HD11 HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -117.48 124.63 49.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.411 -0.589 . . . . 1.51 109.411 179.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -122.2 150.03 55.89 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.731 0.3 . . . . 0.91 111.055 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.77 130.32 21.67 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.365 2.043 . . . . 0.28 111.092 172.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.91 -9.73 58.38 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.834 -0.698 . . . . 0.22 111.967 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -87.48 145.47 26.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.258 -0.275 . . . . 1.28 110.258 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 m -72.22 134.37 45.6 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.462 -0.57 . . . . 0.17 109.462 173.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.53 160.2 37.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.776 0.798 . . . . 0.31 111.098 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.84 132.08 56.62 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.429 -1.259 . . . . 0.78 108.65 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.544 ' CD2' HD13 ' A' ' 41' ' ' LEU . 26.0 p90 -142.48 178.67 7.44 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.612 -0.722 . . . . 0.11 109.583 -172.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.1 m -128.68 119.35 24.5 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.163 -0.68 . . . . 0.86 109.163 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.29 99.44 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.81 0.814 . . . . 0.36 110.986 -173.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.68 122.99 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.423 -0.808 . . . . 0.42 109.794 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 36.7 m -86.09 125.77 33.7 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.094 -0.503 . . . . 0.67 111.008 -177.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -63.98 109.92 1.95 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.826 -0.625 . . . . 1.82 109.527 175.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.432 ' H ' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -60.86 -23.14 64.92 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.238 0.459 . . . . 1.95 112.238 -175.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.424 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 7.2 tpm_? -93.66 -47.11 6.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.655 -0.418 . . . . 3.99 111.145 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -81.36 -30.81 33.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 2.21 111.586 -174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.45 -10.24 75.07 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.952 -0.642 . . . . 0.69 112.463 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -93.98 156.08 16.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.022 -0.733 . . . . 2.42 109.022 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.552 ' HB2' HG11 ' A' ' 45' ' ' VAL . 3.2 m -107.75 170.62 7.88 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.435 -0.506 . . . . 1.08 111.173 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.3 p -144.07 159.84 41.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.69 -0.686 . . . . 0.87 110.122 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.918 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -96.3 123.98 40.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.349 -0.387 . . . . 0.17 110.367 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -116.86 149.16 40.53 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.001 -1.111 . . . . 0.68 108.001 176.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 57.11 72.25 0.52 Allowed 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.82 0.7 . . . . 1.82 110.321 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.505 HG12 HD11 ' A' ' 65' ' ' LEU . 96.2 t -89.58 105.4 16.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.565 0.697 . . . . 0.32 110.639 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.491 ' CD1' ' HG3' ' A' ' 59' ' ' GLN . 4.0 mm? -106.7 148.95 27.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.161 -0.927 . . . . 1.12 110.648 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.42 ' HB2' ' OE1' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -81.66 129.47 34.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.676 -0.693 . . . . 1.33 111.224 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.5 mm . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.704 -0.68 . . . . 0.28 110.427 -178.232 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.536 0.207 . . . . 1.34 110.992 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 2.6 mppt? -106.86 120.99 43.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.145 0.498 . . . . 2.11 110.423 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -105.11 144.89 31.29 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.484 -0.78 . . . . 1.27 110.26 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -118.84 127.17 53.27 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.664 -0.414 . . . . 1.65 110.578 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.63 179.67 8.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.69 -0.686 . . . . 0.08 109.579 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.44 144.5 30.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.045 -0.354 . . . . 0.14 110.045 -177.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.531 ' HA ' HD23 ' A' ' 41' ' ' LEU . 57.6 t -63.98 117.43 4.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.142 0.496 . . . . 0.14 110.577 176.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.421 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 8.5 t70 -69.2 -47.86 63.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.031 -0.986 . . . . 0.6 109.616 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 74.1 m -167.92 164.49 13.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.775 -0.648 . . . . 1.07 109.699 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 mt -136.52 132.97 49.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.672 -0.492 . . . . 0.19 109.672 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -126.79 89.34 2.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 1.56 110.227 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.37 -107.77 2.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.75 -0.738 . . . . 0.29 112.592 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -97.37 9.64 41.78 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.808 -0.231 . . . . 2.1 110.761 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.51 141.2 51.05 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.184 0.516 . . . . 0.32 111.006 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.526 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.9 157.16 21.47 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.387 -0.824 . . . . 0.11 111.152 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 68.8 m-85 -129.73 148.61 51.63 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.09 -0.708 . . . . 0.18 109.09 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' A' ' 73' ' ' PHE . 8.8 mt -123.72 153.05 41.42 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.662 -0.495 . . . . 0.59 109.662 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -75.1 73.59 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.487 -0.56 . . . . 1.53 109.487 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.439 ' HB3' HD12 ' A' ' 51' ' ' LEU . 27.9 t80 -150.26 98.56 2.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.41 -0.814 . . . . 0.28 109.536 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 47.2 mt-10 -81.67 100.5 9.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.485 0.66 . . . . 1.81 109.695 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 84' ' ' SER . 27.2 m -72.21 -35.68 53.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.078 -0.965 . . . . 0.85 111.446 -176.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 7.9 tp10 -145.05 179.65 7.21 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.376 -1.713 . . . . 2.24 106.376 -175.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.523 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 23.8 t70 -27.75 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.271 1.428 . . . . 1.55 114.38 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.519 ' HA2' ' OE1' ' A' ' 44' ' ' GLU . . . 66.84 19.72 69.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.992 -0.623 . . . . 0.67 111.768 173.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 40.8 mmtm -82.88 109.05 16.67 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 110.061 -0.348 . . . . 2.5 110.061 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -74.39 128.95 36.83 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.712 -0.847 . . . . 1.32 108.712 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.506 ' HG ' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -64.66 126.73 28.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.597 -0.274 . . . . 0.19 110.646 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -112.27 156.66 22.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.97 0.414 . . . . 0.39 110.031 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.864 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 17.2 p90 -146.84 161.46 40.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.911 -0.586 . . . . 0.16 109.524 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -102.09 140.35 36.48 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.246 -0.65 . . . . 0.34 109.246 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.484 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 1.8 tmt? -51.13 -23.84 3.56 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.827 0.851 . . . . 2.43 112.657 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.6 t -60.27 -23.22 63.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.642 0.258 . . . . 0.91 111.215 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -95.74 0.06 52.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.8 -0.182 . . . . 1.96 111.474 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -74.91 137.35 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.305 0.574 . . . . 0.27 111.422 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.83 104.07 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.858 -1.064 . . . . 1.6 111.972 -175.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.03 -84.55 0.49 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.58 113.074 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -135.19 158.17 45.06 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.893 -0.41 . . . . 2.2 109.893 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.9 p -74.5 -8.52 56.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.568 0.699 . . . . 0.95 110.138 178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.43 -1.09 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.306 -0.861 . . . . 1.39 109.904 175.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.87 -39.85 4.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.79 -0.641 . . . . 0.57 110.423 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.644 HD11 HG11 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -95.32 123.35 38.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.298 -0.63 . . . . 1.51 109.298 178.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -134.58 158.2 75.62 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.637 -0.256 . . . . 0.91 111.116 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.529 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 28.1 Cg_endo -63.53 142.19 83.43 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.689 2.259 . . . . 0.28 111.745 176.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.96 -6.49 83.11 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.58 -0.819 . . . . 0.22 112.742 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -95.08 158.65 15.37 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.61 -0.515 . . . . 1.28 109.61 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -81.75 137.79 35.29 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.229 -0.656 . . . . 0.17 109.229 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.644 HG11 HD11 ' A' ' 65' ' ' LEU . 10.4 m -137.91 156.46 31.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.421 0.629 . . . . 0.31 109.857 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.39 133.16 55.91 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.505 -0.924 . . . . 0.78 108.505 175.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.532 ' CD2' HD13 ' A' ' 41' ' ' LEU . 28.6 p90 -142.5 179.46 6.95 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.71 -0.677 . . . . 0.11 109.789 -173.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.4 t -127.95 116.31 19.88 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.995 -1.113 . . . . 0.86 107.995 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.3 p -81.64 98.22 4.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.906 0.86 . . . . 0.36 110.557 -173.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 p -102.62 116.31 46.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.23 -0.896 . . . . 0.42 109.788 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 30.2 m -73.99 130.7 40.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.117 -0.492 . . . . 0.67 110.496 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -68.96 112.18 5.45 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.212 -0.662 . . . . 1.82 109.212 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -52.91 -31.32 39.35 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.826 0.704 . . . . 1.95 111.889 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -94.24 -53.86 3.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.828 0.347 . . . . 3.99 111.591 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -74.06 -18.41 60.83 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.296 0.48 . . . . 2.21 112.296 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.93 -24.38 6.06 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.991 -0.624 . . . . 0.69 113.173 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -91.4 154.12 19.4 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.457 -0.571 . . . . 2.42 109.457 178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.549 ' HB2' HG11 ' A' ' 45' ' ' VAL . 17.6 m -101.11 179.98 4.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.951 0.405 . . . . 1.08 111.706 -174.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.1 m -146.37 155.94 42.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.794 -0.639 . . . . 0.87 109.43 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.864 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -96.23 120.67 36.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.89 0.376 . . . . 0.17 110.601 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.3 m -116.99 156.97 26.56 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.954 -0.758 . . . . 0.68 108.954 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 t30 55.9 62.54 2.35 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.694 0.621 . . . . 1.82 109.988 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.7 t -81.25 104.95 10.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.771 -0.649 . . . . 0.32 110.892 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.0 mp -107.29 150.53 26.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.293 -0.867 . . . . 1.12 111.364 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.91 129.23 34.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.996 -0.547 . . . . 1.33 110.253 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mm . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 120.757 0.313 . . . . 0.28 110.766 -177.635 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.421 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 6.4 tp60 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.923 0.392 . . . . 1.34 110.319 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -109.22 112.84 25.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.316 0.579 . . . . 2.11 110.337 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -99.07 151.25 21.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.378 -0.828 . . . . 1.27 110.856 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.423 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 43.1 mtm180 -119.25 127.89 53.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.714 0.292 . . . . 1.65 110.385 174.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.63 179.71 8.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.871 -0.604 . . . . 0.08 109.491 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.82 141.56 36.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 110.155 -0.313 . . . . 0.14 110.155 -177.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HA ' HD23 ' A' ' 41' ' ' LEU . 47.1 t -62.77 118.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.762 0.315 . . . . 0.14 110.257 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.403 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 4.4 t70 -68.05 -43.81 77.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.459 -0.791 . . . . 0.6 110.098 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.6 p -178.52 165.66 1.74 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.31 -0.859 . . . . 1.07 109.511 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.5 mt -131.19 131.45 63.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.264 0.554 . . . . 0.19 109.958 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -123.66 85.71 2.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.385 -0.825 . . . . 1.56 110.249 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.09 -111.25 3.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.829 -0.7 . . . . 0.29 112.415 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -96.83 11.7 34.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.681 0.277 . . . . 2.1 110.746 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -131.61 139.73 49.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.191 0.52 . . . . 0.32 110.621 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.527 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -121.96 156.15 16.74 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.783 -0.927 . . . . 0.11 110.783 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -129.32 146.63 51.17 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.036 -0.727 . . . . 0.18 109.036 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.564 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.1 mt -117.69 152.68 34.74 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.103 -0.703 . . . . 0.59 109.103 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.66 72.94 2.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.926 0.869 . . . . 1.53 109.532 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.404 ' HB3' HD12 ' A' ' 51' ' ' LEU . 27.1 t80 -145.58 99.92 3.36 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.417 -1.265 . . . . 0.28 108.027 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.614 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 92.6 mt-10 -98.75 103.15 15.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.571 0.701 . . . . 1.81 110.763 -174.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.5 m -70.67 -37.11 68.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.521 -1.218 . . . . 0.85 112.483 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 2.5 tp10 -151.25 121.3 7.16 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 121.485 -0.086 . . . . 2.24 111.018 -176.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.9 t70 62.39 15.92 8.13 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.625 0.726 . . . . 1.55 111.87 169.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.536 ' HA2' ' OE2' ' A' ' 44' ' ' GLU . . . 94.33 28.42 10.66 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.577 -0.821 . . . . 0.67 112.056 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -81.07 110.16 16.33 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.604 -0.517 . . . . 2.5 109.604 179.164 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -68.63 130.27 42.36 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.649 0.593 . . . . 1.32 109.772 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 51' ' ' LEU . 2.1 mt -66.41 124.22 22.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.158 -0.474 . . . . 0.19 110.737 176.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -107.4 160.09 15.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.247 -0.433 . . . . 0.39 110.1 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.815 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 33.7 p90 -152.03 152.61 32.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.464 -0.789 . . . . 0.16 109.037 173.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -91.79 152.87 19.94 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.692 -0.855 . . . . 0.34 108.692 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.452 ' SD ' HG21 ' A' ' 58' ' ' VAL . 3.4 tpt -68.65 0.68 3.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.635 0.374 . . . . 2.43 111.927 -173.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 p -79.95 -37.54 34.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.958 0.409 . . . . 0.91 110.877 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -72.37 -16.23 61.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.771 -0.65 . . . . 1.96 110.14 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.452 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -61.06 150.81 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.141 -0.936 . . . . 0.27 111.778 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.459 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -66.32 93.81 0.24 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.347 -0.842 . . . . 1.6 112.16 -176.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.86 -91.87 0.52 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.566 -0.743 . . . . 0.58 113.58 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -103.87 159.34 15.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.848 0.356 . . . . 2.2 110.098 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.5 p -79.86 -21.12 44.46 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.045 -0.525 . . . . 0.95 111.542 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.8 p -83.18 -9.42 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.373 0.606 . . . . 1.39 110.667 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 -19.7 28.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.551 -0.749 . . . . 0.57 111.383 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.512 HD11 HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -114.84 123.89 50.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.637 -0.71 . . . . 1.51 109.272 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -123.47 155.88 64.95 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 0.91 111.452 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.449 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.7 Cg_endo -68.98 132.53 24.79 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.502 2.135 . . . . 0.28 111.535 174.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.21 -11.04 63.75 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.931 -0.652 . . . . 0.22 111.758 -177.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -84.47 149.45 25.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.04 -0.356 . . . . 1.28 110.04 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 m -75.69 139.0 41.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.519 -0.549 . . . . 0.17 109.519 174.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.22 162.92 24.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 120.829 0.347 . . . . 0.31 111.218 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -114.43 148.0 38.42 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.869 -1.16 . . . . 0.78 107.869 172.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.564 ' CD2' HD13 ' A' ' 41' ' ' LEU . 29.5 p90 -153.62 -179.46 7.81 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.381 -0.6 . . . . 0.11 109.381 -175.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.6 m -128.07 114.26 16.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.988 -0.745 . . . . 0.86 108.988 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.6 p -84.24 99.87 7.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.597 0.713 . . . . 0.36 111.293 -175.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.81 121.89 60.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.685 -0.689 . . . . 0.42 109.589 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 22.1 m -80.36 128.58 33.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.71 0.29 . . . . 0.67 111.166 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 75.1 m-20 -74.09 114.66 12.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.157 -0.474 . . . . 1.82 109.875 177.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -64.03 -24.82 67.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.384 . . . . 1.95 111.835 -173.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -90.34 -45.54 8.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 3.99 111.342 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -85.72 -23.05 27.51 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.913 0.338 . . . . 2.21 111.913 -174.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.54 -21.08 14.94 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 121.237 -0.506 . . . . 0.69 112.764 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 39.7 pttt -98.05 142.76 29.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.292 0.568 . . . . 2.42 110.757 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.4 m -84.94 179.51 7.29 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.24 -0.891 . . . . 1.08 111.876 -175.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.4 m -147.37 157.45 43.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.652 -0.704 . . . . 0.87 109.479 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.815 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -98.86 122.2 41.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.901 0.381 . . . . 0.17 110.843 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 80.1 m -116.21 141.55 48.0 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.05 -0.523 . . . . 0.68 110.14 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.25 67.84 0.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.801 0.688 . . . . 1.82 110.144 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.512 HG12 HD11 ' A' ' 65' ' ' LEU . 92.7 t -84.73 103.76 12.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.593 -0.73 . . . . 0.32 110.645 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.522 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 8.1 mp -108.14 147.85 30.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.79 -0.641 . . . . 1.12 111.199 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.28 129.04 35.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.636 -0.711 . . . . 1.33 111.414 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.6 mm . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.963 -0.562 . . . . 0.28 111.518 -176.416 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 120.817 0.341 . . . . 1.34 110.483 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -97.1 111.73 23.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.465 0.65 . . . . 2.11 110.254 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 73.1 mmtt -94.27 160.21 14.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.992 -1.004 . . . . 1.27 110.308 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 17.6 mtm180 -128.72 127.52 42.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.959 0.409 . . . . 1.65 110.131 175.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.49 178.21 9.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.679 -0.691 . . . . 0.08 109.724 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.04 141.21 33.17 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.276 -0.639 . . . . 0.14 109.276 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.434 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 51.1 t -62.31 114.42 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.821 -0.437 . . . . 0.14 109.821 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.29 -47.15 62.5 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.307 -0.86 . . . . 0.6 109.973 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.5 m -160.72 160.14 31.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.596 -0.729 . . . . 1.07 110.392 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.413 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 10.2 mt -137.26 120.12 20.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.174 -0.676 . . . . 0.19 109.174 173.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -110.23 86.38 2.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.544 -0.753 . . . . 1.56 109.767 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.8 -109.15 2.76 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.683 -0.77 . . . . 0.29 112.247 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -91.18 2.75 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.926 -0.161 . . . . 2.1 111.269 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -124.07 141.0 52.43 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.305 -0.558 . . . . 0.32 111.335 -174.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 34' ' ' ILE . . . -122.56 158.66 17.23 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.517 -0.765 . . . . 0.11 111.415 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 49.6 m-85 -136.11 136.23 39.95 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.882 -0.784 . . . . 0.18 108.882 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.497 HD21 ' CD2' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -106.26 155.08 19.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.458 -0.942 . . . . 0.59 108.458 177.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -76.32 73.5 3.11 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.419 0.628 . . . . 1.53 109.581 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -141.66 98.82 3.42 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.065 -0.971 . . . . 0.28 109.657 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.75 100.69 7.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.616 0.722 . . . . 1.81 110.101 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.48 ' CG1' ' HG ' ' A' ' 51' ' ' LEU . 31.6 m -80.23 -34.5 14.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.014 -0.993 . . . . 0.85 110.992 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.511 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 8.3 tp10 -137.08 177.61 7.73 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.019 -1.845 . . . . 2.24 106.019 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.511 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 29.2 t70 -40.56 85.94 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.815 1.043 . . . . 1.55 113.815 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.22 16.99 71.68 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.775 -0.93 . . . . 0.67 110.775 173.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -88.5 109.42 20.03 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.004 -0.739 . . . . 2.5 109.004 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -75.46 134.32 40.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.65 -0.5 . . . . 1.32 109.65 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 1.4 mt -64.69 125.01 23.41 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.253 0.346 . . . . 0.19 111.037 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -108.78 158.61 17.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.962 -0.384 . . . . 0.39 109.962 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.886 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 45.9 p90 -153.11 154.25 34.45 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.065 -0.717 . . . . 0.16 109.065 173.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -94.54 152.07 18.84 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.627 -0.879 . . . . 0.34 108.627 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.527 ' SD ' HG21 ' A' ' 58' ' ' VAL . 9.4 mmt -63.87 0.79 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.28 0.474 . . . . 2.43 112.28 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.3 t -86.13 -23.05 26.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.713 0.292 . . . . 0.91 110.327 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -91.11 -2.59 57.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.025 0.44 . . . . 1.96 110.079 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.527 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.2 t -72.66 151.28 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.53 -0.759 . . . . 0.27 112.389 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.445 ' HG2' HD13 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -60.53 96.27 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.05 -0.977 . . . . 1.6 111.57 -178.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.17 -84.11 0.41 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.753 -0.658 . . . . 0.58 113.569 170.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -113.25 145.74 40.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.139 0.495 . . . . 2.2 110.579 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.482 HG22 ' HB3' ' A' ' 55' ' ' MET . 81.6 p -72.3 -9.63 58.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 0.95 111.705 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.8 t -95.36 -2.92 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.499 -0.773 . . . . 1.39 110.373 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.94 -17.59 22.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.096 0.474 . . . . 0.57 111.445 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.511 HD11 HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -113.1 124.0 51.56 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.163 -0.68 . . . . 1.51 109.163 -176.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -123.29 155.63 64.71 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.656 0.265 . . . . 0.91 111.269 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.434 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.0 Cg_endo -67.12 128.36 18.44 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.341 2.027 . . . . 0.28 111.339 172.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.74 -11.62 53.31 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.684 -0.769 . . . . 0.22 112.072 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -81.14 149.16 29.25 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.645 0.259 . . . . 1.28 110.522 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.6 m -76.86 131.35 38.56 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.525 -0.917 . . . . 0.17 108.525 171.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.481 HG11 HD21 ' A' ' 65' ' ' LEU . 35.7 m -135.01 159.48 41.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 122.04 0.924 . . . . 0.31 111.006 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -114.52 139.75 49.31 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.844 -1.526 . . . . 0.78 108.708 177.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.535 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 29.9 p90 -152.37 -179.68 7.77 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.463 -0.569 . . . . 0.11 109.463 -174.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 t -124.99 127.81 47.59 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.803 -0.814 . . . . 0.86 108.803 177.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.4 p -95.01 98.45 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.919 0.866 . . . . 0.36 110.835 -176.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.0 p -104.7 110.82 31.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.246 -0.888 . . . . 0.42 110.09 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 31.8 m -69.37 123.8 22.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.095 -0.502 . . . . 0.67 110.454 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 0.9 OUTLIER -69.92 109.38 4.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.516 -0.549 . . . . 1.82 109.516 178.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.44 ' CD ' ' H ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -64.57 -13.37 52.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.788 0.328 . . . . 1.95 111.316 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -94.37 -36.14 12.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.402 -0.363 . . . . 3.99 111.47 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -99.82 -29.36 12.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.253 0.464 . . . . 2.21 112.253 -174.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.17 -24.38 25.24 Favored Glycine 0 C--N 1.32 -0.313 0 C-N-CA 121.239 -0.505 . . . . 0.69 112.103 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 18.3 pttm -95.03 154.46 17.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.622 -0.511 . . . . 2.42 109.622 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.465 ' H ' HG21 ' A' ' 45' ' ' VAL . 2.0 m -94.97 -179.26 4.77 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.843 0.354 . . . . 1.08 110.736 -177.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -146.36 146.88 30.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.244 -0.65 . . . . 0.87 109.244 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.886 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -88.92 118.41 28.62 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.912 0.386 . . . . 0.17 110.424 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.8 m -117.16 149.09 40.95 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.257 -0.646 . . . . 0.68 109.257 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 m120 61.61 67.95 0.74 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.491 0.662 . . . . 1.82 109.532 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.511 HG12 HD11 ' A' ' 65' ' ' LEU . 86.0 t -89.92 111.76 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.286 -0.87 . . . . 0.32 110.748 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.445 HD13 ' HG2' ' A' ' 59' ' ' GLN . 4.2 mm? -107.46 147.27 30.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.574 -0.739 . . . . 1.12 110.903 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 114.17 21.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.748 -0.66 . . . . 1.33 110.136 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.9 mm . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 115.56 -0.746 . . . . 0.28 111.135 -175.831 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.335 0.112 . . . . 1.34 110.965 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.26 125.51 51.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.314 0.578 . . . . 2.11 110.836 176.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 68.2 mmtt -104.12 147.55 27.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.58 -0.736 . . . . 1.27 109.198 171.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.401 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 17.5 mtm180 -124.16 128.11 48.76 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.96 -0.296 . . . . 1.65 110.852 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.79 179.49 9.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.753 . . . . 0.08 110.429 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.07 146.65 28.05 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.117 -0.492 . . . . 0.14 110.335 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 31.0 t -67.26 121.73 16.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.157 0.503 . . . . 0.14 110.325 176.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -80.95 -41.69 22.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.434 -0.803 . . . . 0.6 109.914 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.3 p -163.96 166.9 21.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 1.07 110.643 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.419 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 7.3 mt -140.86 130.92 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.256 0.551 . . . . 0.19 109.873 175.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -124.82 88.16 2.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.383 -0.826 . . . . 1.56 110.411 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.48 -110.91 3.49 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.674 -0.774 . . . . 0.29 112.192 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -92.34 5.81 49.24 Favored 'General case' 0 C--O 1.225 -0.236 0 O-C-N 122.77 -0.253 . . . . 2.1 110.88 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -126.36 140.72 52.28 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.212 -0.595 . . . . 0.32 111.499 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.82 157.95 17.43 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.319 -0.855 . . . . 0.11 111.176 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 80.1 m-85 -130.26 140.54 50.68 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.292 -0.633 . . . . 0.18 109.292 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.466 HD13 ' CD2' ' A' ' 73' ' ' PHE . 6.8 mt -116.28 153.42 31.96 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.777 -0.453 . . . . 0.59 109.777 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -75.97 73.84 2.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.597 0.713 . . . . 1.53 109.817 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -144.45 109.27 4.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.845 -1.07 . . . . 0.28 109.275 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -92.81 115.02 27.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.848 -0.614 . . . . 1.81 110.576 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' A' ' 84' ' ' SER . 13.9 m -85.62 -47.49 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.78 -0.645 . . . . 0.85 111.46 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.611 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 8.4 pt-20 -157.1 144.64 18.91 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.486 -0.561 . . . . 2.24 109.486 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.9 t70 59.63 10.76 2.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.969 0.89 . . . . 1.55 112.009 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.13 30.58 37.4 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.609 -0.805 . . . . 0.67 112.106 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 8.1 mtpp -73.34 112.45 9.41 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.451 -0.203 . . . . 2.5 110.451 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.07 120.73 14.76 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.58 0.55 . . . . 1.32 109.527 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.4 mt -58.54 128.02 35.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.025 -0.534 . . . . 0.19 112.074 -176.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -106.17 161.65 14.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.905 0.383 . . . . 0.39 110.559 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.911 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 21.2 p90 -152.76 157.17 40.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.95 -0.568 . . . . 0.16 109.572 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -99.49 150.66 21.97 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.952 -0.759 . . . . 0.34 108.952 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.474 ' SD ' HG21 ' A' ' 58' ' ' VAL . 16.4 mmt -61.89 -9.43 6.84 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.114 0.412 . . . . 2.43 112.114 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.1 t -71.36 -26.06 62.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.823 0.344 . . . . 0.91 110.196 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -92.98 -2.07 56.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.417 -0.356 . . . . 1.96 110.588 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.474 HG21 ' SD ' ' A' ' 55' ' ' MET . 1.2 t -73.25 151.44 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.397 0.617 . . . . 0.27 112.569 -174.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.447 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 17.1 tm0? -68.03 98.82 0.8 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.903 -1.044 . . . . 1.6 112.5 -174.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.55 -81.89 0.39 Allowed Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.814 -0.63 . . . . 0.58 113.354 172.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -114.34 150.11 35.04 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.928 0.394 . . . . 2.2 110.159 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.7 p -71.22 -16.44 62.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.808 -0.633 . . . . 0.95 110.625 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 t -97.36 10.46 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.449 -0.796 . . . . 1.39 109.856 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.32 -27.22 12.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.118 0.485 . . . . 0.57 110.916 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.751 HD21 HG12 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -102.29 124.29 47.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.042 -0.725 . . . . 1.51 109.042 178.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.6 154.19 69.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.618 0.246 . . . . 0.91 111.33 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.448 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.6 Cg_endo -67.49 121.56 8.68 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.307 2.005 . . . . 0.28 111.422 173.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.494 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 103.05 -5.91 50.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.813 -0.708 . . . . 0.22 111.786 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.28 152.23 22.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.374 -0.602 . . . . 1.28 109.374 176.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 7.1 m -81.1 141.59 34.15 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.077 -0.712 . . . . 0.17 109.077 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.751 HG12 HD21 ' A' ' 65' ' ' LEU . 4.3 m -137.26 161.65 34.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.412 0.625 . . . . 0.31 110.83 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.61 141.33 47.91 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.43 -1.322 . . . . 0.78 107.43 170.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.516 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 30.9 p90 -151.64 178.98 8.8 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.978 0.418 . . . . 0.11 110.103 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.2 m -127.31 129.91 48.55 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.871 -0.788 . . . . 0.86 108.871 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 p -89.25 99.79 9.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.69 0.757 . . . . 0.36 110.979 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.4 p -107.33 101.93 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.741 0.781 . . . . 0.42 109.932 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 m -70.46 130.83 42.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.416 -0.811 . . . . 0.67 110.867 -177.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.45 104.8 3.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.7 -0.852 . . . . 1.82 108.7 172.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -62.65 -16.78 58.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.847 0.356 . . . . 1.95 111.407 -176.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -90.75 -40.79 11.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.126 -0.488 . . . . 3.99 111.038 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -94.37 -31.47 14.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.864 0.364 . . . . 2.21 111.709 -173.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.28 -23.76 33.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.108 -0.568 . . . . 0.69 112.273 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.439 ' HD3' ' HE2' ' A' ' 49' ' ' LYS . 21.4 pttt -91.44 154.08 19.4 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.052 -0.351 . . . . 2.42 110.052 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.42 ' HB3' HG11 ' A' ' 45' ' ' VAL . 14.6 t -108.25 -176.46 3.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.439 -0.346 . . . . 1.08 110.808 -173.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 p -155.28 147.13 23.35 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.787 -0.642 . . . . 0.87 109.338 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.911 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -87.22 123.01 31.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 120.974 0.416 . . . . 0.17 111.081 -177.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 89.5 m -117.35 150.95 37.99 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.876 -0.602 . . . . 0.68 109.475 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 58.4 63.01 1.82 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.413 0.446 . . . . 1.82 109.809 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 79.3 t -84.16 103.78 11.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.873 -0.603 . . . . 0.32 110.325 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.447 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 4.6 mm? -101.31 147.59 26.13 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.698 -0.683 . . . . 1.12 109.888 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.568 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -82.3 126.93 32.71 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.47 -0.567 . . . . 1.33 109.47 178.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.517 ' O ' ' HB ' ' A' ' 70' ' ' THR . 38.7 mm . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 115.906 -0.588 . . . . 0.28 110.103 -176.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.033 0.444 . . . . 1.34 111.903 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -111.7 111.67 22.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.741 -0.663 . . . . 2.11 110.22 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -87.14 153.66 21.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.686 -0.688 . . . . 1.27 110.215 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 43.9 mtm180 -125.5 135.63 52.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.859 0.361 . . . . 1.65 110.527 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.81 179.34 8.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.558 -0.746 . . . . 0.08 109.447 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.25 147.09 28.44 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.003 -0.369 . . . . 0.14 110.003 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.548 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 26.7 t -69.34 120.33 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.077 0.465 . . . . 0.14 110.317 177.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -72.18 -41.81 66.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.312 -0.858 . . . . 0.6 110.631 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.8 p -175.66 163.3 2.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.685 -0.688 . . . . 1.07 109.477 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 mt -131.06 131.28 64.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.259 0.552 . . . . 0.19 110.264 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -121.86 86.37 2.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.141 -0.936 . . . . 1.56 109.775 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.15 -112.48 4.06 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.659 -0.782 . . . . 0.29 112.193 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -93.34 7.28 45.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.59 0.233 . . . . 2.1 110.743 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.24 141.64 51.4 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.081 0.467 . . . . 0.32 111.007 -174.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.74 157.52 18.18 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 111.038 -0.825 . . . . 0.11 111.038 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 81.1 m-85 -130.19 143.28 50.69 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.82 -0.437 . . . . 0.18 109.82 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.491 HD13 ' CD2' ' A' ' 73' ' ' PHE . 8.4 mt -117.5 152.88 34.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.075 -0.512 . . . . 0.59 109.918 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -74.37 74.76 1.89 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.671 0.748 . . . . 1.53 109.723 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -151.06 99.26 2.67 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.882 -1.054 . . . . 0.28 108.654 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.671 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 14.1 mt-10 -94.41 101.54 13.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.709 0.766 . . . . 1.81 111.296 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.652 HG23 ' H ' ' A' ' 46' ' ' GLU . 2.4 m -75.43 -59.07 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.247 -1.342 . . . . 0.85 111.262 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.652 ' H ' HG23 ' A' ' 45' ' ' VAL . 10.9 tp10 -106.82 179.87 4.14 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.131 -1.433 . . . . 2.24 107.131 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.422 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 31.3 t70 -30.54 83.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.854 1.262 . . . . 1.55 113.914 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 66.23 16.09 64.16 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.792 -0.718 . . . . 0.67 111.512 172.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 2.4 mmmt -77.14 108.09 9.98 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 110.021 -0.363 . . . . 2.5 110.021 -174.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -74.93 123.11 24.51 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.976 -1.12 . . . . 1.32 107.976 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 4.1 mt -57.55 122.22 12.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.818 0.342 . . . . 0.19 111.423 -174.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -101.07 155.07 18.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.896 -0.593 . . . . 0.39 109.954 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.955 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 33.1 p90 -149.4 157.13 43.05 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.632 -0.713 . . . . 0.16 109.276 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -99.77 150.11 22.66 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.238 -0.653 . . . . 0.34 109.238 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.522 ' SD ' HG21 ' A' ' 58' ' ' VAL . 11.0 mmt -60.47 -6.89 1.77 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.631 0.604 . . . . 2.43 112.631 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.409 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . 17.6 t -79.01 -28.98 43.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.693 0.282 . . . . 0.91 110.284 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' OE2' ' HB3' ' A' ' 56' ' ' SER . 2.6 mp0 -85.61 -4.47 59.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.972 0.415 . . . . 1.96 110.593 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.522 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -69.5 148.38 11.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.605 -0.725 . . . . 0.27 112.486 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.449 ' HG2' HD13 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -64.15 99.9 0.3 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.467 -1.242 . . . . 1.6 111.883 -175.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.56 -89.65 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.866 -0.607 . . . . 0.58 113.131 173.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -106.07 151.06 25.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.986 0.422 . . . . 2.2 110.603 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.0 p -63.76 -33.79 76.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.478 -0.783 . . . . 0.95 111.076 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.6 t -88.3 7.22 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.828 -0.624 . . . . 1.39 110.443 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.82 -9.42 34.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.093 0.473 . . . . 0.57 110.788 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.764 HD21 HG12 ' A' ' 71' ' ' VAL . 1.1 tm? -121.36 124.5 44.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.622 -0.881 . . . . 1.51 108.622 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -122.87 152.33 62.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.452 -0.34 . . . . 0.91 111.407 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 44.8 Cg_endo -69.74 115.92 4.31 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.585 2.19 . . . . 0.28 111.907 176.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.548 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 119.77 -18.85 9.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.14 -0.553 . . . . 0.22 112.247 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.21 155.92 24.68 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.755 -0.461 . . . . 1.28 109.755 175.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 3.0 m -78.45 143.11 36.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.677 -0.49 . . . . 0.17 109.677 176.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.764 HG12 HD21 ' A' ' 65' ' ' LEU . 26.6 m -137.53 157.52 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 121.699 0.762 . . . . 0.31 110.215 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -115.41 141.51 47.94 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.27 -1.332 . . . . 0.78 108.359 171.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.491 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.5 p90 -152.04 179.57 8.36 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.05 -0.722 . . . . 0.11 109.05 -173.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.85 128.51 47.75 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.961 -0.755 . . . . 0.86 108.961 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.05 98.69 7.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.759 0.79 . . . . 0.36 110.61 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.88 125.64 67.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.292 -0.867 . . . . 0.42 109.367 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.7 m -81.4 128.98 34.44 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.351 -0.386 . . . . 0.67 110.48 -178.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -68.1 111.14 4.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.68 -0.489 . . . . 1.82 109.68 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.55 -18.84 44.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.081 -0.509 . . . . 1.95 112.035 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -95.06 -38.12 10.78 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.841 0.312 . . . . 3.99 111.841 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.444 ' HB3' ' HE2' ' A' ' 83' ' ' LYS . 11.2 m120 -113.73 -5.74 13.31 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.045 0.758 . . . . 2.21 113.045 -172.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.94 -9.42 24.77 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.893 -0.67 . . . . 0.69 114.017 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -97.45 152.87 18.53 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.581 -0.526 . . . . 2.42 109.581 179.227 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.1 t -97.01 -179.67 4.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.158 0.504 . . . . 1.08 111.745 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.7 p -154.97 150.4 27.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.35 -0.841 . . . . 0.87 108.783 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.955 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -87.22 122.58 31.2 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.201 0.524 . . . . 0.17 110.51 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 84.0 m -116.92 144.88 44.03 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.524 -0.762 . . . . 0.68 109.739 178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 56.79 73.26 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.812 0.695 . . . . 1.82 109.792 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 73.3 t -87.75 105.69 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.741 -0.663 . . . . 0.32 110.46 -178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.449 HD13 ' HG2' ' A' ' 59' ' ' GLN . 4.3 mm? -101.98 149.05 24.62 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.358 -0.837 . . . . 1.12 110.298 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.537 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -84.54 115.85 22.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.326 -0.62 . . . . 1.33 109.326 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 70' ' ' THR . 43.2 mm . . . . . 0 C--N 1.319 -0.72 0 CA-C-O 121.158 0.504 . . . . 0.28 111.801 -172.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.5 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 4.0 tp60 . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.202 0.525 . . . . 1.34 110.767 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -104.11 112.63 25.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.656 -0.702 . . . . 2.11 110.421 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 67.7 mmtt -100.05 157.52 16.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.424 -0.807 . . . . 1.27 111.4 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -124.53 140.04 53.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.44 -0.346 . . . . 1.65 110.122 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.42 179.26 6.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.048 -0.523 . . . . 0.08 110.184 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.01 145.14 30.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.239 -0.437 . . . . 0.14 110.103 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.512 ' HA ' HD23 ' A' ' 41' ' ' LEU . 46.2 t -68.98 119.9 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.38 -0.373 . . . . 0.14 110.565 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -72.88 -40.41 65.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.826 -0.625 . . . . 0.6 110.344 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 p -171.12 164.3 7.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.067 -0.515 . . . . 1.07 110.628 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.7 mt -136.56 130.82 47.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.587 -0.523 . . . . 0.19 109.587 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -128.27 101.29 6.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.475 -0.784 . . . . 1.56 110.171 -175.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.27 -105.89 1.43 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.665 -0.778 . . . . 0.29 112.392 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -106.12 6.76 31.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.934 -0.395 . . . . 2.1 109.934 -177.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -125.4 140.64 52.62 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.377 0.608 . . . . 0.32 111.091 -174.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -123.79 156.58 18.04 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.957 -0.857 . . . . 0.11 110.957 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -131.0 144.95 51.87 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.711 -0.478 . . . . 0.18 109.711 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.551 HD13 ' CD2' ' A' ' 73' ' ' PHE . 4.8 mt -121.07 152.1 39.05 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.275 -0.639 . . . . 0.59 109.275 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -75.54 75.26 2.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.314 0.578 . . . . 1.53 109.585 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -143.12 98.17 3.22 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.433 -0.803 . . . . 0.28 109.509 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -79.47 101.31 8.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.915 -0.584 . . . . 1.81 109.844 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 84' ' ' SER . 31.5 m -75.21 -43.96 43.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.536 -0.756 . . . . 0.85 110.609 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 6.0 tp10 -129.08 179.37 5.79 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 106.328 -1.731 . . . . 2.24 106.328 174.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.519 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 14.2 t70 -31.23 83.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.229 1.412 . . . . 1.55 114.059 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.03 8.65 61.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.273 -0.489 . . . . 0.67 111.954 173.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -74.32 110.38 8.57 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.505 -0.554 . . . . 2.5 109.505 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.486 ' NZ ' ' HB2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -78.9 129.77 34.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.668 -0.696 . . . . 1.32 110.193 -173.716 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 51' ' ' LEU . 3.2 mt -67.95 127.56 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.318 -0.401 . . . . 0.19 111.274 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -113.51 157.27 22.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.738 -0.664 . . . . 0.39 109.47 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.937 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 32.3 p90 -146.05 153.23 40.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.992 -0.549 . . . . 0.16 109.759 174.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -94.36 148.13 22.53 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.142 -0.688 . . . . 0.34 109.142 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.63 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 21.7 ttp -65.12 2.9 0.68 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.272 0.629 . . . . 2.43 111.635 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.7 t -89.53 -19.23 25.28 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.648 -0.251 . . . . 0.91 110.751 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -85.85 -11.19 53.97 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 121.378 0.608 . . . . 1.96 109.426 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 62' ' ' THR . 1.6 t -64.41 146.78 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.783 -1.099 . . . . 0.27 112.593 -174.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.37 98.65 0.25 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.831 -1.077 . . . . 1.6 111.899 -173.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.92 -77.54 1.12 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.58 113.512 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -119.87 149.92 41.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.068 0.461 . . . . 2.2 110.025 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.63 ' HB ' ' SD ' ' A' ' 55' ' ' MET . 43.0 p -69.21 -21.89 63.92 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.33 -0.85 . . . . 0.95 112.233 -171.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.9 t -98.92 4.9 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.568 0.699 . . . . 1.39 110.169 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.13 -25.54 27.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.162 -0.472 . . . . 0.57 110.493 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.683 HD21 HG12 ' A' ' 71' ' ' VAL . 1.1 tm? -104.04 125.28 50.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.862 -0.608 . . . . 1.51 109.563 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -124.15 154.81 68.47 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.523 0.201 . . . . 0.91 111.134 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 39.3 Cg_endo -68.55 144.57 61.22 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.659 2.239 . . . . 0.28 112.152 176.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.48 -11.98 64.36 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.925 -0.655 . . . . 0.22 112.345 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.02 154.03 20.81 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.43 -0.211 . . . . 1.28 110.43 177.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.6 m -76.33 138.5 40.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.705 -0.48 . . . . 0.17 109.705 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.683 HG12 HD21 ' A' ' 65' ' ' LEU . 11.3 m -138.09 163.22 29.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.398 0.618 . . . . 0.31 109.877 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -116.5 149.21 39.92 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.98 -1.009 . . . . 0.78 108.476 172.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.551 ' CD2' HD13 ' A' ' 41' ' ' LEU . 36.1 p90 -156.75 178.25 10.55 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.039 -0.356 . . . . 0.11 110.039 -175.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -124.36 132.67 53.55 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.94 -0.763 . . . . 0.86 108.94 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.32 99.01 8.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.693 0.759 . . . . 0.36 110.496 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.19 126.71 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.459 -0.792 . . . . 0.42 110.589 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.6 m -74.33 132.66 42.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.088 -0.506 . . . . 0.67 111.287 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -75.17 116.46 15.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.092 -0.707 . . . . 1.82 109.092 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -58.16 -28.03 64.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.08 0.4 . . . . 1.95 112.08 -175.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -94.08 -51.58 4.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.919 0.34 . . . . 3.99 111.919 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -81.77 -31.69 31.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.941 0.349 . . . . 2.21 111.941 -172.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.13 -21.98 43.21 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.676 -0.773 . . . . 0.69 112.674 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -82.35 166.59 19.32 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 109.467 -0.568 . . . . 2.42 109.467 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.537 ' HB2' HG11 ' A' ' 45' ' ' VAL . 11.4 m -104.93 -177.66 3.43 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.577 -0.449 . . . . 1.08 111.008 -177.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.6 m -147.82 144.84 28.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.455 -0.572 . . . . 0.87 109.455 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.937 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -84.59 120.59 26.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.969 0.414 . . . . 0.17 110.647 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.4 m -117.7 146.02 44.02 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.528 -0.76 . . . . 0.68 109.738 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.4 m120 56.6 74.45 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.677 0.611 . . . . 1.82 110.766 -175.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 76.1 t -86.93 110.44 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.634 -0.712 . . . . 0.32 110.991 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.59 148.82 24.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.706 -0.679 . . . . 1.12 110.833 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.92 122.58 26.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.197 -0.668 . . . . 1.33 109.197 174.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mm . . . . . 0 C--N 1.321 -0.659 0 CA-C-O 121.09 0.471 . . . . 0.28 111.352 -177.315 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.53 HE21 ' HE3' ' A' ' 27' ' ' LYS . 62.9 tp60 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 112.008 0.373 . . . . 1.34 112.008 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -111.83 135.53 52.32 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.517 -0.549 . . . . 2.11 109.517 172.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HE3' HE21 ' A' ' 25' ' ' GLN . 28.7 mmtp -112.76 144.88 41.55 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.106 -0.702 . . . . 1.27 109.106 172.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 4.1 mtm180 -121.74 127.59 50.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.051 0.453 . . . . 1.65 110.846 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.67 179.65 9.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.39 -0.823 . . . . 0.08 110.059 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.81 144.05 30.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.547 -0.297 . . . . 0.14 110.566 -178.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.506 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 43.4 t -65.08 115.73 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.827 -0.434 . . . . 0.14 109.827 175.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.73 -48.68 58.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.082 -0.508 . . . . 0.6 110.079 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 m -159.64 160.64 34.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.632 -0.713 . . . . 1.07 109.687 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.43 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 11.5 mt -138.09 130.79 40.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.426 -0.583 . . . . 0.19 109.426 173.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -129.88 94.73 3.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.648 -0.706 . . . . 1.56 110.242 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.45 -106.04 1.56 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.815 -0.707 . . . . 0.29 112.554 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -100.86 13.64 34.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.521 -0.178 . . . . 2.1 110.521 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -133.18 142.39 48.59 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.201 0.524 . . . . 0.32 111.381 -174.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -126.48 157.4 20.27 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 111.002 -0.839 . . . . 0.11 111.002 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -130.86 149.3 52.56 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.438 -0.578 . . . . 0.18 109.438 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 73' ' ' PHE . 5.9 mt -124.38 148.64 47.4 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.812 -0.81 . . . . 0.59 108.812 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 62.4 t30 -78.05 72.9 4.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.578 0.704 . . . . 1.53 109.731 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -139.47 98.75 3.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.952 -1.022 . . . . 0.28 109.104 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 50.6 mt-10 -84.82 101.2 12.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.612 0.72 . . . . 1.81 110.356 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 84' ' ' SER . 34.1 m -81.12 -32.0 12.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.911 -1.04 . . . . 0.85 110.622 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 5.5 tp10 -134.09 177.47 7.71 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.77 -1.937 . . . . 2.24 105.77 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.499 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 26.4 t0 -39.78 84.93 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.119 0.968 . . . . 1.55 113.44 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 73.26 8.29 74.47 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.751 -0.54 . . . . 0.67 111.751 174.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 9.0 mmtm -67.53 110.32 3.61 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.831 -0.184 . . . . 2.5 110.686 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 8.9 tppt? -79.53 123.7 27.82 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.12 -0.696 . . . . 1.32 109.12 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 51' ' ' LEU . 1.7 mt -61.06 136.03 57.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.585 -0.279 . . . . 0.19 111.046 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -118.3 160.7 21.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.404 . . . . 0.39 110.54 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.669 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 28.6 p90 -150.38 153.74 36.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.711 -0.677 . . . . 0.16 109.509 173.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -92.34 147.29 23.03 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.621 -0.881 . . . . 0.34 108.621 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.456 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 11.6 tmm? -59.3 -15.57 16.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.997 -0.547 . . . . 2.43 112.175 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 t -64.33 -29.25 70.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.785 0.326 . . . . 0.91 110.189 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -91.27 -3.79 56.55 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.539 -0.3 . . . . 1.96 111.161 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.827 HG22 HD13 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -63.21 152.0 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.944 -0.571 . . . . 0.27 111.053 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.502 ' HG2' HD13 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -67.38 96.93 0.53 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.118 -0.492 . . . . 1.6 111.417 -176.599 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.36 -99.13 0.13 Allowed Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.611 0.57 . . . . 0.58 113.578 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -88.79 140.3 29.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.779 0.799 . . . . 2.2 110.41 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.4 p -75.43 -19.81 59.25 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.102 -0.954 . . . . 0.95 111.219 -174.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.1 t -90.31 7.51 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.673 . . . . 1.39 109.717 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -102.73 -13.92 16.86 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.966 -0.561 . . . . 0.57 110.76 177.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.827 HD13 HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -121.83 123.4 41.68 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.244 -0.65 . . . . 1.51 109.244 -177.439 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -135.4 159.01 73.28 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.661 0.267 . . . . 0.91 111.444 -174.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.506 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 30.7 Cg_endo -64.78 129.86 24.6 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.132 1.888 . . . . 0.28 111.94 175.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.15 -16.1 54.0 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.939 -0.648 . . . . 0.22 111.823 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -79.21 147.23 32.69 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.909 -0.404 . . . . 1.28 109.909 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 5.5 m -76.31 137.48 39.89 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.735 -0.839 . . . . 0.17 108.735 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.465 HG11 HD21 ' A' ' 65' ' ' LEU . 28.5 m -139.42 159.18 28.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 122.205 -0.31 . . . . 0.31 110.504 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.757 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 10.4 pt-20 -115.63 144.97 43.15 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.605 -0.887 . . . . 0.78 108.605 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.584 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 17.8 p90 -148.05 178.89 8.16 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.501 -0.772 . . . . 0.11 109.431 -172.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 m -125.65 126.01 44.02 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.817 -0.808 . . . . 0.86 108.817 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 75' ' ' VAL . 8.3 p -90.02 98.69 8.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 122.058 0.932 . . . . 0.36 111.165 -171.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.0 p -106.77 131.11 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.57 -0.741 . . . . 0.42 109.662 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.4 m -77.9 132.28 37.86 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.904 -0.589 . . . . 0.67 111.627 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.61 122.36 24.53 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.584 -0.525 . . . . 1.82 109.584 173.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -69.73 -5.11 22.95 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.422 0.527 . . . . 1.95 112.422 -174.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.16 -60.94 1.83 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.998 -0.371 . . . . 3.99 109.998 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 83' ' ' LYS . 18.9 m120 -96.62 -30.48 13.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.815 0.341 . . . . 2.21 111.576 -173.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.44 -3.17 63.4 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.545 -0.836 . . . . 0.69 111.253 -171.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.46 ' HG2' ' HB2' ' A' ' 81' ' ' ASN . 60.1 pttt -79.02 144.72 34.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.322 -0.621 . . . . 2.42 109.322 175.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.504 ' HB2' HG11 ' A' ' 45' ' ' VAL . 9.8 m -89.56 177.56 6.52 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.393 0.616 . . . . 1.08 111.894 -174.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.9 m -149.04 153.74 38.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.98 -1.009 . . . . 0.87 109.322 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -93.89 121.88 35.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.979 0.419 . . . . 0.17 109.998 177.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.7 t -117.35 157.42 26.18 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.167 -1.049 . . . . 0.68 108.167 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.4 t30 55.77 63.99 1.88 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.793 0.683 . . . . 1.82 109.764 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.622 HG12 HD11 ' A' ' 65' ' ' LEU . 78.4 t -83.77 118.41 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.36 -0.836 . . . . 0.32 111.276 -176.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.757 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 4.2 mm? -112.93 148.56 34.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.261 -0.427 . . . . 1.12 110.943 -178.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -83.49 116.17 22.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.408 0.623 . . . . 1.33 111.216 178.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.462 ' O ' ' HB ' ' A' ' 70' ' ' THR . 48.7 mm . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 115.305 -0.861 . . . . 0.28 109.926 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 111.884 -0.486 . . . . 18.87 111.884 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.21 121.56 33.85 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.847 0.356 . . . . 17.7 110.987 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -97.98 116.85 31.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.615 -0.513 . . . . 17.44 109.615 174.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.83 55.77 4.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.778 -0.725 . . . . 14.34 112.225 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -76.09 149.9 37.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.971 0.415 . . . . 13.69 110.473 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.65 166.57 11.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.068 -0.515 . . . . 11.39 110.547 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.3 p -121.08 128.29 76.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.406 -0.59 . . . . 8.82 109.406 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 m -78.55 32.88 0.2 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.136 0.493 . . . . 7.95 111.213 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -104.85 -48.15 3.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.978 -0.555 . . . . 7.07 111.293 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.82 114.05 7.4 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.608 -0.437 . . . . 6.67 111.448 -175.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.429 HG22 ' HG3' ' A' ' 13' ' ' GLU . 28.3 mm -129.78 150.69 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.453 -0.944 . . . . 2.89 108.453 173.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -66.34 -37.24 84.9 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.563 0.579 . . . . 3.29 112.563 -175.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.429 ' HG3' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -66.55 -9.78 38.45 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.055 0.455 . . . . 2.96 111.745 -176.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.9 t -78.49 -0.81 30.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.278 0.561 . . . . 2.31 110.125 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.39 56.95 2.05 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.697 -0.763 . . . . 1.86 111.831 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -78.6 98.8 6.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.051 0.453 . . . . 5.03 110.952 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.12 -22.31 25.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.433 -0.803 . . . . 2.37 111.134 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.11 -28.84 66.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.925 -0.579 . . . . 2.38 111.024 -175.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.3 t -136.56 129.47 30.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.693 -0.854 . . . . 2.75 108.693 173.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 p -169.53 153.22 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.37 -0.604 . . . . 1.88 109.37 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -83.24 -48.37 10.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.648 0.261 . . . . 2.71 110.965 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.36 151.28 20.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.71 -0.223 . . . . 1.95 110.533 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.28 93.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 123.169 0.293 . . . . 1.72 111.329 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.9 25.82 0.06 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.596 1.159 . . . . 2.92 112.733 -177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 5.0 tp60 -103.75 52.46 0.77 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.263 0.554 . . . . 1.34 111.382 -171.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -79.0 114.04 17.61 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.393 -0.595 . . . . 2.11 109.393 172.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 74.3 mmtt -99.9 156.39 17.16 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.851 -0.613 . . . . 1.27 110.4 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -125.93 128.74 48.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.858 0.361 . . . . 1.65 110.449 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.91 179.45 9.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.514 -0.766 . . . . 0.08 109.477 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.25 143.45 32.95 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.672 -0.492 . . . . 0.14 109.672 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.495 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 41.3 t -63.54 119.4 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.265 0.555 . . . . 0.14 110.074 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.96 -44.68 30.36 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.987 -1.006 . . . . 0.6 109.526 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.0 m -161.17 164.56 30.45 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.613 -0.721 . . . . 1.07 110.251 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.418 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 5.8 mt -141.63 130.38 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.056 0.455 . . . . 0.19 109.987 175.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 64.3 mmtt -125.43 104.05 8.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.479 -0.782 . . . . 1.56 110.469 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.07 -108.52 1.94 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.028 -0.606 . . . . 0.29 112.515 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -100.54 10.58 41.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.455 0.169 . . . . 2.1 110.693 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -128.89 140.63 51.59 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.163 0.506 . . . . 0.32 111.003 -173.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.88 157.36 17.42 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 120.638 -0.791 . . . . 0.11 111.433 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.508 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 77.0 m-85 -132.22 137.58 47.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.161 -0.681 . . . . 0.18 109.161 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.487 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.1 mt -110.13 154.65 23.01 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.714 -0.476 . . . . 0.59 109.714 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -74.76 73.09 2.05 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.587 0.708 . . . . 1.53 109.558 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -148.02 97.57 2.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.832 -1.076 . . . . 0.28 108.678 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 23.9 mp0 -85.65 110.01 18.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.723 -0.671 . . . . 1.81 109.966 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.486 HG11 ' HB2' ' A' ' 84' ' ' SER . 28.8 m -78.73 -36.4 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.85 112.024 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -156.42 123.16 5.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.511 -0.313 . . . . 2.24 110.488 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.2 t70 60.97 12.92 4.19 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.641 0.734 . . . . 1.55 111.966 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.0 21.08 14.43 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.635 -0.793 . . . . 0.67 112.979 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 4.0 mmtm -69.41 110.93 4.96 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.874 -0.417 . . . . 2.5 109.874 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -71.72 129.61 39.11 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.669 -0.493 . . . . 1.32 109.669 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.1 mt -66.66 123.3 19.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.594 -0.276 . . . . 0.19 110.97 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -105.28 158.3 16.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.045 0.45 . . . . 0.39 110.661 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.86 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 32.3 p90 -151.44 155.22 38.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.682 -0.69 . . . . 0.16 109.163 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -97.08 152.04 19.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.994 -0.743 . . . . 0.34 108.994 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.539 ' SD ' HG21 ' A' ' 58' ' ' VAL . 14.2 mmt -64.51 -3.06 2.7 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.431 0.53 . . . . 2.43 112.431 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.8 t -82.76 -25.31 32.94 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.851 -0.426 . . . . 0.91 109.851 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.84 -6.17 59.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.922 0.391 . . . . 1.96 110.421 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.539 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.0 t -71.6 152.38 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.69 -0.686 . . . . 0.27 112.45 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.78 98.33 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.483 -1.235 . . . . 1.6 112.041 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.87 -84.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.0 -0.545 . . . . 0.58 113.602 172.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -106.68 142.31 36.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.758 0.313 . . . . 2.2 110.179 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.413 HG22 ' HB3' ' A' ' 55' ' ' MET . 82.7 p -67.7 -21.37 65.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.271 0.558 . . . . 0.95 111.503 -177.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.6 t -95.01 2.19 9.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.285 0.564 . . . . 1.39 110.428 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.63 -13.8 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.443 -0.344 . . . . 0.57 111.297 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.659 HD21 HG12 ' A' ' 71' ' ' VAL . 1.1 tm? -110.65 124.69 52.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.976 -0.75 . . . . 1.51 108.976 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -117.92 150.19 46.76 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.559 -0.291 . . . . 0.91 111.121 -172.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.495 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.2 Cg_endo -66.49 135.76 40.49 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.443 2.095 . . . . 0.28 111.933 173.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.53 -2.36 73.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.916 -0.659 . . . . 0.22 112.367 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -95.91 154.7 17.09 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.804 -0.443 . . . . 1.28 109.804 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 m -79.72 136.03 36.67 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.466 -0.568 . . . . 0.17 109.466 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.659 HG12 HD21 ' A' ' 65' ' ' LEU . 20.0 m -136.48 161.3 37.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.432 0.634 . . . . 0.31 110.805 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.45 139.0 49.88 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.837 -1.172 . . . . 0.78 107.837 171.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.487 ' CD2' HD13 ' A' ' 41' ' ' LEU . 19.2 p90 -148.53 179.82 7.52 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.824 0.345 . . . . 0.11 110.193 -174.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.8 m -129.85 115.01 16.61 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.088 -0.708 . . . . 0.86 109.088 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.4 p -85.37 101.93 10.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.538 0.685 . . . . 0.36 110.834 -175.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.63 121.58 59.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.757 -0.656 . . . . 0.42 109.87 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.8 m -79.62 128.34 33.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.861 -0.608 . . . . 0.67 111.068 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -68.48 102.32 1.42 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.516 -0.765 . . . . 1.82 109.218 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -64.23 -8.03 11.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.217 0.532 . . . . 1.95 111.413 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -93.73 -39.34 10.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.883 -0.599 . . . . 3.99 111.044 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -114.28 -21.25 10.53 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.554 0.575 . . . . 2.21 112.554 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.7 -20.18 51.66 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.764 -0.731 . . . . 0.69 113.36 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -81.78 174.6 11.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.005 -0.739 . . . . 2.42 109.005 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.486 ' HB2' HG11 ' A' ' 45' ' ' VAL . 19.1 m -128.81 175.68 8.43 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.284 -0.566 . . . . 1.08 110.632 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.2 p -145.91 155.97 43.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.274 -0.421 . . . . 0.87 110.433 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.86 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -93.2 118.31 31.09 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.118 0.485 . . . . 0.17 110.24 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 97.3 m -116.74 144.05 44.91 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.132 -0.692 . . . . 0.68 109.132 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 63.68 69.01 0.56 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.084 -0.71 . . . . 1.82 109.084 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 71.0 t -87.94 116.66 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.406 -0.815 . . . . 0.32 110.722 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.35 149.03 30.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.903 -0.589 . . . . 1.12 110.705 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -77.91 126.42 30.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.139 -0.482 . . . . 1.33 109.891 176.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.09 138.85 46.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 110.072 -0.344 . . . . 0.28 110.072 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -104.35 125.87 50.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.823 0.344 . . . . 2.57 110.699 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.052 -0.522 . . . . 3.08 110.216 176.75 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 111.967 -0.453 . . . . 18.87 111.967 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.23 121.64 44.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.837 0.351 . . . . 17.7 110.523 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -105.76 92.73 4.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.117 0.485 . . . . 17.44 110.723 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.52 -28.19 7.22 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.02 -0.832 . . . . 14.34 111.02 173.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 72.9 -2.14 2.8 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.861 0.865 . . . . 13.69 112.853 173.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt -86.34 80.46 8.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.881 0.372 . . . . 11.39 110.307 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.0 p -140.88 145.82 24.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.059 -0.519 . . . . 8.82 110.021 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 m -79.63 36.35 0.32 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.478 -0.328 . . . . 7.95 111.356 -176.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -125.17 -9.67 7.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.988 0.423 . . . . 7.07 111.174 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.451 ' HA ' ' HD3' ' A' ' 10' ' ' ARG . 18.8 mmt180 -115.81 158.48 22.83 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.1 -0.64 . . . . 6.67 112.701 -175.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.1 mt -129.88 125.4 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 114.898 -1.047 . . . . 2.89 111.32 -171.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -92.04 -43.42 9.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.988 0.423 . . . . 3.29 110.544 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.517 ' HB2' HH12 ' A' ' 28' ' ' ARG . 12.3 pt-20 -59.53 -14.17 11.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.501 -0.772 . . . . 2.96 112.196 -174.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 t -62.9 -27.56 69.45 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.116 -0.327 . . . . 2.31 110.116 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.74 57.56 4.47 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.964 -0.636 . . . . 1.86 112.616 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -88.53 133.45 34.15 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.943 -0.303 . . . . 5.03 110.282 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.96 -15.15 3.07 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.944 0.72 . . . . 2.37 112.944 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.11 -16.62 64.44 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.773 0.32 . . . . 2.38 110.758 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.5 t -146.66 130.6 17.21 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.68 -0.859 . . . . 2.75 108.68 171.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 p -147.25 141.2 19.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.803 0.335 . . . . 1.88 110.1 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -144.57 154.07 42.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.52 -0.309 . . . . 2.71 111.411 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 57.1 22.76 7.76 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.95 0.782 . . . . 1.95 111.659 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.8 t 57.78 67.98 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.818 -0.628 . . . . 1.72 109.75 -172.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 47.01 30.77 1.34 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.409 1.084 . . . . 2.92 113.142 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -107.48 74.87 0.99 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.047 0.451 . . . . 1.34 110.906 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -99.37 115.4 29.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 2.11 110.172 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 28.2 mmtp -99.03 151.35 21.02 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.893 -0.594 . . . . 1.27 111.859 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.517 HH12 ' HB2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -115.02 127.15 55.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.73 -0.668 . . . . 1.65 110.264 176.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . . . -157.25 178.94 9.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.269 -0.271 . . . . 0.08 110.269 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.07 148.02 26.73 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.442 -0.345 . . . . 0.14 110.098 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.531 ' HA ' HD23 ' A' ' 41' ' ' LEU . 45.5 t -68.77 122.14 19.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.978 0.418 . . . . 0.14 110.624 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.41 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 22.3 t70 -75.07 -40.79 59.94 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.313 -0.858 . . . . 0.6 110.053 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 t -171.65 169.41 6.0 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.643 -0.708 . . . . 1.07 109.113 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.429 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 9.2 mt -136.45 126.4 39.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.254 0.55 . . . . 0.19 109.618 175.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 62.6 mmtt -120.16 85.54 2.4 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.325 -0.852 . . . . 1.56 110.361 -175.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.11 -114.55 4.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.746 -0.74 . . . . 0.29 112.549 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.59 12.78 24.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.074 -0.343 . . . . 2.1 110.074 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -132.19 140.11 48.6 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.013 0.435 . . . . 0.32 110.417 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.29 159.61 16.86 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.631 -0.795 . . . . 0.11 111.215 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 77.5 m-85 -131.47 149.54 52.49 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.03 -0.73 . . . . 0.18 109.03 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.571 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.0 mt -124.14 157.6 34.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.15 -0.315 . . . . 0.59 110.15 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -76.78 73.33 3.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.509 0.671 . . . . 1.53 109.554 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.424 ' HB3' HD12 ' A' ' 51' ' ' LEU . 16.7 t80 -148.04 98.79 2.98 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.049 -0.978 . . . . 0.28 108.859 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 43.4 mt-10 -86.95 103.36 15.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.292 -0.413 . . . . 1.81 110.135 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.535 HG21 ' H ' ' A' ' 84' ' ' SER . 27.6 m -80.65 -30.34 12.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.624 0.602 . . . . 0.85 112.624 -173.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 5.2 tp10 -161.31 110.82 1.62 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 110.57 -0.159 . . . . 2.24 110.57 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.8 t0 55.23 37.88 29.57 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.294 0.569 . . . . 1.55 111.735 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.85 20.98 54.7 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.365 -0.921 . . . . 0.67 113.087 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 38.3 mmtm -74.19 110.05 8.17 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.135 -0.691 . . . . 2.5 109.135 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -72.61 126.1 29.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.644 -0.873 . . . . 1.32 108.644 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.5 mt -63.25 128.58 36.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.114 -0.494 . . . . 0.19 110.847 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -112.49 156.72 22.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.345 -0.389 . . . . 0.39 110.302 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.906 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 25.8 p90 -146.48 149.07 32.95 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.623 -0.717 . . . . 0.16 109.717 174.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -91.74 145.48 24.54 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.555 -0.906 . . . . 0.34 108.555 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.51 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -58.11 -11.95 3.02 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.522 0.564 . . . . 2.43 112.522 -177.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.1 t -67.39 -25.85 66.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.823 0.345 . . . . 0.91 110.454 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -86.6 -13.87 44.46 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.242 -0.435 . . . . 1.96 110.464 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -65.82 148.39 12.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.42 -0.809 . . . . 0.27 112.298 -175.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.16 102.21 0.36 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 114.748 -1.115 . . . . 1.6 111.241 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.58 -91.59 0.26 Allowed Glycine 0 C--O 1.237 0.301 0 CA-C-N 115.952 -0.567 . . . . 0.58 113.61 173.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -101.44 151.31 22.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.648 -0.501 . . . . 2.2 109.648 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.3 p -77.71 -15.36 59.19 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.928 -0.578 . . . . 0.95 111.168 -173.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.74 2.92 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.609 -0.723 . . . . 1.39 110.078 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.48 -24.65 19.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.57 111.335 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.637 HD21 HG12 ' A' ' 71' ' ' VAL . 1.6 tm? -98.42 125.06 43.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.155 -0.683 . . . . 1.51 109.155 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -117.41 152.96 50.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 111.93 0.344 . . . . 0.91 111.93 -171.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.484 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 52.1 Cg_endo -69.65 141.9 46.95 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.991 2.461 . . . . 0.28 111.48 173.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.54 -5.13 82.58 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.776 -0.726 . . . . 0.22 112.031 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -93.93 159.61 15.1 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.401 -0.592 . . . . 1.28 109.401 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.5 m -85.02 132.19 34.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.353 -0.61 . . . . 0.17 109.353 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.637 HG12 HD21 ' A' ' 65' ' ' LEU . 6.3 m -135.3 165.2 31.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.162 0.506 . . . . 0.31 109.984 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -120.32 146.08 46.48 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.364 -0.976 . . . . 0.78 108.364 174.227 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.571 ' CD2' HD13 ' A' ' 41' ' ' LEU . 25.3 p90 -152.57 179.19 8.81 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.682 -0.488 . . . . 0.11 109.682 -174.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.4 m -126.83 123.32 37.06 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.877 -0.786 . . . . 0.86 108.877 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 p -92.69 99.49 9.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.666 0.746 . . . . 0.36 111.642 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.7 p -111.7 123.51 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.567 -0.742 . . . . 0.42 109.994 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 30.2 m -72.88 129.02 37.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.911 0.386 . . . . 0.67 110.933 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.415 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.9 OUTLIER -69.37 117.82 11.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 1.82 109.631 177.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -71.36 -15.72 62.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.156 0.503 . . . . 1.95 110.76 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -94.89 -42.28 8.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.703 -0.681 . . . . 3.99 111.095 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -94.97 -29.09 14.82 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.317 -0.401 . . . . 2.21 111.724 -171.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.52 -24.21 26.69 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.69 112.568 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -95.24 155.85 16.56 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.46 -0.57 . . . . 2.42 109.46 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.535 ' H ' HG21 ' A' ' 45' ' ' VAL . 4.4 m -88.08 175.59 7.67 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.094 0.474 . . . . 1.08 111.289 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -141.32 153.08 44.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.692 -0.685 . . . . 0.87 109.376 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.906 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -90.73 119.62 31.11 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.112 0.482 . . . . 0.17 110.044 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 88.6 m -117.01 149.32 40.46 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.321 -0.854 . . . . 0.68 109.921 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 t30 56.87 69.26 0.76 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 123.593 0.558 . . . . 1.82 110.62 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 74.5 t -85.88 122.75 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.632 -0.713 . . . . 0.32 111.708 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.94 147.57 35.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.517 -0.765 . . . . 1.12 110.209 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.455 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -79.4 117.0 19.98 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.942 -0.762 . . . . 1.33 108.942 175.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 72' ' ' GLU . 45.7 mm -101.46 121.55 52.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.116 0.484 . . . . 0.28 110.216 -178.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -90.29 126.62 35.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.595 -0.73 . . . . 2.57 110.495 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 115.401 -0.818 . . . . 3.08 110.857 175.096 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.27 -0.332 . . . . 18.87 112.27 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.47 152.72 49.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.696 0.284 . . . . 17.7 110.63 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -137.69 168.25 20.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.09 -0.504 . . . . 17.44 110.007 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.72 85.91 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.768 -0.73 . . . . 14.34 112.115 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.28 86.78 4.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.73 -0.47 . . . . 13.69 109.73 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.95 118.04 29.22 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.189 -0.671 . . . . 11.39 109.189 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.8 t -77.18 71.33 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.497 0.665 . . . . 8.82 110.537 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.6 p -91.96 85.01 5.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.945 -0.571 . . . . 7.95 110.123 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -89.01 -25.46 21.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.855 -0.611 . . . . 7.07 110.965 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.85 107.2 2.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.562 0.696 . . . . 6.67 110.246 175.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 36.7 mm -140.86 117.26 7.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.4 -0.818 . . . . 2.89 109.463 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.4 -40.78 97.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.314 0.578 . . . . 3.29 110.722 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -81.41 15.02 2.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.857 -1.065 . . . . 2.96 111.733 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.466 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 5.8 t -77.35 -18.22 57.59 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.06 -0.4 . . . . 2.31 110.559 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.72 58.01 0.31 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.217 -0.992 . . . . 1.86 112.353 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -75.16 114.26 13.46 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.063 -0.347 . . . . 5.03 110.063 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.59 -15.92 58.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.263 -0.426 . . . . 2.37 112.002 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.68 -23.98 64.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.534 -0.303 . . . . 2.38 111.4 -176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.2 p -140.07 129.83 24.52 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.375 -0.602 . . . . 2.75 109.375 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.6 p -169.39 164.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 110.361 -0.237 . . . . 1.88 110.361 -175.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -129.83 -176.29 3.88 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.98 -0.748 . . . . 2.71 108.98 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 74' ' ' SER . . . 57.84 23.95 10.28 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.845 0.458 . . . . 1.95 112.191 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t 62.21 71.09 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.734 -0.666 . . . . 1.72 110.78 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? 45.84 32.56 1.31 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.44 1.096 . . . . 2.92 113.921 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -123.12 112.6 17.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.694 0.283 . . . . 1.34 111.087 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -118.37 136.89 53.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.28 0.562 . . . . 2.11 111.308 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -112.75 150.71 31.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.232 -0.894 . . . . 1.27 110.561 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -120.46 127.17 51.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.907 0.385 . . . . 1.65 110.408 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.97 179.87 8.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.802 -0.635 . . . . 0.08 109.529 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 144.52 30.64 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 110.194 -0.299 . . . . 0.14 110.194 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.426 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 47.5 t -66.32 114.0 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.2 -0.296 . . . . 0.14 110.2 176.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.451 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 7.1 t70 -66.95 -50.21 63.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.955 -0.566 . . . . 0.6 109.861 177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.9 m -159.79 163.81 34.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.468 -0.787 . . . . 1.07 110.016 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.445 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 7.7 mt -137.47 126.1 33.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.456 -0.572 . . . . 0.19 109.456 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -118.77 90.45 3.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.256 -0.884 . . . . 1.56 109.862 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.37 -112.1 4.14 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.721 -0.752 . . . . 0.29 112.476 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -96.84 11.69 34.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 2.1 110.246 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -129.71 142.04 50.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.143 0.497 . . . . 0.32 110.751 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.92 155.95 17.27 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.379 -0.828 . . . . 0.11 111.378 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 70.7 m-85 -129.82 139.75 51.17 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.826 -0.805 . . . . 0.18 108.826 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.541 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.4 mt -111.58 156.7 21.37 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.784 -0.45 . . . . 0.59 109.784 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.62 73.25 1.99 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.966 -0.753 . . . . 1.53 108.966 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -149.57 98.43 2.76 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.624 -0.717 . . . . 0.28 109.289 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 23.0 mp0 -75.73 100.71 4.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 1.81 109.712 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.648 HG11 ' HB3' ' A' ' 84' ' ' SER . 35.3 m -74.39 -30.39 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.713 -0.676 . . . . 0.85 111.519 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -156.73 109.79 2.59 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 116.092 -0.504 . . . . 2.24 110.354 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t0 54.52 29.6 11.55 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.185 0.517 . . . . 1.55 112.286 171.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.11 1.49 44.97 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.161 -1.018 . . . . 0.67 113.151 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 4.0 mmtp -64.64 111.77 2.89 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.862 0.331 . . . . 2.5 110.61 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -65.78 138.89 58.23 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.271 0.357 . . . . 1.32 110.181 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.594 ' HG ' ' CG1' ' A' ' 45' ' ' VAL . 1.3 mt -74.68 125.22 28.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.45 -0.341 . . . . 0.19 110.348 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -106.87 157.22 17.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.39 110.064 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.906 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 28.1 p90 -151.05 157.06 42.33 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.596 -0.729 . . . . 0.16 109.394 174.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -98.92 151.01 21.34 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.111 -0.7 . . . . 0.34 109.111 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.441 ' SD ' HG21 ' A' ' 58' ' ' VAL . 9.4 mmt -62.39 -6.94 3.69 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.797 0.665 . . . . 2.43 112.797 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -81.23 -25.28 36.77 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.241 -0.184 . . . . 0.91 111.068 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -81.77 -15.69 53.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.032 0.444 . . . . 1.96 110.157 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.441 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.8 t -62.56 151.84 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.212 -0.904 . . . . 0.27 112.188 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.506 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -64.63 88.96 0.06 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.005 -0.998 . . . . 1.6 112.38 -173.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.37 -66.47 2.28 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.974 -0.557 . . . . 0.58 113.337 170.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -122.31 143.7 49.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.296 0.57 . . . . 2.2 110.264 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.7 p -72.3 -26.64 62.03 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.119 -0.946 . . . . 0.95 110.926 -174.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 t -95.67 22.99 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.753 0.787 . . . . 1.39 109.633 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.9 -15.68 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.598 -0.728 . . . . 0.57 109.765 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.562 HD21 HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -119.49 124.74 47.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.889 -1.05 . . . . 1.51 109.603 -178.028 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -122.99 153.63 64.21 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.682 -0.235 . . . . 0.91 111.235 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.426 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 41.4 Cg_endo -68.47 129.06 18.27 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.523 2.149 . . . . 0.28 111.972 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.58 -14.04 56.51 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.918 -0.583 . . . . 0.22 111.84 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 1.3 m-20 -82.16 154.14 25.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 1.28 110.323 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m -78.71 141.88 37.54 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.298 -0.63 . . . . 0.17 109.298 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.562 HG11 HD21 ' A' ' 65' ' ' LEU . 30.6 m -139.87 161.41 26.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.654 0.74 . . . . 0.31 111.761 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.33 137.51 51.71 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.447 -1.251 . . . . 0.78 108.096 172.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.541 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.8 p90 -149.48 178.55 8.71 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.29 -0.633 . . . . 0.11 109.29 -174.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' A' ' 22' ' ' ALA . 3.7 m -124.29 132.33 53.56 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.09 -0.707 . . . . 0.86 109.09 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.02 99.14 8.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.504 0.668 . . . . 0.36 110.978 -175.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.42 ' HB ' ' CB ' ' A' ' 22' ' ' ALA . 7.5 p -114.46 116.95 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.47 0.653 . . . . 0.42 110.719 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.9 m -69.98 125.96 28.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.703 -0.681 . . . . 0.67 110.483 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.96 114.44 5.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 1.82 109.326 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -58.59 -31.24 67.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.41 -0.359 . . . . 1.95 111.357 -175.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.42 -36.79 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.341 -0.391 . . . . 3.99 111.42 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -92.83 -23.36 18.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.054 0.39 . . . . 2.21 112.054 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.58 -24.57 7.32 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.028 -0.606 . . . . 0.69 113.484 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -88.44 149.94 23.41 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.812 -0.44 . . . . 2.42 109.812 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.648 ' HB3' HG11 ' A' ' 45' ' ' VAL . 42.7 t -85.32 177.59 7.77 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.794 0.331 . . . . 1.08 110.709 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.4 m -150.74 149.96 30.43 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.286 -0.635 . . . . 0.87 109.286 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.906 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -91.94 121.51 33.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.025 0.441 . . . . 0.17 110.614 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.0 m -117.49 144.39 45.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.028 -0.533 . . . . 0.68 109.909 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 57.71 73.11 0.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.743 0.652 . . . . 1.82 110.31 -175.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 94.0 t -92.05 105.01 16.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.568 -0.742 . . . . 0.32 110.308 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 11.1 mp -105.89 149.08 26.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.594 -0.73 . . . . 1.12 110.735 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.41 ' HD3' ' HB3' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -86.18 103.25 14.64 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.907 -0.588 . . . . 1.33 110.795 -174.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.6 mm -85.21 118.54 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.585 -0.734 . . . . 0.28 110.235 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -86.09 110.87 19.83 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.069 -0.514 . . . . 2.57 110.997 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 3.08 109.598 173.947 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 -0.079 0 N-CA-C 112.121 -0.392 . . . . 18.87 112.121 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.37 135.02 33.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.805 0.336 . . . . 17.7 110.747 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -108.92 122.04 46.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.075 -0.511 . . . . 17.44 109.694 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.26 21.5 0.23 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.346 -0.93 . . . . 14.34 112.824 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -87.56 82.53 7.43 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.236 -0.653 . . . . 13.69 109.236 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.0 mt -88.27 107.33 18.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.965 -0.561 . . . . 11.39 110.498 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 t -91.6 80.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.267 0.556 . . . . 8.82 110.905 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 t -101.43 84.91 2.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.008 -0.738 . . . . 7.95 109.008 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -85.44 8.58 18.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.677 -0.692 . . . . 7.07 111.375 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.554 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 1.2 ppt_? -145.42 144.07 30.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.173 0.511 . . . . 6.67 112.081 -172.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.0 mm -110.27 120.91 62.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 107.883 -1.155 . . . . 2.89 107.883 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.504 ' HB2' HD21 ' A' ' 90' ' ' LEU . 72.8 m-20 -63.69 -29.97 71.14 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.583 0.586 . . . . 3.29 112.583 -168.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -80.34 10.28 4.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.717 0.294 . . . . 2.96 111.588 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.1 t -72.52 -12.09 60.93 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.56 0.219 . . . . 2.31 111.163 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.56 58.44 1.0 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.427 -0.892 . . . . 1.86 112.787 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -63.23 100.55 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.825 0.345 . . . . 5.03 110.823 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.59 -21.99 28.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.023 -0.535 . . . . 2.37 110.889 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.52 -21.53 61.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.871 -0.604 . . . . 2.38 111.727 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 53.7 t -159.22 132.63 7.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.802 0.334 . . . . 2.75 110.61 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -168.49 151.4 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.842 -0.617 . . . . 1.88 109.42 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -95.16 44.89 1.09 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.566 0.698 . . . . 2.71 110.341 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -170.72 160.09 6.84 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.368 -0.833 . . . . 1.95 109.211 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.87 82.09 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.73 -0.388 . . . . 1.72 110.146 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 43.16 30.35 0.27 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.522 1.129 . . . . 2.92 113.183 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -115.29 90.17 3.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.993 0.425 . . . . 1.34 110.775 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -109.61 123.72 49.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.02 -0.537 . . . . 2.11 110.558 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -109.08 153.02 24.26 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.625 -0.716 . . . . 1.27 110.687 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -122.85 128.34 50.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.738 0.304 . . . . 1.65 110.303 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.73 179.7 8.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.641 -0.709 . . . . 0.08 109.095 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.74 145.38 29.21 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.761 -0.459 . . . . 0.14 109.761 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.519 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 41.9 t -64.85 114.37 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.159 0.504 . . . . 0.14 109.977 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.475 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 9.9 t70 -67.86 -45.28 75.02 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.858 -1.065 . . . . 0.6 109.747 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.7 m -169.05 166.5 10.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.514 -0.766 . . . . 1.07 109.868 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.415 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 8.3 mt -137.96 128.48 36.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.944 -0.391 . . . . 0.19 109.944 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -115.22 88.02 2.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.686 -0.688 . . . . 1.56 109.856 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.03 -106.99 1.88 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.733 -0.746 . . . . 0.29 112.816 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -96.35 5.34 51.12 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.58 0.228 . . . . 2.1 111.178 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -125.75 140.38 52.74 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.002 0.43 . . . . 0.32 110.368 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.541 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.17 158.28 16.86 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.51 -0.852 . . . . 0.11 111.323 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -132.08 141.12 49.08 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.867 -0.79 . . . . 0.18 108.867 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.551 HD13 ' CD2' ' A' ' 73' ' ' PHE . 4.8 mt -115.09 150.75 35.47 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.427 -0.953 . . . . 0.59 108.427 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -75.21 72.97 2.32 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.272 0.558 . . . . 1.53 109.64 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -142.61 98.07 3.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.156 -0.929 . . . . 0.28 108.57 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 15.4 mp0 -90.23 107.62 19.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.039 -0.528 . . . . 1.81 109.791 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.451 HG11 ' HB2' ' A' ' 84' ' ' SER . 29.2 m -74.62 -32.69 30.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.622 -0.717 . . . . 0.85 111.851 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -156.45 114.06 3.23 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.532 -0.304 . . . . 2.24 110.572 -174.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 51.8 34.06 12.46 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.387 0.884 . . . . 1.55 113.387 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 44' ' ' GLU . . . 89.97 20.34 43.43 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.233 -0.984 . . . . 0.67 112.725 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -79.98 109.16 14.15 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.033 -0.728 . . . . 2.5 109.033 176.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -71.63 138.81 48.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.636 -0.711 . . . . 1.32 110.726 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.497 HD23 ' HA ' ' A' ' 51' ' ' LEU . 4.5 mt -74.89 122.65 23.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.477 -0.329 . . . . 0.19 111.222 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -107.37 161.29 14.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.427 -0.351 . . . . 0.39 110.07 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.735 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 17.1 p90 -152.69 158.77 42.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.132 -0.485 . . . . 0.16 109.741 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.403 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . 9.5 t-160 -99.97 156.05 17.36 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.718 -0.845 . . . . 0.34 108.718 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.448 ' SD ' HG21 ' A' ' 58' ' ' VAL . 13.2 mmt -65.03 3.18 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.257 0.465 . . . . 2.43 112.257 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.3 t -87.39 -28.01 22.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.91 110.127 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' A' ' 54' ' ' HIS . 9.9 mp0 -84.53 -11.01 56.91 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.236 -0.438 . . . . 1.96 110.188 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.473 HG22 HD22 ' A' ' 65' ' ' LEU . 2.4 t -68.38 150.3 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.463 -0.789 . . . . 0.27 111.649 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -58.23 88.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.045 -0.979 . . . . 1.6 111.736 -177.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.11 -91.2 0.03 OUTLIER Glycine 0 CA--C 1.52 0.403 0 O-C-N 123.501 0.501 . . . . 0.58 113.199 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -79.27 129.93 34.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.482 0.658 . . . . 2.2 110.587 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.5 p -80.44 -10.3 59.75 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.062 -0.972 . . . . 0.95 110.963 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.54 -11.12 10.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.529 -0.76 . . . . 1.39 110.234 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.5 -19.11 31.69 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.939 0.4 . . . . 0.57 111.693 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -105.91 124.29 49.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.595 -0.52 . . . . 1.51 109.595 -177.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -123.35 156.21 64.06 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.583 0.23 . . . . 0.91 111.058 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.472 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 47.4 Cg_endo -69.23 129.09 17.51 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.425 2.084 . . . . 0.28 111.477 174.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.519 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 102.5 -13.02 56.85 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.674 -0.775 . . . . 0.22 112.114 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -82.02 152.57 26.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.275 -0.269 . . . . 1.28 110.275 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -76.5 137.81 39.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.051 -0.722 . . . . 0.17 109.051 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -139.13 163.71 26.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.902 0.382 . . . . 0.31 111.216 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.555 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 3.4 pt-20 -114.02 150.56 33.72 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.294 -1.372 . . . . 0.78 107.294 170.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.551 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.3 p90 -156.97 179.85 8.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.192 -0.67 . . . . 0.11 109.192 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.7 m -129.88 113.89 15.21 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.828 -0.805 . . . . 0.86 108.828 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.1 p -86.31 97.76 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 CA-C-O 122.019 0.914 . . . . 0.36 110.488 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -105.68 117.13 50.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.174 -0.921 . . . . 0.42 109.315 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.8 m -73.65 126.53 30.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.333 0.587 . . . . 0.67 110.786 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -69.78 113.76 7.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.0 -1.0 . . . . 1.82 110.001 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -65.52 -16.8 64.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.314 0.578 . . . . 1.95 110.402 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -91.07 -38.19 12.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.58 -0.736 . . . . 3.99 111.584 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -103.44 -26.61 12.81 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.119 0.414 . . . . 2.21 112.119 -171.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.82 -23.21 24.43 Favored Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 121.053 -0.594 . . . . 0.69 112.013 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 49' ' ' LYS . 15.1 pttp -91.28 174.74 7.23 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.27 -0.641 . . . . 2.42 109.27 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.451 ' HB2' HG11 ' A' ' 45' ' ' VAL . 19.0 m -114.28 179.92 3.82 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.741 -0.384 . . . . 1.08 110.643 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.8 m -147.19 147.01 30.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.7 -0.682 . . . . 0.87 109.338 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -86.33 117.38 25.1 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.171 0.51 . . . . 0.17 110.53 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.4 m -116.25 150.04 38.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.579 -0.737 . . . . 0.68 109.407 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.53 ' ND2' HD13 ' A' ' 90' ' ' LEU . 0.2 OUTLIER 61.91 59.17 1.77 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.16 -0.681 . . . . 1.82 109.16 -178.002 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 90.1 t -85.05 101.49 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.854 -0.612 . . . . 0.32 110.147 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.555 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 3.2 mp -106.21 145.99 30.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.242 0.544 . . . . 1.12 111.517 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.84 117.46 17.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.548 -0.751 . . . . 1.33 110.807 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mm -103.76 125.84 58.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.719 -0.673 . . . . 0.28 111.114 -175.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -96.07 133.03 40.81 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.282 -0.872 . . . . 2.57 108.797 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 116.491 -0.322 . . . . 3.08 110.74 -178.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.309 -0.317 . . . . 18.87 112.309 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.34 76.76 1.04 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.066 0.46 . . . . 17.7 110.772 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -139.54 171.57 14.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.834 -0.621 . . . . 17.44 109.605 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.16 -131.61 4.16 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.538 -0.625 . . . . 14.34 111.538 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -110.41 125.29 53.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.936 0.398 . . . . 13.69 110.017 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.3 mt -77.76 -46.53 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.219 0.533 . . . . 11.39 109.824 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.9 p -125.37 121.03 59.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.696 -0.684 . . . . 8.82 109.962 176.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.8 t -78.41 78.28 4.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.397 0.618 . . . . 7.95 109.579 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -151.66 -66.39 0.18 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.443 -0.799 . . . . 7.07 109.309 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.742 ' HD3' ' O ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -91.91 95.0 9.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.027 0.918 . . . . 6.67 110.093 175.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.434 HG22 ' HG2' ' A' ' 13' ' ' GLU . 43.9 mm -106.45 120.55 57.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.706 -0.679 . . . . 2.89 110.132 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.2 -49.2 75.17 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.36 -0.836 . . . . 3.29 111.243 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.746 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 13.3 pt-20 -61.22 -26.91 68.06 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.156 0.503 . . . . 2.96 111.141 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.6 m -70.37 -36.03 73.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.107 -0.497 . . . . 2.31 110.543 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.34 57.46 16.68 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.182 -0.532 . . . . 1.86 113.197 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -68.02 145.39 54.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.77 0.285 . . . . 5.03 110.651 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.81 -17.39 9.09 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.184 0.809 . . . . 2.37 113.184 -172.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.42 -16.64 63.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.605 0.224 . . . . 2.38 111.605 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.6 p -154.43 130.78 10.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.688 0.28 . . . . 2.75 110.657 176.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 p -168.6 150.11 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.986 -0.376 . . . . 1.88 109.986 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -86.64 -57.09 3.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.755 0.312 . . . . 2.71 110.497 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 74' ' ' SER . . . -81.75 176.93 9.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.9 0.381 . . . . 1.95 110.238 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -78.64 84.54 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.123 -0.49 . . . . 1.72 110.137 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.7 37.0 0.66 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.633 1.173 . . . . 2.92 113.436 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.5 tp60 -128.67 104.02 7.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.487 -0.324 . . . . 1.34 110.664 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.34 112.59 20.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.015 0.436 . . . . 2.11 110.426 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -96.05 160.64 14.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.899 -0.592 . . . . 1.27 111.041 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.54 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 71.6 mtm-85 -132.31 127.86 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.033 0.444 . . . . 1.65 111.348 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.72 179.92 8.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.593 -0.73 . . . . 0.08 109.359 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.44 145.07 30.55 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 110.01 -0.367 . . . . 0.14 110.01 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.554 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 47.5 t -65.79 120.41 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 120.923 0.392 . . . . 0.14 109.958 176.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.56 -44.14 68.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.308 -0.86 . . . . 0.6 109.574 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.2 m -173.48 169.25 4.41 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.438 -0.801 . . . . 1.07 109.87 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.7 mt -136.69 135.2 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.945 0.402 . . . . 0.19 110.2 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -123.91 97.38 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.555 -0.748 . . . . 1.56 110.17 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.7 -107.1 1.78 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.819 -0.705 . . . . 0.29 112.405 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -98.67 4.07 47.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.568 0.223 . . . . 2.1 110.771 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -123.71 141.14 52.3 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 120.468 -0.493 . . . . 0.32 111.16 -171.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.41 156.08 18.39 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 120.579 -0.82 . . . . 0.11 111.319 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 74.3 m-85 -130.16 141.47 50.67 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.179 -0.675 . . . . 0.18 109.179 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.518 HD13 ' CD2' ' A' ' 73' ' ' PHE . 5.5 mt -112.09 156.17 22.67 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.739 -0.467 . . . . 0.59 109.739 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -78.26 72.83 4.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.566 0.698 . . . . 1.53 109.677 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.467 ' HB3' HD12 ' A' ' 51' ' ' LEU . 25.2 t80 -142.59 98.57 3.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.797 -1.092 . . . . 0.28 108.186 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 41.8 mt-10 -93.16 104.34 16.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.35 0.595 . . . . 1.81 110.928 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.2 m -72.74 -34.13 46.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.407 -0.815 . . . . 0.85 111.529 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 5.6 tt0 -155.05 118.34 4.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.631 -0.259 . . . . 2.24 110.756 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.9 t70 56.11 29.48 14.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.524 0.678 . . . . 1.55 112.162 167.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.416 ' HA2' ' CD ' ' A' ' 44' ' ' GLU . . . 88.5 24.5 33.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.149 -1.024 . . . . 0.67 112.873 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 12.5 mmtm -71.71 109.81 5.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.917 -0.771 . . . . 2.5 108.917 172.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -77.97 121.53 24.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.24 -0.436 . . . . 1.32 109.97 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.467 HD12 ' HB3' ' A' ' 43' ' ' PHE . 2.5 mt -58.83 123.93 18.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.945 -0.571 . . . . 0.19 110.912 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -106.12 157.46 17.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.93 0.395 . . . . 0.39 110.701 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.936 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 35.7 p90 -151.2 153.79 35.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.718 -0.674 . . . . 0.16 109.277 173.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -95.3 150.66 20.01 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.441 -0.948 . . . . 0.34 108.441 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.7 mtt -64.66 2.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.317 0.488 . . . . 2.43 112.317 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 t -83.71 -27.09 29.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.897 -0.408 . . . . 0.91 109.897 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.32 -8.03 58.69 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.979 0.419 . . . . 1.96 110.203 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 65' ' ' LEU . 2.1 t -65.63 152.21 9.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.354 -0.839 . . . . 0.27 112.709 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 12.9 tm0? -66.62 95.15 0.32 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.166 -0.924 . . . . 1.6 112.299 -175.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.87 -81.43 0.54 Allowed Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.939 -0.573 . . . . 0.58 113.461 172.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -107.7 148.2 29.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.896 0.379 . . . . 2.2 110.294 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.8 p -67.48 -24.77 65.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.869 -0.605 . . . . 0.95 110.832 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.5 t -93.18 3.42 8.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.787 -0.642 . . . . 1.39 110.637 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -87.79 -24.07 23.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.018 0.437 . . . . 0.57 110.709 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.711 HD22 ' HG2' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -105.67 124.74 50.05 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.842 -0.799 . . . . 1.51 108.842 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -119.99 149.78 49.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.668 -0.242 . . . . 0.91 110.892 -173.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.425 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 36.9 Cg_endo -67.34 122.0 9.2 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.33 2.02 . . . . 0.28 111.358 172.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.554 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 102.58 -11.42 56.5 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.779 -0.724 . . . . 0.22 112.203 -176.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.5 155.28 22.24 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.912 -0.403 . . . . 1.28 109.912 175.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.4 m -78.77 141.72 37.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.218 -0.66 . . . . 0.17 109.218 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.665 HG11 HD11 ' A' ' 65' ' ' LEU . 6.2 m -136.92 165.7 27.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.842 0.83 . . . . 0.31 111.251 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.746 ' OE1' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -121.51 144.05 48.92 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.216 -1.356 . . . . 0.78 107.988 171.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.518 ' CD2' HD13 ' A' ' 41' ' ' LEU . 23.0 p90 -154.04 178.99 9.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.868 -0.419 . . . . 0.11 109.868 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.465 ' HB3' ' HB3' ' A' ' 22' ' ' ALA . 18.1 m -127.43 118.15 23.51 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.883 -0.784 . . . . 0.86 108.883 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.3 p -82.95 98.97 5.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 122.072 0.939 . . . . 0.36 110.777 -175.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.9 122.86 64.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.152 -0.931 . . . . 0.42 109.863 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.4 m -76.53 130.34 37.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.987 -0.552 . . . . 0.67 111.022 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -73.98 106.55 5.72 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.994 -0.743 . . . . 1.82 108.994 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -64.65 -15.39 61.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.639 0.256 . . . . 1.95 111.681 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.547 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 4.3 tpm_? -90.83 -43.84 9.79 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.675 0.25 . . . . 3.99 111.675 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.488 ' OD1' ' HG2' ' A' ' 83' ' ' LYS . 22.6 t-20 -95.28 -31.97 13.21 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.803 -0.359 . . . . 2.21 111.18 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.42 -21.01 40.59 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.126 -0.559 . . . . 0.69 113.014 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.488 ' HG2' ' OD1' ' A' ' 81' ' ' ASN . 58.7 pttt -91.32 171.16 9.41 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 109.455 -0.572 . . . . 2.42 109.455 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.7 m -108.93 176.16 5.2 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.606 -0.438 . . . . 1.08 111.396 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.1 p -145.83 154.78 42.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.621 . . . . 0.87 109.881 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.936 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -93.27 117.46 30.1 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.273 0.558 . . . . 0.17 110.417 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.4 m -117.26 145.18 44.12 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.741 -0.663 . . . . 0.68 109.602 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.13 71.33 0.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.427 0.632 . . . . 1.82 109.777 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 80.2 t -89.8 121.81 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.077 -0.965 . . . . 0.32 111.223 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.513 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 4.3 mm? -112.26 148.37 34.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.79 -0.641 . . . . 1.12 109.916 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.711 ' HG2' HD22 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -87.51 118.18 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.155 -0.683 . . . . 1.33 109.155 177.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.0 mm -104.75 131.1 54.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.275 -0.875 . . . . 0.28 110.781 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -81.0 117.1 21.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.21 -0.45 . . . . 2.57 110.021 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.394 -0.821 . . . . 3.08 111.415 -179.664 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.103 0 N-CA-C 112.282 -0.327 . . . . 18.87 112.282 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.84 164.24 33.8 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.01 -0.367 . . . . 17.7 110.01 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -93.14 110.79 22.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.055 0.455 . . . . 17.44 110.087 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.4 42.34 1.94 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.742 -0.742 . . . . 14.34 112.348 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.08 160.74 23.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.12 0.485 . . . . 13.69 110.897 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.1 mt -102.54 163.12 12.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.519 . . . . 11.39 110.976 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.7 p -111.78 119.93 61.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.084 -0.507 . . . . 8.82 110.041 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.5 p -74.01 88.49 1.88 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.116 0.484 . . . . 7.95 110.569 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -161.21 -47.17 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.776 -0.647 . . . . 7.07 110.634 -174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.05 103.67 7.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.133 0.492 . . . . 6.67 111.274 -176.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.444 HG22 ' HG3' ' A' ' 13' ' ' GLU . 26.1 mm -123.94 143.23 37.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.251 -0.648 . . . . 2.89 109.251 177.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -70.11 -44.22 69.43 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.327 0.492 . . . . 3.29 112.327 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' HG3' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -66.58 -10.74 48.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.36 0.6 . . . . 2.96 111.309 -177.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.4 m -77.36 -13.46 59.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 2.31 111.291 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.78 58.3 0.6 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.537 -0.839 . . . . 1.86 112.073 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -89.16 100.93 13.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.134 0.493 . . . . 5.03 111.437 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.17 -17.22 37.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.781 -0.645 . . . . 2.37 110.541 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.96 -25.43 64.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.795 -0.638 . . . . 2.38 112.051 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.2 t -152.43 130.99 12.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.885 0.374 . . . . 2.75 110.715 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -168.81 131.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.759 -0.655 . . . . 1.88 109.326 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -73.99 -27.3 60.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 2.71 111.43 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.81 175.59 5.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.199 -0.455 . . . . 1.95 110.247 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -81.62 78.45 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.983 -0.377 . . . . 1.72 109.983 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? 44.29 26.39 0.16 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.409 1.084 . . . . 2.92 113.06 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -105.46 92.24 4.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.891 0.376 . . . . 1.34 110.506 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -104.54 122.66 46.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.126 0.488 . . . . 2.11 110.312 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 72.0 mmtt -100.43 144.8 29.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.652 -0.704 . . . . 1.27 110.78 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.522 ' HE ' ' HB2' ' A' ' 72' ' ' GLU . 9.5 mmt85 -112.77 128.37 56.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.204 -0.453 . . . . 1.65 110.056 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . . . -159.04 179.98 8.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.84 -0.43 . . . . 0.08 109.84 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.76 147.4 28.64 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.289 -0.263 . . . . 0.14 110.289 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.458 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 38.5 t -66.42 113.83 3.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.199 0.523 . . . . 0.14 109.824 174.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.41 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 20.7 t70 -72.5 -44.36 62.35 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.053 -0.976 . . . . 0.6 109.615 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.3 m -164.28 166.86 20.52 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.805 -0.634 . . . . 1.07 110.562 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.447 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 5.3 mt -139.76 134.52 38.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.168 0.508 . . . . 0.19 109.942 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -127.53 91.88 3.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.423 -0.808 . . . . 1.56 110.313 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.51 -106.66 1.81 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.721 -0.752 . . . . 0.29 112.786 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -98.27 6.43 47.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.611 0.243 . . . . 2.1 110.363 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -128.47 140.85 51.61 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.125 0.488 . . . . 0.32 110.72 -173.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.519 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.67 158.73 15.56 Favored Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.313 -0.858 . . . . 0.11 111.148 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 80.7 m-85 -131.86 131.41 42.77 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.79 -0.819 . . . . 0.18 108.79 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.554 HD22 HG21 ' A' ' 71' ' ' VAL . 9.6 mt -103.93 153.49 20.74 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.573 -0.529 . . . . 0.59 109.573 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -76.32 73.4 3.1 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.995 -0.743 . . . . 1.53 108.995 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.423 ' HB3' HD12 ' A' ' 51' ' ' LEU . 28.0 t80 -150.1 98.68 2.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.735 -1.121 . . . . 0.28 109.091 -178.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.503 ' HG2' ' HA2' ' A' ' 48' ' ' GLY . 3.3 mp0 -82.12 100.75 9.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.452 -0.795 . . . . 1.81 109.978 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.631 HG11 ' HB3' ' A' ' 84' ' ' SER . 7.4 m -71.36 -39.37 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.422 -0.808 . . . . 0.85 111.978 -176.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' H ' ' HB2' ' A' ' 49' ' ' LYS . 5.9 tp10 -140.44 101.57 4.14 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.881 0.372 . . . . 2.24 111.0 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 t70 58.92 20.17 7.84 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.565 -0.743 . . . . 1.55 112.927 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.503 ' HA2' ' HG2' ' A' ' 44' ' ' GLU . . . 111.43 11.73 16.89 Favored Glycine 0 C--N 1.315 -0.589 0 C-N-CA 119.976 -1.107 . . . . 0.67 112.737 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.505 ' HB2' ' H ' ' A' ' 46' ' ' GLU . 23.3 mmtm -69.72 110.63 5.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.344 -0.613 . . . . 2.5 109.344 173.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -70.55 132.19 45.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.878 -0.416 . . . . 1.32 109.878 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 3.0 mt -71.85 122.02 20.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.423 -0.353 . . . . 0.19 111.098 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -105.07 157.56 17.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.286 -0.416 . . . . 0.39 109.955 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.875 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 26.6 p90 -151.44 153.35 34.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.903 -0.59 . . . . 0.16 109.518 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.401 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . 16.6 t-80 -96.58 152.22 18.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.962 -0.755 . . . . 0.34 108.962 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.571 ' SD ' HG21 ' A' ' 58' ' ' VAL . 15.5 mmt -65.14 -1.66 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.417 0.525 . . . . 2.43 112.417 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.8 t -84.92 -19.47 32.17 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.08 -0.387 . . . . 0.91 110.209 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.401 ' OE2' ' HB3' ' A' ' 54' ' ' HIS . 1.8 mp0 -90.03 -6.03 55.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.313 -0.403 . . . . 1.96 110.326 176.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.571 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -71.42 150.11 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.786 0.661 . . . . 0.27 112.786 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.42 93.5 0.07 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.87 -1.059 . . . . 1.6 112.128 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.99 -66.38 3.41 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 121.201 -0.523 . . . . 0.58 113.969 169.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -131.27 141.86 50.05 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.19 0.519 . . . . 2.2 110.018 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.8 p -70.87 -23.58 62.34 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.129 -0.941 . . . . 0.95 110.89 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.6 t -93.47 12.07 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 115.252 -0.885 . . . . 1.39 110.075 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.75 -38.0 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.484 -0.326 . . . . 0.57 111.226 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.661 HD21 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -90.17 124.99 35.3 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.158 -0.682 . . . . 1.51 109.158 -178.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -132.15 160.88 66.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.415 -0.357 . . . . 0.91 111.211 -173.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.458 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 27.0 Cg_endo -62.38 140.81 84.49 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.592 2.195 . . . . 0.28 111.887 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.26 -14.36 63.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.075 -0.583 . . . . 0.22 112.468 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.408 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 2.7 m-20 -79.0 148.69 32.44 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.981 -0.378 . . . . 1.28 109.981 174.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 5.5 m -81.67 140.27 34.45 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.821 -0.807 . . . . 0.17 108.821 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.661 HG12 HD21 ' A' ' 65' ' ' LEU . 34.4 m -135.5 157.24 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.962 0.887 . . . . 0.31 111.351 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.522 ' HB2' ' HE ' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -114.74 132.25 56.5 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.856 -1.52 . . . . 0.78 107.688 171.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.501 ' CD2' HD13 ' A' ' 41' ' ' LEU . 20.1 p90 -143.25 179.54 7.01 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.639 -0.504 . . . . 0.11 109.639 -175.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.6 m -127.1 121.46 31.52 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.957 -0.757 . . . . 0.86 108.957 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 p -81.22 98.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.701 0.762 . . . . 0.36 110.593 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.55 120.53 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.717 -0.674 . . . . 0.42 110.45 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.7 m -68.78 133.0 47.73 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.736 -0.666 . . . . 0.67 111.279 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -71.05 105.23 3.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.736 -0.839 . . . . 1.82 108.736 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -63.93 -13.25 44.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.287 -0.415 . . . . 1.95 112.046 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -96.0 -36.8 10.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.472 -0.331 . . . . 3.99 111.563 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -107.38 -31.41 8.19 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.363 0.505 . . . . 2.21 112.363 -169.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.91 -21.24 38.8 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.236 -0.983 . . . . 0.69 113.663 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -85.33 175.46 8.89 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.287 -0.635 . . . . 2.42 109.287 177.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.631 ' HB3' HG11 ' A' ' 45' ' ' VAL . 19.6 t -117.43 -178.15 3.39 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.587 -0.445 . . . . 1.08 110.981 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.0 p -156.79 152.99 27.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.908 -0.587 . . . . 0.87 109.942 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.875 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -86.73 118.4 26.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.939 0.4 . . . . 0.17 110.627 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 33.9 m -116.74 140.86 48.94 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.269 -0.423 . . . . 0.68 109.916 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 63.39 72.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.622 0.725 . . . . 1.82 109.237 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 54.5 t -87.98 116.8 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.803 -1.09 . . . . 0.32 110.505 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 4.1 mm? -108.47 148.91 29.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.03 -0.532 . . . . 1.12 110.523 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.505 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -81.56 125.4 30.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.267 -0.642 . . . . 1.33 109.267 173.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.465 ' O ' ' HB ' ' A' ' 70' ' ' THR . 40.1 mm -117.38 137.86 49.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.12 -0.491 . . . . 0.28 111.037 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -103.38 120.0 39.96 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.275 -1.009 . . . . 2.57 108.275 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.2 t0 . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 116.569 -0.287 . . . . 3.08 110.51 -174.537 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.147 -0.381 . . . . 18.87 112.147 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.98 149.16 26.95 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.794 -0.203 . . . . 17.7 110.504 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? 61.58 35.38 17.33 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.536 0.684 . . . . 17.44 110.791 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.23 41.89 2.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.905 -0.664 . . . . 14.34 111.996 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -86.77 -179.11 6.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.9 0.381 . . . . 13.69 110.643 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.409 ' HA ' HH11 ' A' ' 16' ' ' ARG . 89.3 mt -88.08 64.57 7.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.985 0.421 . . . . 11.39 110.597 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.74 100.66 3.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.027 -0.533 . . . . 8.82 110.71 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 p -87.76 81.15 7.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.286 0.565 . . . . 7.95 109.718 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.412 ' H ' ' H ' ' A' ' 10' ' ' ARG . 87.9 t80 -177.86 9.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.098 -0.955 . . . . 7.07 109.235 -173.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.412 ' H ' ' H ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -142.33 -70.65 0.34 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.102 -0.499 . . . . 6.67 110.614 -170.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 10' ' ' ARG . 4.3 mp -120.94 97.33 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 C-N-CA 120.558 -0.457 . . . . 2.89 109.8 171.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.443 ' HA ' ' HG2' ' A' ' 16' ' ' ARG . 3.1 m-20 -102.07 -18.06 15.76 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.626 -0.715 . . . . 3.29 111.211 -176.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -4.15 15.08 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.69 0.757 . . . . 2.96 110.669 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.4 m -93.54 -8.41 41.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.242 -0.89 . . . . 2.31 111.201 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.31 59.01 0.69 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 119.923 -1.132 . . . . 1.86 113.894 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.443 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 27.1 mmt180 -89.01 113.22 24.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 117.284 0.542 . . . . 5.03 110.102 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.36 -15.51 57.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.071 -0.513 . . . . 2.37 111.951 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.07 -14.98 62.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.419 -0.355 . . . . 2.38 111.61 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.9 t -136.21 130.38 33.04 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.217 -1.031 . . . . 2.75 108.217 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.1 p -168.81 142.46 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.767 0.318 . . . . 1.88 111.016 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -116.41 -51.85 2.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.128 0.49 . . . . 2.71 109.715 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' A' ' 74' ' ' SER . . . -97.55 123.63 41.5 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.996 -0.372 . . . . 1.95 109.996 176.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.461 HG12 ' HG3' ' A' ' 24' ' ' ARG . 20.4 t -60.8 108.9 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.929 -0.578 . . . . 1.72 111.773 -174.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HG3' HG12 ' A' ' 23' ' ' VAL . 0.1 OUTLIER 44.17 25.93 0.13 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.933 1.293 . . . . 2.92 113.966 178.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 5.5 tp60 -115.82 75.72 0.97 Allowed 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.999 -0.438 . . . . 1.34 110.99 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -96.24 126.14 41.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.691 -0.485 . . . . 2.11 109.691 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 12.9 mmtm -113.3 145.5 40.94 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.775 -0.648 . . . . 1.27 110.28 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -116.89 132.49 56.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.94 0.4 . . . . 1.65 110.696 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.73 179.84 8.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.802 -0.636 . . . . 0.08 109.787 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.8 144.15 31.87 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.206 -0.452 . . . . 0.14 110.023 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.487 ' HA ' HD23 ' A' ' 41' ' ' LEU . 61.3 t -67.2 116.34 6.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.133 0.492 . . . . 0.14 110.463 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.434 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 10.6 t70 -67.69 -51.79 45.49 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.08 -0.963 . . . . 0.6 109.636 177.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.7 m -159.41 166.76 30.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.893 -0.594 . . . . 1.07 110.564 -175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.432 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 6.0 mt -142.55 132.39 22.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.876 -0.602 . . . . 0.19 110.07 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -126.76 93.84 3.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.623 -0.717 . . . . 1.56 110.641 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.85 -106.43 1.64 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.73 -0.748 . . . . 0.29 112.393 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -99.02 7.65 45.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.633 0.254 . . . . 2.1 110.687 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -126.79 143.34 51.28 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.279 0.562 . . . . 0.32 111.469 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.18 161.95 21.97 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.713 -0.756 . . . . 0.11 111.52 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 70.7 m-85 -136.96 143.35 42.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.174 -0.676 . . . . 0.18 109.174 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.5 mt -117.81 156.53 28.19 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.335 -0.246 . . . . 0.59 110.335 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -74.85 72.81 2.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.35 0.595 . . . . 1.53 109.729 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -146.53 100.79 3.4 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.107 -0.951 . . . . 0.28 109.284 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -81.56 106.03 13.19 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.271 -0.877 . . . . 1.81 110.062 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.1 t -71.01 -66.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.522 -0.763 . . . . 0.85 111.194 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.66 ' H ' ' HB2' ' A' ' 49' ' ' LYS . 1.0 OUTLIER -133.71 116.29 15.6 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.081 -0.963 . . . . 2.24 109.49 -178.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 t70 64.18 19.17 11.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.466 0.651 . . . . 1.55 111.637 171.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.35 21.4 13.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.557 -0.83 . . . . 0.67 112.841 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.66 ' HB2' ' H ' ' A' ' 46' ' ' GLU . 27.6 mmtm -65.09 109.97 2.35 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.443 -0.577 . . . . 2.5 109.443 175.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -72.3 118.62 15.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.098 -0.705 . . . . 1.32 109.098 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.1 mt -60.38 125.2 22.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.417 -0.356 . . . . 0.19 111.506 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -106.44 157.29 17.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.138 -0.483 . . . . 0.39 109.916 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.782 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 27.0 p90 -148.86 154.66 39.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.68 -0.691 . . . . 0.16 109.178 173.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -98.32 151.87 20.05 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.619 -0.882 . . . . 0.34 108.619 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.594 ' HB3' HG22 ' A' ' 62' ' ' THR . 14.3 mmt -61.03 -12.44 11.71 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.37 0.507 . . . . 2.43 112.37 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.9 m -72.48 -25.39 61.41 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.192 -0.318 . . . . 0.91 110.82 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.45 -13.74 51.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 1.96 110.71 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.576 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.0 t -64.04 152.31 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 112.861 0.689 . . . . 0.27 112.861 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -62.77 95.79 0.08 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.948 -1.024 . . . . 1.6 112.173 -176.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.47 -81.62 0.6 Allowed Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.58 113.288 172.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -110.92 143.6 41.29 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.677 -0.49 . . . . 2.2 109.677 -177.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 ' HB3' ' A' ' 55' ' ' MET . 66.6 p -57.9 -42.69 85.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.127 0.489 . . . . 0.95 111.873 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 63' ' ' VAL . 2.6 m -78.94 4.7 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.952 -0.567 . . . . 1.39 112.477 -177.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.5 -9.78 40.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.69 0.281 . . . . 0.57 111.21 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.732 HD21 HG12 ' A' ' 71' ' ' VAL . 1.6 tm? -115.9 125.46 52.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.915 -0.772 . . . . 1.51 108.915 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 45.4 m-70 -120.33 149.78 50.35 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-O 120.579 0.228 . . . . 0.91 111.065 -171.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.461 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 37.0 Cg_endo -66.04 139.52 56.4 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.655 2.237 . . . . 0.28 111.881 174.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.67 -15.48 61.46 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.921 -0.657 . . . . 0.22 111.999 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -82.7 149.75 27.13 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.39 -0.226 . . . . 1.28 110.39 177.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.1 m -76.22 137.85 40.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.199 -0.667 . . . . 0.17 109.199 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.732 HG12 HD21 ' A' ' 65' ' ' LEU . 16.1 m -136.07 157.51 38.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.525 0.678 . . . . 0.31 109.98 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 132.07 56.59 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.203 -1.036 . . . . 0.78 108.203 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.514 ' CD2' HD13 ' A' ' 41' ' ' LEU . 36.7 p90 -141.93 179.15 7.04 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.855 -0.611 . . . . 0.11 109.889 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.648 ' HB3' ' HB3' ' A' ' 22' ' ' ALA . 25.0 m -128.63 119.69 25.19 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.917 -0.772 . . . . 0.86 108.917 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 75' ' ' VAL . 8.5 p -91.4 108.38 19.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.767 0.794 . . . . 0.36 111.269 -172.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 84' ' ' SER . 6.8 p -116.0 124.42 72.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.533 -0.758 . . . . 0.42 110.061 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.2 m -83.35 127.03 33.33 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.173 0.511 . . . . 0.67 110.611 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.595 ' CB ' ' HB3' ' A' ' 81' ' ' ASN . 9.2 m120 -70.45 121.29 17.49 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.518 -0.764 . . . . 1.82 109.765 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -73.78 -21.46 60.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.942 0.401 . . . . 1.95 111.222 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -96.09 -33.67 12.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.023 0.439 . . . . 3.99 110.979 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.595 ' HB3' ' CB ' ' A' ' 78' ' ' ASN . 60.4 t30 -97.05 -18.23 19.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.331 0.586 . . . . 2.21 110.788 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.99 -25.96 2.96 Favored Glycine 0 C--O 1.229 -0.175 0 CA-C-N 115.525 -0.761 . . . . 0.69 113.919 174.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.492 ' HE2' HD21 ' A' ' 81' ' ' ASN . 18.5 pttm -99.62 168.47 9.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.22 0.51 . . . . 2.42 111.358 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 69.5 m -102.34 175.45 5.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.561 -0.745 . . . . 1.08 111.64 -175.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -143.69 156.39 44.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.566 -0.743 . . . . 0.87 109.157 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.782 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -99.47 118.59 36.4 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 110.029 -0.36 . . . . 0.17 110.029 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.2 m -116.56 148.33 40.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.437 -0.347 . . . . 0.68 110.664 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.2 m120 62.06 52.09 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.646 0.591 . . . . 1.82 109.881 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.468 ' HB ' ' HA ' ' A' ' 58' ' ' VAL . 77.2 t -72.89 100.62 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.473 -0.785 . . . . 0.32 110.81 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 8.0 mp -102.84 148.31 25.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.641 -0.709 . . . . 1.12 110.95 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.485 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -77.17 127.95 33.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.014 -0.539 . . . . 1.33 110.006 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.1 mm -115.86 134.24 59.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.301 -0.409 . . . . 0.28 110.267 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -109.87 119.93 40.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.503 -0.317 . . . . 2.57 111.758 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--O 1.235 0.342 0 CA-C-N 115.39 -0.823 . . . . 3.08 109.549 170.922 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.515 -0.234 . . . . 18.87 112.515 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.85 107.08 13.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.982 0.42 . . . . 17.7 110.337 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -89.29 41.42 1.03 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.556 0.693 . . . . 17.44 109.564 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.15 77.72 0.28 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.493 -0.776 . . . . 14.34 113.454 -173.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -132.84 138.0 46.91 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.525 -0.917 . . . . 13.69 108.525 170.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 mp -67.31 117.99 10.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.378 0.609 . . . . 11.39 111.079 -174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.8 m -91.85 144.41 9.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.145 -0.934 . . . . 8.82 110.688 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.3 p -74.99 11.17 1.17 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.086 -0.506 . . . . 7.95 111.265 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -82.59 -30.87 29.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.105 -0.498 . . . . 7.07 111.239 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.46 21.2 8.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.957 0.354 . . . . 6.67 111.957 -173.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 14' ' ' SER . 38.9 mm -86.22 149.58 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.753 0.311 . . . . 2.89 110.172 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.468 ' HA ' ' CG ' ' A' ' 16' ' ' ARG . 4.5 m-20 -57.8 -49.41 76.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.12 -0.491 . . . . 3.29 111.839 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.428 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 10.3 pt-20 -59.76 -25.55 64.98 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.248 -0.433 . . . . 2.96 111.287 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 11' ' ' ILE . 42.9 m -65.52 -24.0 67.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.017 -0.538 . . . . 2.31 111.22 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.31 58.17 0.3 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.412 -0.899 . . . . 1.86 112.639 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.468 ' CG ' ' HA ' ' A' ' 12' ' ' ASP . 21.0 mmm180 -67.59 99.03 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.879 0.371 . . . . 5.03 110.539 176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.81 -17.48 35.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.946 -0.57 . . . . 2.37 111.089 176.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.95 -37.7 79.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.113 -0.494 . . . . 2.38 111.039 -175.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.0 m -124.44 130.87 53.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.799 -0.815 . . . . 2.75 108.799 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -162.27 150.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.859 0.361 . . . . 1.88 110.96 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.497 HD22 ' HB3' ' A' ' 87' ' ' CYS . 94.1 m-20 -108.39 -49.81 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.927 0.394 . . . . 2.71 110.636 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.13 161.78 16.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.377 -0.374 . . . . 1.95 110.037 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.404 ' C ' ' HG3' ' A' ' 24' ' ' ARG . 22.7 t -76.02 84.55 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 121.155 -0.218 . . . . 1.72 110.942 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.404 ' HG3' ' C ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER 45.9 23.6 0.18 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.695 1.198 . . . . 2.92 113.452 177.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 6.5 tp60 -106.81 84.92 2.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.984 0.421 . . . . 1.34 110.912 -176.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -93.91 135.02 35.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.117 -0.492 . . . . 2.11 110.105 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 16.1 mmtm -118.84 147.33 44.05 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.764 -0.653 . . . . 1.27 109.781 174.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.404 ' CD ' ' HB2' ' A' ' 72' ' ' GLU . 16.7 mtm180 -122.94 132.19 54.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.019 0.438 . . . . 1.65 110.617 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.78 179.75 8.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.454 -0.794 . . . . 0.08 109.623 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.53 144.47 31.37 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.07 -0.344 . . . . 0.14 110.07 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.479 ' HA ' HD23 ' A' ' 41' ' ' LEU . 43.7 t -64.27 124.24 18.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.932 0.396 . . . . 0.14 110.383 176.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.72 -48.44 13.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.725 -0.67 . . . . 0.6 109.988 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 m -158.48 166.06 33.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.649 -0.705 . . . . 1.07 110.057 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.407 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 5.3 mt -140.9 126.89 19.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.033 0.444 . . . . 0.19 109.987 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -114.13 86.68 2.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.417 -0.81 . . . . 1.56 110.257 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.71 -106.28 1.43 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.606 -0.807 . . . . 0.29 112.899 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -93.28 4.66 53.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.562 0.22 . . . . 2.1 111.263 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -126.98 140.33 52.39 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.038 0.447 . . . . 0.32 110.614 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.29 161.0 14.72 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.422 -0.894 . . . . 0.11 111.422 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 84.1 m-85 -132.88 137.08 46.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.496 -0.557 . . . . 0.18 109.496 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.541 HD13 ' CD2' ' A' ' 73' ' ' PHE . 4.7 mt -114.6 154.49 28.24 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.539 -0.541 . . . . 0.59 109.539 -177.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.505 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 65.1 t30 -78.03 73.65 4.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.621 0.724 . . . . 1.53 109.821 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -140.53 106.35 5.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.761 -1.108 . . . . 0.28 108.442 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -94.63 105.33 17.27 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.427 0.632 . . . . 1.81 110.814 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 84' ' ' SER . 38.9 t -77.66 -77.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.797 -1.092 . . . . 0.85 111.788 -173.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 10.1 tt0 -111.75 111.37 22.3 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.392 -0.822 . . . . 2.24 110.479 -173.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.9 t70 61.22 22.5 12.83 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.459 0.647 . . . . 1.55 111.714 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.36 27.84 8.95 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.317 -0.944 . . . . 0.67 112.669 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 27.4 mmmt -77.92 110.93 13.25 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.153 -0.684 . . . . 2.5 109.153 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.505 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 9.3 tppt? -75.56 126.15 30.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.134 -0.691 . . . . 1.32 109.134 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 51' ' ' LEU . 4.5 mt -62.6 130.24 44.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.404 0.52 . . . . 0.19 112.404 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -111.62 159.31 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.659 -0.7 . . . . 0.39 109.216 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.931 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 32.7 p90 -149.41 149.78 31.37 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.705 -0.479 . . . . 0.16 109.705 176.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -90.32 149.68 22.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.068 -0.716 . . . . 0.34 109.068 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -0.93 0.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.249 0.463 . . . . 2.43 112.249 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.6 t -71.32 -32.18 68.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.076 0.465 . . . . 0.91 110.045 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -86.65 -10.55 53.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.87 -0.605 . . . . 1.96 110.956 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.26 145.14 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.467 0.651 . . . . 0.27 112.417 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.533 ' HG3' ' H ' ' A' ' 91' ' ' LYS . 0.9 OUTLIER -66.1 110.12 2.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.578 -1.192 . . . . 1.6 111.79 -175.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.66 -93.14 0.72 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.035 -0.602 . . . . 0.58 113.083 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.54 155.99 23.41 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.231 -0.285 . . . . 2.2 110.231 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.3 p -61.56 -32.04 72.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.157 -0.474 . . . . 0.95 111.35 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.39 17.62 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.283 0.563 . . . . 1.39 110.61 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.58 2.04 27.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.183 0.516 . . . . 0.57 111.179 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.649 HD21 HG12 ' A' ' 71' ' ' VAL . 1.8 tm? -129.25 125.63 37.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.344 -0.984 . . . . 1.51 108.344 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -122.8 154.02 63.69 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 111.685 0.254 . . . . 0.91 111.685 -171.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.463 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.4 Cg_endo -68.07 134.81 32.85 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.8 2.333 . . . . 0.28 112.369 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.87 -4.73 72.14 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.692 -0.766 . . . . 0.22 111.98 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -95.7 155.25 16.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.594 -0.521 . . . . 1.28 109.594 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -83.47 132.07 34.98 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.62 -0.511 . . . . 0.17 109.62 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.649 HG12 HD21 ' A' ' 65' ' ' LEU . 4.3 m -134.26 160.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.787 0.803 . . . . 0.31 110.84 -176.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -119.12 138.8 52.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.359 -1.291 . . . . 0.78 108.911 177.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.541 ' CD2' HD13 ' A' ' 41' ' ' LEU . 36.5 p90 -150.81 180.0 7.75 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.935 -0.575 . . . . 0.11 109.854 -173.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.1 m -127.41 131.49 50.28 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.913 -0.773 . . . . 0.86 108.913 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.432 HG23 ' OG ' ' A' ' 84' ' ' SER . 3.5 p -91.35 98.11 8.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-O 121.985 0.898 . . . . 0.36 110.436 -175.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.5 p -102.53 114.36 41.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.193 -0.912 . . . . 0.42 110.241 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.2 m -80.15 127.14 31.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.853 -0.612 . . . . 0.67 110.922 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.97 104.3 2.49 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.019 -0.734 . . . . 1.82 109.019 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -57.23 -26.98 61.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.843 0.354 . . . . 1.95 111.652 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.456 ' HE ' ' HA ' ' A' ' 80' ' ' ARG . 5.1 tpm_? -84.41 -41.35 16.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.347 -0.388 . . . . 3.99 111.599 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -95.05 -30.71 13.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.221 0.452 . . . . 2.21 112.221 -170.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.89 -24.16 32.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.078 -0.582 . . . . 0.69 112.907 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -86.75 175.88 8.02 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.661 -0.317 . . . . 2.42 110.495 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.468 ' HB3' HG21 ' A' ' 45' ' ' VAL . 32.7 t -116.95 -179.23 3.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.104 0.478 . . . . 1.08 110.969 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 m -149.56 147.84 28.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.317 -0.994 . . . . 0.87 108.317 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.931 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -86.97 121.63 29.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.867 0.365 . . . . 0.17 110.653 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.497 ' HB3' HD22 ' A' ' 21' ' ' ASN . 68.4 m -117.33 144.59 44.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.857 -0.611 . . . . 0.68 110.359 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.45 70.43 0.65 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 123.991 0.807 . . . . 1.82 110.336 -177.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 92.7 t -84.99 115.34 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.273 0.559 . . . . 0.32 111.021 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.27 149.1 30.66 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.793 -0.64 . . . . 1.12 110.509 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.533 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -81.56 124.12 29.24 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.105 -0.702 . . . . 1.33 109.105 174.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 92' ' ' ILE . 28.1 mm -105.53 133.52 49.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.962 -0.563 . . . . 0.28 111.559 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -80.32 121.38 25.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.423 -0.808 . . . . 2.57 108.934 173.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.058 -0.519 . . . . 3.08 110.711 -175.563 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.403 0 N-CA-C 111.878 -0.489 . . . . 18.87 111.878 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.56 169.28 11.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.501 0.191 . . . . 17.7 110.614 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -82.1 124.36 29.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.288 0.566 . . . . 17.44 110.214 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.94 5.88 54.59 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.38 -1.088 . . . . 14.34 110.38 -170.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -126.73 146.78 50.09 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.046 -0.724 . . . . 13.69 109.046 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.0 mt -84.16 94.58 8.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.041 0.448 . . . . 11.39 111.297 -174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.418 HG13 ' H ' ' A' ' 9' ' ' PHE . 7.1 p -76.32 -34.04 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.693 -0.685 . . . . 8.82 110.548 175.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.5 m 61.69 20.56 11.45 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.452 0.538 . . . . 7.95 112.452 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.418 ' H ' HG13 ' A' ' 7' ' ' VAL . 80.8 t80 -92.53 -37.26 12.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.268 0.556 . . . . 7.07 109.554 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -171.82 120.55 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.074 -0.966 . . . . 6.67 109.296 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.513 ' CG2' ' HG3' ' A' ' 13' ' ' GLU . 38.9 mm -122.42 134.11 66.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.225 -0.59 . . . . 2.89 111.468 -177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.492 ' OD1' HD21 ' A' ' 90' ' ' LEU . 13.7 p-10 -100.15 -17.33 17.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.887 -0.597 . . . . 3.29 112.424 -174.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.514 ' HB3' HD23 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -73.19 -15.1 61.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.716 0.769 . . . . 2.96 109.613 173.115 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 m -68.72 -17.51 64.08 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.92 -1.036 . . . . 2.31 110.846 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.14 53.36 46.34 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 116.035 -0.53 . . . . 1.86 113.23 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -82.36 162.9 22.04 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.215 -0.661 . . . . 5.03 109.215 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.74 -16.67 17.77 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.366 0.506 . . . . 2.37 112.366 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.26 -18.47 63.86 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.872 0.323 . . . . 2.38 111.872 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 52.0 t -155.67 131.19 9.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.902 0.382 . . . . 2.75 110.672 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -164.43 133.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.177 0.513 . . . . 1.88 110.719 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -130.34 159.05 38.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.382 -0.372 . . . . 2.71 110.575 -176.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 64.36 21.43 12.49 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.211 0.604 . . . . 1.95 111.539 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 t 59.89 72.56 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.09 -0.505 . . . . 1.72 110.467 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER 47.57 25.61 0.68 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.336 1.054 . . . . 2.92 113.199 178.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -107.66 74.12 0.94 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.941 0.401 . . . . 1.34 111.361 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -91.76 132.92 36.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.031 0.443 . . . . 2.11 110.377 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 72.5 mmtt -114.47 149.71 35.91 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.799 -0.637 . . . . 1.27 109.663 175.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.49 ' HG2' ' CB ' ' A' ' 72' ' ' GLU . 59.5 mtm-85 -122.96 127.89 49.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.067 0.461 . . . . 1.65 111.059 177.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 179.53 9.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.183 -0.917 . . . . 0.08 109.807 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.4 146.18 29.21 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.849 -0.426 . . . . 0.14 109.849 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.557 ' HA ' HD23 ' A' ' 41' ' ' LEU . 40.8 t -67.2 123.06 19.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.856 0.36 . . . . 0.14 110.866 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -75.16 -42.46 55.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.6 110.144 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 p -172.04 165.25 6.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.517 -0.765 . . . . 1.07 110.201 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.7 mt -135.48 129.93 49.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.092 0.472 . . . . 0.19 109.965 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -126.16 95.23 4.32 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.562 -0.744 . . . . 1.56 110.613 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.83 -106.28 1.77 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.29 112.726 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -103.07 9.99 38.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.686 0.279 . . . . 2.1 110.417 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -129.58 141.12 51.02 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.225 0.536 . . . . 0.32 111.054 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.473 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -123.97 159.02 18.63 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.137 -0.785 . . . . 0.11 111.137 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 76.8 m-85 -131.06 147.49 52.63 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.859 -0.422 . . . . 0.18 109.859 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.601 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 5.7 mt -124.82 146.99 48.98 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.385 -0.598 . . . . 0.59 109.385 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -72.92 74.63 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.574 0.702 . . . . 1.53 110.505 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -138.0 97.63 3.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.836 -1.074 . . . . 0.28 108.539 177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.502 ' CG ' ' HA2' ' A' ' 48' ' ' GLY . 19.5 mp0 -74.15 102.15 4.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.948 -1.024 . . . . 1.81 110.966 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.615 HG11 ' HB2' ' A' ' 84' ' ' SER . 28.6 m -80.12 -32.44 13.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.494 -0.775 . . . . 0.85 111.108 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -157.98 116.89 3.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.128 -0.487 . . . . 2.24 110.33 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.2 t70 58.87 22.57 10.37 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.507 0.558 . . . . 1.55 112.507 169.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.502 ' HA2' ' CG ' ' A' ' 44' ' ' GLU . . . 102.38 2.68 50.75 Favored Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.418 -0.896 . . . . 0.67 112.966 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -60.72 115.08 3.38 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 122.167 0.187 . . . . 2.5 110.795 179.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -70.49 148.95 47.69 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.628 -0.508 . . . . 1.32 109.628 176.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 3.4 mt -79.02 132.68 36.72 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.904 -0.589 . . . . 0.19 110.274 177.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -107.31 154.24 21.56 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.579 -0.526 . . . . 0.39 109.579 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.852 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 18.5 p90 -146.4 156.22 43.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.338 -0.616 . . . . 0.16 109.338 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -97.33 149.64 21.86 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.897 -0.779 . . . . 0.34 108.897 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.465 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -61.82 -8.23 4.61 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.909 0.337 . . . . 2.43 111.909 -178.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 t -79.25 -19.55 50.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.95 0.405 . . . . 0.91 110.288 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' ' 87' ' ' CYS . 2.3 mp0 -92.2 -10.83 37.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.977 0.418 . . . . 1.96 110.171 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.1 t -64.62 149.14 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.454 -0.793 . . . . 0.27 111.897 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -63.31 92.01 0.06 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.219 -0.9 . . . . 1.6 112.52 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.1 -77.56 0.69 Allowed Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.006 -0.543 . . . . 0.58 113.732 172.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 1.9 m-20 -103.93 140.16 38.09 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.606 -0.516 . . . . 2.2 109.606 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 69.6 p -70.53 -22.67 62.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.974 -0.557 . . . . 0.95 111.64 -173.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.4 t -100.38 7.16 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.271 0.558 . . . . 1.39 110.503 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . . . -93.69 -11.1 32.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.316 -0.402 . . . . 0.57 110.928 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.615 HD21 HG12 ' A' ' 71' ' ' VAL . 1.4 tm? -110.04 124.51 51.58 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.702 -0.851 . . . . 1.51 108.702 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -115.46 150.66 44.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.743 0.306 . . . . 0.91 111.533 -170.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.474 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.2 Cg_endo -68.06 140.82 50.94 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.379 2.053 . . . . 0.28 111.895 173.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.55 -1.31 88.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.645 -0.788 . . . . 0.22 112.451 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -96.16 159.32 15.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.729 -0.471 . . . . 1.28 109.729 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -83.96 134.97 34.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.565 -0.531 . . . . 0.17 109.565 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.615 HG12 HD21 ' A' ' 65' ' ' LEU . 10.2 m -136.7 160.04 37.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 110.068 -0.345 . . . . 0.31 110.068 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 4.6 pt-20 -116.03 141.65 47.84 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.601 -0.888 . . . . 0.78 108.601 170.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.522 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 26.5 p90 -146.82 179.7 7.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.33 -0.85 . . . . 0.11 109.672 -173.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m -127.65 127.18 43.34 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.942 -0.762 . . . . 0.86 108.942 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 75' ' ' VAL . 8.2 p -92.68 99.4 9.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.835 0.826 . . . . 0.36 111.508 -172.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 84' ' ' SER . 5.1 p -99.11 112.34 31.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.819 -0.628 . . . . 0.42 109.944 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.1 m -93.76 140.45 29.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.508 -0.769 . . . . 0.67 111.128 -173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 80' ' ' ARG . 5.1 t-20 -71.61 134.64 46.53 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.711 0.291 . . . . 1.82 110.359 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 19.2 pm0 -76.87 -12.48 59.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.497 -0.319 . . . . 1.95 111.07 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.472 ' HB3' ' OD1' ' A' ' 78' ' ' ASN . 7.0 tpm_? -95.56 -59.27 1.91 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.568 -0.287 . . . . 3.99 111.605 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -109.04 -0.48 19.48 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.202 0.445 . . . . 2.21 112.202 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.93 80.03 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.494 -0.86 . . . . 0.69 113.159 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.51 131.55 34.86 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.42 0.628 . . . . 2.42 111.494 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.615 ' HB2' HG11 ' A' ' 45' ' ' VAL . 65.3 m -106.7 170.2 8.08 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.912 -1.04 . . . . 1.08 111.357 -172.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.8 m -148.6 152.91 37.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.63 -0.714 . . . . 0.87 109.338 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.852 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -95.33 122.55 38.15 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 120.87 0.367 . . . . 0.17 110.373 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.412 ' HA ' ' HG2' ' A' ' 57' ' ' GLU . 94.1 m -116.69 148.55 40.95 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.129 -0.487 . . . . 0.68 110.22 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.8 m120 59.32 62.03 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.674 0.609 . . . . 1.82 110.338 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.7 t -80.87 99.14 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.472 -0.786 . . . . 0.32 110.656 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.609 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 6.7 mp -99.79 147.87 25.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.349 -0.841 . . . . 1.12 110.545 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.485 ' HG2' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -78.62 123.71 27.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.969 -0.382 . . . . 1.33 109.969 178.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.58 120.74 60.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.093 0.473 . . . . 0.28 110.667 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -90.93 107.29 19.1 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.922 -0.581 . . . . 2.57 110.486 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.8 t0 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 116.024 -0.535 . . . . 3.08 110.251 178.982 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 N-CA-C 112.235 -0.346 . . . . 18.87 112.235 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.09 -36.6 64.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.074 0.464 . . . . 17.7 111.253 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 3' ' ' LYS . 24.8 mmtp -117.08 22.11 12.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.086 -0.506 . . . . 17.44 110.565 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.17 89.63 1.53 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.093 -0.803 . . . . 14.34 111.093 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -81.92 171.4 14.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.92 0.391 . . . . 13.69 110.495 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.4 mp -85.5 105.86 16.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.161 -0.472 . . . . 11.39 110.81 -174.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.4 p -112.08 137.95 42.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.005 -0.543 . . . . 8.82 110.843 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.0 t -76.86 95.82 4.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.288 -0.634 . . . . 7.95 109.288 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -98.65 -35.98 10.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.843 -0.617 . . . . 7.07 110.993 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -157.99 151.9 24.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.019 -0.537 . . . . 6.67 110.192 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.439 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.1 mp -92.24 121.27 42.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.196 -0.456 . . . . 2.89 109.982 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -69.02 -30.51 68.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.822 0.82 . . . . 3.29 109.926 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.648 ' HG2' HD12 ' A' ' 90' ' ' LEU . 2.6 mt-10 -82.41 15.2 2.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.301 -1.318 . . . . 2.96 110.572 -176.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.2 t -70.85 -25.95 63.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.265 -0.88 . . . . 2.31 111.435 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.97 59.37 0.33 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.197 -1.001 . . . . 1.86 111.39 -174.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -63.41 107.47 1.11 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.73 0.3 . . . . 5.03 111.662 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.52 -17.11 42.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.306 0.574 . . . . 2.37 110.269 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.8 -26.27 64.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.416 -0.811 . . . . 2.38 111.484 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.2 m -135.36 130.08 34.39 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.002 -0.74 . . . . 2.75 109.002 177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.66 HG22 ' H ' ' A' ' 22' ' ' ALA . 14.9 p -168.42 139.46 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.892 0.377 . . . . 1.88 110.031 -178.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -115.74 12.14 15.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.805 0.812 . . . . 2.71 109.706 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.66 ' H ' HG22 ' A' ' 20' ' ' VAL . . . -142.23 -162.31 1.39 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.402 -0.817 . . . . 1.95 110.094 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 24' ' ' ARG . 1.7 t -86.18 175.4 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.423 -0.584 . . . . 1.72 109.423 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.554 ' H ' HG12 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -72.11 24.84 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.752 0.649 . . . . 2.92 112.752 178.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 23' ' ' VAL . 56.8 tp60 -106.68 111.46 24.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.491 -0.188 . . . . 1.34 110.491 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -109.1 112.31 24.41 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.349 -0.54 . . . . 2.11 110.228 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -90.72 154.31 19.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.595 -0.729 . . . . 1.27 109.59 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -128.11 128.32 44.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.999 -0.371 . . . . 1.65 109.999 176.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 179.53 9.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.803 -0.635 . . . . 0.08 109.376 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.55 140.09 38.0 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 110.345 -0.243 . . . . 0.14 110.345 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.515 ' HA ' HD23 ' A' ' 41' ' ' LEU . 43.7 t -62.04 115.7 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 120.986 0.422 . . . . 0.14 110.337 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.03 -47.26 65.87 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.446 -0.797 . . . . 0.6 110.019 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.1 m -168.86 168.56 10.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 1.07 109.36 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.434 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 11.2 mt -135.79 126.97 44.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.639 -0.504 . . . . 0.19 109.639 175.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -116.88 92.16 3.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.643 -0.708 . . . . 1.56 110.089 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.96 -109.27 2.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.789 -0.72 . . . . 0.29 112.238 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -96.99 6.02 49.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.71 0.255 . . . . 2.1 110.758 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -125.06 144.18 50.54 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.321 0.581 . . . . 0.32 111.234 -173.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.525 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -120.79 159.41 15.45 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.595 -0.812 . . . . 0.11 111.308 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.0 142.47 47.65 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.376 -0.601 . . . . 0.18 109.376 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 31' ' ' VAL . 8.8 mt -116.15 152.22 34.13 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.247 -0.649 . . . . 0.59 109.247 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -75.48 76.0 2.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.505 0.669 . . . . 1.53 109.417 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.413 ' HB3' HD12 ' A' ' 51' ' ' LEU . 23.9 t80 -147.73 98.13 2.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.983 -1.008 . . . . 0.28 109.121 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 33.3 mt-10 -87.88 101.99 14.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.325 0.583 . . . . 1.81 110.573 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 84' ' ' SER . 15.6 m -73.35 -45.09 53.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.41 -0.814 . . . . 0.85 112.078 -175.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.462 ' H ' ' HB2' ' A' ' 49' ' ' LYS . 4.8 tt0 -140.71 116.61 10.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.572 -0.286 . . . . 2.24 110.537 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 t70 57.87 21.83 8.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.324 0.583 . . . . 1.55 112.131 167.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.47 19.82 19.41 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.443 -0.884 . . . . 0.67 112.955 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 32.6 mmtm -70.99 110.41 5.67 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.892 -0.41 . . . . 2.5 109.892 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -75.24 126.89 31.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.503 -0.554 . . . . 1.32 109.503 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 51' ' ' LEU . 3.8 mt -66.75 126.83 30.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.532 -0.304 . . . . 0.19 111.314 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.443 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 9.5 p90 -111.25 162.53 14.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.427 -0.351 . . . . 0.39 110.138 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.918 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 30.2 p90 -155.17 159.75 40.38 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.174 -0.676 . . . . 0.16 109.174 174.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -99.86 153.65 18.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.342 -0.614 . . . . 0.34 109.342 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 19.6 mtt -66.76 3.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.44 0.533 . . . . 2.43 112.44 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.1 t -89.45 -22.75 22.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.542 -0.54 . . . . 0.91 109.542 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -90.07 -5.67 56.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.511 . . . . 1.96 110.27 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.465 HG22 HD13 ' A' ' 65' ' ' LEU . 1.3 t -67.62 152.45 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.223 -0.899 . . . . 0.27 112.818 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.499 ' HG3' ' H ' ' A' ' 91' ' ' LYS . 1.1 tm0? -59.41 99.02 0.05 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 114.863 -1.062 . . . . 1.6 112.419 -176.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.44 -85.0 0.25 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.58 113.258 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -105.71 145.67 30.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.677 -0.49 . . . . 2.2 109.677 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.0 p -59.98 -40.36 88.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.619 0.6 . . . . 0.95 112.619 -174.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.36 19.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.512 0.672 . . . . 1.39 110.522 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.52 11.54 38.84 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.429 0.633 . . . . 0.57 110.141 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.549 HD11 HG12 ' A' ' 89' ' ' VAL . 1.8 tt -137.86 124.03 20.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.121 -0.945 . . . . 1.51 108.534 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.409 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 89.8 m-70 -121.78 159.2 52.08 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.755 0.312 . . . . 0.91 111.151 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.424 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 38.2 Cg_endo -67.41 144.71 68.61 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.436 2.09 . . . . 0.28 111.924 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.08 -9.15 77.96 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.053 -0.594 . . . . 0.22 112.063 -177.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' ' 66' ' ' HIS . 3.6 m-20 -87.14 141.36 28.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.583 0.23 . . . . 1.28 110.722 177.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 m -70.01 139.25 52.71 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.172 -0.677 . . . . 0.17 109.172 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -139.19 161.02 28.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.364 0.602 . . . . 0.31 111.1 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.13 134.53 54.83 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.826 -1.175 . . . . 0.78 107.826 173.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.487 ' CD2' HD13 ' A' ' 41' ' ' LEU . 23.5 p90 -146.13 178.93 7.85 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.86 -0.609 . . . . 0.11 109.471 -174.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.1 t -126.19 126.63 44.4 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.954 -0.758 . . . . 0.86 108.954 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.9 98.4 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.705 -0.679 . . . . 0.36 110.54 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 p -100.85 113.83 38.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.522 -0.763 . . . . 0.42 109.917 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.9 m -76.78 130.53 37.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.708 -0.678 . . . . 0.67 110.926 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.562 ' HB3' ' H ' ' A' ' 82' ' ' GLY . 3.6 t-20 -65.22 111.91 3.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.923 -0.769 . . . . 1.82 108.923 175.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -12.28 60.38 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.905 -0.318 . . . . 1.95 111.287 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -96.74 -58.55 2.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.035 -0.53 . . . . 3.99 111.558 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -90.75 -28.67 18.12 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.677 0.621 . . . . 2.21 112.677 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.562 ' H ' ' HB3' ' A' ' 78' ' ' ASN . . . 103.7 -24.57 29.34 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.416 -0.897 . . . . 0.69 113.851 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 0.0 OUTLIER -74.8 151.33 39.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.439 0.62 . . . . 2.42 110.006 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.496 ' HB2' HG11 ' A' ' 45' ' ' VAL . 8.3 m -99.43 175.05 5.99 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.563 -0.455 . . . . 1.08 111.469 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 m -142.78 163.24 33.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.419 -0.809 . . . . 0.87 109.161 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.918 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -103.16 117.06 33.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.248 0.547 . . . . 0.17 110.358 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 64.5 m -116.97 147.99 41.81 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.914 -0.773 . . . . 0.68 108.914 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.473 ' ND2' HD23 ' A' ' 90' ' ' LEU . 8.0 t30 64.55 69.24 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.082 -0.71 . . . . 1.82 109.082 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.549 HG12 HD11 ' A' ' 65' ' ' LEU . 84.9 t -93.41 105.98 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 115.426 -0.806 . . . . 0.32 110.9 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.648 HD12 ' HG2' ' A' ' 13' ' ' GLU . 4.2 mm? -112.3 150.32 31.15 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.61 -0.723 . . . . 1.12 111.016 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.499 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -83.35 123.75 29.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.553 -0.748 . . . . 1.33 110.948 -172.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.5 mm -117.37 142.61 30.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.83 -0.623 . . . . 0.28 111.05 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -114.33 146.02 41.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.865 -0.607 . . . . 2.57 109.459 172.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 C--N 1.317 -0.824 0 CA-C-N 116.317 -0.401 . . . . 3.08 109.93 174.897 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.455 -0.258 . . . . 18.87 112.455 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.62 112.22 12.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.049 0.452 . . . . 17.7 110.994 -177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -92.0 83.82 5.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.858 -0.793 . . . . 17.44 108.858 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.36 -158.07 34.3 Favored Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 120.901 -0.666 . . . . 14.34 113.139 -173.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.07 77.71 3.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.665 0.745 . . . . 13.69 111.058 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.0 mt -91.45 89.52 7.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.771 0.796 . . . . 11.39 109.449 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.5 m -84.83 99.22 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 114.762 -1.108 . . . . 8.82 111.469 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.6 p -84.25 88.14 7.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.851 -0.613 . . . . 7.95 110.005 176.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -105.69 3.23 28.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.305 0.574 . . . . 7.07 109.897 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -155.62 -176.58 6.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.095 -0.957 . . . . 6.67 110.329 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.4 mm -66.07 141.06 18.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 123.395 0.434 . . . . 2.89 110.085 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.23 -47.27 86.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.147 -0.479 . . . . 3.29 112.154 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -3.26 5.15 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.924 -0.58 . . . . 2.96 112.195 -172.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.7 p -58.89 -34.4 71.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.885 -0.598 . . . . 2.31 111.67 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.05 43.41 8.79 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.779 -0.724 . . . . 1.86 112.423 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -78.53 157.14 28.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.133 -0.321 . . . . 5.03 110.133 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.89 -16.75 53.05 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.328 0.492 . . . . 2.37 112.328 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.32 -24.26 63.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.521 -0.308 . . . . 2.38 111.818 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 12.3 p -155.92 130.72 9.14 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.933 -0.307 . . . . 2.75 111.186 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.2 p -169.49 143.57 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.371 -0.377 . . . . 1.88 110.321 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -126.56 162.55 25.4 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.763 0.316 . . . . 2.71 111.37 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.9 19.61 10.82 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.486 -0.779 . . . . 1.95 112.013 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.9 t 60.43 76.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.094 0.473 . . . . 1.72 110.509 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 46.0 26.83 0.44 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.445 1.098 . . . . 2.92 113.422 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -106.4 70.04 0.81 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.091 0.472 . . . . 1.34 110.65 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -97.6 118.32 33.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.44 0.638 . . . . 2.11 110.286 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -99.99 156.44 17.15 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.868 -1.06 . . . . 1.27 109.719 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.466 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 11.0 mtm180 -130.27 127.31 39.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.49 . . . . 1.65 110.559 175.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.46 -179.96 8.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.256 -0.884 . . . . 0.08 110.031 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.4 145.6 28.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.366 -0.379 . . . . 0.14 109.984 -178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.42 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 48.8 t -68.33 123.33 21.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.516 -0.311 . . . . 0.14 110.379 175.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -76.39 -41.9 46.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.109 -0.496 . . . . 0.6 110.406 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.5 p -171.04 161.69 6.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.845 -0.616 . . . . 1.07 110.014 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.413 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 13.1 mt -133.73 129.13 54.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.079 0.466 . . . . 0.19 110.114 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -119.59 95.19 4.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 1.56 110.132 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.17 -114.13 5.85 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.815 -0.707 . . . . 0.29 112.282 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -96.38 14.81 23.13 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 110.031 -0.359 . . . . 2.1 110.031 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -128.13 141.06 51.59 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.563 -0.455 . . . . 0.32 111.014 -175.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -127.19 158.71 21.14 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.503 -0.856 . . . . 0.11 111.525 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -132.33 142.71 49.44 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.235 -0.654 . . . . 0.18 109.235 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.491 HD13 ' CD2' ' A' ' 73' ' ' PHE . 6.3 mt -116.74 152.53 34.14 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.146 -0.686 . . . . 0.59 109.146 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -75.09 73.47 2.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.782 0.801 . . . . 1.53 109.585 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -147.51 110.69 4.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.623 -1.172 . . . . 0.28 108.674 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 90.1 mt-10 -105.82 107.08 17.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.5 0.667 . . . . 1.81 111.136 -177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 m -74.06 -55.28 12.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.659 -1.155 . . . . 0.85 112.121 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.695 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 4.1 tp10 -136.38 118.92 15.88 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.552 -0.294 . . . . 2.24 110.703 -171.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.1 t70 61.86 16.59 8.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.41 0.624 . . . . 1.55 112.057 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.09 31.13 9.37 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.205 -0.997 . . . . 0.67 112.107 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.695 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 41.2 mmtm -75.49 109.88 9.41 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.509 -0.923 . . . . 2.5 108.509 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.93 122.32 22.37 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.726 -0.842 . . . . 1.32 108.726 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 51' ' ' LEU . 3.6 mt -59.7 126.55 28.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.131 -0.486 . . . . 0.19 111.6 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -108.41 161.82 14.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.856 -0.611 . . . . 0.39 110.229 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.956 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 30.0 p90 -152.5 151.88 31.25 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.558 -0.746 . . . . 0.16 109.205 173.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.454 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . 23.3 t-80 -93.69 156.39 16.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.628 -0.879 . . . . 0.34 108.628 174.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.467 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 51.0 ttm -71.73 3.69 3.89 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.875 0.369 . . . . 2.43 111.538 -176.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.2 t -88.38 -27.57 21.52 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.777 -0.453 . . . . 0.91 109.777 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.454 ' OE2' ' HB3' ' A' ' 54' ' ' HIS . 1.9 mp0 -79.36 -14.97 58.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.855 -0.611 . . . . 1.96 109.626 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.493 HG11 ' HA ' ' A' ' 62' ' ' THR . 1.8 t -62.68 152.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.882 -1.054 . . . . 0.27 111.939 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.434 HE21 ' HB3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -45.07 158.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.359 -1.291 . . . . 1.6 110.985 176.005 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -44.78 -32.5 3.08 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 114.62 0.608 . . . . 0.58 114.62 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -104.26 125.03 50.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.645 -0.502 . . . . 2.2 109.645 173.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.493 ' HA ' HG11 ' A' ' 58' ' ' VAL . 70.7 p -79.18 -36.54 40.11 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.413 -0.812 . . . . 0.95 111.977 -171.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 t -87.15 7.35 2.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.484 0.659 . . . . 1.39 110.257 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.33 -3.12 31.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.928 -0.578 . . . . 0.57 111.087 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.542 HD21 HG12 ' A' ' 71' ' ' VAL . 1.5 tm? -104.71 124.04 48.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.031 -1.1 . . . . 1.51 108.031 175.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -121.02 151.81 55.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.828 0.347 . . . . 0.91 111.549 -171.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 43.0 Cg_endo -67.8 137.41 41.69 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.721 2.28 . . . . 0.28 111.856 173.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.31 -8.99 72.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.815 -0.707 . . . . 0.22 112.628 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -95.25 159.69 14.89 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.418 -0.586 . . . . 1.28 109.418 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 m -80.27 135.96 36.34 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.208 -0.664 . . . . 0.17 109.208 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.542 HG12 HD21 ' A' ' 65' ' ' LEU . 12.1 m -135.71 161.6 38.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.25 0.548 . . . . 0.31 109.895 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.66 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.59 149.13 37.04 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.726 -0.842 . . . . 0.78 108.726 177.502 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.491 ' CD2' HD13 ' A' ' 41' ' ' LEU . 37.9 p90 -163.06 178.61 8.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.006 0.431 . . . . 0.11 110.515 -172.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -128.85 131.56 47.7 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.022 -0.733 . . . . 0.86 109.022 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.9 p -99.35 98.84 7.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.802 0.81 . . . . 0.36 111.018 -174.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.0 p -110.2 118.89 58.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.558 -0.746 . . . . 0.42 110.006 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.0 m -73.32 126.19 29.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.138 -0.483 . . . . 0.67 110.778 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 29.1 m-80 -68.79 115.18 7.83 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.203 -0.453 . . . . 1.82 109.955 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -60.47 -30.85 69.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.166 -0.47 . . . . 1.95 112.113 -173.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 1.6 tpm_? -95.28 -31.9 13.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.959 0.409 . . . . 3.99 111.645 -176.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -95.94 -26.41 15.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.286 0.565 . . . . 2.21 110.455 -171.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 -24.84 18.38 Favored Glycine 0 C--O 1.23 -0.127 0 C-N-CA 121.201 -0.523 . . . . 0.69 113.421 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 20.1 pttm -98.77 151.95 20.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.216 0.508 . . . . 2.42 110.808 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -87.45 179.47 6.56 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.859 -0.61 . . . . 1.08 111.082 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.8 p -153.45 139.17 17.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.004 -0.543 . . . . 0.87 109.773 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.956 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -74.01 119.25 17.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.191 0.52 . . . . 0.17 111.105 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 99.4 m -116.89 143.88 45.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.778 -0.646 . . . . 0.68 109.306 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 62.52 70.51 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.418 0.628 . . . . 1.82 109.717 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 90.4 t -93.11 113.05 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.328 -0.851 . . . . 0.32 111.159 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.25 150.05 32.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.178 -0.464 . . . . 1.12 110.92 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.47 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -73.71 128.48 35.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.043 -0.526 . . . . 1.33 109.906 176.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.4 mm -119.28 140.14 44.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.803 0.335 . . . . 0.28 110.91 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -99.61 115.08 28.58 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.221 -0.659 . . . . 2.57 109.221 172.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 116.444 -0.344 . . . . 3.08 111.178 -176.033 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 111.643 -0.583 . . . . 18.87 111.643 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.78 161.26 40.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.926 0.393 . . . . 17.7 111.281 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -91.25 124.98 35.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.77 -0.65 . . . . 17.44 109.654 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.57 -29.41 0.34 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.987 -1.101 . . . . 14.34 113.534 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -93.72 176.26 6.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.155 0.478 . . . . 13.69 110.26 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.8 mt -97.65 127.38 43.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.076 0.465 . . . . 11.39 111.44 -174.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.9 p -154.05 126.56 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.711 -0.677 . . . . 8.82 109.464 174.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 m -83.84 97.55 9.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.324 -0.398 . . . . 7.95 110.449 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -123.67 -0.05 8.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.29 0.567 . . . . 7.07 109.83 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -144.53 135.31 24.87 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.599 -0.728 . . . . 6.67 112.195 -173.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' HB ' ' OG ' ' A' ' 14' ' ' SER . 3.9 mp -132.55 121.27 44.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.024 -0.989 . . . . 2.89 109.504 177.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -93.56 -14.97 25.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.749 0.309 . . . . 3.29 111.643 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -85.39 4.05 37.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.449 0.642 . . . . 2.96 109.765 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.403 ' OG ' ' HB ' ' A' ' 11' ' ' ILE . 10.1 m -73.63 17.64 0.15 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.412 -0.813 . . . . 2.31 112.547 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.28 59.99 7.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.878 -0.677 . . . . 1.86 113.571 172.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -60.89 99.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.024 0.412 . . . . 5.03 110.701 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.28 -31.99 19.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.377 0.51 . . . . 2.37 112.377 -177.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.02 -34.78 75.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.307 -0.406 . . . . 2.38 111.432 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.8 p -148.78 131.52 15.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.218 -0.447 . . . . 2.75 110.394 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 22' ' ' ALA . 12.5 p -167.22 153.16 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.871 -0.789 . . . . 1.88 108.871 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -92.64 10.47 30.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.912 0.387 . . . . 2.71 110.942 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.432 ' H ' HG22 ' A' ' 20' ' ' VAL . . . -142.98 -162.31 1.41 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.492 -0.558 . . . . 1.95 109.492 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.0 m -86.78 163.16 2.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.092 0.472 . . . . 1.72 110.241 174.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.533 ' HD2' ' H ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -62.13 -10.43 10.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.421 -0.809 . . . . 2.92 111.717 178.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -77.6 97.09 4.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.025 -0.534 . . . . 1.34 110.899 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -95.51 121.05 36.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.419 0.628 . . . . 2.11 110.559 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.461 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 31.0 mmtp -105.37 144.12 32.59 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.152 -0.931 . . . . 1.27 109.544 177.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 28' ' ' ARG . 2.1 mtm180 -120.01 127.37 52.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.085 0.469 . . . . 1.65 110.196 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.496 ' HB1' ' OD1' ' A' ' 42' ' ' ASN . . . -150.87 -179.63 7.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.516 -0.765 . . . . 0.08 109.448 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.91 143.42 32.52 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.81 -0.441 . . . . 0.14 109.81 -177.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.48 ' HA ' HD23 ' A' ' 41' ' ' LEU . 43.8 t -64.89 114.19 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.904 0.383 . . . . 0.14 110.433 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -65.07 -45.12 86.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.121 -0.945 . . . . 0.6 110.153 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 p -171.71 164.73 6.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.396 -0.82 . . . . 1.07 110.093 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.4 mt -137.57 128.95 40.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.669 -0.493 . . . . 0.19 109.669 176.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 35' ' ' LYS . 71.4 mmtt -122.92 94.31 4.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.534 -0.757 . . . . 1.56 109.807 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.88 -106.92 2.0 Allowed Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.717 -0.754 . . . . 0.29 112.434 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -101.06 4.25 42.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.178 0.191 . . . . 2.1 110.793 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -122.87 140.5 52.89 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 121.254 0.55 . . . . 0.32 111.374 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.01 157.09 21.01 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.116 -0.947 . . . . 0.11 111.416 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -130.46 151.79 50.55 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.362 -0.607 . . . . 0.18 109.362 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.572 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.2 mt -125.09 155.28 40.08 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.329 -0.619 . . . . 0.59 109.329 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.496 ' OD1' ' HB1' ' A' ' 29' ' ' ALA . 28.0 p-10 -76.23 72.9 3.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 122.229 1.014 . . . . 1.53 109.994 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -148.15 98.63 2.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.757 -1.11 . . . . 0.28 109.028 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 21.3 mt-10 -95.58 100.97 12.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.746 0.784 . . . . 1.81 110.284 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 46' ' ' GLU . 16.2 m -68.12 -43.31 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.222 -1.354 . . . . 0.85 111.301 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 8.7 tp10 -129.87 176.06 8.35 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.281 -1.748 . . . . 2.24 106.281 -176.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 28.3 t70 -33.19 86.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.195 1.183 . . . . 1.55 114.195 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.54 ' HA2' ' OE2' ' A' ' 44' ' ' GLU . . . 68.58 16.55 69.87 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.654 -0.784 . . . . 0.67 111.464 171.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.722 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 32.0 mmtm -82.29 107.03 14.65 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.569 -0.53 . . . . 2.5 109.569 -178.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -79.52 129.62 34.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.062 -0.718 . . . . 1.32 109.062 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 51' ' ' LEU . 3.1 mt -63.69 124.09 20.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.728 0.299 . . . . 0.19 111.157 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -106.61 158.91 16.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.833 -0.622 . . . . 0.39 109.998 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.939 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 30.4 p90 -150.29 154.87 38.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.517 -0.765 . . . . 0.16 109.166 173.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -99.03 149.87 22.56 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.657 -0.868 . . . . 0.34 108.657 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.543 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 27.5 mtt -60.23 -7.07 1.71 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.215 0.45 . . . . 2.43 112.215 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 t -68.66 -29.96 68.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.221 -0.445 . . . . 0.91 110.776 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -92.93 -1.21 56.92 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.845 0.355 . . . . 1.96 111.138 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.562 HG13 HD13 ' A' ' 65' ' ' LEU . 2.1 t -74.42 150.66 7.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.593 0.59 . . . . 0.27 112.593 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.539 ' CG ' HD13 ' A' ' 90' ' ' LEU . 1.4 tm0? -54.37 100.06 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 114.758 -1.11 . . . . 1.6 111.805 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.52 -92.18 0.01 OUTLIER Glycine 0 C--N 1.332 0.317 0 O-C-N 123.873 0.733 . . . . 0.58 114.342 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -89.73 131.34 35.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 2.2 110.174 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.543 ' HB ' ' SD ' ' A' ' 55' ' ' MET . 30.7 p -75.45 -12.04 60.16 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.471 -0.786 . . . . 0.95 111.096 -172.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.0 t -92.85 -2.15 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.499 -0.773 . . . . 1.39 110.05 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.88 -14.54 29.51 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.394 0.616 . . . . 0.57 110.895 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.562 HD13 HG13 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -103.34 124.6 48.99 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.528 -0.76 . . . . 1.51 109.084 179.226 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 95.3 m-70 -121.8 153.14 60.05 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.884 0.373 . . . . 0.91 111.316 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.407 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.0 Cg_endo -67.64 134.85 34.04 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.499 2.132 . . . . 0.28 111.243 173.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.22 -17.34 59.32 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.826 -0.702 . . . . 0.22 111.93 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 66' ' ' HIS . 23.5 m-20 -74.23 151.05 40.01 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 110.101 -0.333 . . . . 1.28 110.101 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 m -81.17 135.18 35.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.395 -0.965 . . . . 0.17 108.395 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.452 HG11 HD21 ' A' ' 65' ' ' LEU . 29.6 m -134.9 167.09 26.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.214 0.531 . . . . 0.31 110.945 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.641 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -113.88 150.07 34.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.014 -1.106 . . . . 0.78 108.014 172.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.572 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.2 p90 -157.85 179.06 9.55 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.335 -0.617 . . . . 0.11 109.335 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -130.29 133.69 46.66 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.253 -1.017 . . . . 0.86 108.253 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 p -94.5 98.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.658 0.742 . . . . 0.36 111.087 -172.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -102.54 107.64 22.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.39 -0.823 . . . . 0.42 109.725 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 26.8 m -74.43 129.67 38.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.983 0.421 . . . . 0.67 110.864 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 39.7 m-80 -76.83 101.06 5.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.879 -0.6 . . . . 1.82 109.528 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -60.9 -21.31 63.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.957 0.408 . . . . 1.95 111.119 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -72.52 -41.11 66.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.714 -0.675 . . . . 3.99 111.585 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -114.65 -31.49 6.16 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.517 0.562 . . . . 2.21 112.517 -172.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.44 -20.36 25.46 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.003 -0.618 . . . . 0.69 113.303 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 21.1 pttp -96.89 150.72 20.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.036 0.418 . . . . 2.42 110.752 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 13.4 m -93.3 -176.29 4.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.11 -0.496 . . . . 1.08 111.607 -175.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.8 m -150.05 150.08 31.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.828 -0.624 . . . . 0.87 109.434 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.939 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -89.82 120.93 31.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.217 0.532 . . . . 0.17 111.101 -177.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 50.0 m -117.32 144.38 44.95 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.759 -0.655 . . . . 0.68 110.126 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.5 t30 62.82 66.84 0.73 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.764 0.665 . . . . 1.82 109.792 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 95.2 t -89.33 100.85 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.518 -0.764 . . . . 0.32 110.675 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.539 HD13 ' CG ' ' A' ' 59' ' ' GLN . 2.1 mm? -105.45 147.53 28.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.833 -0.621 . . . . 1.12 110.81 -177.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.36 122.75 24.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 1.33 110.741 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.4 mm -110.34 133.31 56.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.597 -0.728 . . . . 0.28 110.738 -176.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -80.66 117.83 21.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.889 -0.596 . . . . 2.57 110.11 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 116.259 -0.428 . . . . 3.08 110.656 178.931 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 111.816 -0.514 . . . . 18.87 111.816 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 176.97 -166.47 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.171 -0.677 . . . . 17.7 109.171 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -95.67 84.98 4.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.99 0.424 . . . . 17.44 110.238 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.74 -135.65 1.86 Allowed Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.78 -0.646 . . . . 14.34 111.688 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.23 -52.11 8.58 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.212 -0.292 . . . . 13.69 110.212 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -71.62 96.11 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.216 0.531 . . . . 11.39 110.221 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 p 178.53 140.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.089 -0.959 . . . . 8.82 109.065 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 t -77.33 95.0 4.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.794 -0.817 . . . . 7.95 108.794 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -173.72 -33.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.976 -1.12 . . . . 7.07 107.976 -172.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.434 ' HE ' ' HB3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -77.59 -175.25 3.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 113.899 -1.5 . . . . 6.67 109.939 175.136 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.2 mt -68.84 101.4 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.383 -0.527 . . . . 2.89 109.992 174.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -87.73 -23.35 24.16 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.509 -0.769 . . . . 3.29 111.514 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -64.89 -21.28 66.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.114 0.483 . . . . 2.96 110.199 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.0 m -65.05 -9.93 26.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.332 -0.849 . . . . 2.31 112.235 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.54 59.56 1.35 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 119.748 -1.215 . . . . 1.86 112.896 175.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 36.8 mmm-85 -59.96 117.54 5.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.119 -0.326 . . . . 5.03 110.119 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.81 -26.92 27.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.853 0.359 . . . . 2.37 111.035 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.09 70.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.04 -0.527 . . . . 2.38 110.973 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 52.5 t -145.44 131.02 18.82 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.716 -0.846 . . . . 2.75 108.716 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.65 155.38 7.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.73 0.3 . . . . 1.88 110.56 -173.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -119.61 149.77 41.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 2.71 110.25 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 74' ' ' SER . . . 64.06 16.57 10.05 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.708 0.63 . . . . 1.95 111.807 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.2 t 60.03 75.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.779 -0.646 . . . . 1.72 111.174 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 44.49 31.01 0.55 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.64 1.176 . . . . 2.92 113.992 175.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -115.87 94.22 4.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.115 0.483 . . . . 1.34 110.878 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -109.31 112.73 25.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.145 0.497 . . . . 2.11 110.628 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -89.51 150.29 22.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.57 -0.741 . . . . 1.27 110.294 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -123.66 127.3 48.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.95 0.405 . . . . 1.65 110.347 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.58 179.36 9.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.015 -0.735 . . . . 0.08 109.015 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.93 142.62 32.15 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 110.133 -0.321 . . . . 0.14 110.133 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.522 ' HA ' HD23 ' A' ' 41' ' ' LEU . 43.7 t -64.22 117.54 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.517 -0.549 . . . . 0.14 109.517 174.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.93 -40.47 63.07 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.768 -0.651 . . . . 0.6 110.513 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 p -174.41 156.0 2.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.56 -0.746 . . . . 1.07 109.697 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.4 mt -127.6 132.38 69.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.186 -0.461 . . . . 0.19 110.005 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -121.96 85.95 2.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.568 -0.742 . . . . 1.56 110.458 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.37 -107.13 1.95 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.915 -0.659 . . . . 0.29 112.605 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -97.63 10.7 39.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 2.1 110.509 -175.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -132.73 142.22 48.93 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 120.942 0.401 . . . . 0.32 110.643 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.6 153.88 19.83 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.226 -0.749 . . . . 0.11 111.226 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 64.6 m-85 -127.88 146.11 50.73 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.57 -0.529 . . . . 0.18 109.57 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.544 HD13 ' CD2' ' A' ' 73' ' ' PHE . 6.0 mt -117.65 157.12 27.0 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.926 -0.398 . . . . 0.59 109.926 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -76.75 73.53 3.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.508 0.67 . . . . 1.53 109.677 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.438 ' HB3' HD12 ' A' ' 51' ' ' LEU . 33.7 t80 -146.19 102.46 3.62 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.293 -0.867 . . . . 0.28 109.301 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.56 101.0 12.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.934 -0.575 . . . . 1.81 110.275 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' A' ' 84' ' ' SER . 21.3 m -74.06 -46.42 45.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.801 0.81 . . . . 0.85 110.648 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.476 ' N ' HG23 ' A' ' 45' ' ' VAL . 34.5 tt0 -124.55 -179.11 4.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.803 -1.554 . . . . 2.24 106.803 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.429 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 8.1 t70 -41.09 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.089 0.956 . . . . 1.55 112.948 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.16 13.96 67.9 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.651 -0.785 . . . . 0.67 111.701 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.94 108.99 10.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.23 -0.655 . . . . 2.5 109.23 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -72.61 136.15 45.67 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.161 -0.681 . . . . 1.32 109.161 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -70.2 123.68 22.25 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.837 -0.431 . . . . 0.19 109.837 177.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -107.0 156.85 18.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.714 -0.476 . . . . 0.39 109.714 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.918 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 22.7 p90 -147.84 152.73 38.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.655 -0.702 . . . . 0.16 109.11 172.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -91.87 146.93 23.36 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.048 -0.723 . . . . 0.34 109.048 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.579 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 41.8 ttp -53.23 -17.16 1.55 Allowed 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 123.704 0.801 . . . . 2.43 112.274 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -64.57 -32.32 73.92 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.601 0.239 . . . . 0.91 110.868 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -78.08 -15.12 59.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.141 0.496 . . . . 1.96 110.822 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.579 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -64.03 147.46 12.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.395 -0.82 . . . . 0.27 111.956 -174.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.491 ' HG3' ' CD1' ' A' ' 90' ' ' LEU . 1.1 tt0 -64.06 86.77 0.04 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.776 -1.102 . . . . 1.6 112.933 -171.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.69 -90.82 0.25 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.293 -0.479 . . . . 0.58 113.26 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -92.99 143.83 25.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.277 0.56 . . . . 2.2 110.589 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.1 p -69.31 -33.56 73.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.217 -0.901 . . . . 0.95 110.926 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.56 -11.47 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.43 -0.805 . . . . 1.39 111.162 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -90.58 -8.5 50.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.607 -0.724 . . . . 0.57 111.728 -173.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.505 HD11 HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -117.48 124.63 49.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.411 -0.589 . . . . 1.51 109.411 179.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -122.2 150.03 55.89 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.731 0.3 . . . . 0.91 111.055 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.77 130.32 21.67 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.365 2.043 . . . . 0.28 111.092 172.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.91 -9.73 58.38 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.834 -0.698 . . . . 0.22 111.967 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -87.48 145.47 26.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.258 -0.275 . . . . 1.28 110.258 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 m -72.22 134.37 45.6 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.462 -0.57 . . . . 0.17 109.462 173.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.53 160.2 37.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.776 0.798 . . . . 0.31 111.098 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.84 132.08 56.62 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.429 -1.259 . . . . 0.78 108.65 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.544 ' CD2' HD13 ' A' ' 41' ' ' LEU . 26.0 p90 -142.48 178.67 7.44 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.612 -0.722 . . . . 0.11 109.583 -172.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 22' ' ' ALA . 4.1 m -128.68 119.35 24.5 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.163 -0.68 . . . . 0.86 109.163 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.29 99.44 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.81 0.814 . . . . 0.36 110.986 -173.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.68 122.99 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.423 -0.808 . . . . 0.42 109.794 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 36.7 m -86.09 125.77 33.7 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.094 -0.503 . . . . 0.67 111.008 -177.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -63.98 109.92 1.95 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.826 -0.625 . . . . 1.82 109.527 175.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.432 ' H ' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -60.86 -23.14 64.92 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.238 0.459 . . . . 1.95 112.238 -175.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.424 ' NE ' ' HA ' ' A' ' 80' ' ' ARG . 7.2 tpm_? -93.66 -47.11 6.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.655 -0.418 . . . . 3.99 111.145 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -81.36 -30.81 33.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 2.21 111.586 -174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.45 -10.24 75.07 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.952 -0.642 . . . . 0.69 112.463 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -93.98 156.08 16.8 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.022 -0.733 . . . . 2.42 109.022 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.552 ' HB2' HG11 ' A' ' 45' ' ' VAL . 3.2 m -107.75 170.62 7.88 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.435 -0.506 . . . . 1.08 111.173 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.3 p -144.07 159.84 41.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.69 -0.686 . . . . 0.87 110.122 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.918 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -96.3 123.98 40.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.349 -0.387 . . . . 0.17 110.367 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -116.86 149.16 40.53 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.001 -1.111 . . . . 0.68 108.001 176.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 57.11 72.25 0.52 Allowed 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.82 0.7 . . . . 1.82 110.321 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.505 HG12 HD11 ' A' ' 65' ' ' LEU . 96.2 t -89.58 105.4 16.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.565 0.697 . . . . 0.32 110.639 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.491 ' CD1' ' HG3' ' A' ' 59' ' ' GLN . 4.0 mm? -106.7 148.95 27.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.161 -0.927 . . . . 1.12 110.648 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.42 ' HB2' ' OE1' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -81.66 129.47 34.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.676 -0.693 . . . . 1.33 111.224 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.5 mm -117.88 142.35 32.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.704 -0.68 . . . . 0.28 110.427 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -92.45 121.57 34.05 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.158 -0.682 . . . . 2.57 109.158 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.883 -0.599 . . . . 3.08 109.867 -175.141 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 111.993 -0.443 . . . . 18.87 111.993 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.78 147.05 25.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.768 0.318 . . . . 17.7 110.519 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.19 92.32 8.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.286 0.565 . . . . 17.44 109.975 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.88 57.64 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.373 -1.091 . . . . 14.34 110.373 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -90.56 155.8 18.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.114 -0.543 . . . . 13.69 111.51 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.1 tp -145.55 146.65 31.49 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.615 -0.883 . . . . 11.39 108.615 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 p -114.04 98.29 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.887 0.851 . . . . 8.82 111.677 -175.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.1 t -126.51 103.38 7.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.417 -0.81 . . . . 7.95 109.043 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -97.5 11.85 35.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.908 -0.587 . . . . 7.07 110.471 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -157.28 176.88 12.11 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.348 -0.842 . . . . 6.67 109.899 -172.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.498 ' HB ' ' OG ' ' A' ' 14' ' ' SER . 21.3 mm -85.63 142.68 12.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.377 -0.972 . . . . 2.89 108.377 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.62 -39.59 73.63 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.958 -0.464 . . . . 3.29 111.254 -176.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.814 ' HA ' HD23 ' A' ' 90' ' ' LEU . 2.3 pm0 -76.37 14.19 0.8 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.307 -0.406 . . . . 2.96 111.646 177.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.498 ' OG ' ' HB ' ' A' ' 11' ' ' ILE . 57.7 m -77.85 -6.98 56.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.332 . . . . 2.31 110.774 174.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.15 57.17 1.82 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.341 -0.933 . . . . 1.86 112.226 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -62.73 113.35 2.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.914 0.388 . . . . 5.03 110.956 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.75 -20.38 31.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.265 -0.425 . . . . 2.37 111.307 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.29 -13.94 61.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.389 -0.369 . . . . 2.38 111.475 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.8 m -145.99 129.96 17.34 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.785 -0.45 . . . . 2.75 109.785 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -168.76 140.94 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.911 -0.586 . . . . 1.88 109.833 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -90.03 30.03 1.14 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.711 0.291 . . . . 2.71 111.782 -174.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.477 ' HB3' ' OG ' ' A' ' 74' ' ' SER . . . -164.42 -177.79 5.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.096 -0.705 . . . . 1.95 109.096 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.56 74.39 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.803 0.335 . . . . 1.72 110.837 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 43.16 26.13 0.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.755 1.222 . . . . 2.92 113.959 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -102.97 96.97 7.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.233 -0.439 . . . . 1.34 110.992 -175.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 2.6 mppt? -106.86 120.99 43.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.145 0.498 . . . . 2.11 110.423 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -105.11 144.89 31.29 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.484 -0.78 . . . . 1.27 110.26 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -118.84 127.17 53.27 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.664 -0.414 . . . . 1.65 110.578 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.63 179.67 8.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.69 -0.686 . . . . 0.08 109.579 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.44 144.5 30.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.045 -0.354 . . . . 0.14 110.045 -177.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.531 ' HA ' HD23 ' A' ' 41' ' ' LEU . 57.6 t -63.98 117.43 4.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.142 0.496 . . . . 0.14 110.577 176.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.421 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 8.5 t70 -69.2 -47.86 63.7 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.031 -0.986 . . . . 0.6 109.616 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 74.1 m -167.92 164.49 13.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.775 -0.648 . . . . 1.07 109.699 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 mt -136.52 132.97 49.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.672 -0.492 . . . . 0.19 109.672 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -126.79 89.34 2.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 1.56 110.227 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.37 -107.77 2.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.75 -0.738 . . . . 0.29 112.592 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -97.37 9.64 41.78 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.808 -0.231 . . . . 2.1 110.761 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.51 141.2 51.05 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.184 0.516 . . . . 0.32 111.006 -175.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.526 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.9 157.16 21.47 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.387 -0.824 . . . . 0.11 111.152 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 68.8 m-85 -129.73 148.61 51.63 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.09 -0.708 . . . . 0.18 109.09 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' A' ' 73' ' ' PHE . 8.8 mt -123.72 153.05 41.42 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.662 -0.495 . . . . 0.59 109.662 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -75.1 73.59 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.487 -0.56 . . . . 1.53 109.487 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.439 ' HB3' HD12 ' A' ' 51' ' ' LEU . 27.9 t80 -150.26 98.56 2.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.41 -0.814 . . . . 0.28 109.536 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 47.2 mt-10 -81.67 100.5 9.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.485 0.66 . . . . 1.81 109.695 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 84' ' ' SER . 27.2 m -72.21 -35.68 53.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.078 -0.965 . . . . 0.85 111.446 -176.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 7.9 tp10 -145.05 179.65 7.21 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.376 -1.713 . . . . 2.24 106.376 -175.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.523 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 23.8 t70 -27.75 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.271 1.428 . . . . 1.55 114.38 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.519 ' HA2' ' OE1' ' A' ' 44' ' ' GLU . . . 66.84 19.72 69.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.992 -0.623 . . . . 0.67 111.768 173.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 40.8 mmtm -82.88 109.05 16.67 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 110.061 -0.348 . . . . 2.5 110.061 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -74.39 128.95 36.83 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.712 -0.847 . . . . 1.32 108.712 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.506 ' HG ' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -64.66 126.73 28.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.597 -0.274 . . . . 0.19 110.646 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -112.27 156.66 22.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.97 0.414 . . . . 0.39 110.031 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.864 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 17.2 p90 -146.84 161.46 40.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.911 -0.586 . . . . 0.16 109.524 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -102.09 140.35 36.48 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.246 -0.65 . . . . 0.34 109.246 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.484 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 1.8 tmt? -51.13 -23.84 3.56 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.827 0.851 . . . . 2.43 112.657 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.6 t -60.27 -23.22 63.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.642 0.258 . . . . 0.91 111.215 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -95.74 0.06 52.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.8 -0.182 . . . . 1.96 111.474 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 55' ' ' MET . 2.0 t -74.91 137.35 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.305 0.574 . . . . 0.27 111.422 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.83 104.07 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.858 -1.064 . . . . 1.6 111.972 -175.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.03 -84.55 0.49 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.58 113.074 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -135.19 158.17 45.06 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.893 -0.41 . . . . 2.2 109.893 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.9 p -74.5 -8.52 56.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.568 0.699 . . . . 0.95 110.138 178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.43 -1.09 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.306 -0.861 . . . . 1.39 109.904 175.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.87 -39.85 4.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.79 -0.641 . . . . 0.57 110.423 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.644 HD11 HG11 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -95.32 123.35 38.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.298 -0.63 . . . . 1.51 109.298 178.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -134.58 158.2 75.62 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.637 -0.256 . . . . 0.91 111.116 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.529 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 28.1 Cg_endo -63.53 142.19 83.43 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.689 2.259 . . . . 0.28 111.745 176.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.96 -6.49 83.11 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.58 -0.819 . . . . 0.22 112.742 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -95.08 158.65 15.37 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.61 -0.515 . . . . 1.28 109.61 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 94' ' ' ASP . 3.2 m -81.75 137.79 35.29 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.229 -0.656 . . . . 0.17 109.229 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.644 HG11 HD11 ' A' ' 65' ' ' LEU . 10.4 m -137.91 156.46 31.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.421 0.629 . . . . 0.31 109.857 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.39 133.16 55.91 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.505 -0.924 . . . . 0.78 108.505 175.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.532 ' CD2' HD13 ' A' ' 41' ' ' LEU . 28.6 p90 -142.5 179.46 6.95 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.71 -0.677 . . . . 0.11 109.789 -173.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 22' ' ' ALA . 5.4 t -127.95 116.31 19.88 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.995 -1.113 . . . . 0.86 107.995 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.3 p -81.64 98.22 4.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.906 0.86 . . . . 0.36 110.557 -173.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 p -102.62 116.31 46.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.23 -0.896 . . . . 0.42 109.788 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 30.2 m -73.99 130.7 40.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.117 -0.492 . . . . 0.67 110.496 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -68.96 112.18 5.45 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.212 -0.662 . . . . 1.82 109.212 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -52.91 -31.32 39.35 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.826 0.704 . . . . 1.95 111.889 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -94.24 -53.86 3.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.828 0.347 . . . . 3.99 111.591 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -74.06 -18.41 60.83 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.296 0.48 . . . . 2.21 112.296 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.93 -24.38 6.06 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.991 -0.624 . . . . 0.69 113.173 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -91.4 154.12 19.4 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.457 -0.571 . . . . 2.42 109.457 178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.549 ' HB2' HG11 ' A' ' 45' ' ' VAL . 17.6 m -101.11 179.98 4.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.951 0.405 . . . . 1.08 111.706 -174.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.1 m -146.37 155.94 42.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.794 -0.639 . . . . 0.87 109.43 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.864 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -96.23 120.67 36.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.89 0.376 . . . . 0.17 110.601 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.3 m -116.99 156.97 26.56 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.954 -0.758 . . . . 0.68 108.954 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 t30 55.9 62.54 2.35 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.694 0.621 . . . . 1.82 109.988 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.7 t -81.25 104.95 10.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.771 -0.649 . . . . 0.32 110.892 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.814 HD23 ' HA ' ' A' ' 13' ' ' GLU . 4.0 mp -107.29 150.53 26.58 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.293 -0.867 . . . . 1.12 111.364 -176.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.91 129.23 34.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.996 -0.547 . . . . 1.33 110.253 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mm -130.21 148.56 33.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.757 0.313 . . . . 0.28 110.766 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -119.86 103.72 9.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.039 0.447 . . . . 2.57 109.988 169.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.403 ' HB2' HG21 ' A' ' 70' ' ' THR . 9.9 t70 . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 115.825 -0.625 . . . . 3.08 110.892 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.225 0 N-CA-C 112.047 -0.421 . . . . 18.87 112.047 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.21 145.8 51.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.269 . . . . 17.7 110.721 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -133.71 132.89 41.16 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.167 -0.469 . . . . 17.44 110.089 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.99 -39.78 0.21 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.033 -1.08 . . . . 14.34 112.811 177.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -75.18 173.4 10.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.991 0.424 . . . . 13.69 110.038 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.561 ' H ' HD23 ' A' ' 6' ' ' LEU . 2.7 pt? -126.36 141.72 51.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.281 -0.418 . . . . 11.39 110.391 -177.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.0 p -120.74 137.17 55.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.649 -0.705 . . . . 8.82 110.381 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -72.34 77.0 1.01 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.379 0.609 . . . . 7.95 110.676 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -149.74 -37.53 0.15 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.949 -1.023 . . . . 7.07 109.556 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.466 ' HA ' ' HD3' ' A' ' 10' ' ' ARG . 9.3 mmt180 -72.55 147.89 45.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.496 -0.775 . . . . 6.67 110.777 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 14' ' ' SER . 0.1 OUTLIER -121.89 155.45 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.726 -0.67 . . . . 2.89 112.341 -168.393 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.72 -47.22 2.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.063 -0.971 . . . . 3.29 110.181 173.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.402 ' H ' ' HG3' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -71.0 9.16 0.75 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.929 0.715 . . . . 2.96 112.929 179.111 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.518 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 27.7 t -79.08 1.4 24.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.938 0.399 . . . . 2.31 111.164 -176.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.97 58.44 1.79 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.153 -1.022 . . . . 1.86 112.618 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -67.57 104.19 1.53 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.746 0.308 . . . . 5.03 110.389 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.61 -25.45 28.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.971 0.415 . . . . 2.37 110.746 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.46 -35.88 76.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.035 -0.529 . . . . 2.38 110.759 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 32.8 m -121.13 130.49 53.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.754 -0.832 . . . . 2.75 108.754 175.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.7 p -163.81 159.74 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 121.095 -0.242 . . . . 1.88 110.444 -173.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -98.39 -59.47 1.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.505 -0.316 . . . . 2.71 110.537 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.15 -174.29 4.99 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.065 -0.516 . . . . 1.95 110.961 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 m -76.71 69.81 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.967 -0.56 . . . . 1.72 111.469 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? 42.57 31.54 0.3 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.16 0.984 . . . . 2.92 112.523 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.421 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 6.4 tp60 -109.44 92.97 4.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.827 -0.624 . . . . 1.34 110.319 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -109.22 112.84 25.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.316 0.579 . . . . 2.11 110.337 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -99.07 151.25 21.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.378 -0.828 . . . . 1.27 110.856 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.423 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 43.1 mtm180 -119.25 127.89 53.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.714 0.292 . . . . 1.65 110.385 174.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.63 179.71 8.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.871 -0.604 . . . . 0.08 109.491 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.82 141.56 36.29 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 110.155 -0.313 . . . . 0.14 110.155 -177.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HA ' HD23 ' A' ' 41' ' ' LEU . 47.1 t -62.77 118.23 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.762 0.315 . . . . 0.14 110.257 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.403 ' H ' ' HA ' ' A' ' 41' ' ' LEU . 4.4 t70 -68.05 -43.81 77.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.459 -0.791 . . . . 0.6 110.098 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.6 p -178.52 165.66 1.74 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.31 -0.859 . . . . 1.07 109.511 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.5 mt -131.19 131.45 63.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.264 0.554 . . . . 0.19 109.958 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -123.66 85.71 2.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.385 -0.825 . . . . 1.56 110.249 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.09 -111.25 3.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.829 -0.7 . . . . 0.29 112.415 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -96.83 11.7 34.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.681 0.277 . . . . 2.1 110.746 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -131.61 139.73 49.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.191 0.52 . . . . 0.32 110.621 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.527 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -121.96 156.15 16.74 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 110.783 -0.927 . . . . 0.11 110.783 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -129.32 146.63 51.17 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.036 -0.727 . . . . 0.18 109.036 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.564 HD13 ' CD2' ' A' ' 73' ' ' PHE . 7.1 mt -117.69 152.68 34.74 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.103 -0.703 . . . . 0.59 109.103 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.66 72.94 2.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.926 0.869 . . . . 1.53 109.532 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.404 ' HB3' HD12 ' A' ' 51' ' ' LEU . 27.1 t80 -145.58 99.92 3.36 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.417 -1.265 . . . . 0.28 108.027 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.614 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 92.6 mt-10 -98.75 103.15 15.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.571 0.701 . . . . 1.81 110.763 -174.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.5 m -70.67 -37.11 68.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.521 -1.218 . . . . 0.85 112.483 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 2.5 tp10 -151.25 121.3 7.16 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 121.485 -0.086 . . . . 2.24 111.018 -176.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.9 t70 62.39 15.92 8.13 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.625 0.726 . . . . 1.55 111.87 169.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.536 ' HA2' ' OE2' ' A' ' 44' ' ' GLU . . . 94.33 28.42 10.66 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.577 -0.821 . . . . 0.67 112.056 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -81.07 110.16 16.33 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.604 -0.517 . . . . 2.5 109.604 179.164 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -68.63 130.27 42.36 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.649 0.593 . . . . 1.32 109.772 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 51' ' ' LEU . 2.1 mt -66.41 124.22 22.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.158 -0.474 . . . . 0.19 110.737 176.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -107.4 160.09 15.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.247 -0.433 . . . . 0.39 110.1 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.815 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 33.7 p90 -152.03 152.61 32.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.464 -0.789 . . . . 0.16 109.037 173.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -91.79 152.87 19.94 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.692 -0.855 . . . . 0.34 108.692 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.452 ' SD ' HG21 ' A' ' 58' ' ' VAL . 3.4 tpt -68.65 0.68 3.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.635 0.374 . . . . 2.43 111.927 -173.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.0 p -79.95 -37.54 34.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.958 0.409 . . . . 0.91 110.877 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -72.37 -16.23 61.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.771 -0.65 . . . . 1.96 110.14 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.452 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -61.06 150.81 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.141 -0.936 . . . . 0.27 111.778 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.459 ' HG2' ' HG ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -66.32 93.81 0.24 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.347 -0.842 . . . . 1.6 112.16 -176.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.86 -91.87 0.52 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.566 -0.743 . . . . 0.58 113.58 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -103.87 159.34 15.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.848 0.356 . . . . 2.2 110.098 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.5 p -79.86 -21.12 44.46 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.045 -0.525 . . . . 0.95 111.542 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.8 p -83.18 -9.42 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.373 0.606 . . . . 1.39 110.667 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 -19.7 28.19 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.551 -0.749 . . . . 0.57 111.383 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.512 HD11 HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -114.84 123.89 50.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.637 -0.71 . . . . 1.51 109.272 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -123.47 155.88 64.95 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 0.91 111.452 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.449 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.7 Cg_endo -68.98 132.53 24.79 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.502 2.135 . . . . 0.28 111.535 174.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.21 -11.04 63.75 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.931 -0.652 . . . . 0.22 111.758 -177.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -84.47 149.45 25.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.04 -0.356 . . . . 1.28 110.04 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 m -75.69 139.0 41.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.519 -0.549 . . . . 0.17 109.519 174.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.22 162.92 24.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 120.829 0.347 . . . . 0.31 111.218 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -114.43 148.0 38.42 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.869 -1.16 . . . . 0.78 107.869 172.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.564 ' CD2' HD13 ' A' ' 41' ' ' LEU . 29.5 p90 -153.62 -179.46 7.81 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.381 -0.6 . . . . 0.11 109.381 -175.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.6 m -128.07 114.26 16.83 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.988 -0.745 . . . . 0.86 108.988 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.6 p -84.24 99.87 7.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.597 0.713 . . . . 0.36 111.293 -175.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.81 121.89 60.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.685 -0.689 . . . . 0.42 109.589 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 22.1 m -80.36 128.58 33.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.71 0.29 . . . . 0.67 111.166 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 75.1 m-20 -74.09 114.66 12.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.157 -0.474 . . . . 1.82 109.875 177.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -64.03 -24.82 67.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.384 . . . . 1.95 111.835 -173.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -90.34 -45.54 8.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 3.99 111.342 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -85.72 -23.05 27.51 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.913 0.338 . . . . 2.21 111.913 -174.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.54 -21.08 14.94 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 121.237 -0.506 . . . . 0.69 112.764 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 39.7 pttt -98.05 142.76 29.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.292 0.568 . . . . 2.42 110.757 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 7.4 m -84.94 179.51 7.29 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.24 -0.891 . . . . 1.08 111.876 -175.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.4 m -147.37 157.45 43.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.652 -0.704 . . . . 0.87 109.479 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.815 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -98.86 122.2 41.79 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.901 0.381 . . . . 0.17 110.843 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 80.1 m -116.21 141.55 48.0 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.05 -0.523 . . . . 0.68 110.14 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.25 67.84 0.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.801 0.688 . . . . 1.82 110.144 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.512 HG12 HD11 ' A' ' 65' ' ' LEU . 92.7 t -84.73 103.76 12.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.593 -0.73 . . . . 0.32 110.645 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.522 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 8.1 mp -108.14 147.85 30.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.79 -0.641 . . . . 1.12 111.199 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.28 129.04 35.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.636 -0.711 . . . . 1.33 111.414 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.6 mm -118.7 133.44 65.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.963 -0.562 . . . . 0.28 111.518 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.611 HD22 ' H ' ' A' ' 93' ' ' ASN . 0.1 OUTLIER -90.73 105.87 18.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.639 0.733 . . . . 2.57 110.41 173.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 t70 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.633 -0.712 . . . . 3.08 110.632 -176.085 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.122 -0.391 . . . . 18.87 112.122 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.72 150.72 20.07 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.205 -0.294 . . . . 17.7 110.205 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -84.0 159.72 21.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.872 0.368 . . . . 17.44 110.27 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.0 -16.48 30.38 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.677 -0.773 . . . . 14.34 111.373 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -102.18 -170.44 1.81 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.488 -0.56 . . . . 13.69 109.488 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.3 tp -72.16 115.2 11.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.003 0.43 . . . . 11.39 111.178 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.437 HG23 ' CE1' ' A' ' 9' ' ' PHE . 3.1 p -91.54 98.29 8.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.773 0.796 . . . . 8.82 110.86 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.6 p -97.71 7.6 46.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.642 -0.708 . . . . 7.95 111.121 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.437 ' CE1' HG23 ' A' ' 7' ' ' VAL . 34.4 p90 -109.63 9.43 25.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.277 -0.42 . . . . 7.07 111.503 -176.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.18 -177.45 5.94 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.945 0.403 . . . . 6.67 111.697 -174.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.8 mp -102.49 133.88 44.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.525 -0.761 . . . . 2.89 111.294 -170.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -89.96 -43.62 10.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.54 0.209 . . . . 3.29 111.096 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.36 -9.58 1.63 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.165 0.586 . . . . 2.96 111.356 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 t -67.74 -20.76 65.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.507 -0.77 . . . . 2.31 110.791 174.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.32 60.29 0.75 Allowed Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.425 -0.893 . . . . 1.86 112.455 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.418 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 4.7 mmp_? -57.82 99.98 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.84 0.352 . . . . 5.03 111.509 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.76 -26.08 26.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.965 0.412 . . . . 2.37 111.22 175.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.19 -34.59 75.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.017 -0.538 . . . . 2.38 111.32 -175.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.8 p -146.98 131.92 18.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.033 -0.53 . . . . 2.75 110.087 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.52 HG22 ' H ' ' A' ' 22' ' ' ALA . 14.7 p -167.51 144.11 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.456 -0.572 . . . . 1.88 109.456 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -97.46 16.8 19.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.045 0.45 . . . . 2.71 110.865 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.52 ' H ' HG22 ' A' ' 20' ' ' VAL . . . -152.7 -168.89 3.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.149 -0.478 . . . . 1.95 110.517 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 24' ' ' ARG . 2.2 t -86.54 177.29 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.796 -0.816 . . . . 1.72 108.796 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.558 ' H ' HG12 ' A' ' 23' ' ' VAL . 3.8 ppt_? -71.84 55.41 0.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.627 0.727 . . . . 2.92 111.292 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -132.76 82.58 2.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.62 -0.718 . . . . 1.34 110.483 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -97.1 111.73 23.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.465 0.65 . . . . 2.11 110.254 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 73.1 mmtt -94.27 160.21 14.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.992 -1.004 . . . . 1.27 110.308 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 17.6 mtm180 -128.72 127.52 42.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.959 0.409 . . . . 1.65 110.131 175.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.49 178.21 9.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.679 -0.691 . . . . 0.08 109.724 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.04 141.21 33.17 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.276 -0.639 . . . . 0.14 109.276 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.434 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 51.1 t -62.31 114.42 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.821 -0.437 . . . . 0.14 109.821 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.29 -47.15 62.5 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.307 -0.86 . . . . 0.6 109.973 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.5 m -160.72 160.14 31.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.596 -0.729 . . . . 1.07 110.392 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.413 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 10.2 mt -137.26 120.12 20.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.174 -0.676 . . . . 0.19 109.174 173.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -110.23 86.38 2.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.544 -0.753 . . . . 1.56 109.767 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.8 -109.15 2.76 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.683 -0.77 . . . . 0.29 112.247 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -91.18 2.75 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.926 -0.161 . . . . 2.1 111.269 -177.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -124.07 141.0 52.43 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.305 -0.558 . . . . 0.32 111.335 -174.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 34' ' ' ILE . . . -122.56 158.66 17.23 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.517 -0.765 . . . . 0.11 111.415 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 49.6 m-85 -136.11 136.23 39.95 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.882 -0.784 . . . . 0.18 108.882 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.497 HD21 ' CD2' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -106.26 155.08 19.85 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.458 -0.942 . . . . 0.59 108.458 177.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -76.32 73.5 3.11 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.419 0.628 . . . . 1.53 109.581 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -141.66 98.82 3.42 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.065 -0.971 . . . . 0.28 109.657 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.75 100.69 7.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.616 0.722 . . . . 1.81 110.101 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.48 ' CG1' ' HG ' ' A' ' 51' ' ' LEU . 31.6 m -80.23 -34.5 14.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.014 -0.993 . . . . 0.85 110.992 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.511 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 8.3 tp10 -137.08 177.61 7.73 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.019 -1.845 . . . . 2.24 106.019 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.511 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 29.2 t70 -40.56 85.94 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.815 1.043 . . . . 1.55 113.815 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.22 16.99 71.68 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.775 -0.93 . . . . 0.67 110.775 173.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -88.5 109.42 20.03 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.004 -0.739 . . . . 2.5 109.004 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -75.46 134.32 40.88 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.65 -0.5 . . . . 1.32 109.65 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 1.4 mt -64.69 125.01 23.41 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.253 0.346 . . . . 0.19 111.037 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -108.78 158.61 17.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.962 -0.384 . . . . 0.39 109.962 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.886 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 45.9 p90 -153.11 154.25 34.45 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.065 -0.717 . . . . 0.16 109.065 173.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -94.54 152.07 18.84 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.627 -0.879 . . . . 0.34 108.627 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.527 ' SD ' HG21 ' A' ' 58' ' ' VAL . 9.4 mmt -63.87 0.79 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.28 0.474 . . . . 2.43 112.28 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.3 t -86.13 -23.05 26.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.713 0.292 . . . . 0.91 110.327 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -91.11 -2.59 57.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.025 0.44 . . . . 1.96 110.079 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.527 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.2 t -72.66 151.28 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.53 -0.759 . . . . 0.27 112.389 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.445 ' HG2' HD13 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -60.53 96.27 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.05 -0.977 . . . . 1.6 111.57 -178.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.17 -84.11 0.41 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.753 -0.658 . . . . 0.58 113.569 170.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -113.25 145.74 40.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.139 0.495 . . . . 2.2 110.579 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.482 HG22 ' HB3' ' A' ' 55' ' ' MET . 81.6 p -72.3 -9.63 58.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 0.95 111.705 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.8 t -95.36 -2.92 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.499 -0.773 . . . . 1.39 110.373 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.94 -17.59 22.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.096 0.474 . . . . 0.57 111.445 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.511 HD11 HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -113.1 124.0 51.56 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.163 -0.68 . . . . 1.51 109.163 -176.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -123.29 155.63 64.71 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.656 0.265 . . . . 0.91 111.269 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.434 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 38.0 Cg_endo -67.12 128.36 18.44 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.341 2.027 . . . . 0.28 111.339 172.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.74 -11.62 53.31 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.684 -0.769 . . . . 0.22 112.072 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -81.14 149.16 29.25 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.645 0.259 . . . . 1.28 110.522 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.6 m -76.86 131.35 38.56 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.525 -0.917 . . . . 0.17 108.525 171.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.481 HG11 HD21 ' A' ' 65' ' ' LEU . 35.7 m -135.01 159.48 41.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 122.04 0.924 . . . . 0.31 111.006 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -114.52 139.75 49.31 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.844 -1.526 . . . . 0.78 108.708 177.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.535 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 29.9 p90 -152.37 -179.68 7.77 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.463 -0.569 . . . . 0.11 109.463 -174.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 t -124.99 127.81 47.59 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.803 -0.814 . . . . 0.86 108.803 177.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.4 p -95.01 98.45 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 121.919 0.866 . . . . 0.36 110.835 -176.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.0 p -104.7 110.82 31.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.246 -0.888 . . . . 0.42 110.09 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 31.8 m -69.37 123.8 22.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.095 -0.502 . . . . 0.67 110.454 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 83' ' ' LYS . 0.9 OUTLIER -69.92 109.38 4.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.516 -0.549 . . . . 1.82 109.516 178.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.44 ' CD ' ' H ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -64.57 -13.37 52.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.788 0.328 . . . . 1.95 111.316 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -94.37 -36.14 12.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.402 -0.363 . . . . 3.99 111.47 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -99.82 -29.36 12.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.253 0.464 . . . . 2.21 112.253 -174.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.17 -24.38 25.24 Favored Glycine 0 C--N 1.32 -0.313 0 C-N-CA 121.239 -0.505 . . . . 0.69 112.103 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 78' ' ' ASN . 18.3 pttm -95.03 154.46 17.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.622 -0.511 . . . . 2.42 109.622 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.465 ' H ' HG21 ' A' ' 45' ' ' VAL . 2.0 m -94.97 -179.26 4.77 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.843 0.354 . . . . 1.08 110.736 -177.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -146.36 146.88 30.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.244 -0.65 . . . . 0.87 109.244 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.886 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -88.92 118.41 28.62 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.912 0.386 . . . . 0.17 110.424 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.8 m -117.16 149.09 40.95 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.257 -0.646 . . . . 0.68 109.257 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 m120 61.61 67.95 0.74 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.491 0.662 . . . . 1.82 109.532 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.511 HG12 HD11 ' A' ' 65' ' ' LEU . 86.0 t -89.92 111.76 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.286 -0.87 . . . . 0.32 110.748 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.445 HD13 ' HG2' ' A' ' 59' ' ' GLN . 4.2 mm? -107.46 147.27 30.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.574 -0.739 . . . . 1.12 110.903 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 114.17 21.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.748 -0.66 . . . . 1.33 110.136 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.9 mm -101.29 135.3 38.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.56 -0.746 . . . . 0.28 111.135 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -71.2 115.2 10.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.607 -0.724 . . . . 2.57 110.218 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.812 -0.631 . . . . 3.08 111.069 178.445 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 112.031 -0.428 . . . . 18.87 112.031 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.09 -26.22 62.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.994 0.426 . . . . 17.7 110.839 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -105.13 87.69 2.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.152 0.501 . . . . 17.44 110.994 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.63 81.35 0.29 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.935 -0.866 . . . . 14.34 110.935 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -90.23 -170.8 2.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.109 0.48 . . . . 13.69 112.211 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.2 117.03 13.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 11.39 112.55 -171.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.29 125.59 68.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.847 -0.615 . . . . 8.82 109.843 171.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.458 ' HA ' HH22 ' A' ' 16' ' ' ARG . 17.0 m -83.43 95.18 8.17 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.866 -0.42 . . . . 7.95 109.866 176.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -156.75 -36.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.871 -0.604 . . . . 7.07 110.971 -174.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -84.44 177.71 8.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.155 -0.475 . . . . 6.67 111.976 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.0 mm -70.11 119.07 15.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.611 -0.722 . . . . 2.89 110.908 -175.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -84.79 -29.69 25.22 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.387 0.514 . . . . 3.29 112.387 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 2.0 pt-20 -66.06 -7.01 14.87 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.358 0.599 . . . . 2.96 110.833 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.5 t -71.19 -25.9 62.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.635 -0.711 . . . . 2.31 109.873 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.64 47.11 35.5 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.888 -0.885 . . . . 1.86 110.888 -174.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.458 HH22 ' HA ' ' A' ' 8' ' ' SER . 17.9 ptt180 -57.9 122.81 13.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.356 0.598 . . . . 5.03 111.438 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.27 -14.48 7.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.823 -1.081 . . . . 2.37 112.801 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.76 -27.98 68.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.631 -0.259 . . . . 2.38 110.9 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.4 t -143.6 128.71 18.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 2.75 110.175 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.584 HG22 ' H ' ' A' ' 22' ' ' ALA . 15.0 p -169.95 138.06 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.897 -0.592 . . . . 1.88 109.833 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -93.67 -13.32 27.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.149 0.499 . . . . 2.71 110.57 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.584 ' H ' HG22 ' A' ' 20' ' ' VAL . . . -114.32 -178.54 3.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.046 -0.524 . . . . 1.95 110.585 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.465 ' C ' ' HG3' ' A' ' 24' ' ' ARG . 2.5 m -86.48 73.24 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.18 -0.463 . . . . 1.72 111.993 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HG3' ' C ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 40.42 46.1 1.99 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.912 0.885 . . . . 2.92 113.064 175.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -132.73 112.27 11.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.159 -0.473 . . . . 1.34 110.965 -176.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.26 125.51 51.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.314 0.578 . . . . 2.11 110.836 176.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . 68.2 mmtt -104.12 147.55 27.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.58 -0.736 . . . . 1.27 109.198 171.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.401 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 17.5 mtm180 -124.16 128.11 48.76 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.96 -0.296 . . . . 1.65 110.852 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.79 179.49 9.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.542 -0.753 . . . . 0.08 110.429 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.07 146.65 28.05 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.117 -0.492 . . . . 0.14 110.335 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 31.0 t -67.26 121.73 16.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.157 0.503 . . . . 0.14 110.325 176.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -80.95 -41.69 22.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.434 -0.803 . . . . 0.6 109.914 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.3 p -163.96 166.9 21.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 1.07 110.643 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.419 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 7.3 mt -140.86 130.92 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.256 0.551 . . . . 0.19 109.873 175.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -124.82 88.16 2.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.383 -0.826 . . . . 1.56 110.411 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.48 -110.91 3.49 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.674 -0.774 . . . . 0.29 112.192 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -92.34 5.81 49.24 Favored 'General case' 0 C--O 1.225 -0.236 0 O-C-N 122.77 -0.253 . . . . 2.1 110.88 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -126.36 140.72 52.28 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.212 -0.595 . . . . 0.32 111.499 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -122.82 157.95 17.43 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.319 -0.855 . . . . 0.11 111.176 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 80.1 m-85 -130.26 140.54 50.68 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.292 -0.633 . . . . 0.18 109.292 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.466 HD13 ' CD2' ' A' ' 73' ' ' PHE . 6.8 mt -116.28 153.42 31.96 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.777 -0.453 . . . . 0.59 109.777 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -75.97 73.84 2.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.597 0.713 . . . . 1.53 109.817 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -144.45 109.27 4.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.845 -1.07 . . . . 0.28 109.275 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -92.81 115.02 27.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.848 -0.614 . . . . 1.81 110.576 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' A' ' 84' ' ' SER . 13.9 m -85.62 -47.49 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.78 -0.645 . . . . 0.85 111.46 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.611 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 8.4 pt-20 -157.1 144.64 18.91 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.486 -0.561 . . . . 2.24 109.486 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.9 t70 59.63 10.76 2.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.969 0.89 . . . . 1.55 112.009 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.13 30.58 37.4 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.609 -0.805 . . . . 0.67 112.106 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 8.1 mtpp -73.34 112.45 9.41 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.451 -0.203 . . . . 2.5 110.451 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.07 120.73 14.76 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.58 0.55 . . . . 1.32 109.527 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 2.4 mt -58.54 128.02 35.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.025 -0.534 . . . . 0.19 112.074 -176.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -106.17 161.65 14.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.905 0.383 . . . . 0.39 110.559 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.911 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 21.2 p90 -152.76 157.17 40.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.95 -0.568 . . . . 0.16 109.572 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -99.49 150.66 21.97 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.952 -0.759 . . . . 0.34 108.952 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.474 ' SD ' HG21 ' A' ' 58' ' ' VAL . 16.4 mmt -61.89 -9.43 6.84 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.114 0.412 . . . . 2.43 112.114 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.1 t -71.36 -26.06 62.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.823 0.344 . . . . 0.91 110.196 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -92.98 -2.07 56.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.417 -0.356 . . . . 1.96 110.588 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.474 HG21 ' SD ' ' A' ' 55' ' ' MET . 1.2 t -73.25 151.44 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.397 0.617 . . . . 0.27 112.569 -174.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.447 ' HB2' ' HA ' ' A' ' 90' ' ' LEU . 17.1 tm0? -68.03 98.82 0.8 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.903 -1.044 . . . . 1.6 112.5 -174.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.55 -81.89 0.39 Allowed Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.814 -0.63 . . . . 0.58 113.354 172.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -114.34 150.11 35.04 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.928 0.394 . . . . 2.2 110.159 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.7 p -71.22 -16.44 62.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.808 -0.633 . . . . 0.95 110.625 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 t -97.36 10.46 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.449 -0.796 . . . . 1.39 109.856 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.32 -27.22 12.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.118 0.485 . . . . 0.57 110.916 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.751 HD21 HG12 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -102.29 124.29 47.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.042 -0.725 . . . . 1.51 109.042 178.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.6 154.19 69.92 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.618 0.246 . . . . 0.91 111.33 -172.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.448 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 39.6 Cg_endo -67.49 121.56 8.68 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.307 2.005 . . . . 0.28 111.422 173.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.494 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 103.05 -5.91 50.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.813 -0.708 . . . . 0.22 111.786 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.28 152.23 22.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.374 -0.602 . . . . 1.28 109.374 176.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 7.1 m -81.1 141.59 34.15 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.077 -0.712 . . . . 0.17 109.077 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.751 HG12 HD21 ' A' ' 65' ' ' LEU . 4.3 m -137.26 161.65 34.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.412 0.625 . . . . 0.31 110.83 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -114.61 141.33 47.91 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.43 -1.322 . . . . 0.78 107.43 170.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.516 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 30.9 p90 -151.64 178.98 8.8 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.978 0.418 . . . . 0.11 110.103 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.2 m -127.31 129.91 48.55 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.871 -0.788 . . . . 0.86 108.871 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 p -89.25 99.79 9.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.69 0.757 . . . . 0.36 110.979 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.4 p -107.33 101.93 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.741 0.781 . . . . 0.42 109.932 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 m -70.46 130.83 42.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.416 -0.811 . . . . 0.67 110.867 -177.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -71.45 104.8 3.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.7 -0.852 . . . . 1.82 108.7 172.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -62.65 -16.78 58.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.847 0.356 . . . . 1.95 111.407 -176.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -90.75 -40.79 11.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.126 -0.488 . . . . 3.99 111.038 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -94.37 -31.47 14.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.864 0.364 . . . . 2.21 111.709 -173.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.28 -23.76 33.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.108 -0.568 . . . . 0.69 112.273 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.439 ' HD3' ' HE2' ' A' ' 49' ' ' LYS . 21.4 pttt -91.44 154.08 19.4 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.052 -0.351 . . . . 2.42 110.052 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.42 ' HB3' HG11 ' A' ' 45' ' ' VAL . 14.6 t -108.25 -176.46 3.06 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.439 -0.346 . . . . 1.08 110.808 -173.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 p -155.28 147.13 23.35 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.787 -0.642 . . . . 0.87 109.338 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.911 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -87.22 123.01 31.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 120.974 0.416 . . . . 0.17 111.081 -177.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 89.5 m -117.35 150.95 37.99 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.876 -0.602 . . . . 0.68 109.475 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 58.4 63.01 1.82 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.413 0.446 . . . . 1.82 109.809 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 79.3 t -84.16 103.78 11.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.873 -0.603 . . . . 0.32 110.325 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.447 ' HA ' ' HB2' ' A' ' 59' ' ' GLN . 4.6 mm? -101.31 147.59 26.13 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.698 -0.683 . . . . 1.12 109.888 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.568 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -82.3 126.93 32.71 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.47 -0.567 . . . . 1.33 109.47 178.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.517 ' O ' ' HB ' ' A' ' 70' ' ' THR . 38.7 mm -116.82 132.23 67.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.906 -0.588 . . . . 0.28 110.103 -176.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -119.74 137.29 54.03 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.402 0.62 . . . . 2.57 111.355 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--N 1.317 -0.817 0 CA-C-N 115.066 -0.97 . . . . 3.08 110.511 175.78 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 111.839 -0.505 . . . . 18.87 111.839 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.44 89.92 3.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.929 0.395 . . . . 17.7 110.499 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -86.63 93.56 9.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.208 0.528 . . . . 17.44 110.298 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.46 175.84 15.87 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.802 -0.713 . . . . 14.34 111.948 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -95.25 102.18 13.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.957 -0.386 . . . . 13.69 109.957 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 mp -87.6 144.26 26.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.822 0.344 . . . . 11.39 110.624 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 9' ' ' PHE . 7.4 p -88.75 118.03 33.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.976 -0.556 . . . . 8.82 110.032 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 m -78.3 -8.59 58.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.249 -0.432 . . . . 7.95 110.812 -177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.495 ' H ' HG22 ' A' ' 7' ' ' VAL . 37.5 p90 50.51 28.45 3.4 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.618 1.167 . . . . 7.07 112.004 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -166.14 129.69 2.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.192 -0.458 . . . . 6.67 110.811 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 13' ' ' GLU . 46.5 mm -116.75 138.86 45.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.325 -0.991 . . . . 2.89 108.325 166.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -66.77 -20.0 65.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.867 0.365 . . . . 3.29 111.251 -174.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.603 ' H ' HG22 ' A' ' 11' ' ' ILE . 9.6 mt-10 -73.29 -4.25 32.08 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.26 0.552 . . . . 2.96 110.536 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.4 t -73.73 -16.89 61.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.298 -0.41 . . . . 2.31 110.903 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.01 57.76 2.21 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.202 -0.999 . . . . 1.86 111.024 -176.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -85.94 143.75 28.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.054 0.454 . . . . 5.03 110.925 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.94 -15.04 40.25 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.408 -0.814 . . . . 2.37 112.783 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.0 -27.01 67.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.675 0.25 . . . . 2.38 111.675 -174.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.4 m -149.05 129.28 13.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.828 0.347 . . . . 2.75 110.292 175.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.474 HG22 ' H ' ' A' ' 22' ' ' ALA . 13.6 p -169.34 142.53 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.876 -0.602 . . . . 1.88 109.918 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -116.16 -4.75 11.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.474 0.654 . . . . 2.71 110.3 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.474 ' H ' HG22 ' A' ' 20' ' ' VAL . . . -128.83 -129.11 0.22 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.331 -0.85 . . . . 1.95 109.615 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 25' ' ' GLN . 16.2 m -131.19 -165.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.946 0.403 . . . . 1.72 110.912 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -48.9 -27.63 3.22 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.337 1.055 . . . . 2.92 113.594 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' H ' HG23 ' A' ' 23' ' ' VAL . 27.7 tt0 -82.26 107.37 14.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.033 0.444 . . . . 1.34 111.903 -168.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -111.7 111.67 22.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.741 -0.663 . . . . 2.11 110.22 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -87.14 153.66 21.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.686 -0.688 . . . . 1.27 110.215 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 43.9 mtm180 -125.5 135.63 52.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.859 0.361 . . . . 1.65 110.527 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.81 179.34 8.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.558 -0.746 . . . . 0.08 109.447 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.25 147.09 28.44 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 110.003 -0.369 . . . . 0.14 110.003 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.548 ' HB ' ' H ' ' A' ' 68' ' ' GLY . 26.7 t -69.34 120.33 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.077 0.465 . . . . 0.14 110.317 177.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -72.18 -41.81 66.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.312 -0.858 . . . . 0.6 110.631 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.8 p -175.66 163.3 2.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.685 -0.688 . . . . 1.07 109.477 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 mt -131.06 131.28 64.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.259 0.552 . . . . 0.19 110.264 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -121.86 86.37 2.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.141 -0.936 . . . . 1.56 109.775 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.15 -112.48 4.06 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.659 -0.782 . . . . 0.29 112.193 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -93.34 7.28 45.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.59 0.233 . . . . 2.1 110.743 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.24 141.64 51.4 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.081 0.467 . . . . 0.32 111.007 -174.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.74 157.52 18.18 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 111.038 -0.825 . . . . 0.11 111.038 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 81.1 m-85 -130.19 143.28 50.69 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.82 -0.437 . . . . 0.18 109.82 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.491 HD13 ' CD2' ' A' ' 73' ' ' PHE . 8.4 mt -117.5 152.88 34.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.075 -0.512 . . . . 0.59 109.918 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -74.37 74.76 1.89 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.671 0.748 . . . . 1.53 109.723 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -151.06 99.26 2.67 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.882 -1.054 . . . . 0.28 108.654 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.671 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 14.1 mt-10 -94.41 101.54 13.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.709 0.766 . . . . 1.81 111.296 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.652 HG23 ' H ' ' A' ' 46' ' ' GLU . 2.4 m -75.43 -59.07 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.247 -1.342 . . . . 0.85 111.262 -178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.652 ' H ' HG23 ' A' ' 45' ' ' VAL . 10.9 tp10 -106.82 179.87 4.14 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.131 -1.433 . . . . 2.24 107.131 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.422 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 31.3 t70 -30.54 83.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.854 1.262 . . . . 1.55 113.914 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 66.23 16.09 64.16 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.792 -0.718 . . . . 0.67 111.512 172.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 2.4 mmmt -77.14 108.09 9.98 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 110.021 -0.363 . . . . 2.5 110.021 -174.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -74.93 123.11 24.51 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.976 -1.12 . . . . 1.32 107.976 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 4.1 mt -57.55 122.22 12.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.818 0.342 . . . . 0.19 111.423 -174.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -101.07 155.07 18.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.896 -0.593 . . . . 0.39 109.954 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.955 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 33.1 p90 -149.4 157.13 43.05 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.632 -0.713 . . . . 0.16 109.276 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -99.77 150.11 22.66 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.238 -0.653 . . . . 0.34 109.238 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.522 ' SD ' HG21 ' A' ' 58' ' ' VAL . 11.0 mmt -60.47 -6.89 1.77 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.631 0.604 . . . . 2.43 112.631 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.409 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . 17.6 t -79.01 -28.98 43.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.693 0.282 . . . . 0.91 110.284 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' OE2' ' HB3' ' A' ' 56' ' ' SER . 2.6 mp0 -85.61 -4.47 59.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.972 0.415 . . . . 1.96 110.593 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.522 HG21 ' SD ' ' A' ' 55' ' ' MET . 2.1 t -69.5 148.38 11.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.605 -0.725 . . . . 0.27 112.486 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.449 ' HG2' HD13 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -64.15 99.9 0.3 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.467 -1.242 . . . . 1.6 111.883 -175.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.56 -89.65 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.866 -0.607 . . . . 0.58 113.131 173.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -106.07 151.06 25.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.986 0.422 . . . . 2.2 110.603 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.0 p -63.76 -33.79 76.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.478 -0.783 . . . . 0.95 111.076 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.6 t -88.3 7.22 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.828 -0.624 . . . . 1.39 110.443 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.82 -9.42 34.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.093 0.473 . . . . 0.57 110.788 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.764 HD21 HG12 ' A' ' 71' ' ' VAL . 1.1 tm? -121.36 124.5 44.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.622 -0.881 . . . . 1.51 108.622 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -122.87 152.33 62.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.452 -0.34 . . . . 0.91 111.407 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 44.8 Cg_endo -69.74 115.92 4.31 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.585 2.19 . . . . 0.28 111.907 176.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.548 ' H ' ' HB ' ' A' ' 31' ' ' VAL . . . 119.77 -18.85 9.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.14 -0.553 . . . . 0.22 112.247 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.21 155.92 24.68 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.755 -0.461 . . . . 1.28 109.755 175.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 3.0 m -78.45 143.11 36.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.677 -0.49 . . . . 0.17 109.677 176.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.764 HG12 HD21 ' A' ' 65' ' ' LEU . 26.6 m -137.53 157.52 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 121.699 0.762 . . . . 0.31 110.215 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -115.41 141.51 47.94 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.27 -1.332 . . . . 0.78 108.359 171.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.491 ' CD2' HD13 ' A' ' 41' ' ' LEU . 30.5 p90 -152.04 179.57 8.36 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.05 -0.722 . . . . 0.11 109.05 -173.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.85 128.51 47.75 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.961 -0.755 . . . . 0.86 108.961 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.05 98.69 7.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.759 0.79 . . . . 0.36 110.61 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.88 125.64 67.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.292 -0.867 . . . . 0.42 109.367 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.7 m -81.4 128.98 34.44 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.351 -0.386 . . . . 0.67 110.48 -178.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -68.1 111.14 4.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.68 -0.489 . . . . 1.82 109.68 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.55 -18.84 44.03 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.081 -0.509 . . . . 1.95 112.035 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -95.06 -38.12 10.78 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.841 0.312 . . . . 3.99 111.841 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.444 ' HB3' ' HE2' ' A' ' 83' ' ' LYS . 11.2 m120 -113.73 -5.74 13.31 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.045 0.758 . . . . 2.21 113.045 -172.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.94 -9.42 24.77 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.893 -0.67 . . . . 0.69 114.017 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -97.45 152.87 18.53 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.581 -0.526 . . . . 2.42 109.581 179.227 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.1 t -97.01 -179.67 4.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.158 0.504 . . . . 1.08 111.745 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.7 p -154.97 150.4 27.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.35 -0.841 . . . . 0.87 108.783 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.955 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -87.22 122.58 31.2 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.201 0.524 . . . . 0.17 110.51 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 84.0 m -116.92 144.88 44.03 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.524 -0.762 . . . . 0.68 109.739 178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 56.79 73.26 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.812 0.695 . . . . 1.82 109.792 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 73.3 t -87.75 105.69 15.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.741 -0.663 . . . . 0.32 110.46 -178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.449 HD13 ' HG2' ' A' ' 59' ' ' GLN . 4.3 mm? -101.98 149.05 24.62 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.358 -0.837 . . . . 1.12 110.298 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.537 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -84.54 115.85 22.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.326 -0.62 . . . . 1.33 109.326 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 70' ' ' THR . 43.2 mm -109.62 137.48 41.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.158 0.504 . . . . 0.28 111.801 -172.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -108.45 133.14 53.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.833 -0.802 . . . . 2.57 108.833 169.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 115.905 -0.588 . . . . 3.08 110.93 -175.76 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 111.999 -0.44 . . . . 18.87 111.999 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.01 18.99 11.74 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.264 0.554 . . . . 17.7 111.304 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -105.76 91.0 3.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.905 -0.589 . . . . 17.44 109.612 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.48 -40.85 1.98 Allowed Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.685 -0.769 . . . . 14.34 112.753 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.24 117.33 12.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.036 0.446 . . . . 13.69 110.483 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.9 mt -81.79 119.01 23.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.501 0.667 . . . . 11.39 111.192 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.7 m -91.91 23.5 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.039 -0.982 . . . . 8.82 110.349 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 m 64.17 24.12 13.33 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.299 -0.864 . . . . 7.95 110.827 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -73.65 -30.46 62.94 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.774 0.797 . . . . 7.07 109.277 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -158.13 141.56 15.26 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.701 -1.136 . . . . 6.67 109.496 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 11' ' ' ILE . 3.0 mp -122.27 140.83 44.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.869 -0.789 . . . . 2.89 108.869 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.88 -28.49 66.74 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.09 0.404 . . . . 3.29 112.09 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.777 ' HA ' ' OE1' ' A' ' 72' ' ' GLU . 10.7 pt-20 -60.05 -15.01 19.36 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.171 0.51 . . . . 2.96 110.689 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 p -70.15 -27.34 64.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.411 -0.813 . . . . 2.31 111.011 -178.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.98 57.36 2.16 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.584 -0.817 . . . . 1.86 111.704 -175.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -59.09 120.99 10.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.713 0.292 . . . . 5.03 111.472 -176.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.59 -17.68 40.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 2.37 111.961 -177.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.27 -36.57 77.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.654 0.264 . . . . 2.38 111.18 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 44.5 t -151.23 131.85 13.94 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.467 -0.568 . . . . 2.75 109.467 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.9 p -168.04 153.38 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.169 -0.469 . . . . 1.88 109.764 -175.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -84.52 -55.25 4.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.08 0.467 . . . . 2.71 110.646 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.15 -166.03 1.39 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.766 -0.652 . . . . 1.95 110.334 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -91.94 -160.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.176 -0.676 . . . . 1.72 109.176 178.094 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.529 ' H ' HG12 ' A' ' 23' ' ' VAL . 4.3 ppt_? -71.43 15.4 0.13 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.041 0.386 . . . . 2.92 112.041 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.5 ' HA ' ' OE1' ' A' ' 25' ' ' GLN . 4.0 tp60 -91.73 80.15 5.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.202 0.525 . . . . 1.34 110.767 -174.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -104.11 112.63 25.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.656 -0.702 . . . . 2.11 110.421 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 67.7 mmtt -100.05 157.52 16.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.424 -0.807 . . . . 1.27 111.4 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -124.53 140.04 53.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.44 -0.346 . . . . 1.65 110.122 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.42 179.26 6.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.048 -0.523 . . . . 0.08 110.184 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.01 145.14 30.33 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.239 -0.437 . . . . 0.14 110.103 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.512 ' HA ' HD23 ' A' ' 41' ' ' LEU . 46.2 t -68.98 119.9 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.38 -0.373 . . . . 0.14 110.565 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -72.88 -40.41 65.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.826 -0.625 . . . . 0.6 110.344 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 p -171.12 164.3 7.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.067 -0.515 . . . . 1.07 110.628 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.7 mt -136.56 130.82 47.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.587 -0.523 . . . . 0.19 109.587 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -128.27 101.29 6.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.475 -0.784 . . . . 1.56 110.171 -175.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.27 -105.89 1.43 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.665 -0.778 . . . . 0.29 112.392 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -106.12 6.76 31.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.934 -0.395 . . . . 2.1 109.934 -177.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -125.4 140.64 52.62 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.377 0.608 . . . . 0.32 111.091 -174.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -123.79 156.58 18.04 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.957 -0.857 . . . . 0.11 110.957 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -131.0 144.95 51.87 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.711 -0.478 . . . . 0.18 109.711 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.551 HD13 ' CD2' ' A' ' 73' ' ' PHE . 4.8 mt -121.07 152.1 39.05 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.275 -0.639 . . . . 0.59 109.275 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -75.54 75.26 2.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.314 0.578 . . . . 1.53 109.585 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -143.12 98.17 3.22 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.433 -0.803 . . . . 0.28 109.509 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -79.47 101.31 8.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.915 -0.584 . . . . 1.81 109.844 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 84' ' ' SER . 31.5 m -75.21 -43.96 43.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.536 -0.756 . . . . 0.85 110.609 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 6.0 tp10 -129.08 179.37 5.79 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 106.328 -1.731 . . . . 2.24 106.328 174.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.519 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 14.2 t70 -31.23 83.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.229 1.412 . . . . 1.55 114.059 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.03 8.65 61.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.273 -0.489 . . . . 0.67 111.954 173.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -74.32 110.38 8.57 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.505 -0.554 . . . . 2.5 109.505 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.486 ' NZ ' ' HB2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -78.9 129.77 34.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.668 -0.696 . . . . 1.32 110.193 -173.716 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 51' ' ' LEU . 3.2 mt -67.95 127.56 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.318 -0.401 . . . . 0.19 111.274 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -113.51 157.27 22.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.738 -0.664 . . . . 0.39 109.47 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.937 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 32.3 p90 -146.05 153.23 40.5 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.992 -0.549 . . . . 0.16 109.759 174.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -94.36 148.13 22.53 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.142 -0.688 . . . . 0.34 109.142 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.63 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 21.7 ttp -65.12 2.9 0.68 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.272 0.629 . . . . 2.43 111.635 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.7 t -89.53 -19.23 25.28 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.648 -0.251 . . . . 0.91 110.751 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -85.85 -11.19 53.97 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 121.378 0.608 . . . . 1.96 109.426 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 62' ' ' THR . 1.6 t -64.41 146.78 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.783 -1.099 . . . . 0.27 112.593 -174.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.37 98.65 0.25 Allowed 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.831 -1.077 . . . . 1.6 111.899 -173.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.92 -77.54 1.12 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.58 113.512 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -119.87 149.92 41.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.068 0.461 . . . . 2.2 110.025 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.63 ' HB ' ' SD ' ' A' ' 55' ' ' MET . 43.0 p -69.21 -21.89 63.92 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.33 -0.85 . . . . 0.95 112.233 -171.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.9 t -98.92 4.9 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.568 0.699 . . . . 1.39 110.169 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.13 -25.54 27.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.162 -0.472 . . . . 0.57 110.493 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.683 HD21 HG12 ' A' ' 71' ' ' VAL . 1.1 tm? -104.04 125.28 50.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.862 -0.608 . . . . 1.51 109.563 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -124.15 154.81 68.47 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.523 0.201 . . . . 0.91 111.134 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' A' ' 31' ' ' VAL . 39.3 Cg_endo -68.55 144.57 61.22 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.659 2.239 . . . . 0.28 112.152 176.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.48 -11.98 64.36 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.925 -0.655 . . . . 0.22 112.345 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.02 154.03 20.81 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.43 -0.211 . . . . 1.28 110.43 177.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.6 m -76.33 138.5 40.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.705 -0.48 . . . . 0.17 109.705 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.683 HG12 HD21 ' A' ' 65' ' ' LEU . 11.3 m -138.09 163.22 29.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.398 0.618 . . . . 0.31 109.877 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.777 ' OE1' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -116.5 149.21 39.92 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.98 -1.009 . . . . 0.78 108.476 172.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.551 ' CD2' HD13 ' A' ' 41' ' ' LEU . 36.1 p90 -156.75 178.25 10.55 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.039 -0.356 . . . . 0.11 110.039 -175.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -124.36 132.67 53.55 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.94 -0.763 . . . . 0.86 108.94 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.32 99.01 8.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.693 0.759 . . . . 0.36 110.496 -174.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.19 126.71 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.459 -0.792 . . . . 0.42 110.589 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.6 m -74.33 132.66 42.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.088 -0.506 . . . . 0.67 111.287 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -75.17 116.46 15.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.092 -0.707 . . . . 1.82 109.092 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -58.16 -28.03 64.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.08 0.4 . . . . 1.95 112.08 -175.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -94.08 -51.58 4.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.919 0.34 . . . . 3.99 111.919 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -81.77 -31.69 31.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.941 0.349 . . . . 2.21 111.941 -172.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.13 -21.98 43.21 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.676 -0.773 . . . . 0.69 112.674 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -82.35 166.59 19.32 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 109.467 -0.568 . . . . 2.42 109.467 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.537 ' HB2' HG11 ' A' ' 45' ' ' VAL . 11.4 m -104.93 -177.66 3.43 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.577 -0.449 . . . . 1.08 111.008 -177.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.6 m -147.82 144.84 28.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.455 -0.572 . . . . 0.87 109.455 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.937 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -84.59 120.59 26.53 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.969 0.414 . . . . 0.17 110.647 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.4 m -117.7 146.02 44.02 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.528 -0.76 . . . . 0.68 109.738 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.4 m120 56.6 74.45 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.677 0.611 . . . . 1.82 110.766 -175.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 72' ' ' GLU . 76.1 t -86.93 110.44 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.634 -0.712 . . . . 0.32 110.991 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.59 148.82 24.77 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.706 -0.679 . . . . 1.12 110.833 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.92 122.58 26.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.197 -0.668 . . . . 1.33 109.197 174.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.9 mm -118.16 137.25 52.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.09 0.471 . . . . 0.28 111.352 -177.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -113.34 143.24 44.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.015 -0.735 . . . . 2.57 109.015 173.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 120.873 0.368 . . . . 3.08 110.993 179.015 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 111.797 -0.521 . . . . 18.87 111.797 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.27 114.46 20.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.753 0.311 . . . . 17.7 110.605 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -126.0 143.57 51.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.975 -0.557 . . . . 17.44 110.387 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.93 165.78 12.01 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.79 -0.719 . . . . 14.34 112.036 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -149.63 135.25 18.5 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.981 -0.377 . . . . 13.69 109.981 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.22 145.02 27.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.323 -0.399 . . . . 11.39 110.069 -178.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 9' ' ' PHE . 21.4 t -67.99 -40.45 83.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.141 -0.481 . . . . 8.82 110.502 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.0 m 59.36 26.85 15.8 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.37 -0.832 . . . . 7.95 111.167 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.523 ' HB2' HG12 ' A' ' 7' ' ' VAL . 79.2 t80 -76.55 -35.04 58.45 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.563 0.696 . . . . 7.07 109.716 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.429 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 6.5 ppt_? -150.43 133.0 15.74 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.164 -0.926 . . . . 6.67 109.564 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.7 110.26 19.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.862 0.363 . . . . 2.89 110.354 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -107.56 -9.98 15.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.065 -0.516 . . . . 3.29 111.188 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.53 10.05 16.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.466 -0.568 . . . . 2.96 109.466 172.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.5 t -53.8 -36.05 62.04 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.336 -0.847 . . . . 2.31 112.522 -171.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.68 50.94 62.24 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.659 -0.781 . . . . 1.86 111.972 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -68.0 156.03 38.22 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.661 -0.496 . . . . 5.03 109.661 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.95 -16.56 1.94 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.321 0.859 . . . . 2.37 113.321 -173.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.9 -18.82 64.17 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.667 0.247 . . . . 2.38 111.667 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.0 t -154.64 132.41 11.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 2.75 110.696 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.1 p -164.83 139.62 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.026 -0.534 . . . . 1.88 110.491 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -135.06 164.76 26.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.988 -0.375 . . . . 2.71 109.988 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 74' ' ' SER . . . 63.08 21.54 12.93 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.474 0.484 . . . . 1.95 111.842 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t 60.55 70.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.997 -0.547 . . . . 1.72 110.644 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.75 20.96 0.38 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.056 1.342 . . . . 2.92 114.19 176.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.53 HE21 ' HE3' ' A' ' 27' ' ' LYS . 62.9 tp60 -104.52 112.34 25.37 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.667 -0.413 . . . . 1.34 112.008 -174.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -111.83 135.53 52.32 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.517 -0.549 . . . . 2.11 109.517 172.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HE3' HE21 ' A' ' 25' ' ' GLN . 28.7 mmtp -112.76 144.88 41.55 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.106 -0.702 . . . . 1.27 109.106 172.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 4.1 mtm180 -121.74 127.59 50.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.051 0.453 . . . . 1.65 110.846 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.67 179.65 9.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.39 -0.823 . . . . 0.08 110.059 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.81 144.05 30.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.547 -0.297 . . . . 0.14 110.566 -178.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.506 ' CG1' ' HA ' ' A' ' 67' ' ' PRO . 43.4 t -65.08 115.73 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.827 -0.434 . . . . 0.14 109.827 175.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.73 -48.68 58.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.082 -0.508 . . . . 0.6 110.079 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 m -159.64 160.64 34.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.632 -0.713 . . . . 1.07 109.687 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.43 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 11.5 mt -138.09 130.79 40.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.426 -0.583 . . . . 0.19 109.426 173.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -129.88 94.73 3.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.648 -0.706 . . . . 1.56 110.242 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.45 -106.04 1.56 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.815 -0.707 . . . . 0.29 112.554 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -100.86 13.64 34.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.521 -0.178 . . . . 2.1 110.521 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -133.18 142.39 48.59 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.201 0.524 . . . . 0.32 111.381 -174.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 53' ' ' PHE . . . -126.48 157.4 20.27 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 111.002 -0.839 . . . . 0.11 111.002 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -130.86 149.3 52.56 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.438 -0.578 . . . . 0.18 109.438 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 73' ' ' PHE . 5.9 mt -124.38 148.64 47.4 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.812 -0.81 . . . . 0.59 108.812 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 62.4 t30 -78.05 72.9 4.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.578 0.704 . . . . 1.53 109.731 -178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -139.47 98.75 3.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.952 -1.022 . . . . 0.28 109.104 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 50.6 mt-10 -84.82 101.2 12.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.612 0.72 . . . . 1.81 110.356 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 84' ' ' SER . 34.1 m -81.12 -32.0 12.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.911 -1.04 . . . . 0.85 110.622 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 5.5 tp10 -134.09 177.47 7.71 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.77 -1.937 . . . . 2.24 105.77 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.499 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 26.4 t0 -39.78 84.93 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.119 0.968 . . . . 1.55 113.44 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 46' ' ' GLU . . . 73.26 8.29 74.47 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.751 -0.54 . . . . 0.67 111.751 174.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 44' ' ' GLU . 9.0 mmtm -67.53 110.32 3.61 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.831 -0.184 . . . . 2.5 110.686 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 8.9 tppt? -79.53 123.7 27.82 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.12 -0.696 . . . . 1.32 109.12 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 51' ' ' LEU . 1.7 mt -61.06 136.03 57.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.585 -0.279 . . . . 0.19 111.046 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -118.3 160.7 21.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.404 . . . . 0.39 110.54 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.669 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 28.6 p90 -150.38 153.74 36.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.711 -0.677 . . . . 0.16 109.509 173.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -92.34 147.29 23.03 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.621 -0.881 . . . . 0.34 108.621 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.456 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 11.6 tmm? -59.3 -15.57 16.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.997 -0.547 . . . . 2.43 112.175 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 t -64.33 -29.25 70.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.785 0.326 . . . . 0.91 110.189 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -91.27 -3.79 56.55 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.539 -0.3 . . . . 1.96 111.161 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.827 HG22 HD13 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -63.21 152.0 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.944 -0.571 . . . . 0.27 111.053 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.502 ' HG2' HD13 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -67.38 96.93 0.53 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.118 -0.492 . . . . 1.6 111.417 -176.599 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.36 -99.13 0.13 Allowed Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.611 0.57 . . . . 0.58 113.578 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -88.79 140.3 29.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.779 0.799 . . . . 2.2 110.41 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.4 p -75.43 -19.81 59.25 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.102 -0.954 . . . . 0.95 111.219 -174.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.1 t -90.31 7.51 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.673 . . . . 1.39 109.717 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -102.73 -13.92 16.86 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.966 -0.561 . . . . 0.57 110.76 177.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.827 HD13 HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -121.83 123.4 41.68 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.244 -0.65 . . . . 1.51 109.244 -177.439 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -135.4 159.01 73.28 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.661 0.267 . . . . 0.91 111.444 -174.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.506 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 30.7 Cg_endo -64.78 129.86 24.6 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.132 1.888 . . . . 0.28 111.94 175.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.15 -16.1 54.0 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.939 -0.648 . . . . 0.22 111.823 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -79.21 147.23 32.69 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.909 -0.404 . . . . 1.28 109.909 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 92' ' ' ILE . 5.5 m -76.31 137.48 39.89 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.735 -0.839 . . . . 0.17 108.735 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.465 HG11 HD21 ' A' ' 65' ' ' LEU . 28.5 m -139.42 159.18 28.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 O-C-N 122.205 -0.31 . . . . 0.31 110.504 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.757 ' HG2' ' HB2' ' A' ' 90' ' ' LEU . 10.4 pt-20 -115.63 144.97 43.15 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.605 -0.887 . . . . 0.78 108.605 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.584 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 17.8 p90 -148.05 178.89 8.16 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.501 -0.772 . . . . 0.11 109.431 -172.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 22' ' ' ALA . 18.2 m -125.65 126.01 44.02 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.817 -0.808 . . . . 0.86 108.817 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 75' ' ' VAL . 8.3 p -90.02 98.69 8.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 122.058 0.932 . . . . 0.36 111.165 -171.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.0 p -106.77 131.11 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.57 -0.741 . . . . 0.42 109.662 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.4 m -77.9 132.28 37.86 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.904 -0.589 . . . . 0.67 111.627 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.61 122.36 24.53 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.584 -0.525 . . . . 1.82 109.584 173.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -69.73 -5.11 22.95 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.422 0.527 . . . . 1.95 112.422 -174.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.16 -60.94 1.83 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.998 -0.371 . . . . 3.99 109.998 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 83' ' ' LYS . 18.9 m120 -96.62 -30.48 13.24 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.815 0.341 . . . . 2.21 111.576 -173.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.44 -3.17 63.4 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.545 -0.836 . . . . 0.69 111.253 -171.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.46 ' HG2' ' HB2' ' A' ' 81' ' ' ASN . 60.1 pttt -79.02 144.72 34.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.322 -0.621 . . . . 2.42 109.322 175.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.504 ' HB2' HG11 ' A' ' 45' ' ' VAL . 9.8 m -89.56 177.56 6.52 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.393 0.616 . . . . 1.08 111.894 -174.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.9 m -149.04 153.74 38.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.98 -1.009 . . . . 0.87 109.322 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . . . -93.89 121.88 35.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.979 0.419 . . . . 0.17 109.998 177.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.7 t -117.35 157.42 26.18 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.167 -1.049 . . . . 0.68 108.167 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.4 t30 55.77 63.99 1.88 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.793 0.683 . . . . 1.82 109.764 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.622 HG12 HD11 ' A' ' 65' ' ' LEU . 78.4 t -83.77 118.41 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.36 -0.836 . . . . 0.32 111.276 -176.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.757 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 4.2 mm? -112.93 148.56 34.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.261 -0.427 . . . . 1.12 110.943 -178.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -83.49 116.17 22.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.408 0.623 . . . . 1.33 111.216 178.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.462 ' O ' ' HB ' ' A' ' 70' ' ' THR . 48.7 mm -104.95 115.12 46.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.305 -0.861 . . . . 0.28 109.926 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -96.54 107.14 19.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.611 -0.722 . . . . 2.57 110.537 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.554 -0.748 . . . . 3.08 111.172 -176.965 . . . . . . . . 0 0 . 1 stop_ save_